2025/04/30 更新

写真a

タナカ フミアキ
田中 章景
Fumiaki Tanaka
所属
医学研究科 医科学専攻 神経内科学・脳卒中医学 主任教授
医学部 医学科
職名
主任教授
プロフィール
筋萎縮性側索硬化症、脊髄小脳変性症、ポリグルタミン病をはじめとする神経変性疾患、多発性硬化症を中心とした神経免疫疾患の分子病態解明研究を行っている。また、パーキンソン病およびその関連疾患、脊髄小脳変性症を中心に画像解析、高次脳機能解析などの臨床研究も推進している。
外部リンク

学位

  • 医学博士 ( 名古屋大学 )

研究キーワード

  • Elucidation of Pathogenesis of Neurodegenerative Disorders

  • 神経変性疾患の病態解明と治療法開発

研究分野

  • ライフサイエンス / 神経内科学

  • ライフサイエンス / 病態医化学

  • ライフサイエンス / 医化学

学歴

  • 名古屋大学   医学部   医学科

    1980年 - 1986年

      詳細を見る

    国名: 日本国

    researchmap

  • 名古屋大学

    - 1986年

      詳細を見る

経歴

  • 横浜市立大学

    2012年 - 現在

      詳細を見る

  • 名古屋大学

    2007年 - 2012年

      詳細を見る

  • - Associate Professor of Neurology, Nagoya University

    2007年

      詳細を見る

  • COE Associate Professor of Nagoya University

    2007年

      詳細を見る

  • COE Associate Professor of Nagoya University

    2005年 - 2007年

      詳細を見る

  • 名古屋大学

    2005年 - 2007年

      詳細を見る

  • 名古屋大学

    2003年 - 2005年

      詳細を見る

  • Visiting Associate Professor of Nagoya University

    2003年 - 2005年

      詳細を見る

  • 米国国立衛生研究所(NIH)神経遺伝学部門 客員科学者

    1999年 - 2002年

      詳細を見る

  • Visiting Scientist, Neurogenetics Branch, National Institute of Health (NIH), USA

    1999年 - 2002年

      詳細を見る

▼全件表示

所属学協会

委員歴

  • 日本神経学会   評議員  

    2006年   

      詳細を見る

    団体区分:学協会

    日本神経学会

    researchmap

  • 日本末梢神経学会   評議員  

    2005年   

      詳細を見る

    団体区分:学協会

    日本末梢神経学会

    researchmap

論文

  • Siponimod inhibits microglial inflammasome activation. 国際誌

    Hiroyasu Komiya, Hideyuki Takeuchi, Akihiro Ogasawara, Yuki Ogawa, Shun Kubota, Shunta Hashiguchi, Keita Takahashi, Misako Kunii, Kenichi Tanaka, Mikiko Tada, Hiroshi Doi, Fumiaki Tanaka

    Neuroscience research   2025年2月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Siponimod is the first oral drug approved for active secondary progressive multiple sclerosis. It acts as a functional antagonist of sphingosine-1-phosphate (S1P) receptor 1 (S1P1) through S1P1 internalization, and also serves an agonist of S1P5; however, the detailed mechanisms of its therapeutic effects on glial cells have yet to be elucidated. In this study, we investigated the anti-inflammatory mechanism of siponimod in microglia. Pretreatment with either siponimod or the S1P1 antagonist W146 significantly suppressed the production of interleukin-1β in activated microglia stimulated with lipopolysaccharide plus nigericin, an inflammasome activator. Furthermore, siponimod treatment reduced the protein levels of cleaved caspase-1 and inhibited the formation of aggregates of apoptosis-associated speck-like protein containing a C-terminal caspase recruitment domain (ASC specks) in microglia. Our data indicate that siponimod achieves its anti-inflammatory effects by inhibiting inflammasome activation in microglia via S1P1 antagonism. This process is inferred to play a crucial role in mitigating the secondary progression of multiple sclerosis, where microglial activation in the gray matter is considered a key pathological factor.

    DOI: 10.1016/j.neures.2025.02.002

    PubMed

    researchmap

  • Collet-Sicard症候群を呈したAnterior Condylar Confluence硬膜動静脈瘻の77歳男性例

    西濱 脩平, 古宮 裕泰, 浅野 徹也, 橋口 俊太, 高橋 慶太, 東山 雄一, 土井 宏, 田中 章景

    臨床神経学   65 ( 1 )   56 - 56   2025年1月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • A case report of an individual with Creutzfeldt-Jakob disease characterized by prolonged isolated thalamic lesions and rare MM2-cortical-type pathology. 国際誌

    Misako Kunii, Hitaru Kishida, Mikiko Tada, Mitsuo Okamoto, Keiichiro Asano, Haruko Nakamura, Keita Takahashi, Shunta Hashiguchi, Shun Kubota, Masaki Okubo, Hideyuki Takeuchi, Naohisa Ueda, Katsuya Satoh, Tetsuyuki Kitamoto, Hiroshi Doi, Fumiaki Tanaka

    BMC neurology   24 ( 1 )   456 - 456   2024年11月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    BACKGROUND: Diffusion-weighted magnetic resonance imaging (DWI) is essential for diagnosing Creutzfeldt-Jakob disease (CJD). Thalamic lesions are rarely detected by DWI in sporadic CJD (sCJD) cases with methionine homozygosity at polymorphic codon 129 (129MM) of the prion protein (PrP) gene. Here, we describe an unusual sCJD case, characterized by prolonged isolated thalamic diffusion hyperintensities and atypical brain pathology, in combination with the 129MM genotype. CASE PRESENTATION: A 72-year-old Japanese man developed a mild unsteady gait that had persisted for 1 year. DWI revealed isolated thalamic diffusion hyperintensities. Over the following 4 years, his condition progressed to include ataxia and cognitive decline. Repeated cerebrospinal fluid tests were negative for 14-3-3 protein, total tau protein, and real-time quaking-induced conversion assay. Electroencephalography did not show periodic sharp wave complexes or generalized periodic discharges. Despite these findings, thalamic DWI abnormalities persisted and evolved to include cortical lesions in the later stage of the disease. Genetic testing confirmed a 129MM genotype with no pathogenic PrP gene variants. Brain autopsy identified type 2 pathogenic PrP and the absence of the M2-thalamic prion strain, suggesting an MM2-cortical (MM2C)-subtype of sCJD. Histopathology revealed small vacuoles (sv) and patchy-perivacuolar PrP deposits without large vacuoles (lv). Patchy-perivacuolar deposits are a characteristic feature of the MM2C (lv) subtype and indicate MM2C (lv) pathology. Thus, this case was classified as a rare MM2C (sv + lv) subtype. No PrP protein staining was observed in the thalamus, despite spongiform changes with small vacuoles. CONCLUSIONS: This case underscores the diagnostic challenges of atypical CJD with isolated thalamic abnormalities on DWI. Despite negative cerebrospinal fluid findings and clinical diagnostic criteria, persistent DWI abnormalities and evolving clinical symptoms continued to raise suspicion of CJD. A definitive diagnosis, being the MM2C (sv + lv) subtype of sCJD, was confirmed upon pathological examination. Even when atypical findings, such as isolated thalamic abnormalities, are observed and various tests are negative, if suspicion of CJD cannot be ruled out, it is important to confirm the diagnosis and pathological subtypes via postmortem analysis.

    DOI: 10.1186/s12883-024-03958-9

    PubMed

    researchmap

  • UCHL1ヘテロ接合性ナンセンスバリアントを認めた成人発症SPG79の74歳男性例

    豊田 夏実, 古宮 裕泰, 橋口 俊太, 宮地 洋輔, 東山 雄一, 松本 直通, 土井 宏, 田中 章景

    臨床神経学   64 ( 11 )   836 - 836   2024年11月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • Correlation between clinical and neuropathological subtypes of progressive supranuclear palsy. 国際誌

    Ryuichi Koizumi, Akio Akagi, Yuichi Riku, Hiroaki Miyahara, Jun Sone, Fumiaki Tanaka, Mari Yoshida, Yasushi Iwasaki

    Parkinsonism & related disorders   127   106076 - 106076   2024年10月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    INTRODUCTION: Progressive supranuclear palsy (PSP) is characterized by pathology prominently in the basal ganglia, the tegmentum of the brainstem, and the frontal cortex. However, pathology varies according to clinical features. This study aimed to statistically verify the correspondence between the clinical and pathological subtypes of PSP. METHODS: We identified patients with a pathological diagnosis of PSP and classified the eight clinical subtypes of the Movement Disorders Society criteria for the clinical diagnosis of PSP (MDS-PSP criteria) into the Richardson, Akinesia, and Cognitive groups. We used anti-phosphorylated tau antibody immunostaining to semi-quantitatively evaluate neurofibrillary tangles (NFTs) and coiled bodies/threads (CB/Ths) in the globus pallidus, subthalamic nucleus, and midbrain tegmentum. In the frontal cortex, tufted astrocytes (TAs) and CB/Ths were assessed on a 3-point scale. We compared the pathology among the three groups, recorded the phenotypes ranked the second and lower in the multiple allocation extinction rule and examined whether the pathology changed depending on applying each phenotype. RESULTS: The Richardson group exhibited severe NFTs and CB/Ths in the midbrain tegmentum. The Akinesia group showed severe NFTs in the globus pallidus. The Cognitive group had severe TAs and CB/Ths in the frontal cortex. TAs and CB/Ths in the frontal cortex correspond to behavioral variant frontotemporal dementia, and supranuclear vertical oculomotor palsy. CONCLUSION: These clinical symptoms may reflect the distribution of tau pathologies in PSP.

    DOI: 10.1016/j.parkreldis.2024.106076

    PubMed

    researchmap

  • 全身炎症に伴うCCR2陽性マクロファージの中枢神経浸潤がALS病態を促進する

    小笠原 陽大, 竹内 英之, 古宮 裕泰, 小川 有紀, 池田 拓也, 高橋 慶太, 大久保 正紀, 橋口 俊太, 中村 治子, 土井 宏, 田中 章景

    神経免疫学   29 ( 1 )   253 - 253   2024年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経免疫学会  

    researchmap

  • 髄液LOTUS濃度を用いた多発性硬化症の病勢把握

    中澤 謙介, 高橋 慶太, 池田 拓也, 古宮 裕泰, 窪田 瞬, 橋口 俊太, 中村 治子, 田中 健一, 土井 宏, 竹内 英之, 田中 章景

    臨床神経学   64 ( Suppl. )   S331 - S331   2024年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 広範なミオキミアを呈した成人発症遺伝性痙性対麻痺(SPG79)の74歳男性例

    豊田 夏実, 古宮 裕泰, 橋口 俊太, 東山 雄一, 宮地 洋輔, 松本 直通, 土井 宏, 田中 章景

    臨床神経生理学   52 ( 5 )   610 - 610   2024年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本臨床神経生理学会  

    researchmap

  • MS【WS2】髄液LOTUS濃度のELISA法を用いた測定によるMSの病勢把握の試み

    高橋 慶太, 中澤 謙介, 池田 拓也, 古宮 裕泰, 土井 宏, 竹内 英之, 田中 章景

    神経免疫学   29 ( 1 )   211 - 211   2024年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経免疫学会  

    researchmap

  • 成人の脊髄性筋萎縮症5例におけるヌシネルセン治療の長期的な有効性と評価法の検討

    高橋 慶太, 岸田 日帯, 中澤 謙介, 池田 拓也, 宮地 洋輔, 竹内 英之, 土井 宏, 上田 直久, 田中 章景

    臨床神経学   64 ( Suppl. )   S348 - S348   2024年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 抗AQP4抗体・オリゴクローナルバンドが陽性であった中枢脱髄性疾患に対しオファツムマブを開始した一例

    小林 卓雄, 岸田 日帯, 西村 直暁, 渡邉 裕樹, 安部 克哉, 木村 活生, 上田 直久, 田中 章景

    神経免疫学   29 ( 1 )   246 - 246   2024年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経免疫学会  

    researchmap

  • 原発性進行性失語症におけるBouba-Kiki効果と,その神経基盤についての検討

    小林 絵礼奈, 東山 雄一, 伊東 毅, 森原 啓介, 林 紀子, 宮地 洋輔, 木村 活生, 岸田 日帯, 土井 宏, 上田 直久, 田中 章景

    臨床神経学   64 ( Suppl. )   S260 - S260   2024年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 筋萎縮性側索硬化症の診断におけるルーチンF波検査でのsplit hand indexの有用性

    宮地 洋輔, 森口 紗矢香, 佐藤 瞳, 林 紀子, 木村 活生, 岸田 日帯, 上田 直久, 伊東 毅, 小林 絵礼奈, 東山 雄一, 土井 宏, 田中 章景

    臨床神経学   64 ( Suppl. )   S329 - S329   2024年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • ここまで治せる不随意運動 ここまで治せるDBS ジストニア・不随意運動症に対する脳深部刺激療法の効果と適応

    木村 活生, 岸田 日帯, 上田 直久, 田中 章景

    臨床神経学   64 ( Suppl. )   S70 - S70   2024年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 病巣・ネットワーク解析を用いた,脳卒中による書字障害の神経基盤についての検討

    伊東 毅, 東山 雄一, 小林 絵礼奈, 森原 啓介, 浜田 智哉, 浦野 雅世, 林 紀子, 宮地 洋輔, 木村 活生, 岸田 日帯, 土井 宏, 上田 直久, 城倉 健, 田中 章景

    臨床神経学   64 ( Suppl. )   S260 - S260   2024年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • ヌシネルセンナトリウムからリスジプラムへ変更した脊髄性筋萎縮症の5症例

    岸田 日帯, 林 紀子, 木村 活生, 安部 克哉, 小林 卓雄, 渡邉 裕樹, 豊田 夏実, 西村 直暁, 高橋 慶太, 宮地 洋輔, 東山 雄一, 土井 宏, 上田 直久, 田中 章景

    臨床神経学   64 ( Suppl. )   S348 - S348   2024年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • Multi-omics analysis using antibody-based in situ biotinylation technique suggests the mechanism of Cajal body formation

    Keisuke Noguchi, Hidefumi Suzuki, Ryota Abe, Keiko Horiuchi, Rena Onoguchi-Mizutani, Nobuyoshi Akimitsu, Shintaro Ogawa, Tomohiko Akiyama, Yoko Ike, Yoko Ino, Yayoi Kimura, Akihide Ryo, Hiroshi Doi, Fumiaki Tanaka, Yutaka Suzuki, Atsushi Toyoda, Yuki Yamaguchi, Hidehisa Takahashi

    Cell Reports   43 ( 9 )   2024年9月

     詳細を見る

    掲載種別:研究論文(学術雑誌)  

    Membrane-less subcellular compartments play important roles in various cellular functions. Although techniques exist to identify components of cellular bodies, a comprehensive method for analyzing both static and dynamic states has not been established. Here, we apply an antibody-based in situ biotinylation proximity-labeling technique to identify components of static and dynamic nuclear bodies. Using this approach, we comprehensively identify DNA, RNA, and protein components of Cajal bodies (CBs) and then clarify their interactome. By inhibiting transcription, we capture dynamic changes in CBs. Our analysis reveals that nascent small nuclear RNAs (snRNAs) transcribed in CBs contribute to CB formation by assembling RNA-binding proteins, including frontotemporal dementia-related proteins, RNA-binding motif proteins, and heterogeneous nuclear ribonucleoproteins.

    DOI: 10.1016/j.celrep.2024.114734

    Scopus

    PubMed

    researchmap

  • Hereditary spastic paraplegia and extensive leukoencephalopathy: a case report of a unique phenotype associated with a GJB1/Cx32 p.Pro174Ser variant. 国際誌

    Haruko Nakamura, Hiroshi Doi, Yosuke Miyaji, Taishi Wada, Erisa Takahashi, Mikiko Tada, Hiromi Fukuda, Atsushi Fujita, Yuichi Higashiyama, Yuri Nagao, Kazue Kimura, Masaharu Hayashi, Kyoko Hoshino, Naomichi Matsumoto, Fumiaki Tanaka

    BMC neurology   24 ( 1 )   310 - 310   2024年9月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    BACKGROUND: Pathogenic variants in Gap junction protein beta 1 (GJB1), which encodes Connexin 32, are known to cause X-linked Charcot-Marie-Tooth disease (CMTX), the second most common form of CMT. CMTX presents with the following five central nervous systems (CNS) phenotypes: subclinical electrophysiological abnormalities, mild fixed abnormalities on neurological examination and/or imaging, transient CNS dysfunction, cognitive impairment, and persistent CNS manifestations. CASE PRESENTATION: A 40-year-old Japanese male showed CNS symptoms, including nystagmus, prominent spastic paraplegia, and mild cerebellar ataxia, accompanied by subclinical peripheral neuropathy. Brain magnetic resonance imaging revealed hyperintensities in diffusion-weighted images of the white matter, particularly along the pyramidal tract, which had persisted since childhood. Nerve conduction assessment showed a mild decrease in motor conduction velocity, and auditory brainstem responses beyond wave II were absent. Peripheral and central conduction times in somatosensory evoked potentials elicited by stimulation of the median nerve were prolonged. Genetic analysis identified a hemizygous GJB1 variant, NM_000166.6:c.520C > T p.Pro174Ser. CONCLUSIONS: The patient in the case described here, with a GJB1 p.Pro174Ser variant, presented with a unique CNS-dominant phenotype, characterized by spastic paraplegia and persistent extensive leukoencephalopathy, rather than CMTX. Similar phenotypes have also been observed in patients with GJC2 and CLCN2 variants, likely because of the common function of these genes in regulating ion and water balance, which is essential for maintaining white matter function. CMTX should be considered within the spectrum of GJB1-related disorders, which can include patients with predominant CNS symptoms, some of which can potentially be classified as a new type of spastic paraplegia.

    DOI: 10.1186/s12883-024-03823-9

    PubMed

    researchmap

  • 脊髄小脳変性症のすべて 脊髄小脳変性症 病気の理解と最新の治療について

    橋口 俊太, 土井 宏, 田中 章景

    難病と在宅ケア   30 ( 6 )   28 - 31   2024年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)日本プランニングセンター  

    researchmap

  • ジストニア遺伝子/ジストニア治療/カタプレキシー ジストニア治療

    木村 活生, 岸田 日帯, 安部 克哉, 川崎 隆, 上田 直久, 田中 章景

    パーキンソン病・運動障害疾患コングレスプログラム・抄録集   18回   65 - 65   2024年7月

     詳細を見る

    記述言語:日本語   出版者・発行元:Movement Disorder Society of Japan (MDSJ)  

    researchmap

  • ホスレボドパ・ホスカルビドパ持続皮下注射導入患者の特徴

    安部 克哉, 木村 活生, 渡邉 裕樹, 小林 卓雄, 岸田 日帯, 上田 直久, 田中 章景

    パーキンソン病・運動障害疾患コングレスプログラム・抄録集   18回   88 - 88   2024年7月

     詳細を見る

    記述言語:日本語   出版者・発行元:Movement Disorder Society of Japan (MDSJ)  

    researchmap

  • 局所損傷・変性疾患・発達障害の比較神経心理学 局所損傷と変性疾患における病巣-症候連関 言語障害を例に

    東山 雄一, 田中 章景

    神経心理学   40 ( 2 )   115 - 125   2024年6月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本神経心理学会  

    researchmap

  • Complete nanopore repeat sequencing of SCA27B (GAA-FGF14 ataxia) in Japanese. 国際誌

    Satoko Miyatake, Hiroshi Doi, Hiroaki Yaguchi, Eriko Koshimizu, Naoki Kihara, Tomoyasu Matsubara, Yasuko Mori, Kenjiro Kunieda, Yusaku Shimizu, Tomoko Toyota, Shinichi Shirai, Masaaki Matsushima, Masaki Okubo, Taishi Wada, Misako Kunii, Ken Johkura, Ryosuke Miyamoto, Yusuke Osaki, Takabumi Miyama, Mai Satoh, Atsushi Fujita, Yuri Uchiyama, Naomi Tsuchida, Kazuharu Misawa, Kohei Hamanaka, Haruka Hamanoue, Takeshi Mizuguchi, Hiroyuki Morino, Yuishin Izumi, Takayoshi Shimohata, Kunihiro Yoshida, Hiroaki Adachi, Fumiaki Tanaka, Ichiro Yabe, Naomichi Matsumoto

    Journal of neurology, neurosurgery, and psychiatry   2024年5月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    BACKGROUND: Although pure GAA expansion is considered pathogenic in SCA27B, non-GAA repeat motif is mostly mixed into longer repeat sequences. This study aimed to unravel the complete sequencing of FGF14 repeat expansion to elucidate its repeat motifs and pathogenicity. METHODS: We screened FGF14 repeat expansion in a Japanese cohort of 460 molecularly undiagnosed adult-onset cerebellar ataxia patients and 1022 controls, together with 92 non-Japanese controls, and performed nanopore sequencing of FGF14 repeat expansion. RESULTS: In the Japanese population, the GCA motif was predominantly observed as the non-GAA motif, whereas the GGA motif was frequently detected in non-Japanese controls. The 5'-common flanking variant was observed in all Japanese GAA repeat alleles within normal length, demonstrating its meiotic stability against repeat expansion. In both patients and controls, pure GAA repeat was up to 400 units in length, whereas non-pathogenic GAA-GCA repeat was larger, up to 900 units, but they evolved from different haplotypes, as rs534066520, located just upstream of the repeat sequence, completely discriminated them. Both (GAA)≥250 and (GAA)≥200 were enriched in patients, whereas (GAA-GCA)≥200 was similarly observed in patients and controls, suggesting the pathogenic threshold of (GAA)≥200 for cerebellar ataxia. We identified 14 patients with SCA27B (3.0%), but their single-nucleotide polymorphism genotype indicated different founder alleles between Japanese and Caucasians. The low prevalence of SCA27B in Japanese may be due to the lower allele frequency of (GAA)≥250 in the Japanese population than in Caucasians (0.15% vs 0.32%-1.26%). CONCLUSIONS: FGF14 repeat expansion has unique features of pathogenicity and allelic origin, as revealed by a single ethnic study.

    DOI: 10.1136/jnnp-2024-333541

    PubMed

    researchmap

  • (IV章)運動神経疾患類縁 脊髄性筋萎縮症/球脊髄性筋萎縮症

    岸田 日帯, 田中 章景

    脳神経内科学レビュー   2024-'25   160 - 168   2024年5月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)総合医学社  

    <最近の動向とガイドライン>●脊髄性筋萎縮症(SMA)と球脊髄性筋萎縮症(SBMA)は,いずれも下位運動ニューロン障害による筋萎縮・筋力低下を主症状とする遺伝性神経変性疾患である.神経変性疾患のなかでは,いずれも早期に疾患修飾薬が登場したSMA,SBMAともに,新たな病態解明に基づく次なる治療開発研究が進められている.●SMAでは,疾患修飾薬の優れた有効性が明らかとなったことより,特に早期診断・治療の重要性が増し,さまざまな国や地域で新生児スクリーニング検査が開始されている.発症前もしくは発症後早期の治療が疾患の経過を大きく変える時代となり,今後は成書に記載されていた疾患分類や自然史が書き換わっていくことになろう.また,さらなる病態解明につながる基礎研究も活発になっており,新たな治療薬のシーズの発見が期待されている.●SBMAは,筋萎縮・筋力低下だけでなく,振戦や感覚障害,嚥下障害のほか,女性化乳房,耐糖能異常,脂質異常症,肝機能障害,ブルガダ症候群など多彩な臓器障害を合併する神経疾患である.2017年8月にわが国でリュープロレリン治療が承認され,嚥下障害の進行抑制などで一定の効果が得られている.また,基礎研究から新たな病態が明らかになっており,新規治療薬への期待が高まっている.(著者抄録)

    researchmap

  • パーキンソン病の軽度認知障害診断における語流暢性課題の役割とその神経基盤の検討

    浜田 智哉, 東山 雄一, 森原 啓介, 田中 章景

    高次脳機能研究   44 ( 1 )   58 - 58   2024年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本高次脳機能学会  

    researchmap

  • 原発性進行性失語症におけるBouba-Kiki効果についての検討

    小林 絵礼奈, 東山 雄一, 伊東 毅, 森原 啓介, 土井 宏, 田中 章景

    高次脳機能研究   44 ( 1 )   71 - 72   2024年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本高次脳機能学会  

    researchmap

  • 網膜色素変性症および繰り返す脳卒中様発作で発症した神経核内封入体病の82歳女性例

    小林 怜右, 橋口 俊太, 柳泉 茉由莉, 武田 むつき, 小林 絵礼奈, 古宮 裕泰, 東山 雄一, 田中 章景

    臨床神経学   64 ( 3 )   212 - 212   2024年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • Adaptive DBSにおけるLFPの解析により,オフ症状が非運動性であると鑑別できたParkinson病の55歳女性例

    渡邉 裕樹, 木村 活生, 安部 克哉, 岸田 日帯, 川崎 隆, 坂田 勝巳, 上田 直久, 田中 章景

    臨床神経学   64 ( 1 )   48 - 48   2024年1月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • Granuloma, vasculitis, and demyelination in sarcoid neuropathy. 国際誌

    Naohiro Mouri, Haruki Koike, Yuki Fukami, Mie Takahashi, Satoru Yagi, Soma Furukawa, Masashi Suzuki, Yoshiyuki Kishimoto, Kenichiro Murate, Takamasa Nukui, Tamaki Yoshida, Yosuke Kudo, Mikiko Tada, Yuichi Higashiyama, Hirohisa Watanabe, Yuji Nakatsuji, Fumiaki Tanaka, Masahisa Katsuno

    European journal of neurology   31 ( 1 )   e16091   2024年1月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    BACKGROUND: Despite the suggestion that direct compression by granuloma and ischemia resulting from vasculitis can cause nerve fiber damage, the mechanisms underlying sarcoid neuropathy have not yet been fully clarified. METHODS: We examined the clinicopathological features of sarcoid neuropathy by focusing on electrophysiological and histopathological findings of sural nerve biopsy specimens. We included 18 patients with sarcoid neuropathy who had non-caseating epithelioid cell granuloma in their sural nerve biopsy specimens. RESULTS: Although electrophysiological findings suggestive of axonal neuropathy were observed, particularly in the lower limbs, all but three patients showed ≥1 abnormalities in nerve conduction velocity or distal motor latency. Additionally, a conduction block was observed in 11 of the 16 patients for whom waveforms were assessed; five of them fulfilled motor nerve conduction criteria strongly supportive of demyelination as defined in the European Academy of Neurology/Peripheral Nerve Society (EAN/PNS) guideline for chronic inflammatory demyelinating polyneuropathy (CIDP). In most patients, sural nerve biopsy specimens revealed a mild to moderate degree of myelinated fiber loss. Fibrinoid necrosis was observed in one patient, and electron microscopy analysis revealed demyelinated axons close to granulomas in six patients. CONCLUSIONS: Patients with sarcoid neuropathy may meet the EAN/PNS electrophysiological criteria for CIDP due to the frequent presence of conduction blocks. Based on our results, in addition to the ischemic damage resulting from granulomatous inflammation, demyelination may play an important role in the mechanism underlying sarcoid neuropathy.

    DOI: 10.1111/ene.16091

    PubMed

    researchmap

  • Lateral olfactory tract usher substance (LOTUS), an endogenous Nogo receptor antagonist, ameliorates disease progression in amyotrophic lateral sclerosis model mice. 国際誌

    Takuya Ikeda, Keita Takahashi, Minatsu Higashi, Hiroyasu Komiya, Tetsuya Asano, Akihiro Ogasawara, Shun Kubota, Shunta Hashiguchi, Misako Kunii, Kenichi Tanaka, Mikiko Tada, Hiroshi Doi, Hideyuki Takeuchi, Kohtaro Takei, Fumiaki Tanaka

    Cell death discovery   9 ( 1 )   454 - 454   2023年12月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Nogo-Nogo receptor 1 (NgR1) signaling is significantly implicated in neurodegeneration in amyotrophic lateral sclerosis (ALS). We previously showed that lateral olfactory tract usher substance (LOTUS) is an endogenous antagonist of NgR1 that prevents all myelin-associated inhibitors (MAIs), including Nogo, from binding to NgR1. Here we investigated the role of LOTUS in ALS pathogenesis by analyzing G93A-mutated human superoxide dismutase 1 (SOD1) transgenic (Tg) mice, as an ALS model, as well as newly generated LOTUS-overexpressing SOD1 Tg mice. We examined expression profiles of LOTUS and MAIs and compared motor functions and survival periods in these mice. We also investigated motor neuron survival, glial proliferation in the lumbar spinal cord, and neuromuscular junction (NMJ) morphology. We analyzed downstream molecules of NgR1 signaling such as ROCK2, LIMK1, cofilin, and ataxin-2, and also neurotrophins. In addition, we investigated LOTUS protein levels in the ventral horn of ALS patients. We found significantly decreased LOTUS expression in both SOD1 Tg mice and ALS patients. LOTUS overexpression in SOD1 Tg mice increased lifespan and improved motor function, in association with prevention of motor neuron loss, reduced gliosis, increased NMJ innervation, maintenance of cofilin phosphorylation dynamics, decreased levels of ataxin-2, and increased levels of brain-derived neurotrophic factor (BDNF). Reduced LOTUS expression may enhance neurodegeneration in SOD1 Tg mice and ALS patients by activating NgR1 signaling, and in this study LOTUS overexpression significantly ameliorated ALS pathogenesis. LOTUS might serve as a promising therapeutic target for ALS.

    DOI: 10.1038/s41420-023-01758-7

    PubMed

    researchmap

  • RNA foci in two bi-allelic RFC1 expansion carriers. 国際誌

    Taishi Wada, Hiroshi Doi, Masaki Okubo, Mikiko Tada, Naohisa Ueda, Hidefumi Suzuki, Wakana Tominaga, Haruki Koike, Hiroyasu Komiya, Shun Kubota, Shunta Hashiguchi, Haruko Nakamura, Keita Takahashi, Misako Kunii, Kenichi Tanaka, Yosuke Miyaji, Yuichi Higashiyama, Eriko Koshimizu, Satoko Miyatake, Masahisa Katsuno, Satoshi Fujii, Hidehisa Takahashi, Naomichi Matsumoto, Hideyuki Takeuchi, Fumiaki Tanaka

    Annals of neurology   2023年12月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Cerebellar ataxia, neuropathy, vestibular areflexia syndrome (CANVAS) is a late-onset, autosomal recessive neurodegenerative disorder caused by biallelic AAGGG/ACAGG repeat expansion (AAGGG-exp/ACAGG-exp) in RFC1. The recent identification of patients with CANVAS exhibiting compound heterozygosity for AAGGG-exp and truncating variants supports the loss-of-function of RFC1 in CANVAS patients. We investigated the pathological changes in two autopsied patients with CANVAS harboring biallelic ACAGG-exp and AAGGG-exp. RNA fluorescence in situ hybridization of the two patients revealed CCTGT- and CCCTT-containing RNA foci, respectively, in neuronal nuclei of tissues with neuronal loss. Our findings suggest that RNA toxicity may be involved in the pathogenesis of CANVAS. This article is protected by copyright. All rights reserved.

    DOI: 10.1002/ana.26848

    PubMed

    researchmap

  • 両側声帯麻痺を呈し気管切開術を要したβプロペラ蛋白関連神経変性症(BPAN)の57歳女性例

    小林 怜右, 古宮 裕泰, 小林 絵礼奈, 橋口 俊太, 高橋 慶太, 東山 雄一, 土井 宏, 田中 章景

    臨床神経学   63 ( 11 )   775 - 775   2023年11月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 両側声帯麻痺を呈し気管切開術を要したβプロペラ蛋白関連神経変性症(BPAN)の57歳女性例

    小林 怜右, 古宮 裕泰, 小林 絵礼奈, 橋口 俊太, 高橋 慶太, 東山 雄一, 土井 宏, 田中 章景

    臨床神経学   63 ( 11 )   775 - 775   2023年11月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 筋萎縮性側索硬化症の診断におけるF波検査でのsplit hand所見の有用性

    宮地 洋輔, 森口 紗矢香, 佐藤 瞳, 林 紀子, 木村 活生, 岸田 日帯, 上田 直久, 伊東 毅, 小林 絵礼奈, 東山 雄一, 土井 宏, 田中 章景

    臨床神経生理学   51 ( 5 )   571 - 571   2023年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本臨床神経生理学会  

    researchmap

  • 皮膚生検後に外側腓腹皮神経障害を呈した水疱性類天疱瘡の1例 感覚神経伝導検査での診断

    高橋 えり沙, 宮地 洋輔, 古宮 裕泰, 中村 玲奈, 宮武 和馬, 田中 章景

    臨床神経生理学   51 ( 5 )   607 - 607   2023年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本臨床神経生理学会  

    researchmap

  • 家系内で異なる臨床像を呈しVCP遺伝子バリアントを認めた家族性筋萎縮性側索硬化症の兄弟例

    細田 航平, 古宮 裕泰, 橋口 俊太, 田中 健一, 宮地 洋輔, 土井 宏, 竹内 英之, 田中 章景

    臨床神経学   63 ( 9 )   605 - 605   2023年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • ミクログリアに対するインフラマソームを介したシポニモドの抗炎症作用

    古宮 裕泰, 竹内 英之, 小笠原 陽大, 高橋 慶太, 土井 宏, 田中 章景

    神経免疫学   28 ( 1 )   240 - 240   2023年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経免疫学会  

    researchmap

  • 家系内で異なる臨床像を呈しVCP遺伝子バリアントを認めた家族性筋萎縮性側索硬化症の兄弟例

    細田 航平, 古宮 裕泰, 橋口 俊太, 田中 健一, 宮地 洋輔, 土井 宏, 竹内 英之, 田中 章景

    臨床神経学   63 ( 9 )   605 - 605   2023年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 3Dモーションキャプチャーによる軽微な小脳性運動失調とパーキンソニズムの鑑別

    上田 直久, 伊東 毅, 林 紀子, 東山 雄一, 宮地 洋輔, 木村 活生, 土井 宏, 岸田 日帯, 竹内 英之, 田中 章景

    臨床神経学   63 ( Suppl. )   S317 - S317   2023年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • MRI拡散強調画像で両側視床高信号を呈したプリオン病の2症例

    岸田 日帯, 國井 美紗子, 多田 美紀子, 林 紀子, 木村 活生, 宮地 洋輔, 東山 雄一, 土井 宏, 竹内 英之, 上田 直久, 児矢野 繁, 北本 哲之, 田中 章景

    臨床神経学   63 ( Suppl. )   S325 - S325   2023年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 【急性期から在宅まで活用できる!!脳神経内科疾患と看護】(2章)脳神経内科疾患と看護(5)神経難病 フリードライヒ運動失調症(Friedreich病)

    橋口 俊太, 田中 章景

    Brain Nursing   ( 2023夏季増刊 )   219 - 221   2023年8月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)メディカ出版  

    researchmap

  • 【パーキンソン病2023-基礎・臨床の最新動向-】パーキンソン病の治療 パーキンソン病の進行期治療 デバイス治療(DBS)

    木村 活生, 田中 章景

    日本臨床   81 ( 8 )   1201 - 1208   2023年8月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)日本臨床社  

    researchmap

  • 運動障害疾患の機能外科アップデート 術後のフォロー,プログラミング・内服調整の実際

    木村 活生, 岸田 日帯, 川崎 隆, 上田 直久, 田中 章景

    パーキンソン病・運動障害疾患コングレスプログラム・抄録集   17回   62 - 62   2023年7月

     詳細を見る

    記述言語:日本語   出版者・発行元:Movement Disorder Society of Japan (MDSJ)  

    researchmap

  • Lドーパ/カルビドパ配合経腸用液療法の合併症に関する単施設における報告

    堀口 遼平, 木村 活生, 平形 寿顕, 小栗 忠晃, 小林 卓雄, 林 紀子, 岸田 日帯, 厚坂 励生, 福地 剛英, 宮地 洋輔, 東山 雄一, 土井 宏, 竹内 英之, 上田 直久, 田中 章景

    パーキンソン病・運動障害疾患コングレスプログラム・抄録集   17回   113 - 113   2023年7月

     詳細を見る

    記述言語:日本語   出版者・発行元:Movement Disorder Society of Japan (MDSJ)  

    researchmap

  • Long-read sequencing revealing intragenic deletions in exome-negative spastic paraplegias. 国際誌

    Hiromi Fukuda, Takeshi Mizuguchi, Hiroshi Doi, Shinichi Kameyama, Misako Kunii, Hideto Joki, Tatsuya Takahashi, Hiroyasu Komiya, Mei Sasaki, Yosuke Miyaji, Sachiko Ohori, Eriko Koshimizu, Yuri Uchiyama, Naomi Tsuchida, Atsushi Fujita, Kohei Hamanaka, Kazuharu Misawa, Satoko Miyatake, Fumiaki Tanaka, Naomichi Matsumoto

    Journal of human genetics   68 ( 10 )   689 - 697   2023年6月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Hereditary spastic paraplegias (HSPs) are a heterogeneous group of neurodegenerative disorders characterized by progressive spasticity and weakness in the lower extremities. To date, a total of 88 types of SPG are known. To diagnose HSP, multiple technologies, including microarray, direct sequencing, multiplex ligation-dependent probe amplification, and short-read next-generation sequencing, are often chosen based on the frequency of HSP subtypes. Exome sequencing (ES) is commonly used. We used ES to analyze ten cases of HSP from eight families. We identified pathogenic variants in three cases (from three different families); however, we were unable to determine the cause of the other seven cases using ES. We therefore applied long-read sequencing to the seven undetermined HSP cases (from five families). We detected intragenic deletions within the SPAST gene in four families, and a deletion within PSEN1 in the remaining family. The size of the deletion ranged from 4.7 to 12.5 kb and involved 1-7 exons. All deletions were entirely included in one long read. We retrospectively performed an ES-based copy number variation analysis focusing on pathogenic deletions, but were not able to accurately detect these deletions. This study demonstrated the efficiency of long-read sequencing in detecting intragenic pathogenic deletions in ES-negative HSP patients.

    DOI: 10.1038/s10038-023-01170-0

    PubMed

    researchmap

  • An autopsy case of copper deficiency myelopathy and selenium deficiency-associated central nervous system disorder after total parenteral nutrition. 国際誌

    Ryuichi Koizumi, Hideki Kato, Akio Akagi, Yuichi Riku, Jun Sone, Hiroaki Miyahara, Takuya Oguri, Hiroyuki Yuasa, Fumiaki Tanaka, Mari Yoshida, Yasushi Iwasaki

    Journal of the neurological sciences   448   120636 - 120636   2023年5月

     詳細を見る

  • 進行期Parkinson病の治療戦略 Device aided therapy時代の進行期Parkinson病の治療戦略と将来の展望

    木村 活生, 田中 章景

    神経治療学   40 ( 3 )   363 - 367   2023年5月

  • 辺縁系脳炎との鑑別を要した、意識障害を初発とする神経梅毒の2症例

    池田 理紗, 高橋 慶太, 細田 航平, 浅野 史織, 古宮 裕泰, 窪田 瞬, 土井 宏, 田中 章景

    臨床神経学   63 ( 4 )   232 - 232   2023年4月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 呼吸筋障害と片側声帯麻痺を認めたCharcot-Marie-Tooth病2A型の23歳女性例

    山田 亮, 橋口 俊太, 西町 明浩, 浅野 徹也, 小林 絵礼奈, 田中 健一, 多田 美紀子, 田中 章景

    臨床神経学   63 ( 3 )   175 - 175   2023年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • Association of biallelic RFC1 expansion with early-onset Parkinson's disease. 国際誌

    Pauli Ylikotila, Jussi Sipilä, Tiina Alapirtti, Riitta Ahmasalo, Eriko Koshimizu, Satoko Miyatake, Anri Hurme-Niiranen, Ari Siitonen, Hiroshi Doi, Fumiaki Tanaka, Naomichi Matsumoto, Kari Majamaa, Laura Kytövuori

    European journal of neurology   30 ( 5 )   1256 - 1261   2023年1月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    BACKGROUND: The biallelic repeat expansion (AAGGG)exp in the replication factor C subunit 1 gene (RFC1) is a frequent cause of cerebellar ataxia, neuropathy and vestibular areflexia syndrome (CANVAS) as well as late-onset ataxia. The clinical spectrum of RFC1 disease has expanded since the first identification of biallelic (AAGGG)exp and includes now various nonclassical phenotypes. We have recently found biallelic (AAGGG)exp in RFC1 in patients with clinically confirmed Parkinson's disease (PD). METHODS: A nationwide cohort of 273 Finnish patients with early-onset PD was examined for the biallelic intronic expansion in RFC1. The expansion (AAGGG)exp was first screened using XL-PCRs and flanking multiplex PCR. The presence of biallelic (AAGGG)exp was then confirmed by repeat-primed PCR and, finally, the repeat length was determined by long-read sequencing. RESULTS: Three patients were found with the biallelic (AAGGG)exp in RFC1 giving a frequency of 1.10 % (0.23-3.18 %; 95 % confidence interval). The three patients fulfilled the diagnostic criteria of PD, none of them had ataxia or neuropathy, and only one patient had a mild vestibular dysfunction. The age at onset of PD symptoms was 40 - 48 years and their disease course had been unremarkable apart from the early onset. CONCLUSIONS: Our results suggest that (AAGGG)exp in RFC1 is a rare cause of early-onset PD. Other populations should be examined in order to determine, if our findings are specific to the Finnish population.

    DOI: 10.1111/ene.15717

    PubMed

    researchmap

  • パーキンソン病に対する最新技術を用いた外科治療-私はこう治療している-手術適応、ターゲッティング法、刺激調整法など パーキンソン病に対する脳深部刺激療法の適応

    木村 活生, 岸田 日帯, 東島 威史, 川崎 隆, 上田 直久, 田中 章景

    日本定位・機能神経外科学会プログラム・抄録集   62回   62 - 62   2023年1月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本定位・機能神経外科学会  

    researchmap

  • Adaptive DBSが有効であったGPi-DBSを施行したパーキンソン病の67歳女性例

    小栗 忠晃, 木村 活生, 小林 卓雄, 林 紀子, 岸田 日帯, 高木 良介, 東島 威史, 川崎 隆, 上田 直久, 田中 章景

    日本定位・機能神経外科学会プログラム・抄録集   62回   133 - 133   2023年1月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本定位・機能神経外科学会  

    researchmap

  • Reduced likelihood of the Poggendorff illusion in cerebellar strokes: a clinical and neuroimaging study. 国際誌

    Yuichi Higashiyama, Miho Kuroki, Yosuke Kudo, Tomoya Hamada, Keisuke Morihara, Asami Saito, Yosuke Miyaji, Katsuo Kimura, Hideto Joki, Hitaru Kishida, Hiroshi Doi, Naohisa Ueda, Hideyuki Takeuchi, Ken Johkura, Fumiaki Tanaka

    Brain communications   5 ( 2 )   fcad053   2023年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    This study aimed to test our hypothesis that the cerebellum plays an important role in the generation of the optical-geometric illusion known as the Poggendorff illusion, the mechanism of which has been explained by accumulated experience with natural scene geometry. A total of 79 participants, comprising 28 patients with isolated cerebellar stroke, 27 patients with isolated cerebral stroke and 24 healthy controls, performed Poggendorff illusion tasks and 2 different control tasks. We also investigated core brain regions underpinning changes in the experience of the illusion effect using multivariate lesion-symptom mapping. Our results indicate that patients with isolated cerebellar stroke were significantly less likely to experience the Poggendorff illusion effect than patients with isolated cerebral stroke or healthy controls (74.6, 90.5 and 89.8%, respectively; F(2,76) = 6.675, P = 0.002). However, there were no inter-group differences in the control tasks. Lesion-symptom mapping analysis revealed that the brain lesions associated with the reduced frequency of the Poggendorff illusion effect were mainly centred on the right posteromedial cerebellar region, including the right lobules VI, VII, VIII, IX and Crus II. Our findings demonstrated, for the first time, that patients with cerebellar damage were significantly less likely to experience the Poggendorff illusion effect and that right posteromedial cerebellar lesions played an important role in this effect. These results provide new insight into alterations of a geometric illusion effect in patients with cerebellar disorders and pave the way for future clinical use of the illusion task to detect cerebellar abnormalities.

    DOI: 10.1093/braincomms/fcad053

    PubMed

    researchmap

  • The advances in the early and accurate diagnosis of Creutzfeldt-Jakob disease and other prion diseases: where are we today? 国際誌

    Hitaru Kishida, Naohisa Ueda, Fumiaki Tanaka

    Expert review of neurotherapeutics   23 ( 9 )   803 - 817   2023年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    INTRODUCTION: Before the introduction of MRI diffusion-weighted images (DWI), the diagnosis of Creutzfeldt-Jakob disease (CJD) relied upon nonspecific findings including clinical symptoms, EEG abnormalities, and elevated levels of cerebrospinal fluid 14-3-3 protein. Subsequently, the use of DWI has improved diagnostic accuracy, but it sometimes remains difficult to differentiate CJD from encephalitis, epilepsy, and other dementing disorders. The revised diagnostic criteria include real-time quaking-induced conversion (RT-QuIC), detecting small amounts of CJD-specific prion protein, and clinically sensitive DWI. Combining these techniques has further improved diagnostic accuracy, enabling earlier diagnosis. AREAS COVERED: Herein, the authors review the recent advances in diagnostic methods and revised diagnostic criteria for sporadic CJD. They also discuss other prion diseases, such as variant CJD and chronic wasting disease, where the emergence of new types is a concern. EXPERT OPINION: Despite improvements in diagnostic methods and criteria, some subtypes of prion disease are still difficult to diagnose, and even the diagnosis using the most innovative RT-QuIC test remains a challenge in terms of accuracy and standardization. However, these revised criteria can be adapted to the emergence of new types of prion diseases. It is essential to continue careful surveillance and update information on the latest prion disease phenotypes.

    DOI: 10.1080/14737175.2023.2246653

    PubMed

    researchmap

  • 腫瘤を形成せず慢性髄膜脳炎の経過を呈した中枢神経原発低悪性度B細胞リンパ腫の45歳男性例

    西町 明浩, 橋口 俊太, 田中 健一, 宮地 洋輔, 多田 美紀子, 土井 宏, 竹内 英之, 田中 章景

    臨床神経学   62 ( 12 )   966 - 966   2022年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • Buccofacial apraxia in primary progressive aphasia

    Keisuke Morihara, Shoko Ota, Kazuo Kakinuma, Nobuko Kawakami, Yuichi Higashiyama, Shigenori Kanno, Fumiaki Tanaka, Kyoko Suzuki

    Cortex   2022年11月

     詳細を見る

    掲載種別:研究論文(学術雑誌)   出版者・発行元:Elsevier BV  

    DOI: 10.1016/j.cortex.2022.10.010

    researchmap

  • [Chronic Cough in CANVAS].

    Hiroshi Doi, Fumiaki Tanaka

    Brain and nerve = Shinkei kenkyu no shinpo   74 ( 11 )   1267 - 1271   2022年11月

     詳細を見る

    記述言語:日本語   掲載種別:研究論文(学術雑誌)  

    Among patients with RFC1 spectrum disorders represented by the phenotype of cerebellar ataxia with neuropathy and vestibular areflexia syndrome (CANVAS), at least 60% are known to manifest chronic, paroxysmal, and spasmodic dry cough. Chronic cough is a key diagnostic feature of RFC1-related diseases. It is often the first symptom and, in some cases, precedes neurological symptoms such as ataxia and sensory disturbance for more than 30 years. Although the pathogenesis of the cough remains unclear, it is possible that impairment of the vagus nerve, which includes an afferent pathway of the cough reflex, or the cerebellum would have contributed to the generation of the cough.

    DOI: 10.11477/mf.1416202226

    PubMed

    researchmap

  • [Motor Neuron Involvement in RFC1 CANVAS/Spectrum Disorders].

    Yosuke Miyaji, Hiroshi Doi, Fumiaki Tanaka

    Brain and nerve = Shinkei kenkyu no shinpo   74 ( 11 )   1287 - 1291   2022年11月

     詳細を見る

    記述言語:日本語   掲載種別:研究論文(学術雑誌)  

    Cerebellar ataxia with neuropathy and vestibular areflexia syndrome (CANVAS) is characterized by the triad of cerebellar ataxia, bilateral vestibular impairment, and sensory neuropathy. The responsible anatomical region for the sensory disturbance in CANVAS is reportedly the dorsal root ganglion, which suggests neuronopathy rather than neuropathy as the pathomechanism of this peripheral nervous system disorder. Early on, motor neuron involvement was considered rare in CANVAS. The etiology of CANVAS includes the homozygous pentanucleotide repeat expansion within the RFC1 gene, resulting in diverse phenotypes and motor deficits such as brisk reflex, extensor plantar responses, or spasticity of the upper motor neurons and muscle wasting, weakness, cramp, or fasciculation of the lower motor neurons. CANVAS patients with AAGGG repeat expansions may show motor neuron involvement, with considerable variation in the reported frequencies. In contrast, although some patients with ACAGG repeat expansions also show motor neuron involvement, its frequency remains elusive.

    DOI: 10.11477/mf.1416202229

    PubMed

    researchmap

  • Rapid and comprehensive diagnostic method for repeat expansion diseases using nanopore sequencing

    Satoko Miyatake, Eriko Koshimizu, Atsushi Fujita, Hiroshi Doi, Masaki Okubo, Taishi Wada, Kohei Hamanaka, Naohisa Ueda, Hitaru Kishida, Gaku Minase, Atsuhiro Matsuno, Minori Kodaira, Katsuhisa Ogata, Rumiko Kato, Atsuhiko Sugiyama, Ayako Sasaki, Takabumi Miyama, Mai Satoh, Yuri Uchiyama, Naomi Tsuchida, Haruka Hamanoue, Kazuharu Misawa, Kiyoshi Hayasaka, Yoshiki Sekijima, Hiroaki Adachi, Kunihiro Yoshida, Fumiaki Tanaka, Takeshi Mizuguchi, Naomichi Matsumoto

    npj Genomic Medicine   7 ( 1 )   2022年10月

     詳細を見る

    掲載種別:研究論文(学術雑誌)   出版者・発行元:Springer Science and Business Media LLC  

    Abstract

    We developed a diagnostic method for repeat expansion diseases using a long-read sequencer to improve currently available, low throughput diagnostic methods. We employed the real-time target enrichment system of the nanopore GridION sequencer using the adaptive sampling option, in which software-based target assignment is available without prior sample enrichment, and built an analysis pipeline that prioritized the disease-causing loci. Twenty-two patients with various neurological and neuromuscular diseases, including 12 with genetically diagnosed repeat expansion diseases and 10 manifesting cerebellar ataxia, but without genetic diagnosis, were analyzed. We first sequenced the 12 molecularly diagnosed patients and accurately confirmed expanded repeats in all with uniform depth of coverage across the loci. Next, we applied our method and a conventional method to 10 molecularly undiagnosed patients. Our method corrected inaccurate diagnoses of two patients by the conventional method. Our method is superior to conventional diagnostic methods in terms of speed, accuracy, and comprehensiveness.

    DOI: 10.1038/s41525-022-00331-y

    researchmap

    その他リンク: https://www.nature.com/articles/s41525-022-00331-y

  • Clinicopathological features of progressive supranuclear palsy with asymmetrical atrophy of the superior cerebellar peduncle. 国際誌

    Ryuichi Koizumi, Akio Akagi, Yuichi Riku, Jun Sone, Hiroaki Miyahara, Fumiaki Tanaka, Mari Yoshida, Yasushi Iwasaki

    Neuropathology : official journal of the Japanese Society of Neuropathology   2022年10月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Progressive supranuclear palsy (PSP) can be diagnosed despite the presence of asymmetrical parkinsonism depending on the clinical diagnostic criteria. Some studies have reported that atrophy of the superior cerebellar peduncle (SCP) is more frequent in PSP than in Parkinson's disease. There have also been reports of PSP cases with an asymmetrically atrophic SCP. Therefore, we analyzed 48 specimens from consecutive autopsy cases that were neuropathologically diagnosed as PSP to investigate the laterality of brain lesions, including the SCP. We measured the width of the SCP and evaluated the laterality of atrophy. We semi-quantitatively evaluated neuronal loss, atrophy/myelin pallor, and tau pathology in three steps. Asymmetrical atrophy of the SCP was present in seven (14.6%) of 48 cases. The atrophic side of the SCP corresponded to the dominant side of the tau pathology in the cerebellar dentate nucleus. It was opposite to the dominant side of the myelin pallor and tau pathology in the red nucleus and of the tau pathology in the central tegmental tract and inferior olivary nucleus, coinciding with the neurologically systematic anatomy of the Guillain-Mollaret triangle. Neurodegeneration of PSP can progress asymmetrically from one side to the initially intact side in PSP with an initial predominance of Richardson's syndrome, progressive gait freezing, ocular motor dysfunction, parkinsonism, or corticobasal syndrome. To our knowledge, no previous study has reported asymmetrical PSP neuropathology; this is the first study to report the presence of PSP cases with asymmetrical SCP atrophy and systematically asymmetrical degeneration of the Guillain-Mollaret triangle.

    DOI: 10.1111/neup.12868

    PubMed

    researchmap

  • 新型コロナウイルスワクチン接種を契機に発症した抗横紋筋抗体陽性免疫関連有害事象の1症例

    小林 卓雄, 林 紀子, 木村 活生, 上田 直久, 田中 章景

    神経治療学   39 ( 6 )   S260 - S260   2022年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経治療学会  

    researchmap

  • CRMP1のリン酸化阻害は筋萎縮性側索硬化症モデルマウスの生存期間,運動機能の改善をもたらす

    浅野 徹也, 中村 治子, 川本 裕子, 木村 弥生, 高野 洋志, 八尾 良司, 橋口 俊太, 高橋 慶太, 田中 健一, 五嶋 良郎, 中村 史雄, 竹内 英之, 土井 宏, 田中 章景

    神経治療学   39 ( 6 )   S255 - S255   2022年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経治療学会  

    researchmap

  • Nogo受容体の内因性アンタゴニストであるLOTUSはALSモデルマウスの症状を改善する

    池田 拓也, 高橋 慶太, 橋口 俊太, 田中 健一, 土井 宏, 竹居 光太郎, 竹内 英之, 田中 章景

    神経治療学   39 ( 6 )   S255 - S255   2022年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経治療学会  

    researchmap

  • 神経筋疾患の問題症例 経過7年の多発性単ニューロパチーを呈する44歳女性例 multifocal CIDPか?

    宮地 洋輔, 國井 美紗子, 古宮 裕泰, 田中 章景

    臨床神経生理学   50 ( 5 )   353 - 353   2022年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本臨床神経生理学会  

    researchmap

  • SCA42モデルマウスに対するエトサクシミドの治療効果

    大久保 正紀, 土井 宏, 橋口 俊太, 高橋 慶太, 田中 健一, 竹内 英之, 石川 太郎, 田中 章景

    神経治療学   39 ( 6 )   S234 - S234   2022年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経治療学会  

    researchmap

  • Lesion network mappingを用いた,外国語様アクセント症候群の神経機構の検討

    東山 雄一, 浜田 智哉, 森原 啓介, 斎藤 麻美, 宮地 洋輔, 木村 活生, 岡本 光生, 上木 英人, 岸田 日帯, 土井 宏, 上田 直久, 竹内 英之, 田中 章景

    臨床神経学   62 ( Suppl. )   S242 - S242   2022年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • Japan REgistry for Adult subjeCTs of SMA(jREACT) ベースライン解析

    佐橋 健太郎, 齊藤 利雄, 高嶋 博, 田中 章景, 鍬塚 八千代, 橋詰 淳, 本間 泰平, 安藤 昌彦, 勝野 雅央

    神経治療学   39 ( 6 )   S260 - S260   2022年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経治療学会  

    researchmap

  • 3Dモーションキャプチャーによる軽微な小脳性運動失調の解析

    上田 直久, 森原 啓介, 林 紀子, 東山 雄一, 宮地 洋輔, 木村 活生, 上木 英人, 土井 宏, 岸田 日帯, 竹内 英之, 児矢野 繁, 田中 章景

    臨床神経学   62 ( Suppl. )   S208 - S208   2022年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 筋萎縮性側索硬化症における経皮内視鏡的胃瘻造設術の鎮静に関する検討

    上木 英人, 宮地 洋輔, 東山 雄一, 小林 絵礼奈, 林 紀子, 木村 活生, 岸田 日帯, 上田 直久, 土井 宏, 竹内 英之, 田中 章景

    臨床神経学   62 ( Suppl. )   S329 - S329   2022年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • CANVASにおける線維束性収縮と運動ニューロン障害

    宮地 洋輔, 土井 宏, 宮武 聡子, 林 紀子, 東山 雄一, 木村 活生, 上木 英人, 岸田 日帯, 竹内 英之, 松本 直通, 上田 直久, 田中 章景

    臨床神経学   62 ( Suppl. )   S329 - S329   2022年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 静脈血栓塞栓症を伴う癌関連脳梗塞におけるヘパリンと直接第Xa因子阻害剤の治療効果

    山浦 弦平, 伊東 毅, 宮地 洋輔, 上田 直久, 中江 啓晴, 桃尾 隆之, 仲野 達, 城村 裕司, 東山 雄一, 上木 英人, 土井 宏, 竹内 英之, 高橋 竜哉, 児矢野 繁, 山口 滋紀, 横山 睦美, 田中 章景

    臨床神経学   62 ( Suppl. )   S239 - S239   2022年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • Lesion network mappingを用いた,外国語様アクセント症候群の神経機構の検討

    東山 雄一, 浜田 智哉, 森原 啓介, 斎藤 麻美, 宮地 洋輔, 木村 活生, 岡本 光生, 上木 英人, 岸田 日帯, 土井 宏, 上田 直久, 竹内 英之, 田中 章景

    臨床神経学   62 ( Suppl. )   S242 - S242   2022年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • ミクログリアに対するインフラマソームを介したシポニモドの抗炎症作用

    古宮 裕泰, 竹内 英之, 小笠原 陽大, 高橋 慶太, 田中 健一, 多田 美紀子, 土井 宏, 田中 章景

    神経免疫学   27 ( 1 )   187 - 187   2022年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経免疫学会  

    researchmap

  • 3Dモーションキャプチャーによる軽微な小脳性運動失調の解析

    上田 直久, 森原 啓介, 林 紀子, 東山 雄一, 宮地 洋輔, 木村 活生, 上木 英人, 土井 宏, 岸田 日帯, 竹内 英之, 児矢野 繁, 田中 章景

    臨床神経学   62 ( Suppl. )   S208 - S208   2022年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • エフガルチギモドによりステロイド減量が可能となった全身型重症筋無力症の26歳女性

    岸田 日帯, 林 紀子, 小林 卓雄, 小栗 忠晃, 木村 活生, 上田 直久, 田中 章景

    神経免疫学   27 ( 1 )   168 - 168   2022年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経免疫学会  

    researchmap

  • FilmArray髄膜炎・脳炎パネルを用いた神経感染症診断症例の臨床的特徴

    林 紀子, 岸田 日帯, 木村 活生, 上田 直久, 田中 章景

    臨床神経学   62 ( Suppl. )   S269 - S269   2022年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • Cerebellar ataxia with neuropathy and vestibular areflexia syndromeにおける線維束性収縮と運動ニューロン障害

    宮地 洋輔, 土井 宏, 宮武 聡子, 伊東 毅, 林 紀子, 東山 雄一, 木村 活生, 岸田 日帯, 竹内 英之, 松本 直通, 上田 直久, 田中 章景

    臨床神経生理学   50 ( 5 )   405 - 405   2022年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本臨床神経生理学会  

    researchmap

  • 進行期パーキンソン病の治療戦略 DAT時代の進行期パーキンソン病治療戦略と将来の展望

    木村 活生, 岸田 日帯, 上田 直久, 田中 章景

    神経治療学   39 ( 6 )   S148 - S148   2022年10月

  • 神経筋疾患の問題症例 経過7年の多発性単ニューロパチーを呈する44歳女性例 multifocal CIDPか?

    宮地 洋輔, 國井 美紗子, 古宮 裕泰, 田中 章景

    臨床神経生理学   50 ( 5 )   353 - 353   2022年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本臨床神経生理学会  

    researchmap

  • Phosphorylated CRMP1, axon guidance protein, is a component of spheroids and is involved in axonal pathology in amyotrophic lateral sclerosis

    Yuko Kawamoto, Mikiko Tada, Tetsuya Asano, Haruko Nakamura, Aoi Jitsuki-Takahashi, Hiroko Makihara, Shun Kubota, Shunta Hashiguchi, Misako Kunii, Toshio Ohshima, Yoshio Goshima, Hideyuki Takeuchi, Hiroshi Doi, Fumio Nakamura, Fumiaki Tanaka

    Frontiers in Neurology   13   2022年9月

     詳細を見る

    掲載種別:研究論文(学術雑誌)   出版者・発行元:Frontiers Media SA  

    In amyotrophic lateral sclerosis (ALS), neurodegeneration is characterized by distal axonopathy that begins at the distal axons, including the neuromuscular junctions, and progresses proximally in a “dying back” manner prior to the degeneration of cell bodies. However, the molecular mechanism for distal axonopathy in ALS has not been fully addressed. Semaphorin 3A (Sema3A), a repulsive axon guidance molecule that phosphorylates collapsin response mediator proteins (CRMPs), is known to be highly expressed in Schwann cells near distal axons in a mouse model of ALS. To clarify the involvement of Sema3A–CRMP signaling in the axonal pathogenesis of ALS, we investigated the expression of phosphorylated CRMP1 (pCRMP1) in the spinal cords of 35 patients with sporadic ALS and seven disease controls. In ALS patients, we found that pCRMP1 accumulated in the proximal axons and co-localized with phosphorylated neurofilaments (pNFs), which are a major protein constituent of spheroids. Interestingly, the pCRMP1:pNF ratio of the fluorescence signal in spheroid immunostaining was inversely correlated with disease duration in 18 evaluable ALS patients, indicating that the accumulation of pCRMP1 may precede that of pNFs in spheroids or promote ALS progression. In addition, overexpression of a phospho-mimicking CRMP1 mutant inhibited axonal outgrowth in Neuro2A cells. Taken together, these results indicate that pCRMP1 may be involved in the pathogenesis of axonopathy in ALS, leading to spheroid formation through the proximal progression of axonopathy.

    DOI: 10.3389/fneur.2022.994676

    researchmap

  • Patients with biallelic GGC repeat expansions in NOTCH2NLC exhibiting a typical neuronal intranuclear inclusion disease phenotype. 国際誌

    Shinichi Kameyama, Takeshi Mizuguchi, Hiroshi Doi, Shigeru Koyano, Masaki Okubo, Mikiko Tada, Hiroshi Shimizu, Hiromi Fukuda, Naomi Tsuchida, Yuri Uchiyama, Eriko Koshimizu, Kohei Hamanaka, Atsushi Fujita, Kazuharu Misawa, Satoko Miyatake, Kazuaki Kanai, Fumiaki Tanaka, Naomichi Matsumoto

    Genomics   114 ( 5 )   110469 - 110469   2022年8月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    We report two patients with autosomal dominant neuronal intranuclear inclusion disease (NIID) harboring the biallelic GGC repeat expansion in NOTCH2NLC to uncover the impact of repeat expansion zygosity on the clinical phenotype. The zygosity of the entire NOTCH2NLC GGC repeat expansion and DNA methylation were comprehensively evaluated using fluorescent amplicon length PCR (AL-PCR), Southern blotting and targeted long-read sequencing, and detailed genetic/epigenetic and clinical features were described. In AL-PCR, we could not recognize the wild-type allele in both patients. Targeted long-read sequencing revealed that one patient harbored a homozygous repeat expansion. The other patient harbored compound heterozygous repeat expansions. The GGC repeats and the nearest CpG island were hypomethylated in all expanded alleles in both patients. Both patients harboring the biallelic GGC repeat expansion showed a typical dementia-dominant NIID phenotype. In conclusion, the biallelic GGC repeat expansion in two typical NIID patients indicated that NOTCH2NLC-related diseases could be completely dominant.

    DOI: 10.1016/j.ygeno.2022.110469

    PubMed

    researchmap

  • Risk factors for unfavourable outcomes after shunt surgery in patients with idiopathic normal-pressure hydrocephalus

    Erena Kobayashi, Shigenori Kanno, Nobuko Kawakami, Wataru Narita, Makoto Saito, Keiko Endo, Masaki Iwasaki, Tomohiro Kawaguchi, Shigeki Yamada, Kazunari Ishii, Hiroaki Kazui, Masakazu Miyajima, Masatsune Ishikawa, Etsuro Mori, Teiji Tominaga, Fumiaki Tanaka, Kyoko Suzuki

    Scientific Reports   12 ( 1 )   2022年8月

     詳細を見る

    掲載種別:研究論文(学術雑誌)   出版者・発行元:Springer Science and Business Media LLC  

    Abstract

    A number of vascular risk factors (VRFs) have been reported to be associated with idiopathic normal-pressure hydrocephalus (iNPH), but it remains unclear whether these VRFs are related to patient outcomes after shunt surgery. Therefore, we investigated the risk factors for unfavourable outcomes after shunt surgery in iNPH patients using two samples from Tohoku University Hospital and from a multicentre prospective trial of lumboperitoneal (LP) shunt surgery for patients with iNPH (SINPHONI-2). We enrolled 158 iNPH patients. We compared the prevalence of VRFs and clinical measures between patients with favourable and unfavourable outcomes and identified predictors of unfavourable outcomes using multivariate logistic regression analyses. The presence of hypertension, longer disease duration, more severe urinary dysfunction, and a lower Evans’ index were predictors of unfavourable outcomes after shunt surgery. In addition, hypertension and longer disease duration were also predictors in patients with independent walking, and a lower Evans’ index was the only predictor in patients who needed assistance to walk or could not walk. Our findings indicate that hypertension is the only VRF related to unfavourable outcomes after shunt surgery in iNPH patients. Larger-scale studies are needed to elucidate the reason why hypertension can affect the irreversibility of symptoms after shunt placement.

    DOI: 10.1038/s41598-022-18209-5

    researchmap

    その他リンク: https://www.nature.com/articles/s41598-022-18209-5

  • 脳出血後に発症した片側バリズムに対し脳深部刺激療法を施行した67歳女性例

    山田 亮, 小林 卓雄, 木村 活生, 岸田 日帯, 川崎 隆, 坂田 勝巳, 上田 直久, 田中 章景

    臨床神経学   62 ( 8 )   662 - 662   2022年8月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • Ocular flutter as the presenting manifestation of autoimmune glial fibrillary acidic protein astrocytopathy. 国際誌

    Taishi Wada, Yuichi Higashiyama, Misako Kunii, Takashi Jono, Takuo Kobayashi, Shun Kubota, Mikiko Tada, Makoto Hara, Akio Kimura, Hiroshi Doi, Hideyuki Takeuchi, Fumiaki Tanaka

    Clinical neurology and neurosurgery   219   107307 - 107307   2022年8月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    A 39-year-old man exhibited ocular flutter and cerebellar ataxia following a subacute disturbance of consciousness and partial seizure. He was diagnosed with autoimmune glial fibrillary acidic protein (GFAP) astrocytopathy by tissue- and cell-based antibody assays. Brain single-photon emission computed tomography detected a significant increase in blood flow in the fastigial nucleus, a critical region for eye saccade control. Immunotherapies diminished the ocular flutter and reduced hyperperfusion in the fastigial nucleus. This case suggests that autoimmune GFAP astrocytopathy can cause ocular flutter and provides strong imaging evidence supporting the hypothesis that ocular flutter is caused by hyperactivity or disinhibition of the fastigial nucleus.

    DOI: 10.1016/j.clineuro.2022.107307

    PubMed

    researchmap

  • 舞踏運動を主徴とし、抗リン脂質抗体と抗amphiphysin抗体が陽性であった69歳男性例

    森下 良志, 原田 康平, 古宮 裕泰, 橋口 俊太, 田中 健一, 多田 美紀子, 土井 宏, 田中 章景

    臨床神経学   62 ( 8 )   676 - 676   2022年8月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • Anti-inflammatory effects of siponimod on astrocytes

    Akihiro Ogasawara, Hideyuki Takeuchi, Hiroyasu Komiya, Yuki Ogawa, Koki Nishimura, Shun Kubota, Shunta Hashiguchi, Keita Takahashi, Misako Kunii, Kenichi Tanaka, Mikiko Tada, Hiroshi Doi, Fumiaki Tanaka

    Neuroscience Research   2022年8月

     詳細を見る

    掲載種別:研究論文(学術雑誌)   出版者・発行元:Elsevier BV  

    DOI: 10.1016/j.neures.2022.08.003

    researchmap

  • Ocular tilt reactionを呈した右中脳梗塞の71歳男性例

    石井 義人, 東山 雄一, 窪田 瞬, 高橋 慶太, 工藤 洋祐, 竹内 英之, 城倉 健, 田中 章景

    臨床神経学   62 ( 8 )   646 - 646   2022年8月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • COVID-19ワクチン接種後に感覚性運動失調と味覚障害で発症したギラン・バレー症候群の70歳男性例

    緒方 俊介, 高橋 慶太, 石井 義人, 窪田 瞬, 東山 雄一, 上木 英人, 竹内 英之, 田中 章景

    臨床神経学   62 ( 8 )   660 - 660   2022年8月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 舞踏運動を主徴とし、抗リン脂質抗体と抗amphiphysin抗体が陽性であった69歳男性例

    森下 良志, 原田 康平, 古宮 裕泰, 橋口 俊太, 田中 健一, 多田 美紀子, 土井 宏, 田中 章景

    臨床神経学   62 ( 8 )   676 - 676   2022年8月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • LFPセンシングを用いたアダプティブDBS施行例の長期予後

    木村 活生, 岸田 日帯, 東島 威史, 川崎 隆, 上田 直久, 田中 章景

    パーキンソン病・運動障害疾患コングレスプログラム・抄録集   16回   80 - 80   2022年7月

     詳細を見る

    記述言語:日本語   出版者・発行元:Movement Disorder Society of Japan (MDSJ)  

    researchmap

  • Inhibition of Crmp1 phosphorylation at Ser522 ameliorates motor function and neuronal pathology in amyotrophic lateral sclerosis model mice. 国際誌

    Tetsuya Asano, Haruko Nakamura, Yuko Kawamoto, Mikiko Tada, Yayoi Kimura, Hiroshi Takano, Ryoji Yao, Hiroya Saito, Takuya Ikeda, Hiroyasu Komiya, Shun Kubota, Shunta Hashiguchi, Keita Takahashi, Misako Kunii, Kenichi Tanaka, Yoshio Goshima, Fumio Nakamura, Hideyuki Takeuchi, Hiroshi Doi, Fumiaki Tanaka

    eNeuro   9 ( 3 )   2022年5月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Amyotrophic lateral sclerosis (ALS) is a rapidly progressive and fatal neurodegenerative disorder that affects upper and lower motor neurons; however, its pathomechanism has not been fully elucidated. Using a comprehensive phosphoproteomic approach, we have identified elevated phosphorylation of collapsin response mediator protein 1 (Crmp1) at serine 522 in the lumbar spinal cord of ALS model mice overexpressing a human superoxide dismutase mutant (SOD1G93A). We investigated the effects of Crmp1 phosphorylation and depletion in SOD1G93A mice using Crmp1S522A (Ser522→Ala) knockin (Crmp1ki/ki ) mice in which the S522 phosphorylation site was abolished and Crmp1 knockout (Crmp1 -/-) mice, respectively. Crmp1ki/ki/SOD1G93A mice showed longer latency to fall in a rotarod test while Crmp1-/-/SOD1G93A mice showed shorter latency compared with SOD1G93A mice. Survival was prolonged in Crmp1ki/ki/SOD1G93A mice but not in Crmp1-/-/SOD1G93A mice. In agreement with these phenotypic findings, residual motor neurons and innervated neuromuscular junctions were comparatively well-preserved in Crmp1ki/ki/SOD1G93A mice without affecting microglial and astroglial pathology. Pathway analysis of proteome alterations showed that the sirtuin signaling pathway had opposite effects in Crmp1ki/ki/SOD1G93A and Crmp1-/-/SOD1G93A mice. Our study indicates that modifying CRMP1 phosphorylation is a potential therapeutic strategy for ALS.Significance StatementCollapsin response mediator protein 1 (CRMP1) is an intracellular molecule that mediates semaphorin 3A (Sema3A) signaling. Phosphoproteomic analysis showed that the Semaphorin Neuronal Repulsive Signaling Pathway, which includes Crmp1 phosphorylation at Ser522, is upregulated in SOD1G93A mice that serve as a model of amyotrophic lateral sclerosis (ALS). While deleting both copies of the Crmp1 gene (Crmp1-/- ) leads to deterioration of motor function in SOD1G93A mice, phospho-null Crmp1 (Crmp1ki/ki ) improves motor function while preventing motor neuron loss and denervation of neuromuscular junctions. Among the Sema3A-mediated axon guidance pathways, we propose that CRMP1 phosphorylation is a potential therapeutic target for ALS.

    DOI: 10.1523/ENEURO.0133-22.2022

    PubMed

    researchmap

  • Parallel Appearance of Polyglutamine and Transactivation-Responsive DNA-Binding Protein 43 and Their Complementary Subcellular Localization in Brains of Patients With Spinocerebellar Ataxia Type 2. 国際誌

    Shigeru Koyano, Saburo Yagishita, Mikiko Tada, Hiroshi Doi, Toshiki Uchihara, Fumiaki Tanaka

    Journal of neuropathology and experimental neurology   81 ( 7 )   535 - 544   2022年5月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Spinocerebellar ataxia type 2 (SCA2) is caused by mutations in the ATXN2 gene in which toxic effects are triggered by expanded polyglutamine repeats within ataxin-2. SCA2 is accompanied by motor neuron degeneration as occurs in amyotrophic lateral sclerosis (ALS). We investigated the distribution patterns of ataxin-2 and transactivation-responsive DNA-binding protein 43 (TDP-43), a major disease-related protein in ALS, in the CNS of 3 SCA2 patients. Phosphorylated TDP-43 (pTDP-43)-positive lesions were widely distributed throughout the CNS and generally overlapped with 1C2 (expanded polyglutamine)-immunoreactive lesions. This distribution pattern is different from the pattern in limbic-predominant age-related TDP-43 encephalopathy. In SCA2, double immunostaining of TDP-43 and 1C2 in motor neurons revealed 3 staining patterns: cytoplasmic 1C2 and nuclear TDP-43, nucleocytoplasmic 1C2 and nuclear TDP-43, and nuclear 1C2 and cytoplasmic TDP-43, which reflect the early, active, and final stages of pathological change, respectively. The translocation of TDP-43 from the nucleus to the cytoplasm along with the translocation of 1C2 in the opposite direction indicates that nuclear accumulation of the disease-specific protein ataxin-2 affects the intracellular dynamics of TDP-43. Such a close interrelationship between mutant ataxin-2 and TDP-43 in the cell might account for the similarity of their distribution in the CNS of patients with SCA2.

    DOI: 10.1093/jnen/nlac032

    PubMed

    researchmap

  • Parkinson病のdevice-aided therapy,deep brain stimulation,levodopa-carbidopa intestinal gel therapyをめぐって

    木村 活生, 田中 章景

    神経治療学   39 ( 3 )   177 - 182   2022年5月

  • Repeat conformation heterogeneity in cerebellar ataxia, neuropathy, vestibular areflexia syndrome. 国際誌

    Satoko Miyatake, Kunihiro Yoshida, Eriko Koshimizu, Hiroshi Doi, Mitsunori Yamada, Yosuke Miyaji, Naohisa Ueda, Jun Tsuyuzaki, Minori Kodaira, Hiroyuki Onoue, Masataka Taguri, Shintaro Imamura, Hiromi Fukuda, Kohei Hamanaka, Atsushi Fujita, Mai Satoh, Takabumi Miyama, Nobuko Watanabe, Yusuke Kurita, Masaki Okubo, Kenichi Tanaka, Hitaru Kishida, Shigeru Koyano, Tatsuya Takahashi, Yoya Ono, Kazuhiro Higashida, Nobuaki Yoshikura, Katsuhisa Ogata, Rumiko Kato, Naomi Tsuchida, Yuri Uchiyama, Noriko Miyake, Takayoshi Shimohata, Fumiaki Tanaka, Takeshi Mizuguchi, Naomichi Matsumoto

    Brain : a journal of neurology   145 ( 3 )   1139 - 1150   2022年4月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Cerebellar ataxia, neuropathy, vestibular areflexia syndrome (CANVAS) is a late-onset, slow-progressing multisystem neurodegenerative disorder. Biallelic AAGGG repeat expansion in RFC1 has been identified as causative of this disease, and repeat conformation heterogeneity (ACAGG repeat) was also recently implied. To molecularly characterize this disease in Japanese patients with adult-onset ataxia, we accumulated and screened 212 candidate families by an integrated approach consisting of flanking PCR, repeat-primed PCR, Southern blotting and long-read sequencing using Sequel II, GridION or PromethION. We identified 16 patients from 11 families, of whom seven had ACAGG expansions [(ACAGG)exp/(ACAGG)exp] (ACAGG homozygotes), two had ACAGG and AAGGG expansions [(ACAGG)exp/(AAGGG)exp] (ACAGG/AAGGG compound heterozygotes) and seven had AAGGG expansions [(AAGGG)exp/(AAGGG)exp] (AAGGG homozygotes). The overall detection rate was 5.2% (11/212 families including one family having two expansion genotypes). Long-read sequencers revealed the entire sequence of both AAGGG and ACAGG repeat expansions at the nucleotide level of resolution. Clinical assessment and neuropathology results suggested that patients with ACAGG expansions have similar clinical features to previously reported patients with homozygous AAGGG expansions, although motor neuron involvement was more notable in patients with ACAGG expansions (even if one allele was involved). Furthermore, a later age of onset and slower clinical progression were implied in patients with ACAGG/AAGGG compound heterozygous expansions compared with either ACAGG or AAGGG homozygotes in our very limited cohort. Our study clearly shows the occurrence of repeat conformation heterogeneity, with possible different impacts on the affected nervous systems. The difference in disease onset and progression between compound heterozygotes and homozygotes might also be suspected but with very limited certainty due to the small sample number of cases in our study. Studies of additional patients are needed to confirm this.

    DOI: 10.1093/brain/awab363

    PubMed

    researchmap

  • 腋窩多汗症に対するボツリヌス毒素局注療法後に広範な筋無力症状を呈した50歳女性例

    城野 誉士, 東山 雄一, 宮地 洋輔, 窪田 瞬, 國井 美紗子, 多田 美紀子, 竹内 英之, 田中 章景

    臨床神経学   62 ( 4 )   317 - 317   2022年4月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 心筋症で発症した抗横紋筋抗体陽性重症筋無力症の67歳男性例

    原田 康平, 田中 健一, 城野 誉士, 宮地 洋輔, 多田 美紀子, 土井 宏, 竹内 英之, 田中 章景

    臨床神経学   62 ( 4 )   329 - 329   2022年4月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 神経フェリチン症の肺病変 肺内フェリチン封入体と高度肺気腫を呈した1剖検報告

    田中 玲子, 澤住 知枝, 木村 活生, 多田 美紀子, 土井 宏, 千葉 佐和子, 大谷 方子, 上田 直久, 田中 章景, 稲山 嘉明

    診断病理   39 ( 2 )   120 - 125   2022年4月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本病理学会  

    神経フェリチン症は、フェリチン軽鎖遺伝子の変異による常染色体優性の神経変性疾患で、組織学的には大脳基底核を主体に神経細胞やグリア細胞に鉄染色、抗フェリチン抗体染色ともに陽性の封入体形成がみられる。世界での剖検報告は4例にすぎず、脳以外への同様の封入体沈着は、肝細胞、線維芽細胞、腎尿細管上皮や血管内皮に限られていた。本症例では肺においてマクロファージや肺胞上皮細胞に多数の封入体形成がみられた点で既報告と異なっていた。背景肺は高度の気腫性変化を伴っており、鉄沈着と肺気腫との関連性についても考察する。(著者抄録)

    researchmap

  • 全身性舞踏運動を呈し左鎖骨下動脈拡張術により改善した84歳男性例

    礒田 将徳, 木村 活生, 松永 祐己, 岸田 日帯, 間中 浩, 坂田 勝巳, 上田 直久, 田中 章景

    臨床神経学   62 ( 4 )   314 - 314   2022年4月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • Sensory Ataxic Guillain-Barré Syndrome with Dysgeusia after mRNA COVID-19 Vaccination.

    Shunsuke Ogata, Yoshito Ishi, Keiichiro Asano, Erena Kobayashi, Shun Kubota, Keita Takahashi, Yosuke Miyaji, Yuichi Higashiyama, Hideto Joki, Hiroshi Doi, Michiaki Koga, Hideyuki Takeuchi, Fumiaki Tanaka

    Internal medicine (Tokyo, Japan)   61 ( 11 )   1757 - 1760   2022年3月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Guillain-Barré syndrome (GBS) has occasionally occurred in people who have received coronavirus disease 2019 (COVID-19) vaccines. Dysgeusia is rare symptom of GBS. We herein report a rare case of sensory ataxic GBS with dysgeusia just after the second dose of the Pfizer-BioNTech COVID-19 vaccine. Although autoantibodies against glycolipids were not detected, immunotherapy with intravenous immunoglobulin and methylprednisolone pulse therapy effectively ameliorated the symptoms. Our report suggests that the COVID-19 vaccine may induce various clinical subtypes of GBS, including a rare variant with sensory ataxia and dysgeusia.

    DOI: 10.2169/internalmedicine.8967-21

    PubMed

    researchmap

  • Ultrasonographic evaluation reveals thinning of cervical nerve roots and peripheral nerves in spinal and bulbar muscular atrophy. 国際誌

    Daisuke Watanabe, Hiroshi Tsukamoto, Tatsuya Abe, Ruriko Kitao, Aya Okuma, Masatoshi Mihara, Atsuko Katsumoto, Yukiko Iwahashi, Yuichi Higashiyama, Yosuke Miyaji, Hideto Joki, Hiroshi Doi, Tetsuo Komori, Fumiaki Tanaka

    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology   43 ( 7 )   4267 - 4274   2022年3月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    BACKGROUND: Ultrasonography (US) is a noninvasive and patient-friendly tool for the evaluation of peripheral nerves. In motor neuron diseases, amyotrophic lateral sclerosis (ALS) has been reported to show the atrophy of peripheral nerves on US. However, the US findings are still unclear in spinal and bulbar muscular atrophy (SBMA), an adult-onset lower motor neuron disease caused by an abnormal CAG repeat expansion in the androgen receptor gene. METHODS: We prospectively recruited and evaluated 11 patients with genetically confirmed SBMA and 9 patients with ALS diagnosed according to the revised El Escorial ALS criteria or the Awaji electrodiagnostic criteria. The C5-C7 cervical nerve roots and the median and ulnar nerves were evaluated ultrasonographically. RESULTS: The cross-sectional areas (CSAs) of the C6 and C7 nerve roots, the median nerve in the upper arm and forearm, and the ulnar nerve in the upper arm were smaller in patients with SBMA than those in patients with ALS (p < 0.05), whereas the CSAs of the C5 nerve root and the ulnar nerve in the forearm were not smaller. CONCLUSIONS: US showed that the peripheral nerves in patients with SBMA were thinner than those in patients with ALS despite similar degrees of weakness and motor neuron loss. Possible causes include additional sensory nerve involvement and longer disease duration in patients with SBMA than those in patients with ALS.

    DOI: 10.1007/s10072-022-05969-1

    PubMed

    researchmap

  • Relationship between motor learning and gambling propensity in Parkinson's disease. 国際誌

    Naohisa Ueda, Yuichi Higashiyama, Asami Saito, Katsuo Kimura, Yoshiharu Nakae, Masanao Endo, Hideto Joki, Chiharu Kugimoto, Hitaru Kishida, Hiroshi Doi, Hideyuki Takeuchi, Shigeru Koyano, Fumiaki Tanaka

    Journal of clinical and experimental neuropsychology   44 ( 1 )   50 - 61   2022年2月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    INTRODUCTION: The basal ganglia and related dopaminergic cortical areas are important neural systems underlying motor learning and are also implicated in impulse control disorders (ICDs). Motor learning impairments and ICDs are frequently observed in Parkinson's disease (PD). Nevertheless, the relationship between motor learning ability and ICDs has not been elucidated. METHODS: We examined the relationship between motor learning ability and gambling propensity, a possible symptom for prodromal ICDs, in PD patients. Fifty-nine PD patients without clinical ICDs and 43 normal controls (NC) were administered a visuomotor rotation perturbation task and the Iowa Gambling Task (IGT) to evaluate motor learning ability and gambling propensity, respectively. Participants also performed additional cognitive assessments and underwent brain perfusion SPECT imaging. RESULTS: Better motor learning ability was significantly correlated with lower IGT scores, i.e., higher gambling propensity, in PD patients but not in NC. The higher scores on assessments reflecting prefrontal lobe function and well-preserved blood perfusion in prefrontal areas were correlated with lower IGT scores along with better motor learning ability. CONCLUSIONS: Our findings suggest that better motor learning ability and higher gambling propensity are based on better prefrontal functions, which are in accordance with the theory that the prefrontal cortex is one of the common essential regions for both motor learning and ICDs.

    DOI: 10.1080/13803395.2022.2083083

    PubMed

    researchmap

  • 【Parkinson病および類縁疾患の新しい治療】Parkinson病治療の変遷 過去から現在まで

    木村 活生, 田中 章景

    脳神経内科   96 ( 2 )   127 - 133   2022年2月

     詳細を見る

    記述言語:日本語   出版者・発行元:(有)科学評論社  

    researchmap

  • Biallelic expansion in RFC1 as a rare cause of Parkinson's disease. 国際誌

    Laura Kytövuori, Jussi Sipilä, Hiroshi Doi, Anri Hurme-Niiranen, Ari Siitonen, Eriko Koshimizu, Satoko Miyatake, Naomichi Matsumoto, Fumiaki Tanaka, Kari Majamaa

    NPJ Parkinson's disease   8 ( 1 )   6 - 6   2022年1月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    An intronic expansion (AAGGG)exp in the RFC1 gene has recently been shown to cause recessively inherited cerebellar ataxia, neuropathy, and vestibular areflexia syndrome and, furthermore, a few patients with ataxia and parkinsonism have been reported. We investigated 569 Finnish patients with medicated parkinsonism for RFC1 and found biallelic (AAGGG)exp in three non-consanguineous patients with clinically confirmed Parkinson's disease without ataxia suggesting that RFC1-related disorders include Parkinson's disease as well.

    DOI: 10.1038/s41531-021-00275-7

    PubMed

    researchmap

  • パーキンソン病患者における脊髄刺激療法施行後の運動機能・疼痛スコアの変化

    安部 克哉, 木村 活生, 柳泉 亮太, 東島 威史, 川崎 隆, 岸田 日帯, 上田 直久, 田中 章景

    日本定位・機能神経外科学会プログラム・抄録集   61回   114 - 114   2022年1月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本定位・機能神経外科学会  

    researchmap

  • STN-DBSにおけるGuideXTを用いた刺激導入法の検討

    木村 活生, 岸田 日帯, 東島 威史, 川崎 隆, 上田 直久, 田中 章景

    日本定位・機能神経外科学会プログラム・抄録集   61回   133 - 133   2022年1月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本定位・機能神経外科学会  

    researchmap

  • 脳出血後に発症した片側バリズムに対し脳深部刺激療法を施行した67歳女性例

    山田 亮, 木村 活生, 小林 卓雄, 伊藤 知美, 上村 直哉, 林 紀子, 岸田 日帯, 東島 威史, 川崎 隆, 坂田 勝巳, 上田 直久, 田中 章景

    日本定位・機能神経外科学会プログラム・抄録集   61回   99 - 99   2022年1月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本定位・機能神経外科学会  

    researchmap

  • パーキンソン病患者における脊髄刺激療法施行後の運動機能・疼痛スコアの変化

    安部 克哉, 木村 活生, 柳泉 亮太, 東島 威史, 川崎 隆, 岸田 日帯, 上田 直久, 田中 章景

    日本定位・機能神経外科学会プログラム・抄録集   61回   114 - 114   2022年1月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本定位・機能神経外科学会  

    researchmap

  • 【自律神経と心血管系調節】Parkinson病における血圧日内変動と非運動症状との相関

    上木 英人, 田中 章景

    脳神経内科   96 ( 1 )   80 - 85   2022年1月

     詳細を見る

    記述言語:日本語   出版者・発行元:(有)科学評論社  

    researchmap

  • 左右差のある両下肢筋力低下で発症した成人発症脊髄性筋萎縮症の37歳男性

    薦田 理博, 岸田 日帯, 川口 優花, 上村 直哉, 木村 活生, 上田 直久, 田中 章景

    臨床神経学   62 ( 1 )   83 - 83   2022年1月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 発熱・意識障害で発症し、経過中にocular flutterを呈した抗GFAP抗体陽性髄膜脳炎の39歳男性例

    和田 大司, 東山 雄一, 高橋 慶太, 國井 美紗子, 木村 暁夫, 原 誠, 竹内 英之, 田中 章景

    臨床神経学   62 ( 1 )   80 - 80   2022年1月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • Mutation screening of the DNAJC7 gene in Japanese patients with sporadic amyotrophic lateral sclerosis. 国際誌

    Genki Tohnai, Ryoichi Nakamura, Naoki Atsuta, Masahiro Nakatochi, Naoki Hayashi, Daisuke Ito, Hazuki Watanabe, Hirohisa Watanabe, Masahisa Katsuno, Yuishin Izumi, Akira Taniguchi, Kazuaki Kanai, Mitsuya Morita, Osamu Kano, Satoshi Kuwabara, Masaya Oda, Koji Abe, Masashi Aoki, Ikuko Aiba, Koichi Okamoto, Kouichi Mizoguchi, Tomohiko Ishihara, Akihiro Kawata, Takanori Yokota, Kazuko Hasegawa, Isao Nagano, Ichiro Yabe, Fumiaki Tanaka, Satoshi Kuru, Nobutaka Hattori, Kenji Nakashima, Ryuji Kaji, Gen Sobue

    Neurobiology of aging   113   131 - 136   2021年12月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DNAJC7 has recently been identified as an amyotrophic lateral sclerosis (ALS) gene via large-scale exome analysis, and its involvement in ALS is still unclear in various populations. This study aimed to determine the frequencies and characteristics of the DNAJC7 variants in a Japanese ALS cohort. A total of 807 unrelated Japanese patients with sporadic ALS were screened via exome analysis. In total, we detected six rare missense variants and one splice-site variant of the DNAJC7 gene, which are not reported in the Japanese public database. Furthermore, the missense variants are located around the TPR domain, which is important for the function of DNAJC7. The total frequency of the DNAJC7 variants in Japanese ALS patients was estimated at 0.87%. Collectively, these results suggest that variants of DNAJC7 are rare cause of Japanese patients with sporadic ALS.

    DOI: 10.1016/j.neurobiolaging.2021.12.002

    PubMed

    researchmap

  • "COVID arm" detected by MR neurography. 国際誌

    Hiroyasu Komiya, Kohei Harada, Ryoji Morishita, Shunta Hashiguchi, Mikiko Tada, Kenichi Tanaka, Hiroshi Doi, Hideyuki Takeuchi, Fumiaki Tanaka

    eNeurologicalSci   25   100377 - 100377   2021年12月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.1016/j.ensci.2021.100377

    PubMed

    researchmap

  • 【言語と脳up date】機能画像からみる言語と脳の関係 言語ネットワークはどこまでわかったのか

    東山 雄一, 田中 章景

    神経心理学   37 ( 4 )   272 - 290   2021年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本神経心理学会  

    Broca野,Wernicke野,角回そして弓状束で構成されるWernicke-Geschwindのモデルは,脳の言語モデルとして広く知られている.しかし,詳細な画像検査に裏打ちされた症例の蓄積と,脳機能画像研究を中心とした脳神経科学の進歩を背景に,Broca野やWernicke野以外の様々な脳領域がヒトの言語活動に関与していることが明らかになっている.さらに近年では拡散MRIを用いた数々の物理モデルの登場により,ヒトの白質線維の走行を詳細に評価することが可能となり,多数の機能領域とそれらを橋渡しする複雑な白質線維から構成されるネットワークとして脳を捉える考え方が主流になりつつある.本章では,こうした古典モデルに代わる新たな言語モデルと,その展望について概説を行う.(著者抄録)

    researchmap

  • Ablation of interleukin-19 improves motor function in a mouse model of amyotrophic lateral sclerosis

    Hiroyasu Komiya, Hideyuki Takeuchi, Yuki Ogawa, Kosuke Suzuki, Akihiro Ogasawara, Keita Takahashi, Yasu-Taka Azuma, Hiroshi Doi, Fumiaki Tanaka

    Molecular Brain   14 ( 1 )   2021年12月

     詳細を見る

    掲載種別:研究論文(学術雑誌)   出版者・発行元:Springer Science and Business Media LLC  

    <title>Abstract</title>Neuroinflammation by activated microglia and astrocytes plays a critical role in progression of amyotrophic lateral sclerosis (ALS). Interleukin-19 (IL-19) is a negative-feedback regulator that limits pro-inflammatory responses of microglia in an autocrine and paracrine manner, but it remains unclear how IL-19 contributes to ALS pathogenesis. We investigated the role of IL-19 in ALS using transgenic mice carrying human superoxide dismutase 1 with the G93A mutation (SOD1<sup>G93A</sup> Tg mice). We generated IL-19–deficient SOD1<sup>G93A</sup> Tg (IL-19<sup>−/−</sup>/SOD1<sup>G93A</sup> Tg) mice by crossing SOD1<sup>G93A</sup> Tg mice with IL-19<sup>−/−</sup> mice, and then evaluated disease progression, motor function, survival rate, and pathological and biochemical alternations in the resultant mice. In addition, we assessed the effect of IL-19 on glial cells using primary microglia and astrocyte cultures from the embryonic brains of SOD1<sup>G93A</sup> Tg mice and IL-19<sup>−/−</sup>/SOD1<sup>G93A</sup> Tg mice. Expression of IL-19 in primary microglia and lumbar spinal cord was higher in SOD1<sup>G93A</sup> Tg mice than in wild-type mice. Unexpectedly, IL-19<sup>−/−</sup>/SOD1<sup>G93A</sup> Tg mice exhibited significant improvement of motor function. Ablation of IL-19 in SOD1<sup>G93A</sup> Tg mice increased expression of both neurotoxic and neuroprotective factors, including tumor necrosis factor-α (TNF-α), IL-1β, glial cell line–derived neurotrophic factor (GDNF), and transforming growth factor β1, in lumbar spinal cord. Primary microglia and astrocytes from IL-19<sup>−/−</sup>/SOD1<sup>G93A</sup> Tg mice expressed higher levels of TNF-α, resulting in release of GDNF from astrocytes. Inhibition of IL-19 signaling may alleviate ALS symptoms.

    DOI: 10.1186/s13041-021-00785-8

    researchmap

    その他リンク: https://link.springer.com/article/10.1186/s13041-021-00785-8/fulltext.html

  • Father-to-offspring transmission of extremely long NOTCH2NLC repeat expansions with contractions: genetic and epigenetic profiling with long-read sequencing. 国際誌

    Hiromi Fukuda, Daisuke Yamaguchi, Kristofor Nyquist, Yasushi Yabuki, Satoko Miyatake, Yuri Uchiyama, Kohei Hamanaka, Ken Saida, Eriko Koshimizu, Naomi Tsuchida, Atsushi Fujita, Satomi Mitsuhashi, Kazuyuki Ohbo, Yuki Satake, Jun Sone, Hiroshi Doi, Keisuke Morihara, Tomoko Okamoto, Yuji Takahashi, Aaron M Wenger, Norifumi Shioda, Fumiaki Tanaka, Naomichi Matsumoto, Takeshi Mizuguchi

    Clinical epigenetics   13 ( 1 )   204 - 204   2021年11月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    BACKGROUND: GGC repeat expansions in NOTCH2NLC are associated with neuronal intranuclear inclusion disease. Very recently, asymptomatic carriers with NOTCH2NLC repeat expansions were reported. In these asymptomatic individuals, the CpG island in NOTCH2NLC is hypermethylated, suggesting that two factors repeat length and DNA methylation status should be considered to evaluate pathogenicity. Long-read sequencing can be used to simultaneously profile genomic and epigenomic alterations. We analyzed four sporadic cases with NOTCH2NLC repeat expansion and their phenotypically normal parents. The native genomic DNA that retains base modification was sequenced on a per-trio basis using both PacBio and Oxford Nanopore long-read sequencing technologies. A custom workflow was developed to evaluate DNA modifications. With these two technologies combined, long-range DNA methylation information was integrated with complete repeat DNA sequences to investigate the genetic origins of expanded GGC repeats in these sporadic cases. RESULTS: In all four families, asymptomatic fathers had longer expansions (median: 522, 390, 528 and 650 repeats) compared with their affected offspring (median: 93, 117, 162 and 140 repeats, respectively). These expansions are much longer than the disease-causing range previously reported (in general, 41-300 repeats). Repeat lengths were extremely variable in the father, suggesting somatic mosaicism. Instability is more frequent in alleles with uninterrupted pure GGCs. Single molecule epigenetic analysis revealed complex DNA methylation patterns and epigenetic heterogeneity. We identified an aberrant gain-of-methylation region (2.2 kb in size beyond the CpG island and GGC repeats) in asymptomatic fathers. This methylated region was unmethylated in the normal allele with bilateral transitional zones with both methylated and unmethylated CpG dinucleotides, which may be protected from methylation to ensure NOTCH2NLC expression. CONCLUSIONS: We clearly demonstrate that the four sporadic NOTCH2NLC-related cases are derived from the paternal GGC repeat contraction associated with demethylation. The entire genetic and epigenetic landscape of the NOTCH2NLC region was uncovered using the custom workflow of long-read sequence data, demonstrating the utility of this method for revealing epigenetic/mutational changes in repetitive elements, which are difficult to characterize by conventional short-read/bisulfite sequencing methods. Our approach should be useful for biomedical research, aiding the discovery of DNA methylation abnormalities through the entire genome.

    DOI: 10.1186/s13148-021-01192-5

    PubMed

    researchmap

  • Association between neurosarcoidosis with autonomic dysfunction and anti-ganglionic acetylcholine receptor antibodies. 国際誌

    Makoto Oishi, Akihiro Mukaino, Misako Kunii, Asami Saito, Yukimasa Arita, Haruki Koike, Osamu Higuchi, Yasuhiro Maeda, Norio Abiru, Naohiro Yamaguchi, Hiroaki Kawano, Eiko Tsuiki, Tomonori Tanaka, Hidenori Matsuo, Masahisa Katsuno, Fumiaki Tanaka, Akira Tsujino, Shunya Nakane

    Journal of neurology   268 ( 11 )   4265 - 4279   2021年11月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    OBJECTIVE: To determine whether autonomic dysfunction in neurosarcoidosis is associated with anti-ganglionic acetylcholine receptor (gAChR) antibodies, which are detected in autoimmune autonomic ganglionopathy. METHODS: We retrospectively extracted cases of sarcoidosis from 1787 serum samples of 1,381 patients between 2012 and 2018. Anti-gAChR antibodies against the α3 and β4 subunit were measured by luciferase immunoprecipitation to confirm the clinical features of each case. We summarized literature reviews of neurosarcoidosis with severe dysautonomia to identify relevant clinical features and outcomes. RESULTS: We extracted three new cases of neurosarcoidosis with severe dysautonomia, among which two were positive for anti-gAChR antibodies: Case 1 was positive for antibodies against the β4 subunit, and Case 2 was positive for antibodies against both the α3 and β4 subunits. We reviewed the cases of 15 patients with neurosarcoidosis and severe dysautonomia, including the three cases presented herein. Orthostatic hypotension and orthostatic intolerance were the most common symptoms. Among the various types of neuropathy, small fiber neuropathy (SFN) was the most prevalent, with seven of nine cases exhibiting definite SFN. Six of eight cases had impaired postganglionic fibers, of which the present three cases revealed abnormality of 123I-MIBG myocardial scintigraphy. Of the 11 cases, 10 were responsive to immunotherapy, except one seropositive case (Case 2). CONCLUSIONS: The presence of gAChR antibodies may constitute one of the mechanisms by which dysautonomia arises in neurosarcoidosis.

    DOI: 10.1007/s00415-021-10551-4

    PubMed

    researchmap

  • Seen by a Glance, But Not by a Stare-A Case Study of a Patient With Simultanagnosia. 国際誌

    Keisuke Morihara, Yuichi Higashiyama, Shiori Asano, Yuki Matsunaga, Keita Takahashi, Ryoko Miyake, Kenichi Tanaka, Hideto Joki, Hiroshi Doi, Hideyuki Takeuchi, Fumiaki Tanaka

    Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists   37 ( 4 )   865 - 871   2021年10月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    OBJECTIVE: Simultanagnosia is a rare neuropsychological symptom characterized by difficulty recognizing global structures while preserving perception of local detail. The condition is classified into ventral and dorsal types. Clinical presentation of ventral simultanagnosia includes a reduced ability to recognize multiple visual stimuli rapidly, that is, part-by-part recognition. Here, we report a case of ventral simultanagnosia with a unique presentation; when short-duration visual stimuli were presented, the patient could perform global recognition by improving his part-by-part approach. To investigate the relationship between local and global perception bias and the duration of the present stimulus, we conducted a visual perception test using hierarchically organized Navon figures. METHODS/RESULTS: The patient was a 62-year-old right-handed man who suffered from cerebral infarction in the right occipitotemporal lobe. He had no language dysfunction but exhibited left unilateral neglect, prosopagnosia, and ventral-type simultanagnosia. We conducted a visual perception test using the Navon figures and control figures as a visual stimulus. We randomly presented the figures for intervals of 0.2 or 20 s and let the patient report all the letters (global and/or local element) that he recognized. Global elements of the Navon letter were recognized a rate of 0% and 78.3% at intervals of 20 and 0.2 s, respectively, indicating that shorter presentation made the part-by-part approach less likely to manifest. CONCLUSIONS: We assumed that the simultanagnosia in this case was caused by failure to maintain the initially perceived global information for a long period of time during visual presentation, due to right occipitotemporal damage.

    DOI: 10.1093/arclin/acab088

    PubMed

    researchmap

  • Molecular epidemiology of hereditary ataxia in Finland. 国際誌

    Joonas Lipponen, Seppo Helisalmi, Joose Raivo, Ari Siitonen, Hiroshi Doi, Harri Rusanen, Maria Lehtilahti, Mervi Ryytty, Markku Laakso, Fumiaki Tanaka, Kari Majamaa, Laura Kytövuori

    BMC neurology   21 ( 1 )   382 - 382   2021年10月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    BACKGROUND: The genetics of cerebellar ataxia is complex. Hundreds of causative genes have been identified, but only a few cause more than single cases. The spectrum of ataxia-causing genes differs considerably between populations. The aim of the study was to investigate the molecular epidemiology of ataxia in the Finnish population. PATIENTS AND METHODS: All patients in hospital database were reviewed for the diagnosis of unspecified ataxia. Acquired ataxias and nongenetic ataxias such as those related to infection, trauma or stroke were excluded. Sixty patients with sporadic ataxia with unknown etiology and 36 patients with familial ataxia of unknown etiology were recruited in the study. Repeat expansions in the SCA genes (ATXN1, 2, 3, 7, 8/OS, CACNA1A, TBP), FXN, and RFC1 were determined. Point mutations in POLG, SPG7 and in mitochondrial DNA (mtDNA) were investigated. In addition, DNA from 8 patients was exome sequenced. RESULTS: A genetic cause of ataxia was found in 33 patients (34.4%). Seven patients had a dominantly inherited repeat expansion in ATXN8/OS. Ten patients had mitochondrial ataxia resulting from mutations in nuclear mitochondrial genes POLG or RARS2, or from a point mutation m.8561C > G or a single deletion in mtDNA. Interestingly, five patients were biallelic for the recently identified pathogenic repeat expansion in RFC1. All the five patients presented with the phenotype of cerebellar ataxia, neuropathy, and vestibular areflexia (CANVAS). Moreover, screening of 54 patients with Charcot-Marie-Tooth neuropathy revealed four additional patients with biallelic repeat expansion in RFC1, but none of them had cerebellar symptoms. CONCLUSIONS: Expansion in ATXN8/OS results in the majority of dominant ataxias in Finland, while mutations in RFC1 and POLG are the most common cause of recessive ataxias. Our results suggest that analysis of RFC1 should be included in the routine diagnostics of idiopathic ataxia and Charcot-Marie-Tooth polyneuropathy.

    DOI: 10.1186/s12883-021-02409-z

    PubMed

    researchmap

  • IL-19欠損はALSモデルマウスの運動機能改善をもたらす

    古宮 裕泰, 竹内 英之, 小川 有紀, 小笠原 陽大, 高橋 慶太, 田中 章景

    神経免疫学   26 ( 1 )   139 - 139   2021年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経免疫学会  

    researchmap

  • Therapeutic efficacy of heparin and direct factor Xa inhibitors in cancer-associated cryptogenic ischemic stroke with venous thromboembolism

    Genpei Yamaura, Takeshi Ito, Yosuke Miyaji, Naohisa Ueda, Yoshiharu Nakae, Takayuki Momoo, Tatsu Nakano, Yuji Johmura, Yuichi Higashiyama, Hideto Joki, Hiroshi Doi, Hideyuki Takeuchi, Tatsuya Takahashi, Shigeru Koyano, Shigeki Yamaguchi, Mutsumi Yokoyama, Fumiaki Tanaka

    Thrombosis Research   206   99 - 103   2021年10月

     詳細を見る

    掲載種別:研究論文(学術雑誌)   出版者・発行元:Elsevier BV  

    DOI: 10.1016/j.thromres.2021.08.016

    researchmap

  • フィンゴリモド治療中の多発性硬化症患者におけるCOVID-19の経過

    岸田 日帯, 木村 活生, 林 紀子, 上村 直哉, 小林 卓雄, 伊藤 知美, 山田 亮, 上田 直久, 田中 章景

    神経免疫学   26 ( 1 )   145 - 145   2021年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経免疫学会  

    researchmap

  • Therapeutic efficacy of heparin and direct factor Xa inhibitors in cancer-associated cryptogenic ischemic stroke with venous thromboembolism. 国際誌

    Genpei Yamaura, Takeshi Ito, Yosuke Miyaji, Naohisa Ueda, Yoshiharu Nakae, Takayuki Momoo, Tatsu Nakano, Yuji Johmura, Yuichi Higashiyama, Hideto Joki, Hiroshi Doi, Hideyuki Takeuchi, Tatsuya Takahashi, Shigeru Koyano, Shigeki Yamaguchi, Mutsumi Yokoyama, Fumiaki Tanaka

    Thrombosis research   206   99 - 103   2021年10月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    BACKGROUND: Anticoagulation therapy, especially using heparin or recently developed oral direct factor Xa inhibitors (DiXals), is recommended as first-line treatment for cancer-related venous thromboembolism (VTE). However, the preventive efficacy of these anticoagulants for cancer-associated ischemic stroke is still unknown. We retrospectively investigated the efficacy of subcutaneous unfractionated heparin (UFH) and DiXals for preventing the recurrence of cancer-associated cryptogenic ischemic stroke with VTE. METHODS: We retrospectively studied consecutive patients with cancer-associated cryptogenic ischemic stroke and comorbid VTE who received subcutaneous UFH or oral DiXaIs at 9 hospitals. RESULT: Fifty-three patients (24 treated with UFH and 29 treated with DiXaIs) were enrolled. Of these, 47 demonstrated systemic metastasis (cancer stage IV). During 30-day follow-up after initiation of anticoagulation therapy, recurrent ischemic stroke was observed in only 1 patient (4%) in the UFH group and in 9 patients (31%) in the DiXal group. The incidence of major bleeding complications was similar between the 2 groups (4% and 10%, respectively). The cumulative risk of ischemic stroke recurrence within 30 days was lower with UFH than with DiXals (competing risk analysis, p = 0.008). In the DiXal group, patients who experienced recurrence showed significantly higher D-dimer levels than those without recurrence. CONCLUSION: In patients with cancer-associated cryptogenic ischemic stroke and comorbid VTE, UFH demonstrated a lower rate of recurrent ischemic stroke than DiXaIs, and there were no differences in bleeding risk between the 2 treatments. D-dimer levels at stroke onset increased the risk of recurrence in the DiXal group but not in the UFH group.

    DOI: 10.1016/j.thromres.2021.08.016

    PubMed

    researchmap

  • 多発性硬化症治療薬siponimodのグリア細胞における作用機序

    小笠原 陽大, 古宮 裕泰, 小川 有紀, 高橋 慶太, 竹内 英之, 田中 章景

    神経免疫学   26 ( 1 )   129 - 129   2021年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経免疫学会  

    researchmap

  • Usefulness of rapid MR angiography using two-point Dixon for evaluating carotid and aortic plaques. 国際誌

    Keisuke Morihara, Tatsu Nakano, Kentaro Mori, Issei Fukui, Motohiro Nomura, Keiichiro Suzuki, Kenichi Hirano, Mitsuyuki Takahashi, Hideyuki Takeuchi, Hiroshi Doi, Yoshihisa Kitamura, Fumiaki Tanaka

    Neuroradiology   64 ( 4 )   693 - 702   2021年9月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    PURPOSE: Recently, various magnetic resonance imaging (MRI) modalities have been developed to easily detect carotid and aortic plaques, but these techniques are time-consuming and vulnerable to motion artifacts. We investigated the utility of a gradient echo MRI technique known as liver acquisition with volume acceleration flexible (LAVA-Flex) to detect carotid and aortic atherosclerotic plaques. METHODS: Ten patients who underwent carotid endarterectomy (CEA) were assessed regarding the correspondence between LAVA-Flex findings and the histopathology of excised carotid plaques. In addition, 47 patients with cryptogenic ischemic stroke underwent LAVA-Flex and transesophageal echocardiography (TEE) for detection of embolic sources in the thoracic aorta. We analyzed the relationship between the thickness of the aortic plaque measured by TEE and the presence of high-intensity lesions on LAVA-Flex. RESULTS: Nine of 10 patients (90.0%) who underwent CEA showed a high-intensity carotid lesion on LAVA-Flex, which corresponded pathologically to plaques containing large lipid cores and hemorrhage. Twenty-four (51.1%) of 47 cryptogenic stroke patients showed a high-intensity lesion in the thoracic aorta on LAVA-Flex; of these, 21 (87.5%) also demonstrated a large plaque (thickness ≥4 mm) on TEE. Twenty-two (95.7%) of 23 patients without a high-intensity lesion on LAVA-Flex demonstrated no large plaque on TEE. LAVA-Flex had a sensitivity of 95.5% and a specificity of 88.0% in patients with large plaques. CONCLUSION: This study showed that LAVA-Flex successfully detected carotid and aortic plaques. This imaging technique may be useful to rapidly diagnose and evaluate carotid and aortic plaques, which are critical risk factors for aortogenic stroke.

    DOI: 10.1007/s00234-021-02812-w

    PubMed

    researchmap

  • Erratum to: Complete sequencing of expanded SAMD12 repeats by long-read sequencing and Cas9-mediated enrichment. 国際誌

    Takeshi Mizuguchi, Tomoko Toyota, Satoko Miyatake, Satomi Mitsuhashi, Hiroshi Doi, Yosuke Kudo, Hitaru Kishida, Noriko Hayashi, Rie S Tsuburaya, Masako Kinoshita, Tetsuhiro Fukuyama, Hiromi Fukuda, Eriko Koshimizu, Naomi Tsuchida, Yuri Uchiyama, Atsushi Fujita, Atsushi Takata, Noriko Miyake, Mitsuhiro Kato, Fumiaki Tanaka, Hiroaki Adachi, Naomichi Matsumoto

    Brain : a journal of neurology   144 ( 8 )   e67   2021年9月

     詳細を見る

    記述言語:英語  

    DOI: 10.1093/brain/awab183

    PubMed

    researchmap

  • パーキンソン病における運動学習後の転移の障害

    上田 直久, 東山 雄一, 森原 啓介, 北澤 悠, 木村 活生, 上木 英人, 土井 宏, 岸田 日帯, 児矢野 繁, 竹内 英之, 田中 章景

    臨床神経学   61 ( Suppl. )   S236 - S236   2021年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 脊髄性筋萎縮症9例に対するヌシネルセンNa髄注の効果(第2報)

    岸田 日帯, 木村 活生, 川口 優花, 松永 祐己, 上村 直哉, 薦田 理博, 礒田 将徳, 上田 直久, 田中 章景

    臨床神経学   61 ( Suppl. )   S322 - S322   2021年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • パーキンソン病における認知機能低下の予測因子としての血圧日内変動関連因子の検討

    上木 英人, 宮地 洋輔, 北澤 悠, 東山 雄一, 木村 活生, 岸田 日帯, 上田 直久, 土井 宏, 竹内 英之, 田中 章景

    臨床神経学   61 ( Suppl. )   S350 - S350   2021年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • パーキンソン病における認知機能低下の予測因子としての血圧日内変動関連因子の検討

    上木 英人, 宮地 洋輔, 北澤 悠, 東山 雄一, 木村 活生, 岸田 日帯, 上田 直久, 土井 宏, 竹内 英之, 田中 章景

    臨床神経学   61 ( Suppl. )   S350 - S350   2021年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • パーキンソン病における運動学習後の転移の障害

    上田 直久, 東山 雄一, 森原 啓介, 北澤 悠, 木村 活生, 上木 英人, 土井 宏, 岸田 日帯, 児矢野 繁, 竹内 英之, 田中 章景

    臨床神経学   61 ( Suppl. )   S236 - S236   2021年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 脊髄性筋萎縮症9例に対するヌシネルセンNa髄注の効果(第2報)

    岸田 日帯, 木村 活生, 川口 優花, 松永 祐己, 上村 直哉, 薦田 理博, 礒田 将徳, 上田 直久, 田中 章景

    臨床神経学   61 ( Suppl. )   S322 - S322   2021年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • Qualitative Deficits in Verbal Fluency in Parkinson’s Disease with Mild Cognitive Impairment: A Clinical and Neuroimaging Study

    Tomoya Hamada, Yuichi Higashiyama, Asami Saito, Keisuke Morihara, Ramon Landin-Romero, Mitsuo Okamoto, Katsuo Kimura, Yousuke Miyaji, Hideto Joki, Hitaru Kishida, Hiroshi Doi, Naohisa Ueda, Hideyuki Takeuchi, Fumiaki Tanaka

    Journal of Parkinson's Disease   1 - 12   2021年8月

     詳細を見る

    掲載種別:研究論文(学術雑誌)   出版者・発行元:IOS Press  

    Background: Mild cognitive impairment (MCI) in Parkinson’s disease (PD) is considered a risk factor for PD with dementia (PDD). Verbal fluency tasks are widely used to assess executive function in PDD. However, in cases of PD with MCI (PD-MCI), the relative diagnostic accuracy of different qualitative verbal fluency measures and their related neural mechanisms remain unknown. Objective: This study aimed to investigate the relative diagnostic accuracy of qualitative (clustering and switching) verbal fluency strategies and their correlates with functional imaging in PD-MCI. Methods: Forty-five patients with PD (26 with MCI and 19 without MCI) and 25 healthy controls underwent comprehensive neurocognitive testing and resting-state functional magnetic resonance imaging. MCI in patients with PD was diagnosed according to established clinical criteria. The diagnostic accuracy of verbal fluency measures was determined via receiver operating characteristic analysis. Changes in brain functional connectivity between groups and across clinical measures were assessed using seed-to-voxel analyses. Results: Patients with PD-MCI generated fewer words and switched less frequently in semantic and phonemic fluency tasks compared to other groups. Switching in semantic fluency showed high diagnostic accuracy for PD-MCI and was associated with reduced functional connectivity in the salience network. Conclusion: Our results indicate that reduced switching in semantic fluency tasks is a sensitive and specific marker for PD-MCI. Qualitative verbal fluency deficits and salience network dysfunction represent early clinical changes observed in PD-MCI.

    DOI: 10.3233/jpd-202473

    researchmap

  • STN-DBSにおけるGuideXTを用いた刺激導入法の検討

    木村 活生, 岸田 日帯, 宮地 洋輔, 東山 雄一, 上木 英人, 土井 宏, 竹内 英之, 東島 威史, 川崎 隆, 上田 直久, 田中 章景

    パーキンソン病・運動障害疾患コングレスプログラム・抄録集   15回   94 - 94   2021年7月

     詳細を見る

    記述言語:日本語   出版者・発行元:Movement Disorder Society of Japan (MDSJ)  

    researchmap

  • Bedside video-oculographic evaluation of eye movements in acute supratentorial stroke patients: A potential biomarker for hemispatial neglect. 国際誌

    Yosuke Kudo, Koji Takahashi, Eriko Sugawara, Tomoki Nakamizo, Miho Kuroki, Yuichi Higashiyama, Fumiaki Tanaka, Ken Johkura

    Journal of the neurological sciences   425   117442 - 117442   2021年6月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    BACKGROUND AND PURPOSE: The presence of hemispatial neglect adversely affects functional outcomes in stroke patients; consequently, it warrants early targeted rehabilitative intervention. Nevertheless, hemispatial neglect in the acute phase of stroke has often been underdiagnosed. In this study, we aimed to detect hemispatial neglect at the bedside in acute stroke patients by measuring eye movements using video-oculography (VOG). METHODS: Forty-seven patients with acute unilateral supratentorial stroke were enrolled. We quantitatively measured horizontal saccade (latency, velocity, and amplitude) and smooth pursuit (gain) at the bedside using VOG and compared these variables with scores on the Behavioral Inattention Test (BIT), a screening battery to assess hemispatial neglect. RESULTS: Contralesional saccade latency, velocity, and amplitude, and ipsilesional smooth pursuit gain were suppressed compared with those in the opposite directions (p = 0.08, 0.02, 0.04, and 0.02, respectively). These directional ocular hypokinesia values correlated with the total BIT score (correlation coefficients -0.53, 0.48, 0.51, and 0.39, respectively). The association was significant even after adjusting for age and stroke severity. CONCLUSIONS: Eye movement measurements performed using VOG significantly correlated with the tendency for hemispatial neglect in acute supratentorial stroke patients. Bedside VOG measurement may be a simple biomarker for detecting hemispatial neglect even in patients in the supine position during the acute phase of stroke.

    DOI: 10.1016/j.jns.2021.117442

    PubMed

    researchmap

  • Improvement in callosal disconnection syndrome with recovery of callosal connectivity. 国際誌

    Keisuke Morihara, Kazuo Kakinuma, Erena Kobayashi, Nobuko Kawakami, Wataru Narita, Shigenori Kanno, Fumiaki Tanaka, Kyoko Suzuki

    Neurocase   27 ( 3 )   323 - 331   2021年6月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Recent advancements in radiological techniques have enabled the observation of the topographic distribution of the human corpus callosum. However, its functional connectivity remains to be elucidated. The symptoms of callosal disconnection syndrome (CDS) can potentially reveal the functional connections between the cerebral hemispheres. Herein, we report a patient with CDS, whose callosal lesion was restricted to the posterior midbody, isthmus, and an anterior part of the dorsal splenium. A 53-year-old right-handed woman demonstrated CDS following cerebral infarction associated with subarachnoid hemorrhage. She exhibited CDS including ideomotor apraxia, and tactile anomia with the left hand, cross-replication of hand postures, cross-localization of the fingers, and constructional impairment with the right hand. Six months after onset, the left-handed ideomotor apraxia on imitation improved, but that to command did not, which indicated the difference in the nature of the transcallosal connections between ideomotor apraxia on imitation and ideomotor apraxia to command. Longitudinal CDS observation and corpus callosum tractography will prove useful in expanding our understanding of the nature of the organization of interhemispheric information transference.

    DOI: 10.1080/13554794.2021.1959935

    PubMed

    researchmap

  • 【進行性失語】進行性非流暢性失語症・非流暢/失文法型原発性進行性失語症

    東山 雄一, 田中 章景

    脳神経内科   94 ( 6 )   743 - 752   2021年6月

     詳細を見る

    記述言語:日本語   出版者・発行元:(有)科学評論社  

    researchmap

  • Complete sequencing of expanded SAMD12 repeats by long-read sequencing and Cas9-mediated enrichment. 国際誌

    Takeshi Mizuguchi, Tomoko Toyota, Satoko Miyatake, Satomi Mitsuhashi, Hiroshi Doi, Yosuke Kudo, Hitaru Kishida, Noriko Hayashi, Rie S Tsuburaya, Masako Kinoshita, Tetsuhiro Fukuyama, Hiromi Fukuda, Eriko Koshimizu, Naomi Tsuchida, Yuri Uchiyama, Atsushi Fujita, Atsushi Takata, Noriko Miyake, Mitsuhiro Kato, Fumiaki Tanaka, Hiroaki Adachi, Naomichi Matsumoto

    Brain : a journal of neurology   144 ( 4 )   1103 - 1117   2021年5月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    A pentanucleotide TTTCA repeat insertion into a polymorphic TTTTA repeat element in SAMD12 causes benign adult familial myoclonic epilepsy. Although the precise determination of the entire SAMD12 repeat sequence is important for molecular diagnosis and research, obtaining this sequence remains challenging when using conventional genomic/genetic methods, and even short-read and long-read next-generation sequencing technologies have been insufficient. Incomplete information regarding expanded repeat sequences may hamper our understanding of the pathogenic roles played by varying numbers of repeat units, genotype-phenotype correlations, and mutational mechanisms. Here, we report a new approach for the precise determination of the entire expanded repeat sequence and present a workflow designed to improve the diagnostic rates in various repeat expansion diseases. We examined 34 clinically diagnosed benign adult familial myoclonic epilepsy patients, from 29 families using repeat-primed PCR, Southern blot, and long-read sequencing with Cas9-mediated enrichment. Two cases with questionable results from repeat-primed PCR and/or Southern blot were confirmed as pathogenic using long-read sequencing with Cas9-mediated enrichment, resulting in the identification of pathogenic SAMD12 repeat expansions in 76% of examined families (22/29). Importantly, long-read sequencing with Cas9-mediated enrichment was able to provide detailed information regarding the sizes, configurations, and compositions of the expanded repeats. The inserted TTTCA repeat size and the proportion of TTTCA sequences among the overall repeat sequences were highly variable, and a novel repeat configuration was identified. A genotype-phenotype correlation study suggested that the insertion of even short (TTTCA)14 repeats contributed to the development of benign adult familial myoclonic epilepsy. However, the sizes of the overall TTTTA and TTTCA repeat units are also likely to be involved in the pathology of benign adult familial myoclonic epilepsy. Seven unsolved SAMD12-negative cases were investigated using whole-genome long-read sequencing, and infrequent, disease-associated, repeat expansions were identified in two cases. The strategic workflow resolved two questionable SAMD12-positive cases and two previously SAMD12-negative cases, increasing the diagnostic yield from 69% (20/29 families) to 83% (24/29 families). This study indicates the significant utility of long-read sequencing technologies to explore the pathogenic contributions made by various repeat units in complex repeat expansions and to improve the overall diagnostic rate.

    DOI: 10.1093/brain/awab021

    PubMed

    researchmap

  • Azure Lunulae and Leukoencephalopathy in Wilson Disease.

    Hiroko Hori, Yosuke Kudo, Yoshiyuki Kuroiwa, Fumiaki Tanaka

    Internal medicine (Tokyo, Japan)   60 ( 9 )   1479 - 1479   2021年5月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.2169/internalmedicine.5417-20

    PubMed

    researchmap

  • Ablation of interleukin-19 improves motor function in a mouse model of amyotrophic lateral sclerosis. 国際誌

    Hiroyasu Komiya, Hideyuki Takeuchi, Yuki Ogawa, Kosuke Suzuki, Akihiro Ogasawara, Keita Takahashi, Yasu-Taka Azuma, Hiroshi Doi, Fumiaki Tanaka

    Molecular brain   14 ( 1 )   74 - 74   2021年4月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Neuroinflammation by activated microglia and astrocytes plays a critical role in progression of amyotrophic lateral sclerosis (ALS). Interleukin-19 (IL-19) is a negative-feedback regulator that limits pro-inflammatory responses of microglia in an autocrine and paracrine manner, but it remains unclear how IL-19 contributes to ALS pathogenesis. We investigated the role of IL-19 in ALS using transgenic mice carrying human superoxide dismutase 1 with the G93A mutation (SOD1G93A Tg mice). We generated IL-19-deficient SOD1G93A Tg (IL-19-/-/SOD1G93A Tg) mice by crossing SOD1G93A Tg mice with IL-19-/- mice, and then evaluated disease progression, motor function, survival rate, and pathological and biochemical alternations in the resultant mice. In addition, we assessed the effect of IL-19 on glial cells using primary microglia and astrocyte cultures from the embryonic brains of SOD1G93A Tg mice and IL-19-/-/SOD1G93A Tg mice. Expression of IL-19 in primary microglia and lumbar spinal cord was higher in SOD1G93A Tg mice than in wild-type mice. Unexpectedly, IL-19-/-/SOD1G93A Tg mice exhibited significant improvement of motor function. Ablation of IL-19 in SOD1G93A Tg mice increased expression of both neurotoxic and neuroprotective factors, including tumor necrosis factor-α (TNF-α), IL-1β, glial cell line-derived neurotrophic factor (GDNF), and transforming growth factor β1, in lumbar spinal cord. Primary microglia and astrocytes from IL-19-/-/SOD1G93A Tg mice expressed higher levels of TNF-α, resulting in release of GDNF from astrocytes. Inhibition of IL-19 signaling may alleviate ALS symptoms.

    DOI: 10.1186/s13041-021-00785-8

    PubMed

    researchmap

  • Association between neurosarcoidosis with autonomic dysfunction and anti-ganglionic acetylcholine receptor antibodies. 国際誌

    Makoto Oishi, Akihiro Mukaino, Misako Kunii, Asami Saito, Yukimasa Arita, Haruki Koike, Osamu Higuchi, Yasuhiro Maeda, Norio Abiru, Naohiro Yamaguchi, Hiroaki Kawano, Eiko Tsuiki, Tomonori Tanaka, Hidenori Matsuo, Masahisa Katsuno, Fumiaki Tanaka, Akira Tsujino, Shunya Nakane

    Journal of neurology   268 ( 11 )   4265 - 4279   2021年4月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    OBJECTIVE: To determine whether autonomic dysfunction in neurosarcoidosis is associated with anti-ganglionic acetylcholine receptor (gAChR) antibodies, which are detected in autoimmune autonomic ganglionopathy. METHODS: We retrospectively extracted cases of sarcoidosis from 1787 serum samples of 1,381 patients between 2012 and 2018. Anti-gAChR antibodies against the α3 and β4 subunit were measured by luciferase immunoprecipitation to confirm the clinical features of each case. We summarized literature reviews of neurosarcoidosis with severe dysautonomia to identify relevant clinical features and outcomes. RESULTS: We extracted three new cases of neurosarcoidosis with severe dysautonomia, among which two were positive for anti-gAChR antibodies: Case 1 was positive for antibodies against the β4 subunit, and Case 2 was positive for antibodies against both the α3 and β4 subunits. We reviewed the cases of 15 patients with neurosarcoidosis and severe dysautonomia, including the three cases presented herein. Orthostatic hypotension and orthostatic intolerance were the most common symptoms. Among the various types of neuropathy, small fiber neuropathy (SFN) was the most prevalent, with seven of nine cases exhibiting definite SFN. Six of eight cases had impaired postganglionic fibers, of which the present three cases revealed abnormality of 123I-MIBG myocardial scintigraphy. Of the 11 cases, 10 were responsive to immunotherapy, except one seropositive case (Case 2). CONCLUSIONS: The presence of gAChR antibodies may constitute one of the mechanisms by which dysautonomia arises in neurosarcoidosis.

    DOI: 10.1007/s00415-021-10551-4

    PubMed

    researchmap

  • Interleukin‐19 ameliorates experimental autoimmune encephalitis

    Hideyuki Takeuchi, Hiroshi Horiuchi, Bijay Parajuli, Hiroyasu Komiya, Fumiaki Tanaka, Akio Suzumura

    Clinical and Experimental Neuroimmunology   2021年4月

     詳細を見る

    掲載種別:研究論文(学術雑誌)   出版者・発行元:Wiley  

    DOI: 10.1111/cen3.12642

    researchmap

    その他リンク: https://onlinelibrary.wiley.com/doi/full-xml/10.1111/cen3.12642

  • SGTA associates with intracellular aggregates in neurodegenerative diseases. 国際誌

    Shun Kubota, Hiroshi Doi, Shigeru Koyano, Kenichi Tanaka, Hiroyasu Komiya, Atsuko Katsumoto, Shingo Ikeda, Shunta Hashiguchi, Haruko Nakamura, Ryoko Fukai, Keita Takahashi, Misako Kunii, Mikiko Tada, Hideyuki Takeuchi, Fumiaki Tanaka

    Molecular brain   14 ( 1 )   59 - 59   2021年3月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Intracellular aggregates are a common pathological hallmark of neurodegenerative diseases such as polyglutamine (polyQ) diseases, amyotrophic lateral sclerosis (ALS), Parkinson's disease (PD), and multiple system atrophy (MSA). Aggregates are mainly formed by aberrant disease-specific proteins and are accompanied by accumulation of other aggregate-interacting proteins. Although aggregate-interacting proteins have been considered to modulate the formation of aggregates and to be involved in molecular mechanisms of disease progression, the components of aggregate-interacting proteins remain unknown. In this study, we showed that small glutamine-rich tetratricopeptide repeat-containing protein alfa (SGTA) is an aggregate-interacting protein in neurodegenerative diseases. Immunohistochemistry showed that SGTA interacted with intracellular aggregates in Huntington disease (HD) cell models and neurons of HD model mice. We also revealed that SGTA colocalized with intracellular aggregates in postmortem brains of patients with polyQ diseases including spinocerebellar ataxia (SCA)1, SCA2, SCA3, and dentatorubral-pallidoluysian atrophy. In addition, SGTA colocalized with glial cytoplasmic inclusions in the brains of MSA patients, whereas no accumulation of SGTA was observed in neurons of PD and ALS patients. In vitro study showed that SGTA bound to polyQ aggregates through its C-terminal domain and SGTA overexpression reduced intracellular aggregates. These results suggest that SGTA may play a role in the formation of aggregates and may act as potential modifier of molecular pathological mechanisms of polyQ diseases and MSA.

    DOI: 10.1186/s13041-021-00770-1

    PubMed

    researchmap

  • 【マルチリンガルブレイン】Foreign Accent Syndrome

    東山 雄一, 田中 章景

    BRAIN and NERVE: 神経研究の進歩   73 ( 3 )   0257 - 0263   2021年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)医学書院  

    <文献概要>Foreign accent syndromeとは「外国語のようだ」という違和感を持つ発話障害を特徴とした症候群である。これまで100例以上の報告がなされ,構音の歪みや音韻性錯語などの分節素の障害,高低・強弱・リズム異常などの超分節素の障害が特徴とされている。脳卒中以外にもさまざまな原因疾患が知られ,その責任病巣も多様である。原因も病巣もさまざまであることから,症候群として扱うほどの一貫性・普遍性があるのかなど,問題が山積している。

    researchmap

  • [Foreign Accent Syndrome].

    Yuichi Higashiyama, Fumiaki Tanaka

    Brain and nerve = Shinkei kenkyu no shinpo   73 ( 3 )   257 - 263   2021年3月

     詳細を見る

    記述言語:日本語   掲載種別:研究論文(学術雑誌)  

    Foreign accent syndrome (FAS) is a rare speech disorder characterized by the emergence of a foreign accent. To date, more than a hundred cases of FAS have been reported, and the impression of accent change is regarded to be the result of a combination of segmental deficits (i.e., phonetic distortions and phonemic paraphasias) and supra-segmental changes (i.e., stress, pitch, or rhythm variation). The most common etiology of FAS is stroke, followed by other causes. Various lesion locations have been identified to cause FAS. Owing to various heterogeneous etiologies and lesion locations, it remains controversial whether there is enough consistency or universality to treat FAS as a "syndrome".

    DOI: 10.11477/mf.1416201748

    PubMed

    researchmap

  • De novo ATP1A3 variants cause polymicrogyria. 国際誌

    Satoko Miyatake, Mitsuhiro Kato, Takuma Kumamoto, Tomonori Hirose, Eriko Koshimizu, Takaaki Matsui, Hideyuki Takeuchi, Hiroshi Doi, Keisuke Hamada, Mitsuko Nakashima, Kazunori Sasaki, Akio Yamashita, Atsushi Takata, Kohei Hamanaka, Mai Satoh, Takabumi Miyama, Yuri Sonoda, Momoko Sasazuki, Hiroyuki Torisu, Toshiro Hara, Yasunari Sakai, Yushi Noguchi, Mazumi Miura, Yoko Nishimura, Kazuyuki Nakamura, Hideyuki Asai, Nodoka Hinokuma, Fuyuki Miya, Tatsuhiko Tsunoda, Masami Togawa, Yukihiro Ikeda, Nobusuke Kimura, Kaoru Amemiya, Asako Horino, Masataka Fukuoka, Hiroko Ikeda, Goni Merhav, Nina Ekhilevitch, Masaki Miura, Takeshi Mizuguchi, Noriko Miyake, Atsushi Suzuki, Shouichi Ohga, Hirotomo Saitsu, Hidehisa Takahashi, Fumiaki Tanaka, Kazuhiro Ogata, Chiaki Ohtaka-Maruyama, Naomichi Matsumoto

    Science advances   7 ( 13 )   2021年3月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Polymicrogyria is a common malformation of cortical development whose etiology remains elusive. We conducted whole-exome sequencing for 124 patients with polymicrogyria and identified de novo ATP1A3 variants in eight patients. Mutated ATP1A3 causes functional brain diseases, including alternating hemiplegia of childhood (AHC), rapid-onset dystonia parkinsonism (RDP), and cerebellar ataxia, areflexia, pes cavus, optic nerve atrophy, and sensorineural deafness (CAPOS). However, our patients showed no clinical features of AHC, RDP, or CAPOS and had a completely different phenotype: a severe form of polymicrogyria with epilepsy and developmental delay. Detected variants had different locations in ATP1A3 and different functional properties compared with AHC-, RDP-, or CAPOS-associated variants. In the developing cerebral cortex of mice, radial neuronal migration was impaired in neurons overexpressing the ATP1A3 variant of the most severe patients, suggesting that this variant is involved in cortical malformation pathogenesis. We propose a previously unidentified category of polymicrogyria associated with ATP1A3 abnormalities.

    DOI: 10.1126/sciadv.abd2368

    PubMed

    researchmap

  • Two distinct mechanisms of neuropathy in immunoglobulin light chain (AL) amyloidosis. 国際誌

    Haruki Koike, Naohiro Mouri, Yuki Fukami, Masahiro Iijima, Koji Matsuo, Nobuyasu Yagi, Asami Saito, Haruko Nakamura, Keita Takahashi, Yoshiharu Nakae, Yohei Okada, Fumiaki Tanaka, Gen Sobue, Masahisa Katsuno

    Journal of the neurological sciences   421   117305 - 117305   2021年2月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    INTRODUCTION: Although polyneuropathy in patients with immunoglobulin light chain (AL) amyloidosis has been considered to be attributable to axonal degeneration resulting from amyloid deposition, patients with nerve conduction parameters indicating demyelination that mimics chronic inflammatory demyelinating polyneuropathy (CIDP) have also been reported anecdotally. METHODS: We evaluated the electrophysiological and pathological features of 8 consecutive patients with AL amyloidosis who were referred for sural nerve biopsy. RESULTS: Although findings of axonal neuropathy predominantly in the lower limbs were the cardinal feature, all patients showed one or more abnormalities of nerve conduction velocities or distal motor latencies. In particular, 2 of these patients fulfilled the definite electrophysiological for CIDP defined by the European Federation of Neurological Societies/Peripheral Nerve Society (EFNS/PNS). On electron microscopic examination of sural nerve biopsy specimens, Schwann cells apposed to amyloid fibrils became atrophic in all patients, suggesting that amyloid deposits directly affect neighboring tissues. Additionally, detachment of the neurilemma from the outermost compacted myelin lamella was seen where amyloid fibrils were absent in 4 patients. Electrophysiological findings suggestive of demyelination were more conspicuous in these patients compared with the other patients. The detachment of the neurilemma from the outermost compacted myelin lamella was particularly conspicuous in patients who fulfilled the definite EFNS/PNS electrophysiological criteria for CIDP. CONCLUSION: Abnormalities of myelinated fibers unrelated to amyloid deposition may frequently occur in AL amyloidosis. Disjunction between myelin and the neurilemma may induce nerve conduction abnormalities suggestive of demyelination.

    DOI: 10.1016/j.jns.2020.117305

    PubMed

    researchmap

  • The identified clinical features of Parkinson's disease in homo-, heterozygous and digenic variants of PINK1. 国際誌

    Arisa Hayashida, Yuanzhe Li, Hiroyo Yoshino, Kensuke Daida, Aya Ikeda, Kotaro Ogaki, Atsuhito Fuse, Akio Mori, Masashi Takanashi, Toshiki Nakahara, Asako Yoritaka, Yuji Tomizawa, Yoshiaki Furukawa, Kazuaki Kanai, Yoshiaki Nakayama, Hidefumi Ito, Mieko Ogino, Yuko Hattori, Tatsuya Hattori, Yuta Ichinose, Yoshihisa Takiyama, Tsukasa Saito, Takashi Kimura, Hitoshi Aizawa, Hiroshi Shoji, Yuri Mizuno, Takuya Matsushita, Mitsuto Sato, Yoshiki Sekijima, Masayo Morita, Akio Iwasaki, Hirofumi Kusaka, Mikiko Tada, Fumiaki Tanaka, Yusuke Sakiyama, Takeshi Fujimoto, Yuko Nagara, Kenichi Kashihara, Hiroyuki Todo, Kouichi Nakao, Kazuhito Tsuruta, Masaaki Yoshikawa, Hideo Hara, Hiroaki Yokote, Nagako Murase, Kiyotaka Nakamagoe, Akira Tamaoka, Motonori Takamiya, Nobutoshi Morimoto, Kazuya Nokura, Tetsuharu Kako, Manabu Funayama, Kenya Nishioka, Nobutaka Hattori

    Neurobiology of aging   97   146.e1-146.e13   2021年1月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    To investigate the prevalence and genotype-phenotype correlations of phosphatase and tensin homolog induced putative kinase 1 (PINK1) variants in Parkinson's disease (PD) patients, we analyzed 1700 patients (842 familial PD and 858 sporadic PD patients from Japanese origin). We screened the entire exon and exon-intron boundaries of PINK1 using Sanger sequencing and target sequencing by Ion torrent system. We identified 30 patients with heterozygous variants, 3 with homozygous variants, and 3 with digenic variants of PINK1-PRKN. Patients with homozygous variants presented a significantly younger age at onset than those with heterozygous variants. The allele frequency of heterozygous variants in patients with age at onset at 50 years and younger with familial PD and sporadic PD showed no differences. [123I]meta-iodobenzylguanidine (MIBG) myocardial scintigraphy indicated that half of patients harboring PINK1 heterozygous variants showed a decreased heart to mediastinum ratio (12/23). Our findings emphasize the importance of PINK1 variants for the onset of PD in patients with age at onset at 50 years and younger and the broad spectrum of clinical symptoms in patients with PINK1 variants.

    DOI: 10.1016/j.neurobiolaging.2020.06.017

    PubMed

    researchmap

  • 多発脳神経麻痺と左上肢の筋力低下を認め、腕神経叢生検により診断し得たNeurolymphomatosisの80歳男性例

    小林 卓雄, 東山 雄一, 窪田 瞬, 國井 美紗子, 多田 美紀子, 竹内 英之, 田中 章景

    臨床神経学   61 ( 1 )   67 - 67   2021年1月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • Efficient detection of copy-number variations using exome data: Batch- and sex-based analyses. 国際誌

    Yuri Uchiyama, Daisuke Yamaguchi, Kazuhiro Iwama, Satoko Miyatake, Kohei Hamanaka, Naomi Tsuchida, Hiromi Aoi, Yoshiteru Azuma, Toshiyuki Itai, Ken Saida, Hiromi Fukuda, Futoshi Sekiguchi, Tomohiro Sakaguchi, Ming Lei, Sachiko Ohori, Masamune Sakamoto, Mitsuhiro Kato, Takayoshi Koike, Yukitoshi Takahashi, Koichi Tanda, Yuki Hyodo, Rachel S Honjo, Debora Romeo Bertola, Chong Ae Kim, Masahide Goto, Tetsuya Okazaki, Hiroyuki Yamada, Yoshihiro Maegaki, Hitoshi Osaka, Lock-Hock Ngu, Ch'ng G Siew, Keng W Teik, Manami Akasaka, Hiroshi Doi, Fumiaki Tanaka, Tomohide Goto, Long Guo, Shiro Ikegawa, Kazuhiro Haginoya, Muzhirah Haniffa, Nozomi Hiraishi, Yoko Hiraki, Satoru Ikemoto, Atsuro Daida, Shin-Ichiro Hamano, Masaki Miura, Akihiko Ishiyama, Osamu Kawano, Akane Kondo, Hiroshi Matsumoto, Nobuhiko Okamoto, Tohru Okanishi, Yukimi Oyoshi, Eri Takeshita, Toshifumi Suzuki, Yoshiyuki Ogawa, Hiroshi Handa, Yayoi Miyazono, Eriko Koshimizu, Atsushi Fujita, Atsushi Takata, Noriko Miyake, Takeshi Mizuguchi, Naomichi Matsumoto

    Human mutation   42 ( 1 )   50 - 65   2021年1月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Many algorithms to detect copy number variations (CNVs) using exome sequencing (ES) data have been reported and evaluated on their sensitivity and specificity, reproducibility, and precision. However, operational optimization of such algorithms for a better performance has not been fully addressed. ES of 1199 samples including 763 patients with different disease profiles was performed. ES data were analyzed to detect CNVs by both the eXome Hidden Markov Model (XHMM) and modified Nord's method. To efficiently detect rare CNVs, we aimed to decrease sequencing biases by analyzing, at the same time, the data of all unrelated samples sequenced in the same flow cell as a batch, and to eliminate sex effects of X-linked CNVs by analyzing female and male sequences separately. We also applied several filtering steps for more efficient CNV selection. The average number of CNVs detected in one sample was <5. This optimization together with targeted CNV analysis by Nord's method identified pathogenic/likely pathogenic CNVs in 34 patients (4.5%, 34/763). In particular, among 142 patients with epilepsy, the current protocol detected clinically relevant CNVs in 19 (13.4%) patients, whereas the previous protocol identified them in only 14 (9.9%) patients. Thus, this batch-based XHMM analysis efficiently selected rare pathogenic CNVs in genetic diseases.

    DOI: 10.1002/humu.24129

    PubMed

    researchmap

  • PLA2G6 variants associated with the number of affected alleles in Parkinson's disease in Japan. 国際誌

    Kensuke Daida, Kenya Nishioka, Yuanzhe Li, Hiroyo Yoshino, Tomoyo Shimada, Nobuhiro Dougu, Yuji Nakatsuji, Shinji Ohara, Takao Hashimoto, Ryoichi Okiyama, Fusako Yokochi, Chieko Suzuki, Masahiko Tomiyama, Katsuo Kimura, Naohisa Ueda, Fumiaki Tanaka, Hitoshi Yamada, Shinsuke Fujioka, Yoshio Tsuboi, Takenori Uozumi, Takanobu Takei, Shigeru Matsuzaki, Morikazu Shibasaki, Kenichi Kashihara, Ryoichi Kurisaki, Tetsuji Yamashita, Nobuya Fujita, Yoshinori Hirata, Yuichiro Ii, Chizu Wada, Nobuyuki Eura, Kazuma Sugie, Yujiro Higuchi, Fumikazu Kojima, Hisamasa Imai, Kazuyuki Noda, Yasushi Shimo, Manabu Funayama, Nobutaka Hattori

    Neurobiology of aging   97   147.e1-147.e9   2021年1月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    This study aimed to evaluate genotype-phenotype correlations of Parkinson's disease (PD) patients with phospholipase A2 group V (PLA2G6) variants. We analyzed the DNA of 798 patients with PD, including 78 PD patients reported previously, and 336 in-house controls. We screened the exons and exon-intron boundaries of PLA2G6 using the Ion Torrent system and Sanger method. We identified 21 patients with 18 rare variants, such that 1, 9, and 11 patients were homozygous, heterozygous, and compound heterozygous, respectively, with respect to PLA2G6 variants. The allele frequency was approximately equal between patients with familial PD and those with sporadic PD. The PLA2G6 variants detected frequently were identified in the early-onset sporadic PD group. Patients who were homozygous for a variant showed more severe symptoms than those who were heterozygous for the variant. The most common variant was p.R635Q in our cohort, which was considered a risk variant for PD. Thus, the variants of PLA2G6 may play a role in familial PD and early-onset sporadic PD.

    DOI: 10.1016/j.neurobiolaging.2020.07.004

    PubMed

    researchmap

  • Qualitative Deficits in Verbal Fluency in Parkinson's Disease with Mild Cognitive Impairment: A Clinical and Neuroimaging Study. 国際誌

    Tomoya Hamada, Yuichi Higashiyama, Asami Saito, Keisuke Morihara, Ramon Landin-Romero, Mitsuo Okamoto, Katsuo Kimura, Yousuke Miyaji, Hideto Joki, Hitaru Kishida, Hiroshi Doi, Naohisa Ueda, Hideyuki Takeuchi, Fumiaki Tanaka

    Journal of Parkinson's disease   11 ( 4 )   2005 - 2016   2021年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    BACKGROUND: Mild cognitive impairment (MCI) in Parkinson's disease (PD) is considered a risk factor for PD with dementia (PDD). Verbal fluency tasks are widely used to assess executive function in PDD. However, in cases of PD with MCI (PD-MCI), the relative diagnostic accuracy of different qualitative verbal fluency measures and their related neural mechanisms remain unknown. OBJECTIVE: This study aimed to investigate the relative diagnostic accuracy of qualitative (clustering and switching) verbal fluency strategies and their correlates with functional imaging in PD-MCI. METHODS: Forty-five patients with PD (26 with MCI and 19 without MCI) and 25 healthy controls underwent comprehensive neurocognitive testing and resting-state functional magnetic resonance imaging. MCI in patients with PD was diagnosed according to established clinical criteria. The diagnostic accuracy of verbal fluency measures was determined via receiver operating characteristic analysis. Changes in brain functional connectivity between groups and across clinical measures were assessed using seed-to-voxel analyses. RESULTS: Patients with PD-MCI generated fewer words and switched less frequently in semantic and phonemic fluency tasks compared to other groups. Switching in semantic fluency showed high diagnostic accuracy for PD-MCI and was associated with reduced functional connectivity in the salience network. CONCLUSION: Our results indicate that reduced switching in semantic fluency tasks is a sensitive and specific marker for PD-MCI. Qualitative verbal fluency deficits and salience network dysfunction represent early clinical changes observed in PD-MCI.

    DOI: 10.3233/JPD-202473

    PubMed

    researchmap

  • Case Report: Severe Osteoporosis and Preventive Therapy in RNA Polymerase III-Related Leukodystrophy. 国際誌

    Soma Furukawa, Misako Kunii, Hiroshi Doi, Naohide Kondo, Aya Ogura, Koichi Hirabuki, Takayuki Itoh, Naomichi Matsumoto, Fumiaki Tanaka, Masahisa Katsuno, Yasuhiro Ito

    Frontiers in neurology   12   622355 - 622355   2021年

     詳細を見る

    記述言語:英語  

    RNA polymerase III (POLR3)-related leukodystrophy is an autosomal recessive form of leukodystrophy caused by homozygous or compound heterozygous mutations of the RNA polymerase III subunit genes, including subunit A (POLR3A). With respect to the manifestation triad, hypomyelination, hypodontia, and hypogonadotropic hypogonadism, it is also known as 4H leukodystrophy. Here, we report a 41-year-old woman of POLR3-related leukodystrophy by carrying compound heterozygous pathogenic variants of c.2554A>G (p.M852V) and c.2668G>T (p.V890F) in the POLR3A gene. She was amenorrheic and became a wheelchair user from the age of 15 years and suffered from multiple episodes of pathologic fractures, starting with a subtrochanteric fracture of the right femur after a tonic seizure at age 30 years. Head magnetic resonance imaging demonstrated hypomyelination and atrophies of the cerebellum, brainstem, and corpus callosum. Laboratory examination revealed a marked decrease of gonadotropins and estrogen, low bone density, and high bone resorption markers. Administration of anti-receptor activator of nuclear factor kappa-B ligand monoclonal antibody restored bone resorption markers to a normal level and prevented further pathological bone fractures. Our case emphasizes that osteoporosis should be recognized as a potential but serious complication in POLR3-related leukodystrophy. It may be feasible to prevent pathologic fractures by intensive osteoporosis therapy after endocrinological examinations and evaluation of bone metabolism.

    DOI: 10.3389/fneur.2021.622355

    PubMed

    researchmap

  • Case Report: Anti-MOG Antibody Seroconversion Accompanied by Dimethyl Fumarate Treatment. 国際誌

    Keita Takahashi, Hideyuki Takeuchi, Ryoko Fukai, Haruko Nakamura, Keisuke Morihara, Yuichi Higashiyama, Toshiyuki Takahashi, Hiroshi Doi, Fumiaki Tanaka

    Frontiers in immunology   12   625465 - 625465   2021年

     詳細を見る

    記述言語:英語  

    Here we report three cases of anti-myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease (MOGAD) mimicking multiple sclerosis in which seropositivity for anti-MOG antibodies occurred during disease-modifying drug dimethyl fumarate (DMF) treatment. These patients developed relapses with anti-MOG antibody seroconversion after switching from fingolimod or steroid pulse therapy to DMF, which was associated with peripheral lymphocyte recovery. MOGAD is considered a humoral immune disease, and DMF reportedly enhances Th2-skewed humoral immune activity. Therefore, we suggest that DMF, but not fingolimod, may exacerbate humoral immune imbalance and enhance autoantibody production, leading to aggravation of MOGAD.

    DOI: 10.3389/fimmu.2021.625465

    PubMed

    researchmap

  • Is Generalized and Segmental Dystonia Accompanied by Impairments in the Dopaminergic System? 国際誌

    Jun Ikezawa, Fusako Yokochi, Ryoichi Okiyama, Satoko Kumada, Maya Tojima, Tsutomu Kamiyama, Takashi Hanakawa, Hiroshi Matsuda, Fumiaki Tanaka, Yasuhiro Nakata, Eiji Isozaki

    Frontiers in neurology   12   751434 - 751434   2021年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Background: The pathogenesis of dystonia is remarkably diverse. Some types of dystonia, such as DYT5 (DYT-GCH1) and tardive dystonia, are related to dysfunction of the dopaminergic system. Furthermore, on pathological examination, cell loss in the substantia nigra (SN) of patients with dystonia has been reported, suggesting that impaired dopamine production may be involved in DYT5 and in other types of dystonia. Objectives: To investigate functional dopaminergic impairments, we compared patients with dystonia and those with Parkinson's disease (PD) with normal controls using neuromelanin-sensitive magnetic resonance imaging (NM-MRI) and dopamine transporter single photon emission computed tomography (DAT SPECT). Methods: A total of 18, 18, and 27 patients with generalized or segmental dystonia, patients with PD, and healthy controls, respectively, were examined using NM-MRI. The mean area corresponding to NM in the SN (NM-SN) was blindly quantified. DAT SPECT was performed on 17 and eight patients with dystonia and PD, respectively. The imaging data of DAT SPECT were harmonized with the Japanese database using striatum phantom calibration. These imaging data were compared between patients with dystonia or PD and controls from the Japanese database in 256 healthy volunteers using the calibrated specific binding ratio (cSBR). The symptoms of dystonia were evaluated using the Fahn-Marsden Dystonia Rating Scale (FMDRS), and the correlation between the results of imaging data and FMDRS was examined. Results: The mean areas corresponding to NM in the SN (NM-SN) were 31 ± 4.2, 28 ± 3.8, and 43 ± 3.8 pixels in patients with dystonia, PD, and in healthy controls, respectively. The mean cSBRs were 5 ± 0.2, 2.8 ± 0.2, 9.2 (predictive) in patients with dystonia, PD, and in healthy controls, respectively. The NM-SN area (r = -0.49, p < 0.05) and the cSBR (r = -0.54, p < 0.05) were inversely correlated with the FMDRS. There was no significant difference between the dystonia and PD groups regarding NM-SN (p = 0.28). In contrast, the cSBR was lower in patients with PD than in those with dystonia (p < 0.5 × 10-6). Conclusions: Impairments of the dopaminergic system may be involved in developing generalized and segmental dystonia. SN abnormalities in patients with dystonia were supposed to be different from degeneration in PD.

    DOI: 10.3389/fneur.2021.751434

    PubMed

    researchmap

  • Case Report: Takotsubo Cardiomyopathy in Bickerstaff Brainstem Encephalitis Triggered by COVID-19. 国際誌

    Mizuki Kimura, Shunta Hashiguchi, Kenichi Tanaka, Manato Hagiwara, Keita Takahashi, Yosuke Miyaji, Hideto Joki, Hiroshi Doi, Michiaki Koga, Hideyuki Takeuchi, Fumiaki Tanaka

    Frontiers in neurology   12   822247 - 822247   2021年

     詳細を見る

    記述言語:英語  

    Takotsubo cardiomyopathy (TCM) is a stress-induced cardiomyopathy triggered by critical illness including severe neurological disorders. However, an association between TCM and Bickerstaff brainstem encephalitis (BBE) has rarely been described. During the current coronavirus disease 2019 (COVID-19) pandemic, growing evidence indicates that COVID-19 often leads to various neurological disorders, but there are few reports of an association between COVID-19 and BBE. Here we report a case of TCM associated with BBE triggered by COVID-19, which subsided with immunotherapy for BBE. Both transthoracic echocardiography and electrocardiography led to early and accurate diagnosis of TCM. Sustained hemodynamic instability due to TCM was immediately lessened with immunotherapy whereas additional plasmapheresis and immunotherapy were required to treat BBE. This case indicates that BBE might follow COVID-19 and TCM should be considered when hemodynamic status remains unstable in a patient with BBE.

    DOI: 10.3389/fneur.2021.822247

    PubMed

    researchmap

  • Neural mechanisms of foreign accent syndrome: Lesion and network analysis

    Yuichi Higashiyama, Tomoya Hamada, Asami Saito, Keisuke Morihara, Mitsuo Okamoto, Katsuo Kimura, Hideto Joki, Hitaru Kishida, Hiroshi Doi, Naohisa Ueda, Hideyuki Takeuchi, Fumiaki Tanaka

    NeuroImage: Clinical   31   102760 - 102760   2021年

     詳細を見る

    掲載種別:研究論文(学術雑誌)   出版者・発行元:Elsevier BV  

    DOI: 10.1016/j.nicl.2021.102760

    researchmap

  • Case Report: Extremely Early Detection of Preclinical Magnetic Resonance Imaging Abnormality in Creutzfeldt-Jakob Disease With the V180I Mutation. 国際誌

    Ryuichi Koizumi, Naohisa Ueda, Atsushi Mugita, Katsuo Kimura, Hitaru Kishida, Fumiaki Tanaka

    Frontiers in neurology   12   751750 - 751750   2021年

     詳細を見る

    記述言語:英語  

    The diagnosis of presymptomatic Creutzfeldt-Jakob disease (CJD) is challenging. The levels of total tau protein, 14-3-3 protein, and protease-resistant isoform of prion protein (PrPres) in the cerebrospinal fluid; periodic sharp wave complexes on electroencephalography; and diffusion-weighted imaging (DWI) of brain magnetic resonance imaging (MRI) have all been used to diagnose symptomatic CJD, but none of these markers have been established in the diagnosis of presymptomatic CJD. Here, we report a case of genetic CJD with the V180I mutation in which a small punctate cortical hyperintensity was detected on DWI 6 months before symptom onset and 9 months before diagnosis. Presymptomatic CJD is currently impossible to diagnose because of the lack of established early diagnostic markers. However, since MRI is increasingly used in daily clinical practice, the chance detection of such DWI abnormalities would have important implications in terms of providing a clue to examine a highly specific early diagnostic marker to be developed in the future for CJD. This will allow presymptomatic intervention by disease-modifying therapy in the near future.

    DOI: 10.3389/fneur.2021.751750

    PubMed

    researchmap

  • Interleukin-19 Abrogates Experimental Autoimmune Encephalomyelitis by Attenuating Antigen-Presenting Cell Activation. 国際誌

    Hiroshi Horiuchi, Bijay Parajuli, Hiroyasu Komiya, Yuki Ogawa, Shijie Jin, Keita Takahashi, Yasu-Taka Azuma, Fumiaki Tanaka, Akio Suzumura, Hideyuki Takeuchi

    Frontiers in immunology   12   615898 - 615898   2021年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Interleukin-19 (IL-19) acts as a negative-feedback regulator to limit proinflammatory response of macrophages and microglia in autocrine/paracrine manners in various inflammatory diseases. Multiple sclerosis (MS) is a major neuroinflammatory disease in the central nervous system (CNS), but it remains uncertain how IL-19 contributes to MS pathogenesis. Here, we demonstrate that IL-19 deficiency aggravates experimental autoimmune encephalomyelitis (EAE), a mouse model of MS, by promoting IL-17-producing helper T cell (Th17 cell) infiltration into the CNS. In addition, IL-19-deficient splenic macrophages expressed elevated levels of major histocompatibility complex (MHC) class II, co-stimulatory molecules, and Th17 cell differentiation-associated cytokines such as IL-1β, IL-6, IL-23, TGF-β1, and TNF-α. These observations indicated that IL-19 plays a critical role in suppression of MS pathogenesis by inhibiting macrophage antigen presentation, Th17 cell expansion, and subsequent inflammatory responses. Furthermore, treatment with IL-19 significantly abrogated EAE. Our data suggest that IL-19 could provide significant therapeutic benefits in patients with MS.

    DOI: 10.3389/fimmu.2021.615898

    PubMed

    researchmap

  • Neural mechanisms of foreign accent syndrome: Lesion and network analysis. 国際誌

    Yuichi Higashiyama, Tomoya Hamada, Asami Saito, Keisuke Morihara, Mitsuo Okamoto, Katsuo Kimura, Hideto Joki, Hitaru Kishida, Hiroshi Doi, Naohisa Ueda, Hideyuki Takeuchi, Fumiaki Tanaka

    NeuroImage. Clinical   31   102760 - 102760   2021年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    BACKGROUND: Foreign accent syndrome (FAS) is a rare acquired speech disorder wherein an individual's spoken accent is perceived as "foreign." Most reported cases involve left frontal brain lesions, but it is known that various other lesions can also cause FAS. To determine whether heterogeneous FAS-causing lesions are localized to a common functional speech network rather than to a single anatomical site, we employed a recently validated image analysis technique known as "lesion network mapping." METHODS: We identified 25 published cases of acquired neurogenic FAS without aphasia, and mapped each lesion volume onto a reference brain. We next identified the network of brain regions functionally connected to each FAS lesion using a connectome dataset from normative participants. Network maps were then overlapped to identify common network sites across the lesions. RESULTS: Classical lesion overlap analysis showed heterogeneity in lesion anatomical location, consistent with prior reports. However, at least 80% of lesions showed network overlap in the bilateral lower and middle portions of the precentral gyrus and in the medial frontal cortex. The left lower portion of the precentral gyrus is suggested to be the location of lesions causing apraxia of speech (AOS), and the middle portion is considered to be a larynx-specific motor area associated with the production of vowels and stop/nasal consonants and with the determination of pitch accent. CONCLUSIONS: The lesions that cause FAS are anatomically heterogeneous, but they share a common functional network located in the bilateral posterior region of the frontal lobe. This network specifically includes not only the lower portion of the central gyrus, but also its middle region, which is referred to as the larynx motor cortex and is known to be associated with phonation. Our findings suggest that disrupted networks in FAS might be anatomically different from those in AOS.

    DOI: 10.1016/j.nicl.2021.102760

    PubMed

    researchmap

  • Hepatitis B Virus-related Vasculitic Neuropathy in an Inactive Virus Carrier Treated with Intravenous Immunoglobulin.

    Kaori Kusama, Yoshiharu Nakae, Mikiko Tada, Yuichi Higashiyama, Yosuke Miyaji, Genpei Yamaura, Misako Kunii, Kenichi Tanaka, Ken Ohyama, Haruki Koike, Hideto Joki, Hiroshi Doi, Shigeru Koyano, Fumiaki Tanaka

    Internal medicine (Tokyo, Japan)   59 ( 23 )   3075 - 3078   2020年12月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    We herein report a 33-year-old woman who was an asymptomatic hepatitis B virus (HBV) carrier and presented with distal muscle weakness in the legs and asymmetrical paresthesia in the distal extremities. A nerve biopsy specimen revealed fibrinoid necrosis associated with inflammatory infiltration in the perineural space, and deposition of hepatitis B core antigen and C4d complement was detected in the vascular endothelial cells as well as around the vessels. She was diagnosed with HBV-related vasculitic neuropathy and treated with intravenous immunoglobulin (IVIG). Her symptoms completely subsided after eight weeks. Vasculitic neuropathy rarely develops in the chronic inactive stages of HBV infection. This is the first report of an HBV-inactive carrier with vasculitic neuropathy successfully treated with IVIG.

    DOI: 10.2169/internalmedicine.4498-20

    PubMed

    researchmap

  • Azure Lunulae and Leukoencephalopathy in Wilson Disease.

    Hiroko Hori, Yosuke Kudo, Yoshiyuki Kuroiwa, Fumiaki Tanaka

    Internal medicine (Tokyo, Japan)   60 ( 9 )   1479 - 1479   2020年11月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.2169/internalmedicine.5417-20

    PubMed

    researchmap

  • CGG expansion in NOTCH2NLC is associated with oculopharyngodistal myopathy with neurological manifestations. 国際誌

    Masashi Ogasawara, Aritoshi Iida, Theerawat Kumutpongpanich, Ayami Ozaki, Yasushi Oya, Hirofumi Konishi, Akinori Nakamura, Ryuta Abe, Hiroshi Takai, Ritsuko Hanajima, Hiroshi Doi, Fumiaki Tanaka, Hisayoshi Nakamura, Ikuya Nonaka, Zhaoxia Wang, Shinichiro Hayashi, Satoru Noguchi, Ichizo Nishino

    Acta neuropathologica communications   8 ( 1 )   204 - 204   2020年11月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Oculopharyngodistal myopathy (OPDM) is a rare hereditary muscle disease characterized by progressive distal limb weakness, ptosis, ophthalmoplegia, bulbar muscle weakness and rimmed vacuoles on muscle biopsy. Recently, CGG repeat expansions in the noncoding regions of two genes, LRP12 and GIPC1, have been reported to be causative for OPDM. Furthermore, neuronal intranuclear inclusion disease (NIID) has been recently reported to be caused by CGG repeat expansions in NOTCH2NLC. We aimed to identify and to clinicopathologically characterize patients with OPDM who have CGG repeat expansions in NOTCH2NLC (OPDM_NOTCH2NLC). Note that 211 patients from 201 families, who were clinically or clinicopathologically diagnosed with OPDM or oculopharyngeal muscular dystrophy, were screened for CGG expansions in NOTCH2NLC by repeat primed-PCR. Clinical information and muscle pathology slides of identified patients with OPDM_NOTCH2NLC were re-reviewed. Intra-myonuclear inclusions were evaluated using immunohistochemistry and electron microscopy (EM). Seven Japanese OPDM patients had CGG repeat expansions in NOTCH2NLC. All seven patients clinically demonstrated ptosis, ophthalmoplegia, dysarthria and muscle weakness; they myopathologically had intra-myonuclear inclusions stained with anti-poly-ubiquitinated proteins, anti-SUMO1 and anti-p62 antibodies, which were diagnostic of NIID (typically on skin biopsy), in addition to rimmed vacuoles. The sample for EM was available only from one patient, which demonstrated intranuclear inclusions of 12.6 ± 1.6 nm in diameter. We identified seven patients with OPDM_NOTCH2NLC. Our patients had various additional central and/or peripheral nervous system involvement, although all were clinicopathologically compatible; thus, they were diagnosed as having OPDM and expanding a phenotype of the neuromyodegenerative disease caused by CGG repeat expansions in NOTCH2NLC.

    DOI: 10.1186/s40478-020-01084-4

    PubMed

    researchmap

  • Tonsillectomy Improved Therapeutic Response in Anti-SRP Myopathy With Chronic Tonsillitis

    Takuya Ikeda, Hideyuki Takeuchi, Keita Takahashi, Haruko Nakamura, Misako Kunii, Atsuko Katsumoto, Mikiko Tada, Yuichi Higashiyama, Takashi Hibiya, Shigeaki Suzuki, Ichizo Nishino, Shigeru Koyano, Hiroshi Doi, Fumiaki Tanaka

    Frontiers in Immunology   11   2020年11月

     詳細を見る

    掲載種別:研究論文(学術雑誌)   出版者・発行元:Frontiers Media SA  

    Chronic tonsillitis has been attracted attention as a source of abnormal immune responses and a possible trigger of autoimmune diseases such as IgA nephritis, IgA vasculitis, palmoplantar pustulosis, psoriasis, rheumatoid arthritis, Behçet’s disease, and myositis. Here we present the first report of anti–signal recognition particle antibody–associated necrotizing myopathy (anti-SRP myopathy) with IgA nephropathy and chronic tonsillitis in which the therapeutic response to intravenous immunoglobulin (IVIG) treatment was dramatically improved after tonsillectomy and accompanied by a rapid increase in ΔIgG, defined as the change in serum IgG levels 2 weeks after the start of IVIG treatment relative to pre-treatment levels. Moreover, serum anti-SRP antibody titers became undetectable after tonsillectomy even though the resected tonsils did not produce anti-SRP antibodies. Tonsillectomy should be considered when chronic tonsillitis is observed in patients with autoimmune diseases showing poor response to treatment, including anti-SRP myopathy.

    DOI: 10.3389/fimmu.2020.595480

    researchmap

  • Pathologically Proven Gadolinium-enhanced MRI Lesions in the Bilateral Corticospinal Tracts in Lymphomatosis Cerebri.

    Genpei Yamaura, Akihiro Ogasawara, Takeshi Ito, Shizuka Ohsugi, Yoichi Kanatsuka, Ryuichiro Hayashi, Hiromichi Iwashita, Hiroyuki Hayashi, Shigeru Koyano, Shigeki Yamaguchi, Fumiaki Tanaka

    Internal medicine (Tokyo, Japan)   59 ( 22 )   2931 - 2934   2020年11月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    A 78-year-old woman in complete remission of mass-forming primary central nervous system lymphoma (PCNSL) showed diffuse leukoencephalopathy as well as corticospinal tract lesions with intense gadolinium enhancement on magnetic resonance imaging (MRI). She died 3 months later. In line with the MRI findings, pathological examination revealed dense infiltration of atypical lymphoid cells, consistent with a diagnosis of lymphomatosis cerebri (LC)-type PCNSL. This is the first report of LC in which the corticospinal tracts demonstrated robust contrast enhancement directly corresponding to the neuropathological findings, and it is also a rare instance in which LC presented as a recurrence of typical PCNSL.

    DOI: 10.2169/internalmedicine.4382-19

    PubMed

    researchmap

  • Efficient detection of copy-number variations using exome data: Batch- and sex-based analyses. 国際誌

    Yuri Uchiyama, Daisuke Yamaguchi, Kazuhiro Iwama, Satoko Miyatake, Kohei Hamanaka, Naomi Tsuchida, Hiromi Aoi, Yoshiteru Azuma, Toshiyuki Itai, Ken Saida, Hiromi Fukuda, Futoshi Sekiguchi, Tomohiro Sakaguchi, Ming Lei, Sachiko Ohori, Masamune Sakamoto, Mitsuhiro Kato, Takayoshi Koike, Yukitoshi Takahashi, Koichi Tanda, Yuki Hyodo, Rachel S Honjo, Debora Romeo Bertola, Chong Ae Kim, Masahide Goto, Tetsuya Okazaki, Hiroyuki Yamada, Yoshihiro Maegaki, Hitoshi Osaka, Lock-Hock Ngu, Ch'ng G Siew, Keng W Teik, Manami Akasaka, Hiroshi Doi, Fumiaki Tanaka, Tomohide Goto, Long Guo, Shiro Ikegawa, Kazuhiro Haginoya, Muzhirah Haniffa, Nozomi Hiraishi, Yoko Hiraki, Satoru Ikemoto, Atsuro Daida, Shin-Ichiro Hamano, Masaki Miura, Akihiko Ishiyama, Osamu Kawano, Akane Kondo, Hiroshi Matsumoto, Nobuhiko Okamoto, Tohru Okanishi, Yukimi Oyoshi, Eri Takeshita, Toshifumi Suzuki, Yoshiyuki Ogawa, Hiroshi Handa, Yayoi Miyazono, Eriko Koshimizu, Atsushi Fujita, Atsushi Takata, Noriko Miyake, Takeshi Mizuguchi, Naomichi Matsumoto

    Human mutation   42 ( 1 )   50 - 65   2020年11月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Many algorithms to detect copy number variations (CNVs) using exome sequencing (ES) data have been reported and evaluated on their sensitivity and specificity, reproducibility, and precision. However, operational optimization of such algorithms for a better performance has not been fully addressed. ES of 1199 samples including 763 patients with different disease profiles was performed. ES data were analyzed to detect CNVs by both the eXome Hidden Markov Model (XHMM) and modified Nord's method. To efficiently detect rare CNVs, we aimed to decrease sequencing biases by analyzing, at the same time, the data of all unrelated samples sequenced in the same flow cell as a batch, and to eliminate sex effects of X-linked CNVs by analyzing female and male sequences separately. We also applied several filtering steps for more efficient CNV selection. The average number of CNVs detected in one sample was <5. This optimization together with targeted CNV analysis by Nord's method identified pathogenic/likely pathogenic CNVs in 34 patients (4.5%, 34/763). In particular, among 142 patients with epilepsy, the current protocol detected clinically relevant CNVs in 19 (13.4%) patients, whereas the previous protocol identified them in only 14 (9.9%) patients. Thus, this batch-based XHMM analysis efficiently selected rare pathogenic CNVs in genetic diseases.

    DOI: 10.1002/humu.24129

    PubMed

    researchmap

  • Proteomic analysis of exosome-enriched fractions derived from cerebrospinal fluid of amyotrophic lateral sclerosis patients. 国際誌

    Noriko Hayashi, Hiroshi Doi, Yoichi Kurata, Hiroyuki Kagawa, Yoshitoshi Atobe, Kengo Funakoshi, Mikiko Tada, Atsuko Katsumoto, Kenichi Tanaka, Misako Kunii, Haruko Nakamura, Keita Takahashi, Hideyuki Takeuchi, Shigeru Koyano, Yayoi Kimura, Hisashi Hirano, Fumiaki Tanaka

    Neuroscience research   160   43 - 49   2020年11月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Exosomes contain many proteins associated with neurodegenerative diseases. To identify new candidate biomarkers and proteins associated with amyotrophic lateral sclerosis (ALS), we performed liquid chromatography-tandem mass spectrometry proteomic analysis of exosome-enriched fractions isolated from cerebrospinal fluid (CSF) of sporadic ALS patients using gel filtration chromatography. Proteomic data revealed that three proteins were increased and 11 proteins were decreased in ALS patients. The protein with the greatest increase in exosome-enriched fractions of CSF derived from ALS was novel INHAT repressor (NIR), which is closely associated with nucleolar function. By immunohistochemical analysis, we found that NIR was reduced in the nucleus of motor neurons in ALS patients. Our results demonstrate the potential utility of our methodology for proteomic analysis of CSF exosomes and suggest that nucleolar stress might play a role in sporadic ALS pathogenesis through the dysfunction of NIR.

    DOI: 10.1016/j.neures.2019.10.010

    PubMed

    researchmap

  • パーキンソン病における血圧日内変動と非運動症状との相関

    上木 英人, 宮地 洋輔, 北澤 悠, 木村 活生, 岸田 日帯, 上田 直久, 土井 宏, 児矢野 繁, 竹内 英之, 田中 章景

    臨床神経学   60 ( Suppl. )   S447 - S447   2020年11月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • パーキンソン病における運動および知的学習の転移効果

    上田 直久, 森原 啓介, 北澤 悠, 木村 活生, 上木 英人, 土井 宏, 岸田 日帯, 竹内 英之, 児矢野 繁, 田中 章景

    臨床神経学   60 ( Suppl. )   S339 - S339   2020年11月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 集学的治療により発作症状の軽減が得られた成人発症型Rasmussen症候群の一例

    北澤 悠, 萩原 真斗, 宮城 哲哉, 岡本 智子, 太組 一朗, 木村 活生, 岸田 日帯, 上木 英人, 土井 宏, 竹内 英之, 上田 直久, 田中 章景

    臨床神経学   60 ( Suppl. )   S439 - S439   2020年11月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 視覚呈示時間による全体と部分認知の関連性 Navon図形を用いた症例検討

    森原 啓介, 東山 雄一, 浅野 史織, 松永 祐己, 高橋 慶太, 三宅 綾子, 田中 健一, 木村 活生, 岸田 日帯, 上田 直久, 上木 英人, 土井 宏, 竹内 英之, 田中 章景

    臨床神経学   60 ( Suppl. )   S337 - S337   2020年11月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 腋窩多汗症に対するA型ボツリヌス毒素局注療法後に広範な筋無力症状を認めた1例

    城野 誉士, 宮地 洋輔, 東山 雄一, 小林 卓雄, 和田 大司, 窪田 瞬, 國井 美紗子, 多田 美紀子, 竹内 英之, 土井 宏, 田中 章景

    臨床神経生理学   48 ( 5 )   597 - 597   2020年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本臨床神経生理学会  

    researchmap

  • De novo CACNA1G variants in developmental delay and early-onset epileptic encephalopathies. 査読 国際誌

    Misako Kunii, Hiroshi Doi, Shunta Hashiguchi, Toyojiro Matsuishi, Yasunari Sakai, Mizue Iai, Masaki Okubo, Haruko Nakamura, Keita Takahashi, Atsuko Katsumoto, Mikiko Tada, Hideyuki Takeuchi, Taro Ishikawa, Noriko Miyake, Hirotomo Saitsu, Naomichi Matsumoto, Fumiaki Tanaka

    Journal of the neurological sciences   416   117047 - 117047   2020年9月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Elsevier BV  

    INTRODUCTION: Variants of CACNA1G, which encodes CaV3.1, have been reported to be associated with various neurological disorders. METHODS: Whole-exome sequencing of genomic DNA from 348 Japanese patients with neurodevelopmental disorders and their parents was conducted, and de novo variants of CACNA1G were extracted. The electrophysiological properties of each mutant channel were investigated by voltage-clamp and current-clamp analyses of HEK293T cells overexpressing these channels. RESULTS: Two patients diagnosed with Rett syndrome and West syndrome were found to have known pathological CACNA1G mutations reported in cerebellar ataxia cohorts: c.2881G > A, p.Ala961Thr and c.4591A > G, p.Met1531Val, respectively. One patient with Lennox-Gastaut syndrome was revealed to harbor a previously unreported heterozygous variant: c.3817A > T, p.Ile1273Phe. Clinical symptoms of the two patients with known mutations included severe developmental delay without acquisition of the ability to walk independently. The patient with a potentially novel mutation showed developmental delay, intractable seizures, and mild cerebral atrophy on MRI, but the severity of symptoms was milder than in the former two cases. Electrophysiological study using HEK293T cells demonstrated significant changes of T-type Ca2+ currents by p.Ala961Thr and p.Met1531Val SNVs, which were likely to enhance oscillation of membrane potential at low frequencies. In contrast, p.Ile1273Phe showed no significant effects in our electrophysiological evaluations, with its pathogenesis remaining undetermined. CONCLUSION: De novo variants of CACNA1G explain some neurodevelopmental disorders. Our study further provides information to understand the genotype-phenotype correlations of patients with CACNA1G mutations.

    DOI: 10.1016/j.jns.2020.117047

    PubMed

    researchmap

  • Reply to "GGC Repeat Expansion of NOTCH2NLC is Rare in European Leukoencephalopathy". 査読 国際誌

    Hiroshi Doi, Masaki Okubo, Ryoko Fukai, Atsushi Fujita, Satomi Mitsuhashi, Keita Takahashi, Misako Kunii, Mikiko Tada, Hiromi Fukuda, Takeshi Mizuguchi, Satoko Miyatake, Noriko Miyake, Jun Sone, Gen Sobue, Hideyuki Takeuchi, Naomichi Matsumoto, Fumiaki Tanaka

    Annals of neurology   88 ( 3 )   642 - 643   2020年9月

     詳細を見る

    記述言語:英語  

    DOI: 10.1002/ana.25819

    PubMed

    researchmap

  • [A case of subacute hypertrophic pachymeningitis caused by Pseudomonas aeruginosa infection presenting with subdural hygroma].

    Misako Kunii, Mitsuo Okamoto, Dan Takei, Shun Kubota, Haruko Nakamura, Fumiaki Tanaka

    Rinsho shinkeigaku = Clinical neurology   60 ( 8 )   538 - 542   2020年8月

     詳細を見る

    記述言語:日本語   掲載種別:研究論文(学術雑誌)  

    A 78-year-old woman with bilateral fungal sinusitis, which resulted in right orbital apex syndrome, underwent endoscopic sinus surgery and optic nerve decompression. Two months after the operation, she complained of anxiety and insomnia. Head CT showed subdural hematoma-like effusion and burr hole drainage was conducted. The collected fluid was not hematoma, but bloody, xanthochromic effusion with no pathogenic bacteria. Ten days later, she underwent drainage and dural biopsy after craniotomy because of relapse of subdural hygroma and progression of hypertrophic pachymeningitis associated with aggravation of psychiatric symptoms. A sample of the dura mater showed dense fibrosis with thickening, and Pseudomonas aeruginosa (P. aeruginosa) was detected by culture. Although otitis or sinusitis secondary to P. aeruginosa infection has been reported as a leading cause of infectious pachymeningitis, psychiatric symptoms alone and concomitant refractory subdural hygroma are atypical and unreported manifestations. In patients with pachymeningitis and a history of transnasal endoscopic surgery, P. aeruginosa infection should be considered, irrespective of an atypical clinical course and negative blood or fluid culture. Additionally, dural biopsy might help in detection of pathogenic bacteria.

    DOI: 10.5692/clinicalneurol.60.cn-001418

    PubMed

    researchmap

  • Interleukin-19 alleviates experimental autoimmune encephalomyelitis by attenuating antigen-presenting cell activation 査読

    Hiroshi Horiuchi, Bijay Parajuli, Yuki Ogawa, Hiroyasu Komiya, Jin Shijie, Keita Takahashi, Yasu-Taka Azuma, Fumiaki Tanaka, Akio Suzumura, Hideyuki Takeuchi

    2020年7月

     詳細を見る

    出版者・発行元:Cold Spring Harbor Laboratory  

    Interleukin-19 (IL-19) acts as an anti-inflammatory cytokine in various inflammatory diseases. Multiple sclerosis (MS) is a major neuroinflammatory disease in the central nervous system, but it remains uncertain how IL-19 contributes to MS pathogenesis. Here, we demonstrate that IL-19 deficiency aggravates experimental autoimmune encephalomyelitis (EAE), a mouse model of MS, by promoting IL-17-producing helper T cell (Th17 cell) infiltration into the central nervous system. In addition, IL-19-deficient splenic macrophages expressed elevated levels of major histocompatibility complex class II, co-stimulatory molecules, and Th17 cell differentiation-associated cytokines such as IL-1β, IL-6, IL-23, TGF-β1, and TNF-α. These observations indicated that IL-19 plays a critical role in suppression of MS pathogenesis by inhibiting macrophage antigen presentation, Th17 cell expansion, and subsequent inflammatory responses. Furthermore, treatment with IL-19 significantly abrogated EAE. Our data suggest that IL-19 could provide significant therapeutic benefits in patients with MS.

    DOI: 10.1101/2020.07.15.204826

    researchmap

  • PLA2G6 variants associated with the number of affected alleles in Parkinson's disease in Japan. 国際誌

    Kensuke Daida, Kenya Nishioka, Yuanzhe Li, Hiroyo Yoshino, Tomoyo Shimada, Nobuhiro Dougu, Yuji Nakatsuji, Shinji Ohara, Takao Hashimoto, Ryoichi Okiyama, Fusako Yokochi, Chieko Suzuki, Masahiko Tomiyama, Katsuo Kimura, Naohisa Ueda, Fumiaki Tanaka, Hitoshi Yamada, Shinsuke Fujioka, Yoshio Tsuboi, Takenori Uozumi, Takanobu Takei, Shigeru Matsuzaki, Morikazu Shibasaki, Kenichi Kashihara, Ryoichi Kurisaki, Tetsuji Yamashita, Nobuya Fujita, Yoshinori Hirata, Yuichiro Ii, Chizu Wada, Nobuyuki Eura, Kazuma Sugie, Yujiro Higuchi, Fumikazu Kojima, Hisamasa Imai, Kazuyuki Noda, Yasushi Shimo, Manabu Funayama, Nobutaka Hattori

    Neurobiology of aging   97   147.e1-147.e9   2020年7月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    This study aimed to evaluate genotype-phenotype correlations of Parkinson's disease (PD) patients with phospholipase A2 group V (PLA2G6) variants. We analyzed the DNA of 798 patients with PD, including 78 PD patients reported previously, and 336 in-house controls. We screened the exons and exon-intron boundaries of PLA2G6 using the Ion Torrent system and Sanger method. We identified 21 patients with 18 rare variants, such that 1, 9, and 11 patients were homozygous, heterozygous, and compound heterozygous, respectively, with respect to PLA2G6 variants. The allele frequency was approximately equal between patients with familial PD and those with sporadic PD. The PLA2G6 variants detected frequently were identified in the early-onset sporadic PD group. Patients who were homozygous for a variant showed more severe symptoms than those who were heterozygous for the variant. The most common variant was p.R635Q in our cohort, which was considered a risk variant for PD. Thus, the variants of PLA2G6 may play a role in familial PD and early-onset sporadic PD.

    DOI: 10.1016/j.neurobiolaging.2020.07.004

    PubMed

    researchmap

  • The identified clinical features of Parkinson's disease in homo-, heterozygous and digenic variants of PINK1. 国際誌

    Arisa Hayashida, Yuanzhe Li, Hiroyo Yoshino, Kensuke Daida, Aya Ikeda, Kotaro Ogaki, Atsuhito Fuse, Akio Mori, Masashi Takanashi, Toshiki Nakahara, Asako Yoritaka, Yuji Tomizawa, Yoshiaki Furukawa, Kazuaki Kanai, Yoshiaki Nakayama, Hidefumi Ito, Mieko Ogino, Yuko Hattori, Tatsuya Hattori, Yuta Ichinose, Yoshihisa Takiyama, Tsukasa Saito, Takashi Kimura, Hitoshi Aizawa, Hiroshi Shoji, Yuri Mizuno, Takuya Matsushita, Mitsuto Sato, Yoshiki Sekijima, Masayo Morita, Akio Iwasaki, Hirofumi Kusaka, Mikiko Tada, Fumiaki Tanaka, Yusuke Sakiyama, Takeshi Fujimoto, Yuko Nagara, Kenichi Kashihara, Hiroyuki Todo, Kouichi Nakao, Kazuhito Tsuruta, Masaaki Yoshikawa, Hideo Hara, Hiroaki Yokote, Nagako Murase, Kiyotaka Nakamagoe, Akira Tamaoka, Motonori Takamiya, Nobutoshi Morimoto, Kazuya Nokura, Tetsuharu Kako, Manabu Funayama, Kenya Nishioka, Nobutaka Hattori

    Neurobiology of aging   97   146.e1-146.e13   2020年7月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    To investigate the prevalence and genotype-phenotype correlations of phosphatase and tensin homolog induced putative kinase 1 (PINK1) variants in Parkinson's disease (PD) patients, we analyzed 1700 patients (842 familial PD and 858 sporadic PD patients from Japanese origin). We screened the entire exon and exon-intron boundaries of PINK1 using Sanger sequencing and target sequencing by Ion torrent system. We identified 30 patients with heterozygous variants, 3 with homozygous variants, and 3 with digenic variants of PINK1-PRKN. Patients with homozygous variants presented a significantly younger age at onset than those with heterozygous variants. The allele frequency of heterozygous variants in patients with age at onset at 50 years and younger with familial PD and sporadic PD showed no differences. [123I]meta-iodobenzylguanidine (MIBG) myocardial scintigraphy indicated that half of patients harboring PINK1 heterozygous variants showed a decreased heart to mediastinum ratio (12/23). Our findings emphasize the importance of PINK1 variants for the onset of PD in patients with age at onset at 50 years and younger and the broad spectrum of clinical symptoms in patients with PINK1 variants.

    DOI: 10.1016/j.neurobiolaging.2020.06.017

    PubMed

    researchmap

  • Ventricular volumetry and free-water corrected diffusion tensor imaging of the anterior thalamic radiation in idiopathic normal pressure hydrocephalus. 査読 国際誌

    Asami Saito, Koji Kamagata, Ryo Ueda, Misaki Nakazawa, Christina Andica, Ryusuke Irie, Madoka Nakajima, Masakazu Miyajima, Masaaki Hori, Fumiaki Tanaka, Hajime Arai, Shigeki Aoki

    Journal of neuroradiology = Journal de neuroradiologie   47 ( 4 )   312 - 317   2020年6月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    BACKGROUND AND PURPOSE: The pathophysiology of idiopathic normal pressure hydrocephalus (iNPH) has not been completely clarified. We investigated the brain structure in iNPH using automatic ventricular volumetry, single-tensor diffusion tensor imaging (DTI) and bi-tensor free-water (FW) imaging analyses while focusing on cognitive impairments before and after lumboperitoneal shunt surgery. MATERIALS AND METHODS: This retrospective study included 12 iNPH patients with structural magnetic resonance imaging (MRI) and diffusion MRI (dMRI) on a 3T-MRI scanner who underwent neuropsychological assessments before and after shunting and 8 healthy controls. Ventricular volumetry was conducted on structural MRI datasets using FreeSurfer. Ventricular volume was compared pre- and postoperatively. Correlation analyses were performed between ventricular volume or volume change and neuropsychological scores or score change. Tract-based spatial statistics were performed using dMRI datasets for group analyses between iNPH and controls and between pre- and post-surgery iNPH patients and for correlation analyses using neuropsychological scores. Tract-specific analyses were performed in the anterior thalamic radiation (ATR), followed by comparison and correlation analyses. RESULTS: The third ventricular volume was significantly decreased after shunting; its volume reduction negatively correlated with a neuropsychological improvement. Compared with controls, iNPH patients had lower fractional anisotropy and higher axial, radial, and mean diffusivities, and FW in the periventricular white matter including ATR, resulting in no difference in FW-corrected indices. Single-tensor DTI indices partially correlated with neuropsychological improvements, while FW-corrected indices had no correlations. CONCLUSION: Third ventricle enlargement is possibly linked to cognitive impairment and FW imaging possibly provides better white matter characterization in iNPH.

    DOI: 10.1016/j.neurad.2019.04.003

    PubMed

    researchmap

  • Long-read sequencing identifies the pathogenic nucleotide repeat expansion in RFC1 in a Japanese case of CANVAS. 査読 国際誌

    Haruko Nakamura, Hiroshi Doi, Satomi Mitsuhashi, Satoko Miyatake, Kazutaka Katoh, Martin C Frith, Tetsuya Asano, Yosuke Kudo, Takuya Ikeda, Shun Kubota, Misako Kunii, Yu Kitazawa, Mikiko Tada, Mitsuo Okamoto, Hideto Joki, Hideyuki Takeuchi, Naomichi Matsumoto, Fumiaki Tanaka

    Journal of human genetics   65 ( 5 )   475 - 480   2020年5月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Recently, a recessively inherited intronic repeat expansion in replication factor C1 (RFC1) was identified in cerebellar ataxia with neuropathy and bilateral vestibular areflexia syndrome (CANVAS). Here, we describe a Japanese case of genetically confirmed CANVAS with autonomic failure and auditory hallucination. The case showed impaired uptake of iodine-123-metaiodobenzylguanidine and 123I-ioflupane in the cardiac sympathetic nerve and dopaminergic neurons, respectively, by single-photon emission computed tomography. Long-read sequencing identified biallelic pathogenic (AAGGG)n nucleotide repeat expansion in RFC1 and heterozygous benign (TAAAA)n and (TAGAA)n expansions in brain expressed, associated with NEDD4 (BEAN1). Enrichment of the repeat regions in RFC1 and BEAN1 using a Cas9-mediated system clearly distinguished between pathogenic and benign repeat expansions. The haplotype around RFC1 indicated that the (AAGGG)n expansion in our case was on the same ancestral allele as that of European cases. Thus, long-read sequencing facilitates precise genetic diagnosis of diseases with complex repeat structures and various expansions.

    DOI: 10.1038/s10038-020-0733-y

    PubMed

    researchmap

  • CCR2 is localized in microglia and neurons, as well as infiltrating monocytes, in the lumbar spinal cord of ALS mice. 国際誌

    Hiroyasu Komiya, Hideyuki Takeuchi, Yuki Ogawa, Yuki Hatooka, Keita Takahashi, Atsuko Katsumoto, Shun Kubota, Haruko Nakamura, Misako Kunii, Mikiko Tada, Hiroshi Doi, Fumiaki Tanaka

    Molecular brain   13 ( 1 )   64 - 64   2020年4月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    It remains controversial whether circulating monocytes expressing CCR2 infiltrate the central nervous system (CNS) and contribute to pathogenicity of amyotrophic lateral sclerosis (ALS). A previous report used conventional immunohistochemistry to show that CCR2 is exclusively expressed by astrocytes, but not infiltrating monocytes/microglia or neurons, in the spinal cords of ALS model mice. In this study, we assessed the cellular distribution of CCR2 in the CNS of ALS mice using CCR2-reporter mice (Ccr2rfp/+-Cx3cr1gfp/+-SOD1G93A Tg mice), a more sophisticated method for directly detecting the distribution of CCR2 protein. We found that infiltration of CCR2+ monocytes in the lumbar spinal cord increased over the course of disease progression. Moreover, from the middle stage of disease, CCR2 was partially distributed in microglia and neurons, but not astrocytes, in striking contrast to the previous findings. These novel observations suggested that CCR2+ monocyte infiltration leads to CNS environmental deterioration due to toxic conversion of microglia and neurons, creating a vicious cycle of neuroinflammation and leading to acceleration of ALS pathology. Our findings also show that this reporter mouse is a useful and powerful tool for obtaining new insights into the pathomechanisms of ALS.

    DOI: 10.1186/s13041-020-00607-3

    PubMed

    researchmap

  • 本年の動向 小脳と認知機能

    東山 雄一, 田中 章景

    Annual Review神経   2020   91 - 98   2020年4月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)中外医学社  

    researchmap

  • A new method to define cutoff values in nerve conduction studies for carpal tunnel syndrome considering the presence of false-positive cases. 査読 国際誌

    Yosuke Miyaji, Masahito Kobayashi, Chizuko Oishi, Yoshikazu Mizoi, Fumiaki Tanaka, Masahiro Sonoo

    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology   41 ( 3 )   669 - 677   2020年3月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    BACKGROUND: Nerve conduction studies (NCS) are useful tools for diagnosing carpal tunnel syndrome (CTS). Establishing the normal values is the first step required for utilizing NCS for diagnosis. Previous epidemiological studies demonstrated the presence of fairly large number of false-positive subjects regarding NCS among control population, which has not been properly considered in past studies. This study proposed a new method to address this issue. METHODS: Non-diabetic 144 CTS patients were retrospectively enrolled using clinically defined inclusion criteria. Controls consisted of 73 age-matched volunteers without hand symptoms. Six NCS parameters were evaluated including peak-latency difference by the thumb method (thumbdif) and that by the ring-finger method (ringdif). The Youden index of the receiver operator characteristic curve was used both to judge the sensitivity of a parameter and to identify false-positive cases that were thought to have subclinical median neuropathy at the wrist. The linear function of six parameters was constructed, and the coefficient for each parameter was variously changed. RESULTS: When the Youden index took on the maximum value, seven control subjects (10%) were identified as false-positive and were excluded from the calculation of normal values. The most sensitive parameter before exclusion was thumbdif, whereas ringdif became the most sensitive after exclusion. The cut-off value for ringdif was 1.15 ms before exclusion, but was 0.37 ms after exclusion. CONCLUSION: This method can be widely applied to solve the statistical problem when the gold standard is lacking, and the outside reference standard is not completely reliable.

    DOI: 10.1007/s10072-019-04145-2

    PubMed

    researchmap

  • 【前頭葉-脳の司令塔】臨床 障害 読み書き障害

    浜田 智哉, 東山 雄一, 田中 章景

    Clinical Neuroscience   38 ( 2 )   206 - 210   2020年2月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)中外医学社  

    researchmap

  • Pitfall of Light Transmission Aggregometry-Based Assessment of Platelet Function in Acute Ischemic Stroke Patients. 査読 国際誌

    Eriko Sugawara, Mie Shimizu, Masahiro Yamamoto, Yosuke Kudo, Fumiaki Tanaka, Ken Johkura

    Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association   29 ( 1 )   104496 - 104496   2020年1月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    BACKGROUND: The utility of light transmission aggregometry (LTA)-based assessment of platelet function in acute ischemic stroke patients remains controversial. This study aimed to clarify why LTA failed to estimate platelet function in acute ischemic stroke patients. METHODS: Using LTA, we evaluated the platelet aggregation abilities of citrated blood samples from 22 acute noncardiogenic ischemic stroke patients prior to treatment and compared them with those of 65 heathy volunteer controls. Platelet counts and mean platelet volumes (MPV) of citrated blood and platelet-rich plasma (PRP) prepared for LTA were evaluated simultaneously. Using a hematology analyzer, we also measured and compared the aggregation-prone properties of platelets in the hematology analysis process between patient and control samples. RESULTS: Although platelets aggregated more easily and frequently in patient samples (P < .01), the maximum aggregation rate (MA%) of LTA was paradoxically lower in patients than in controls (P < .05). The PRP/citrated blood ratio of platelet counts and MPV were significantly lower in patients than in controls (P < .05). CONCLUSIONS: Our results suggest that MA% of LTA is erroneously displayed as lower values than the actual status in patients with increased platelet aggregation ability such as acute ischemic stroke because activated large platelets are preaggregated and thus decreased in the PRP on LTA.

    DOI: 10.1016/j.jstrokecerebrovasdis.2019.104496

    PubMed

    researchmap

  • Tonsillectomy Improved Therapeutic Response in Anti-SRP Myopathy With Chronic Tonsillitis. 国際誌

    Takuya Ikeda, Hideyuki Takeuchi, Keita Takahashi, Haruko Nakamura, Misako Kunii, Atsuko Katsumoto, Mikiko Tada, Yuichi Higashiyama, Takashi Hibiya, Shigeaki Suzuki, Ichizo Nishino, Shigeru Koyano, Hiroshi Doi, Fumiaki Tanaka

    Frontiers in immunology   11   595480 - 595480   2020年

     詳細を見る

    記述言語:英語  

    Chronic tonsillitis has been attracted attention as a source of abnormal immune responses and a possible trigger of autoimmune diseases such as IgA nephritis, IgA vasculitis, palmoplantar pustulosis, psoriasis, rheumatoid arthritis, Behçet's disease, and myositis. Here we present the first report of anti-signal recognition particle antibody-associated necrotizing myopathy (anti-SRP myopathy) with IgA nephropathy and chronic tonsillitis in which the therapeutic response to intravenous immunoglobulin (IVIG) treatment was dramatically improved after tonsillectomy and accompanied by a rapid increase in ΔIgG, defined as the change in serum IgG levels 2 weeks after the start of IVIG treatment relative to pre-treatment levels. Moreover, serum anti-SRP antibody titers became undetectable after tonsillectomy even though the resected tonsils did not produce anti-SRP antibodies. Tonsillectomy should be considered when chronic tonsillitis is observed in patients with autoimmune diseases showing poor response to treatment, including anti-SRP myopathy.

    DOI: 10.3389/fimmu.2020.595480

    PubMed

    researchmap

  • GGC Repeat Expansion of NOTCH2NLC in Adult Patients with Leukoencephalopathy. 査読 国際誌

    Masaki Okubo, Hiroshi Doi, Ryoko Fukai, Atsushi Fujita, Satomi Mitsuhashi, Shunta Hashiguchi, Hitaru Kishida, Naohisa Ueda, Keisuke Morihara, Akihiro Ogasawara, Yuko Kawamoto, Tatsuya Takahashi, Keita Takahashi, Haruko Nakamura, Misako Kunii, Mikiko Tada, Atsuko Katsumoto, Hiromi Fukuda, Takeshi Mizuguchi, Satoko Miyatake, Noriko Miyake, Junichiro Suzuki, Yasuhiro Ito, Jun Sone, Gen Sobue, Hideyuki Takeuchi, Naomichi Matsumoto, Fumiaki Tanaka

    Annals of neurology   86 ( 6 )   962 - 968   2019年12月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Leukoencephalopathies comprise a broad spectrum of disorders, but the genetic background of adult leukoencephalopathies has rarely been assessed. In this study, we analyzed 101 Japanese patients with genetically unresolved adult leukoencephalopathy using whole-exome sequencing and repeat-primed polymerase chain reaction for detecting GGC expansion in NOTCH2NLC. NOTCH2NLC was recently identified as the cause of neuronal intranuclear inclusion disease. We found 12 patients with GGC expansion in NOTCH2NLC as the most frequent cause of adult leukoencephalopathy followed by NOTCH3 variants in our cohort. Furthermore, we found 1 case with de novo GGC expansion, which might explain the underlying pathogenesis of sporadic cases. ANN NEUROL 2019;86:962-968.

    DOI: 10.1002/ana.25586

    PubMed

    researchmap

  • 視床下核脳深部刺激療法施行症例における刺激調整の検討

    山田 塁, 木村 活生, 岸田 日帯, 北澤 悠, 安部 克哉, 東山 雄一, 岡本 光生, 上木 英人, 土井 宏, 竹内 英之, 川崎 隆, 上田 直久, 田中 章景

    臨床神経学   59 ( Suppl. )   S219 - S219   2019年11月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • A Case of Cerebral Venous Thrombosis and Deep Venous Thrombosis Due to Hyperthyroidism with Increased Factor VIII Activity. 査読 国際誌

    Mutsumi Yokoyama, Ryotaro Yamashita, Masayuki Furuya, Maiko Yamazaki, Kazuo Koyama, Fumiaki Tanaka

    Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association   28 ( 11 )   104364 - 104364   2019年11月

     詳細を見る

    記述言語:英語  

    A 48-year-old woman was admitted to our hospital because of headache and fever. She was diagnosed with aseptic meningitis. Five days later, she had a seizure and developed left hemiparesis. Magnetic resonance imaging showed hyperintensity in the right parietal area on fluid attenuated inversion recovery imaging. She was diagnosed as having cerebral venous thrombosis (CVT) because the suprasagittal sinus was invisible on the venographic studies. Moreover, deep venous thrombosis (DVT) was detected in her left lower extremity. Laboratory findings showed hyperthyroidism and markedly increased factor VIII activity. This is a rare case of concomitant CVT and DVT induced by high factor VIII activity due to hyperthyroidism under the presence of meningitis, an additional risk factor for thrombosis.

    DOI: 10.1016/j.jstrokecerebrovasdis.2019.104364

    PubMed

    researchmap

  • 脊髄性筋萎縮症9例に対するルシネルセンNa髄注の効果

    岸田 日帯, 木村 活生, 北澤 悠, 土橋 裕一, 安部 克哉, 鈴木 聡, 古泉 龍一, 高橋 慶太, 中村 治子, 竹内 英之, 上田 直久, 田中 章景

    臨床神経学   59 ( Suppl. )   S274 - S274   2019年11月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • てんかんを疑われ当科外来を紹介受診した患者の診断についての検討

    萩原 真斗, 北澤 悠, 木村 活生, 岸田 日帯, 古泉 龍一, 東山 雄一, 岡本 光生, 上木 英人, 土井 宏, 竹内 英之, 上田 直久, 田中 章景

    臨床神経学   59 ( Suppl. )   S343 - S343   2019年11月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 視床下核脳深部刺激療法におけるLevodopa Equivalent Daily Amplitudeの検討

    安部 克哉, 木村 活生, 岸田 日帯, 北澤 悠, 山田 塁, 東山 雄一, 岡本 光生, 上木 英人, 土井 宏, 竹内 英之, 川崎 隆, 上田 直久, 田中 章景

    臨床神経学   59 ( Suppl. )   S219 - S219   2019年11月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • パーキンソン病における運動および知的学習の転移効果

    上田 直久, 北澤 悠, 東山 雄一, 木村 活生, 岡本 光生, 上木 英人, 土井 宏, 岸田 日帯, 竹内 英之, 児矢野 繁, 田中 章景

    臨床神経学   59 ( Suppl. )   S230 - S230   2019年11月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • パーキンソン病における血圧日内変動と認知機能低下

    上木 英人, 東山 雄一, 岡本 光生, 木村 活生, 岸田 日帯, 上田 直久, 土井 宏, 竹内 英之, 児矢野 繁, 田中 章景

    臨床神経学   59 ( Suppl. )   S355 - S355   2019年11月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • Recurrent NUS1 canonical splice donor site mutation in two unrelated individuals with epilepsy, myoclonus, ataxia and scoliosis - a case report. 査読 国際誌

    Kouhei Den, Yosuke Kudo, Mitsuhiro Kato, Kosuke Watanabe, Hiroshi Doi, Fumiaki Tanaka, Hirokazu Oguni, Satoko Miyatake, Takeshi Mizuguchi, Atsushi Takata, Noriko Miyake, Satomi Mitsuhashi, Naomichi Matsumoto

    BMC neurology   19 ( 1 )   253 - 253   2019年10月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    BACKGROUND: We encountered two unrelated individuals suffering from neurological disorders, including epilepsy and scoliosis. CASE PRESENTATION: Whole-exome sequencing identified the same recurrent, de novo, pathogenic variant in NUS1 [NM_138459.4:c.691 + 1C > A] in both individuals. This variant is located in the conserved cis-prenyltransferase domain of the nuclear undecaprenyl pyrophosphate synthase 1 gene (NUS1), which encodes the Nogo-B receptor, an essential catalyst for protein glycosylation. This variant was confirmed to create a new splice donor site, resulting in aberrant RNA splicing resulting in a 91-bp deletion in exon 3 in both individuals. The mutant mRNA was partially degraded by nonsense mediated mRNA decay. To date, only four de novo variants and one homozygous variant have been reported in NUS1, which cause developmental and epileptic encephalopathy, early onset Parkinson's disease, and a congenital disorder of glycosylation. Seven patients, including our two patients, have presented with epileptic seizures and intellectual disabilities. CONCLUSIONS: Our study strongly supports the finding that this recurrent, de novo, variant in NUS1 causes developmental and epileptic encephalopathy with involuntary movement, ataxia and scoliosis.

    DOI: 10.1186/s12883-019-1489-x

    PubMed

    researchmap

  • Proteomic analysis of exosome-enriched fractions derived from cerebrospinal fluid of amyotrophic lateral sclerosis patients. 査読 国際誌

    Noriko Hayashi, Hiroshi Doi, Yoichi Kurata, Hiroyuki Kagawa, Yoshitoshi Atobe, Kengo Funakoshi, Mikiko Tada, Atsuko Katsumoto, Kenichi Tanaka, Misako Kunii, Haruko Nakamura, Keita Takahashi, Hideyuki Takeuchi, Shigeru Koyano, Yayoi Kimura, Hisashi Hirano, Fumiaki Tanaka

    Neuroscience research   160   43 - 49   2019年10月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Exosomes contain many proteins associated with neurodegenerative diseases. To identify new candidate biomarkers and proteins associated with amyotrophic lateral sclerosis (ALS), we performed liquid chromatography-tandem mass spectrometry proteomic analysis of exosome-enriched fractions isolated from cerebrospinal fluid (CSF) of sporadic ALS patients using gel filtration chromatography. Proteomic data revealed that three proteins were increased and 11 proteins were decreased in ALS patients. The protein with the greatest increase in exosome-enriched fractions of CSF derived from ALS was novel INHAT repressor (NIR), which is closely associated with nucleolar function. By immunohistochemical analysis, we found that NIR was reduced in the nucleus of motor neurons in ALS patients. Our results demonstrate the potential utility of our methodology for proteomic analysis of CSF exosomes and suggest that nucleolar stress might play a role in sporadic ALS pathogenesis through the dysfunction of NIR.

    DOI: 10.1016/j.neures.2019.10.010

    PubMed

    researchmap

  • 声帯麻痺を呈したSlow Channel Congenital Myasthenic Syndrome(SCCMS)の52歳男性例

    竹歳 卓人, 國井 美紗子, 古宮 裕泰, 多田 美紀子, 北澤 悠, 上木 英人, 土井 宏, 竹内 英之, 田中 章景

    神経治療学   36 ( 6 )   S289 - S289   2019年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経治療学会  

    researchmap

  • 難治性中耳炎に肥厚性硬膜炎を合併しステロイド治療が奏効した58歳女性例

    森原 啓介, 竹井 暖, 林 紀子, 高橋 慶太, 勝元 敦子, 東山 雄一, 上木 英人, 土井 宏, 竹内 英之, 田中 章景

    神経治療学   36 ( 6 )   S282 - S282   2019年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経治療学会  

    researchmap

  • Ataxic phenotype with altered CaV3.1 channel property in a mouse model for spinocerebellar ataxia 42. 査読 国際誌

    Shunta Hashiguchi, Hiroshi Doi, Misako Kunii, Yukihiro Nakamura, Misa Shimuta, Etsuko Suzuki, Shigeru Koyano, Masaki Okubo, Hitaru Kishida, Masaaki Shiina, Kazuhiro Ogata, Fumiko Hirashima, Yukichi Inoue, Shun Kubota, Noriko Hayashi, Haruko Nakamura, Keita Takahashi, Atsuko Katsumoto, Mikiko Tada, Kenichi Tanaka, Toshikuni Sasaoka, Satoko Miyatake, Noriko Miyake, Hirotomo Saitsu, Nozomu Sato, Kokoro Ozaki, Kiyobumi Ohta, Takanori Yokota, Hidehiro Mizusawa, Jun Mitsui, Hiroyuki Ishiura, Jun Yoshimura, Shinichi Morishita, Shoji Tsuji, Hideyuki Takeuchi, Kinya Ishikawa, Naomichi Matsumoto, Taro Ishikawa, Fumiaki Tanaka

    Neurobiology of disease   130   104516 - 104516   2019年10月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Spinocerebellar ataxia 42 (SCA42) is a neurodegenerative disorder recently shown to be caused by c.5144G > A (p.Arg1715His) mutation in CACNA1G, which encodes the T-type voltage-gated calcium channel CaV3.1. Here, we describe a large Japanese family with SCA42. Postmortem pathological examination revealed severe cerebellar degeneration with prominent Purkinje cell loss without ubiquitin accumulation in an SCA42 patient. To determine whether this mutation causes ataxic symptoms and neurodegeneration, we generated knock-in mice harboring c.5168G > A (p.Arg1723His) mutation in Cacna1g, corresponding to the mutation identified in the SCA42 family. Both heterozygous and homozygous mutants developed an ataxic phenotype from the age of 11-20 weeks and showed Purkinje cell loss at 50 weeks old. Degenerative change of Purkinje cells and atrophic thinning of the molecular layer were conspicuous in homozygous knock-in mice. Electrophysiological analysis of Purkinje cells using acute cerebellar slices from young mice showed that the point mutation altered the voltage dependence of CaV3.1 channel activation and reduced the rebound action potentials after hyperpolarization, although it did not significantly affect the basic properties of synaptic transmission onto Purkinje cells. Finally, we revealed that the resonance of membrane potential of neurons in the inferior olivary nucleus was decreased in knock-in mice, which indicates that p.Arg1723His CaV3.1 mutation affects climbing fiber signaling to Purkinje cells. Altogether, our study shows not only that a point mutation in CACNA1G causes an ataxic phenotype and Purkinje cell degeneration in a mouse model, but also that the electrophysiological abnormalities at an early stage of SCA42 precede Purkinje cell loss.

    DOI: 10.1016/j.nbd.2019.104516

    PubMed

    researchmap

  • Adult-onset vocal cord paralysis in slow-channel congenital myasthenic syndrome. 査読 国際誌

    Haruko Nakamura, Hiroyasu Komiya, Eri Uematsu, Yoshiharu Nakae, Kenichi Tanaka, Misako Kunii, Mikiko Tada, Hideto Joki, Shigeru Koyano, Naomichi Matsumoto, Hiroshi Doi, Hideyuki Takeuchi, Fumiaki Tanaka

    Neurology. Clinical practice   9 ( 5 )   e45-e47   2019年10月

     詳細を見る

  • Novel VRK1 Mutations in a Patient with Childhood-onset Motor Neuron Disease. 査読

    Genpei Yamaura, Yuichi Higashiyama, Kaori Kusama, Misako Kunii, Kenichi Tanaka, Shigeru Koyano, Mitsuko Nakashima, Yoshinori Tsurusaki, Noriko Miyake, Hirotomo Saitsu, Yukiko Iwahashi, Hideto Joki, Naomichi Matsumoto, Hiroshi Doi, Fumiaki Tanaka

    Internal medicine (Tokyo, Japan)   58 ( 18 )   2715 - 2719   2019年9月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    A 24-year-old Japanese man exhibited slowly progressive gait disturbance from childhood to young adulthood. Physical and physiological examinations showed the involvement of both upper and lower motor neurons, fulfilling the diagnostic criteria for amyotrophic lateral sclerosis (ALS). Mild cognitive impairment and subclinical sensory involvement were also observed. A genetic analysis revealed novel compound heterozygous mutations, c.767C>T (p.Thr256Ile) and c.800A>G (p.Asp267Gly), in the vaccinia-related kinase 1 gene (VRK1). This is the first report of a Japanese patient with a motor neuron disease phenotype caused by VRK1 mutations. This diagnosis should be considered in atypical cases of juvenile-onset and slowly progressive types of motor neuron disease.

    DOI: 10.2169/internalmedicine.2126-18

    PubMed

    researchmap

  • 難治性中耳炎と肥厚性硬膜炎を合併しステロイドで改善を得た58歳女性例

    栗田 悠輔, 高橋 慶太, 森原 啓介, 東山 雄一, 土井 宏, 竹内 英之, 田中 章景

    臨床神経学   59 ( 9 )   617 - 617   2019年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • てんかんを疑われ当科外来を紹介受診した患者の診断についての検討(A study of diagnosis for patients who referred to our clinic with suspicion of epilepsy)

    萩原 真斗, 北澤 悠, 木村 活生, 岸田 日帯, 東山 雄一, 岡本 光生, 上木 英人, 土井 宏, 竹内 英之, 上田 直久, 田中 章景

    てんかん研究   37 ( 2 )   712 - 712   2019年9月

     詳細を見る

    記述言語:英語   出版者・発行元:(一社)日本てんかん学会  

    researchmap

  • 臨床ケース 広汎な自律神経障害を伴うサルコイドーシスの3症例 抗gAChR抗体との関連性について

    向野 晃弘, 國井 美紗子, 有田 行正, 樋口 理, 前田 泰宏, 田中 章景, 辻野 彰, 松尾 秀徳, 中根 俊成

    神経免疫学   24 ( 1 )   114 - 114   2019年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本神経免疫学会  

    researchmap

  • 集学的治療により発作症状の軽減が得られた成人発症型Rasmussen症候群の一例

    北澤 悠, 木村 活生, 宮城 哲哉, 岡本 智子, 太組 一朗, 岸田 日帯, 上木 英人, 土井 宏, 竹内 英之, 上田 直久, 田中 章景

    てんかん研究   37 ( 2 )   708 - 708   2019年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本てんかん学会  

    researchmap

  • Long-read sequencing identifies GGC repeat expansions in NOTCH2NLC associated with neuronal intranuclear inclusion disease. 査読 国際誌

    Jun Sone, Satomi Mitsuhashi, Atsushi Fujita, Takeshi Mizuguchi, Kohei Hamanaka, Keiko Mori, Haruki Koike, Akihiro Hashiguchi, Hiroshi Takashima, Hiroshi Sugiyama, Yutaka Kohno, Yoshihisa Takiyama, Kengo Maeda, Hiroshi Doi, Shigeru Koyano, Hideyuki Takeuchi, Michi Kawamoto, Nobuo Kohara, Tetsuo Ando, Toshiaki Ieda, Yasushi Kita, Norito Kokubun, Yoshio Tsuboi, Kazutaka Katoh, Yoshihiro Kino, Masahisa Katsuno, Yasushi Iwasaki, Mari Yoshida, Fumiaki Tanaka, Ikuo K Suzuki, Martin C Frith, Naomichi Matsumoto, Gen Sobue

    Nature genetics   51 ( 8 )   1215 - 1221   2019年8月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Neuronal intranuclear inclusion disease (NIID) is a progressive neurodegenerative disease that is characterized by eosinophilic hyaline intranuclear inclusions in neuronal and somatic cells. The wide range of clinical manifestations in NIID makes ante-mortem diagnosis difficult1-8, but skin biopsy enables its ante-mortem diagnosis9-12. The average onset age is 59.7 years among approximately 140 NIID cases consisting of mostly sporadic and several familial cases. By linkage mapping of a large NIID family with several affected members (Family 1), we identified a 58.1 Mb linked region at 1p22.1-q21.3 with a maximum logarithm of the odds score of 4.21. By long-read sequencing, we identified a GGC repeat expansion in the 5' region of NOTCH2NLC (Notch 2 N-terminal like C) in all affected family members. Furthermore, we found similar expansions in 8 unrelated families with NIID and 40 sporadic NIID cases. We observed abnormal anti-sense transcripts in fibroblasts specifically from patients but not unaffected individuals. This work shows that repeat expansion in human-specific NOTCH2NLC, a gene that evolved by segmental duplication, causes a human disease.

    DOI: 10.1038/s41588-019-0459-y

    PubMed

    researchmap

  • Effectiveness of Nonvitamin K Antagonist Oral Anticoagulants and Warfarin for Preventing Further Cerebral Microbleeds in Acute Ischemic Stroke Patients with Nonvalvular Atrial Fibrillation and At Least One Microbleed: CMB-NOW Multisite Pilot Trial. 査読 国際誌

    Mutsumi Yokoyama, Atsushi Mizuma, Tohru Terao, Fumiaki Tanaka, Kazutoshi Nishiyama, Yasuhiro Hasegawa, Eiichiro Nagata, Shigeru Nogawa, Hiroyuki Kobayashi, Noriharu Yanagimachi, Takashi Okazaki, Kazuo Kitagawa, Shunya Takizawa

    Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association   28 ( 7 )   1918 - 1925   2019年7月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    BACKGROUND: Nonvitamin K antagonist oral anticoagulants (NOACs) are considered superior, or at least noninferior, to warfarin in preventing stroke or systemic embolism in patients with nonvalvular atrial fibrillation. Here, we recruited acute ischemic stroke patients with nonvalvular atrial fibrillation and at least one cerebral microbleed (CMB), and evaluated the proportion of patients who had an increased number of CMBs (%) after receiving anticoagulant therapy with NOACs or with warfarin for 12 months. METHODS: This was a multicenter, prospective, observational cohort study at 20 centers, conducted between 2015 and 2017, in which we recruited 85 patients with at least one CMB detected by 1.5T magnetic resonance imaging (T2*WI) at baseline, who received NOACs or warfarin for at least 12 months. We compared the proportions of patients with increased numbers of CMBs in the NOACs and warfarin treatment groups. RESULTS: The proportions of patients with increased numbers of CMBs at month 12 of treatment were 28.6% and 66.7% in the NOACs and warfarin groups, respectively. The new CMBs showed no specific regional localization in either group. In the NOACs and warfarin groups, physicians prescribed lower-than-standard dosing in 13.3% and 50% of the cases, respectively. The administration of reduced doses at physicians' discretion did not appear to alter the incidence of new CMBs. DISCUSSION: This is the first evidence to suggest efficacy of NOACs for preventing further CMBs in patients with at least one CMB, although no statistical evaluation was carried out.

    DOI: 10.1016/j.jstrokecerebrovasdis.2019.03.050

    PubMed

    researchmap

  • Anomalous anastomosis between the external carotid artery and vertebrobasilar artery via the hypoglossal canal: a case report and review of literature. 査読 国際誌

    Ryoo Yamamoto, Naoki Mori, Yoshiharu Nakae, Fumiaki Tanaka, Ken Johkura

    Surgical and radiologic anatomy : SRA   41 ( 7 )   849 - 852   2019年7月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    We report a case of an anomalous anastomosis formed between the external carotid artery (ECA) and the vertebrobasilar artery (VBA) and passing through the hypoglossal canal. A carotid-vertebrobasilar anastomosis of this kind is typically considered a variant of persistent primitive hypoglossal artery which usually originates from the internal carotid artery. However, the anastomotic vessel in this case had a common trunk with the occipital artery (OA), a remnant of the primitive proatlantal artery. The proximal and distal parts of the anastomotic vessel seemed to have been derived from the primitive proatlantal artery and the primitive hypoglossal artery, respectively. Thus, we propose that this ECA-VBA anastomosis, which passed through the hypoglossal canal and had a common trunk with the OA, be referred to as a dilated primitive hypoglossal-proatlantal anastomosis; that is, a dilated ascending pharyngeal artery rather than a variant of persistent primitive hypoglossal artery.

    DOI: 10.1007/s00276-019-02205-y

    PubMed

    researchmap

  • 脳深部刺激療法を施行したパーキンソン病症例における脊髄刺激療法施行前後の歩行機能変化

    安部 克哉, 木村 活生, 山田 塁, 柳泉 亮太, 田澤 利治, 川崎 隆, 岸田 日帯, 北澤 悠, 東山 雄一, 岡本 光生, 上木 英人, 土井 宏, 竹内 英之, 上田 直久, 田中 章景

    パーキンソン病・運動障害疾患コングレスプログラム・抄録集   13回   99 - 99   2019年7月

     詳細を見る

    記述言語:日本語   出版者・発行元:Movement Disorder Society of Japan (MDSJ)  

    researchmap

  • ディレクショナルモード設定を使用したSTN-DBS症例の長期予後

    木村 活生, 岸田 日帯, 川崎 隆, 岡本 光生, 東山 雄一, 上木 英人, 土井 宏, 竹内 英之, 上田 直久, 田中 章景

    パーキンソン病・運動障害疾患コングレスプログラム・抄録集   13回   83 - 83   2019年7月

     詳細を見る

    記述言語:日本語   出版者・発行元:Movement Disorder Society of Japan (MDSJ)  

    researchmap

  • 難治性嚥下障害に対しエクリズマブが著効した重症筋無力症の23歳女性

    萩原 真斗, 岸田 日帯, 古泉 龍一, 北澤 悠, 木村 活生, 上田 直久, 田中 章景

    臨床神経学   59 ( 7 )   472 - 472   2019年7月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • STN-DBS施行症例における刺激調整の検討

    山田 塁, 木村 活生, 岸田 日帯, 北澤 悠, 安部 克哉, 東山 雄一, 岡本 光生, 上木 英人, 土井 宏, 竹内 英之, 川崎 隆, 上田 直久, 田中 章景

    パーキンソン病・運動障害疾患コングレスプログラム・抄録集   13回   84 - 84   2019年7月

     詳細を見る

    記述言語:日本語   出版者・発行元:Movement Disorder Society of Japan (MDSJ)  

    researchmap

  • Tumefactive Brain Lesionを合併したMAG抗体陽性ニューロパチーの79歳女性

    安部 克哉, 岸田 日帯, 山田 塁, 北澤 悠, 藤井 啓太, 坂田 勝巳, 上田 直久, 田中 章景

    臨床神経学   59 ( 4 )   221 - 221   2019年4月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • Influence of Platelet Aggregate Formation in Blood Samples on Light Transmission Aggregometry Results. 査読 国際誌

    Eriko Sugawara, Mie Shimizu, Masahiro Yamamoto, Yosuke Kudo, Fumiaki Tanaka, Ken Johkura

    Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association   28 ( 4 )   1001 - 1006   2019年4月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    BACKGROUND: Light transmission aggregometry is a standard method used to evaluate platelet function. However, in clinical settings, light transmission aggregometry results sometimes fail to reflect actual platelet hyperactivity. In patients with suspected platelet hyperactivity such as thrombosis, platelet aggregates are frequently detected in citrated blood samples using a scattergram of a hematology analyzer. This study aimed to evaluate the effects of platelet aggregate formation on light transmission aggregometry results. METHODS: We used 19 citrated blood samples in which platelet aggregate formation was intentionally induced by a hematology analysis process. Employing fully automated light transmission aggregometry and agonists including adenosine diphosphate or collagen, light transmission aggregometry maximum aggregation percentage, platelet count, and mean platelet volume of platelet-rich plasma before and after platelet aggregate formation were evaluated. RESULTS: Light transmission aggregometry maximum aggregation percentage with adenosine diphosphate or collagen was significantly lower in the samples after than before platelet aggregate formation. Platelet count and mean platelet volume were both decreased by platelet aggregate formation (P < .01), suggesting that maximum aggregation percentage reduction was caused by the decrease in activated large platelets in the platelet-rich plasma. CONCLUSION: This study clarified that platelet aggregate formation in blood samples interfered with an accurate assessment of platelet hyperactivity. To ensure reliability of light transmission aggregometry results, we must confirm that platelet aggregates have not formed in the sample, especially in those of patients with platelet hyperactivity.

    DOI: 10.1016/j.jstrokecerebrovasdis.2018.12.014

    PubMed

    researchmap

  • Non-traumatic Acute Epidural Hematoma in Multiple Sclerosis Treated With Fingolimod. 査読 国際誌

    Ryoko Fukai, Keita Takahashi, Hiroyuki Abe, Yuichi Higashiyama, Hiroshi Doi, Hideyuki Takeuchi, Fumiaki Tanaka

    Frontiers in neurology   10   763 - 763   2019年

     詳細を見る

    記述言語:英語  

    Fingolimod acts as a functional antagonist of the sphingosine-1-phosphate receptor and is widely used for relapsing-remitting multiple sclerosis (MS). Here we report the first case of non-traumatic acute epidural hematoma in a relapsing-remitting MS patient treated with fingolimod. Fingolimod might increase the risk of hemorrhage by enhancing vasospasm and causing vascular disruption. Switching fingolimod to other disease-modifying drugs, including dimethyl fumarate, should be considered when non-traumatic hemorrhage is observed in MS patients.

    DOI: 10.3389/fneur.2019.00763

    PubMed

    researchmap

  • Adjustment of Subthalamic Deep Brain Stimulation Parameters Improves Wheeze and Dyspnea in Parkinson's Disease. 査読 国際誌

    Hiroyasu Komiya, Katsuo Kimura, Hitaru Kishida, Takashi Kawasaki, Koichi Hamada, Hiroyuki Koizumi, Naohisa Ueda, Fumiaki Tanaka

    Frontiers in neurology   10   1317 - 1317   2019年

     詳細を見る

    記述言語:英語  

    Subthalamic nucleus deep brain stimulation (STN-DBS) is an effective treatment for motor features in Parkinson's disease (PD). We present the case of a 56-year-old man with a 17-year history of PD. He underwent bilateral STN-DBS at the age of 51 years because of troublesome dyskinesia and wearing off. His motor features dramatically improved after the operation; however, he developed dysarthria and a refractory wheeze associated with dyspnea due to abnormal hyperadduction of the false vocal fold. By adjusting the stimulation site of STN, his severe wheeze, which was considered to be the result of the unfavorable spread of current to the corticobulbar tract, was significantly improved. This report provides concrete evidence that wheezing is caused by hyperadduction of the false vocal fold as an adverse effect of STN-DBS and can be reversed by adjusting the stimulation site for STN-DBS.

    DOI: 10.3389/fneur.2019.01317

    PubMed

    researchmap

  • Tau Pathology in Chronic Traumatic Encephalopathy and Alzheimer's Disease: Similarities and Differences. 査読 国際誌

    Atsuko Katsumoto, Hideyuki Takeuchi, Fumiaki Tanaka

    Frontiers in neurology   10   980 - 980   2019年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Traumatic brain injury (TBI) has been associated with the development of Alzheimer's disease (AD) because these conditions share common pathological hallmarks: amyloid-β and hyperphosphorylated tau accumulation. However, given recent data it is uncertain if a history of TBI leads to the development of AD. Moreover, chronic traumatic encephalopathy (CTE), caused by repetitive mild TBI and characterized by progressive neurodegeneration with hyperphosphorylated tau, has come to be recognized as distinct from AD. Therefore, it is important to elucidate the clinical outcomes and molecular mechanisms underlying tau pathology following TBI. We summarize the histopathological features and clinical course of TBI in CTE, comparing the tau pathology with that in AD. Following brain injury, diffuse axonal injury, and hyperphosphorylated tau aggregates are observed within a shorter period than in AD. Hyperphosphorylated tau deposition usually begins in the perivascular area of the sulci in the cerebral cortex, then spreads unevenly in the cortex in CTE, while AD shows diffuse distribution of hyperphosphorylated tau in the cortical areas. We also highlight the molecular profile of tau and the implications of tau progression throughout the brain in both diseases. Tau contains phosphorylation sites common to both conditions. In particular, phosphorylation at Thr231 triggers a conformational change to the toxic cis form of tau, which is suggested to drive neurodegeneration. Although the mechanism of rapid tau accumulation remains unknown, the structural diversity of tau might result in these different outcomes. Finally, future perspectives on CTE in terms of tau reduction are discussed.

    DOI: 10.3389/fneur.2019.00980

    PubMed

    researchmap

  • An attempt to treat ocular flutter and opsoclonus by cerebellar magnetic stimulation. 査読 国際誌

    Yosuke Kudo, Eriko Sugawara, Koji Takahashi, Fumiaki Tanaka, Ken Johkura

    Journal of the neurological sciences   395   119 - 120   2018年12月

     詳細を見る

  • 【神経心理学のマイスター】Wernicke 失語への貢献

    浜田 智哉, 東山 雄一, 田中 章景

    神経内科   89 ( 6 )   585 - 591   2018年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(有)科学評論社  

    researchmap

  • Biallelic COLGALT1 variants are associated with cerebral small vessel disease. 査読 国際誌

    Satoko Miyatake, Sacha Schneeberger, Norihisa Koyama, Kenji Yokochi, Kayo Ohmura, Masaaki Shiina, Harushi Mori, Eriko Koshimizu, Eri Imagawa, Yuri Uchiyama, Satomi Mitsuhashi, Martin C Frith, Atsushi Fujita, Mai Satoh, Masataka Taguri, Yasuko Tomono, Keita Takahashi, Hiroshi Doi, Hideyuki Takeuchi, Mitsuko Nakashima, Takeshi Mizuguchi, Atsushi Takata, Noriko Miyake, Hirotomo Saitsu, Fumiaki Tanaka, Kazuhiro Ogata, Thierry Hennet, Naomichi Matsumoto

    Annals of neurology   84 ( 6 )   843 - 853   2018年12月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    OBJECTIVE: Approximately 5% of cerebral small vessel diseases are hereditary, which include COL4A1/COL4A2-related disorders. COL4A1/COL4A2 encode type IV collagen α1/2 chains in the basement membranes of cerebral vessels. COL4A1/COL4A2 mutations impair the secretion of collagen to the extracellular matrix, thereby resulting in vessel fragility. The diagnostic yield for COL4A1/COL4A2 variants is around 20 to 30%, suggesting other mutated genes might be associated with this disease. This study aimed to identify novel genes that cause COL4A1/COL4A2-related disorders. METHODS: Whole exome sequencing was performed in 2 families with suspected COL4A1/COL4A2-related disorders. We validated the role of COLGALT1 variants by constructing a 3-dimensional structural model, evaluating collagen β (1-O) galactosyltransferase 1 (ColGalT1) protein expression and ColGalT activity by Western blotting and collagen galactosyltransferase assays, and performing in vitro RNA interference and rescue experiments. RESULTS: Exome sequencing demonstrated biallelic variants in COLGALT1 encoding ColGalT1, which was involved in the post-translational modification of type IV collagen in 2 unrelated patients: c.452 T > G (p.Leu151Arg) and c.1096delG (p.Glu366Argfs*15) in Patient 1, and c.460G > C (p.Ala154Pro) and c.1129G > C (p.Gly377Arg) in Patient 2. Three-dimensional model analysis suggested that p.Leu151Arg and p.Ala154Pro destabilized protein folding, which impaired enzymatic activity. ColGalT1 protein expression and ColGalT activity in Patient 1 were undetectable. RNA interference studies demonstrated that reduced ColGalT1 altered COL4A1 secretion, and rescue experiments showed that mutant COLGALT1 insufficiently restored COL4A1 production in cells compared with wild type. INTERPRETATION: Biallelic COLGALT1 variants cause cerebral small vessel abnormalities through a common molecular pathogenesis with COL4A1/COL4A2-related disorders. Ann Neurol 2018;84:843-853.

    DOI: 10.1002/ana.25367

    PubMed

    researchmap

  • A variant at 9q34.11 is associated with HLA-DQB1*06:02 negative essential hypersomnia. 査読 国際誌

    Miyagawa T, Khor SS, Toyoda H, Kanbayashi T, Imanishi A, Sagawa Y, Kotorii N, Kotorii T, Ariyoshi Y, Hashizume Y, Ogi K, Hiejima H, Kamei Y, Hida A, Miyamoto M, Ikegami A, Wada Y, Takami M, Higashiyama Y, Miyake R, Kondo H, Fujimura Y, Tamura Y, Taniyama Y, Omata N, Tanaka Y, Moriya S, Furuya H, Kato M, Kawamura Y, Otowa T, Miyashita A, Kojima H, Saji H, Shimada M, Yamasaki M, Kobayashi T, Misawa R, Shigematsu Y, Kuwano R, Sasaki T, Ishigooka J, Wada Y, Tsuruta K, Chiba S, Tanaka F, Yamada N, Okawa M, Kuroda K, Kume K, Hirata K, Uchimura N, Shimizu T, Inoue Y, Honda Y, Mishima K, Honda M, Tokunaga K

    Journal of human genetics   63 ( 12 )   1259 - 1267   2018年12月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.1038/s10038-018-0518-8

    PubMed

    researchmap

  • パーキンソン病における運動学習の転移

    上田 直久, 東山 雄一, 木村 活生, 岡本 光生, 上木 英人, 土井 宏, 岸田 日帯, 竹内 英之, 児矢野 繁, 田中 章景

    臨床神経学   58 ( Suppl. )   S343 - S343   2018年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 急性期脳卒中患者のベッドサイドでの眼球運動評価 小脳病変での検討(第3報)

    工藤 洋祐, 高橋 幸治, 田中 理, 菅原 恵梨子, 中溝 知樹, 黒木 美百, 東山 雄一, 田中 章景, 城倉 健

    臨床神経学   58 ( Suppl. )   S307 - S307   2018年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • モーフィング課題を用いた神経変性疾患の視覚認知に関する予備実験

    岡本 光生, 東山 雄一, 上田 直久, 岸田 日帯, 木村 活生, 上木 英人, 土井 宏, 児矢野 繁, 竹内 英之, 田中 章景

    臨床神経学   58 ( Suppl. )   S300 - S300   2018年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 表情定量解析を用いたパーキンソン病の仮面様顔貌の病態解明

    東山 雄一, 木村 活生, 上木 英人, 岸田 日帯, 土井 宏, 上田 直久, 竹内 英之, 田中 章景

    臨床神経学   58 ( Suppl. )   S244 - S244   2018年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 外国語様アクセント症候群(FAS)

    東山 雄一, 田中 章景

    Journal of Clinical Rehabilitation   27 ( 13 )   1303 - 1308   2018年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:医歯薬出版(株)  

    researchmap

  • パーキンソン病に対するDBSにおいて周術期せん妄をおこすリスクについての検討

    岸田 日帯, 木村 活生, 濱田 幸一, 川崎 隆, 岡村 泰, 樋口 優理子, 東山 雄一, 岡本 光生, 上木 英人, 土井 宏, 竹内 英之, 上田 直久, 田中 章景

    臨床神経学   58 ( Suppl. )   S288 - S288   2018年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • パーキンソン病における疲労と血圧日内変動

    上木 英人, 東山 雄一, 岡本 光生, 土井 宏, 木村 活生, 岸田 日帯, 上田 直久, 竹内 英之, 児矢野 繁, 田中 章景

    臨床神経学   58 ( Suppl. )   S263 - S263   2018年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 軽度認知機能障害で発症した成人大脳型副腎白質ジストロフィーの60歳男性例

    池田 拓也, 東山 雄一, 松永 祐己, 森原 啓介, 三宅 綾子, 上木 英人, 竹内 英之, 田中 章景

    臨床神経学   58 ( 12 )   782 - 782   2018年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • ディレクショナルリードをもちいたSTN-DBSにおける簡便な刺激導入法の検討

    木村 活生, 岸田 日帯, 東山 雄一, 岡本 光生, 上木 英人, 土井 宏, 竹内 英之, 濱田 幸一, 川崎 隆, 上田 直久, 田中 章景

    神経治療学   35 ( 6 )   S241 - S241   2018年11月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経治療学会  

    researchmap

  • Interpretation of acid α-glucosidase activity in creatine kinase elevation: A case of Becker muscular dystrophy. 査読 国際誌

    Oitani Y, Ishiyama A, Kosuga M, Iwasawa K, Ogata A, Tanaka F, Takeshita E, Shimizu-Motohashi Y, Komaki H, Nishino I, Okuyama T, Sasaki M

    Brain & development   40 ( 9 )   837 - 840   2018年10月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.1016/j.braindev.2018.05.001

    PubMed

    researchmap

  • A Japanese Family of Spinocerebellar Ataxia Type 21: Clinical and Neuropathological Studies. 査読 国際誌

    Hiroyuki Yahikozawa, Satoko Miyatake, Toshiaki Sakai, Takeshi Uehara, Mitsunori Yamada, Norinao Hanyu, Yasuhiro Futatsugi, Hiroshi Doi, Shigeru Koyano, Fumiaki Tanaka, Atsushi Suzuki, Naomichi Matsumoto, Kunihiro Yoshida

    Cerebellum (London, England)   17 ( 5 )   525 - 530   2018年10月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Spinocerebellar ataxia type 21 (SCA21) is a rare subtype of autosomal dominant cerebellar ataxias, which was first identified in a French family and has been reported almost exclusively in French ancestry so far. We here report the first Japanese family with SCA21, in which all affected members examined carried a heterozygous c.509C > T:p.Pro170Leu variant in TMEM240. Their clinical features were summarized as a slowly progressive ataxia of young-adult onset (5-48 years) associated with various degree of psychomotor retardation or cognitive impairment. The MR images revealed atrophy in the cerebellum, but not in the cerebrum or brainstem. These clinical findings were consistent with those in the original French families with SCA21. Neuropathological findings in one autopsied patient showed a prominent decrease of cerebellar Purkinje cells, but no specific abnormalities outside the cerebellum.

    DOI: 10.1007/s12311-018-0941-6

    PubMed

    researchmap

  • Two cases of anaphylactic shock by methylprednisolone in neuromyelitis optica. 査読 国際誌

    Keita Takahashi, Tetsuya Asano, Yuichi Higashiyama, Shigeru Koyano, Hiroshi Doi, Hideyuki Takeuchi, Fumiaki Tanaka

    Multiple sclerosis (Houndmills, Basingstoke, England)   24 ( 11 )   1514 - 1516   2018年10月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Steroid pulse therapy with methylprednisolone (mPSL) succinate ester is the most common treatment for neuromyelitis optica (NMO); no cases of anaphylaxis have been reported to date. Here, we report two cases of anaphylactic shock induced by mPSL pulse therapy in patients with NMO and concurrent systemic lupus erythematosus. Both patients had received several courses of mPSL pulse therapy without any problems previously. Repeated mPSL pulse therapy and comorbid humoral autoimmune disease might increase the risk of anaphylaxis. Corticosteroids without succinate esters should be considered as an alternative therapy to prevent anaphylaxis.

    DOI: 10.1177/1352458518763099

    PubMed

    researchmap

  • Proteome and behavioral alterations in phosphorylation-deficient mutant Collapsin Response Mediator Protein2 knock-in mice. 査読 国際誌

    Haruko Nakamura, Aoi Takahashi-Jitsuki, Hiroko Makihara, Tetsuya Asano, Yayoi Kimura, Jun Nakabayashi, Naoya Yamashita, Yuko Kawamoto, Fumio Nakamura, Toshio Ohshima, Hisashi Hirano, Fumiaki Tanaka, Yoshio Goshima

    Neurochemistry international   119   207 - 217   2018年10月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    CRMP2, alternatively designated as DPYSL2, was the first CRMP family member to be identified as an intracellular molecule mediating the signaling of the axon guidance molecule Semaphorin 3A (Sema3A). In Sema3A signaling, cyclin-dependent kinase 5 (Cdk5) primarily phosphorylates CRMP2 at Ser522. Glycogen synthase kinase-3β (GSK-3β) subsequently phosphorylates the residues of Thr509 and Thr514 of CRMP2. Previous studies showed that CRMP2 is involved in pathogenesis of neurological disorders such as Alzheimer's disease. In Alzheimer's disease, hyper-phosphorylated forms of CRMP2 are accumulated in the paired helical filaments. To get insight into the possible involvement of the phosphorylation of CRMP2 in pathogenesis of neurological disorders, we previously created CRMP2 S522A knock-in (crmp2ki/ki) mice and demonstrated that the phosphorylation of CRMP2 at Ser522 is involved in normal dendrite patterning in cortical neurons. However, the behavioral impact and in vivo signaling network of the CRMP2 phosphorylation are not fully understood. In this study, we performed behavioral and proteomics analysis of crmp2ki/ki mice. The crmp2ki/ki mice appeared healthy and showed no obvious differences in physical characteristics compared to wild-type mice, but they showed impaired emotional behavior, reduced sociality, and low sensitivity to pain stimulation. Through mass-spectrometry-based proteomic analysis, we found that 59 proteins were increased and 77 proteins were decreased in the prefrontal cortex of crmp2ki/ki mice. Notably, CRMP3, CRMP4, and CRMP5, the other CRMP family proteins, were increased in crmp2ki/ki mice. KEGG (Kyoto Encyclopedia of Genes and Genomes) pathway analyses identified 14 pathways in increased total proteins and 13 pathways in decreased total proteins which are associated with the pathogenesis of Parkinson's, Alzheimer's, and Huntington's diseases. We also detected 20 pathways in increased phosphopeptides and 16 pathways in decreased phosphopeptides including "inflammatory mediator regulation of TRP channels" in crmp2ki/ki mice. Our study suggests that the phosphorylation of CRMP2 at Ser522 is involved in the signaling pathways that may be related to neuropsychiatric and neurodegenerative diseases and pain.

    DOI: 10.1016/j.neuint.2018.04.009

    PubMed

    researchmap

  • 若年ミオクロニーてんかんの多剤併用療法における薬剤選択 査読

    北澤 悠, 神 一敬, 柿坂 庸介, 藤川 真由, 中里 信和, 田中 章景

    てんかん研究   36 ( 2 )   570 - 570   2018年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本てんかん学会  

    researchmap

  • Case of immune-mediated necrotizing myopathy associated with anti-signal recognition particle antibodies: Dramatic improvement after rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone therapy for intravascular large B-cell lymphoma 査読

    Hiroyasu Komiya, Maki Hagihara, Kenichi Tanaka, Mikiko Tada, Hideto Joki, Shigeru Koyano, Hiroshi Doi, Ichizo Nishino, Hideyuki Takeuchi, Fumiaki Tanaka

    Clinical and Experimental Neuroimmunology   9 ( 3 )   177 - 181   2018年8月

     詳細を見る

    掲載種別:研究論文(学術雑誌)  

    © 2018 Japanese Society for Neuroimmunology Immune-mediated necrotizing myopathy associated with anti-signal recognition particle antibodies (anti-SRP myopathy) is representative of several subtypes of necrotizing immune-mediated myopathy, and is characterized by rapidly progressive proximal muscle weakness, dysphagia and poor responsiveness to conventional immunosuppressive therapies. We report a 71-year-old man who developed anti-SRP myopathy followed by malignant lymphoma, and whose condition dramatically improved with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone therapy. He showed progressive proximal muscle weakness with severe dysphagia, and was diagnosed with anti-SRP myopathy by antibody tests and pathological examination. He was treated with conventional immunosuppressive therapies, specifically corticosteroids, intravenous immunoglobulin and tacrolimus; however, none of these therapies were effective. Two months after starting tacrolimus, the patient developed intravascular large B-cell lymphoma, which was suspected to be an iatrogenic immunodeficiency-associated lymphoproliferative disorder. Rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone therapy resulted in not only complete remission of lymphoma, but also dramatic improvement of anti-SRP myopathy. The present case suggests that rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone therapy is a potential treatment for anti-SRP myopathy.

    DOI: 10.1111/cen3.12469

    Scopus

    researchmap

  • Predictive factors of higher drug load for seizure freedom in idiopathic generalized epilepsy: Comparison between juvenile myoclonic epilepsy and other types. 査読 国際誌

    Yu Kitazawa, Kazutaka Jin, Yosuke Kakisaka, Mayu Fujikawa, Fumiaki Tanaka, Nobukazu Nakasato

    Epilepsy research   144   20 - 24   2018年8月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    PURPOSE: Predictive factors of higher drug load for seizure freedom were investigated in idiopathic generalized epilepsy (IGE), focusing on the difference between juvenile myoclonic epilepsy (JME) and other types of IGE (non-JME IGE). METHODS: Twelve patients with JME and 12 patients with non-JME IGE, who achieved seizure freedom for 1 year or longer with appropriate antiepileptic drugs (AEDs) after video electroencephalography monitoring, were reviewed retrospectively. The sum of prescribed daily dose/defined daily dose ratio of all prescribed AEDs at the final visit was defined as total AED load. Patients requiring total AED load >1 were classified into the higher AED load group. Clinical background and the presence of interictal focal epileptiform abnormalities (FEAs) were compared between the higher and lower AED load groups. RESULTS: Higher AED load group of patients with JME had interictal FEAs and family history of epilepsy more frequently than the lower AED load group (p = 0.03 and p = 0.03). Similar comparison of patients with non-JME IGE showed no significant differences. CONCLUSIONS: The presence of interictal FEAs and a family history of epilepsy are significantly associated variables for higher AED load for seizure freedom in patients with JME, but not in patients with non-JME IGE.

    DOI: 10.1016/j.eplepsyres.2018.04.009

    PubMed

    researchmap

  • Genetic analysis of adult leukoencephalopathy patients using a custom-designed gene panel. 査読

    Kunii M, Doi H, Ishii Y, Ohba C, Tanaka K, Tada M, Fukai R, Hashiguchi S, Kishida H, Ueda N, Kudo Y, Kugimoto C, Nakano T, Udaka N, Miyatake S, Miyake N, Saitsu H, Ito Y, Takahashi K, Nakamura H, Tomita-Katsumoto A, Takeuchi H, Koyano S, Matsumoto N, Tanaka F

    Clin Genet.   94 ( 2 )   232 - 238   2018年8月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    researchmap

  • Severe rebound relapse of multiple sclerosis after switching from fingolimod to dimethyl fumarate

    Shiori Asano, Hideyuki Takeuchi, Keisuke Morihara, Keita Takahashi, Kenichi Tanaka, Yuichi Higashiyama, Hiroshi Doi, Shigeru Koyano, Fumiaki Tanaka

    Clinical and Experimental Neuroimmunology   9 ( 3 )   173 - 176   2018年8月

     詳細を見る

    掲載種別:研究論文(学術雑誌)  

    Background: Dimethyl fumarate (DMF) was the second oral disease-modifying drug to be approved for multiple sclerosis (MS) in Japan, after fingolimod. Switching from fingolimod to DMF treatment is becoming increasingly common, because DMF has shown a better risk–benefit profile and an equivalent efficacy to fingolimod. Case presentation: We report a 35-year-old woman who was positive for anti-John Cunningham virus antibody and who developed severe rebound relapse of MS after switching from fingolimod to DMF. Five months after starting DMF treatment, she had a severe relapse attack with disseminated lesions in the cerebrum and cervical spinal cord. Furthermore, subsequent relapse attacks occurred with new lesions in the thoracic spinal cord, even during repeated steroid pulse therapies and plasma exchanges. The disease activity finally ceased after natalizumab administration. Conclusions: Switching from fingolimod to DMF carries the risk of MS reactivation and rebound. Natalizumab treatment for a limited period might be recommended to treat MS rebound in anti-John Cunningham virus antibody-positive patients.

    DOI: 10.1111/cen3.12470

    Scopus

    researchmap

  • Confirmation of SLC5A7-related distal hereditary motor neuropathy 7 in a family outside Wales. 査読 国際誌

    K Hamanaka, K Takahashi, S Miyatake, S Mitsuhashi, H Hamanoue, Y Miyaji, R Fukai, H Doi, A Fujita, E Imagawa, K Iwama, M Nakashima, T Mizuguchi, A Takata, N Miyake, H Takeuchi, F Tanaka, N Matsumoto

    Clinical genetics   94 ( 2 )   274 - 275   2018年8月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.1111/cge.13369

    PubMed

    researchmap

  • 心臓ペースメーカー埋込後のPD症例に対する脳深部刺激療法施行時の配慮

    森下 良志, 木村 活生, 岸田 日帯, 東山 雄一, 岡本 光生, 上木 英人, 土井 宏, 竹内 英之, 濱田 幸一, 川崎 隆, 上田 直久, 田中 章景

    パーキンソン病・運動障害疾患コングレスプログラム・抄録集   12回   83 - 83   2018年7月

     詳細を見る

    記述言語:日本語   出版者・発行元:Movement Disorder Society of Japan (MDSJ)  

    researchmap

  • Directional Leadをもちいた視床中間腹側核脳深部刺激療法(VIM-DBS)の有用性

    池田 拓也, 木村 活生, 岸田 日帯, 上田 直久, 濱田 幸一, 川崎 隆, 東山 雄一, 岡本 光生, 上木 英人, 土井 宏, 竹内 英之, 田中 章景

    パーキンソン病・運動障害疾患コングレスプログラム・抄録集   12回   96 - 96   2018年7月

     詳細を見る

    記述言語:日本語   出版者・発行元:Movement Disorder Society of Japan (MDSJ)  

    researchmap

  • PLA2G6変異を有するPARK14に対する脳深部刺激療法の長期予後

    草間 香里, 木村 活生, 岸田 日帯, 東山 雄一, 岡本 光生, 上木 英人, 土井 宏, 竹内 英之, 濱田 幸一, 川崎 隆, 上田 直久, 田中 章景

    パーキンソン病・運動障害疾患コングレスプログラム・抄録集   12回   94 - 94   2018年7月

     詳細を見る

    記述言語:日本語   出版者・発行元:Movement Disorder Society of Japan (MDSJ)  

    researchmap

  • ディレクショナルリードをもちいたSTN-DBSにおける簡便な刺激導入法の検討

    木村 活生, 岸田 日帯, 東山 雄一, 岡本 光生, 上木 英人, 土井 宏, 竹内 英之, 濱田 幸一, 川崎 隆, 上田 直久, 田中 章景

    パーキンソン病・運動障害疾患コングレスプログラム・抄録集   12回   94 - 94   2018年7月

     詳細を見る

    記述言語:日本語   出版者・発行元:Movement Disorder Society of Japan (MDSJ)  

    researchmap

  • 特発性正常圧水頭症でみられる脳梁離断症候についての検討

    東山 雄一, 斉藤 麻美, 森原 啓介, 木村 活生, 岡本 光生, 岸田 日帯, 土井 宏, 上田 直久, 竹内 英之, 田中 章景

    認知神経科学   20 ( 2 )   89 - 89   2018年6月

     詳細を見る

    記述言語:日本語   出版者・発行元:認知神経科学会  

    researchmap

  • 同時失認における視覚提示時間の影響Navon図形を用いた症例検討

    森原 啓介, 東山 雄一, 浅野 史織, 松永 祐己, 三宅 綾子, 高橋 慶太, 上木 英人, 竹内 英之, 田中 章景

    日本神経心理学会総会プログラム・予稿集   42回   127 - 127   2018年6月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本神経心理学会  

    researchmap

  • A Case of McLeod Syndrome with A Novel <i>XK</i> Missense Mutation. 査読 国際誌

    Komiya H, Takasu M, Hashiguchi S, Uematsu E, Fukai R, Tanaka K, Tada M, Joki H, Takahashi T, Koyano S, Doi H, Takeuchi H, Tanaka F

    Movement disorders clinical practice   5 ( 3 )   333 - 336   2018年5月

     詳細を見る

    記述言語:英語  

    DOI: 10.1002/mdc3.12614

    PubMed

    researchmap

  • Cerebellar ataxia-dominant phenotype in patients with ERCC4 mutations. 査読 国際誌

    Hiroshi Doi, Shigeru Koyano, Satoko Miyatake, Shinji Nakajima, Yuka Nakazawa, Misako Kunii, Atsuko Tomita-Katsumoto, Kayoko Oda, Yukie Yamaguchi, Ryoko Fukai, Shingo Ikeda, Rumiko Kato, Katsuhisa Ogata, Shun Kubota, Noriko Hayashi, Keita Takahashi, Mikiko Tada, Kenichi Tanaka, Mitsuko Nakashima, Yoshinori Tsurusaki, Noriko Miyake, Hirotomo Saitsu, Tomoo Ogi, Michiko Aihara, Hideyuki Takeuchi, Naomichi Matsumoto, Fumiaki Tanaka

    Journal of human genetics   63 ( 4 )   417 - 423   2018年4月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Autosomal recessive cerebellar ataxias (ARCAs) are clinically and genetically heterogeneous neurological disorders. Through whole-exome sequencing of Japanese ARCA patients, we identified three index patients from unrelated families who had biallelic mutations in ERCC4. ERCC4 mutations have been known to cause xeroderma pigmentosum complementation group F (XP-F), Cockayne syndrome, and Fanconi anemia phenotypes. All of the patients described here showed very slowly progressive cerebellar ataxia and cognitive decline with choreiform involuntary movement, with young adolescent or midlife onset. Brain MRI demonstrated atrophy that included the cerebellum and brainstem. Of note, cutaneous symptoms were very mild: there was normal to very mild pigmentation of exposed skin areas and/or an equivocal history of pathological sunburn. However, an unscheduled DNA synthesis assay of fibroblasts from the patient revealed impairment of nucleotide excision repair. A similar phenotype was very recently recognized through genetic analysis of Caucasian cerebellar ataxia patients. Our results confirm that biallelic ERCC4 mutations cause a cerebellar ataxia-dominant phenotype with mild cutaneous symptoms, possibly accounting for a high proportion of the genetic causes of ARCA in Japan, where XP-F is prevalent.

    DOI: 10.1038/s10038-017-0408-5

    PubMed

    researchmap

  • Cerebrospinal fluid level of Nogo receptor 1 antagonist lateral olfactory tract usher substance (LOTUS) correlates inversely with the extent of neuroinflammation. 査読 国際誌

    Keita Takahashi, Hideyuki Takeuchi, Yuji Kurihara, Hiroshi Doi, Misako Kunii, Kenichi Tanaka, Haruko Nakamura, Ryoko Fukai, Atsuko Tomita-Katsumoto, Mikiko Tada, Yuichi Higashiyama, Hideto Joki, Shigeru Koyano, Kohtaro Takei, Fumiaki Tanaka

    Journal of neuroinflammation   15 ( 1 )   46 - 46   2018年2月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    BACKGROUND: Although inflammation in the central nervous system is responsible for multiple neurological diseases, the lack of appropriate biomarkers makes it difficult to evaluate inflammatory activities in these diseases. Therefore, a new biomarker reflecting neuroinflammation is required for accurate diagnosis, appropriate therapy, and comprehension of pathogenesis of these neurological disorders. We previously reported that the cerebrospinal fluid (CSF) concentration of lateral olfactory tract usher substance (LOTUS), which promotes axonal growth as a Nogo receptor 1 antagonist, negatively correlates with disease activity in multiple sclerosis, suggesting that variation in LOTUS reflects the inflammatory activities and is a useful biomarker to evaluate the disease activity. To extend this observation, we analyzed the variation of LOTUS in the CSF of patients with bacterial and viral meningitis, which are the most common neuroinflammatory diseases. METHODS: CSF samples were retrospectively obtained from patients with meningitis (n = 40), who were followed up by CSF study at least twice, and from healthy controls (n = 27). Patients were divided into bacterial (n = 14) and viral meningitis (n = 18) after exclusion of eight patients according to the criteria of this study. LOTUS concentrations, total protein levels, and CSF cell counts in the acute and recovery phases were analyzed chronologically. We also used lipopolysaccharide-injected mice as a model of neuroinflammation to evaluate LOTUS mRNA and protein expression in the brain. RESULTS: Regardless of whether meningitis was viral or bacterial, LOTUS concentrations in the CSF of patients in acute phase were lower than those of healthy controls. As the patients recovered from meningitis, LOTUS levels in the CSF returned to the normal range. Lipopolysaccharide-injected mice also exhibited reduced LOTUS mRNA and protein expression in the brain. CONCLUSIONS: CSF levels of LOTUS correlated inversely with disease activity in both bacterial and viral meningitis, as well as in multiple sclerosis, because neuroinflammation downregulated LOTUS expression. Our data strongly suggest that variation of CSF LOTUS is associated with neuroinflammation and is useful as a biomarker for a broader range of neuroinflammatory diseases.

    DOI: 10.1186/s12974-018-1084-x

    PubMed

    researchmap

  • White matter hyperintensities on MRI in dementia with Lewy bodies, Parkinson's disease with dementia, and Alzheimer's disease. 査読 国際誌

    Hideto Joki, Yuichi Higashiyama, Yoshiharu Nakae, Chiharu Kugimoto, Hiroshi Doi, Katsuo Kimura, Hitaru Kishida, Naohisa Ueda, Tatsu Nakano, Tatsuya Takahashi, Shigeru Koyano, Hideyuki Takeuchi, Fumiaki Tanaka

    Journal of the neurological sciences   385   99 - 104   2018年2月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    BACKGROUND: In dementia with Lewy bodies (DLB) and Parkinson's disease with dementia (PDD), it is still debated whether white matter hyperintensities (WMH) on MRI reflect atherosclerotic cerebrovascular changes or Alzheimer's disease (AD)-related pathology such as cerebral amyloid angiopathy. To examine AD-related pathology in DLB and PDD, we compared the severity of WMH and medial temporal lobe atrophy among patients with DLB, PDD, non-demented PD (PDND), and AD. METHODS: We retrospectively studied sex- and age-matched outpatients with AD, DLB, PDD, and PDND, as well as subjects without central nervous system disorders as normal controls (n=50 each). All subjects underwent 1.5-T MRI examinations, and WMH detected by T2-weighted images or fluid-attenuated inversion recovery images were semiquantified according to the Fazekas method. Medial temporal lobe atrophy (MTA) was visually assessed by the MTA score. RESULTS: WMH were more prominent in AD, DLB, and PDD patients than in PDND patients and normal controls (NCs). DLB as well as AD showed more severe WMH than PDD. Visual assessment of medial temporal lobe atrophy showed that AD patients had the most severe atrophy, followed by DLB, PDD, and PDND patients, and NC subjects in that order. MTA scores showed significant correlations with WMH severity. CONCLUSION: Our results indicated that DLB was more similar to AD than to PDD in terms of MRI findings, suggesting that WMH in DLB may reflect mainly AD-related pathology rather than atherosclerotic cerebrovascular changes.

    DOI: 10.1016/j.jns.2017.12.018

    PubMed

    researchmap

  • Fasciculation potentials and decremental responses in amyotrophic lateral sclerosis. 査読 国際誌

    Yosuke Miyaji, Yuki Hatanaka, Mana Higashihara, Takamichi Kanbayashi, Fumiaki Tanaka, Masahiro Sonoo

    Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology   129 ( 2 )   345 - 348   2018年2月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    OBJECTIVE: The positive correlation between fasciculation potentials (FPs) and decremental responses in repetitive nerve stimulation test (RNS) in amyotrophic lateral sclerosis (ALS) patients has been described based on only one past study. We revisited this issue. METHODS: Subjects consisted of 30 prospectively-enrolled ALS patients on whom both needle EMG and RNS were conducted in the same trapezius muscle. Fasciculation potentials (FPs) were identified off-line from the restored 3-min signal. Firing rate of FPs (FR-FP) per minute was calculated from the total count of FPs of different origins. Correlations between FR-FP, decremental percentage (Decr%) and the amplitude of the initial compound muscle action potential (CMAPamp) in RNS were investigated. RESULTS: There was no correlation between FR-FP and Decr% (r = 0.03) or between FR-FP and CMAPamp (r = 0.04). A significant negative correlation was observed between CMAPamp and Decr% (r = -0.56, P < .005). CONCLUSION: FPs are not correlated with the decremental response in RNS. SIGNIFICANCE: The underlying mechanism for FPs and decremental responses in ALS must be different and unrelated to each other.

    DOI: 10.1016/j.clinph.2017.11.007

    PubMed

    researchmap

  • Matrin 3 Is a Component of Neuronal Cytoplasmic Inclusions of Motor Neurons in Sporadic Amyotrophic Lateral Sclerosis. 査読 国際誌

    Mikiko Tada, Hiroshi Doi, Shigeru Koyano, Shun Kubota, Ryoko Fukai, Shunta Hashiguchi, Noriko Hayashi, Yuko Kawamoto, Misako Kunii, Kenichi Tanaka, Keita Takahashi, Yuki Ogawa, Ryo Iwata, Shoji Yamanaka, Hideyuki Takeuchi, Fumiaki Tanaka

    The American journal of pathology   188 ( 2 )   507 - 514   2018年2月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Mutations in the MATR3 gene have been identified as a cause of familial amyotrophic lateral sclerosis, but involvement of the matrin 3 (MATR3) protein in sporadic amyotrophic lateral sclerosis (SALS) pathology has not been fully assessed. We immunohistochemically analyzed MATR3 pathology in the spinal cords of SALS and control autopsy specimens. MATR3 immunostaining of the motor neuron nuclei revealed two distinct patterns: mild and strong staining. There were no differences in the ratio of mild versus strong nuclear staining between the SALS and control cases. MATR3-containing neuronal cytoplasmic inclusions (NCIs) were observed in 60% of SALS cases. Most motor neurons with MATR3-positive NCIs exhibited a mild nuclear staining pattern. Although 16.8% of NCIs positive for transactivating response region DNA-binding protein 43 (TDP-43) were estimated as double-labeled by MATR3, no MATR3-positive or TDP-43-negative NCIs were observed. Although a previous study found that MATR3-positive NCIs are present only in cases with C9orf72 hexanucleotide repeat expansion, ubiquitin-positive granular NCIs were not observed in the cerebellum, which have been reported as specific to C9orf72-related ALS. Six ALS cases were confirmed to be negative for the GGGGCC hexanucleotide. Our results reveal that MATR3 is a component of TDP-43-positive NCIs in motor neurons, even in SALS, and indicate the broader involvement of MATR3 in ALS pathology and the heterogeneity of TDP-43-positive NCIs.

    DOI: 10.1016/j.ajpath.2017.10.007

    PubMed

    researchmap

  • Integrative Analyses of De Novo Mutations Provide Deeper Biological Insights into Autism Spectrum Disorder. 査読 国際誌

    Atsushi Takata, Noriko Miyake, Yoshinori Tsurusaki, Ryoko Fukai, Satoko Miyatake, Eriko Koshimizu, Itaru Kushima, Takashi Okada, Mako Morikawa, Yota Uno, Kanako Ishizuka, Kazuhiko Nakamura, Masatsugu Tsujii, Takeo Yoshikawa, Tomoko Toyota, Nobuhiko Okamoto, Yoko Hiraki, Ryota Hashimoto, Yuka Yasuda, Shinji Saitoh, Kei Ohashi, Yasunari Sakai, Shouichi Ohga, Toshiro Hara, Mitsuhiro Kato, Kazuyuki Nakamura, Aiko Ito, Chizuru Seiwa, Emi Shirahata, Hitoshi Osaka, Ayumi Matsumoto, Saoko Takeshita, Jun Tohyama, Tomoko Saikusa, Toyojiro Matsuishi, Takumi Nakamura, Takashi Tsuboi, Tadafumi Kato, Toshifumi Suzuki, Hirotomo Saitsu, Mitsuko Nakashima, Takeshi Mizuguchi, Fumiaki Tanaka, Norio Mori, Norio Ozaki, Naomichi Matsumoto

    Cell reports   22 ( 3 )   734 - 747   2018年1月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Recent studies have established important roles of de novo mutations (DNMs) in autism spectrum disorders (ASDs). Here, we analyze DNMs in 262 ASD probands of Japanese origin and confirm the "de novo paradigm" of ASDs across ethnicities. Based on this consistency, we combine the lists of damaging DNMs in our and published ASD cohorts (total number of trios, 4,244) and perform integrative bioinformatics analyses. Besides replicating the findings of previous studies, our analyses highlight ATP-binding genes and fetal cerebellar/striatal circuits. Analysis of individual genes identified 61 genes enriched for damaging DNMs, including ten genes for which our dataset now contributes to statistical significance. Screening of compounds altering the expression of genes hit by damaging DNMs reveals a global downregulating effect of valproic acid, a known risk factor for ASDs, whereas cardiac glycosides upregulate these genes. Collectively, our integrative approach provides deeper biological and potential medical insights into ASDs.

    DOI: 10.1016/j.celrep.2017.12.074

    PubMed

    researchmap

  • 検査からみる神経疾患 前頭側頭葉変性症の診断と認知機能テスト 言語の障害について

    浜田 智哉, 東山 雄一, 田中 章景

    Clinical Neuroscience   36 ( 1 )   116 - 118   2018年1月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)中外医学社  

    researchmap

  • Contributions of caspase-8 and -9 to liver injury from CYP2E1-produced metabolites of halogenated hydrocarbons. 査読

    Ijiri Y, Kato R, Sadamatsu M, Takano M, Yasuda Y, Tanaka F, Oishi C, Imano H, Okada Y, Tanaka K, Hayashi T

    Xenobiotica; the fate of foreign compounds in biological systems   48 ( 1 )   60 - 72   2018年1月

  • Clinicopathological characteristics of disseminated carcinomatosis of the bone marrow in breast cancer patients. 査読

    Shinden Y, Sugimachi K, Tanaka F, Fujiyoshi K, Kijima Y, Natsugoe S, Mimori K

    Molecular and clinical oncology   8 ( 1 )   93 - 98   2018年1月

  • 特発性正常圧水頭症でみられる脳梁離断症候についての検討

    東山 雄一, 斉藤 麻美, 森原 啓介, 木村 活生, 岡本 光生, 岸田 日帯, 土井 宏, 上田 直久, 竹内 英之, 田中 章景

    認知神経科学   20 ( 2 )   89_2 - 89_2   2018年

     詳細を見る

    記述言語:日本語   出版者・発行元:認知神経科学会  

    DOI: 10.11253/ninchishinkeikagaku.20.89_2

    CiNii Research

    researchmap

  • A variant in CRAT is associated with HLA-DQB1*06:02 negative essential hypersomnia (narcolepsy without cataplexy and idiopathic hypersomnia without long sleep time) 査読

    Miyagawa T, Khor S-S, Toyoda H, Kanbayashi T, Imanishi A, Sagawa Y, Kotorii N, Kotorii T, Ariyoshi Y, Hashizume Y, Ogi K, Hiejima H, Kamei Y, Hida A, Miyamoto M, Ikegami A, Wada Y, Takami M, Higashiyama Y, Miyake R, Kondo H, Fujimura Y, Tamura Y, Taniyama Y, Omata N, Tanaka Y, Moriya S, Furuya H, Kato M, Kawamura Y, Otowa T, Miyashita A, Kojima H, Saji H, Shimada M, Yamasaki M, Kobayashi T, Misawa R, Kuwano R, Sasaki T, Ishigooka J, Wada Y, Tsuruta K, Chiba S, Tanaka F, Yamada N, Okawa M, Kuroda K, Kume K, Hirata K, Uchimura N, Shimizu T, Inoue Y, Honda Y, Mishima K, Honda M, Tokunaga K

    Journal of Human Genetics   (in press)   2018年

     詳細を見る

  • Microglia in Alzheimer's Disease: Risk Factors and Inflammation. 査読 国際誌

    Atsuko Katsumoto, Hideyuki Takeuchi, Keita Takahashi, Fumiaki Tanaka

    Frontiers in neurology   9   978 - 978   2018年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Microglia are resident immune cells in the central nervous system (CNS) that originate from myeloid progenitor cells in the embryonic yolk sac and are maintained independently of circulating monocytes throughout life. In the healthy state, microglia are highly dynamic and control the environment by rapidly extending and retracting their processes. When the CNS is inflamed, microglia can give rise to macrophages, but the regulatory mechanisms underlying this process have not been fully elucidated. Recent genetic studies have suggested that microglial function is compromised in Alzheimer's disease (AD), and that environmental factors such as diet and brain injury also affect microglial activation. In addition, studies of triggering receptor expressed on myeloid cells 2-deficiency in AD mice revealed heterogeneous microglial reactions at different disease stages, complicating the therapeutic strategy for AD. In this paper, we describe the relationship between genetic and environmental risk factors and the roles of microglia in AD pathogenesis, based on studies performed in human patients and animal models. We also discuss the mechanisms of inflammasomes and neurotransmitters in microglia, which accelerate the development of amyloid-β and tau pathology.

    DOI: 10.3389/fneur.2018.00978

    PubMed

    researchmap

  • Foreign accent syndromeについて

    東山 雄一, 田中 章景

    神経心理学   34 ( 1 )   45 - 62   2018年

     詳細を見る

    記述言語:日本語   出版者・発行元:日本神経心理学会  

    &lt;p&gt;外国語様アクセント症候群(foreign accent syndrome:FAS)とは,同じ母国語を使用する第三者が&quot;外国語のようだ&quot;という違和感を持つような発話障害を特徴とした症候群である.比較的稀な症候ではあるが,これまで100例以上の報告がなされており,発話障害の特徴として,音の高低や強弱,リズム,音調などのイントネーションの異常といった超分節素の障害や,母音・子音変化などの分節素の障害が報告されている.脳卒中以外にも様々な原因疾患で生じることが知られており,その責任病巣については左中心前回など左半球による報告が多いが,右半球や脳幹,小脳病巣での報告もあり多様である.このように,FASは原因も病巣も様々であることから,そもそも&quot;症候群&quot;として扱うほどの一貫性や普遍性があるのか,発語失行(apraxia of speech:AOS)との異同についてなど未解決の問題が山積している.&lt;/p&gt;&lt;p&gt;今回,FASを呈した自験例の紹介と既報告例を振り返ることで,FASの特徴や発現機序などについて考察を行った.特に日本人FAS例は,英語アクセント型と中国・韓国語アクセント型の2つに分類されることが多く,AOSの特徴が目立つ例では,母音や子音の長さの変化を特徴とした英語アクセント型に,AOSの特徴が目立たずピッチの障害が目立つ例は中国・韓国語アクセント型になる可能性が考えられた.&lt;/p&gt;&lt;p&gt;また,失語症を伴わないFAS既報告例の病巣を用いたlesion network mapping解析を行った結果,喉頭の運動野(Larynx/Phonation area)として報告されている中心前回中部が,FASの神経基盤として重要である可能性が示唆された.&lt;/p&gt;

    DOI: 10.20584/neuropsychology.17025

    researchmap

  • Long-term outcome of adipose-derived regenerative cell-enriched autologous fat transplantation for reconstruction after breast-conserving surgery for Japanese women with breast cancer. 査読

    Ito S, Kai Y, Masuda T, Tanaka F, Matsumoto T, Kamohara Y, Hayakawa H, Ueo H, Iwaguro H, Hedrick MH, Mimori K, Mori M

    Surgery today   47 ( 12 )   1500 - 1511   2017年12月

  • [A surgical case of mesial temporal lobe epilepsy associated with hippocampal sclerosis and traumatic neocortical lesion]. 査読

    Yu Kitazawa, Kazutaka Jin, Masaki Iwasaki, Hiroyoshi Suzuki, Fumiaki Tanaka, Nobukazu Nakasato

    Rinsho shinkeigaku = Clinical neurology   57 ( 11 )   698 - 704   2017年11月

     詳細を見る

    記述言語:日本語   掲載種別:研究論文(学術雑誌)  

    A 26-year-old right-handed woman, with a history of left temporal lobe contusion caused by a fall at the age of 9 months, started to have complex partial seizures with oral automatism at the age of 7 years. The seizures occurred once or twice a month despite combination therapy with several antiepileptic agents. Her history and imaging studies suggested the diagnosis of epilepsy arising from traumatic neocortical temporal lesion. Comprehensive assessment including long-term video EEG monitoring, MRI, FDG-PET, MEG, and neuropsychological evaluation was performed at the age of 26 years. The diagnosis was left mesial temporal lobe epilepsy associated with hippocampal atrophy and traumatic temporal cortical lesion. The patient was readmitted for surgical treatment at the age of 27 years. Intracranial EEG monitoring showed that ictal discharges started in the left hippocampus and spread to the traumatic lesion in the left posterior superior temporal gyrus 10 seconds after the onset. This case could not be classified as dual pathology exactly, because the traumatic left temporal cortical lesion did not show independent epileptogenicity. However, the traumatic lesion was highly likely to be the source of the epileptogenicity, and she had right hemispheric dominance for language and functional deterioration in the whole temporal cortex. Therefore, left amygdalo-hippocampectomy and left temporal lobectomy including the traumatic lesion were performed according to the diagnosis of dual pathology. Subsequently, she remained seizure-free for 3 years. Comprehensive assessment of seizure semiology, neurophysiology, neuroradiology, and neuropsychology is important to determine the optimum therapeutic strategies for drug-resistant epilepsy.

    DOI: 10.5692/clinicalneurol.cn-001029

    PubMed

    researchmap

  • メチルプレドニゾロンによりアナフィラキシーショックが誘発された視神経脊髄炎の2症例

    高橋 慶太, 浅野 徹也, 東山 雄一, 児矢野 繁, 土井 宏, 竹内 英之, 田中 章景

    神経治療学   34 ( 6 )   S223 - S223   2017年11月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経治療学会  

    researchmap

  • パーキンソン病に対するあたらしいDBS治療 利点と効果

    木村 活生, 岸田 日帯, 川崎 隆, 濱田 幸一, 東山 雄一, 上木 英人, 上田 直久, 田中 章景

    パーキンソン病・運動障害疾患コングレスプログラム・抄録集   11回   65 - 65   2017年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:Movement Disorder Society of Japan (MDSJ)  

    researchmap

  • 多発性脳梗塞を呈する血管内リンパ腫で発症したメトトレキサート関連リンパ増殖性疾患の1例

    國井 美紗子, 大瀧 浩之, 浅野 徹也, 小川 有紀, 高橋 慶太, 東山 雄一, 土井 宏, 竹内 英之, 田中 章景

    神経免疫学   22 ( 1 )   122 - 122   2017年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本神経免疫学会  

    researchmap

  • 流暢性の失語症学 外国人アクセント症候群

    東山 雄一, 田中 章景

    日本神経心理学会総会プログラム・予稿集   41回   58 - 58   2017年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本神経心理学会  

    researchmap

  • Reply: Neuronal intranuclear (hyaline) inclusion disease and fragile X-associated tremor/ataxia syndrome: a morphological and molecular dilemma. 査読 国際誌

    Jun Sone, Tomohiko Nakamura, Haruki Koike, Masahisa Katsuno, Fumiaki Tanaka, Yasushi Iwasaki, Mari Yoshida, Gen Sobue

    Brain : a journal of neurology   140 ( 8 )   e52   2017年8月

     詳細を見る

    記述言語:英語  

    DOI: 10.1093/brain/awx158

    PubMed

    researchmap

  • 最前線の知識と実践がわかる ナースが知りたい!認知症のハナシ(第5回) 病態を理解する せん妄を理解する

    東山 雄一, 田中 章景

    ナーシング   37 ( 6 )   114 - 120   2017年4月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)学研メディカル秀潤社  

    researchmap

  • 睡眠時と覚醒時に発作時発話を呈した傍シルビウス裂多小脳回の1例 査読

    北澤 悠, 柿坂 庸介, 神 一敬, 藤川 真由, 田中 章景, 中里 信和

    てんかん研究   34 ( 3 )   646 - 646   2017年1月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本てんかん学会  

    researchmap

  • Electrochemically Switchable Molecular-Tweezers. 査読

    Arimura T, Do JH, Tanaka F

    Journal of oleo science   66 ( 4 )   419 - 423   2017年

     詳細を見る

    記述言語:英語   出版者・発行元:公益社団法人 日本油化学会  

    <p>Synthetic receptors possessing two complexing chromophores connected by a single spacer are referred to as molecular tweezers. We report an electrochemically triggered molecular tweezers, which is a calix[4]arene-bis-porphyrin conjugate, that acts as a proof-of-concept demonstration system showing an electro-statically induced approach to guest release. The electrochemical behavior represents that 1,4-diazabicyclo[2.2.2]octane (DABCO) is released from the complex formed between calix[4]arene-bis-porphyrin conjugate and DABCO, just after cooperative two-oxidation occurs at 0.41 V.</p>

    DOI: 10.5650/jos.ess17027

    PubMed

    CiNii Books

    researchmap

  • Late Seizures after Stroke in Clinical Practice: The Prevalence of Non-convulsive Seizures. 査読

    Yosuke Miyaji, Yuichi Kawabata, Hideto Joki, Shunsuke Seki, Kentaro Mori, Tomoya Kamide, Akira Tamase, Hiroshi Shima, Motohiro Nomura, Yoshihisa Kitamura, Fumiaki Tanaka

    Internal medicine (Tokyo, Japan)   56 ( 6 )   627 - 630   2017年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:JAPAN SOC INTERNAL MEDICINE  

    Objective The prevalence of the non-convulsive type of late seizure after stroke is unknown. The aim of the present study was to clarify the characteristics of late seizure in clinical practice, mainly focusing on the prevalence of non-convulsive seizure. Methods A total of 178 consecutive patients who were admitted and diagnosed with late seizure after stroke were retrospectively enrolled, and the data of 127 patients for whom the complete seizure was observed by a bystander were analyzed. Clinical information was obtained from the medical records and nursing notes. Results A non-convulsive seizure was observed in 37 patients (29%). A focal seizure and its secondary generalization accounted for 79% of the seizure types. Status epilepticus was observed in 60 patients (47%), including 11 patients (9%) without convulsion. The patients with non-convulsive seizures were significantly younger than those with convulsive seizures, but there were no other significant differences between the two groups with respect to sex, classification or the lesion of stroke. Conclusion There was a high rate of non-convulsive seizures in patients with late seizure after stroke. A non-convulsive seizure may be caused by any type or location of preceding stroke. More attention is needed in the differential diagnosis of neurological deterioration after stroke.

    DOI: 10.2169/internalmedicine.56.7162

    Web of Science

    PubMed

    researchmap

  • 失語症者の保続症状に対する TAP (Treatment of Aphasic Perseveration) の効果

    浜田 智哉, 田中 果南, 今井 友城, 東山 雄一, 田中 章景

    高次脳機能研究 (旧 失語症研究)   37 ( 2 )   228 - 235   2017年

     詳細を見る

    記述言語:日本語   出版者・発行元:一般社団法人 日本高次脳機能障害学会  

    &lt;p&gt;&amp;ensp;&amp;ensp;失語症臨床において保続を観察する機会は多いが, 保続は失語症評価訓練の阻害要因の 1 つとしても知られている。今回, 発症から 6 ヵ月経過し, 保続が主症状の 1 つであった失語症者に対して TAP (Treatment of Aphasic Perseveration) を参考に保続の減少を目的とした訓練を約 1 ヵ月間施行した。訓練手続きは TAP のエラーコントロールメソッドを取り入れ, さらに訓練中に表出された保続の種類の質的な分析を行うことで, 保続に対する TAP の作用機序を明らかにしようと試みた。結果として, TAP による保続の減少は訓練語以外へも汎化し, さらに実生活での言語表出能力をも向上させたことがわかった。 一方, 保続の質的分析の結果からは, TAP は主に直後型保続の減少に寄与していることが明らかとなった。&lt;/p&gt;

    researchmap

  • Clinicopathological features of adult-onset neuronal intranuclear inclusion disease. 査読 国際誌

    Jun Sone, Keiko Mori, Tomonori Inagaki, Ryu Katsumata, Shinnosuke Takagi, Satoshi Yokoi, Kunihiko Araki, Toshiyasu Kato, Tomohiko Nakamura, Haruki Koike, Hiroshi Takashima, Akihiro Hashiguchi, Yutaka Kohno, Takashi Kurashige, Masaru Kuriyama, Yoshihisa Takiyama, Mai Tsuchiya, Naoyuki Kitagawa, Michi Kawamoto, Hajime Yoshimura, Yutaka Suto, Hiroyuki Nakayasu, Naoko Uehara, Hiroshi Sugiyama, Makoto Takahashi, Norito Kokubun, Takuya Konno, Masahisa Katsuno, Fumiaki Tanaka, Yasushi Iwasaki, Mari Yoshida, Gen Sobue

    Brain : a journal of neurology   139 ( Pt 12 )   3170 - 3186   2016年12月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Neuronal intranuclear inclusion disease (NIID) is a slowly progressive neurodegenerative disease characterized by eosinophilic hyaline intranuclear inclusions in the central and peripheral nervous system, and also in the visceral organs. NIID has been considered to be a heterogeneous disease because of the highly variable clinical manifestations, and ante-mortem diagnosis has been difficult. However, since we reported the usefulness of skin biopsy for the diagnosis of NIID, the number of NIID diagnoses has increased, in particular adult-onset NIID. In this study, we studied 57 cases of adult-onset NIID and described their clinical and pathological features. We analysed both NIID cases diagnosed by post-mortem dissection and by ante-mortem skin biopsy based on the presence of characteristic eosinophilic, hyaline and ubiquitin-positive intanuclear inclusion: 38 sporadic cases and 19 familial cases, from six families. In the sporadic NIID cases with onset age from 51 to 76, dementia was the most prominent initial symptom (94.7%) as designated 'dementia dominant group', followed by miosis, ataxia and unconsciousness. Muscle weakness and sensory disturbance were also observed. It was observed that, in familial NIID cases with onset age less than 40 years, muscle weakness was seen most frequently (100%), as designated 'limb weakness group', followed by sensory disturbance, miosis, bladder dysfunction, and dementia. In familial cases with more than 40 years of onset age, dementia was most prominent (100%). Elevated cerebrospinal fluid protein and abnormal nerve conduction were frequently observed in both sporadic and familial NIID cases. Head magnetic resonance imaging showed high intensity signal in corticomedullary junction in diffusion-weighted image in both sporadic and familial NIID cases, a strong clue to the diagnosis. All of the dementia dominant cases presented with this type of leukoencephalopathy on head magnetic resonance imaging. Both sporadic and familial NIID cases presented with a decline in Mini-Mental State Examination and Frontal Assessment Battery scores. Based on these clinicopathological features, we proposed a diagnosis flow chart of adult-onset NIID. Our study suggested that the prevalence rate of adult-onset NIID may be higher than previously thought, and that NIID may be underdiagnosed. We should take NIID into account for differential diagnosis of leukoencephalopathy and neuropathy.

    DOI: 10.1093/brain/aww249

    PubMed

    researchmap

  • Biallelic TBCD Mutations Cause Early-Onset Neurodegenerative Encephalopathy. 査読 国際誌

    Noriko Miyake, Ryoko Fukai, Chihiro Ohba, Takahiro Chihara, Masayuki Miura, Hiroshi Shimizu, Akiyoshi Kakita, Eri Imagawa, Masaaki Shiina, Kazuhiro Ogata, Jiu Okuno-Yuguchi, Noboru Fueki, Yoshifumi Ogiso, Hiroshi Suzumura, Yoshiyuki Watabe, George Imataka, Huey Yin Leong, Aviva Fattal-Valevski, Uri Kramer, Satoko Miyatake, Mitsuhiro Kato, Nobuhiko Okamoto, Yoshinori Sato, Satomi Mitsuhashi, Ichizo Nishino, Naofumi Kaneko, Akira Nishiyama, Tomohiko Tamura, Takeshi Mizuguchi, Mitsuko Nakashima, Fumiaki Tanaka, Hirotomo Saitsu, Naomichi Matsumoto

    American journal of human genetics   99 ( 4 )   950 - 961   2016年10月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    We describe four families with affected siblings showing unique clinical features: early-onset (before 1 year of age) progressive diffuse brain atrophy with regression, postnatal microcephaly, postnatal growth retardation, muscle weakness/atrophy, and respiratory failure. By whole-exome sequencing, we identified biallelic TBCD mutations in eight affected individuals from the four families. TBCD encodes TBCD (tubulin folding co-factor D), which is one of five tubulin-specific chaperones playing a pivotal role in microtubule assembly in all cells. A total of seven mutations were found: five missense mutations, one nonsense, and one splice site mutation resulting in a frameshift. In vitro cell experiments revealed the impaired binding between most mutant TBCD proteins and ARL2, TBCE, and β-tubulin. The in vivo experiments using olfactory projection neurons in Drosophila melanogaster indicated that the TBCD mutations caused loss of function. The wide range of clinical severity seen in this neurodegenerative encephalopathy may result from the residual function of mutant TBCD proteins. Furthermore, the autopsied brain from one deceased individual showed characteristic neurodegenerative findings: cactus and somatic sprout formations in the residual Purkinje cells in the cerebellum, which are also seen in some diseases associated with mitochondrial impairment. Defects of microtubule formation caused by TBCD mutations may underlie the pathomechanism of this neurodegenerative encephalopathy.

    DOI: 10.1016/j.ajhg.2016.08.005

    PubMed

    J-GLOBAL

    researchmap

  • Critical illness myopathyの神経伝導検査所見の経時的変化

    宮地 洋輔, 畑中 裕己, 神林 隆道, 神谷 久雄, 河村 保臣, 北國 圭一, 藤野 悟央, 平 賢一郎, 清水 潤, 田中 章景, 園生 雅弘

    臨床神経生理学   44 ( 5 )   446 - 446   2016年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本臨床神経生理学会  

    researchmap

  • Comprehensive behavioral study and proteomic analyses of CRMP2-deficient mice. 査読 国際誌

    Haruko Nakamura, Naoya Yamashita, Ayuko Kimura, Yayoi Kimura, Hisashi Hirano, Hiroko Makihara, Yuko Kawamoto, Aoi Jitsuki-Takahashi, Kumiko Yonezaki, Kenkichi Takase, Tomoyuki Miyazaki, Fumio Nakamura, Fumiaki Tanaka, Yoshio Goshima

    Genes to cells : devoted to molecular & cellular mechanisms   21 ( 10 )   1059 - 1079   2016年10月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Collapsin response mediator protein 2 (CRMP2) plays a key role in axon guidance, dendritic morphogenesis and cell polarization. CRMP2 is implicated in various neurological and psychiatric disorders. However, in vivo functions of CRMP2 remain unknown. We generated CRMP2 gene-deficient (crmp2-/- ) mice and examined their behavioral phenotypes. During 24-h home cage monitoring, the activity level during the dark phase of crmp2-/- mice was significantly higher than that of wild-type (WT) mice. Moreover, the time during the open arm of an elevated plus maze was longer for crmp2-/- mice than for WT mice. The duration of social interaction was shorter for crmp2-/- mice than for WT mice. Crmp2-/- mice also showed mild impaired contextual learning. We then examined the methamphetamine-induced behavioral change of crmp2-/- mice. Crmp2-/- mice showed increased methamphetamine-induced ambulatory activity and serotonin release. Crmp2-/- mice also showed altered expression of proteins involved in GABAergic synapse, glutamatergic synapse and neurotrophin signaling pathways. In addition, SNAP25, RAB18, FABP5, ARF5 and LDHA, which are related genes to schizophrenia and methamphetamine sensitization, are also decreased in crmp2-/- mice. Our study implies that dysregulation of CRMP2 may be involved in pathophysiology of neuropsychiatric disorders.

    DOI: 10.1111/gtc.12403

    PubMed

    J-GLOBAL

    researchmap

  • Primary aldosteronism in patients with acute stroke: prevalence and diagnosis during initial hospitalization. 査読 国際誌

    Yosuke Miyaji, Yuichi Kawabata, Hideto Joki, Shunsuke Seki, Kentaro Mori, Tomoya Kamide, Akira Tamase, Hiroshi Shima, Motohiro Nomura, Yoshihisa Kitamura, Hirotatsu Nakaguchi, Taichi Minami, Tetsuji Tsunoda, Mayuko Sasaki, Masayo Yamada, Fumiaki Tanaka

    BMC neurology   16 ( 1 )   177 - 177   2016年9月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    BACKGROUND: Hypertension is the prime risk factor for stroke, and primary aldosteronism (PA) is the most common cause of secondary hypertension. The prevalence of PA in stroke patients has never been reported. The aim of this study was to elucidate the prevalence of PA. METHODS: A total of 427 consecutive patients with acute stroke were prospectively enrolled for this study. The screening tests were performed at the initial visit and a week after admission by measuring plasma aldosterone concentration and plasma renin activity. The rapid adrenocorticotropic hormone (ACTH) test was performed as the confirmatory test when both screening tests were positive. The primary endpoint was a final diagnosis of PA. RESULTS: The sensitivity of the dual screening system for the diagnosis of PA was 88.2 %, and PA was finally diagnosed in 4.0 % of acute stroke patients and in 4.9 % of stroke patients with a history of hypertension. Patients with PA were less likely to be male and have diabetes, and they had higher blood pressure at the initial visit, lower potassium concentration, and more intracerebral hemorrhage. The rapid ACTH test was performed safely even in acute stroke patients. CONCLUSIONS: The prevalence of PA is not low among acute stroke patients. Efficient screening of PA should be performed particularly for patients with risk factors. TRIAL REGISTRATION: UMIN-CTR; UMIN000011021 . Trial registration date: June 23, 2013 (retrospectively registered).

    DOI: 10.1186/s12883-016-0701-5

    PubMed

    J-GLOBAL

    researchmap

  • 若年ミオクロニーてんかんにカルバマゼピンは有効か? 査読

    北澤 悠, 神 一敬, 柿坂 庸介, 藤川 真由, 田中 章景, 中里 信和

    てんかん研究   34 ( 2 )   525 - 525   2016年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本てんかん学会  

    researchmap

  • CRMP1 and CRMP2 have synergistic but distinct roles in dendritic development. 査読 国際誌

    Hiroko Makihara, Shiori Nakai, Wataru Ohkubo, Naoya Yamashita, Fumio Nakamura, Hiroshi Kiyonari, Go Shioi, Aoi Jitsuki-Takahashi, Haruko Nakamura, Fumiaki Tanaka, Tomoko Akase, Pappachan Kolattukudy, Yoshio Goshima

    Genes to cells : devoted to molecular & cellular mechanisms   21 ( 9 )   994 - 1005   2016年9月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Collapsin response mediator protein 2, CRMP2, has been identified as an intracellular signaling mediator for Semaphorin 3A (Sema3A). CRMP2 plays a key role in axon guidance, dendritic morphogenesis, and cell polarization. It has been also implicated in a variety of neurological and psychiatric disorders. However, the in vivo functions of CRMP2 remain unknown. We generated CRMP2 gene-deficient (crmp2(-/-) ) mice. The crmp2(-/-) mice showed irregular development of dendritic spines in cortical neurons. The density of dendritic spines was reduced in the cortical layer V pyramidal neurons of crmp2(-/-) mice as well as in those of sema3A(-/-) and crmp1(-/-) mice. However, no abnormality was found in dendritic patterning in crmp2(-/-) compared to wild-type (WT) neurons. The level of CRMP1 was increased in crmp2(-/-) , but the level of CRMP2 was not altered in crmp1(-/-) compared to WT cortical brain lysates. Dendritic spine density and branching were reduced in double-heterozygous sema3A(+/-) ;crmp2(+/-) and sema3A(+/-) ;crmp1(+/-) mice. The phenotypic defects had no genetic interaction between crmp1 and crmp2. These findings suggest that both CRMP1 and CRMP2 mediate Sema3A signaling to regulate dendritic spine maturation and patterning, but through overlapping and distinct signaling pathways.

    DOI: 10.1111/gtc.12399

    PubMed

    J-GLOBAL

    researchmap

  • D-Dimer versus International Normalized Ratio of Prothrombin Time in Ischemic Stroke Patients Treated with Sufficient Warfarin. 査読 国際誌

    Ryoo Yamamoto, Yoshiharu Nakae, Fumiaki Tanaka, Ken Johkura

    Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association   25 ( 7 )   1781 - 1785   2016年7月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    BACKGROUND: In patients receiving chronic warfarin therapy, the international normalized ratio of prothrombin time (PT-INR) reportedly correlates with the incidence, size, severity, and outcome of ischemic stroke, and thus there are guidelines for the optimal PT-INR range that is to be maintained during secondary or primary prevention of ischemic stroke. However, the details of ischemic stroke in patients in whom an optimal PT-INR is maintained by warfarin therapy have not been thoroughly investigated. We conducted a retrospective study to determine the predictors of the size, severity, and outcome of ischemic stroke occurring in patients under chronic warfarin therapy and maintenance of an optimum PT-INR. METHODS: The study group comprised 22 consecutive acute ischemic stroke patients who were receiving warfarin and whose PT-INR was within the optimal range on admission. The PT-INR and plasma D-dimer level of these patients on admission were analyzed in relation to infarction volume, National Institutes of Health Stroke Scale score on admission, and modified Rankin Scale score at discharge. RESULTS: PT-INR did not correlate with infarction volume, severity, or outcome. The D-dimer level correlated positively and significantly with the volume (r = .49, P < .05), severity (r = .54, P < .05), and outcome of ischemic stroke (r = .61, P < .01) and did not correlate with the PT-INR (r = -.27, P = .23). CONCLUSIONS: When the PT-INR is within optimal range in patients receiving chronic warfarin therapy but who suffer an ischemic stroke, the admission D-dimer level, but not PT-INR, correlates with the size, severity, and outcome of the stroke. Thus, monitoring the D-dimer level in patients receiving long-term warfarin therapy is important, regardless of whether the optimal PT-INR is maintained.

    DOI: 10.1016/j.jstrokecerebrovasdis.2016.03.037

    PubMed

    J-GLOBAL

    researchmap

  • Autosomal recessive spinocerebellar ataxias in Japan. 査読

    Fumiaki Tanaka, Hiroshi Doi, Misako Kunii

    Rinsho shinkeigaku = Clinical neurology   56 ( 6 )   395 - 9   2016年6月

     詳細を見る

    記述言語:日本語   掲載種別:研究論文(学術雑誌)  

    Recent new sequencing techniques allow the identification of novel responsible genes for autosomal recessive spinocerebellar ataxias (ARCAs). However, the same phenotypes are sometimes attributed to the different responsible genes in ARCAs. On the contrary, the same responsible genes may cause heterogeneous phenotypes with respect to the age at onset, symptoms, and the severity of the disease progression. In addition, it is an important issue to clarify whether the gene mutations identified in Caucasian patients with infantile-onset ARCAs are also observed in Japanese patients with adult-onset ARCAs. In this article we review the characteristics of several ARCAs, the existence of which has been recently identified or confirmed in Japan.

    DOI: 10.5692/clinicalneurol.cn-000879

    PubMed

    J-GLOBAL

    researchmap

  • Author Reply to "Fornix Infarction Due to Involvement of Posterior Circulation". 査読 国際誌

    Takashi Kurokawa, Yasuhisa Baba, Kimihiro Fujino, Yoshiyuki Kuroiwa, Yusuke Tomita, Makoto Nakane, Shoko Merrit Yamada, Fumiaki Tanaka

    Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association   25 ( 6 )   1559 - 60   2016年6月

  • De novo missense mutations in NALCN cause developmental and intellectual impairment with hypotonia. 査読 国際誌

    Ryoko Fukai, Hirotomo Saitsu, Nobuhiko Okamoto, Yasunari Sakai, Aviva Fattal-Valevski, Shiina Masaaki, Yukihiro Kitai, Michiko Torio, Kanako Kojima-Ishii, Kenji Ihara, Veronika Chernuha, Mitsuko Nakashima, Satoko Miyatake, Fumiaki Tanaka, Noriko Miyake, Naomichi Matsumoto

    Journal of human genetics   61 ( 5 )   451 - 5   2016年5月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Three recessive mutations in the sodium leak channel, nonselective (NALCN) have been reported to cause intellectual disability and hypotonia. In addition, 14 de novo heterozygous mutations have been identified in 15 patients with arthrogryposis and neurodevelopmental impairment. Here, we report three patients with neurodevelopmental disease and hypotonia, harboring one recurrent (p.R1181Q) and two novel mutations (p.L312V and p.V1020F) occurring de novo in NALCN. Mutation p.L312 is located in the pore forming S6 region of domain I and p.V1020F in the S5 region of domain III. Mutation p.R1181Q is in a linker region. Mapping these three mutations to a model of NALCN showed p.Leu312 and p.Val1020 positioned in the hydrophobic core of the pore modules, indicating these two mutations may affect the gating function of NALCN. Although p.R1181Q is unlikely to affect the ion channel structure, previous studies have shown that an analogous mutation in Caenorhabditis elegans produced a phenotype with a coiling locomotion, suggesting that p.R1181Q could also affect NALCN function. Our three patients showed profound intellectual disability and growth delay, facial dysmorphologies and hypotonia. The present data support previous work suggesting heterozygous NALCN mutations lead to syndromic neurodevelopmental impairment.

    DOI: 10.1038/jhg.2015.163

    PubMed

    J-GLOBAL

    researchmap

  • De novo KCNH1 mutations in four patients with syndromic developmental delay, hypotonia and seizures. 査読 国際誌

    Ryoko Fukai, Hirotomo Saitsu, Yoshinori Tsurusaki, Yasunari Sakai, Kazuhiro Haginoya, Kazumasa Takahashi, Monika Weisz Hubshman, Nobuhiko Okamoto, Mitsuko Nakashima, Fumiaki Tanaka, Noriko Miyake, Naomichi Matsumoto

    Journal of human genetics   61 ( 5 )   381 - 7   2016年5月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    The voltage-gated Kv10.1 potassium channel, also known as ether-a-go-go-related gene 1, encoded by KCNH1 (potassium voltage-gated channel, subfamily H (eag related), member 1) is predominantly expressed in the central nervous system. Recently, de novo missense KCNH1 mutations have been identified in six patients with Zimmermann-Laband syndrome and in four patients with Temple-Baraitser syndrome. These syndromes were historically considered distinct. Here we report three de novo missense KCNH1 mutations in four patients with syndromic developmental delay and epilepsy. Two novel KCNH1 mutations (p.R357Q and p.R357P), found in three patients, were located at the evolutionally highly conserved arginine in the channel voltage-sensor domain (S4). Another mutation (p.G496E) was found in the channel pore domain (S6) helix, which acts as a hinge in activation gating and mainly conducts non-inactivating outward potassium current. A previously reported p.G496R mutation was shown to produce no voltage-dependent outward current in CHO cells, suggesting that p.G496E may also disrupt the proper function of the Kv channel pore. Our report confirms that KCNH1 mutations are associated with syndromic neurodevelopmental disorder, and also support the functional importance of the S4 domain.

    DOI: 10.1038/jhg.2016.1

    PubMed

    J-GLOBAL

    researchmap

  • Genomic Landscape of Esophageal Squamous Cell Carcinoma in a Japanese Population. 査読

    Sawada G, Niida A, Uchi R, Hirata H, Shimamura T, Suzuki Y, Shiraishi Y, Chiba K, Imoto S, Takahashi Y, Iwaya T, Sudo T, Hayashi T, Takai H, Kawasaki Y, Matsukawa T, Eguchi H, Sugimachi K, Tanaka F, Suzuki H, Yamamoto K, Ishii H, Shimizu M, Yamazaki H, Yamazaki M, Tachimori Y, Kajiyama Y, Natsugoe S, Fujita H, Mafune K, Tanaka Y, Kelsell DP, Scott CA, Tsuji S, Yachida S, Shibata T, Sugano S, Doki Y, Akiyama T, Aburatani H, Ogawa S, Miyano S, Mori M, Mimori K

    Gastroenterology   150 ( 5 )   1171 - 1182   2016年5月

     詳細を見る

    掲載種別:研究論文(学術雑誌)  

    DOI: 10.1053/j.gastro.2016.01.035

    PubMed

    researchmap

  • Genomic Landscape of Esophageal Squamous Cell Carcinoma in a Japanese Population. 国際誌

    Genta Sawada, Atsushi Niida, Ryutaro Uchi, Hidenari Hirata, Teppei Shimamura, Yutaka Suzuki, Yuichi Shiraishi, Kenichi Chiba, Seiya Imoto, Yusuke Takahashi, Takeshi Iwaya, Tomoya Sudo, Tomoatsu Hayashi, Hiroki Takai, Yoshihiro Kawasaki, Takashi Matsukawa, Hidetoshi Eguchi, Keishi Sugimachi, Fumiaki Tanaka, Hiromichi Suzuki, Ken Yamamoto, Hideshi Ishii, Makiko Shimizu, Hiroshi Yamazaki, Makoto Yamazaki, Yuji Tachimori, Yoshiaki Kajiyama, Shoji Natsugoe, Hiromasa Fujita, Kenichi Mafune, Yoichi Tanaka, David P Kelsell, Claire A Scott, Shoji Tsuji, Shinichi Yachida, Tatsuhiro Shibata, Sumio Sugano, Yuichiro Doki, Tetsu Akiyama, Hiroyuki Aburatani, Seishi Ogawa, Satoru Miyano, Masaki Mori, Koshi Mimori

    Gastroenterology   150 ( 5 )   1171 - 1182   2016年5月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    BACKGROUND & AIMS: Esophageal squamous cell carcinoma (ESCC) is the predominant form of esophageal cancer in Japan. Smoking and drinking alcohol are environmental risk factors for ESCC, whereas single nucleotide polymorphisms in ADH1B and ALDH2, which increase harmful intermediates produced by drinking alcohol, are genetic risk factors. We conducted a large-scale genomic analysis of ESCCs from patients in Japan to determine the mutational landscape of this cancer. METHODS: We performed whole-exome sequence analysis of tumor and nontumor esophageal tissues collected from 144 patients with ESCC who underwent surgery at 5 hospitals in Japan. We also performed single-nucleotide polymorphism array-based copy number profile and germline genotype analyses of polymorphisms in ADH1B and ALDH2. Polymorphisms in CYP2A6, which increase harmful effects of smoking, were analyzed. Functions of TET2 mutants were evaluated in KYSE410 and HEK293FT cells. RESULTS: A high proportion of mutations in the 144 tumor samples were C to T substitution in CpG dinucleotides (called the CpG signature) and C to G/T substitutions with a flanking 5' thymine (called the APOBEC signature). Based on mutational signatures, patients were assigned to 3 groups, which associated with environmental (drinking and smoking) and genetic (polymorphisms in ALDH2 and CYP2A6) factors. Many tumors contained mutations in genes that regulate the cell cycle (TP53, CCND1, CDKN2A, FBXW7); epigenetic processes (MLL2, EP300, CREBBP, TET2); and the NOTCH (NOTCH1, NOTCH3), WNT (FAT1, YAP1, AJUBA) and receptor-tyrosine kinase-phosphoinositide 3-kinase signaling pathways (PIK3CA, EGFR, ERBB2). Mutations in EP300 and TET2 correlated with shorter survival times, and mutations in ZNF750 associated with an increased number of mutations of the APOBEC signature. Expression of mutant forms of TET2 did not increase cellular levels of 5-hydroxymethylcytosine in HEK293FT cells, whereas knockdown of TET2 increased the invasive activity of KYSE410 ESCC cells. Computational analyses associated the mutations in NFE2L2 we identified with transcriptional activation of its target genes. CONCLUSIONS: We associated environmental and genetic factors with base substitution patterns of somatic mutations and provide a registry of genes and pathways that are disrupted in ESCCs. These findings might be used to design specific treatments for patients with esophageal squamous cancers.

    DOI: 10.1053/j.gastro.2016.01.035

    PubMed

    researchmap

  • Next-generation sequencing of 28 ALS-related genes in a Japanese ALS cohort. 査読 国際誌

    Ryoichi Nakamura, Jun Sone, Naoki Atsuta, Genki Tohnai, Hazuki Watanabe, Daichi Yokoi, Masahiro Nakatochi, Hirohisa Watanabe, Mizuki Ito, Jo Senda, Masahisa Katsuno, Fumiaki Tanaka, Yuanzhe Li, Yuishin Izumi, Mitsuya Morita, Akira Taniguchi, Osamu Kano, Masaya Oda, Satoshi Kuwabara, Koji Abe, Ikuko Aiba, Koichi Okamoto, Kouichi Mizoguchi, Kazuko Hasegawa, Masashi Aoki, Nobutaka Hattori, Shoji Tsuji, Kenji Nakashima, Ryuji Kaji, Gen Sobue

    Neurobiology of aging   39   219.e1-8 - 219.e8   2016年3月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    We investigated the frequency and contribution of variants of the 28 known amyotrophic lateral sclerosis (ALS)-related genes in Japanese ALS patients. We designed a multiplex, polymerase chain reaction-based primer panel to amplify the coding regions of the 28 ALS-related genes and sequenced DNA samples from 257 Japanese ALS patients using an Ion Torrent PGM sequencer. We also performed exome sequencing and identified variants of the 28 genes in an additional 251 ALS patients using an Illumina HiSeq 2000 platform. We identified the known ALS pathogenic variants and predicted the functional properties of novel nonsynonymous variants in silico. These variants were confirmed by Sanger sequencing. Known pathogenic variants were identified in 19 (48.7%) of the 39 familial ALS patients and 14 (3.0%) of the 469 sporadic ALS patients. Thirty-two sporadic ALS patients (6.8%) harbored 1 or 2 novel nonsynonymous variants of ALS-related genes that might be deleterious. This study reports the first extensive genetic screening of Japanese ALS patients. These findings are useful for developing genetic screening and counseling strategies for such patients.

    DOI: 10.1016/j.neurobiolaging.2015.11.030

    PubMed

    J-GLOBAL

    researchmap

  • Relationship between cortex and pulvinar abnormalities on diffusion-weighted imaging in status epilepticus. 査読 国際誌

    Yoshiharu Nakae, Yosuke Kudo, Ryoo Yamamoto, Yuichi Dobashi, Yuichi Kawabata, Shingo Ikeda, Mutsumi Yokoyama, Yuichi Higashiyama, Hiroshi Doi, Ken Johkura, Fumiaki Tanaka

    Journal of neurology   263 ( 1 )   127 - 32   2016年1月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    The aim of this study was to analyze the pattern of magnetic resonance diffusion-weighted imaging (DWI) findings in status epilepticus in terms of clinical characteristics. Participants comprised 106 patients with status epilepticus who were admitted to our hospital and underwent DWI. Forty-five patients (42.5 %) showed abnormal findings on DWI and were divided into two groups, comprising 26 patients (24.5 %) with cortex lesions alone and 19 patients (17.9 %) with cortex and pulvinar lesions in the same hemisphere. A long duration of status epilepticus (>120 min) tended to be more prevalent among patients with cortex and pulvinar lesions (57.9 %) than among patients with cortex lesions alone (30.8 %) by univariate and multivariate analyses. Todd's palsy tended to be more frequent in patients with abnormalities on DWI (24/45, 53.3 %) than in patients with normal DWI (21/61, 34.4 %). Six of the 26 patients with cortex lesions alone (23.1 %) had taken anti-epileptic drugs before the attack compared to none of the 19 patients with both cortex and pulvinar lesions. The trend toward a longer duration of status epilepticus in patients with both cortex and pulvinar lesions favors a spreading pattern of seizure discharge from cortex to pulvinar via cortico-pulvinar pathways, and anti-epileptic drugs might, to some extent, prevent spreading of seizure discharge from cortex to pulvinar. In addition, existence of high-intensity areas on DWI at the onset of epilepsy may be a predictive factor for the occurrence of Todd's palsy.

    DOI: 10.1007/s00415-015-7948-4

    PubMed

    J-GLOBAL

    researchmap

  • [Axonal Regeneration-related Molecules as Biomarkers for Multiple Sclerosis]. 査読

    Keita Takahashi, Fumiaki Tanaka, Kohtaro Takei

    Brain and nerve = Shinkei kenkyu no shinpo   68 ( 1 )   82 - 9   2016年1月

     詳細を見る

    記述言語:日本語   掲載種別:研究論文(学術雑誌)  

    Abnormalities in both the nervous and immune systems are thought to be relevant to the pathogenesis of multiple sclerosis (MS). Several functional molecules closely related to axonal regeneration play an important role in not only the nervous system, but also the immune system. Many recent studies revealed that these molecules are associated with the neurological and immunological aspects of the pathogenesis of MS. Therefore, we focused on these molecules as promising biomarkers for MS. Nogo protein and its receptor (Nogo receptor-1; NgR1) are well known representative molecules that prevent axonal regeneration, and we identified lateral olfactory tract usher substance (LOTUS) as an endogenous antagonist of NgR1. We found that LOTUS expression was decreased in the spinal cord in an experimental autoimmune encephalomyelitis mouse model and that variations in LOTUS concentration in the cerebrospinal fluid correlated well with disease activity in MS patients. On the other hand, previous studies have shown that repulsive guidance molecule-a and semaphorins, known to be involved in axonal guidance and regeneration, play a role in MS pathogenesis. We review the association of these molecules with the neurological and immunological aspects of MS pathogenesis, and we show that they are promising, clinically-relevant biomarkers for MS.

    DOI: 10.11477/mf.1416200351

    PubMed

    researchmap

  • 前頭葉病変による読み書き障害

    東山 雄一, 田中 章景

    神経心理学   32 ( 4 )   278 - 289   2016年

     詳細を見る

    記述言語:日本語   出版者・発行元:日本神経心理学会  

    &lt;p&gt;人類の最も偉大な発明の一つである文字言語は,単なるコミュニケーション手段の一つという枠組みを超え,文化の伝承や文明の発達にこれまで重要な役割を果たしてきた.このような現代社会において,文字言語の障害である失読や失書が日常生活に与える影響は,以前に比べてますます大きなものとなっている.&quot;Exnerの書字中枢&quot;とも呼ばれる左中前頭回後部の損傷により純粋失書が生じることは古くから知られていたが,症例報告の蓄積や脳機能画像研究の結果から,その重要性は近年再認識されている.ところが,複雑な書字過程の中でこの脳領域が担う実際の役割については不明な点が多く,書記素から書字運動への変換プロセスや,書字情報を一時的に保持する作動記憶,書記素表象と書字動作の運動企図のインターフェイスとしての機能など諸説あり,いまだ結論は出ていない.本項では前頭葉損傷による書字障害を中心に,前頭葉病変と読み書き障害について,その歴史的な背景から最近の知見についての概説を行う.&lt;/p&gt;

    DOI: 10.20584/neuropsychology.32.4_278

    researchmap

  • Propagated but Topologically Distributed Forebrain Neurons Expressing Alpha-Synuclein in Aged Macaques. 査読 国際誌

    Katsuo Kimura, Ken-Ichi Inoue, Yoshiyuki Kuroiwa, Fumiaki Tanaka, Masahiko Takada

    PloS one   11 ( 11 )   e0166861   2016年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    In neurodegenerative disorders, such as Parkinson's disease (PD), alpha-synuclein (α-syn) accumulates to induce cell death and/or form a cytoplasmic inclusion called Lewy body (LB). This α-syn-related pathology is termed synucleinopathy. It remains unclear how α-syn accumulation expands during the progress of synucleinopathy in the human brain. In our study, we investigated the patterns of distribution and propagation of forebrain neurons expressing α-syn in aged macaques. It was found that the occurrence of α-syn-positive neurons proceeded topologically based on the midbrain dopamine pathways arising from the substantia nigra and the ventral tegmental area where they were primarily observed. In the nigrostriatal or mesolimbic dopamine pathway, the age-dependent increase in α-syn-positive neurons was evident in the striatum or the nucleus accumbens, respectively. Concerning the nigrostriatal pathway, a mediolateral or rostrocaudal gradient was seen in the substantia nigra or the striatum, respectively, and a compensatory increase in dopamine transporter occurred in the striatum regardless of the decreased dopamine level. In the mesocortical dopamine pathway, α-syn-positive neurons appeared in the prefrontal and then motor areas of the frontal lobe. Given that neither LB formation nor clinical phenotype manifestation was detected in any of the monkeys examined in the present study, aged macaques may be useful as a potential presymptomatic model for PD and LB-related neuropsychiatric disorders.

    DOI: 10.1371/journal.pone.0166861

    PubMed

    researchmap

  • タイプライティングの障害とその神経基盤について

    東山 雄一, 田中 章景

    高次脳研   36 ( 3 )   392 - 401   2016年

     詳細を見る

    記述言語:日本語   出版者・発行元:一般社団法人 日本高次脳機能障害学会  

    &lt;p&gt;&amp;ensp;&amp;ensp;コンピュータの急速な普及により, 脳損傷によるタイピング障害が社会生活に与える影響は深刻となりつつある。そこで我々は, 失タイプを呈した自験例の検討と, 健常者 fMRI 研究の結果から, タイピングの神経基盤, 失タイプの責任病巣について検討した。&lt;br&gt;&amp;ensp;&amp;ensp;【症例】78 歳の右利き男性。失語や失行, 半側無視, 運動感覚障害は認めなかったが, 選択的タイプ障害が明らかであった。病歴と脳 MRI, 各種検討課題の結果から, 本例は左中下前頭回後部の脳梗塞により, 音素-書記素変換と書記素バッファに障害を認め, 特に後者が失タイプの原因になっていると考察した。&lt;br&gt;&amp;ensp;&amp;ensp;【fMRI 検討】健常タッチタイピスト16 名を対象に fMRI による, タイプ・書字の神経基盤の検討を行った。その結果, 左上頭頂小葉前部~縁上回, 左上中前頭回後部にタイプ・書字の両課題で有意な賦活を認め, さらに左頭頂間溝 (IPS) 後部内側にタイピングでより強い賦活を認めた。&lt;br&gt;&amp;ensp;&amp;ensp;【考察】タイピングは書字中枢として知られる多くの脳領域や, 左 IPS 後部内側皮質など複数の脳領域が関与する複雑な認知プロセスであり, 障害部位に応じて質の異なる障害が生じる可能性がある。本例のように個々の症例の障害機序を検討していくことで, 失タイプの症候学の確立やリハビリテーションへの発展が今後期待される。&lt;/p&gt;

    DOI: 10.2496/hbfr.36.392

    researchmap

  • 球脊髄性筋萎縮症患者に対するリュープロレリン酢酸塩長期使用の効果

    橋詰 淳, 勝野 雅央, 鈴木 啓介, 坂野 晴彦, 須賀 徳明, 矢部 一郎, 青木 正志, 森田 光哉, 金井 数明, 水澤 英洋, 山本 知孝, 長谷川 一子, 西澤 正豊, 宮嶋 裕明, 苅田 典生, 中島 健二, 辻野 彰, 内野 誠, 田中 章景, 祖父江 元

    臨床神経学   55 ( Suppl. )   S200 - S200   2015年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • LOTUS, a possible endogenous inhibitor of axonal degeneration, as a new biomarker for multiple sclerosis. 査読 国際誌

    Keita Takahashi, Fumiaki Tanaka, Kohtaro Takei

    Neurodegenerative disease management   5 ( 6 )   469 - 72   2015年12月

     詳細を見る

  • De novo KIF1A mutations cause intellectual deficit, cerebellar atrophy, lower limb spasticity and visual disturbance. 査読 国際誌

    Chihiro Ohba, Kazuhiro Haginoya, Hitoshi Osaka, Kazuo Kubota, Akihiko Ishiyama, Takuya Hiraide, Hirofumi Komaki, Masayuki Sasaki, Satoko Miyatake, Mitsuko Nakashima, Yoshinori Tsurusaki, Noriko Miyake, Fumiaki Tanaka, Hirotomo Saitsu, Naomichi Matsumoto

    Journal of human genetics   60 ( 12 )   739 - 42   2015年12月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Recently, de novo KIF1A mutations were identified in patients with intellectual disability, spasticity and cerebellar atrophy and/or optic nerve atrophy. In this study, we analyzed a total of 62 families, including 68 patients with genetically unsolved childhood cerebellar atrophy, by whole-exome sequencing (WES). We identified five de novo missense KIF1A mutations, including only one previously reported mutation (p.Arg316Trp). All the mutations are located in the motor domain of KIF1A. In all patients, initial symptom onset was during the infantile period, and included developmental delay in three patients and gait disturbance in two. Thereafter, they showed gait disturbances, exaggerated deep tendon reflexes, cerebellar symptoms and cerebellar atrophy on brain magnetic resonance imaging. Four patients showed lower limb spasticity, upper limb clumsiness and visual disturbances. Nerve conduction study revealed peripheral neuropathy in three patients. This study further delineates clinical features of de novo KIF1A mutations. Genetic testing of KIF1A should be considered in children with developmental delay, cerebellar atrophy and pyramidal features.

    DOI: 10.1038/jhg.2015.108

    PubMed

    J-GLOBAL

    researchmap

  • 手根管症候群の種々の電気診断手技の感度特異度の比較 偽陽性例の適切な扱いを含めて

    宮地 洋輔, 大石 知瑞子, 神谷 久雄, 畑中 裕己, 小林 正人, 田中 章景, 園生 雅弘

    臨床神経生理学   43 ( 5 )   405 - 405   2015年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本臨床神経生理学会  

    researchmap

  • 筋萎縮性側索硬化症における線維束自発電位と漸減応答(第2報)

    宮地 洋輔, 畑中 裕己, 東原 真奈, 岩波 知子, 田中 章景, 園生 雅弘

    臨床神経生理学   43 ( 5 )   407 - 407   2015年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本臨床神経生理学会  

    researchmap

  • 治療抵抗性若年ミオクロニーてんかんにおける焦点性脳波異常

    北澤 悠, 神 一敬, 加藤 量広, 柿坂 庸介, 藤川 真由, 岩崎 真樹, 田中 章景, 中里 信和

    臨床神経生理学   43 ( 5 )   459 - 459   2015年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本臨床神経生理学会  

    researchmap

  • Characterization of IgG4 anti-neurofascin 155 antibody-positive polyneuropathy. 査読 国際誌

    Hidenori Ogata, Ryo Yamasaki, Akio Hiwatashi, Nobuyuki Oka, Nobutoshi Kawamura, Dai Matsuse, Motoi Kuwahara, Hidekazu Suzuki, Susumu Kusunoki, Yuichi Fujimoto, Koji Ikezoe, Hitaru Kishida, Fumiaki Tanaka, Takuya Matsushita, Hiroyuki Murai, Jun-Ichi Kira

    Annals of clinical and translational neurology   2 ( 10 )   960 - 71   2015年10月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    OBJECTIVE: To investigate anti-neurofascin 155 (NF155) antibody-positive chronic inflammatory demyelinating polyneuropathy (CIDP). METHODS: Sera from 50 consecutive CIDP patients diagnosed in our clinic, 32 patients with multiple sclerosis, 40 patients with other neuropathies including 26 with Guillain-Barré syndrome (GBS)/Fisher syndrome, and 30 healthy controls were measured for anti-NF antibodies by flow cytometry using HEK293 cell lines stably expressing human NF155 or NF186. Four additional CIDP patients with anti-NF155 antibodies referred from other clinics were enrolled for clinical characterization. RESULTS: The positivity rate for anti-NF155 antibodies in CIDP patients was 18% (9/50), who all showed a predominance of IgG4 subclass. No other subjects were positive, except one GBS patient harboring IgG1 anti-NF155 antibodies. No anti-NF155 antibody carriers had anti-NF186 antibodies. Anti-NF155 antibody-positive CIDP patients had a significantly younger onset age, higher frequency of drop foot, gait disturbance, tremor and distal acquired demyelinating symmetric phenotype, greater cervical root diameter on magnetic resonance imaging neurography, higher cerebrospinal fluid protein levels, and longer distal and F-wave latencies than anti-NF155 antibody-negative patients. Marked symmetric hypertrophy of cervical and lumbosacral roots/plexuses was present in all anti-NF155 antibody-positive CIDP patients examined by neurography. Biopsied sural nerves from two patients with anti-NF155 antibodies demonstrated subperineurial edema and occasional paranodal demyelination, but no vasculitis, inflammatory cell infiltrates, or onion bulbs. Among anti-NF155 antibody-positive patients, treatment responders more frequently had daily oral corticosteroids and/or immunosuppressants in addition to intravenous immunoglobulins than nonresponders did. INTERPRETATION: Anti-NF155 antibodies occur in a subset of CIDP patients with distal-dominant involvement and symmetric nerve hypertrophy.

    DOI: 10.1002/acn3.248

    PubMed

    researchmap

  • 日本におけるALS疾患関連遺伝子の網羅的解析

    中村 亮一, 曽根 淳, 熱田 直樹, 藤内 玄規, 中杤 昌弘, 渡辺 はづき, 横井 大知, 渡辺 宏久, 伊藤 瑞規, 勝野 雅央, 田中 章景, 服部 信孝, 和泉 唯信, 森田 光哉, 谷口 彰, 阿部 康二, 織田 雅也, 溝口 功一, 梶 龍兒, 祖父江 元

    神経治療学   32 ( 5 )   838 - 838   2015年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経治療学会  

    researchmap

  • De novo KCNT1 mutations in early-onset epileptic encephalopathy. 査読 国際誌

    Chihiro Ohba, Mitsuhiro Kato, Nobuya Takahashi, Hitoshi Osaka, Takashi Shiihara, Jun Tohyama, Shin Nabatame, Junji Azuma, Yuji Fujii, Munetsugu Hara, Reimi Tsurusawa, Takahito Inoue, Reina Ogata, Yoriko Watanabe, Noriko Togashi, Hirofumi Kodera, Mitsuko Nakashima, Yoshinori Tsurusaki, Noriko Miyake, Fumiaki Tanaka, Hirotomo Saitsu, Naomichi Matsumoto

    Epilepsia   56 ( 9 )   e121-8 - e128   2015年9月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    KCNT1 mutations have been found in epilepsy of infancy with migrating focal seizures (EIMFS; also known as migrating partial seizures in infancy), autosomal dominant nocturnal frontal lobe epilepsy, and other types of early onset epileptic encephalopathies (EOEEs). We performed KCNT1-targeted next-generation sequencing (207 samples) and/or whole-exome sequencing (229 samples) in a total of 362 patients with Ohtahara syndrome, West syndrome, EIMFS, or unclassified EOEEs. We identified nine heterozygous KCNT1 mutations in 11 patients: nine of 18 EIMFS cases (50%) in whom migrating foci were observed, one of 180 West syndrome cases (0.56%), and one of 66 unclassified EOEE cases (1.52%). KCNT1 mutations occurred de novo in 10 patients, and one was transmitted from the patient's mother who carried a somatic mosaic mutation. The mutations accumulated in transmembrane segment 5 (2/9, 22.2%) and regulators of K(+) conductance domains (7/9, 77.8%). Five of nine mutations were recurrent. Onset ages ranged from the neonatal period (<1 month) in five patients (5/11, 45.5%) to 1-4 months in six patients (6/11, 54.5%). A generalized attenuation of background activity on electroencephalography was seen in six patients (6/11, 54.5%). Our study demonstrates that the phenotypic spectrum of de novo KCNT1 mutations is largely restricted to EIMFS.

    DOI: 10.1111/epi.13072

    PubMed

    J-GLOBAL

    researchmap

  • Robust and Soft Elastomeric Electronics Tolerant to Our Daily Lives. 査読

    Sekiguchi A, Tanaka F, Saito T, Kuwahara Y, Sakurai S, Futaba DN, Yamada T, Hata K

    Nano letters   15 ( 9 )   5716 - 5723   2015年9月

  • Protocol for Cerebral Microbleeds during the Non-Vitamin K Antagonist Oral Anticoagulants or Warfarin Therapy in Stroke Patients with Nonvalvular Atrial Fibrillation (CMB-NOW) Study: Multisite Pilot Trial. 査読 国際誌

    Shunya Takizawa, Fumiaki Tanaka, Kazutoshi Nishiyama, Yasuhiro Hasegawa, Eiichiro Nagata, Atsushi Mizuma, Sachiko Yutani, Taira Nakayama, Hiroyuki Kobayashi, Noriharu Yanagimachi, Takashi Okazaki, Kazuo Kitagawa

    Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association   24 ( 9 )   2143 - 8   2015年9月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    RATIONALE: Anticoagulants are widely used to prevent recurrence of ischemic stroke in patients with nonvalvular atrial fibrillation, but in some patients, they also cause bleeding, particularly intracranial hemorrhage. One of the independent predictors of intracerebral hemorrhage is the presence of cerebral microbleeds (CMBs); a high incidence of intracerebral hemorrhage is reported in warfarin-treated patients with multiple CMBs. Longitudinal study suggested that the presence of CMBs at baseline is a predictor of new CMBs in warfarin-treated patients. However, there has been no study on the progression of CMBs in patients receiving the non-vitamin K antagonist oral anticoagulants (NOACs). AIMS: This study tests the hypothesis that the incidence of hemorrhagic stroke is lower in patients receiving NOACs (dabigatran, rivaroxaban, apixaban, and edoxaban) than in those receiving warfarin, and this difference reflects the difference in the effects of warfarin and NOACs on the progression of CMBs. DESIGN: We will enroll 200 patients with at least 1 CMB detected by 1.5 T magnetic resonance imaging (T2(∗)-weighted imaging) at baseline and who have received NOACs or warfarin for at least 12 months. Primary end point is the proportion of subjects with an increased number of CMBs at month 12 of treatment with NOACs or warfarin. If the results of this study support the efficacy of NOACs for preventing increase of CMBs, this would be of great interest to domestic and overseas clinicians, in view of the potential therapeutic impact, including that on primary prevention of ischemic stroke.

    DOI: 10.1016/j.jstrokecerebrovasdis.2015.05.032

    PubMed

    J-GLOBAL

    researchmap

  • Quantitative analysis of intraneuronal transport in human iPS neurons. 査読

    Haruko Nakamura, Naoya Yamashita, Yuri Kanamaru, Takahiko Tachibana, Yuko Sekino, Sandy Chen, Toshiyuki Gotoh, Fumiaki Tanaka, Yoshio Goshima

    Journal of pharmacological sciences   128 ( 4 )   170 - 8   2015年8月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Induced pluripotent stem (iPS) cells are promising tools to investigate disease mechanism and develop new drugs. Intraneuronal transport, which is fundamental for neuronal survival and function, is vulnerable to various pharmacological and chemical agents and is disrupted in some neurodegenerative disorders. We applied a quantification method for axonal transport by counting CM-DiI-labeled particles traveling along the neurite, which allowed us to monitor and quantitate, for the first time, intraneuronal transport in human neurons differentiated from iPS cells (iCell neurons). We evaluated the acute effects of several anti-neoplastic agents that have been previously shown to affect intraneuronal transport. Vincristine, paclitaxel and oxaliplatin decreased the number of moving particle along neurites. Cisplatin, however, produced no effect on intraneuronal transport, which is in contrast to our previous report indicating that it inhibits transport in chick dorsal root ganglion neurons. Our system may be a useful method for assessing intraneuronal transport and neurotoxicity in human iPS neurons.

    DOI: 10.1016/j.jphs.2015.06.006

    PubMed

    J-GLOBAL

    researchmap

  • The Neural Basis of Typewriting: A Functional MRI Study (vol 10, e0134131, 2015) 査読

    Yuichi Higashiyama, Katsuhiko Takeda, Yoshiaki Someya, Yoshiyuki Kuroiwa, Fumiaki Tanaka

    PLOS ONE   10 ( 8 )   e0137265   2015年8月

     詳細を見る

    記述言語:英語   出版者・発行元:PUBLIC LIBRARY SCIENCE  

    DOI: 10.1371/journal.pone.0137265

    Web of Science

    PubMed

    researchmap

  • Arterial spin-labeling magnetic resonance imaging for diagnosis of early seizure after stroke. 査読 国際誌

    Yosuke Miyaji, Yuichi Kawabata, Hideto Joki, Shunsuke Seki, Kentaro Mori, Tomoya Kamide, Akira Tamase, Motohiro Nomura, Yoshihisa Kitamura, Fumiaki Tanaka

    Journal of the neurological sciences   354 ( 1-2 )   127 - 8   2015年7月

     詳細を見る

  • バルプロ酸・ラモトリギン・レベチラセタムの3剤併用で発作消失に至った難治性若年ミオクロニーてんかんの3例

    北澤 悠, 神 一敬, 柿坂 庸介, 藤川 真由, 中里 信和, 加藤 量広, 岩崎 真樹, 田中 章景

    臨床神経学   55 ( 7 )   510 - 510   2015年7月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • A Novel Mutation in ELOVL4 Leading to Spinocerebellar Ataxia (SCA) With the Hot Cross Bun Sign but Lacking Erythrokeratodermia: A Broadened Spectrum of SCA34. 査読 国際誌

    Kokoro Ozaki, Hiroshi Doi, Jun Mitsui, Nozomu Sato, Yoichiro Iikuni, Takamasa Majima, Kiyomi Yamane, Takashi Irioka, Hiroyuki Ishiura, Koichiro Doi, Shinichi Morishita, Miwa Higashi, Teruhiko Sekiguchi, Kazuo Koyama, Naohisa Ueda, Yoshiharu Miura, Satoko Miyatake, Naomichi Matsumoto, Takanori Yokota, Fumiaki Tanaka, Shoji Tsuji, Hidehiro Mizusawa, Kinya Ishikawa

    JAMA neurology   72 ( 7 )   797 - 805   2015年7月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    IMPORTANCE: Although mutations in 26 causative genes have been identified in the spinocerebellar ataxias (SCAs), the causative genes in a substantial number of families with SCA remain unidentified. OBJECTIVE: To identify the causative gene of SCA in 2 Japanese families with distinct neurological symptoms and radiological presentations. DESIGN, SETTING, AND PARTICIPANTS: Clinical genetic study at a referral center of 11 members from 2 Japanese families, which started in 1997. MAIN OUTCOMES AND MEASURES: Results of neurological examinations and radiological evaluations. The causative mutation was identified using genome-wide linkage analysis and next-generation sequencing. RESULTS: Affected members (9 of 11 members [81.8%]) showed slowly progressive cerebellar ataxia (all 9 members [100%]), ocular movement disturbance (all 9 members [100%]), and pyramidal tract signs (8 of 9 members [88.9%]) with an age at onset between the second and sixth decades of life. Besides cerebellar and pontine atrophy, magnetic resonance imaging of the brain revealed the hot cross bun sign (4 of 6 members [66.7%]), pontine midline linear hyperintensity (2 of 6 members [33.3%]), or high intensity in the middle cerebellar peduncle (1 of 6 members [16.7%]), which are all reminiscent of multiple system atrophy in tested patients. Using linkage analysis combined with exome and whole-genome sequencing, we identified a novel heterozygous mutation in the ELOVL fatty acid elongase 4 (ELOVL4) gene (c.736T>G, p.W246G) in both families. Haplotype analysis indicated that it was unlikely that these 2 Japanese families shared a common ancestor. Although a missense mutation in ELOVL4 (c.504G>C, p.L168F) was recently reported to be associated with SCA with erythrokeratodermia variabilis (SCA34) in a French-Canadian family, signs of erythrokeratodermia variabilis were absent in our families. CONCLUSIONS AND RELEVANCE: Combined with the results of the family with SCA34 reported previously, this report confirms that mutations in ELOVL4 can cause dominantly inherited neurodegeneration severely affecting the cerebellum and brainstem. We should be aware that the presence of multiple system atrophy-like features on magnetic resonance imaging scans, together with cerebellar and brainstem atrophy, suggests SCA34, even when erythrokeratodermia variabilis is absent. The present study further broadened the spectrum of the clinical presentations of SCA34 associated with mutations in ELOVL4, which is involved in the biosynthesis of very long-chain fatty acids.

    DOI: 10.1001/jamaneurol.2015.0610

    PubMed

    J-GLOBAL

    researchmap

  • Vertebral Artery Dissection Leading to Fornix Infarction: A Case Report. 査読 国際誌

    Takashi Kurokawa, Yasuhisa Baba, Kimihiro Fujino, Yoshiyuki Kuroiwa, Yusuke Tomita, Makoto Nakane, Shoko Merrit Yamada, Fumiaki Tanaka

    Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association   24 ( 7 )   e169-72 - e172   2015年7月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    BACKGROUND: The subcallosal artery is a proximal branch of the anterior communicating artery and has been recognized as the vessel responsible for fornix infarction. Fornix infarction caused by vascular damage to the posterior circulation has not been reported previously. RESULTS: A 26-year-old woman suffered from fornix infarction due to artery-to-artery embolism after vertebral artery dissection. Cerebral infarctions were also found in the left thalamus, body of the left caudate nucleus, and the left occipital lobe other than the fornix. CONCLUSIONS: Occlusion of the subcallosal artery results in cerebral infarction of fornix, anterior cingulate cortex, and genu of the corpus callosum. However, in our case, lesions were restricted to the territory of posterior circulation. In addition to subcallosal artery, lateral posterior choroidal artery, a perforating branch of the posterior cerebral artery, has been described to send branches to the fornix, so we speculated that the left lateral posterior choroidal artery was actually responsible for fornix infarction.

    DOI: 10.1016/j.jstrokecerebrovasdis.2015.03.030

    PubMed

    J-GLOBAL

    researchmap

  • GRIN1 mutations cause encephalopathy with infantile-onset epilepsy, and hyperkinetic and stereotyped movement disorders. 査読 国際誌

    Chihiro Ohba, Masaaki Shiina, Jun Tohyama, Kazuhiro Haginoya, Tally Lerman-Sagie, Nobuhiko Okamoto, Lubov Blumkin, Dorit Lev, Souichi Mukaida, Fumihito Nozaki, Mitsugu Uematsu, Akira Onuma, Hirofumi Kodera, Mitsuko Nakashima, Yoshinori Tsurusaki, Noriko Miyake, Fumiaki Tanaka, Mitsuhiro Kato, Kazuhiro Ogata, Hirotomo Saitsu, Naomichi Matsumoto

    Epilepsia   56 ( 6 )   841 - 8   2015年6月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    OBJECTIVE: Recently, de novo mutations in GRIN1 have been identified in patients with nonsyndromic intellectual disability and epileptic encephalopathy. Whole exome sequencing (WES) analysis of patients with genetically unsolved epileptic encephalopathies identified four patients with GRIN1 mutations, allowing us to investigate the phenotypic spectrum of GRIN1 mutations. METHODS: Eighty-eight patients with unclassified early onset epileptic encephalopathies (EOEEs) with an age of onset <1 year were analyzed by WES. The effect of mutations on N-methyl-D-aspartate (NMDA) receptors was examined by mapping altered amino acids onto three-dimensional models. RESULTS: We identified four de novo missense GRIN1 mutations in 4 of 88 patients with unclassified EOEEs. In these four patients, initial symptoms appeared within 3 months of birth, including hyperkinetic movements in two patients (2/4, 50%), and seizures in two patients (2/4, 50%). Involuntary movements, severe developmental delay, and intellectual disability were recognized in all four patients. In addition, abnormal eye movements resembling oculogyric crises and stereotypic hand movements were observed in two and three patients, respectively. All the four patients exhibited only nonspecific focal and diffuse epileptiform abnormality, and never showed suppression-burst or hypsarrhythmia during infancy. A de novo mosaic mutation (c.1923G>A) with a mutant allele frequency of 16% (in DNA of blood leukocytes) was detected in one patient. Three mutations were located in the transmembrane domain (3/4, 75%), and one in the extracellular loop near transmembrane helix 1. All the mutations were predicted to impair the function of the NMDA receptor. SIGNIFICANCE: Clinical features of de novo GRIN1 mutations include infantile involuntary movements, seizures, and hand stereotypies, suggesting that GRIN1 mutations cause encephalopathy resulting in seizures and movement disorders.

    DOI: 10.1111/epi.12987

    PubMed

    J-GLOBAL

    researchmap

  • A case of autism spectrum disorder arising from a de novo missense mutation in POGZ. 査読 国際誌

    Ryoko Fukai, Yoko Hiraki, Hiroko Yofune, Yoshinori Tsurusaki, Mitsuko Nakashima, Hirotomo Saitsu, Fumiaki Tanaka, Noriko Miyake, Naomichi Matsumoto

    Journal of human genetics   60 ( 5 )   277 - 9   2015年5月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Autism spectrum disorder (ASD) is a clinically heterogeneous psychiatric disorder with various genetic backgrounds. Here, we report a novel mutation in the pogo transposable element-derived protein with zinc finger domain gene (POGZ) identified by trio-based whole exome sequencing. To date, a total of seven de novo POGZ mutations in ASD have been reported. POGZ contains a total of five functional domains, and this study reports the first de novo missense mutation in the centromere protein B-like DNA-binding domain. POGZ is highly expressed in the human fetal brain and is involved in mitosis and the regulation of neuronal proliferation. Therefore its loss-of-function or pathogenic missense mutations are likely to be causative of ASD.

    DOI: 10.1038/jhg.2015.13

    PubMed

    J-GLOBAL

    researchmap

  • Isolated Unilateral Ptosis due to Paramedian Midbrain Infarction. 査読 国際誌

    Eriko Sugawara, Haruko Nakamura, Masanao Endo, Fumiaki Tanaka, Tatsuya Takahashi

    Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association   24 ( 5 )   e121-3 - 123   2015年5月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    A 59-year-old man who had hypertension, dyslipidemia, diabetes mellitus, and left eye glaucoma developed sudden vertigo and left ptosis; he did not notice diplopia. He visited our hospital on day 3 after onset and neurologic examination showed left ptosis. His left visual acuity was counting fingers, and the light reflex was sluggish owing to glaucoma. Pupil sizes were equal, and eye movements and the lower lid were unremarkable. Magnetic resonance images revealed an acute infarction of the left paramedian midbrain. We considered that selective damage to the oculomotor fascicles innervating the left levator palpebrae superioris caused ipsilateral ptosis. As the fascicles for this ocular muscle run in the small area adjacent to those for the medial rectus, inferior rectus and superior rectus muscles, this is an extremely rare case of midbrain infarction presenting with isolated unilateral ptosis.

    DOI: 10.1016/j.jstrokecerebrovasdis.2015.01.027

    PubMed

    J-GLOBAL

    researchmap

  • An Aerodynamic Study of Phonations in Patients With Parkinson Disease (PD). 査読 国際誌

    Yukiko Ikui, Haruko Nakamura, Daisuke Sano, Hiroshi Hyakusoku, Hitaru Kishida, Yosuke Kudo, Hideto Joki, Shigeru Koyano, Akihito Yamauchi, Shingo Takano, Niro Tayama, Hajime Hirose, Nobuhiko Oridate, Fumiaki Tanaka

    Journal of voice : official journal of the Voice Foundation   29 ( 3 )   273 - 80   2015年5月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    BACKGROUND: The precise comparison of the voice characteristics of Parkinson disease (PD) patients with age-matched normal subjects is still one of the important research projects. The present study aimed at comparing the voice characteristics in sustained phonations of PD patients with an age-matched control group. METHODS: The subjects were 30 Japanese PD patients (15 males and 15 females). The control group consisted of 30 age-matched normal Japanese subjects (15 males and 15 females). Each subject was required to phonate into a mouthpiece attached to Vocal Function Analyzer (PS-77E; Nagashima Medical Instrumental Corporation, Tokyo, Japan) with the airway interruption system, and expiratory lung pressure, mean flow rate, fundamental frequency and intensity of voice, and pitch range were measured. Maximum phonation time was also assessed. RESULTS: The highest pitch level was significantly lower in the PD group than that of the control group in both sexes, whereas the lowest pitch level was significantly higher in the PD group only in males. In both sexes, the pitch range was significantly narrower in the PD group than in the control group. There was no significant difference in intensity, mean flow rate, expiratory pressure, or maximum phonation time between the two groups, for both males and females. CONCLUSION: Only remarkable difference in the voice characteristics between PD patients and age-matched normal elderlies was limited to the narrowing of the pitch range in PD patients. The restriction in pitch regulation in PD patients was considered to be because of difficulty in reciprocal control of the laryngeal muscles secondary to latent rigidity.

    DOI: 10.1016/j.jvoice.2014.08.012

    PubMed

    J-GLOBAL

    researchmap

  • Isolated unilateral oculomotor paresis in pure midbrain stroke. 査読 国際誌

    Yu Amano, Yosuke Kudo, Hideyuki Kikyo, Ryoko Imazeki, Masahiro Yamamoto, Kazumitsu Amari, Fumiaki Tanaka, Ken Johkura

    Journal of the neurological sciences   351 ( 1-2 )   191 - 195   2015年4月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    BACKGROUND AND PURPOSE: Pure midbrain stroke can cause isolated unilateral oculomotor paresis. We attempted to determine whether there is a difference in the oculomotor paresis pattern between pure midbrain infarction and midbrain hemorrhage. METHODS: Pure midbrain stroke patients who presented with isolated unilateral oculomotor paresis were identified from a group of 2447 consecutive patients hospitalized for acute cerebral infarction or hemorrhage during the period May 2008 through April 2014. Detailed oculomotor findings were evaluated in the identified patients per the cause of the stroke. RESULTS: Five patients with infarct and 1 with hemorrhage became our study subjects. Lesions were located in the paramedian area of the midbrain involving the oculomotor fascicles. The pupillary sphincter and inferior rectus muscles were selectively spared in the infarct patients, whereas these muscles were selectively affected in the hemorrhage patient. CONCLUSION: Fibers in the oculomotor fascicle that innervate the levator palpebrae, superior rectus, and inferior oblique muscles appear to be more susceptible to ischemic damage than those that innervate the pupillary sphincter and inferior rectus muscles. Isolated impairment of the pupillary sphincter and inferior rectus muscles may be suggestive of a non-ischemic process.

    DOI: 10.1016/j.jns.2015.03.012

    PubMed

    J-GLOBAL

    researchmap

  • A Japanese case of cerebellar ataxia, spastic paraparesis and deep sensory impairment associated with a novel homozygous TTC19 mutation. 査読 国際誌

    Misako Kunii, Hiroshi Doi, Yuichi Higashiyama, Chiharu Kugimoto, Naohisa Ueda, Junichi Hirata, Atsuko Tomita-Katsumoto, Mari Kashikura-Kojima, Shun Kubota, Midori Taniguchi, Kei Murayama, Mitsuko Nakashima, Yoshinori Tsurusaki, Noriko Miyake, Hirotomo Saitsu, Naomichi Matsumoto, Fumiaki Tanaka

    Journal of human genetics   60 ( 4 )   187 - 91   2015年4月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Mitochondrial complex III (CIII) deficiency comprises a group of complex and heterogeneous genetic disorders. TTC19 mutations constitute a rare cause of CIII deficiency and are associated with neurological disorders in childhood and adulthood. Herein, we describe a 27-year-old Japanese man with cerebellar ataxia, spastic paraparesis, loss of deep sensation, mild frontal lobe dysfunction and transient psychiatric symptoms. Brain magnetic resonance imaging showed cerebellar atrophy and bilateral high-intensity signals in the inferior olives and regions adjacent to periaqueductal gray matter, on T2-weighted images. On whole-exome sequencing, we detected a novel homozygous frameshift mutation c.157_158dup [p.Pro54Alafs*48] in TTC19. Mitochondrial enzyme assays confirmed mild impairment of CIII enzymatic activity in lymphoblasts, which was consistent with TTC19-related CIII deficiency. His symptoms and radiological findings demonstrated an early stage or mild form of this disease, and further clarify the characteristics of patients with rare TTC19 mutations.

    DOI: 10.1038/jhg.2015.7

    PubMed

    J-GLOBAL

    researchmap

  • Clinicopathologic features of folate-deficiency neuropathy. 査読 国際誌

    Haruki Koike, Mie Takahashi, Ken Ohyama, Rina Hashimoto, Yuichi Kawagashira, Masahiro Iijima, Masahisa Katsuno, Hiroshi Doi, Fumiaki Tanaka, Gen Sobue

    Neurology   84 ( 10 )   1026 - 33   2015年3月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    OBJECTIVE: The clinical significance and characteristics of neuropathy caused by folate deficiency remain to be established. METHODS: We examined the clinicopathologic features of 18 consecutive patients with neuropathy caused by folate deficiency who presented with low serum folate levels but normal blood thiamine and serum cobalamin levels in the absence of chronic alcoholism. RESULTS: Symptoms were relatively uniform, characterized by slowly progressive polyneuropathy with predominant involvement of the lower extremities, with a tendency to manifest as sensory rather than motor neuropathy and predominant deep rather than superficial sensory loss. The electrophysiologic features were consistent with axonal neuropathy. The histopathologic features of sural nerve biopsy specimens indicated large fiber-predominant axonal loss without segmental demyelination. Although macrocytosis was found in 7 patients, only 3 patients exhibited hemoglobin levels less than 10 g/dL. During the same study period, we found 12 patients who had low blood thiamine levels but normal serum folate and cobalamin levels without chronic alcoholism. Compared with patients who had thiamine-deficiency neuropathy, patients with a folate deficiency showed significantly slower progression (p < 0.01), a tendency to manifest sensory neuropathy (p < 0.05), predominant deep sensory loss (p < 0.01), and preservation of biceps tendon reflexes (p < 0.05). CONCLUSIONS: Folate-deficiency neuropathy was characterized by a slowly progressive and sensory-dominant pattern, which was different from thiamine-deficiency neuropathy (i.e., beriberi neuropathy). This study demonstrates the importance of folate deficiency in the differential diagnosis of neuropathy, particularly in countries where folic acid fortification has not yet been practiced.

    DOI: 10.1212/WNL.0000000000001343

    PubMed

    J-GLOBAL

    researchmap

  • 【脳梁を再検討する】 脳梁損傷の症候 失行以外について

    東山 雄一, 田中 章景

    神経内科   82 ( 3 )   288 - 296   2015年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(有)科学評論社  

    researchmap

  • Association of cerebrospinal fluid levels of lateral olfactory tract usher substance (LOTUS) with disease activity in multiple sclerosis. 査読 国際誌

    Keita Takahashi, Yuji Kurihara, Yume Suzuki, Yoshio Goshima, Fumiaki Tanaka, Kohtaro Takei

    JAMA neurology   72 ( 2 )   176 - 9   2015年2月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    IMPORTANCE: Although multiple sclerosis (MS) is generally considered an autoimmune demyelinating disorder of the central nervous system, axonal degeneration through Nogo receptor-1 signaling was recently recognized as an important pathological feature. Our previous identification of lateral olfactory tract usher substance (LOTUS), an endogenous Nogo receptor-1 antagonist, prompted us to analyze the relationship between LOTUS levels of cerebrospinal fluid and the clinical course of MS to evaluate whether LOTUS could be a useful biomarker for MS. OBJECTIVE: To examine variations in LOTUS concentrations in the cerebrospinal fluid of patients with MS in accordance with their clinical course. DESIGN, SETTING, AND PARTICIPANTS: Cerebrospinal fluid samples were obtained retrospectively from normal controls (NCs; n = 27) and patients with MS (n = 40), amyotrophic lateral sclerosis (n = 22), and multiple system atrophy (n = 10) between January 1, 2008, and January 1, 2014. Patients with MS were divided into relapsing-remitting MS (RRMS; n = 30) and secondary progressive MS (n = 10). Patients with RRMS were further divided into relapse and remission groups. MAIN OUTCOMES AND MEASURES: The LOTUS concentration in cerebropsinal fluid was quantitatively detected by immunoblotting using a specific LOTUS antibody and the concentrations compared in accordance with the patients' clinical course, such as remission and relapse groups in RRMS and secondary progressive MS. RESULTS: The mean (SD) cerebrospinal fluid LOTUS concentration in the relapse group of RRMS (9.3 [3.6] µg/dL) was lower than that of NCs (19.2 [4.7] µg/dL; P < .001) whereas the level in the remission group of RRMS (19.6 [5.8] µg/dL) was similar to that of NCs. The LOTUS concentration in SPMS (6.7 [1.4] µg/dL; P < .001) was lower than that of NCs and the remission group of RRMS. The LOTUS levels in other neurodegenerative diseases, such as amyotrophic lateral sclerosis and multiple system atrophy, were normal. CONCLUSIONS AND RELEVANCE: Variations in LOTUS concentrations were correlated with disease activity in MS. Therefore, LOTUS concentration may be useful as a possible biomarker for MS. Low LOTUS concentrations may be possibly involved in Nogo receptor-1 signaling, which may induce axonal degeneration in the relapse phase of RRMS and secondary progressive MS.

    DOI: 10.1001/jamaneurol.2014.3613

    PubMed

    J-GLOBAL

    researchmap

  • 重症頭部外傷の既往がある海馬硬化症に伴う内側側頭葉てんかんの一手術例 査読

    北澤 悠, 神 一敬, 加藤 量広, 柿坂 庸介, 藤川 真由, 中里 信和, 岩崎 真樹, 田中 章景

    臨床神経学   55 ( 1 )   60 - 60   2015年1月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • An Integrative Analysis to Identify Driver Genes in Esophageal Squamous Cell Carcinoma. 査読

    Sawada G, Niida A, Hirata H, Komatsu H, Uchi R, Shimamura T, Takahashi Y, Kurashige J, Matsumura T, Ueo H, Takano Y, Ueda M, Sakimura S, Shinden Y, Eguchi H, Sudo T, Sugimachi K, Yamasaki M, Tanaka F, Tachimori Y, Kajiyama Y, Natsugoe S, Fujita H, Tanaka Y, Calin G, Miyano S, Doki Y, Mori M, Mimori K

    PloS one   10 ( 10 )   e0139808   2015年

  • [Aseptic meningitis in a patient with cerebrospinal fluid anti-agalactosyl IgG antibody-positive preclinical rheumatoid arthritis: a case report]. 査読

    Yuichi Kawabata, Yosuke Miyaji, Tatsu Nakano, Hideto Joki, Fumiaki Tanaka

    Rinsho shinkeigaku = Clinical neurology   55 ( 12 )   904 - 8   2015年

     詳細を見る

    記述言語:日本語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Societas Neurologica Japonica  

    A 69-year-old woman presented with non-fluent aphasia, ideomotor apraxia, right hemiparesis and convulsion. Her medical history was unremarkable, and she had not suffered from arthritis. DWI and FLAIR image of brain MRI showed hyperintensities in the subarachnoid space along the left frontal and both parietal lobes, and these lesions were associated with gadolinium enhancement. The levels of serum anti-cyclic citrullinated peptide antibody, anti-agalactosyl IgG antibody and matrix metalloproteinase-3 were elevated. The results of blood cultures were negative. Cerebrospinal fluid (CSF) analysis revealed monocytic pleocytosis and negative findings for infection or malignancy. The level of anti-agalactosyl IgG antibody in CSF was elevated. The antibody index (AI) of anti-agalactosyl IgG antibody (the ratio between the CSF/serum quotient for IgG antibodies, and the CSF/serum quotient for total IgG; normal value of AI < 1.3) showed considerably high value of 8.4, indicating the intrathecal-specific antibody synthesis. As a result, the pathogenesis of her disease was consistent with rheumatoid meningitis despite lack of arthritis. After intravenous administration of methylprednisolone, her symptoms, the level of anti-agalactosyl IgG antibody in CSF, and the MRI findings were ameliorated. Anti-agalactosyl IgG antibody in the CSF was a helpful biomarker in diagnosis and assessment of the severity of rheumatoid meningitis.

    DOI: 10.5692/clinicalneurol.cn-000754

    Scopus

    PubMed

    J-GLOBAL

    researchmap

  • Interleukin 10 Level in the Cerebrospinal Fluid as a Possible Biomarker for Lymphomatosis Cerebri. 査読

    Shunta Hashiguchi, Takayuki Momoo, Yoko Murohashi, Masanao Endo, Megumi Shimamura, Takashi Kawasaki, Sachie Kanada, Akinori Nozawa, Mikiko Tada, Shigeru Koyano, Fumiaki Tanaka

    Internal medicine (Tokyo, Japan)   54 ( 12 )   1547 - 52   2015年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    A 71-year-old immunocompetent man developed cognitive decline and gait disturbance. Brain magnetic resonance imaging (MRI) revealed bilateral diffuse leukoencephalopathy without a mass lesion. An analysis of the cerebrospinal fluid (CSF) showed elevated levels of interleukin (IL)-10. The condition of the patient progressively deteriorated, and intravenous high-dose steroids proved ineffective. Detection of non-destructive, diffusely infiltrating, large B-cell lymphoma in biopsy and autopsy specimens led to a diagnosis of lymphomatosis cerebri (LC). On serial MRI, the basal ganglia and white matter lesions increased in parallel with the levels of IL-10. These findings suggest that the IL-10 level in the CSF may represent a potentially useful biomarker for the early diagnosis and monitoring of the disease progression in LC.

    DOI: 10.2169/internalmedicine.54.3283

    PubMed

    J-GLOBAL

    researchmap

  • Two novel homozygous RAB3GAP1 mutations cause Warburg micro syndrome. 査読 国際誌

    Eri Imagawa, Ryoko Fukai, Mahdiyeh Behnam, Manisha Goyal, Narges Nouri, Mitsuko Nakashima, Yoshinori Tsurusaki, Hirotomo Saitsu, Mansour Salehi, Seema Kapoor, Fumiaki Tanaka, Noriko Miyake, Naomichi Matsumoto

    Human genome variation   2   15034 - 15034   2015年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Warburg micro syndrome is an autosomal recessive disease where patients present with optic, neurologic and genital symptoms. Until now, four disease genes for Warburg micro syndrome, RAB3GAP1, RAB3GAP2, RAB18 and TBC1D20, have been identified. Here, we report two novel homozygous RAB3GAP1 mutations (c.22G>T, p.Glu8* and c.1353delA, p.Pro452Hisfs*5) in two consanguineous families by whole-exome sequencing.

    DOI: 10.1038/hgv.2015.34

    PubMed

    researchmap

  • The Neural Basis of Typewriting: A Functional MRI Study. 査読 国際誌

    Yuichi Higashiyama, Katsuhiko Takeda, Yoshiaki Someya, Yoshiyuki Kuroiwa, Fumiaki Tanaka

    PloS one   10 ( 7 )   e0134131   2015年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    To investigate the neural substrate of typewriting Japanese words and to detect the difference between the neural substrate of typewriting and handwriting, we conducted a functional magnetic resonance imaging (fMRI) study in 16 healthy volunteers. All subjects were skillful touch typists and performed five tasks: a typing task, a writing task, a reading task, and two control tasks. Three brain regions were activated during both the typing and the writing tasks: the left superior parietal lobule, the left supramarginal gyrus, and the left premotor cortex close to Exner's area. Although typing and writing involved common brain regions, direct comparison between the typing and the writing task revealed greater left posteromedial intraparietal cortex activation in the typing task. In addition, activity in the left premotor cortex was more rostral in the typing task than in the writing task. These findings suggest that, although the brain circuits involved in Japanese typewriting are almost the same as those involved in handwriting, there are brain regions that are specific for typewriting.

    DOI: 10.1371/journal.pone.0134131

    PubMed

    J-GLOBAL

    researchmap

  • The Mechanism of Ipsilateral Ataxia in Lacunar Hemiparesis: SPECT Perfusion Imaging 査読

    Ryoo Yamamoto, Ken Johkura, Yoshiharu Nakae, Fumiaki Tanaka

    EUROPEAN NEUROLOGY   73 ( 1-2 )   106 - 111   2015年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:KARGER  

    Background and Purpose: Although ataxic hemiparesis is a common lacunar syndrome, the precise mechanism underlying hemiataxia is not clear. We attempted to identify ataxia-related, cerebral blood flow changes in patients presenting with ataxic hemiparesis after acute capsular infarct. Methods: We used 99mTc-ECD brain perfusion single-photon emission computed tomography to evaluate regional cerebral blood flow in 12 patients with ataxic hemiparesis caused by capsular infarct, and we compared the regional blood flow of these patients with that of 11 patients with pure motor hemiparesis caused by similar lesions. Results: The ipsilateral red nucleus blood flow was significantly decreased in the ataxic hemiparesis patients, whereas the ipsilateral red nucleus blood flow was increased in the pure motor hemiparesis patients. Crossed cerebellar diaschisis (decreased contralateral cerebellar blood flow) was seen in ataxic hemiparesis patients; similarly, it was seen in pure motor hemiparesis patients. Conclusions: Our findings suggest that ataxia in hemiparetic patients with capsular infarct can be caused by ipsilateral red nucleus dysfunction secondary to cortico-rubral pathway disruption at the internal capsule. (C) 2014 S. Karger AG, Basel

    DOI: 10.1159/000369009

    Web of Science

    PubMed

    researchmap

  • The mechanism of ipsilateral ataxia in lacunar hemiparesis: SPECT perfusion imaging. 国際誌

    Ryoo Yamamoto, Ken Johkura, Yoshiharu Nakae, Fumiaki Tanaka

    European neurology   73 ( 1-2 )   106 - 11   2015年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    BACKGROUND AND PURPOSE: Although ataxic hemiparesis is a common lacunar syndrome, the precise mechanism underlying hemiataxia is not clear. We attempted to identify ataxia-related, cerebral blood flow changes in patients presenting with ataxic hemiparesis after acute capsular infarct. METHODS: We used 99mTc-ECD brain perfusion single-photon emission computed tomography to evaluate regional cerebral blood flow in 12 patients with ataxic hemiparesis caused by capsular infarct, and we compared the regional blood flow of these patients with that of 11 patients with pure motor hemiparesis caused by similar lesions. RESULTS: The ipsilateral red nucleus blood flow was significantly decreased in the ataxic hemiparesis patients, whereas the ipsilateral red nucleus blood flow was increased in the pure motor hemiparesis patients. Crossed cerebellar diaschisis (decreased contralateral cerebellar blood flow) was seen in ataxic hemiparesis patients; similarly, it was seen in pure motor hemiparesis patients. CONCLUSIONS: Our findings suggest that ataxia in hemiparetic patients with capsular infarct can be caused by ipsilateral red nucleus dysfunction secondary to cortico-rubral pathway disruption at the internal capsule.

    DOI: 10.1159/000369009

    PubMed

    researchmap

  • Obstructive hydrocephalus and leptomeningeal dissemination with an unknown primary lesion in a 67-year-old man 査読

    Yosuke Miyaji, Saburo Yagishita, Ning Zhang, Daisuke Watanabe, Hidetake Miyasaki, Ikki Mabuchi, Sayoko Taira, Fumiaki Tanaka

    NEUROPATHOLOGY   34 ( 6 )   596 - 601   2014年12月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:WILEY-BLACKWELL  

    DOI: 10.1111/neup.12136

    Web of Science

    PubMed

    researchmap

  • 内臓脂肪・心周囲脂肪組織と脳卒中患者の関連の検討

    桃尾 隆之, 菅原 恵梨子, 北澤 悠, 島村 めぐみ, 田中 章景

    臨床神経学   54 ( Suppl. )   S228 - S228   2014年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • Multi slice CTによる頭頸部動脈評価とPADとの関係 動脈硬化リスクとの相関について

    遠藤 雅直, 島村 めぐみ, 岸田 日帯, 桃尾 隆之, 北澤 悠, 池田 真悟, 菅原 恵梨子, 大久保 正紀, 田中 章景

    臨床神経学   54 ( Suppl. )   S227 - S227   2014年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • Obstructive hydrocephalus and leptomeningeal dissemination with an unknown primary lesion in a 67-year-old man. 国際誌

    Yosuke Miyaji, Saburo Yagishita, Ning Zhang, Daisuke Watanabe, Hidetake Miyasaki, Ikki Mabuchi, Sayoko Taira, Fumiaki Tanaka

    Neuropathology : official journal of the Japanese Society of Neuropathology   34 ( 6 )   596 - 601   2014年12月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.1111/neup.12136

    PubMed

    researchmap

  • 両側視床下核脳深部刺激療法(STN-DBS)後の前頭葉・遂行機能の経時的変化について

    岸田 日帯, 島村 めぐみ, 木村 活生, 桃尾 隆之, 遠藤 雅直, 池田 真悟, 大久保 正紀, 北澤 悠, 菅原 恵梨子, 濱田 幸一, 川崎 隆, 田中 章景

    臨床神経学   54 ( Suppl. )   S192 - S192   2014年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • High-resolution magnetic resonance imaging findings of basilar artery plaque in a patient with branch atheromatous disease: a case report. 査読 国際誌

    Yosuke Miyaji, Yuichi Kawabata, Hideto Joki, Shunsuke Seki, Kentaro Mori, Tomoya Kamide, Akira Tamase, Motohiro Nomura, Yoshihisa Kitamura, Fumiaki Tanaka

    Journal of medical case reports   8 ( 1 )   395 - 395   2014年11月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:BioMed Central Ltd.  

    INTRODUCTION: Intracranial branch atheromatous disease is a type of ischemic stroke that is caused by narrowing or occlusion of the orifice of the penetrating artery by atheromatous plaque. Pontine branch atheromatous disease is usually diagnosed using indirect findings such as the extension of a lesion to the basal surface of the pons because of the difficulty of demonstrating plaque in the basilar artery. CASE PRESENTATION: A 72-year-old Japanese man developed sudden dysarthria and left hemiparesis, and his symptoms deteriorated thereafter. Brain magnetic resonance imaging revealed an acute infarction in the territory of the right paramedian pontine artery extending to the basal surface. Non-contrast-enhanced three-dimensional fast spin-echo T1 imaging with variable flip angles and three-dimensional fast imaging with steady-state acquisition revealed a plaque in the dorsal wall of the basilar artery that spread to the origin of the paramedian pontine artery that branched toward the infarction. Although antithrombotic agents were started, the left hemiparesis got worse and became flaccid on the following day. CONCLUSIONS: This is the first report to confirm the pathological basis of branch atheromatous disease by three-dimensional images using the new modalities of 3-Tesla magnetic resonance imaging. The use of these techniques will foster better understanding of the clinicopathological mechanisms of branch atheromatous disease.

    DOI: 10.1186/1752-1947-8-395

    Scopus

    PubMed

    J-GLOBAL

    researchmap

  • Late-onset spastic ataxia phenotype in a patient with a homozygous DDHD2 mutation. 査読 国際誌

    Hiroshi Doi, Masao Ushiyama, Takashi Baba, Katsuko Tani, Masaaki Shiina, Kazuhiro Ogata, Satoko Miyatake, Yoko Fukuda-Yuzawa, Shoji Tsuji, Mitsuko Nakashima, Yoshinori Tsurusaki, Noriko Miyake, Hirotomo Saitsu, Shu-ichi Ikeda, Fumiaki Tanaka, Naomichi Matsumoto, Kunihiro Yoshida

    Scientific reports   4   7132 - 7132   2014年11月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Autosomal recessive cerebellar ataxias and autosomal recessive hereditary spastic paraplegias (ARHSPs) are clinically and genetically heterogeneous neurological disorders. Herein we describe Japanese siblings with a midlife-onset, slowly progressive type of cerebellar ataxia and spastic paraplegia, without intellectual disability. Using whole exome sequencing, we identified a homozygous missense mutation in DDHD2, whose mutations were recently identified as the cause of early-onset ARHSP with intellectual disability. Brain MRI of the patient showed a thin corpus callosum. Cerebral proton magnetic resonance spectroscopy revealed an abnormal lipid peak in the basal ganglia, which has been reported as the hallmark of DDHD2-related ARHSP (SPG 54). The mutation caused a marked reduction of phospholipase A1 activity, supporting that this mutation is the cause of SPG54. Our cases indicate that the possibility of SPG54 should also be considered when patients show a combination of adult-onset spastic ataxia and a thin corpus callosum. Magnetic resonance spectroscopy may be helpful in the differential diagnosis of patients with spastic ataxia phenotype.

    DOI: 10.1038/srep07132

    PubMed

    J-GLOBAL

    researchmap

  • Neuropathological staging of spinocerebellar ataxia type 2 by semiquantitative 1C2-positive neuron typing. Nuclear translocation of cytoplasmic 1C2 underlies disease progression of spinocerebellar ataxia type 2. 国際誌

    Shigeru Koyano, Saburo Yagishita, Yoshiyuki Kuroiwa, Fumiaki Tanaka, Toshiki Uchihara

    Brain pathology (Zurich, Switzerland)   24 ( 6 )   599 - 606   2014年11月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Spinocerebellar ataxia type 2 (SCA2) is a hereditary neurodegenerative disorder caused by the expansion of the trinucleotide CAG repeats encoding elongated polyglutamine tract in ataxin-2, the SCA2 gene product. Polyglutamine diseases comprise nine genetic entities, including seven different forms of spinocerebellar ataxias, Huntington's disease, and spinal and bulbar muscular atrophy. These are pathologically characterized by neuronal loss and intranuclear aggregates or inclusions of mutant proteins including expanded polyglutamine in selected neuronal groups. Previously, we examined immunolocalization of ubiquitin, expanded polyglutamine (probed by 1C2 antibody), and ataxin-2 in genetically confirmed SCA2 patients. In the present study, we expanded this approach by distinguishing different patterns of subcellular 1C2 immunoreactivity ("granular cytoplasmic," "cytoplasmic and nuclear" and "nuclear with inclusions.") and by quantifying their regional frequencies in three autopsied SCA2 brains at different stage of the disease. Comparison with neuronal loss and gliosis revealed that overall 1C2 immunoreactivity was paralleled with their severity. Furthermore, appearance of granular cytoplasmic pattern corresponded to early stage, cytoplasmic and nuclear pattern to active stage, and nuclear with inclusions pattern to final stage. We conclude that this 1C2-immunoreactive typing may be useful for evaluating the overall severity and extent of affected regions and estimating the neuropathological stage of SCA2.

    DOI: 10.1111/bpa.12146

    PubMed

    researchmap

  • Isolated Index Finger Palsy Due to Cortical Infarction 査読

    Yuichi Kawabata, Yosuke Miyaji, Hideto Joki, Syunsuke Seki, Kentaro Mori, Tomoya Kamide, Akira Tamase, Motohiro Nomura, Yoshihisa Kitamura, Fumiaki Tanaka

    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES   23 ( 10 )   E475 - E476   2014年11月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:ELSEVIER SCIENCE BV  

    The case of an 86-year-old man presenting with isolated left index finger palsy caused by infarction on the lateral side of the right precentral knob is presented. Embolization from aortic atheroma was considered the cause of infarction. Cases with selective palsy of a particular group of fingers without sensory deficits due to cortical infarction of the precentral knob have been reported by several authors, and predominant weakness of radial-side fingers is known to be usually caused by laterally located infarction of the precentral knob. Among the previous reports, only 1 case involved isolated index finger palsy by an atypical, medially located infarction of the precentral knob in association with a concurrent nonrelated lesion. This is the first reported isolated index finger palsy caused by a single lateral precentral knob infarction.

    DOI: 10.1016/j.jstrokecerebrovasdis.2014.07.042

    Web of Science

    PubMed

    J-GLOBAL

    researchmap

  • Neuropathological staging of spinocerebellar ataxia type 2 by semiquantitative 1C2-positive neuron typing. Nuclear translocation of cytoplasmic 1C2 underlies disease progression of spinocerebellar ataxia type 2. 査読 国際誌

    Shigeru Koyano, Saburo Yagishita, Yoshiyuki Kuroiwa, Fumiaki Tanaka, Toshiki Uchihara

    Brain pathology (Zurich, Switzerland)   24 ( 6 )   599 - 606   2014年11月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Spinocerebellar ataxia type 2 (SCA2) is a hereditary neurodegenerative disorder caused by the expansion of the trinucleotide CAG repeats encoding elongated polyglutamine tract in ataxin-2, the SCA2 gene product. Polyglutamine diseases comprise nine genetic entities, including seven different forms of spinocerebellar ataxias, Huntington's disease, and spinal and bulbar muscular atrophy. These are pathologically characterized by neuronal loss and intranuclear aggregates or inclusions of mutant proteins including expanded polyglutamine in selected neuronal groups. Previously, we examined immunolocalization of ubiquitin, expanded polyglutamine (probed by 1C2 antibody), and ataxin-2 in genetically confirmed SCA2 patients. In the present study, we expanded this approach by distinguishing different patterns of subcellular 1C2 immunoreactivity ("granular cytoplasmic," "cytoplasmic and nuclear" and "nuclear with inclusions.") and by quantifying their regional frequencies in three autopsied SCA2 brains at different stage of the disease. Comparison with neuronal loss and gliosis revealed that overall 1C2 immunoreactivity was paralleled with their severity. Furthermore, appearance of granular cytoplasmic pattern corresponded to early stage, cytoplasmic and nuclear pattern to active stage, and nuclear with inclusions pattern to final stage. We conclude that this 1C2-immunoreactive typing may be useful for evaluating the overall severity and extent of affected regions and estimating the neuropathological stage of SCA2.

    DOI: 10.1111/bpa.12146

    PubMed

    J-GLOBAL

    researchmap

  • 高齢者てんかんにおける長時間ビデオ脳波モニタリング 査読

    北澤 悠, 神 一敬, 加藤 量広, 柿坂 庸介, 藤川 真由, 岩崎 真樹, 田中 章景, 中里 信和

    てんかん研究   32 ( 2 )   476 - 476   2014年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本てんかん学会  

    researchmap

  • [Literature review of intravascular lymphomatosis]. 査読

    Shigeru Koyano, Shunta Hashiguchi, Fumiaki Tanaka

    Brain and nerve = Shinkei kenkyu no shinpo   66 ( 8 )   927 - 46   2014年8月

     詳細を見る

    記述言語:日本語   掲載種別:研究論文(学術雑誌)  

    Intravascular lymphoma (IVL) is a rare form of malignant lymphoma characterized by the selective growth of lymphoma cells within the lumina of vessels, without the involvement of adjacent parenchymal tissue. IVL is predominantly of B-cell lineage, but cases of T-cell or natural killer cell lineage have been described occasionally, predominantly involving the skin. IVL usually affects elderly patients with a poor performance status, elevated serum lactic dehydrogenase levels, anemia, and B symptoms. The clinical presentation varies in different geographical areas, particularly between patients diagnosed in Europe and Asia. In European countries, the Western variant of IVL mainly involves the central nervous system and skin; in particular, there is a "cutaneous variant" limited to the skin. In Asian countries, the Asian variant of IVL predominantly accompanies hemophagocytic syndrome. Identification of this disease is difficult because it presents with non-specific clinical symptoms. Although organ biopsies are mandatory for accurate IVL diagnosis, no standard procedure has been established. An additional random skin biopsy may be useful to diagnose IVL at an early stage. Early diagnosis and treatment can improve the outcome of IVL patients following treatment with rituximab-containing chemotherapy.

    PubMed

    researchmap

  • Schwann cell involvement in the peripheral neuropathy of spinocerebellar ataxia type 3. 査読 国際誌

    Noriaki Suga, Masahisa Katsuno, Haruki Koike, Haruhiko Banno, Keisuke Suzuki, Atsushi Hashizume, Tomoo Mano, Masahiro Iijima, Yuichi Kawagashira, Masaaki Hirayama, Tomohiko Nakamura, Hirohisa Watanabe, Fumiaki Tanaka, Gen Sobue

    Neuropathology and applied neurobiology   40 ( 5 )   628 - 39   2014年8月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    AIMS: Spinocerebellar ataxia type 3 (SCA3) is an inherited spinocerebellar ataxia caused by the expansion of trinucleotide CAG repeats in the gene encoding ataxin-3. The clinical manifestations of SCA3 include peripheral neuropathy, which is an important cause of disability in a subset of patients. Although the loss of neurones in the dorsal root ganglion (DRG) has been postulated to be the cause of this neuropathy, the precise mechanism remains to be elucidated. METHODS: To clarify the clinicopathological characteristics of SCA3-associated peripheral neuropathy, we performed nerve conduction studies and histopathological analyses. Nerve conduction studies were carried out in 18 SCA3 patients. Immunohistochemical analyses of the anterior and posterior roots of the spinal cord and peripheral nerves were performed in five SCA3 patients. We also employed immunohistochemistry and immunoelectron microscopy analyses with an anti-polyglutamine antibody. RESULTS: The mean sensory nerve action potentials of the SCA3 patients were half of the normal values. The motor conduction velocities were decreased, and the distal latencies were also significantly prolonged in the nerves studied relative to the those in normal controls. Histopathological analyses detected axonal sprouting and myelin thinning in all cases. Ataxin-3 aggregates were found in the cytoplasm of Schwann cells in all of the SCA3 patients examined but not in control subjects. CONCLUSIONS: In addition to the previously reported neuronopathy, the results of the present study indicate that Schwann cells are involved in the formation of the pathogenic intracytoplasmic ataxin-3 protein aggregates in patients with SCA3-associated neuropathy.

    DOI: 10.1111/nan.12055

    PubMed

    researchmap

  • Quantitative analysis of upper-limb ataxia in patients with spinocerebellar degeneration. 査読 国際誌

    Naohisa Ueda, Yasuhito Hakii, Shigeru Koyano, Yuichi Higashiyama, Hideto Joki, Yasuhisa Baba, Yume Suzuki, Yoshiyuki Kuroiwa, Fumiaki Tanaka

    Journal of neurology   261 ( 7 )   1381 - 6   2014年7月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Spinocerebellar degeneration (SCD) is a progressive neurodegenerative disorder in which cerebellar ataxia causes motor disability. There are no widely applicable methods for objective evaluation of ataxia in SCD. An objective system to evaluate ataxia is necessary for use in clinical trials of newly developed medication and rehabilitation. The aim of this study was to develop a simple method to quantify the degree of upper-limb ataxia. Forty-nine patients with SCD participated in this study. Patients were instructed to trace an Archimedean spiral template, and the gap between the template spiral and the drawn spiral (gap area; GA) was measured using Image J software. Ataxia was rated using the Scale for the Assessment and Rating of Ataxia (SARA) and cerebellar volume was evaluated in 37 patients using an axial cross-section of magnetic resonance images that were obtained within 6 months of clinical evaluation. Regression analysis was performed to assess the relation between GA and patient age, disease duration, SARA score, and cerebellar volume. GA was significantly related to total SARA score (r = 0.660, p < 0.001), the posture and gait (r = 0.551, p < 0.001), speech (r = 0.527, p < 0.001), hand movements (r = 0.553, p < 0.001), and heel-shin slide (r = 0.367, p = 0.036) SARA subscores, and cerebellar volume (r = 0.577, p < 0.001) but was not related to patient age (r = 0.176, p = 0.227) or disease duration (r = 0.236, p = 0.103). GA is a simple, useful method to objectively quantify the degree of cerebellar ataxia, especially upper-limb ataxia, and can be widely adopted in various settings, including clinical trials.

    DOI: 10.1007/s00415-014-7353-4

    PubMed

    J-GLOBAL

    researchmap

  • Early onset epileptic encephalopathy caused by de novo SCN8A mutations. 査読 国際誌

    Chihiro Ohba, Mitsuhiro Kato, Satoru Takahashi, Tally Lerman-Sagie, Dorit Lev, Hiroshi Terashima, Masaya Kubota, Hisashi Kawawaki, Mayumi Matsufuji, Yasuko Kojima, Akihiko Tateno, Hadassa Goldberg-Stern, Rachel Straussberg, Dafna Marom, Esther Leshinsky-Silver, Mitsuko Nakashima, Kiyomi Nishiyama, Yoshinori Tsurusaki, Noriko Miyake, Fumiaki Tanaka, Naomichi Matsumoto, Hirotomo Saitsu

    Epilepsia   55 ( 7 )   994 - 1000   2014年7月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    OBJECTIVE: De novo SCN8A mutations have been reported in patients with epileptic encephalopathy. Herein we report seven patients with de novo heterozygous SCN8A mutations, which were found in our comprehensive genetic analysis (target capture or whole-exome sequencing) for early onset epileptic encephalopathies (EOEEs). METHODS: A total of 163 patients with EOEEs without mutations in known genes, including 6 with malignant migrating partial seizures in infancy (MMPSI), and 60 with unclassified EOEEs, were analyzed by target capture (28 samples) or whole-exome sequencing (135 samples). RESULTS: We identified de novo SCN8A mutations in 7 patients: 6 of 60 unclassified EOEEs (10.0%), and one of 6 MMPSI cases (16.7%). The mutations were scattered through the entire gene: four mutations were located in linker regions, two in the fourth transmembrane segments, and one in the C-terminal domain. The type of the initial seizures was variable including generalized tonic-clonic, atypical absence, partial, apneic attack, febrile convulsion, and loss of tone and consciousness. Onset of seizures was during the neonatal period in two patients, and between 3 and 7 months of age in five patients. Brain magnetic resonance imaging (MRI) showed cerebellar and cerebral atrophy in one and six patients, respectively. All patients with SCN8A missense mutations showed initially uncontrollable seizures by any drugs, but eventually one was seizure-free and three were controlled at the last examination. All patients showed developmental delay or regression in infancy, resulting in severe intellectual disability. SIGNIFICANCE: Our data reveal that SCN8A mutations can cause variable phenotypes, most of which can be diagnosed as unclassified EOEEs, and rarely as MMPSI. Together with previous reports, our study further indicates that genetic testing of SCN8A should be considered in children with unclassified severe epilepsy.

    DOI: 10.1111/epi.12668

    PubMed

    J-GLOBAL

    researchmap

  • Erratum to: PIGN mutations cause congenital anomalies, developmental delay, hypotonia, epilepsy, and progressive cerebellar atrophy (neurogenetics, DOI:10.1007/s10048-013-0384-7) 査読

    Chihiro Ohba, Nobuhiko Okamoto, Yoshiko Murakami, Yasuhiro Suzuki, Yoshinori Tsurusaki, Mitsuko Nakashima, Noriko Miyake, Fumiaki Tanaka, Taroh Kinoshita, Naomichi Matsumoto, Hirotomo Saitsu

    Neurogenetics   15 ( 2 )   93   2014年5月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Springer Verlag  

    DOI: 10.1007/s10048-014-0398-9

    Scopus

    researchmap

  • De novo WDR45 mutation in a patient showing clinically Rett syndrome with childhood iron deposition in brain. 査読 国際誌

    Chihiro Ohba, Shin Nabatame, Yoshitaka Iijima, Kiyomi Nishiyama, Yoshinori Tsurusaki, Mitsuko Nakashima, Noriko Miyake, Fumiaki Tanaka, Keiichi Ozono, Hirotomo Saitsu, Naomichi Matsumoto

    Journal of human genetics   59 ( 5 )   292 - 5   2014年5月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Rett syndrome (RTT) is a neurodevelopmental disorder mostly caused by MECP2 mutations. We identified a de novo WDR45 mutation, which caused a subtype of neurodegeneration with brain iron accumulation, in a patient showing clinically typical RTT. The mutation (c.830+1G>A) led to aberrant splicing in lymphoblastoid cells. Sequential brain magnetic resonance imaging demonstrated that iron deposition in the globus pallidus and the substantia nigra was observed as early as at 11 years of age. Because the patient showed four of the main RTT diagnostic criteria, WDR45 should be investigated in patients with RTT without MECP2 mutations.

    DOI: 10.1038/jhg.2014.18

    PubMed

    J-GLOBAL

    researchmap

  • Clinical and biological impact of cyclin-dependent kinase subunit 2 in esophageal squamous cell carcinoma. 査読

    Kita Y, Nishizono Y, Okumura H, Uchikado Y, Sasaki K, Matsumoto M, Setoyama T, Tanoue K, Omoto I, Mori S, Owaki T, Ishigami S, Nakagawa H, Tanaka F, Mimori K, Mori M, Natsugoe S

    Oncology reports   31 ( 5 )   1986 - 1992   2014年5月

  • PIGN mutations cause congenital anomalies, developmental delay, hypotonia, epilepsy, and progressive cerebellar atrophy. 査読 国際誌

    Chihiro Ohba, Nobuhiko Okamoto, Yoshiko Murakami, Yasuhiro Suzuki, Yoshinori Tsurusaki, Mitsuko Nakashima, Noriko Miyake, Fumiaki Tanaka, Taroh Kinoshita, Naomichi Matsumoto, Hirotomo Saitsu

    Neurogenetics   15 ( 2 )   85 - 92   2014年5月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Defects of the human glycosylphosphatidylinositol (GPI) anchor biosynthetic pathway show a broad range of clinical phenotypes. A homozygous mutation in PIGN, a member of genes involved in the GPI anchor-synthesis pathway, was previously reported to cause dysmorphic features, multiple congenital anomalies, severe neurological impairment, and seizure in a consanguineous family. Here, we report two affected siblings with compound heterozygous PIGN mutations [c.808T >C (p.Ser270Pro) and c.963G >A] showing congenital anomalies, developmental delay, hypotonia, epilepsy, and progressive cerebellar atrophy. The c.808C >T mutation altered an evolutionarily conserved amino acid residue (Ser270), while reverse transcription-PCR and sequencing demonstrated that c.963G >A led to aberrant splicing, in which two mutant transcripts with premature stop codons (p.Ala322Valfs*24 and p.Glu308Glyfs*2) were generated. Expression of GPI-anchored proteins such as CD16 and CD24 on granulocytes from affected siblings was significantly decreased, and expression of the GPI-anchored protein CD59 in PIGN-knockout human embryonic kidney 293 cells was partially or hardly restored by transient expression of p.Ser270Pro and p.Glu308Glyfs*2 mutants, respectively, suggesting severe and complete loss of PIGN activity. Our findings confirm that developmental delay, hypotonia, and epilepsy combined with congenital anomalies are common phenotypes of PIGN mutations and add progressive cerebellar atrophy to this clinical spectrum.

    DOI: 10.1007/s10048-013-0384-7

    PubMed

    J-GLOBAL

    researchmap

  • Castleman病に伴うポリニューロパチーを呈した64歳男性例

    北澤 悠, 菅原 恵梨子, 桃尾 隆之, 島村 めぐみ, 本橋 賢治, 田中 章景

    臨床神経学   54 ( 5 )   451 - 451   2014年5月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • Arterial spin-labeling magnetic resonance imaging for diagnosis of late seizure after stroke. 査読 国際誌

    Yosuke Miyaji, Mutsumi Yokoyama, Yuichi Kawabata, Hideto Joki, Yuji Kushi, Yasutaka Yokoi, Jo Sasame, Shunsuke Seki, Kentaro Mori, Tomoya Kamide, Akira Tamase, Hiroshi Shima, Motohiro Nomura, Yoshihisa Kitamura, Fumiaki Tanaka

    Journal of the neurological sciences   339 ( 1-2 )   87 - 90   2014年4月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    BACKGROUND AND PURPOSE: Arterial spin labeling (ASL) is a non-invasive modality of magnetic resonance imaging (MRI) used to evaluate cerebral perfusion without a contrast agent. The usefulness of ASL for diagnosis in the acute phase of late seizure after stroke was evaluated. METHODS: Twelve consecutive patients diagnosed with late seizure after stroke were enrolled in this study. MRI including ASL was performed for each patient at the time of the emergency department visit. Eight of the patients underwent electroencephalography (EEG). RESULTS: All patients showed hyperperfusion around the stroke lesion on ASL. Only 6 patients showed high signal intensity along the cerebral cortex around the stroke lesion on diffusion-weighted imaging. The patients who underwent EEG showed slow activity, but paroxysmal discharges such as spikes or sharp waves were not observed. CONCLUSIONS: ASL was able to reveal hyperperfusion and was of great diagnostic value in the peri-ictal phase of late seizure after stroke.

    DOI: 10.1016/j.jns.2014.01.026

    PubMed

    J-GLOBAL

    researchmap

  • Therapeutic intervention in spinal and bulbar muscular atrophy (SBMA)

    Haruhiko Banno, Masahisa Katsuno, Keisuke Suzuki, Fumiaki Tanaka, Gen Sobue

    Motor Neuron Diseases: Causes, Classification and Treatments   171 - 184   2014年4月

     詳細を見る

    記述言語:英語   掲載種別:論文集(書籍)内論文   出版者・発行元:Nova Science Publishers, Inc.  

    Spinal and bulbar muscular atrophy (SBMA), also known as Kennedy's disease, is an adult-onset, X-linked motor neuron disease characterized by muscle atrophy, weakness, contraction fasciculations and bulbar involvement. SBMA is caused by the expansion of a CAG triplet repeat, encoding a polyglutamine tract within the first exon of the androgen receptor (AR) gene. The histopathological finding in SBMA is the loss of lower motor neurons in the anterior horn of the spinal cord as well as in the brainstem motor nuclei. There is no well-established disease-modifying therapy for SBMA. Animal studies have revealed that the pathogenesis of SBMA depends on the level of serum testosterone, and that androgen deprivation mitigates neurodegeneration through inhibition of nuclear accumulation and/or stabilization of the pathogenic AR. Heat shock proteins, ubiquitin-proteasome system and transcriptional regulation are also potential targets of therapy development for SBMA. Among these therapeutic approaches, androgen deprivation has been translated into clinic. Surgical castration is shown to reverse motor dysfunction in mouse models of SBMA. The luteinizing hormonereleasing hormone analogue, leuprorelin, prevents nuclear translocation of aberrant AR proteins, resulting in a significant improvement of disease phenotype in a mouse model of SBMA. These results of animal studies were verified in a phase 2 clinical trial of leuprorelin, in which the patients treated with this drug exhibited decreased mutant AR accumulation in scrotal skin biopsy and significantly better swallowing parameters than those receiving placebo. An autopsy of one patient who received leuprorelin suggested that androgen deprivation inhibits the nuclear accumulation of mutant AR in the motor neurons of the spinal cord and brainstem. Phase 3 clinical trial showed the possibility that leuprorelin treatment is associated with improved swallowing function particularly in patients with a disease duration less than 10 years. These observations suggest that pharmacological inhibition of the toxic accumulation of mutant AR is a potential therapy for SBMA.

    Scopus

    researchmap

  • Human prion diseases in Japan: a prospective surveillance from 1999 査読

    Nobuo Sanjo, Maya Higuma, Masaki Hizume, Fumiko Furukawa, Yosikazu Nakamura, Tetsuyuki Kitamoto, Masahito Yamada, Kenji Sakai, Ichiro Nozaki, Moeko Noguchi-Shinohara, Tsuyoshi Hamaguchi, Fumio Moriwaka, Masashi Aoki, Fumiaki Tanaka, Masatoyo Nishizawa, Masatoshi Takeda, Takashi Inuzuka, Koji Abe, Hiroyuki Murai, Shigeo Murayama, Masaki Takao, Katsuya Satoh, Masafumi Harada, Nobuhito Saito, Ichirou Takumi, Hidehiro Mizusawa

    PRION   8   112 - 112   2014年4月

     詳細を見る

    記述言語:英語   出版者・発行元:LANDES BIOSCIENCE  

    Web of Science

    researchmap

  • Hemichorea in a thymoma patient without anti-CRMP-5 antibody 査読

    Yoshiharu Nakae, Shingo Ikeda, Ryoo Yamamoto, Fumiaki Tanaka, Ken Johkura

    NEUROLOGICAL SCIENCES   35 ( 4 )   629 - 630   2014年4月

     詳細を見る

    記述言語:英語   出版者・発行元:SPRINGER-VERLAG ITALIA SRL  

    We reported a 72-year-old man with thymoma who presented with hemichorea. Although his brain CT and MRI revealed no abnormality, regional cerebral blood flow changes, identified by single photon emission computed tomography, suggested that the mechanism underlying the chorea seemed to be a dysfunction of the subthalamic nucleus and pallidum. His hemichorea was completely resolved after thymectomy. Absence of serum anti-neural autoantibodies, including small-cell lung carcinoma-related chorea anti-CRMP-5 antibody, suggests that mechanisms different from cross-talk neural-targeted tumor immune response can be responsible for the thymoma-associated paraneoplastic chorea.

    DOI: 10.1007/s10072-014-1629-4

    Web of Science

    PubMed

    researchmap

  • Hemichorea in a thymoma patient without anti-CRMP-5 antibody. 国際誌

    Yoshiharu Nakae, Shingo Ikeda, Ryoo Yamamoto, Fumiaki Tanaka, Ken Johkura

    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology   35 ( 4 )   629 - 30   2014年4月

     詳細を見る

    記述言語:英語  

    We reported a 72-year-old man with thymoma who presented with hemichorea. Although his brain CT and MRI revealed no abnormality, regional cerebral blood flow changes, identified by single photon emission computed tomography, suggested that the mechanism underlying the chorea seemed to be a dysfunction of the subthalamic nucleus and pallidum. His hemichorea was completely resolved after thymectomy. Absence of serum anti-neural autoantibodies, including small-cell lung carcinoma-related chorea anti-CRMP-5 antibody, suggests that mechanisms different from cross-talk neural-targeted tumor immune response can be responsible for the thymoma-associated paraneoplastic chorea.

    DOI: 10.1007/s10072-014-1629-4

    PubMed

    researchmap

  • 18F-FDG PETが病勢を反映した首下がりの70歳女性例

    阿部 弘基, 東山 雄一, 上木 英人, 岩橋 幸子, 鈴木 ゆめ, 田中 章景

    臨床神経学   54 ( 3 )   259 - 259   2014年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • Neuronal intranuclear inclusion disease cases with leukoencephalopathy diagnosed via skin biopsy. 査読 国際誌

    Jun Sone, Naoyuki Kitagawa, Eriko Sugawara, Masaaki Iguchi, Ryoichi Nakamura, Haruki Koike, Yasushi Iwasaki, Mari Yoshida, Tatsuya Takahashi, Susumu Chiba, Masahisa Katsuno, Fumiaki Tanaka, Gen Sobue

    Journal of neurology, neurosurgery, and psychiatry   85 ( 3 )   354 - 6   2014年3月

     詳細を見る

  • [Central respiratory failure occurred in the subacute phase of unilateral Wallenberg's syndrome: a case report]. 査読

    Eriko Sugawara, Asami Saito, Mitsuo Okamoto, Fumiaki Tanaka, Tatsuya Takahashi

    Rinsho shinkeigaku = Clinical neurology   54 ( 4 )   303 - 7   2014年

     詳細を見る

    記述言語:日本語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Societas Neurologica Japonica  

    A 46-year-old man developed central respiratory failure in the subacute phase of unilateral lateral medullary infarction. He complained of sudden headache and nausea at first. Neurological examination revealed Wallenberg's syndrome. Acute right lateral medullary infarction caused by the dissecting right vertebral artery was identified by magnetic resonance images. He was transferred to our hospital on the 3rd day after the onset. He was alert and conscious on admission, and became restless gradually later. He was intubated for sudden respiratory failure on the 9th day. Blood gas analysis showed hypercapnia and hypoxia. Central respiratory failure was indicated by the fact that various examinations showed no change of his infarction, no subarachnoid hemorrhage, or no worsening of pneumonia. Ventilatory support was required for a month because of repetitive CO2 narcosis. He was weaned from the ventilator on the 39th day. Only a few reports are available on central respiratory failure associated with the subacute phase of unilateral medullary infarction. Delayed central respiratory failure may be lethal. Careful observation is required on the subacute phase of Wallenberg's syndrome.

    DOI: 10.5692/clinicalneurol.54.303

    Scopus

    PubMed

    J-GLOBAL

    researchmap

  • Hypothermia and memory disturbance as initial manifestations associated with lesions of the diencephalon in a patient with anti-aquaporin 4 antibody-associated disorder: A case report 査読

    Tatsu Nakano, Fumi Dei, Yuko Kawamoto, Toshiyuki Takahashi, Fumiaki Tanaka, Kazuo Koyama

    Clinical Neurology   54 ( 8 )   653 - 656   2014年

     詳細を見る

    記述言語:中国語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Societas Neurologica Japonica  

    A 69-year-old woman was admitted due to gradual progression of daytime sleepiness and forgetfulness over a period of approximately 1 month. Bradycardia and hypothermia were observed on admission, and neurological examination revealed memory disturbance, mild dysarthria, and bradykinesia. Fluid-attenuated inversion recovery (FLAIR) images of the brain magnetic resonance imaging (MRI) indicated signal hyperintensity in the region bordering the lateral and third ventricles. Serum anti-aquaporin 4 (AQP4) antibody was detected. The patient had no history or findings of optic neuritis or myelitis, and she was diagnosed as anti-AQP4 antibody-associated disorder. Diencephalon lesion and/or symptoms are rarely observed at the onset of neuromyelitis optica. Differential diagnosis of this disorder is necessary in cases manifesting diencephalon symptoms or involving lesions bordering the third ventricle without evidence of previous optic neuritis or myelitis.

    DOI: 10.5692/clinicalneurol.54.653

    Scopus

    PubMed

    researchmap

  • [Hypothermia and memory disturbance as initial manifestations associated with lesions of the diencephalon in a patient with anti-aquaporin 4 antibody-associated disorder: a case report].

    Tatsu Nakano, Fumi Dei, Yuko Kawamoto, Toshiyuki Takahashi, Fumiaki Tanaka, Kazuo Koyama

    Rinsho shinkeigaku = Clinical neurology   54 ( 8 )   653 - 6   2014年

     詳細を見る

    記述言語:日本語   掲載種別:研究論文(学術雑誌)  

    A 69-year-old woman was admitted due to gradual progression of daytime sleepiness and forgetfulness over a period of approximately 1 month. Bradycardia and hypothermia were observed on admission, and neurological examination revealed memory disturbance, mild dysarthria, and bradykinesia. Fluid-attenuated inversion recovery (FLAIR) images of the brain magnetic resonance imaging (MRI) indicated signal hyperintensity in the region bordering the lateral and third ventricles. Serum anti-aquaporin 4 (AQP4) antibody was detected. The patient had no history or findings of optic neuritis or myelitis, and she was diagnosed as anti-AQP4 antibody-associated disorder. Diencephalon lesion and/or symptoms are rarely observed at the onset of neuromyelitis optica. Differential diagnosis of this disorder is necessary in cases manifesting diencephalon symptoms or involving lesions bordering the third ventricle without evidence of previous optic neuritis or myelitis.

    PubMed

    researchmap

  • Cerebrospinal fluid examination in spinal epidural abscess

    Yosuke Miyaji, Hidetake Miyasaki, Ning Zhan, Daisuke Watanabe, Fumiaki Tanaka

    Yokohama Medical Journal   65 ( 4 )   537 - 544   2014年

     詳細を見る

    記述言語:日本語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Medical Association of Yokohama City University  

    We report the case of an 88-year-old man with spinal epidural abscess without bacterial meningitis who showed decreased glucose levels in cerebrospinal fluid (CSF). We reviewed 90 cases of spinal epidural abscess reported from Japan that mentioned CSF examination. Typical CSF features of bacterial meningitis associated with meningitis were observed in 18 cases. However, even in the 72 cases without meningitis, CSF analysis showed pleocytosis (87%) with a polymorphonuclear predominance (71%) and a high level of protein. A decrease in CSF levels of glucose was found in 49% of cases without meningitis. Regarding the classic triad of meningitis, fever, nuchal rigidity, and unconsciousness were seen in 89%, 72%, and 6% of cases, respectively. In addition, headache was found in 37% of cases without meningitis. These results suggest that discriminating the comorbidity of bacterial meningitis based on clinical information, including results of CSF examination, is difficult in patients with spinal epidural abscess, particularly when decreased CSF levels of glucose are observed.

    Scopus

    researchmap

  • Contrasting expression patterns of histone mRNA and microRNA 760 in patients with gastric cancer. 査読 国際誌

    Iwaya T, Fukagawa T, Suzuki Y, Takahashi Y, Sawada G, Ishibashi M, Kurashige J, Sudo T, Tanaka F, Shibata K, Endo F, Katagiri H, Ishida K, Kume K, Nishizuka S, Iinuma H, Wakabayashi G, Mori M, Sasako M, Mimori K

    Clinical cancer research : an official journal of the American Association for Cancer Research   19 ( 23 )   6438 - 6449   2013年12月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.1158/1078-0432.CCR-12-3186

    PubMed

    researchmap

  • Neck weakness is a potent prognostic factor in sporadic amyotrophic lateral sclerosis patients. 査読 国際誌

    Ryoichi Nakamura, Naoki Atsuta, Hazuki Watanabe, Akihiro Hirakawa, Hirohisa Watanabe, Mizuki Ito, Jo Senda, Masahisa Katsuno, Fumiaki Tanaka, Yuishin Izumi, Mitsuya Morita, Kotaro Ogaki, Akira Taniguchi, Ikuko Aiba, Koichi Mizoguchi, Koichi Okamoto, Kazuko Hasegawa, Masashi Aoki, Akihiro Kawata, Koji Abe, Masaya Oda, Masaaki Konagaya, Takashi Imai, Masanori Nakagawa, Shoji Tsuji, Ryuji Kaji, Imaharu Nakano, Gen Sobue

    Journal of neurology, neurosurgery, and psychiatry   84 ( 12 )   1365 - 71   2013年12月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    OBJECTIVE: To clarify the emergence of muscle weakness in regions of the body that affect survival, and deterioration in activities of daily living (ADL) in amyotrophic lateral sclerosis (ALS) patients. METHODS: We conducted a multicentre-based prospective cohort study of patients with ALS. We enrolled 401 sporadic patients with ALS. Death or the introduction of invasive ventilation was defined as the primary endpoint, and the time to five clinical markers of ADL deterioration associated with bulbar paralysis or limb weakness were defined as ADL milestones. Muscle weakness was assessed in the neck flexor muscles; the bilateral abductors of the shoulders; the bilateral wrist extensor muscles; the bilateral flexor muscles of the hips; and the bilateral ankle dorsiflexion muscles. We performed Cox proportional hazards regression analyses for the primary endpoint and the five ADL milestones, adjusting for known covariate prognostic factors for ALS. RESULTS: The Medical Research Council (MRC) score for the neck flexors was the most significant prognostic factor for the primary endpoint (HR 0.74, p<0.001), loss of speech (HR 0.66, p<0.001), and loss of swallowing function (HR 0.73, p<0.001), and was one of the significant prognostic factors for loss of upper limb function, difficulty turning in bed, and loss of walking ability (p=0.001, 0.002, and 0.008, respectively). The MRC score for the neck flexors was also a significant prognostic factor for covariates of the previously reported prognostic factors. CONCLUSIONS: Neck weakness is an independent prognostic factor for survival and deterioration in ADL in Patients with ALS.

    DOI: 10.1136/jnnp-2013-306020

    PubMed

    researchmap

  • Increased number of astrocytes and macrophages/microglial cells in the corpus callosum in amyotrophic lateral sclerosis. 査読 国際誌

    Mikiko Sugiyama, Masaki Takao, Hiroyuki Hatsuta, Sayaka Funabe, Shinji Ito, Tomokazu Obi, Fumiaki Tanaka, Yoshiyuki Kuroiwa, Shigeo Murayama

    Neuropathology : official journal of the Japanese Society of Neuropathology   33 ( 6 )   591 - 9   2013年12月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by degeneration of both upper and lower motor neurons. Neuropathologically, degeneration of the corticospinal tracts is evident and may be associated with loss of motor neurons in the motor cortex. The data from a recently developed imaging technology, the diffusion tensor imaging method of MRI have suggested that white matter in the corpus callosum (CC) is lost in patients with ALS. However, the specific neuropathologic changes of the commissural fibers remain unclear. To investigate the pathologic changes of the CC in ALS, we analyzed midsagittal sections of the CC from eight individuals with ALS and eight controls by using conventional staining and immunohistochemistry with antibodies against CD68, GFAP and phosphorylated neurofilament (SMI-31). The CC was divided into seven areas. The number of CD68-immunoreactive macrophages/microglia and GFAP-immunoreactive astrocytes was significantly higher in individuals with ALS than in controls in all areas of the CC except the rostrum. Among the patients with ALS, the number of macrophages/microglia and astrocytes was significantly higher in the posterior midbody and isthmus than in the rostrum. There was no significant difference in number of SMI-31 immunoreactive axons between ALS and control group as well as among each area of the CC. These findings suggest that pathologic changes in the CC in ALS are present in the posterior midbody and isthmus, where callosal motor fibers may traverse between the two hemispheres. CD68 and GFAP immunohistochemistry are sensitive methods to detect those pathologic changes in routine paraffin-embedded specimens.

    DOI: 10.1111/neup.12027

    PubMed

    J-GLOBAL

    researchmap

  • Diagnostic utility of whole exome sequencing in patients showing cerebellar and/or vermis atrophy in childhood. 査読 国際誌

    Chihiro Ohba, Hitoshi Osaka, Mizue Iai, Sumimasa Yamashita, Yume Suzuki, Noriko Aida, Nobuyuki Shimozawa, Ayumi Takamura, Hiroshi Doi, Atsuko Tomita-Katsumoto, Kiyomi Nishiyama, Yoshinori Tsurusaki, Mitsuko Nakashima, Noriko Miyake, Yoshikatsu Eto, Fumiaki Tanaka, Naomichi Matsumoto, Hirotomo Saitsu

    Neurogenetics   14 ( 3-4 )   225 - 32   2013年11月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Cerebellar and/or vermis atrophy is recognized in various types of childhood disorders with clinical and genetic heterogeneity. Although careful evaluation of clinical features and neuroimaging can lead to correct diagnosis of disorders, their diagnosis is sometimes difficult because clinical features can overlap with each other. In this study, we performed family-based whole exome sequencing of 23 families including 25 patients with cerebellar and/or vermis atrophy in childhood, who were unable to be diagnosed solely by clinical examination. Pathological mutations of seven genes were found in ten patients from nine families (9/23, 39.1 %): compound heterozygous mutations in FOLR1, C5orf42, POLG, TPP1, PEX16, and de novo mutations in CACNA1A, and ITPR1. Patient 1A with FOLR1 mutations showed extremely low concentration of 5-methyltetrahydrofolate in the cerebrospinal fluid and serum, and Patient 6 with TPP1 mutations demonstrated markedly lowered tripeptidyl peptidase 1 activity in leukocytes. Furthermore, Patient 8 with PEX16 mutations presented a mild increase of very long chain fatty acids in the serum as supportive data for genetic diagnosis. The main clinical features of these ten patients were nonspecific and mixed, and included developmental delay, intellectual disability, ataxia, hypotonia, and epilepsy. Brain MRI revealed both cerebellar and vermis atrophy in eight patients (8/10, 80 %), vermis atrophy/hypoplasia in two patients (2/10, 20 %), and brainstem atrophy in one patient (1/10, 10 %). Our data clearly demonstrate the utility of whole exome sequencing for genetic diagnosis of childhood cerebellar and/or vermis atrophy.

    DOI: 10.1007/s10048-013-0375-8

    PubMed

    J-GLOBAL

    researchmap

  • p62/SQSTM1 differentially removes the toxic mutant androgen receptor via autophagy and inclusion formation in a spinal and bulbar muscular atrophy mouse model. 査読 国際誌

    Hideki Doi, Hiroaki Adachi, Masahisa Katsuno, Makoto Minamiyama, Shinjiro Matsumoto, Naohide Kondo, Yu Miyazaki, Madoka Iida, Genki Tohnai, Qiang Qiang, Fumiaki Tanaka, Toru Yanagawa, Eiji Warabi, Tetsuro Ishii, Gen Sobue

    The Journal of neuroscience : the official journal of the Society for Neuroscience   33 ( 18 )   7710 - 27   2013年5月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Polyglutamine (polyQ) diseases are inherited neurodegenerative disorders that are caused by the expansion of trinucleotide CAG repeats in the causative genes. Spinal and bulbar muscular atrophy (SBMA) is an inherited motor neuron disease that is caused by the expansion of a polyQ tract within the androgen receptor (AR). p62 is a ubiquitin- and light-chain 3-binding protein that is known to regulate the degradation of targeted proteins via autophagy and inclusion formation. In this study, we examined the effects of p62 depletion and overexpression on cultured cells and in a transgenic mouse model that overexpressed the mutant AR. Here, we demonstrate that depletion of p62 significantly exacerbated motor phenotypes and the neuropathological outcome, whereas overexpression of p62 protected against mutant AR toxicity in SBMA mice. Depletion of p62 significantly increased the levels of monomeric mutant AR and mutant AR protein complexes in an SBMA mouse model via the impairment of autophagic degradation. In addition, p62 overexpression improved SBMA mouse phenotypes by inducing cytoprotective inclusion formation. Our results demonstrate that p62 provides two different therapeutic targets in SBMA pathogenesis: (1) autophagy-dependent degradation and (2) benevolent inclusion formation of the mutant AR.

    DOI: 10.1523/JNEUROSCI.3021-12.2013

    PubMed

    researchmap

  • Loss of TDP-43 causes age-dependent progressive motor neuron degeneration. 査読 国際誌

    Yohei Iguchi, Masahisa Katsuno, Jun-ichi Niwa, Shinnosuke Takagi, Shinsuke Ishigaki, Kensuke Ikenaka, Kaori Kawai, Hirohisa Watanabe, Koji Yamanaka, Ryosuke Takahashi, Hidemi Misawa, Shoichi Sasaki, Fumiaki Tanaka, Gen Sobue

    Brain : a journal of neurology   136 ( Pt 5 )   1371 - 82   2013年5月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Amyotrophic lateral sclerosis is a devastating, progressive neurodegenerative disease that affects upper and lower motor neurons. Although several genes are identified as the cause of familial cases, the pathogeneses of sporadic forms, which account for 90% of amyotrophic lateral sclerosis, have not been elucidated. Transactive response DNA-binding protein 43 a nuclear protein regulating RNA processing, redistributes to the cytoplasm and forms aggregates, which are the histopathological hallmark of sporadic amyotrophic lateral sclerosis, in affected motor neurons, suggesting that loss-of-function of transactive response DNA-binding protein 43 is one of the causes of the neurodegeneration. To test this hypothesis, we assessed the effects of knockout of transactive response DNA-binding protein 43 in mouse postnatal motor neurons using Cre/loxp system. These mice developed progressive weight loss and motor impairment around the age of 60 weeks, and exhibited degeneration of large motor axon, grouped atrophy of the skeletal muscle, and denervation in the neuromuscular junction. The spinal motor neurons lacking transactive response DNA-binding protein 43 were not affected for 1 year, but exhibited atrophy at the age of 100 weeks; whereas, extraocular motor neurons, that are essentially resistant in amyotrophic lateral sclerosis, remained preserved even at the age of 100 weeks. Additionally, ultra structural analysis revealed autolysosomes and autophagosomes in the cell bodies and axons of motor neurons of the 100-week-old knockout mice. In summary, the mice in which transactive response DNA-binding protein 43 was knocked-out specifically in postnatal motor neurons exhibited an age-dependent progressive motor dysfunction accompanied by neuropathological alterations, which are common to sporadic amyotrophic lateral sclerosis. These findings suggest that transactive response DNA-binding protein 43 plays an essential role in the long term maintenance of motor neurons and that loss-of-function of this protein seems to contribute to the pathogenesis of amyotrophic lateral sclerosis.

    DOI: 10.1093/brain/awt029

    PubMed

    researchmap

  • [Report from the 16th Tokai chapter educational seminar: genetic disorders in internal medicine]. 査読

    Ishizuka T, Fukuzawa Y, Tanaka F, Nomura S, Horikawa Y, Matsubayashi H, Hozumi I

    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine   102 ( 4 )   1001 - 1009   2013年4月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本内科学会  

    DOI: 10.2169/naika.102.1001

    PubMed

    CiNii Books

    researchmap

    その他リンク: http://hdl.handle.net/20.500.12099/52656

  • Plastin3 is a novel marker for circulating tumor cells undergoing the epithelial-mesenchymal transition and is associated with colorectal cancer prognosis. 査読 国際誌

    Yokobori T, Iinuma H, Shimamura T, Imoto S, Sugimachi K, Ishii H, Iwatsuki M, Ota D, Ohkuma M, Iwaya T, Nishida N, Kogo R, Sudo T, Tanaka F, Shibata K, Toh H, Sato T, Barnard GF, Fukagawa T, Yamamoto S, Nakanishi H, Sasaki S, Miyano S, Watanabe T, Kuwano H, Mimori K, Pantel K, Mori M

    Cancer research   73 ( 7 )   2059 - 2069   2013年4月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.1158/0008-5472.CAN-12-0326

    PubMed

    researchmap

  • A novel SCARB2 mutation causing late-onset progressive myoclonus epilepsy 査読

    Yuichi Higashiyama, Hiroshi Doi, Masatoshi Wakabayashi, Yoshinori Tsurusaki, Noriko Miyake, Hirotomo Saitsu, Chihiro Ohba, Ryoko Fukai, Satoko Miyatake, Hideto Joki, Shigeru Koyano, Yume Suzuki, Fumiaki Tanaka, Yoshiyuki Kuroiwa, Naomichi Matsumoto

    MOVEMENT DISORDERS   28 ( 4 )   552 - 553   2013年4月

     詳細を見る

    記述言語:英語   出版者・発行元:WILEY-BLACKWELL  

    DOI: 10.1002/mds.25296

    Web of Science

    PubMed

    researchmap

  • [Personal genome analysis in amyotrophic lateral sclerosis]. 査読

    Fumiaki Tanaka, Jun Sone, Naoki Atsuta, Ryoichi Nakamura, Hiroshi Doi, Shigeru Koyano, Gen Sobue

    Brain and nerve = Shinkei kenkyu no shinpo   65 ( 3 )   257 - 65   2013年3月

     詳細を見る

    記述言語:日本語   掲載種別:研究論文(学術雑誌)  

    In amyotrophic lateral sclerosis (ALS), 5% of cases are familial, and most of the remaining cases are sporadic. In familial ALS, many causative genes have been identified during the last 20 years of the golden age of genetics. In particular, the recent discovery of a hexanucleotide repeat expansion in chromosome 9 open reading frame 72 (C9orf72) has had a large impact on ALS research, as this mutation is the most frequent cause of familial ALS in Europe and the US. However, the relative rarity of this mutation in Japan and Asia suggests the need to identify further other causative genes of familial ALS. In this regard, the advent of next-generation sequencing technology is expected to accelerate the identification of novel genes. In addition, next-generation sequencing will supersede Sanger sequencing in the molecular diagnosis of familial ALS. A number of genome-wide association studies (GWAS) have been conducted to identify the disease-susceptibility genes of sporadic ALS. In 1,305 Japanese ALS samples, the ZNF512B gene was associated with susceptibility to ALS. This gene has been shown to be one of the prognostic factors in sporadic ALS. Although GWAS that are based on the 'common disease-common variants hypothesis' have successfully revealed many disease-susceptibility genes, including ZNF512B, in sporadic ALS, the odds ratios associated with these risk alleles are generally low. The next challenge in ALS research is to use next-generation sequencing techniques to identify disease-relevant alleles with large effect sizes based on the 'common disease-multiple rare variants hypothesis'.

    PubMed

    researchmap

  • Spliceosome integrity is defective in the motor neuron diseases ALS and SMA. 査読 国際誌

    Hitomi Tsuiji, Yohei Iguchi, Asako Furuya, Ayane Kataoka, Hiroyuki Hatsuta, Naoki Atsuta, Fumiaki Tanaka, Yoshio Hashizume, Hiroyasu Akatsu, Shigeo Murayama, Gen Sobue, Koji Yamanaka

    EMBO molecular medicine   5 ( 2 )   221 - 34   2013年2月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:WILEY-BLACKWELL  

    Two motor neuron diseases, amyotrophic lateral sclerosis (ALS) and spinal muscular atrophy (SMA), are caused by distinct genes involved in RNA metabolism, TDP-43 and FUS/TLS, and SMN, respectively. However, whether there is a shared defective mechanism in RNA metabolism common to these two diseases remains unclear. Here, we show that TDP-43 and FUS/TLS localize in nuclear Gems through an association with SMN, and that all three proteins function in spliceosome maintenance. We also show that in ALS, Gems are lost, U snRNA levels are up-regulated and spliceosomal U snRNPs abnormally and extensively accumulate in motor neuron nuclei, but not in the temporal lobe of FTLD with TDP-43 pathology. This aberrant accumulation of U snRNAs in ALS motor neurons is in direct contrast to SMA motor neurons, which show reduced amounts of U snRNAs, while both have defects in the spliceosome. These findings indicate that a profound loss of spliceosome integrity is a critical mechanism common to neurodegeneration in ALS and SMA, and may explain cell-type specific vulnerability of motor neurons.

    DOI: 10.1002/emmm.201202303

    Web of Science

    PubMed

    researchmap

  • [The genetics of corticobasal syndrome]. 査読

    Hiroshi Doi, Fumiaki Tanaka

    Brain and nerve = Shinkei kenkyu no shinpo   65 ( 1 )   19 - 30   2013年1月

     詳細を見る

    記述言語:日本語   掲載種別:研究論文(学術雑誌)  

    Corticobasal syndrome (CBS) is a clinical syndrome presenting with progressive asymmetric bradykinesia, rigidity, and dystonia accompanied by cortical signs, such as apraxia, alien limb phenomena, cortical sensory loss, myoclonus, and mirror movements. CBS is associated with different pathological conditions including FTLD-tau (corticobasal degeneration, CBD; progressive supranuclear palsy, PSP: and Pick disease), FTLD-TDP, Alzheimer disease, Creutzfeldt-Jakob disease, and Parkinson disease/dementia with Lewy bodies. Among these, the most common pathology is CBD. In patients with familial and sporadic FTLD, MAPT, GRN and C9orf72 mutations are the three main causes of the disease, even though the C9orf72 mutation is rare in Japan. Patients with MAPT mutations present with FTLD-tau, and patients with GRN and C9orf72 mutations exhibit FTLD-TDP. FTLD is also associated with VCP, CHMP2B, TARDBP and FUS mutations, but each of these account for <1% of familial FTLD cases. In sporadic cases, the H1c haplotype and the rare p.A152T variant of MAPT are known to be associated with FTLD-tau, and the common genetic variant (rs5848) in the 3'-UTR of GRN is associated with FTLD-TDP. A recent genome-wide association study identified TMEM106B as a potential risk-modifying factor for FTLD-TDP, and STX6, EIF2AK3 and MOBP, for PSP. Despite major advances in genetic studies in recent years, the majority of sporadic CBS cases are genetically unsolved. Further studies are needed to unveil the genetic background of CBS. In this review, we discuss the recent advances related to the genetics of CBS, particularly about the genetics of FTLD.

    PubMed

    researchmap

  • Laparoscopic surgery minimizes the surgical manipulation of isolated tumor cells leading to decreased metastasis compared to open surgery for colorectal cancer. 査読

    Akiyoshi S, Mimori K, Sudo T, Tanaka F, Shibata K, Mori M

    Surgery today   43 ( 1 )   20 - 25   2013年1月

     詳細を見る

  • Meningitis with pneumocephalus originating from a sacral pressure ulcer.

    Yosuke Miyaji, Takashi Kurokawa, Fumiaki Tanaka, Kazuo Koyama

    Internal medicine (Tokyo, Japan)   52 ( 18 )   2163 - 4   2013年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    PubMed

    researchmap

  • Meningitis with Pneumocephalus Originating from a Sacral Pressure Ulcer 査読

    Yosuke Miyaji, Takashi Kurokawa, Fumiaki Tanaka, Kazuo Koyama

    INTERNAL MEDICINE   52 ( 18 )   2163 - 2164   2013年

     詳細を見る

    記述言語:英語   出版者・発行元:JAPAN SOC INTERNAL MEDICINE  

    DOI: 10.2169/internalmedicine.52.0935

    Web of Science

    PubMed

    researchmap

  • RNP2 of RNA recognition motif 1 plays a central role in the aberrant modification of TDP-43. 査読 国際誌

    Shinnosuke Takagi, Yohei Iguchi, Masahisa Katsuno, Shinsuke Ishigaki, Kensuke Ikenaka, Yusuke Fujioka, Daiyu Honda, Jun-ichi Niwa, Fumiaki Tanaka, Hirohisa Watanabe, Hiroaki Adachi, Gen Sobue

    PloS one   8 ( 6 )   e66966   2013年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Phosphorylated and truncated TAR DNA-binding protein-43 (TDP-43) is a major component of ubiquitinated cytoplasmic inclusions in neuronal and glial cells of two TDP-43 proteinopathies, amyotrophic lateral sclerosis and frontotemporal lobar degeneration. Modifications of TDP-43 are thus considered to play an important role in the pathogenesis of TDP-43 proteinopathies. However, both the initial cause of these abnormal modifications and the TDP-43 region responsible for its aggregation remain uncertain. Here we report that the 32 kDa C-terminal fragment of TDP-43, which lacks the RNP2 motif of RNA binding motif 1 (RRM1), formed aggregates in cultured cells, and that similar phenotypes were obtained when the RNP2 motif was either deleted from or mutated in full-length TDP-43. These aggregations were ubiquitinated, phosphorylated and truncated, and sequestered the 25 kDa C-terminal TDP-43 fragment seen in the neurons of TDP-43 proteinopathy patients. In addition, incubation with RNase decreased the solubility of TDP-43 in cell lysates. These findings suggest that the RNP2 motif of RRM1 plays a substantial role in pathological TDP-43 modifications and that it is possible that disruption of RNA binding may underlie the process of TDP-43 aggregation.

    DOI: 10.1371/journal.pone.0066966

    PubMed

    researchmap

  • [Genetic background of corticobasal syndrome]. 査読

    Hiroshi Doi, Fumiaki Tanaka

    Rinsho shinkeigaku = Clinical neurology   53 ( 11 )   1026 - 8   2013年

     詳細を見る

    記述言語:日本語   掲載種別:研究論文(学術雑誌)  

    Corticobasal syndrome (CBS) is associated with different pathologies including FTLD-tau (corticobasal degeneration; CBD, progressive supranuclear palsy, and Pick disease), FTLD-TDP, Alzheimer disease, Creutzfeldt-Jakob disease, and Parkinson disease/dementia with Lewy bodies. Genetic causes of CBS are also various reflecting diverse pathology. In familial and sporadic FTLD, MAPT, GRN and C9ORF72 mutations are three major causes of the disease. A part of patients harboring these mutations could exhibit CBS. In addition, the patients with TARDBP, FUS, LRRK2 or CSF1R mutations also have potential to exhibit CBS. In sporadic cases, H1 haplotype of MAPT is known to be associated with FTLD-tau, including CBS/CBD. Despite major advances in recent years, the majority of familial and sporadic CBS cases are genetically unsolved. In particular, little is known about both familial and sporadic cases of CBS in Japanese. Further studies are needed to unveil the genetic background of CBS.

    DOI: 10.5692/clinicalneurol.53.1026

    PubMed

    J-GLOBAL

    researchmap

  • [A case of IgM paraproteinemic neuropathy associated with anti-sulfated glucuronic paragloboside (SGPG) IgG antibody without anti-myelin-associated glycoprotein (MAG) activity]. 査読

    Haruko Nakamura, Masanao Endo, Eriko Sugawara, Motoi Kuwahara, Susumu Kusunoki, Fumiaki Tanaka, Tatsuya Takahashi

    Rinsho shinkeigaku = Clinical neurology   53 ( 10 )   799 - 802   2013年

     詳細を見る

    記述言語:日本語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Societas Neurologica Japonica  

    We report a case of IgM paraproteinemic neuropathy associated with anti-sulfated glucuronic paragloboside (SGPG) IgG antibody. An 84-year old man complained of numbness on the left side of the face and in the distal portions of the limbs. Neurological examination showed mild sensory ataxia. The laboratory tests revealed the presence of IgM lambda paraproteinemia and anti-SGPG IgG antibody without anti-myelin-associated glycoprotein (MAG) activity and anti-MAG/SGPG IgM antibody. Results of nerve conduction study showed decreased sensory nerve action potential (SNAP) amplitude, indicating the presence of sensory-dominant axonal polyneuropathy, and the prolongation of distal latency was not observed. Treatment with corticosteroids resulted in a rapid improvement in neurological abnormalities. In IgM paraproteinemic neuropathy associated with anti-MAG/SGPG antibody, distal acquired demyelinating sensory neuropathy and resistance to immunological treatments are the characteristic pathologic and clinical features, respectively. On the other hand our rare case of IgM paraproteinemic neuropathy positive for anti-SGPG IgG antibody presented with axonal sensory polyneuropathy and a good responsiveness to corticosteroids.

    DOI: 10.5692/clinicalneurol.53.799

    Scopus

    PubMed

    J-GLOBAL

    researchmap

  • Ablation of keratan sulfate accelerates early phase pathogenesis of ALS. 査読 国際誌

    Kenichi Hirano, Tomohiro Ohgomori, Kazuyoshi Kobayashi, Fumiaki Tanaka, Tomohiro Matsumoto, Takamitsu Natori, Yukihiro Matsuyama, Kenji Uchimura, Kazuma Sakamoto, Hideyuki Takeuchi, Akihiro Hirakawa, Akio Suzumura, Gen Sobue, Naoki Ishiguro, Shiro Imagama, Kenji Kadomatsu

    PloS one   8 ( 6 )   e66969   2013年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Biopolymers consist of three major classes, i.e., polynucleotides (DNA, RNA), polypeptides (proteins) and polysaccharides (sugar chains). It is widely accepted that polynucleotides and polypeptides play fundamental roles in the pathogenesis of neurodegenerative diseases. But, sugar chains have been poorly studied in this process, and their biological/clinical significance remains largely unexplored. Amyotrophic lateral sclerosis (ALS) is a motoneuron-degenerative disease, the pathogenesis of which requires both cell autonomous and non-cell autonomous processes. Here, we investigated the role of keratan sulfate (KS), a sulfated long sugar chain of proteoglycan, in ALS pathogenesis. We employed ALS model SOD1(G93A) mice and GlcNAc6ST-1(-/-) mice, which are KS-deficient in the central nervous system. Unexpectedly, SOD1(G93A)GlcNAc6ST-1(-/-) mice exhibited a significantly shorter lifespan than SOD1(G93A) mice and an accelerated appearance of clinical symptoms (body weight loss and decreased rotarod performance). KS expression was induced exclusively in a subpopulation of microglia in SOD1(G93A) mice, and became detectable around motoneurons in the ventral horn during the early disease phase before body weight loss. During this phase, the expression of M2 microglia markers was transiently enhanced in SOD1(G93A) mice, while this enhancement was attenuated in SOD1(G93A)GlcNAc6ST-1(-/-) mice. Consistent with this, M2 microglia were markedly less during the early disease phase in SOD1(G93A)GlcNAc6ST-1(-/-) mice. Moreover, KS expression in microglia was also detected in some human ALS cases. This study suggests that KS plays an indispensable, suppressive role in the early phase pathogenesis of ALS and may represent a new target for therapeutic intervention.

    DOI: 10.1371/journal.pone.0066969

    PubMed

    researchmap

  • dnc-1/dynactin 1 knockdown disrupts transport of autophagosomes and induces motor neuron degeneration. 査読 国際誌

    Kensuke Ikenaka, Kaori Kawai, Masahisa Katsuno, Zhe Huang, Yue-Mei Jiang, Yohei Iguchi, Kyogo Kobayashi, Tsubasa Kimata, Masahiro Waza, Fumiaki Tanaka, Ikue Mori, Gen Sobue

    PloS one   8 ( 2 )   e54511   2013年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterized by the progressive loss of motor neurons. We previously showed that the expression of dynactin 1, an axon motor protein regulating retrograde transport, is markedly reduced in spinal motor neurons of sporadic ALS patients, although the mechanisms by which decreased dynactin 1 levels cause neurodegeneration have yet to be elucidated. The accumulation of autophagosomes in degenerated motor neurons is another key pathological feature of sporadic ALS. Since autophagosomes are cargo of dynein/dynactin complexes and play a crucial role in the turnover of several organelles and proteins, we hypothesized that the quantitative loss of dynactin 1 disrupts the transport of autophagosomes and induces the degeneration of motor neuron. In the present study, we generated a Caenorhabditis elegans model in which the expression of DNC-1, the homolog of dynactin 1, is specifically knocked down in motor neurons. This model exhibited severe motor defects together with axonal and neuronal degeneration. We also observed impaired movement and increased number of autophagosomes in the degenerated neurons. Furthermore, the combination of rapamycin, an activator of autophagy, and trichostatin which facilitates axonal transport dramatically ameliorated the motor phenotype and axonal degeneration of this model. Thus, our results suggest that decreased expression of dynactin 1 induces motor neuron degeneration and that the transport of autophagosomes is a novel and substantial therapeutic target for motor neuron degeneration.

    DOI: 10.1371/journal.pone.0054511

    PubMed

    researchmap

  • Demographic features of Japanese patients with sporadic inclusion body myositis: a single-center referral experience. 査読

    Hirotaka Nakanishi, Haruki Koike, Koji Matsuo, Fumiaki Tanaka, Tomoko Noda, Akifumi Fujikake, Seigo Kimura, Masahisa Katsuno, Manabu Doyu, Hirohisa Watanabe, Gen Sobue

    Internal medicine (Tokyo, Japan)   52 ( 3 )   333 - 7   2013年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    OBJECTIVE: The incidence of sporadic inclusion body myositis (sIBM) in the Japanese population has increased, and some researchers have suggested that race and genetic background may influence the clinical features of the disease. The aim of this study was to clarify the demographic features of Japanese patients with sIBM. METHODS: We retrospectively evaluated the demographic features of consecutive patients who were referred to our institution between 1995 and 2011 for diagnostic muscle biopsies and who subsequently were diagnosed to have sIBM. RESULTS: Seventy-three patients comprising 54 men and 19 women received a diagnosis of sIBM during the study period. The patients were divided into two groups based on the date of diagnosis (before and including 2002, and after 2002). The annual number of patients who received a diagnosis of sIBM increased significantly from 3.6±1.6 (mean ± SD) before and including 2002 to 4.9±3.1 (mean ± SD) after 2002 (p<0.05), whereas the annual number of patients who received a diagnosis of polymyositis (PM) or dermatomyositis (DM) remained consistent from 1995 to 2011. The ratio of PM and DM to sIBM was 7.6 during the period from 1995 to 2002 and 5.5 during the period from 2003 to 2011. However, the age-adjusted annual number of patients newly diagnosed with sIBM did not increase significantly after 2002. CONCLUSION: The number of Japanese patients with sIBM appears to have increased in recent years; however, the characteristics of the patients have not changed. Considering the increased size of the elderly population, prolonged lifespans could explain the demographic movement of sIBM in Japan.

    DOI: 10.2169/internalmedicine.52.8910

    PubMed

    researchmap

  • Identification of a novel homozygous SPG7 mutation in a Japanese patient with spastic ataxia: making an efficient diagnosis using exome sequencing for autosomal recessive cerebellar ataxia and spastic paraplegia. 査読

    Hiroshi Doi, Chihiro Ohba, Yoshinori Tsurusaki, Satoko Miyatake, Noriko Miyake, Hirotomo Saitsu, Yuko Kawamoto, Tamaki Yoshida, Shigeru Koyano, Yume Suzuki, Yoshiyuki Kuroiwa, Fumiaki Tanaka, Naomichi Matsumoto

    Internal medicine (Tokyo, Japan)   52 ( 14 )   1629 - 33   2013年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Autosomal recessive cerebellar ataxias and autosomal recessive hereditary spastic paraplegias are clinically and genetically heterogeneous disorders with diverse neurological and non-neurological features. We herein describe a Japanese patient with a slowly progressive form of ataxia and spastic paraplegia. Using whole exome sequencing, we identified a novel homozygous frameshift mutation in SPG7, encoding paraplegin, in this patient. This is the first report of an SPG7 mutation in the Japanese population. For disorders previously undetected in a particular population, or unrecognized/atypical phenotypes, exome sequencing may facilitate molecular diagnosis.

    DOI: 10.2169/internalmedicine.52.0252

    PubMed

    researchmap

  • Heat shock factor-1 influences pathological lesion distribution of polyglutamine-induced neurodegeneration. 査読 国際誌

    Naohide Kondo, Masahisa Katsuno, Hiroaki Adachi, Makoto Minamiyama, Hideki Doi, Shinjiro Matsumoto, Yu Miyazaki, Madoka Iida, Genki Tohnai, Hideaki Nakatsuji, Shinsuke Ishigaki, Yusuke Fujioka, Hirohisa Watanabe, Fumiaki Tanaka, Akira Nakai, Gen Sobue

    Nature communications   4   1405 - 1405   2013年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    A crucial feature of adult-onset neurodegenerative diseases is accumulation of abnormal protein in specific brain regions, although the mechanism underlying this pathological selectivity remains unclear. Heat shock factor-1 is a transcriptional regulator of heat shock proteins, molecular chaperones that abrogate neurodegeneration by refolding and solubilizing pathogenic proteins. Here we show that heat shock factor-1 expression levels are associated with the accumulation of pathogenic androgen receptor in spinal and bulbar muscular atrophy, a polyglutamine-induced neurodegenerative disease. In heterozygous heat shock factor-1-knockout spinal and bulbar muscular atrophy mice, abnormal androgen receptor accumulates in the cerebral visual cortex, liver and pituitary, which are not affected in their genetically unmodified counterparts. The depletion of heat shock factor-1 also expands the distribution of pathogenic androgen receptor accumulation in other neuronal regions. Furthermore, lentiviral-mediated delivery of heat shock factor-1 into the brain of spinal and bulbar muscular atrophy mice topically suppresses the pathogenic androgen receptor accumulation and neuronal atrophy. These results suggest that heat shock factor-1 influences the pathological lesion selectivity in spinal and bulbar muscular atrophy.

    DOI: 10.1038/ncomms2417

    PubMed

    researchmap

  • 球脊髄性筋萎縮症に対する疾患特異的機能評価スケール(SBMAFRS)の開発と信頼性・妥当性評価

    真野 智生, 勝野 雅央, 坂野 晴彦, 鈴木 啓介, 須賀 徳明, 橋詰 淳, 田中 章景, 祖父江 元

    臨床神経学   52 ( 12 )   1604 - 1604   2012年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • Pathogenesis and therapy of spinal and bulbar muscular atrophy (SBMA). 査読 国際誌

    Masahisa Katsuno, Fumiaki Tanaka, Hiroaki Adachi, Haruhiko Banno, Keisuke Suzuki, Hirohisa Watanabe, Gen Sobue

    Progress in neurobiology   99 ( 3 )   246 - 56   2012年12月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:PERGAMON-ELSEVIER SCIENCE LTD  

    Spinal and bulbar muscular atrophy (SBMA) is a late-onset motor neuron disease characterized by slowly progressive muscle weakness and atrophy. During the last two decades, basic and clinical research has provided important insights into the disease phenotype and pathophysiology. The cause of SBMA is the expansion of a trinucleotide CAG repeat encoding a polyglutamine tract within the first exon of the androgen receptor (AR) gene. SBMA exclusively affects adult males, whereas females homozygous for the AR mutation do not manifest neurological symptoms. The ligand-dependent nuclear accumulation of the polyglutamine-expanded AR protein is central to the gender-specific pathogenesis of SBMA, although additional steps, e.g., DNA binding, inter-domain interactions, and post-translational modification of AR, modify toxicity. The interactions with co-regulators are another requisite for the toxic properties of the polyglutamine-expanded AR. It is also shown that the polyglutamine-expanded AR induces diverse molecular events, such as transcriptional dysregulation, axonal transport disruption, and mitochondrial dysfunction, which play causative roles in the neurodegeneration in SBMA. The pathogenic AR-induced myopathy also contributes to the non-cell autonomous degeneration of motor neurons. Pre-clinical studies using animal models show that the pathogenic AR-mediated neurodegeneration is suppressed by androgen inactivation, the efficacy of which has been tested in clinical trials. Pharmacological activation of cellular defense machineries, such as molecular chaperones, ubiquitin-proteasome system, and autophagy, also exerts neuroprotective effects in experimental models of SBMA.

    DOI: 10.1016/j.pneurobio.2012.05.007

    Web of Science

    PubMed

    researchmap

  • microRNA-181a is associated with poor prognosis of colorectal cancer. 査読

    Nishimura J, Handa R, Yamamoto H, Tanaka F, Shibata K, Mimori K, Takemasa I, Mizushima T, Ikeda M, Sekimoto M, Ishii H, Doki Y, Mori M

    Oncology reports   28 ( 6 )   2221 - 2226   2012年12月

  • Downregulation of miR-144 is associated with colorectal cancer progression via activation of mTOR signaling pathway. 査読 国際誌

    Iwaya T, Yokobori T, Nishida N, Kogo R, Sudo T, Tanaka F, Shibata K, Sawada G, Takahashi Y, Ishibashi M, Wakabayashi G, Mori M, Mimori K

    Carcinogenesis   33 ( 12 )   2391 - 2397   2012年12月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.1093/carcin/bgs288

    PubMed

    researchmap

  • 球脊髄性筋萎縮症の自然歴の検討(3年間の前向き研究)

    橋詰 淳, 勝野 雅央, 坂野 晴彦, 鈴木 啓介, 須賀 徳明, 眞野 智生, 田中 章景, 祖父江 元

    臨床神経学   52 ( 12 )   1514 - 1514   2012年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • リュープロレリン酢酸塩の球脊髄性筋萎縮症患者に対する第3相長期継続投与試験(JASMITT-07OP試験)

    鈴木 啓介, 勝野 雅央, 坂野 晴彦, 須賀 徳明, 橋詰 淳, 矢部 一郎, 青木 正志, 中野 今治, 金井 数明, 水澤 英洋, 山本 知孝, 長谷川 一子, 西澤 正豊, 宮嶋 裕明, 苅田 典生, 中島 健二, 辻野 彰, 内野 誠, 田中 章景, 祖父江 元

    臨床神経学   52 ( 12 )   1484 - 1484   2012年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 我が国のALS患者に対する換気補助療法の現状と予後 JaCALSの解析から

    渡辺 はづき, 熱田 直樹, 中村 亮一, 渡辺 宏久, 伊藤 瑞規, 千田 譲, 田中 章景, 梶 龍兒, 和泉 唯信, 森田 光哉, 青木 正志, 溝口 功一, 谷口 彰, 岡本 幸市, 饗場 郁子, 川田 明広, 長谷川 一子, 大垣 光太郎, 中野 今治, 祖父江 元

    臨床神経学   52 ( 12 )   1605 - 1605   2012年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • アカデミア発の創薬 球脊髄性筋萎縮症(SBMA)に対する抗アンドロゲン療法

    勝野 雅央, 坂野 晴彦, 鈴木 啓介, 橋詰 淳, 足立 弘明, 田中 章景, 祖父江 元

    臨床神経学   52 ( 11 )   1207 - 1209   2012年11月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    球脊髄性筋萎縮症(SBMA)はアンドロゲン受容体(AR)遺伝子におけるCAGくりかえし塩基配列の異常延長を原因とする運動ニューロン疾患であり,伸長ポリグルタミン鎖を有する異常AR蛋白質がテストステロンと結合することによってニューロンの核内に蓄積することが病態の本質と考えられている.テストステロンの分泌を抑制するリュープロレリン酢酸塩のSBMAに対する第III相臨床試験では,主要評価項目である咽頭部バリウム残留率について,被験者全体の解析では統計学的有意差はみとめられなかったが,罹病期間が10年以内の被験者のみを対象としたサブ解析では残留率が酢酸リュープロレリン群で有意に低下したことから,発症からの期間が薬効に影響をおよぼすことが示唆された.早期の治療介入や鋭敏なエンドポイントの開発が今後のトランスレーショナルリサーチに重要であると考えられる.(著者抄録)

    researchmap

    その他リンク: https://search.jamas.or.jp/index.php?module=Default&action=Link&pub_year=2012&ichushi_jid=J01550&link_issn=&doc_id=20121213290135&doc_link_id=10.5692%2Fclinicalneurol.52.1207&url=https%3A%2F%2Fdoi.org%2F10.5692%2Fclinicalneurol.52.1207&type=J-STAGE&icon=https%3A%2F%2Fjk04.jamas.or.jp%2Ficon%2F00007_3.gif

  • Cross-sectional and longitudinal analysis of an oxidative stress biomarker for spinal and bulbar muscular atrophy. 査読 国際誌

    Tomoo Mano, Masahisa Katsuno, Haruhiko Banno, Keisuke Suzuki, Noriaki Suga, Atsushi Hashizume, Fumiaki Tanaka, Gen Sobue

    Muscle & nerve   46 ( 5 )   692 - 7   2012年11月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:WILEY-BLACKWELL  

    INTRODUCTION: Spinal and bulbar muscular atrophy (SBMA) is an adult-onset motor neuron disease caused by a CAG repeat expansion in the androgen receptor gene. The aim of this study was to verify whether urinary 8-hydroxydeoxyguanosine (8-OHdG), an oxidative stress marker, is a biomarker for SBMA. METHODS: We measured the levels of urinary 8-OHdG in 33 genetically confirmed SBMA patients and 32 age-matched controls over a 24-month period at 6-month intervals. RESULTS: Urinary 8-OHdG levels in SBMA patients were significantly elevated compared with those of controls and correlated well with motor function scores. During the follow-up period, urinary 8-OHdG levels increased and correlated with motor function at each time-point. In addition, urinary 8-OHdG levels at baseline were correlated with changes in the 6-minute walk test during 24 months. CONCLUSIONS: Urinary 8-OHdG is a biomarker for SBMA, reflecting the severity and possibly predicting the deterioration of motor function.

    DOI: 10.1002/mus.23413

    Web of Science

    PubMed

    researchmap

  • Naratriptan mitigates CGRP1-associated motor neuron degeneration caused by an expanded polyglutamine repeat tract. 査読 国際誌

    Makoto Minamiyama, Masahisa Katsuno, Hiroaki Adachi, Hideki Doi, Naohide Kondo, Madoka Iida, Shinsuke Ishigaki, Yusuke Fujioka, Shinjiro Matsumoto, Yu Miyazaki, Fumiaki Tanaka, Hiroki Kurihara, Gen Sobue

    Nature medicine   18 ( 10 )   1531 - 8   2012年10月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:NATURE PUBLISHING GROUP  

    Spinal and bulbar muscular atrophy (SBMA) is a motor neuron disease caused by the expansion of the CAG triplet repeat within the androgen receptor (AR) gene. Here, we demonstrated that pathogenic AR upregulates the gene encoding calcitonin gene-related peptide α (CGRP1). In neuronal cells, overexpression of CGRP1 induced cellular damage via the activation of the c-Jun N-terminal kinase (JNK) pathway, whereas pharmacological suppression of CGRP1 or JNK attenuated the neurotoxic effects of pathogenic AR. The depletion of CGRP1 inactivated JNK and suppressed neurodegeneration in a mouse model of SBMA. Naratriptan, a serotonin 1B/1D (5-hydroxytryptamine 1B/1D, or 5-HT1B/1D) receptor agonist, decreased CGRP1 expression via the induction of dual-specificity protein phosphatase 1 (DUSP1), attenuated JNK activity and mitigated pathogenic AR-mediated neuronal damage in cellular and mouse SBMA models. These observations suggest that pharmacological activation of the 5-HT1B/1D receptor may be used therapeutically to treat SBMA and other polyglutamine-related neurodegenerative diseases.

    DOI: 10.1038/nm.2932

    Web of Science

    PubMed

    researchmap

  • [109th Scientific Meeting of the Japanese Society of Internal Medicine: symposium: 2. Translational research and evidence-based medicine (EBM) in internal medicine in Japan, translational research; 1) Translational research on neurodegenerative diseases]. 査読

    Masahisa Katsuno, Haruhiko Banno, Keisuke Suzuki, Atsushi Hashizume, Hiroaki Adachi, Fumiaki Tanaka, Gen Sobue

    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine   101 ( 9 )   2533 - 8   2012年9月

     詳細を見る

    記述言語:日本語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.2169/naika.101.2533

    PubMed

    researchmap

  • Longitudinal changes of outcome measures in spinal and bulbar muscular atrophy. 査読 国際誌

    Atsushi Hashizume, Masahisa Katsuno, Haruhiko Banno, Keisuke Suzuki, Noriaki Suga, Tomoo Mano, Naoki Atsuta, Hiroaki Oe, Hirohisa Watanabe, Fumiaki Tanaka, Gen Sobue

    Brain : a journal of neurology   135 ( Pt 9 )   2838 - 48   2012年9月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:OXFORD UNIV PRESS  

    Spinal and bulbar muscular atrophy is an adult-onset, hereditary motor neuron disease caused by the expansion of a trinucleotide CAG repeat within the gene encoding the androgen receptor. To date, several agents have been shown to prevent or slow disease progression in animal models of this disease. For the translational research of these agents, it is necessary to perform the detailed analysis of natural history with quantitative outcome measures and to establish sensitive and validated disease-specific endpoints in the clinical trials. To this end, we performed a prospective observation of disease progression over 3 years in 34 genetically confirmed Japanese patients with spinal and bulbar muscular atrophy by using quantitative outcome measures, including functional and blood parameters. The baseline evaluation revealed that CAG repeat length in the androgen receptor gene correlated not only with the age of onset but also with the timing of substantial changes in activity of daily living. Multiple regression analyses indicated that the serum level of creatinine is the most useful blood parameter that reflects the severity of motor dysfunction in spinal and bulbar muscular atrophy. In 3-year prospective analyses, a slow but steady progression was affirmed in most of the outcome measures we examined. In the analyses using random coefficient models that summarize the individual data into a representative line, disease progression was not affected by CAG repeat length or onset age. These models showed large interindividual variation, which was also independent of the differences of CAG repeat size. Analyses using these models also demonstrated that the subtle neurological deficits at an early or preclinical stage were more likely to be detected by objective motor functional tests such as the 6-min walk test and grip power or serum creatinine levels than by functional rating scales, such as the revised amyotrophic lateral sclerosis functional rating scale or modified Norris scale. Categorization of the clinical phenotypes using factor analysis showed that upper limb function is closely related to bulbar function, but not to lower limb function at baseline, whereas the site of onset had no substantial effects on disease progression. These results suggest that patients with spinal and bulbar muscular atrophy show a slow but steady progression of motor dysfunction over time that is independent of CAG repeat length or clinical phenotype, and that objective outcome measures may be used to evaluate disease severity at an early stage of this disease.

    DOI: 10.1093/brain/aws170

    Web of Science

    PubMed

    researchmap

  • MicroRNA-10b is a prognostic indicator in colorectal cancer and confers resistance to the chemotherapeutic agent 5-fluorouracil in colorectal cancer cells. 査読 国際誌

    Nishida N, Yamashita S, Mimori K, Sudo T, Tanaka F, Shibata K, Yamamoto H, Ishii H, Doki Y, Mori M

    Annals of surgical oncology   19 ( 9 )   3065 - 3071   2012年9月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.1245/s10434-012-2246-1

    PubMed

    researchmap

  • MRI mean diffusivity detects widespread brain degeneration in multiple sclerosis. 査読 国際誌

    Joe Senda, Hirohisa Watanabe, Takashi Tsuboi, Kazuhiro Hara, Hazuki Watanabe, Ryoichi Nakamura, Mizuki Ito, Naoki Atsuta, Fumiaki Tanaka, Shinji Naganawa, Gen Sobue

    Journal of the neurological sciences   319 ( 1-2 )   105 - 10   2012年8月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:ELSEVIER SCIENCE BV  

    We investigated the magnetic resonance imaging (MRI) findings of 32 multiple sclerosis (MS) patients using voxel-based morphometry (VBM) and voxel-based analysis of white matter fluid-attenuated inversion recovery image (FLAIR) high-intensity lesions and diffusion tensor imaging (DTI). Compared with 18 healthy controls, MS patients showed gray matter volume reduction in the thalamus, hypothalamus, caudate, limbic lobe, and frontal lobe. A marked volume reduction of white matter was evident along the ventriculus lateralis and corpus callosum. FLAIR high-intensity lesions were observed beside the ventriculus lateralis. DTI revealed reduced fractional anisotropy areas similar to those of the FLAIR high-intensity lesions. Changes in the volume of increased mean diffusivity (MD) were the most widespread and extended to normal-appearing white matter (p<0.001). Multiple regression analysis revealed that MD values were significantly correlated with both disease duration (r=0.381, p=0.032) and expanded disability status scale scores (EDSS) (r=0.393, p=0.026). This study demonstrated that combined voxel-based analysis for volumetry, FLAIR high-intensity lesions, and DTI could reveal widespread brain abnormalities in MS patients. Furthermore, DTI, especially MD, showed far more widespread brain degeneration than other MRI parameters, and was significantly correlated with both severity and disease duration.

    DOI: 10.1016/j.jns.2012.04.019

    Web of Science

    PubMed

    researchmap

  • Differential, size-dependent sensory neuron involvement in the painful and ataxic forms of primary Sjögren's syndrome-associated neuropathy. 査読 国際誌

    Kawagashira Y, Koike H, Fujioka Y, Hashimoto R, Tomita M, Morozumi S, Iijima M, Katsuno M, Tanaka F, Sobue G

    Journal of the neurological sciences   319 ( 1-2 )   139 - 46   2012年8月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.1016/j.jns.2012.05.022

    Web of Science

    PubMed

    researchmap

  • Neuropathology and omics in motor neuron diseases. 査読 国際誌

    Fumiaki Tanaka, Kensuke Ikenaka, Masahiko Yamamoto, Gen Sobue

    Neuropathology : official journal of the Japanese Society of Neuropathology   32 ( 4 )   458 - 62   2012年8月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:WILEY-BLACKWELL  

    Motor neuron diseases, including amyotrophic lateral sclerosis (ALS), are devastating disorders and effective therapies have not yet been established. One of the reasons for this lack of therapeutics, especially in sporadic ALS (SALS), is attributed to the absence of excellent disease models reflecting its pathology. For this purpose, identifying important key molecules for ALS pathomechanisms and developing disease models is crucial, and omics approaches, including genomics, transcriptomics and proteomics, have been employed. In particular, transcriptome analysis using cDNA microarray is the most popular omics approach and we have previously identified dynactin-1 as an important molecule downregulated in the motor neurons of SALS patients from the early stage of the disease. Dynactin-1 is also known as a causative gene in familial ALS (FALS). Dynactin-1 is a major component of the dynein/dynactin motor protein complex functioning in retrograde axonal transport. In motor neuron diseases as well as other neurodegenerative diseases, the role of axonal transport dysfunction in their pathogenesis always draws attention, but its precise mechanisms remain to be fully elucidated. In this article, we review our previous omics approach to SALS and the role of dynactin-1 in the pathogenesis of ALS. Finally, we emphasize the need for creating novel SALS disease models based on the results of omics analysis, especially based on the observation that dynactin-1 gene expression was downregulated in SALS motor neurons.

    DOI: 10.1111/j.1440-1789.2011.01281.x

    Web of Science

    PubMed

    researchmap

  • Copy number loss of FBXW7 is related to gene expression and poor prognosis in esophageal squamous cell carcinoma. 査読 国際誌

    Yokobori T, Mimori K, Iwatsuki M, Ishii H, Tanaka F, Sato T, Toh H, Sudo T, Iwaya T, Tanaka Y, Onoyama I, Kuwano H, Nakayama KI, Mori M

    International journal of oncology   41 ( 1 )   253 - 259   2012年7月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.3892/ijo.2012.1436

    PubMed

    researchmap

  • Viral delivery of miR-196a ameliorates the SBMA phenotype via the silencing of CELF2. 査読 国際誌

    Yu Miyazaki, Hiroaki Adachi, Masahisa Katsuno, Makoto Minamiyama, Yue-Mei Jiang, Zhe Huang, Hideki Doi, Shinjiro Matsumoto, Naohide Kondo, Madoka Iida, Genki Tohnai, Fumiaki Tanaka, Shin-ichi Muramatsu, Gen Sobue

    Nature medicine   18 ( 7 )   1136 - 41   2012年7月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:NATURE PUBLISHING GROUP  

    Spinal and bulbar muscular atrophy (SBMA) is an inherited neurodegenerative disorder caused by the expansion of the polyglutamine (polyQ) tract of the androgen receptor (AR-polyQ). Characteristics of SBMA include proximal muscular atrophy, weakness, contraction fasciculation and bulbar involvement. MicroRNAs (miRNAs) are a diverse class of highly conserved small RNA molecules that function as crucial regulators of gene expression in animals and plants. Recent functional studies have shown the potent activity of specific miRNAs as disease modifiers both in vitro and in vivo. Thus, potential therapeutic approaches that target the miRNA processing pathway have recently attracted attention. Here we describe a novel therapeutic approach using the adeno-associated virus (AAV) vector–mediated delivery of a specific miRNA for SBMA. We found that miR-196a enhanced the decay of the AR mRNA by silencing CUGBP, Elav-like family member 2 (CELF2). CELF2 directly acted on AR mRNA and enhanced the stability of AR mRNA. Furthermore, we found that the early intervention of miR-196a delivered by an AAV vector ameliorated the SBMA phenotypes in a mouse model. Our results establish the proof of principle that disease-specific miRNA delivery could be useful in neurodegenerative diseases.

    DOI: 10.1038/nm.2791

    Web of Science

    PubMed

    researchmap

  • Pathogenesis and molecular targeted therapy of spinal and bulbar muscular atrophy (SBMA). 査読 国際誌

    Haruhiko Banno, Masahisa Katsuno, Keisuke Suzuki, Fumiaki Tanaka, Gen Sobue

    Cell and tissue research   349 ( 1 )   313 - 20   2012年7月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:SPRINGER  

    Spinal and bulbar muscular atrophy (SBMA), also known as Kennedy's disease, is an adult-onset, X-linked motor neuron disease characterized by muscle atrophy, weakness, contraction fasciculations, and bulbar involvement. SBMA is caused by the expansion of a CAG triplet repeat, encoding a polyglutamine tract within the first exon of the androgen receptor (AR) gene. The histopathological finding in SBMA is the loss of lower motor neurons in the anterior horn of the spinal cord as well as in the brainstem motor nuclei. There is no established disease-modifying therapy for SBMA. Animal studies have revealed that the pathogenesis of SBMA depends on the level of serum testosterone, and that androgen deprivation mitigates neurodegeneration through inhibition of nuclear accumulation and/or stabilization of the pathogenic AR. Heat shock proteins, the ubiquitin-proteasome system and transcriptional regulation are also potential targets for development of therapy for SBMA. Among these therapeutic approaches, the luteinizing hormone-releasing hormone analogue, leuprorelin, prevents nuclear translocation of aberrant AR proteins, resulting in a significant improvement of disease phenotype in a mouse model of SBMA. In a phase 2 clinical trial of leuprorelin, the patients treated with this drug exhibited decreased mutant AR accumulation in scrotal skin biopsy. Phase 3 clinical trial showed the possibility that leuprorelin treatment is associated with improved swallowing function particularly in patients with a disease duration less than 10 years. These observations suggest that pharmacological inhibition of the toxic accumulation of mutant AR is a potential therapy for SBMA.

    DOI: 10.1007/s00441-012-1377-9

    Web of Science

    PubMed

    researchmap

  • Microarray analysis of colorectal cancer stromal tissue reveals upregulation of two oncogenic miRNA clusters. 査読 国際誌

    Nishida N, Nagahara M, Sato T, Mimori K, Sudo T, Tanaka F, Shibata K, Ishii H, Sugihara K, Doki Y, Mori M

    Clinical cancer research : an official journal of the American Association for Cancer Research   18 ( 11 )   3054 - 3070   2012年6月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.1158/1078-0432.CCR-11-1078

    PubMed

    researchmap

  • Down-regulation of miR-125a-3p in human gastric cancer and its clinicopathological significance. 査読 国際誌

    Hashiguchi Y, Nishida N, Mimori K, Sudo T, Tanaka F, Shibata K, Ishii H, Mochizuki H, Hase K, Doki Y, Mori M

    International journal of oncology   40 ( 5 )   1477 - 1482   2012年5月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.3892/ijo.2012.1363

    PubMed

    researchmap

  • Absence of CD71 transferrin receptor characterizes human gastric adenosquamous carcinoma stem cells. 査読 国際誌

    Ohkuma M, Haraguchi N, Ishii H, Mimori K, Tanaka F, Kim HM, Shimomura M, Hirose H, Yanaga K, Mori M

    Annals of surgical oncology   19 ( 4 )   1357 - 1364   2012年4月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.1245/s10434-011-1739-7

    PubMed

    researchmap

  • Molecular pathophysiology and disease-modifying therapies for spinal and bulbar muscular atrophy. 査読 国際誌

    Masahisa Katsuno, Haruhiko Banno, Keisuke Suzuki, Hiroaki Adachi, Fumiaki Tanaka, Gen Sobue

    Archives of neurology   69 ( 4 )   436 - 40   2012年4月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:AMER MEDICAL ASSOC  

    Spinal and bulbar muscular atrophy (SBMA), or Kennedy disease, is an adult-onset lower motor neuron disease characterized by slowly progressive muscle weakness and atrophy. The disease is caused by the expansion of a trinucleotide CAG repeat encoding a polyglutamine tract within the first exon of the androgen receptor (AR) gene. During the 2 decades since the discovery of the AR gene mutation in SBMA, basic and clinical research have deepened our understanding of the disease phenotype and pathophysiology. Spinal and bulbar muscular atrophy exclusively affects men, whereas women homozygous for the AR mutation do not fully develop the disease. The ligand-dependent nuclear accumulation of pathogenic AR protein is central to the pathogenesis, although additional steps, eg, DNA binding and interdomain interactions of AR, are required for toxicity. Downstream molecular events, eg, transcriptional dysregulation, axonal transport disruption, and mitochondrial dysfunction, are implicated in the neurodegeneration in SBMA. Pathogenic AR-induced myopathy also contributes to the degeneration of motor neurons. Several potential therapies, including hormonal manipulation, have emerged from animal studies, some of which have been tested in clinical trials.

    DOI: 10.1001/archneurol.2011.2308

    Web of Science

    PubMed

    researchmap

  • Difference in chronological changes of outcome measures between untreated and placebo-treated patients of spinal and bulbar muscular atrophy. 査読 国際誌

    Atsushi Hashizume, Masahisa Katsuno, Haruhiko Banno, Keisuke Suzuki, Noriaki Suga, Fumiaki Tanaka, Gen Sobue

    Journal of neurology   259 ( 4 )   712 - 9   2012年4月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:SPRINGER HEIDELBERG  

    Spinal and bulbar muscular atrophy (SBMA) is an adult-onset, X-linked motor neuron disease characterized by muscle atrophy, weakness, and bulbar involvement. The aim of this study was to analyze the differential change of various outcome measures by comparing the progression of motor impairment in the two independent groups: placebo-treated group (PTG) and natural history group (NHG). For the PTG, we analyzed 99 patients who participated in a previous double-blind phase III clinical trial and received placebo. For the NHG, a total of 34 patients were followed with no specific treatment. The characteristics of both groups did not differ at baseline except for disease duration. Although the 6 min walk distance (6MWD) showed almost the same progression in both groups (-14.7 ± 7.3 m in NHG, -14.0 ± 4.7 m in PTG; NS), there was a significant difference of progression in the ALSFRS-R between the NHG and PTG (-1.18 ± 0.38, -0.14 ± 0.24; p = 0.03). A similar tendency was also seen in the subgroup analysis of the patients whose disease durations were less than 10 years. Although the relationship between the ALSFRS-R and 6MWD at week 48 was similar to that at baseline in the NHG, the slope of the regression at week 48 was significantly milder than at baseline in the PTG (p = 0.04). In conclusion, these two groups demonstrated a large difference in the chronological analysis of a motor function score, but showed similar changes in objective measures of walking capacity. These findings should be thoroughly considered when designing clinical trials for slowly progressive neurodegenerative diseases such as SBMA.

    DOI: 10.1007/s00415-011-6251-2

    Web of Science

    PubMed

    researchmap

  • [Disease-modifying therapy for spinal and bulbar muscular atrophy (SBMA)].

    Keisuke Suzuki, Haruhiko Banno, Masahisa Katsuno, Hiroaki Adachi, Fumiaki Tanaka, Gen Sobue

    Brain and nerve = Shinkei kenkyu no shinpo   64 ( 3 )   237 - 44   2012年3月

     詳細を見る

    記述言語:日本語   掲載種別:研究論文(学術雑誌)  

    Neurodegenerative diseases have long been construed as incurable disorders. However, therapeutic developments for these diseases are now facing a turning point, that is, analyses of cellular and animal models have provided insights into the pathogenesis of neurodegenerative diseases and have indicated rational therapeutic approaches. Spinal and bulbar muscular atrophy (SBMA) is an adult-onset motor neuron disease characterized by slowly progressive muscle weakness and atrophy. This disease is caused by the expansion of a trinucleotide CAG repeat within the androgen receptor (AR) gene. The results of animal studies suggest that testosterone-dependent nuclear accumulation of the pathogenic AR protein is a fundamental step in the neurodegenerative process. Androgen deprivation with a luteinizing hormone-releasing hormone (LHRH) analogue suppresses the toxicity of the mutant AR in animal models of SBMA. In a phase 3 trial, 48 weeks of treatment with leuprorelin acetate, an LHRH analogue, tended to improve swallowing function in a subgroup of SBMA patients with disease duration less than 10 years but did not significantly affect the total population. Disease duration might influence the efficacy of leuprorelin acetate, and therefore, a further clinical trial that involves sensitive outcome measures is in progress. Advances in basic and clinical research on SBMA are now paving the way for the clinical application of pathogenesis-targeting therapies. To optimize translational research related to the process of testing candidate therapies in humans, it is important to identify biomarkers that can be used as surrogate endpoints in clinical trials for neurodegenerative diseases.

    PubMed

    researchmap

  • Oxidative stress induced by glutathione depletion reproduces pathological modifications of TDP-43 linked to TDP-43 proteinopathies. 査読 国際誌

    Yohei Iguchi, Masahisa Katsuno, Shinnosuke Takagi, Shinsuke Ishigaki, Jun-ichi Niwa, Masato Hasegawa, Fumiaki Tanaka, Gen Sobue

    Neurobiology of disease   45 ( 3 )   862 - 70   2012年3月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:ACADEMIC PRESS INC ELSEVIER SCIENCE  

    TAR DNA-binding protein 43 (TDP-43) is a major component of ubiquitin-positive inclusion of TDP-43 proteinopathies including amyotrophic lateral sclerosis and frontotemporal lobar degeneration with ubiquitinated inclusions, which is now referred to as FTLD-TDP. TDP-43 in the aberrant inclusion is known to be hyperphosphorylated at C-terminal sites, to be truncated at the N-terminal region, and to re-distribute from nucleus to cytoplasm or neurite. The pathogenic role of these modifications, however, has not been clarified. Furthermore, there is no evidence about the initial cause of these modifications. Herein we show that ethacrynic acid (EA), which is able to increase cellular oxidative stress through glutathione depletion, induces TDP-43 C-terminal phosphorylation at serine 403/404 and 409/410, insolubilization, C-terminal fragmentation, and cytoplasmic distribution in NSC34 cells and primary cortical neurons. In the investigation using a nonphosphorylable mutant of TDP-43, there was no evidence that C-terminal phosphorylation of TDP-43 contributes to its solubility or distribution under EA induction. Our findings suggest that oxidative stress induced by glutathione depletion is associated with the process of the pathological TDP-43 modifications and provide new insight for TDP-43 proteinopathies.

    DOI: 10.1016/j.nbd.2011.12.002

    Web of Science

    PubMed

    researchmap

  • 【アカデミアから新規治療の実現へ-トランスレーショナルリサーチの現状】球脊髄性筋萎縮症の病態抑止治療 リュープロレリン酢酸塩

    鈴木 啓介, 坂野 晴彦, 勝野 雅央, 足立 弘明, 田中 章景, 祖父江 元

    BRAIN and NERVE: 神経研究の進歩   64 ( 3 )   237 - 244   2012年3月

  • [Disease-modifying therapy for spinal and bulbar muscular atrophy (SBMA)]. 査読

    Keisuke Suzuki, Haruhiko Banno, Masahisa Katsuno, Hiroaki Adachi, Fumiaki Tanaka, Gen Sobue

    Brain and nerve = Shinkei kenkyu no shinpo   64 ( 3 )   237 - 44   2012年3月

     詳細を見る

    記述言語:日本語   掲載種別:研究論文(学術雑誌)  

    Neurodegenerative diseases have long been construed as incurable disorders. However, therapeutic developments for these diseases are now facing a turning point, that is, analyses of cellular and animal models have provided insights into the pathogenesis of neurodegenerative diseases and have indicated rational therapeutic approaches. Spinal and bulbar muscular atrophy (SBMA) is an adult-onset motor neuron disease characterized by slowly progressive muscle weakness and atrophy. This disease is caused by the expansion of a trinucleotide CAG repeat within the androgen receptor (AR) gene. The results of animal studies suggest that testosterone-dependent nuclear accumulation of the pathogenic AR protein is a fundamental step in the neurodegenerative process. Androgen deprivation with a luteinizing hormone-releasing hormone (LHRH) analogue suppresses the toxicity of the mutant AR in animal models of SBMA. In a phase 3 trial, 48 weeks of treatment with leuprorelin acetate, an LHRH analogue, tended to improve swallowing function in a subgroup of SBMA patients with disease duration less than 10 years but did not significantly affect the total population. Disease duration might influence the efficacy of leuprorelin acetate, and therefore, a further clinical trial that involves sensitive outcome measures is in progress. Advances in basic and clinical research on SBMA are now paving the way for the clinical application of pathogenesis-targeting therapies. To optimize translational research related to the process of testing candidate therapies in humans, it is important to identify biomarkers that can be used as surrogate endpoints in clinical trials for neurodegenerative diseases.

    Scopus

    PubMed

    researchmap

  • Perspectives on molecular targeted therapies and clinical trials for neurodegenerative diseases. 査読 国際誌

    Masahisa Katsuno, Fumiaki Tanaka, Gen Sobue

    Journal of neurology, neurosurgery, and psychiatry   83 ( 3 )   329 - 35   2012年3月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:BMJ PUBLISHING GROUP  

    Recent advancements in neurobiology have provided increasing insights into the pathophysiology of neurodegenerative diseases, and opened doors to the development of molecular targeted therapies. Although many compounds showed positive results in animal studies, there is almost no drug for which the efficacy has been confirmed in clinical trials. This failure reflects a number of unsolved problems: limited knowledge of the exact pathways of neuron loss; safety and delivery issues of compounds; lack of established animal models that faithfully recapitulate human pathology; lack of validated, sensitive outcome measures; and limited tools to diagnose pre-symptomatic patients. To investigate the efficacy of potential disease modifying agents with limited financial and patient resources, the efficiency of both basic and clinical studies should be improved by integrated approaches. The reproduction of positive results from animal experiments that analyse the efficacy of compounds at symptomatic stages is needed to improve the credibility of preclinical studies. To effectuate proof of concept processes, novel designs of phase 2 clinical trials, such as the futility study, are being developed. Given the modest effects of molecular targeted therapies in human, it is necessary to explore clinical outcome measures that are resistant to variability, subjectivity and placebo. Furthermore, there is an increasing need for testing interventions before the onset of symptoms. Analyses of natural histories of biological and neurophysiological markers may provide indispensable information for designing such preventive trials. As it is now clear that conventional approaches are not necessarily appropriate for the development of molecular targeted therapies, both basic and clinical studies require conceptual innovation.

    DOI: 10.1136/jnnp-2011-301307

    Web of Science

    PubMed

    researchmap

  • A novel MPZ mutation in Charcot-Marie-Tooth disease type 1B with focally folded myelin and multiple entrapment neuropathies. 査読 国際誌

    Madoka Iida, Haruki Koike, Tetsuo Ando, Makoto Sugiura, Masahiko Yamamoto, Fumiaki Tanaka, Gen Sobue

    Neuromuscular disorders : NMD   22 ( 2 )   166 - 9   2012年2月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:PERGAMON-ELSEVIER SCIENCE LTD  

    Charcot-Marie-Tooth type 1B (CMT1B) is a demyelinating neuropathy caused by mutations in the myelin protein zero (MPZ) gene. Here, we describe a patient with CMT1B with focally folded myelin, a rarely reported phenotype of CMT1B, who initially presented with multiple entrapment neuropathies. She complained of palmar dysesthesia on both sides and on both soles of her feet in her 30's. She underwent bilateral carpal and tarsal tunnel release at age 44, which provided transient relief from the symptoms. A sural nerve biopsy performed at age 49 revealed focally folded myelin. Molecular genetic analysis revealed a novel Asn131Ser mutation in MPZ.

    DOI: 10.1016/j.nmd.2011.08.005

    Web of Science

    PubMed

    researchmap

  • Discrimination of spinal and bulbar muscular atrophy from amyotrophic lateral sclerosis using sensory nerve action potentials. 査読 国際誌

    Tetsuo Hama, Masaaki Hirayama, Takashi Hara, Tomohiko Nakamura, Naoki Atsuta, Haruhiko Banno, Keisuke Suzuki, Masahisa Katsuno, Fumiaki Tanaka, Gen Sobue

    Muscle & nerve   45 ( 2 )   169 - 74   2012年2月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:WILEY-BLACKWELL  

    INTRODUCTION: Spinal and bulbar muscular atrophy (SBMA) and amyotrophic lateral sclerosis (ALS) are motor neuron diseases. Sensory impairment is sometimes observed, and electrophysiological involvement has been described in the sensory nerves of SBMA patients. We hypothesized that a sensory nerve conduction study (NCS) could be used to discriminate SBMA from ALS. METHODS: We compared the results from NCSs in a total of 120 SBMA cases confirmed by genetic analysis, 188 ALS cases, and 50 normal subjects. RESULTS: Sensory nerve action potential (SNAP) amplitudes of the SBMA group were significantly lower than in the ALS and control groups. In addition, receiver-operating characteristic curve analysis for SNAP amplitude showed that a cut-off value of 13.8 μV for median, 10.7 μV for ulnar, and 9.9 μV for sural nerve best discriminated SBMA from ALS. CONCLUSIONS: The specific decrease of SNAP amplitude in SBMA provides another useful tool for the differential diagnosis of motor neuron diseases.

    DOI: 10.1002/mus.22291

    Web of Science

    PubMed

    researchmap

  • Review: Single nucleotide polymorphisms associated with the oncogenesis of colorectal cancer. 査読

    Mimori K, Tanaka F, Shibata K, Mori M

    Surgery today   42 ( 3 )   215 - 219   2012年2月

  • 我が国の内科領域のトランスレーショナルリサーチとEBM トランスレーショナルリサーチ 神経変性疾患のトランスレーショナルリサーチ

    勝野 雅央, 坂野 晴彦, 鈴木 啓介, 橋詰 淳, 足立 弘明, 田中 章景, 祖父江 元

    日本内科学会雑誌   101 ( Suppl. )   113 - 113   2012年2月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本内科学会  

    researchmap

  • Natural history of transthyretin Val30Met familial amyloid polyneuropathy: analysis of late-onset cases from non-endemic areas. 査読 国際誌

    Haruki Koike, Fumiaki Tanaka, Rina Hashimoto, Minoru Tomita, Yuichi Kawagashira, Masahiro Iijima, Junko Fujitake, Toru Kawanami, Takeo Kato, Masahiko Yamamoto, Gen Sobue

    Journal of neurology, neurosurgery, and psychiatry   83 ( 2 )   152 - 8   2012年2月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:BMJ PUBLISHING GROUP  

    OBJECTIVE: The objective of this study was to elucidate the natural history of late-onset transthyretin Val30Met-associated familial amyloid polyneuropathy (FAP ATTR Val30Met) in non-endemic areas. METHODS: The authors retrospectively assessed the development of major clinical landmarks and abnormalities of nerve conduction and cardiac examination indices in 50 patients with an age of onset older than 50 years and no relationship to endemic foci. RESULTS: Once the neuropathic process was initiated, sensory and motor symptoms of both the upper and lower extremities appeared within a period of one and a half years. Digestive and orthostatic symptoms also tended to occur in the early phase of the disease, whereas urinary symptoms appeared in the middle of the disease progress. Along with pain in the extremities, these symptoms progressed over time and significantly disturbed the quality of life during the late phase of the disease, resulting in the need for wheelchair use. Although cardiomyopathy became clinically apparent only in the late phase of the disease, it was found to be the major cause of death. The mean duration of the disease onset to death was 7.3 years. Although values at the time of diagnosis were extremely variable, serial measurements of electrophysiological indices, the cardiothoracic ratio and interventricular septum thickness indicated a steady exacerbation in these outcomes among patients within a span of a couple of years. CONCLUSIONS: The ages of onset of each clinical landmark were extremely variable between patients. However, once an initial symptom appeared, the chronological sequence of other clinical landmarks tended to be uniform, occurring within a relatively short time span.

    DOI: 10.1136/jnnp-2011-301299

    Web of Science

    PubMed

    researchmap

  • MicroRNA-372 is associated with poor prognosis in colorectal cancer. 査読

    Yamashita S, Yamamoto H, Mimori K, Nishida N, Takahashi H, Haraguchi N, Tanaka F, Shibata K, Sekimoto M, Ishii H, Doki Y, Mori M

    Oncology   82 ( 4 )   205 - 212   2012年

  • Current status of treatment of spinal and bulbar muscular atrophy. 査読 国際誌

    Fumiaki Tanaka, Masahisa Katsuno, Haruhiko Banno, Keisuke Suzuki, Hiroaki Adachi, Gen Sobue

    Neural plasticity   2012   369284 - 369284   2012年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Hindawi Publishing Corporation  

    Spinal and bulbar muscular atrophy (SBMA) is the first member identified among polyglutamine diseases characterized by slowly progressive muscle weakness and atrophy of the bulbar, facial, and limb muscles pathologically associated with motor neuron loss in the spinal cord and brainstem. Androgen receptor (AR), a disease-causing protein of SBMA, is a well-characterized ligand-activated transcription factor, and androgen binding induces nuclear translocation, conformational change and recruitment of coregulators for transactivation of AR target genes. Some therapeutic strategies for SBMA are based on these native functions of AR. Since ligand-induced nuclear translocation of mutant AR has been shown to be a critical step in motor neuron degeneration in SBMA, androgen deprivation therapies using leuprorelin and dutasteride have been developed and translated into clinical trials. Although the results of these trials are inconclusive, renewed clinical trials with more sophisticated design might prove the effectiveness of hormonal intervention in the near future. Furthermore, based on the normal function of AR, therapies targeted for conformational changes of AR including amino-terminal (N) and carboxy-terminal (C) (N/C) interaction and transcriptional coregulators might be promising. Other treatments targeted for mitochondrial function, ubiquitin-proteasome system (UPS), and autophagy could be applicable for all types of polyglutamine diseases.

    DOI: 10.1155/2012/369284

    Scopus

    PubMed

    researchmap

  • [Anti-androgen therapy for spinal and bulbar muscular atrophy (SBMA)]. 査読

    Masahisa Katsuno, Haruhiko Banno, Keisuke Suzuki, Atsushi Hashizume, Hiroaki Adachi, Fumiaki Tanaka, Gen Sobue

    Rinsho shinkeigaku = Clinical neurology   52 ( 11 )   1207 - 9   2012年

     詳細を見る

    記述言語:日本語   掲載種別:研究論文(学術雑誌)  

    Spinal and bulbar muscular atrophy (SBMA), or Kennedy's disease, is an adult-onset lower motor neuron disease caused by the expansion of a trinucleotide CAG repeat encoding a polyglutamine tract within the first exon of the androgen receptor (AR) gene. The testosterone-dependent nuclear accumulation of polyglutamine-expanded AR protein is central to the pathogenesis. This hypothesis is supported by pre-clinical studies showing that testosterone deprivation ameliorates motor neuron degeneration in animal modes of SBMA. In a randomized placebo-controlled multi-centric clinical trial, leuprorelin, which suppresses secretion of testosterone, showed no definite effect on motor functions, although there was the improvement of swallowing function in a subgroup of patients whose disease duration was less than 10 years. Elucidation of the entire disease mechanism, early initiation of therapeutic intervention, and sensitive outcome measures to evaluate drug effect appear to be the key to a successful translational research on SBMA.

    DOI: 10.5692/clinicalneurol.52.1207

    PubMed

    researchmap

  • c-Abl inhibition delays motor neuron degeneration in the G93A mouse, an animal model of amyotrophic lateral sclerosis. 査読 国際誌

    Ryu Katsumata, Shinsuke Ishigaki, Masahisa Katsuno, Kaori Kawai, Jun Sone, Zhe Huang, Hiroaki Adachi, Fumiaki Tanaka, Fumihiko Urano, Gen Sobue

    PloS one   7 ( 9 )   e46185   2012年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:PUBLIC LIBRARY SCIENCE  

    BACKGROUND: Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterized by progressive death of motor neurons. Although the pathogenesis of ALS remains unclear, several cellular processes are known to be involved, including apoptosis. A previous study revealed the apoptosis-related gene c-Abl to be upregulated in sporadic ALS motor neurons. METHODOLOGY/FINDINGS: We investigated the possibility that c-Abl activation is involved in the progression of ALS and that c-Abl inhibition is potentially a therapeutic strategy for ALS. Using a mouse motor neuron cell line, we found that mutation of Cu/Zn-superoxide dismutase-1 (SOD1), which is one of the causative genes of familial ALS, induced the upregulation of c-Abl and decreased cell viability, and that the c-Abl inhibitor dasatinib inhibited cytotoxicity. Activation of c-Abl with a concomitant increase in activated caspase-3 was observed in the lumbar spine of G93A-SOD1 transgenic mice (G93A mice), a widely used model of ALS. The survival of G93A mice was improved by oral administration of dasatinib, which also decreased c-Abl phosphorylation, inactivated caspase-3, and improved the innervation status of neuromuscular junctions. In addition, c-Abl expression in postmortem spinal cord tissues from sporadic ALS patients was increased by 3-fold compared with non-ALS patients. CONCLUSIONS/SIGNIFICANCE: The present results suggest that c-Abl is a potential therapeutic target for ALS and that the c-Abl inhibitor dasatinib has neuroprotective properties in vitro and in vivo.

    DOI: 10.1371/journal.pone.0046185

    Web of Science

    PubMed

    researchmap

  • Disruption of axonal transport in motor neuron diseases. 査読 国際誌

    Kensuke Ikenaka, Masahisa Katsuno, Kaori Kawai, Shinsuke Ishigaki, Fumiaki Tanaka, Gen Sobue

    International journal of molecular sciences   13 ( 1 )   1225 - 38   2012年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:MDPI AG  

    Motor neurons typically have very long axons, and fine-tuning axonal transport is crucial for their survival. The obstruction of axonal transport is gaining attention as a cause of neuronal dysfunction in a variety of neurodegenerative motor neuron diseases. Depletions in dynein and dynactin-1, motor molecules regulating axonal trafficking, disrupt axonal transport in flies, and mutations in their genes cause motor neuron degeneration in humans and rodents. Axonal transport defects are among the early molecular events leading to neurodegeneration in mouse models of amyotrophic lateral sclerosis (ALS). Gene expression profiles indicate that dynactin-1 mRNA is downregulated in degenerating spinal motor neurons of autopsied patients with sporadic ALS. Dynactin-1 mRNA is also reduced in the affected neurons of a mouse model of spinal and bulbar muscular atrophy, a motor neuron disease caused by triplet CAG repeat expansion in the gene encoding the androgen receptor. Pathogenic androgen receptor proteins also inhibit kinesin-1 microtubule-binding activity and disrupt anterograde axonal transport by activating c-Jun N-terminal kinase. Disruption of axonal transport also underlies the pathogenesis of spinal muscular atrophy and hereditary spastic paraplegias. These observations suggest that the impairment of axonal transport is a key event in the pathological processes of motor neuron degeneration and an important target of therapy development for motor neuron diseases.

    DOI: 10.3390/ijms13011225

    Web of Science

    PubMed

    researchmap

  • 臨床調査個人票データから見た我が国のALS患者横断像

    熱田 直樹, 渡辺 宏久, 中村 亮一, 伊藤 瑞規, 千田 譲, 加藤 重典, 田中 章景, 中野 今治, 祖父江 元

    臨床神経学   51 ( 12 )   1360 - 1360   2011年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • Kinesin 18A expression: clinical relevance to colorectal cancer progression. 査読 国際誌

    Nagahara M, Nishida N, Iwatsuki M, Ishimaru S, Mimori K, Tanaka F, Nakagawa T, Sato T, Sugihara K, Hoon DS, Mori M

    International journal of cancer   129 ( 11 )   2543 - 2552   2011年12月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.1002/ijc.25916

    PubMed

    researchmap

  • 球脊髄性筋萎縮症における細胞周期異常

    勝野 雅央, 足立 弘明, 南山 誠, 土井 英樹, 近藤 直英, 松本 慎二郎, 宮崎 雄, 坂野 晴彦, 鈴木 啓介, 田中 章景, 祖父江 元

    臨床神経学   51 ( 12 )   1440 - 1440   2011年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 球脊髄性筋萎縮症における尿中8-OHdGの経時的変化

    眞野 智生, 勝野 雅央, 坂野 晴彦, 鈴木 啓介, 須賀 徳明, 橋詰 淳, 田中 章景, 祖父江 元

    臨床神経学   51 ( 12 )   1366 - 1366   2011年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • ALS患者の縦断像(JaCALSからの解析)

    中村 亮一, 熱田 直樹, 加藤 重典, 千田 譲, 伊藤 瑞規, 渡辺 宏久, 田中 章景, 饗場 郁子, 小長谷 正明, 阿部 康二, 川田 明広, 青木 正志, 岡本 幸市, 長谷川 一子, 谷口 彰, 溝口 功一, 森田 光哉, 和泉 唯信, 梶 龍兒, 中野 今治, 祖父江 元

    臨床神経学   51 ( 12 )   1360 - 1360   2011年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 神経変性をどう考えるか?病態理解にいたる最近の進歩 TGF-βシグナルからみた神経変性機序

    勝野 雅央, 坂野 晴彦, 鈴木 啓介, 足立 弘明, 田中 章景, 祖父江 元

    臨床神経学   51 ( 11 )   982 - 985   2011年11月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    Transforming growth factor-β(TGF-β)は細胞の増殖・分化・移動などを制御する多機能サイトカインであり、ニューロンに対してもtrophic factorとして機能し、その生存や機能を支持することが示されている。球脊髄性筋萎縮症(SBMA)はアンドロゲン受容体(AR)遺伝子におけるCAGくりかえし配列の異常延長を原因とする下位運動ニューロン疾患であるが、SBMAのモデルマウスおよび患者組織では変異ARによりII型TGF-β受容体の発現が低下し、シグナルを伝達する転写因子であるSmad2のリン酸化・核内移行が抑制されることが報告されている。また、筋萎縮性側索硬化症ではTGF-βシグナルの調整因子であるZNF512Bの遺伝子プロモーター領域の塩基多型が疾患感受性に関与していると報告されている。TGF-βシグナルの異常はそのほか脊髄性筋萎縮症や遺伝性痙性対麻痺でも報告されており、運動ニューロン変性のメカニズムとして重要であると考えられる。(著者抄録)

    researchmap

    その他リンク: https://search.jamas.or.jp/index.php?module=Default&action=Link&pub_year=2011&ichushi_jid=J01550&link_issn=&doc_id=20120821230070&doc_link_id=10.5692%2Fclinicalneurol.51.982&url=https%3A%2F%2Fdoi.org%2F10.5692%2Fclinicalneurol.51.982&type=J-STAGE&icon=https%3A%2F%2Fjk04.jamas.or.jp%2Ficon%2F00007_3.gif

  • [Role of axonal transport in ALS]. 査読

    Fumiaki Tanaka, Kensuke Ikenaka, Gen Sobue

    Rinsho shinkeigaku = Clinical neurology   51 ( 11 )   1189 - 91   2011年11月

     詳細を見る

    記述言語:日本語   掲載種別:研究論文(学術雑誌)  

    Proposed hypothesis for pathomechanisms of sporadic ALS include oxidative stress, glutamate toxicity, axonal transport defects, mitochondrial impairment and so on. Although these mechanisms may be interrelated mutually, the whole picture has not been clarified. As for axonal transport defect, it is also prominently involved in the pathogenesis of many major human neurodegenerative diseases including Alzheimer's disease and Parkinson's disease, suggesting a crucial role of axonal transport in maintaining the normal neuronal function. In mutant SOD1 transgenic mice, the most popular disease model of familial ALS, the mutant SOD1 selectively associates with and damages mitochondria, leading to defect of axonal transport because of diminished ATP fuel supply for the molecular motors such as kinesin family or dynein/dynactin complex. Furthermore, the finding that mutations in the dynactin subunit p150Glued cause familial ALS demonstrates a direct role of molecular motor dysfunction and axonal transport defects in ALS. On the other hand, the mechanism of axonal transport impairment in sporadic ALS has been elusive. We have previously demonstrated that gene expression of dynactin subunit p150Glued (dynactin-1) is down-regulated in motor neurons of sporadic ALS patient from the early stage of neurodegeneration. In this article we review the role of axonal transport in the pathogenesis of ALS.

    DOI: 10.5692/clinicalneurol.51.1189

    Scopus

    PubMed

    researchmap

  • [TGF-beta signaling in neurodegenerative diseases]. 査読

    Masahisa Katsuno, Haruhiko Banno, Keisuke Suzuki, Hiroaki Adachi, Fumiaki Tanaka, Gen Sobue

    Rinsho shinkeigaku = Clinical neurology   51 ( 11 )   982 - 5   2011年11月

     詳細を見る

    記述言語:日本語   掲載種別:研究論文(学術雑誌)  

    Transforming growth factor beta (TGF-beta), a pleiotropic cytokine, regulates a diverse range of cellular responses, such as proliferation, differentiation, migration, and apoptosis. Recent studies indicate that disruption of TGF-beta signaling due to the transcriptional dysregulation of its receptor is associated with polyglutamine-induced motor neuron damage in spinal and bulbar muscular atrophy. Moreover, a single-nucleotide polymorphism (SNP) in the promoter region of ZNF512B, a putative regulator of TGF-beta signaling, is shown to be associated with susceptibility to amyotrophic lateral sclerosis. Signal transduction by BMP, a member of the TGF-beta super family, is decreased in a fly model of spinal muscular atrophy, while the abnormal activation of this signaling has been reported in animal models of hereditary spastic paraplegia. These findings support the hypothesis that the disruption of TGF-beta signaling is an important molecular event in the pathogenesis of motor neuron diseases, and that the modification of this signaling pathway represents a new therapeutic strategy against these devastating disorders.

    DOI: 10.5692/clinicalneurol.51.982

    Scopus

    PubMed

    researchmap

  • [JaCALS: a prospective multicenter ALS cohort study]. 査読

    Naoki Atsuta, Ryoichi Nakamura, Hazuki Watanabe, Hirohisa Watanabe, Mizuki Ito, Jo Senda, Fumiaki Tanaka, Gen Sobue

    Rinsho shinkeigaku = Clinical neurology   51 ( 11 )   903 - 5   2011年11月

     詳細を見る

    記述言語:日本語   掲載種別:研究論文(学術雑誌)  

    To investigate the longitudinal course of Japanese patients with Amyotrophic Lateral Sclerosis (ALS), we constructed a multicenter registration and follow-up system called Japanese Consortium for Amyotrophic Lateral Sclerosis research (JaCALS). Genomic DNA samples of ALS patients were stored and linked to the clinical information. We designed a telephone survey system using a clinical research coordinator (CRC) to check the score of the ALS Functional Rating Scale-R (ALSFRS-R) and the prognosis every 3 months. In January 2006, we began registering ALS patients, and, at present, 22 neurology facilities are participating in the JaCALS. Currently, 571 Japanese ALS patients are registered. From the longitudinal data of the 279 patients who were registered before September 2009, the older age at onset was a significant risk factor for not only earlier death or introduction of mechanical ventilation, but also earlier loss of speech, loss of swallowing function and loss of upper limb function. In collaboration with the RIKEN Center for Genomic Medicine, genome-wide association studies (GWAS) using 1,305 ALS samples from the JaCALS and BioBank Japan were conducted, which showed that ZNF512B gene was associated with susceptibility to ALS. The JaCALS has established an efficient registration and follow-up system with genomic DNA resources of ALS patients, and will contribute to identify ALS-associated genes and to promote clinical researches.

    DOI: 10.5692/clinicalneurol.51.903

    PubMed

    researchmap

  • 神経変性疾患の病態と治療(脊髄小脳変性症を含む) 神経変性疾患の分子標的治療

    祖父江 元, 勝野 雅央, 坂野 晴彦, 足立 弘明, 田中 章景

    日本医学会総会会誌   28回 ( I )   178 - 178   2011年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本医学会  

    researchmap

  • Paraneoplastic neuropathy: wide-ranging clinicopathological manifestations. 査読 国際誌

    Haruki Koike, Fumiaki Tanaka, Gen Sobue

    Current opinion in neurology   24 ( 5 )   504 - 10   2011年10月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:LIPPINCOTT WILLIAMS & WILKINS  

    PURPOSE OF REVIEW: Recent progress in serological screening for paraneoplastic autoantibodies and diagnostic imaging techniques to detect malignancies has resulted in a broadening of the concept of paraneoplastic neurologic syndromes through the characterization of nonclassical clinical features. The goal of this article was to review the recent literature describing the wide-ranging clinicopathological manifestations of paraneoplastic neuropathy. RECENT FINDINGS: The classical feature of paraneoplastic neuropathy is subacute sensory neuronopathy; in addition, sensorimotor neuropathies, such as Guillain-Barré syndrome, chronic inflammatory demyelinating polyneuropathy, brachial plexopathy, and vasculitic neuropathy, are sometimes observed. Some studies also describe the occurrence of autonomic neuropathies, including autoimmune autonomic ganglionopathy and chronic gastrointestinal pseudo-obstruction. Whole-body fluorodeoxyglucose positron emission tomography (FDG-PET) or FDG-PET/computed tomography may be helpful to detect malignancies that cannot be detected by conventional screening tests. The presence of paraneoplastic neuropathy should be considered in all patients with malignancy and can occur at any point in the disease, even during or after chemotherapy, radiation, or stem cell transplantation. The presence of paraneoplastic autoantibodies, especially anti-Hu and anti-CV2/CRMP-5 antibodies, may support the diagnosis of paraneoplastic neuropathy. Immunomodulatory treatment before, during, or after antineoplastic therapy may be of benefit for patients with paraneoplastic neuropathy and has been used even when the underlying malignancy cannot be identified. SUMMARY: Recognition of the variable manifestations of paraneoplastic neuropathy is important, as diagnosis at an earlier stage facilitates prompt treatment and provides better chances of good outcomes.

    DOI: 10.1097/WCO.0b013e32834a87b7

    Web of Science

    PubMed

    researchmap

  • Long noncoding RNA HOTAIR regulates polycomb-dependent chromatin modification and is associated with poor prognosis in colorectal cancers. 査読 国際誌

    Kogo R, Shimamura T, Mimori K, Kawahara K, Imoto S, Sudo T, Tanaka F, Shibata K, Suzuki A, Komune S, Miyano S, Mori M

    Cancer research   71 ( 20 )   6320 - 6326   2011年10月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.1158/0008-5472.CAN-11-1021

    PubMed

    researchmap

  • Expression of CLDN1 in colorectal cancer: a novel marker for prognosis. 査読

    Nakagawa S, Miyoshi N, Ishii H, Mimori K, Tanaka F, Sekimoto M, Doki Y, Mori M

    International journal of oncology   39 ( 4 )   791 - 796   2011年10月

  • The significance of PITX2 overexpression in human colorectal cancer. 査読

    Hirose H, Ishii H, Mimori K, Tanaka F, Takemasa I, Mizushima T, Ikeda M, Yamamoto H, Sekimoto M, Doki Y, Mori M

    Annals of surgical oncology   18 ( 10 )   3005 - 3012   2011年10月

  • Histone deacetylase 1 expression in gastric cancer. 査読 国際誌

    Sudo T, Mimori K, Nishida N, Kogo R, Iwaya T, Tanaka F, Shibata K, Fujita H, Shirouzu K, Mori M

    Oncology reports   26 ( 4 )   777 - 782   2011年10月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.3892/or.2011.1361

    PubMed

    researchmap

  • ALSの進行、臨床像に関連する因子の検討 発症年齢について

    渡辺 はづき, 熱田 直樹, 中村 亮一, 渡辺 宏久, 伊藤 瑞規, 千田 譲, 田中 章景, 祖父江 元

    臨床神経学   51 ( 10 )   805 - 805   2011年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • A functional variant in ZNF512B is associated with susceptibility to amyotrophic lateral sclerosis in Japanese. 査読 国際誌

    Aritoshi Iida, Atsushi Takahashi, Michiaki Kubo, Susumu Saito, Naoya Hosono, Yozo Ohnishi, Kazuma Kiyotani, Taisei Mushiroda, Masahiro Nakajima, Kouichi Ozaki, Toshihiro Tanaka, Tatsuhiko Tsunoda, Shuichi Oshima, Motoki Sano, Tetsumasa Kamei, Torao Tokuda, Masashi Aoki, Kazuko Hasegawa, Koichi Mizoguchi, Mitsuya Morita, Yuji Takahashi, Masahisa Katsuno, Naoki Atsuta, Hirohisa Watanabe, Fumiaki Tanaka, Ryuji Kaji, Imaharu Nakano, Naoyuki Kamatani, Shoji Tsuji, Gen Sobue, Yusuke Nakamura, Shiro Ikegawa

    Human molecular genetics   20 ( 18 )   3684 - 92   2011年9月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:OXFORD UNIV PRESS  

    Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterized by the selective loss of motor neurons. Several susceptibility genes for ALS have been reported; however, ALS etiology and pathogenesis remain largely unknown. To identify further ALS-susceptibility genes, we conducted a large-scale case-control association study using gene-based tag single-nucleotide polymorphisms (SNPs). A functional SNP (rs2275294) was found to be significantly associated with ALS through a stepwise screening approach (combined P= 9.3 × 10(-10), odds ratio = 1.32). The SNP was located in an enhancer region of ZNF512B, a transcription factor of unknown biological function, and the susceptibility allele showed decreased activity and decreased binding to nuclear proteins. ZNF512B over-expression increased transforming growth factor-β (TGF-β) signaling, while knockdown had the opposite effect. ZNF512B expression was increased in the anterior horn motor neurons of the spinal cord of ALS patients when compared with controls.  Our results strongly suggest that ZNF512B is an important positive regulator of TGF-β signaling and that decreased ZNF512B expression increases susceptibility to ALS.

    DOI: 10.1093/hmg/ddr268

    Web of Science

    PubMed

    researchmap

  • 新規ALS感受性遺伝子ALSC1は、TGF-βシグナルのポジティブレギュレーターである

    飯田 有俊, 田中 章景, 中村 祐輔, 祖父江 元, 池川 志郎

    日本生化学会大会プログラム・講演要旨集   84回   3T16p - 8   2011年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(公社)日本生化学会  

    researchmap

  • CENTRAL MOTOR CONDUCTION TIME (CMCT) IN PATIENTS WITH SPINAL AND BULBAR MUSCULAR ATROPHY (SBMA) 査読

    K. Suzuki, M. Katsuno, H. Banno, N. Suga, A. Hashizume, T. Hara, T. Hama, T. Nakamura, M. Hirayama, F. Tanaka, G. Sobue

    EUROPEAN JOURNAL OF NEUROLOGY   18   222 - 222   2011年9月

     詳細を見る

    記述言語:英語   出版者・発行元:WILEY-BLACKWELL  

    Web of Science

    researchmap

  • Behavioral changes in early ALS correlate with voxel-based morphometry and diffusion tensor imaging. 査読 国際誌

    Masashi Tsujimoto, Jo Senda, Tetsuro Ishihara, Yoshiki Niimi, Yoshinari Kawai, Naoki Atsuta, Hirohisa Watanabe, Fumiaki Tanaka, Shinji Naganawa, Gen Sobue

    Journal of the neurological sciences   307 ( 1-2 )   34 - 40   2011年8月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:ELSEVIER SCIENCE BV  

    BACKGROUND: Amyotrophic lateral sclerosis (ALS) is a multisystem disorder with impairment of frontotemporal functions such as cognition and behavior, but the behavioral changes associated with ALS are not well defined. METHODS: Twenty-one consecutive patients with sporadic ALS and 21 control subjects participated in the study. The Frontal System Behavior Scale (FrSBe) was used to assess behavioral change. Voxel-based morphometry (VBM) and voxel-based analysis of diffusion tensor images (DTI) were performed to explore the associations of brain degeneration with behavior. All patients were evaluated before the notification of ALS. RESULTS: FrSBe scores of ALS patients before notification were significantly increased compared to those of control subjects. Moreover, the FrSBe Apathy score of ALS patients significantly changed from pre- to post-illness (P<0.001). The severity of apathy was significantly correlated with atrophy in the prefrontal cortex, especially in the orbitofrontal (P=0.006) and dorsolateral prefrontal (P=0.006) cortices in VBM, and in the right frontal gyrus (P<0.001) in DTI. CONCLUSIONS: ALS patients exhibited apathy during the early course of the illness, the severity of which was significantly associated with frontal lobe involvement. These findings support the view that a continuum exits between ALS and frontotemporal dementia.

    DOI: 10.1016/j.jns.2011.05.025

    Web of Science

    PubMed

    researchmap

  • Clinicopathological and biological significance of CDC28 protein kinase regulatory subunit 2 overexpression in human gastric cancer. 査読

    Tanaka F, Matsuzaki S, Mimori K, Kita Y, Inoue H, Mori M

    International journal of oncology   39 ( 2 )   361 - 372   2011年8月

  • [Molecular mechanisms of generation and progression of esophageal cancer]. 査読

    Tanaka F, Ishikawa K, Mori M

    Nihon rinsho. Japanese journal of clinical medicine   69 Suppl 6   62 - 67   2011年8月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本臨床社  

    PubMed

    CiNii Books

    researchmap

    その他リンク: http://search.jamas.or.jp/link/ui/2011340061

  • FBXO31 determines poor prognosis in esophageal squamous cell carcinoma. 査読 国際誌

    Kogo R, Mimori K, Tanaka F, Komune S, Mori M

    International journal of oncology   39 ( 1 )   155 - 159   2011年7月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.3892/ijo.2011.1018

    PubMed

    researchmap

  • Clinical significance of miR-146a in gastric cancer cases. 査読 国際誌

    Kogo R, Mimori K, Tanaka F, Komune S, Mori M

    Clinical cancer research : an official journal of the American Association for Cancer Research   17 ( 13 )   4277 - 4284   2011年7月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.1158/1078-0432.CCR-10-2866

    PubMed

    researchmap

  • Diagnosis of sporadic transthyretin Val30Met familial amyloid polyneuropathy: a practical analysis. 査読 国際誌

    Haruki Koike, Rina Hashimoto, Minoru Tomita, Yuichi Kawagashira, Masahiro Iijima, Fumiaki Tanaka, Gen Sobue

    Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis   18 ( 2 )   53 - 62   2011年6月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:INFORMA HEALTHCARE  

    Transthyretin (TTR) Val30Met-associated familial amyloid polyneuropathy (FAP ATTR Val30Met) is the most common form of FAP and is now prevalent in areas other than those seen within conventional endemic foci. We investigated 15 patients with FAP ATTR Val30Met without a family history of FAP who were referred for sural nerve biopsy. Initial symptoms included somatic neuropathy in all patients, while sensory dissociation and autonomic symptoms were apparent only in two and seven patients, respectively. Nonspecific neuropathic features and slight abnormalities in cerebrospinal fluid protein levels and in electrophysiological indices related to nerve conduction led clinicians to initially suspect chronic inflammatory demyelinating polyneuropathy (CIDP) in some patients. Small-fiber predominant loss was observed in a minority of patients. In terms of cardiac involvement, findings suggestive of subclinical cardiomyopathy due to amyloid deposition, such as cardiomegaly on chest X-ray, thickening of the interventricular septum, and granular sparkling echo on echocardiography, were seen alone or in combination in 11 of 14 examined patients. In conclusion, clinicians should consider the possibility of FAP ATTR Val30Met in patients presenting with neuropathy of undetermined etiology to avoid misdiagnosis. Detecting subclinical cardiac involvement may help to diagnose late-onset FAP ATTR Val30Met in those without a family history of the disease.

    DOI: 10.3109/13506129.2011.565524

    Web of Science

    PubMed

    researchmap

  • Reprogramming of mouse and human cells to pluripotency using mature microRNAs. 査読 国際誌

    Miyoshi N, Ishii H, Nagano H, Haraguchi N, Dewi DL, Kano Y, Nishikawa S, Tanemura M, Mimori K, Tanaka F, Saito T, Nishimura J, Takemasa I, Mizushima T, Ikeda M, Yamamoto H, Sekimoto M, Doki Y, Mori M

    Cell stem cell   8 ( 6 )   633 - 638   2011年6月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.1016/j.stem.2011.05.001

    PubMed

    researchmap

  • MicroRNA miR-125b is a prognostic marker in human colorectal cancer. 査読 国際誌

    Nishida N, Yokobori T, Mimori K, Sudo T, Tanaka F, Shibata K, Ishii H, Doki Y, Kuwano H, Mori M

    International journal of oncology   38 ( 5 )   1437 - 1443   2011年5月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.3892/ijo.2011.969

    PubMed

    researchmap

  • MicroRNA-125a-5p is an independent prognostic factor in gastric cancer and inhibits the proliferation of human gastric cancer cells in combination with trastuzumab. 査読 国際誌

    Nishida N, Mimori K, Fabbri M, Yokobori T, Sudo T, Tanaka F, Shibata K, Ishii H, Doki Y, Mori M

    Clinical cancer research : an official journal of the American Association for Cancer Research   17 ( 9 )   2725 - 2733   2011年5月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.1158/1078-0432.CCR-10-2132

    PubMed

    researchmap

  • Spatial distribution of nerve fiber pathology and vasculitis in microscopic polyangiitis-associated neuropathy. 査読 国際誌

    Saori Morozumi, Haruki Koike, Minoru Tomita, Yuichi Kawagashira, Masahiro Iijima, Masahisa Katsuno, Naoki Hattori, Fumiaki Tanaka, Gen Sobue

    Journal of neuropathology and experimental neurology   70 ( 5 )   340 - 8   2011年5月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:LIPPINCOTT WILLIAMS & WILKINS  

    We analyzed the 3-dimensional distribution of pathologic findings in 8 autopsied cases of neuropathy associated with microscopic polyangiitis. Necrotizing vasculitis was commonly and diffusely present in the epineurium of the sciatic/tibial and median nerves. Although findings of vasculitis were distributed diffusely in proximal to distal segments of the nerve trunks, marked loss of myelinated fibers occurred only from the middle to distal segments of these nerves. Neurons of the sensory and sympathetic ganglia were well preserved, as were myelinated fibers of the anterior and posterior spinal roots. Central fascicular nerve fiber degeneration, suggesting direct ischemic damage, occurred in restricted segments of the proximal-middle portion of the sciatic/tibial and median nerve trunks. Vasculitis was also seen in various visceral organs in all patients, but its distribution differed among individual patients; the severity of vasculitis in the other organs did not correlate with that in the peripheral nerves. The distinct spatial distribution pattern of nerve fiber degeneration, in contrast to the ubiquitous presence of vasculitis, suggested that the ischemic zone that directly damages nerve fibers is present in the proximal-middle portion of peripheral nerve trunks in microscopic polyangiitis.

    DOI: 10.1097/NEN.0b013e3182172290

    Web of Science

    PubMed

    researchmap

  • Replication analysis of SNPs on 9p21.2 and 19p13.3 with amyotrophic lateral sclerosis in East Asians. 査読 国際誌

    Aritoshi Iida, Atsushi Takahashi, Min Deng, Yun Zhang, Jing Wang, Naoki Atsuta, Fumiaki Tanaka, Tetsumasa Kamei, Motoki Sano, Shuichi Oshima, Torao Tokuda, Mitsuya Morita, Chizuru Akimoto, Masahiro Nakajima, Michiaki Kubo, Naoyuki Kamatani, Imaharu Nakano, Gen Sobue, Yusuke Nakamura, Dongsheng Fan, Shiro Ikegawa

    Neurobiology of aging   32 ( 4 )   757.e13-4 - 4   2011年4月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:ELSEVIER SCIENCE INC  

    We performed a replication study of the 2 genetic variants, rs2814707 on 9p21.2 and rs12608932 on 19p13.3 that are recently reported to be most significantly associated with sporadic amyotrophic lateral sclerosis (ALS) in Caucasians. Both rs12608932 and rs2814707 showed no evidence of association in Japanese and Chinese (rs12608932, combined p = 0.58, odds ratio [OR] = 1.03, 95% confidence interval [CI] 0.93-1.13; rs2814707, combined p = 0.88, OR = 1.10, 95% CI 0.93-1.30). The association of these loci with susceptibility to sporadic ALS is considered negative in East Asians.

    DOI: 10.1016/j.neurobiolaging.2010.12.011

    Web of Science

    PubMed

    researchmap

  • Effect of Leuprorelin in Patients with Spinal and Bulbar Muscular Atrophy (SBMA): A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial 査読

    Haruhiko Banno, Masahisa Katsuno, Keisuke Suzuki, Yu Takeuchi, Motoshi Kawashima, Ichiro Yabe, Hidenao Sasaki, Masashi Aoki, Mitsuya Morita, Imaharu Nakano, Kazuaki Kanai, Shoichi Ito, Kinya Ishikawa, Hidehiro Mizusawa, Tomotaka Yamamoto, Shoji Tsuji, Kazuko Hasegawa, Takayoshi Shimohata, Masatoyo Nishizawa, Hiroaki Miyajima, Fumio Kanda, Yasuhiro Watanabe, Kenji Nakashima, Akira Tsujino, Taro Yamashita, Makoto Uchino, Yasushi Fujimoto, Fumiaki Tanaka, Gen Sobue

    NEUROLOGY   76 ( 9 )   A583 - A583   2011年3月

     詳細を見る

    記述言語:英語   出版者・発行元:LIPPINCOTT WILLIAMS & WILKINS  

    Web of Science

    researchmap

  • FOXC2 is a novel prognostic factor in human esophageal squamous cell carcinoma. 査読 国際誌

    Nishida N, Mimori K, Yokobori T, Sudo T, Tanaka F, Shibata K, Ishii H, Doki Y, Mori M

    Annals of surgical oncology   18 ( 2 )   535 - 542   2011年2月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.1245/s10434-010-1274-y

    PubMed

    researchmap

  • Identification of HLA-A*0201/-A*2402-restricted CTL epitope-peptides derived from a novel cancer/testis antigen, MCAK, and induction of a specific antitumor immune response. 査読

    Kawamoto M, Tanaka F, Mimori K, Inoue H, Kamohara Y, Mori M

    Oncology reports   25 ( 2 )   469 - 476   2011年2月

  • STC2: a predictive marker for lymph node metastasis in esophageal squamous-cell carcinoma. 査読 国際誌

    Kita Y, Mimori K, Iwatsuki M, Yokobori T, Ieta K, Tanaka F, Ishii H, Okumura H, Natsugoe S, Mori M

    Annals of surgical oncology   18 ( 1 )   261 - 272   2011年1月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.1245/s10434-010-1271-1

    PubMed

    researchmap

  • Progressive and widespread brain damage in ALS: MRI voxel-based morphometry and diffusion tensor imaging study. 査読 国際誌

    Joe Senda, Shigenori Kato, Tomotsugu Kaga, Mizuki Ito, Naoki Atsuta, Tomohiko Nakamura, Hirohisa Watanabe, Fumiaki Tanaka, Shinji Naganawa, Gen Sobue

    Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases   12 ( 1 )   59 - 69   2011年1月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:INFORMA HEALTHCARE  

    We investigated 17 patients with sporadic amyotrophic lateral sclerosis (ALS) using voxel-based morphometry (VBM) and voxel-based analysis of diffusion tensor images (DTI) at baseline and after a six-month follow-up. Compared with 17 healthy controls, ALS patients at baseline showed only minimal white matter volume decreases in the inferior frontal gyrus but marked decreases in the gray matter of several regions, especially in the bilateral paracentral lobule of the premotor cortex. DTI revealed reduced fractional anisotropy in the bilateral corticospinal tracts, insula, ventrolateral premotor cortex, and parietal cortex. Increased mean diffusivity was noted bilaterally in the motor cortex, ventrolateral premotor cortex, insula, hippocampal formation, and temporal gyrus. At the six-month follow-up, ALS patients showed widespread volume decreases in gray matter, and DTI abnormalities extended mainly into the bilateral frontal lobes, while volume changes in the white matter remained minimal but more distinct. Our combined VBM and DTI techniques revealed extra-corticospinal tract neuronal degeneration mainly in the frontotemporal lobe of ALS patients. In particular, follow-up examinations in these patients showed that whole-brain DTI changes occurred predominantly in the regions of brain atrophy. These objective analyses can be used to assess the disease condition of the ALS brain.

    DOI: 10.3109/17482968.2010.517850

    Web of Science

    PubMed

    researchmap

  • 神経疾患研究の現状と課題

    祖父江 元, 勝野 雅央, 坂野 晴彦, 鈴木 啓介, 田中 章景

    学術の動向   16 ( 7 )   52 - 56   2011年

     詳細を見る

    出版者・発行元:Japan Science Support Foundation  

    DOI: 10.5363/tits.16.7_52

    CiNii Books

    researchmap

    その他リンク: https://jlc.jst.go.jp/DN/JALC/00382004498?from=CiNii

  • Transforming growth factor-β signaling in motor neuron diseases 査読

    Katsuno M, Adachi H, Banno H, Suzuki K, Tanaka F, Sobue G

    Current Molecular Medicine   11 ( 1 )   48 - 56   2011年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.2174/156652411794474356

    Scopus

    PubMed

    researchmap

    その他リンク: http://orcid.org/0000-0002-9302-4663

  • 球脊髄性筋萎縮症における運動単位推定数(MUNE)の特徴

    鈴木 啓介, 勝野 雅央, 坂野 晴彦, 川島 基, 須賀 徳明, 橋詰 淳, 濱 哲夫, 内田 圭, 中村 友彦, 平山 正昭, 田中 章景, 祖父江 元

    臨床神経学   50 ( 12 )   1197 - 1197   2010年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 上位運動ニューロン症候を呈さないALSの臨床病理学的特徴

    熱田 直樹, 吉田 眞理, 渡辺 宏久, 伊藤 瑞規, 千田 譲, 加賀 友継, 加藤 重典, 田中 章景, 橋詰 良夫, 祖父江 元

    臨床神経学   50 ( 12 )   1126 - 1126   2010年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 球脊髄性筋萎縮症(SBMA)の心筋におけるNaチャンネル機能の解析

    勝野 雅央, 坂野 晴彦, 鈴木 啓介, 川島 基, 須賀 徳明, 橋詰 淳, 田中 章景, 祖父江 元

    臨床神経学   50 ( 12 )   1127 - 1127   2010年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 球脊髄性筋萎縮症(SBMA)における血管内皮細胞増殖因子(VEGF)の関与

    川島 基, 勝野 雅央, 坂野 晴彦, 鈴木 啓介, 須賀 徳明, 橋詰 淳, 足立 弘明, 田中 章景, 祖父江 元

    臨床神経学   50 ( 12 )   1197 - 1197   2010年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • Segmental copy-number gain within the region of isopentenyl diphosphate isomerase genes in sporadic amyotrophic lateral sclerosis. 国際誌

    Takeo Kato, Mitsuru Emi, Hidenori Sato, Shigeki Arawaka, Manabu Wada, Toru Kawanami, Tadashi Katagiri, Kenji Tsuburaya, Itaru Toyoshima, Fumiaki Tanaka, Gen Sobue, Kenichi Matsubara

    Biochemical and biophysical research communications   402 ( 2 )   438 - 42   2010年11月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    AIMS: Sporadic amyotrophic lateral sclerosis (SALS) seems to be a multifactorial disease, the pathogenesis of which may involve both genetic and environmental factors. The present study aims at identifying a possible genetic change that confers risk for SALS. METHODS: We performed whole-genome screening of a copy-number variation (CNV) using a CNV beadchip, followed by real-time quantitative polymerase chain reaction (qPCR) and region-targeted high-density oligonucleotide tiling microarray. RESULTS: Within the 40-kb region on 10p15.3 subtelomere, which harbours two genes encoding isopentenyl diphosphate isomerase 1 (IDI1) and IDI2, we found a segmental copy-number gain in a large proportion of SALS patients. qPCR analysis demonstrated the copy-number gain in 46 out of 83 SALS patients, as compared with 10 out of 99 controls (p=4.86×10(-11), Odds Ratio 10.8); subsequent tiling microarray validated qPCR results and elucidated the fine structure of segmental gains. CONCLUSIONS: A segmental copy-number gain in the IDI1/IDI2 gene region may play a significant role in the pathogenesis of SALS.

    DOI: 10.1016/j.bbrc.2010.10.056

    PubMed

    researchmap

  • Morphological progression of myelin abnormalities in IgM-monoclonal gammopathy of undetermined significance anti-myelin-associated glycoprotein neuropathy. 国際誌

    Yuichi Kawagashira, Haruki Koike, Minoru Tomita, Saori Morozumi, Masahiro Iijima, Tomohiko Nakamura, Masahisa Katsuno, Fumiaki Tanaka, Gen Sobue

    Journal of neuropathology and experimental neurology   69 ( 11 )   1143 - 57   2010年11月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    To characterize the morphological progression of neuropathy associated with immunoglobulin M-monoclonal gammopathy of undetermined significance with anti-myelin-associated glycoprotein antibody, we assessed histopathologic features of sural nerve specimens from 15 patients, emphasizing widely spaced myelin (WSM), demyelination, and tomaculous changes. The frequency of WSM correlated with that of demyelination and tomaculous appearance in teased-fiber preparations. In longitudinal sections at nodes of Ranvier and paranodal regions, the spaces between terminal myelin loops, particularly those adjacent to the node of Ranvier, were widened, indicating an early change before demyelination, and there was concomitant swelling of terminal myelin loops. Some conspicuously swollen terminal myelin loops were detached from the paranodal axolemma, thereby widening the nodes of Ranvier. Tomacula coexisted frequently with redundant myelin loops and WSM, particularly in the outermost layer of myelin sheaths, suggesting that loosening of the outer layers contributes to their formation. By immunofluorescence microscopy, immunoglobulin M and myelin-associated glycoprotein were colocalized in paranodal regions and Schmidt-Lanterman incisures. Confocal analysis revealed colocalization of immunoglobulin M and complement product C3d corresponding to the area of WSM. Thus, morphological changes in terminal myelin loops, formation of WSM at paranodes, and subsequent dissociation from paranodal axolemma (which may be associated with activation of the complement pathway) likely contribute to demyelination in this condition. Loosening of compact myelin seems to contribute to tomacula formation.

    DOI: 10.1097/NEN.0b013e3181fa44af

    PubMed

    researchmap

  • Clinical significance of ASB9 in human colorectal cancer. 査読

    Tokuoka M, Miyoshi N, Hitora T, Mimori K, Tanaka F, Shibata K, Ishii H, Sekimoto M, Doki Y, Mori M

    International journal of oncology   37 ( 5 )   1105 - 1111   2010年11月

  • Strong interaction between the effects of alcohol consumption and smoking on oesophageal squamous cell carcinoma among individuals with ADH1B and/or ALDH2 risk alleles. 査読 国際誌

    Tanaka F, Yamamoto K, Suzuki S, Inoue H, Tsurumaru M, Kajiyama Y, Kato H, Igaki H, Furuta K, Fujita H, Tanaka T, Tanaka Y, Kawashima Y, Natsugoe S, Setoyama T, Tokudome S, Mimori K, Haraguchi N, Ishii H, Mori M

    Gut   59 ( 11 )   1457 - 1464   2010年11月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.1136/gut.2009.205724

    PubMed

    researchmap

  • Saline replacement after local resection of the breast: a simple technique with good control and improved patient satisfaction. 査読

    Tanaka F, Mimori K, Tahara K, Inoue H, Mori M

    Breast cancer (Tokyo, Japan)   17 ( 4 )   261 - 264   2010年10月

     詳細を見る

  • Clinical significance of stanniocalcin 2 as a prognostic marker in gastric cancer. 査読 国際誌

    Yokobori T, Mimori K, Ishii H, Iwatsuki M, Tanaka F, Kamohara Y, Ieta K, Kita Y, Doki Y, Kuwano H, Mori M

    Annals of surgical oncology   17 ( 10 )   2601 - 2607   2010年10月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.1245/s10434-010-1086-0

    PubMed

    researchmap

  • Putaminal magnetic resonance imaging features at various magnetic field strengths in multiple system atrophy. 国際誌

    Hirohisa Watanabe, Mizuki Ito, Hiroshi Fukatsu, Jo Senda, Naoki Atsuta, Tomotsugu Kaga, Shigetaka Kato, Masahisa Katsuno, Fumiaki Tanaka, Masaaki Hirayama, Shinji Naganawa, Gen Sobue

    Movement disorders : official journal of the Movement Disorder Society   25 ( 12 )   1916 - 23   2010年9月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    We delineated the effects of magnetic field strength on signal intensities to facilitate the specific findings of multiple system atrophy (MSA). Fifteen patients with probable MSA were imaged by 0.35T fast spin-echo (FSE), 1.5T FSE, and 3.0T FSE using a consistent protocol, testing all field strengths on the same day. Sixty patients with probable Parkinson's disease (PD) also underwent imaging. Moderate or marked hyperintensity at the dorsolateral outer putaminal margin, hyperintensity of the putaminal body, hypointensity relative to the globus pallidus at the dorsolateral putaminal margin, and infratentorial signal changes were evaluated as specific findings for MSA. As the field strength increased, the occurrence of hyperintensity both at the dorsolateral outer putaminal margin and of the putaminal body decreased, while the occurrence of hypointensity at the dorsolateral putaminal margin increased in MSA. The occurrence of uniform mild hyperintensity of the outer putaminal margin was evident in 7% at 0.35T, 40% at 1.5T, and 47% at 3.0T in MSA and in 5% at 0.35T, 60% at 1.5T, and 75% at 3.0T in PD. However, no PD patients showed hyperintensity at the dorsolateral outer putaminal margin and that of the putaminal body. Putaminal magnetic resonance imaging (MRI) findings in MSA were altered considerably by magnetic field strength. The severity and distribution of signal changes are important for assessing putaminal MRI findings in MSA.

    DOI: 10.1002/mds.23196

    PubMed

    researchmap

  • Efficacy and safety of leuprorelin in patients with spinal and bulbar muscular atrophy (JASMITT study): a multicentre, randomised, double-blind, placebo-controlled trial. 国際誌

    Masahisa Katsuno, Haruhiko Banno, Keisuke Suzuki, Yu Takeuchi, Motoshi Kawashima, Ichiro Yabe, Hidenao Sasaki, Masashi Aoki, Mitsuya Morita, Imaharu Nakano, Kazuaki Kanai, Shoichi Ito, Kinya Ishikawa, Hidehiro Mizusawa, Tomotaka Yamamoto, Shoji Tsuji, Kazuko Hasegawa, Takayoshi Shimohata, Masatoyo Nishizawa, Hiroaki Miyajima, Fumio Kanda, Yasuhiro Watanabe, Kenji Nakashima, Akira Tsujino, Taro Yamashita, Makoto Uchino, Yasushi Fujimoto, Fumiaki Tanaka, Gen Sobue

    The Lancet. Neurology   9 ( 9 )   875 - 84   2010年9月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    BACKGROUND: Spinal and bulbar muscular atrophy is a hereditary motor neuron disease caused by the expansion of a polyglutamine tract in the androgen receptor. At present there are no treatments for spinal and bulbar muscular atrophy, although leuprorelin suppressed the accumulation of pathogenic androgen receptors in a phase 2 trial. We aimed to assess the efficacy and safety of leuprorelin for spinal and bulbar muscular atrophy. METHODS: The Japan SBMA Interventional Trial for TAP-144-SR (JASMITT) was a 48-week, randomised, double-blind, placebo-controlled trial done at 14 hospitals between August, 2006, and March, 2008. Patients with spinal and bulbar muscular atrophy were randomly assigned (1:1) by minimisation to subcutaneous 11.25 mg leuprorelin or identical placebo every 12 weeks. Patients and investigators were masked to treatment allocation. The primary endpoint was pharyngeal barium residue, which indicates incomplete bolus clearance, measured at week 48 by videofluorography. All patients who were randomly assigned and who were assessed with videofluorography at least once were included in the analyses. This study is registered with the JMACCT clinical trials registry, number JMA-IIA00009, and the UMIN clinical trials registry, number UMIN000000465. FINDINGS: 204 patients were randomly assigned and 199 started treatment: 100 with leuprorelin and 99 with placebo. At week 48, the pharyngeal barium residue after initial swallowing had changed by -5.1% (SD 21.0) in the leuprorelin group and by 0.2% (18.2) in the placebo group (difference between groups -5.3%; 95% CI -10.8 to 0.3; p=0.063). The mean difference in pharyngeal barium residue after piecemeal deglutition at week 48 was -3.2% (-6.4 to 0.0; p=0.049), but there was no significant difference between the groups after covariate adjustment for the baseline data (-4.1 to 1.6; p=0.392). In a predefined subgroup analysis, leuprorelin treatment was associated with a greater reduction in barium residue after initial swallowing than was placebo in patients with a disease duration less than 10 years (difference between groups -9.8, -17.1 to -2.5; p=0.009). There were no significant differences in the number of drug-related adverse events between groups (57 of 100 in the leuprorelin group and 54 of 99 in the placebo group; p=0.727). INTERPRETATION: 48 weeks of treatment with leuprorelin did not show significant effects on swallowing function in patients with spinal and bulbar muscular atrophy, although it was well tolerated. Disease duration might influence the efficacy of leuprorelin and thus further clinical trials with sensitive outcome measures should be done in subpopulations of patients. FUNDING: Large Scale Clinical Trial Network Project, Japan and Takeda Pharmaceuticals.

    DOI: 10.1016/S1474-4422(10)70182-4

    PubMed

    researchmap

  • Correlated expression of CD47 and SIRPA in bone marrow and in peripheral blood predicts recurrence in breast cancer patients. 査読

    Nagahara M, Mimori K, Kataoka A, Ishii H, Tanaka F, Nakagawa T, Sato T, Ono S, Sugihara K, Mori M

    Clinical cancer research : an official journal of the American Association for Cancer Research   16 ( 18 )   4625 - 4635   2010年9月

  • CD13 is a therapeutic target in human liver cancer stem cells. 査読 国際誌

    Haraguchi N, Ishii H, Mimori K, Tanaka F, Ohkuma M, Kim HM, Akita H, Takiuchi D, Hatano H, Nagano H, Barnard GF, Doki Y, Mori M

    The Journal of clinical investigation   120 ( 9 )   3326 - 3339   2010年9月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.1172/JCI42550

    PubMed

    researchmap

  • Robust and photocontrollable DNA capsules using azobenzenes. 査読

    Tanaka F, Mochizuki T, Liang X, Asanuma H, Tanaka S, Suzuki K, Kitamura S, Nishikawa A, Ui-Tei K, Hagiya M

    Nano letters   10 ( 9 )   3560 - 3565   2010年9月

  • IgM MGUS anti-MAG neuropathy with predominant muscle weakness and extensive muscle atrophy. 国際誌

    Yuichi Kawagashira, Naohide Kondo, Naoki Atsuta, Masahiro Iijima, Haruki Koike, Masahisa Katsuno, Fumiaki Tanaka, Susumu Kusunoki, Gen Sobue

    Muscle & nerve   42 ( 3 )   433 - 5   2010年9月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    We report a patient with anti-myelin-associated glycoprotein (MAG) neuropathy, predominantly exhibiting severe motor symptoms, accompanied by extensive muscle atrophy mimicking Charcot-Marie-Tooth disease. Nerve conduction studies revealed mild retardation of motor conduction velocities and significant prolongation of distal latency. Sural nerve biopsy revealed widely spaced myelin and positive staining of myelinated fibers with an IgM antibody. Predominant motor symptoms with muscle atrophy can be one of the clinical manifestations of anti-MAG neuropathy.

    DOI: 10.1002/mus.21741

    PubMed

    researchmap

  • 球脊髄性筋萎縮症(SBMA)におけるナトリウムチャンネルの発現異常(Expression pattern of sodium channels is dysregulated in spinal and bulbar musclar atrophy (SBMA))

    勝野 雅央, 足立 弘明, 南山 誠, 土井 英樹, 近藤 直英, 松本 慎二郎, 坂野 晴彦, 鈴木 啓介, 田中 章景, 祖父江 元

    神経化学   49 ( 2-3 )   583 - 583   2010年8月

     詳細を見る

    記述言語:英語   出版者・発行元:日本神経化学会  

    researchmap

  • The profile of motor unit number estimation (MUNE) in spinal and bulbar muscular atrophy. 国際誌

    Keisuke Suzuki, Masahisa Katsuno, Haruhiko Banno, Yu Takeuchi, Motoshi Kawashima, Noriaki Suga, Atsushi Hashizume, Tetsuo Hama, Kei Uchida, Fumitada Yamashita, Tomohiko Nakamura, Masaaki Hirayama, Fumiaki Tanaka, Gen Sobue

    Journal of neurology, neurosurgery, and psychiatry   81 ( 5 )   567 - 71   2010年5月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    OBJECTIVE: Spinal and bulbar muscular atrophy (SBMA) is a lower motor neuron disease caused by the expansion of a trinucleotide CAG repeat in the androgen receptor (AR) gene. The fundamental histopathological finding of this disease is an extensive loss of lower motor neurons in the spinal cord and brainstem. It is, however, difficult to evaluate clinically the degree of motor neuron degeneration, which stresses the need for biomarkers to detect the remaining neuronal function. METHODS: The authors performed motor unit number estimation (MUNE) in 52 patients with SBMA, to investigate whether this method could be a potential biomarker of SBMA, and re-evaluated MUNE 1 year later in a subgroup of the patients. RESULTS: The number of functioning motor units was remarkably reduced in patients with SBMA compared with controls, and was correlated with both ipsilateral grip power and disease duration. A longitudinal analysis demonstrated a further reduction in motor units within 1 year. CONCLUSIONS: The results suggest that MUNE is an electrophysiological parameter that reflects the severity and progression of motor neuron degeneration in patients with SBMA.

    DOI: 10.1136/jnnp.2009.190462

    PubMed

    researchmap

  • Clinicopathological and prognostic significance of PDCD4 and microRNA-21 in human gastric cancer. 査読 国際誌

    Motoyama K, Inoue H, Mimori K, Tanaka F, Kojima K, Uetake H, Sugihara K, Mori M

    International journal of oncology   36 ( 5 )   1089 - 1095   2010年5月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.3892/ijo_00000590

    PubMed

    researchmap

  • Disrupted transforming growth factor-beta signaling in spinal and bulbar muscular atrophy. 国際誌

    Masahisa Katsuno, Hiroaki Adachi, Makoto Minamiyama, Masahiro Waza, Hideki Doi, Naohide Kondo, Hiroyuki Mizoguchi, Atsumi Nitta, Kiyofumi Yamada, Haruhiko Banno, Keisuke Suzuki, Fumiaki Tanaka, Gen Sobue

    The Journal of neuroscience : the official journal of the Society for Neuroscience   30 ( 16 )   5702 - 12   2010年4月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Spinal and bulbar muscular atrophy (SBMA) is a late-onset lower motor neuron disease caused by the expansion of a trinucleotide CAG repeat, which encodes a polyglutamine tract in androgen receptor (AR). Although it is commonly held that the pathogenic polyglutamine proteins accumulate in neurons and thereby induce transcriptional dysregulation, the downstream molecular events have remained elusive. Here, we examined whether TGF-beta signaling is dysregulated in SBMA. Nuclear translocation of phosphorylated Smad2/3, a key step in TGF-beta signaling, is suppressed in the spinal motor neurons of male transgenic mice carrying the mutant human AR. A similar finding was also observed in the motor neurons, but not in Purkinje cells, of SBMA patients. The pathogenic AR, the causative protein of SBMA, inhibits the transcription of TGF-beta receptor type II (TbetaRII) via abnormal interactions with NF-Y and p300/CBP-associated factor. Furthermore, overexpression of TbetaRII dampens polyglutamine-induced cytotoxicity in a neuroblastoma cell line expressing the pathogenic AR. The present study thus indicates that disruption of TGF-beta due to the transcriptional dysregulation of TbetaRII is associated with polyglutamine-induced motor neuron damage in SBMA.

    DOI: 10.1523/JNEUROSCI.0388-10.2010

    PubMed

    researchmap

  • TGM2 is a novel marker for prognosis and therapeutic target in colorectal cancer. 査読

    Miyoshi N, Ishii H, Mimori K, Tanaka F, Hitora T, Tei M, Sekimoto M, Doki Y, Mori M

    Annals of surgical oncology   17 ( 4 )   967 - 972   2010年4月

  • Overexpression of SUGT1 in human colorectal cancer and its clinicopathological significance. 査読 国際誌

    Iwatsuki M, Mimori K, Sato T, Toh H, Yokobori T, Tanaka F, Ishikawa K, Baba H, Mori M

    International journal of oncology   36 ( 3 )   569 - 575   2010年3月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.3892/ijo_00000531

    PubMed

    researchmap

  • ATP11A is a novel predictive marker for metachronous metastasis of colorectal cancer. 査読 国際誌

    Miyoshi N, Ishii H, Mimori K, Tanaka F, Nagai K, Uemura M, Sekimoto M, Doki Y, Mori M

    Oncology reports   23 ( 2 )   505 - 510   2010年2月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    PubMed

    researchmap

  • Parkinson病様症状を呈した原発性側索硬化症の1例

    橋詰 淳, 曽根 淳, 伊藤 瑞規, 熱田 直樹, 渡辺 宏久, 田中 章景, 祖父江 元

    臨床神経学   50 ( 2 )   120 - 120   2010年2月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 【Spinocerebellar ataxia(SCA)】Spinocerebellar ataxia type 12

    伊藤 瑞規, 渡邉 宏久, 田中 章景, 祖父江 元

    神経内科   72 ( 2 )   169 - 172   2010年2月

     詳細を見る

    記述言語:日本語   出版者・発行元:(有)科学評論社  

    researchmap

  • Dorfin ameliorates phenotypes in a transgenic mouse model of amyotrophic lateral sclerosis. 国際誌

    Jun Sone, Jun-ichi Niwa, Kaori Kawai, Shinsuke Ishigaki, Shin-ichi Yamada, Hiroaki Adachi, Masahisa Katsuno, Fumiaki Tanaka, Manabu Doyu, Gen Sobue

    Journal of neuroscience research   88 ( 1 )   123 - 35   2010年1月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease that is characterized by progressive motor neuron degeneration and leads to death within a few years of diagnosis. One of the pathogenic mechanisms of ALS is proposed to be a dysfunction in the protein quality-control machinery. Dorfin has been identified as a ubiquitin ligase (E3) that recognizes and ubiquitinates mutant SOD1 proteins, thereby accelerating their degradation and reducing their cellular toxicity. We examined the effects of human Dorfin overexpression in G93A mutant SOD1 transgenic mice, a mouse model of familial ALS. In addition to causing a decrease in the amount of mutant SOD1 protein in the spinal cord, Dorfin overexpression ameliorated neurological phenotypes and motor neuron degeneration. Our results indicate that Dorfin overexpression or the activation or induction of E3 may be a therapeutic avenue for mutant SOD1-associated ALS.

    DOI: 10.1002/jnr.22175

    PubMed

    researchmap

  • Defined factors induce reprogramming of gastrointestinal cancer cells. 査読

    Miyoshi N, Ishii H, Nagai K, Hoshino H, Mimori K, Tanaka F, Nagano H, Sekimoto M, Doki Y, Mori M

    Proceedings of the National Academy of Sciences of the United States of America   107 ( 1 )   40 - 45   2010年1月

  • Familial amyotrophic lateral sclerosis with a novel G85S mutation of superoxide dismutase 1 gene: clinical features of lower motor neuron disease.

    Takanori Takazawa, Ken Ikeda, Takehisa Hirayama, Kiyokazu Kawabe, Yoshikazu Nakamura, Hirono Ito, Osamu Kano, Yasuhiro Yoshii, Fumiaki Tanaka, Gen Sobue, Yasuo Iwasaki

    Internal medicine (Tokyo, Japan)   49 ( 2 )   183 - 6   2010年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Amyotrophic lateral sclerosis (ALS) is a devastating disease characterized by upper and lower motor neuron damage. Mutations of Cu/Zn superoxide dismutase gene (SOD1) account for 20% of familial ALS (FALS). We report a unique clinicogenotype of a Japanese family with a novel SOD 1 mutation. A 37-year-old woman (the proband) noticed muscle weakness in the left lower limb. Her mother had developed progressive lower motor neuron signs in four extremities at 38 years of age. Subsequently she was diagnosed as ALS and died of respiratory failure at 15 months after clinical onset. Neurological examination of the proband showed absent muscle stretch reflexes in the left knee and the left ankle without Babinski signs. Mild to moderate degree of muscle weakness existed in the left lower extremity. Muscle atrophy was presented in the left thigh. Initial pulmonary function revealed forced vital capacity of 91.1%. Electromyography disclosed ongoing denervation muscle potentials in the left lower extremity. SOD1 analysis demonstrated amino acid substitution of glycine by serine at codon 85 (G85S) in exon 4. Six months later, marked muscle weakness and atrophy expanded to four extremities. All muscle stretch reflexes were absent. Three months later, ventilator support with a tracheostomy was needed. The patient died at 18 months after clinical onset. Clinical hallmarks of this FALS family indicate that G85S mutation of SOD1 may cause rapidly progressive form of pure lower motor neuron signs.

    PubMed

    researchmap

  • FHIT suppresses inflammatory carcinogenic activity by inducing apoptosis in esophageal epithelial cells 査読

    Koshi Mimori, Takehiko Yokobori, Masaaki Iwatsuki, Tomoya Sudo, Fumiaki Tanaka, Kohei Shibata, Hideshi Ishii, Masaki Mori

    Journal of Nucleic Acids Investigation   1 ( 1 )   31 - 35   2010年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    We focused on the mechanism by which FHIT suppresses neoplastic transformation in normal but damaged esophageal epithelial cells exposed to inflammatory stimuli in vivo and to chemo-radiotherapy in clinical samples. For in vitro analysis, Adenoviral-FHIT (Ad-FHIT) in TE4 and TE2 were used for microarray analysis. For in vivo analysis, wild-type (WT) FHIT and FHIT-deficient (KO) C57BL/6 mice were exposed to N-nitrosomethylbenzylamine (NMBA) and to a cyclooxygenase-2 inhibitor (COXI). Considering DNA damage on clinical samples, expressions of FHIT, BAX and PCNA were evaluated by comparing between 3 cases of esophageal cancer cases of the chemo-radiotherapy responder and 7 cases of the non-responder. In in vitro analysis, we listed the down-regulated genes in Ad-FHIT that significantly control Lac-Z infected cells, such as prostaglandin E receptor 4, cyclooxygenase-1 and cyclooxygenase-2. In in vivo analysis, FHIT-KO mice were much more susceptible to tumorigenesis than were FHIT-WT mice. A significant difference in PGE2 activation was observed between FHIT-WT mice (5.2 ng/mL) and FHIT-KO mice (28.4 ng/mL) after exposure to NMBA in the absence of COXI as determined by ELISA assay (P&lt
    0.01). BAX expression was significantly higher in FHIT-WT (1.0±0.43) than in FHIT-KO (0.17±0.17) (P&lt
    0.05). The IHC score for FHIT and BAX expression was significantly higher in responders than the others (P&lt
    0.05). FHIT possesses tumor suppressor activity by induction of apoptosis in damaged cells after exposure to inflammatory carcinogens and DNA damaging chemo-radiotherapy. © K. Mimori et al., 2010.

    DOI: 10.4081/jnai.2010.e7

    Scopus

    researchmap

  • Clinical features and molecular mechanisms of spinal and bulbar muscular atrophy (SBMA). 国際誌

    Masahisa Katsuno, Haruhiko Banno, Keisuke Suzuki, Hiroaki Adachi, Fumiaki Tanaka, Gen Sobue

    Advances in experimental medicine and biology   685   64 - 74   2010年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Spinal and bulbar muscular atrophy (SBMA) is an adult-onset neurodegenerative disease characterized by slowly progressive muscle weakness and atrophy. The cause of this disease is the expansion of a trinucleotide CAG repeat, which encodes the polyglutamine tract, within the first exon of the androgen receptor (AR) gene. SBMA exclusively occurs in adult males, whereas both heterozygous and homozygous females are usually asymptomatic. Lower motor neurons in the anterior horn of the spinal cord and those in the brainstem motor nuclei are predominantly affected in SBMA, and other neuronal and nonneuronal tissues are also widely involved to some extent. Testosterone-dependent nuclear accumulation of the pathogenic AR protein has been considered to be a fundamental step of neurodegenerative process, which is followed by several molecular events such as transcriptional dysregulation, axonal transport disruption and mitochondrial dysfunction. Results of animal studies suggest that androgen deprivation and activation of protein quality control systems are potential therapies for SBMA.

    PubMed

    researchmap

  • 運動ニューロン病での感覚神経伝導速度の特異性 ALSとSBMAの比較

    平山 正昭, 中村 友彦, 濱 哲夫, 山下 史匡, 内田 圭, 鈴木 啓介, 坂野 晴彦, 田中 章景, 勝野 雅央, 祖父江 元

    臨床神経学   49 ( 12 )   1174 - 1174   2009年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 球脊髄性筋萎縮症におけるリュープロレリン酢酸塩の第2相試験

    坂野 晴彦, 勝野 雅央, 鈴木 啓介, 竹内 優, 川島 基, 須賀 徳明, 高森 元子, 伊藤 瑞規, 中村 友彦, 松尾 幸司, 山田 新一, 沖 祐美子, 足立 弘明, 南山 誠, 和座 雅浩, 熱田 直樹, 渡邉 宏久, 藤本 保志, 田中 章景, 道勇 学, 祖父江 元

    臨床神経学   49 ( 12 )   980 - 980   2009年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • Heat shock proteins in neurodegenerative diseases: pathogenic roles and therapeutic implications. 国際誌

    Hiroaki Adachi, Masahisa Katsuno, Masahiro Waza, Makoto Minamiyama, Fumiaki Tanaka, Gen Sobue

    International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group   25 ( 8 )   647 - 54   2009年12月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Neurodegenerative diseases including amyotrophic lateral sclerosis, Parkinson's disease, Alzheimer's disease, and polyglutamine (polyQ) diseases are thought to be caused by protein misfolding. Heat shock proteins (HSPs), which function mainly as molecular chaperones, play an important role in the folding and quality control of proteins. The histopathological hallmark of neurodegenerative diseases is accumulation and/or inclusions of the disease-causing proteins in residual neurons in targeted regions of the nervous system. The inclusions combine with many components of molecular chaperone pathways and ubiquitin-proteasome, raising the possibility that misfolding and altered degradation of mutant proteins may be involved in the pathogenesis of neurodegenerative diseases. Overexpression of HSPs has been reported to reduce the number and size of inclusions and accumulation of disease-causing proteins, and ameliorate the phenotypes in neuronal cell and mouse models. Hsp90 inhibitors also exert therapeutic effects through selective proteasome degradation of its client proteins. Elucidation of its pathophysiology using animal models has led to the development of disease-modifying drugs, i.e., Hsp90 inhibitor and HSP inducer, which inhibit the pathogenic process of neuronal degeneration. These findings may provide the basis for development of an HSP-related therapy for neurodegenerative diseases.

    DOI: 10.3109/02656730903315823

    PubMed

    researchmap

  • [Molecular-targeted therapies for spinal and bulbar muscular atrophy]. 査読

    Masahisa Katsuno, Haruhiko Banno, Keisuke Suzuki, Hiroaki Adachi, Fumiaki Tanaka, Gen Sobue

    Rinsho shinkeigaku = Clinical neurology   49 ( 11 )   917 - 20   2009年11月

     詳細を見る

    記述言語:日本語   掲載種別:研究論文(学術雑誌)  

    Spinal and bulbar muscular atrophy (SBMA) is a polyglutamine-mediated lower motor neuron disease characterized by slowly progressive muscle weakness and atrophy. The cause of this disease is the expansion of a trinucleotide CAG repeat, which encodes the polyglutamine tract, within the first exon of the androgen receptor (AR) gene. SBMA exclusively occurs in adult males, whereas both heterozygous and homozygous females are usually asymptomatic. Testosterone-dependent nuclear accumulation of the pathogenic AR protein has been considered to be a fundamental step of neurodegenerative process, which is followed by several molecular events such as transcriptional dysregulation, axonal transport disruption, and mitochondria dysfunction. Androgen deprivation suppresses the toxicity of the mutant AR in animal models of SBMA, and these insights have been translated to clinic. Animal studies have also suggested that activation of protein quality control systems are potential therapies for SBMA. To optimize "proof of concept", the process for testing candidate therapies in humans, it is of importance to identify responders to each therapy, to initiate interventions in early stages of the disease, and to establish biomarkers which can be used for evaluating the efficacy of treatment.

    DOI: 10.5692/clinicalneurol.49.917

    Scopus

    PubMed

    researchmap

  • [Exploration of pathogenesis and therapy development for ALS employing sporadic disease model]. 査読

    Fumiaki Tanaka, Masahiro Waza, Masahiko Yamamoto, Gen Sobue

    Rinsho shinkeigaku = Clinical neurology   49 ( 11 )   811 - 3   2009年11月

     詳細を見る

    記述言語:日本語   掲載種別:研究論文(学術雑誌)  

    The mechanisms underlying motor neuron degeneration in amyotrophic lateral sclerosis (ALS) remain poorly understood even now 140 years after the first description of the disease in 1869 by Jean-Martin Charcot. Exploration of pathogenesis of ALS has long been dependent on transgenic animal models with mutations in the copper/ zinc superoxide dismutase 1 (SOD1) gene. However, the lack of therapeutic concordance between these animal models and human sporadic ALS patients is troubling. The reasons include that there might exist the differences of pathogenesis between sporadic and familial ALS and/or the disease models for sporadic ALS have not been established. We have been working on screening motor neuron-specific genes critical for pathogenesis of sporadic ALS using cDNA microarray and laser capture microdissection techniques. Many of the resultant genes are of intense interest and may provide a powerful tool for determining the molecular mechanisms of sporadic ALS. In particular, dynactin-1, a major component of dynein/dynactin complex and several cell cycle-related genes are the targets of our research. Development and analysis of new disease models for sporadic ALS based on these genes will open an avenue for novel therapeutics.

    DOI: 10.5692/clinicalneurol.49.811

    Scopus

    PubMed

    researchmap

  • ポリグルタミン病への分子生物学的アプローチ 球脊髄性筋萎縮症に対する分子治療

    勝野 雅央, 坂野 晴彦, 鈴木 啓介, 足立 弘明, 田中 章景, 祖父江 元

    臨床神経学   49 ( 11 )   917 - 920   2009年11月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    球脊髄性筋萎縮症(SBMA)は成人男性に発症する運動ニューロン疾患であり、アンドロゲン受容体遺伝子(AR)のCAGくりかえし配列の異常延長を原因とするポリグルタミン病である。病因蛋白質である変異ARが運動ニューロン内に蓄積し、転写障害や軸索輸送障害など様々な細胞機能低下をひきおこすという病態仮説が提唱されている。変異ARの蓄積はテストステロンに依存しており、男性ホルモン抑制剤であるリュープロレリン酢酸塩の有効性がSBMA患者を対象とした第II相臨床試験で示されている。今後SBMAの治療法開発を更に進めるためには、多彩な分子生物学的アプローチと、その効果を臨床試験で検証するための方法論を確立する必要がある。(著者抄録)

    researchmap

    その他リンク: https://search.jamas.or.jp/index.php?module=Default&action=Link&pub_year=2009&ichushi_jid=J01550&link_issn=&doc_id=20091208290058&doc_link_id=10026291112&url=http%3A%2F%2Fci.nii.ac.jp%2Fnaid%2F10026291112&type=CiNii&icon=https%3A%2F%2Fjk04.jamas.or.jp%2Ficon%2F00003_1.gif

  • A platinum agent resistance gene, POLB, is a prognostic indicator in colorectal cancer. 査読 国際誌

    Iwatsuki M, Mimori K, Yokobori T, Tanaka F, Tahara K, Inoue H, Baba H, Mori M

    Journal of surgical oncology   100 ( 3 )   261 - 266   2009年9月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.1002/jso.21275

    PubMed

    researchmap

  • [Upper G.I. cancer: the esophagus and stomach. II. The current status of comprehensive gene analysis of esophageal cancer]. 査読

    Shuto A, Tanaka F, Mimori K, Fujita H, Shirouzu K, Mori M

    Gan to kagaku ryoho. Cancer & chemotherapy   36 ( 9 )   1435 - 1441   2009年9月

     詳細を見る

  • TDP-43 depletion induces neuronal cell damage through dysregulation of Rho family GTPases. 国際誌

    Yohei Iguchi, Masahisa Katsuno, Jun-Ichi Niwa, Shin-Ichi Yamada, Jun Sone, Masahiro Waza, Hiroaki Adachi, Fumiaki Tanaka, Koh-Ichi Nagata, Nariko Arimura, Takashi Watanabe, Kozo Kaibuchi, Gen Sobue

    The Journal of biological chemistry   284 ( 33 )   22059 - 22066   2009年8月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    The 43-kDa TAR DNA-binding protein (TDP-43) is known to be a major component of the ubiquitinated inclusions characteristic of amyotrophic lateral sclerosis and frontotemporal lobar degeneration with ubiquitin-positive inclusions. Although TDP-43 is a nuclear protein, it disappears from the nucleus of affected neurons and glial cells, implicating TDP-43 loss of function in the pathogenesis of neurodegeneration. Here we show that the knockdown of TDP-43 in differentiated Neuro-2a cells inhibited neurite outgrowth and induced cell death. In knockdown cells, the Rho family members RhoA, Rac1, and Cdc42 GTPases were inactivated, and membrane localization of these molecules was reduced. In addition, TDP-43 depletion significantly suppressed protein geranylgeranylation, a key regulating factor of Rho family activity and intracellular localization. In contrast, overexpression of TDP-43 mitigated the cellular damage caused by pharmacological inhibition of geranylgeranylation. Furthermore administration of geranylgeranyl pyrophosphate partially restored cell viability and neurite outgrowth in TDP-43 knockdown cells. In summary, our data suggest that TDP-43 plays a key role in the maintenance of neuronal cell morphology and survival possibly through protein geranylgeranylation of Rho family GTPases.

    DOI: 10.1074/jbc.M109.012195

    PubMed

    researchmap

  • Clinicopathological significance of stanniocalcin 2 gene expression in colorectal cancer. 査読 国際誌

    Ieta K, Tanaka F, Yokobori T, Kita Y, Haraguchi N, Mimori K, Kato H, Asao T, Inoue H, Kuwano H, Mori M

    International journal of cancer   125 ( 4 )   926 - 931   2009年8月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.1002/ijc.24453

    PubMed

    researchmap

  • 【神経・筋疾患の分子標的治療】運動ニューロン疾患の分子標的治療

    坂野 晴彦, 勝野 雅央, 鈴木 啓介, 井口 洋平, 足立 弘明, 田中 章景, 祖父江 元

    BRAIN and NERVE: 神経研究の進歩   61 ( 8 )   891 - 900   2009年8月

  • [Molecular-targeted therapy for motor neuron disease]. 査読

    Haruhiko Banno, Masahisa Katsuno, Keisuke Suzuki, Yohei Iguchi, Hiroaki Adachi, Fumiaki Tanaka, Gen Sobue

    Brain and nerve = Shinkei kenkyu no shinpo   61 ( 8 )   891 - 900   2009年8月

     詳細を見る

    記述言語:日本語   掲載種別:研究論文(学術雑誌)  

    The mechanisms underlying selective motor neuron degeneration in amyotrophic lateral sclerosis (ALS) remain unknown. There have been several important clinical trials on the treatment of ALS and treatment efficacy studies using mouse (SOD1) models of ALS. The latter revealed that diminished mutant SOD1 expression in the astrocytes delayed microglial activation and slowed disease progression. Dyslipidemia has been reported to have a protective effect in ALS patients. Current evidence has implicated a 43-kDa TAR DNA-binding protein (TDP-43) in the pathologenesis of ALS. Several mutations in TDP-43 were discovered in families with inherited motor neuron disease. Although phase III trials revealed that creatine monohydrate and IGF-1 was not beneficial for patients with ALS, favorable outcomes in SOD1 mice were reported with lithium, NADPH oxidase inhibitor, free-radical scavenger, and ammonium tetrathiomolybdate. Spinal and bulbar muscular atrophy (SBMA) is an adult-onset motor neuron disease affecting only males. Animal studies have revealed that the pathogenesis of SBMA depends on the serum testosterone level and that androgen deprivation mitigates neurodegeneration through inhibition of nuclear accumulation of the pathogenic androgen receptor (AR). Our studies have also identified several candidates for the treatment of SBMA. Selective inhibition of heat shock protein (HSP) facilitates the proteasomal degradation of pathogenic AR, leading to improvements in the signs and symptoms of SBMA mice. Oral administration of sodium butyrate--a histone deacetylase inhibitor--resulted in the improvement of neurological dysfunction in the SBMA mouse model, although its therapeutic dose range is narrow.

    Scopus

    PubMed

    researchmap

  • Polycyclic N-heterocyclic compounds. part 59: rearrangement reactions of fused tricyclic 3-(2-bromoethyl)pyrimidin-4(3h)-ones with primary amines via a dimroth-type rearrangement. 査読

    Okuda K, Ohtomo H, Tanaka F, Hirota T, Sasaki K

    Chemical & pharmaceutical bulletin   57 ( 7 )   755 - 758   2009年7月

     詳細を見る

    記述言語:英語   出版者・発行元:公益社団法人 日本薬学会  

    Reaction of some fused tricyclic 3-(2-bromoethyl)pyrimidin-4(3H)-ones with primary alkyl amines gave abnormal fused 3-alkyl-4-alkyliminopyrimidines via a Dimroth-type rearrangement, as well as normal substituted 3-(2-alkylaminoethyl) derivatives in methanol. This abnormal rearrangement reaction depended on reaction solvent.

    DOI: 10.1248/cpb.57.755

    PubMed

    CiNii Books

    researchmap

    その他リンク: https://jlc.jst.go.jp/DN/JALC/00333393374?from=CiNii

  • Clinicopathologic significance of KIAA1199 overexpression in human gastric cancer. 査読

    Matsuzaki S, Tanaka F, Mimori K, Tahara K, Inoue H, Mori M

    Annals of surgical oncology   16 ( 7 )   2042 - 2051   2009年7月

  • 【神経疾患治療の進歩】運動ニューロン疾患の治療の進歩

    田中 章景, 坂野 晴彦, 井口 洋平, 勝野 雅央, 祖父江 元

    神経治療学   26 ( 4 )   471 - 475   2009年7月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経治療学会  

    researchmap

  • [Perspectives on current status and future directions for cancer stem cells theory in gastrointestinal cancer]. 査読

    Takemasa I, Ishii H, Haraguchi N, Mimori K, Tanaka F, Nagano H, Sekimoto M, Doki Y, Mori M

    Nihon Geka Gakkai zasshi   110 ( 4 )   207 - 212   2009年7月

     詳細を見る

    記述言語:日本語   掲載種別:研究論文(学術雑誌)  

    PubMed

    researchmap

  • 中枢神経の障害を示したn-Hexaneニューロパチーの1例 曝露回避による回復の過程について

    橋詰 淳, 川頭 祐一, 伊藤 瑞規, 小池 春樹, 渡邉 宏久, 服部 直樹, 田中 章景, 祖父江 元

    神経治療学   26 ( 3 )   384 - 384   2009年5月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経治療学会  

    researchmap

  • Intravenous immunoglobulin treatment for painful sensory neuropathy associated with Sjögren's syndrome. 国際誌

    Saori Morozumi, Yuichi Kawagashira, Masahiro Iijima, Haruki Koike, Naoki Hattori, Masahisa Katsuno, Fumiaki Tanaka, Gen Sobue

    Journal of the neurological sciences   279 ( 1-2 )   57 - 61   2009年4月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    BACKGROUND: Patients with painful sensory neuropathy associated with Sjögren's syndrome-associated neuropathy often show severe neuropathic pain which is not relieved by conventional treatments. OBJECTIVE: To evaluate the effect of intravenous immunoglobulin (IVIg) therapy in the treatment of neuropathic pain associated with Sjögren's syndrome. PATIENTS AND METHODS: We examined 5 patients affected by painful sensory neuropathy associated with Sjögren's syndrome. All patients were treated with IVIg (0.4 g/kg/day for 5 days) and pain rating was assessed by the Visual Analogue Scale (VAS). RESULTS: All five patients showed a remarkable improvement in neuropathic pain following IVIg therapy. Pain, assessed by the determination of mean VAS score, was reduced by 73.4% from days 2-14 following treatment. The observed clinical improvement persisted for 2 to 6 months. One patient, examined by quantitative sensory testing (QST), showed an improvement of superficial sensory deficit accompanied by pain relief. CONCLUSION: IVIg might be an effective treatment for pain in Sjögren's syndrome-associated neuropathy. Further studies should be done in a controlled, blind study.

    DOI: 10.1016/j.jns.2008.12.018

    PubMed

    researchmap

  • Over- and under-expressed microRNAs in human colorectal cancer. 査読

    Motoyama K, Inoue H, Takatsuno Y, Tanaka F, Mimori K, Uetake H, Sugihara K, Mori M

    International journal of oncology   34 ( 4 )   1069 - 1075   2009年4月

  • 【神経変性疾患研究の新機軸 その新たな研究戦略が謎を解く】運動ニューロン疾患の病因解析と治療法の開発

    勝野 雅央, 坂野 晴彦, 鈴木 啓介, 足立 弘明, 田中 章景, 祖父江 元

    細胞工学   28 ( 5 )   456 - 460   2009年4月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)学研メディカル秀潤社  

    researchmap

  • 17-DMAG ameliorates polyglutamine-mediated motor neuron degeneration through well-preserved proteasome function in an SBMA model mouse. 国際誌

    Keisuke Tokui, Hiroaki Adachi, Masahiro Waza, Masahisa Katsuno, Makoto Minamiyama, Hideki Doi, Keiji Tanaka, Jun Hamazaki, Shigeo Murata, Fumiaki Tanaka, Gen Sobue

    Human molecular genetics   18 ( 5 )   898 - 910   2009年3月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    The ubiquitin-proteasome system (UPS) is the principal protein degradation system that tags and targets short-lived proteins, as well as damaged or misfolded proteins, for destruction. In spinal and bulbar muscular atrophy (SBMA), the androgen receptor (AR), an Hsp90 client protein, is such a misfolded protein that tends to aggregate in neurons. Hsp90 inhibitors promote the degradation of Hsp90 client proteins via the UPS. In a transgenic mouse model of SBMA, we examined whether a functioning UPS is preserved, if it was capable of degrading polyglutamine-expanded mutant AR, and what might be the therapeutic effects of 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin (17-DMAG), an oral Hsp90 inhibitor. Ubiquitin-proteasomal function was well preserved in SBMA mice and was even increased during advanced stages when the mice developed severe phenotypes. Administration of 17-DMAG markedly ameliorated motor impairments in SBMA mice without detectable toxicity and reduced amounts of monomeric and nuclear-accumulated mutant AR. Mutant AR was preferentially degraded in the presence of 17-DMAG in both SBMA cell and mouse models when compared with wild-type AR. 17-DMAG also significantly induced Hsp70 and Hsp40. Thus, 17-DMAG would exert a therapeutic effect on SBMA via preserved proteasome function.

    DOI: 10.1093/hmg/ddn419

    PubMed

    researchmap

  • Neuropathology and therapeutic intervention in spinal and bulbar muscular atrophy. 国際誌

    Haruhiko Banno, Masahisa Katsuno, Keisuke Suzuki, Fumiaki Tanaka, Gen Sobue

    International journal of molecular sciences   10 ( 3 )   1000 - 12   2009年3月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Spinal and bulbar muscular atrophy (SBMA) is a hereditary motor neuron disease caused by the expansion of a polyglutamine tract in the androgen receptor (AR). The histopathological finding in SBMA is loss of lower motor neurons in the anterior horn of the spinal cord as well as in the brainstem motor nuclei. Animal studies have revealed that the pathogenesis of SBMA depends on the level of serum testosterone, and that androgen deprivation mitigates neurodegeneration through inhibition of nuclear accumulation of the pathogenic AR. Heat shock proteins, ubiquitin-proteasome system and transcriptional regulation are also potential targets of therapy development for SBMA.

    PubMed

    researchmap

  • Phase 2 trial of leuprorelin in patients with spinal and bulbar muscular atrophy. 国際誌

    Haruhiko Banno, Masahisa Katsuno, Keisuke Suzuki, Yu Takeuchi, Motoshi Kawashima, Noriaki Suga, Motoko Takamori, Mizuki Ito, Tomohiko Nakamura, Koji Matsuo, Shinichi Yamada, Yumiko Oki, Hiroaki Adachi, Makoto Minamiyama, Masahiro Waza, Naoki Atsuta, Hirohisa Watanabe, Yasushi Fujimoto, Tsutomu Nakashima, Fumiaki Tanaka, Manabu Doyu, Gen Sobue

    Annals of neurology   65 ( 2 )   140 - 50   2009年2月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    OBJECTIVE: Spinal and bulbar muscular atrophy (SBMA) is a hereditary motor neuron disease caused by the expansion of a polyglutamine tract in the androgen receptor (AR). Animal studies have shown that the pathogenesis of SBMA is dependent on serum testosterone level. This study is aimed at evaluating the efficacy and safety of androgen deprivation by leuprorelin acetate in patients with SBMA. METHODS: Fifty SBMA patients underwent subcutaneous injections of leuprorelin acetate or placebo in a randomized, placebo-controlled trial for 48 weeks, followed by an open-label trial for an additional 96 weeks, in which 19 patients of the leuprorelin group and 15 of the placebo group received leuprorelin acetate. The patients who did not participate in the open-label trial were also followed up for the 96-week period (UMIN000000474). RESULTS: Leuprorelin acetate significantly extended the duration of cricopharyngeal opening in videofluorography and decreased mutant AR accumulation in scrotal skin biopsy. The patients treated with leuprorelin acetate for 144 weeks exhibited significantly greater functional scores and better swallowing parameters than those who received placebo. Autopsy of one patient who received leuprorelin acetate for 118 weeks suggested that androgen deprivation inhibits the nuclear accumulation or stabilization, or both, of mutant AR in the motor neurons of the spinal cord and brainstem. INTERPRETATION: These observations suggest that administration of leuprorelin acetate suppresses the deterioration of neuromuscular impairment in SBMA by inhibiting the toxic accumulation of mutant AR. The results of this phase 2 trial support the start of large-scale clinical trials of androgen deprivation for SBMA.

    DOI: 10.1002/ana.21540

    PubMed

    researchmap

  • Age at onset influences on wide-ranged clinical features of sporadic amyotrophic lateral sclerosis. 国際誌

    Naoki Atsuta, Hirohisa Watanabe, Mizuki Ito, Fumiaki Tanaka, Akiko Tamakoshi, Imaharu Nakano, Masashi Aoki, Shoji Tsuji, Tatsuhiko Yuasa, Hiroki Takano, Hideaki Hayashi, Shigeki Kuzuhara, Gen Sobue

    Journal of the neurological sciences   276 ( 1-2 )   163 - 9   2009年1月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    PURPOSE: To profile the detailed clinical features of sporadic amyotrophic lateral sclerosis (ALS) on large-scale samples in Japan. METHODS: We assessed the clinical features of sporadic ALS patients in Japan, based on the nationwide registration system of the Ministry of Health, Labor and Welfare of Japan. We described 3,428 new cases registered cases between 2003 and 2006 to analyze initial symptoms and related clinical features, 4,202 cases registered in the single year of 2005 to describe the cross-sectional overview of the ALS patients, and a total of 2,128 cases with tracheostomy positive pressure ventilation (TPPV) from all of the registration data from 2003 to 2006 to describe the features of ALS patients with TPPV. RESULTS: The patients with an older age at onset progressed more rapidly to the TPPV stage than those with a younger age at onset. The subpopulation of patients with long-standing TPPV showed ophthalmoplegia, while its appearance rate was less in the patients with an older age at onset than in those with a younger age at onset. Furthermore, age at onset strongly influenced the frequency of initial symptoms: dysarthria, dysphagia, neck weakness and respiratory disturbance were more frequent in patients with an older age at onset, while upper or lower limb weakness was observed more frequently in patients with a younger age at onset. In addition, those initial symptoms were still the most prominent at the follow-up stage, suggesting that the initial symptoms determine the major clinical features even in advanced illness. CONCLUSIONS: Our present study demonstrated that symptomatic features of ALS are strongly influenced by the age at onset by the large scale of samples.

    DOI: 10.1016/j.jns.2008.09.024

    PubMed

    researchmap

  • The significance of carpal tunnel syndrome in transthyretin Val30Met familial amyloid polyneuropathy. 国際誌

    Haruki Koike, Saori Morozumi, Yuichi Kawagashira, Masahiro Iijima, Masahiko Yamamoto, Naoki Hattori, Fumiaki Tanaka, Tomohiko Nakamura, Masaaki Hirayama, Yukio Ando, Shu-Ichi Ikeda, Gen Sobue

    Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis   16 ( 3 )   142 - 8   2009年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Carpal tunnel syndrome (CTS) is frequently reported in association with amyloidosis. We determined the significance of CTS in transthyretin Val30Met-associated familial amyloid polyneuropathy (FAP ATTR Val30Met) by comparing the electrophysiological indices of the median and ulnar nerves in 58 patients. As a whole, sensory nerve conduction velocity (SCV) was slowed and distal motor latency (DML) was prolonged to a similar extent in the median and ulnar nerves in these patients. The extent of abnormalities in the median nerve was almost similar to that in the ulnar nerve in both early-onset cases from endemic foci and late-onset cases from non-endemic areas. In age-matched idiopathic patients with CTS (20 patients, 27 hands), the slowing of SCV and the prolongation of DML in the median nerve were significant, while the slowing of motor conduction velocity was much less compared to FAP ATTR Val30Met patients. Although concomitant lesions in the ulnar nerve entrapment site at the wrist cannot be excluded, these findings indicate that CTS is not the sole distinctive feature in the majority of FAP ATTR Val30Met patients. The electrophysiological abnormality at the distal portion of the median nerve may be a consequence of polyneuropathy rather than an entrapment injury.

    DOI: 10.1080/13506120903094074

    PubMed

    researchmap

  • Intravenous immunoglobulin therapy in proximal diabetic neuropathy. 査読 国際誌

    Yuichi Kawagashira, Hirohisa Watanabe, Yumiko Oki, Masahiro Iijima, Haruki Koike, Naoki Hattori, Masahisa Katsuno, Fumiaki Tanaka, Gen Sobue

    BMJ case reports   2009   2009年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    A 57-year-old man with type 2 diabetes mellitus for 10 years showed progressive loss of muscle strength in both legs, pain and muscle atrophy in the femoral region and significant weight loss. On admission, he could not stand alone and used a wheelchair. He also complained of severe pain in the lower extremities. He was diagnosed with proximal diabetic neuropathy (PDN) by characteristic clinical and electrophysiological features. Intravenous immunoglobulin therapy (IVIg 0.4 g/kg×5 days) markedly reduced the severe pain and muscle weakness in the legs. Eventually, pain assessed by the Visual Analogue Scale was relieved by 80% and muscle strength was also well recovered, thereby enabling the patient to walk with a cane. The present case suggests that IVIg therapy may be effective for the relief of pain in PDN.

    DOI: 10.1136/bcr.08.2008.0656

    PubMed

    researchmap

  • MM2-cortical-type sporadic Creutzfeldt-Jakob disease with early stage cerebral cortical pathology presenting with a rapidly progressive clinical course. 国際誌

    Yoshiki Niimi, Yasushi Iwasaki, Toshitaka Umemura, Fumiaki Tanaka, Mari Yoshida, Yoshio Hashizume, Tetsuyuki Kitamoto, Mikio Hirayama, Gen Sobue

    Neuropathology : official journal of the Japanese Society of Neuropathology   28 ( 6 )   645 - 51   2008年12月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    We report the case of a 67-year-old man with MM2-cortical-type sporadic Creutzfeldt-Jakob disease (sCJD) with a rapidly progressive clinical course of 5 months. Initial symptoms were progressive memory disturbance and dementia. MRI revealed high signal-intensity lesions on diffusion-weighted images in the bilateral frontal and occipital cortices. Myoclonus and periodic sharp-wave complexes on the electroencephalogram were observed in the early disease stage. The clinical diagnosis was typical sCJD. Neuropathologic examination at autopsy showed widespread, characteristic cerebral neocortical involvement with large confluent vacuole-type spongiform change. Spongiform degeneration was also evident in the striatum and medial thalamus. In the cerebellar cortex, slight depletion of Purkinje neurons was evident without spongiform change in the molecular layer or apparent neuron loss in the granule cell layer. The inferior olivary nucleus showed slight hypertrophic astrocytosis without neuron loss. Prion protein (PrP) immunostaining showed widespread, characteristic perivacuolar-type PrP deposits with irregular plaque-like PrP deposits in the cerebral neocortex, striatum and medial thalamus. We believe this patient showed early-stage cerebral cortical pathology of MM2-cortical-type sCJD, which may provide clues regarding the pathologic progression of this rare sCJD subtype. Although MM2-cortical-type sCJD generally shows slow progression without myoclonus or periodic sharp-wave complexes, the present patient showed a rapidly progressive clinical course similar to that of MM1-type sCJD.

    DOI: 10.1111/j.1440-1789.2008.00904.x

    PubMed

    researchmap

  • Clinical significance of ApoE expression in human gastric cancer. 査読

    Sakashita K, Tanaka F, Zhang X, Mimori K, Kamohara Y, Inoue H, Sawada T, Hirakawa K, Mori M

    Oncology reports   20 ( 6 )   1313 - 1319   2008年12月

     詳細を見る

  • Clinical significance of low expression of Prostasin mRNA in human gastric cancer. 査読

    Sakashita K, Mimori K, Tanaka F, Tahara K, Inoue H, Sawada T, Ohira M, Hirakawa K, Mori M

    Journal of surgical oncology   98 ( 7 )   559 - 564   2008年12月

  • 神経伝導検査から判明した球脊髄性筋萎縮症における電気生理学的phenotype

    鈴木 啓介, 勝野 雅央, 坂野 晴彦, 竹内 優, 熱田 直樹, 伊藤 瑞規, 渡辺 宏久, 山下 史匡, 堀 紀生, 中村 友彦, 平山 正昭, 田中 章景, 祖父江 元

    末梢神経   19 ( 2 )   303 - 306   2008年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本末梢神経学会  

    researchmap

  • 球脊髄性筋萎縮症における電気生理学的phenotypeの検討

    鈴木 啓介, 勝野 雅央, 坂野 晴彦, 竹内 優, 熱田 直樹, 伊藤 瑞規, 渡辺 宏久, 山下 史匡, 堀 紀生, 中村 友彦, 平山 正昭, 田中 章景, 祖父江 元

    臨床神経学   48 ( 12 )   1200 - 1200   2008年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • Potential role of dendritic cell vaccination with MAGE peptides in gastrointestinal carcinomas. 査読 国際誌

    Tanaka F, Haraguchi N, Isikawa K, Inoue H, Mori M

    Oncology reports   20 ( 5 )   1111 - 1116   2008年11月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    PubMed

    researchmap

  • [Exploration of pathogenesis-associated molecules and development of disease models for sporadic ALS]. 査読

    Fumiaki Tanaka, Masahiro Waza, Jun-ichi Niwa, Masahiko Yamamoto, Gen Sobue

    Rinsho shinkeigaku = Clinical neurology   48 ( 11 )   970 - 2   2008年11月

     詳細を見る

    記述言語:日本語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Societas Neurologica Japonica  

    The mechanism underlying the characteristic selective motor neuron degeneration in amyotrophic lateral sclerosis (ALS) has remained elusive. Modest advances in this research field have been achieved by the identification of copper/zinc superoxide dismutase 1 (SOD1) as one of the causative genes for rare familial ALS and by the development and analysis of mutant SOD1 transgenic animal models. However, in sporadic ALS (SALS) with many more patients, causative or critical genes situated upstream of the disease pathway have not yet been elucidated and no available disease models have been established. We have been working on screening these genes employing and combining several new technologies such as cDNA microarray, molecular indexing, and laser capture microdissection. Many of the resultant genes are of intense interest and may provide a powerful tool for determining the molecular mechanisms of SALS. Of these, in this paper, we will focus on Dorfin, a RING finger-type E3 ubiquitin ligase and dynactin1, a major component of dynein/dynactin complex that is important for retrograde axonal transport. We are now challenging creation of the disease models by simulating the gene expression changes specifically observed in SALS patients.

    DOI: 10.5692/clinicalneurol.48.970

    Scopus

    PubMed

    researchmap

  • Electrophysiological features of late-onset transthyretin Met30 familial amyloid polyneuropathy unrelated to endemic foci. 国際誌

    Haruki Koike, Yuichi Kawagashira, Masahiro Iijima, Masahiko Yamamoto, Naoki Hattori, Fumiaki Tanaka, Masaaki Hirayama, Yukio Ando, Shu-ichi Ikeda, Gen Sobue

    Journal of neurology   255 ( 10 )   1526 - 33   2008年10月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    BACKGROUND: Through the development of gene diagnostic techniques, late-onset transthyretin Met30-associated familial amyloid polyneuropathy (FAP TTR Met30) has been shown to be more prevalent than is generally believed. OBJECTIVE: To examine the electrophysiological features of late-onset FAP TTR Met30 unrelated to endemic foci. METHODS: Nerve conduction findings in 44 cases with an onset of more than 50 years of age in a non-endemic area were assessed and compared with findings from 21 earlier-onset cases related to endemic foci. RESULTS: The extent of the reduction of the compound muscle action potential and, especially, the sensory nerve action potential was more profound in the late-onset group even when the decline of these indices with aging in normal control subjects was taken into account. The feature of predominant lower-limb involvement seemed to be more conspicuous in the late-onset group. Electrophysiological indices tended to be aggravated as the duration of neuropathic symptoms increased in the early-onset group, while most of these indices in the lateonset group did not show this correlation. A slowing of conduction velocity and a prolongation of distal latency, which suggests demyelination, were conspicuous in some patients. Pathologically, a predominant loss of small-fibers was not conspicuous in sural nerve biopsy specimens from late-onset patients. Large myelinated fiber density showed a negative correlation with the disease duration in early-onset cases, but not in late-onset cases. CONCLUSIONS: Electrophysiological differences between late- and early-onset cases were present, probably reflecting the different underlying pathogenic mechanisms of neuropathy. The demyelinating feature does not exclude the possibility of this disease.

    DOI: 10.1007/s00415-008-0962-z

    PubMed

    researchmap

  • CD133+CD44+ population efficiently enriches colon cancer initiating cells. 査読 国際誌

    Haraguchi N, Ohkuma M, Sakashita H, Matsuzaki S, Tanaka F, Mimori K, Kamohara Y, Inoue H, Mori M

    Annals of surgical oncology   15 ( 10 )   2927 - 2933   2008年10月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.1245/s10434-008-0074-0

    PubMed

    researchmap

  • Activin A enhances MMP-7 activity via the transcription factor AP-1 in an esophageal squamous cell carcinoma cell line. 査読 国際誌

    Yoshinaga K, Mimori K, Inoue H, Kamohara Y, Yamashita K, Tanaka F, Mori M

    International journal of oncology   33 ( 3 )   453 - 459   2008年9月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    PubMed

    researchmap

  • Prognostic relevance of Tensin4 expression in human gastric cancer. 査読

    Sakashita K, Mimori K, Tanaka F, Kamohara Y, Inoue H, Sawada T, Hirakawa K, Mori M

    Annals of surgical oncology   15 ( 9 )   2606 - 2613   2008年9月

  • Fractional anisotropy values detect pyramidal tract involvement in multiple system atrophy. 国際誌

    Mizuki Ito, Hirohisa Watanabe, Naoki Atsuta, Jo Senda, Yoshinari Kawai, Fumiaki Tanaka, Shinji Naganawa, Hiroshi Fukatsu, Gen Sobue

    Journal of the neurological sciences   271 ( 1-2 )   40 - 6   2008年8月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    OBJECTIVE: Pathological studies have shown remarkable pyramidal tract involvement in multiple system atrophy (MSA), while clinical pyramidal signs are relatively rare. We investigated the fractional anisotropy (FA) values to assess the degree of pyramidal tract involvement in MSA, in comparison with amyotrophic lateral sclerosis (ALS) and controls. Furthermore, we compared FA values between MSA patients with or without clinical pyramidal signs and controls, and between MSA patients with or without positive conventional MRI findings and controls. METHODS: We evaluated FA values in the internal capsule, corona radiate and whole pyramidal tract using visualized tractography of 65 subjects (20 probable MSA patients, 28 age-matched ALS patients, and 17 age-matched healthy controls) using a 3.0T magnetic resonance system. RESULTS: The FA values in the internal capsule, corona radiate, and whole pyramidal tract were significantly lower in MSA patients than in controls and were at a level similar to those of ALS patients. In addition, low FA values were prominent in MSA patients, even in those with short duration of illness, lacking precentral gyrus hyperintensity in FLAIR images, and without pyramidal signs. CONCLUSION: FA values could identify pyramidal tract degeneration even in patients with early phase MSA and those without clinical pyramidal signs or abnormal MRI findings. More extensive degeneration of the pyramidal tract occurs in MSA than so far believed.

    DOI: 10.1016/j.jns.2008.03.013

    PubMed

    researchmap

  • A strategy for developing effective amyotropic lateral sclerosis pharmacotherapy: from clinical trials to novel pharmacotherapeutic strategies. 国際誌

    Masahiko Yamamoto, Fumiaki Tanaka, Hiroshi Tatsumi, Gen Sobue

    Expert opinion on pharmacotherapy   9 ( 11 )   1845 - 57   2008年8月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    BACKGROUND: The pathomechanism of sporadic amyotropic lateral sclerosis is not clearly understood, although a proportion of familial amyotropic lateral sclerosis is caused by superoxide dismutase 1 mutations. Theories based on studies of human post-mortem tissue, research on animal models and in vitro work have been proposed for the pathogenesis of amyotropic lateral sclerosis, but the pathogenesis is not the same between sporadic and familial amyotropic lateral sclerosis. OBJECTIVE/METHODS: Drug candidates were tested using superoxide dismutase 1 mutant mice. Although the candidates were shown to be effective in mice, clinical trials in humans have failed to identify any truly effective pharmacotherapies in sporadic amyotropic lateral sclerosis, with only riluzole providing a modest improvement in survival. Ongoing or planned trials are exploring the value of antiglutamatergic drugs, antioxidants, neurotrophic factors, anti-inflammatory drugs and anti-aggregation drugs. RESULTS/CONCLUSIONS: A combination of drugs acting on different mechanisms is needed for effective therapy. Moreover, gene expression profiling and genome-wide association studies, together with inhibitory RNA techniques, are helpful for developing new pharmacotherapeutic strategies including gene therapy. It is also likely that the recently advanced generation of induced pluripotent stem cells will lead to the development of cell therapy for amyotropic lateral sclerosis. In addition to finding effective therapies, research is also needed in order to detect early disease markers since pharmacotherapy is most beneficial when given early in the course of sporadic amyotropic lateral sclerosis.

    DOI: 10.1517/14656566.9.11.1845

    PubMed

    researchmap

  • PDGF-BB is a novel prognostic factor in colorectal cancer. 査読

    Nakamura Y, Tanaka F, Yoshikawa Y, Mimori K, Inoue H, Yanaga K, Mori M

    Annals of surgical oncology   15 ( 8 )   2129 - 2136   2008年8月

  • Clinical significance of loss of Fhl1 expression in human gastric cancer. 査読

    Sakashita K, Mimori K, Tanaka F, Kamohara Y, Inoue H, Sawada T, Hirakawa K, Mori M

    Annals of surgical oncology   15 ( 8 )   2293 - 2300   2008年8月

  • The search for cancer stem cells in hepatocellular carcinoma. 査読 国際誌

    Kamohara Y, Haraguchi N, Mimori K, Tanaka F, Inoue H, Mori M, Kanematsu T

    Surgery   144 ( 2 )   119 - 124   2008年8月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.1016/j.surg.2008.04.008

    PubMed

    researchmap

  • Walking capacity evaluated by the 6-minute walk test in spinal and bulbar muscular atrophy. 国際誌

    Yu Takeuchi, Masahisa Katsuno, Haruhiko Banno, Keisuke Suzuki, Motoshi Kawashima, Naoki Atsuta, Mizuki Ito, Hirohisa Watanabe, Fumiaki Tanaka, Gen Sobue

    Muscle & nerve   38 ( 2 )   964 - 71   2008年8月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Spinal and bulbar muscular atrophy (SBMA) is an adult-onset motor neuron disease caused by a CAG repeat expansion in the androgen receptor gene. Because the progression of SBMA is slow, it is plausible to identify biomarkers that monitor disease course for therapeutic development. To verify whether the 6-min walk test (6MWT) is a biomarker of SBMA, we performed the 6MWT in 35 genetically confirmed patients and in 29 age-matched healthy controls. The walk distance covered within 6 min (6MWD) was significantly less in SBMA than it was in controls (323.3 +/- 143.9 m and 637.6 +/- 94.2 m, respectively; P < 0.001). In test-retest analysis, the intraclass correlation coefficient for the 6MWD was high in SBMA patients (r = 0.982). In a 1-year follow-up the 6MWD significantly decreased at a rate of 11.3% per year. Our observations suggest that the 6MWT is a biomarker that can be used to monitor progression of motor impairment in SBMA.

    DOI: 10.1002/mus.21077

    PubMed

    researchmap

  • Clinical significance of BMP7 in human colorectal cancer. 査読

    Motoyama K, Tanaka F, Kosaka Y, Mimori K, Uetake H, Inoue H, Sugihara K, Mori M

    Annals of surgical oncology   15 ( 5 )   1530 - 1537   2008年5月

  • Biological and genetic characteristics of tumor-initiating cells in colon cancer. 査読 国際誌

    Ieta K, Tanaka F, Haraguchi N, Kita Y, Sakashita H, Mimori K, Matsumoto T, Inoue H, Kuwano H, Mori M

    Annals of surgical oncology   15 ( 2 )   638 - 648   2008年2月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.1245/s10434-007-9605-3

    PubMed

    researchmap

  • Efficient identification of a novel cancer/testis antigen for immunotherapy using three-step microarray analysis. 査読

    Yokoe T, Tanaka F, Mimori K, Inoue H, Ohmachi T, Kusunoki M, Mori M

    Cancer research   68 ( 4 )   1074 - 1082   2008年2月

  • CAG repeat size correlates to electrophysiological motor and sensory phenotypes in SBMA. 国際誌

    Keisuke Suzuki, Masahisa Katsuno, Haruhiko Banno, Yu Takeuchi, Naoki Atsuta, Mizuki Ito, Hirohisa Watanabe, Fumitada Yamashita, Norio Hori, Tomohiko Nakamura, Masaaki Hirayama, Fumiaki Tanaka, Gen Sobue

    Brain : a journal of neurology   131 ( Pt 1 )   229 - 39   2008年1月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Spinal and bulbar muscular atrophy (SBMA) is an adult-onset, lower motor neuron disease caused by an aberrant elongation of a CAG repeat in the androgen receptor (AR) gene. The main symptoms are weakness and atrophy of bulbar, facial and limb muscles, but sensory disturbances are frequently found in SBMA patients. Motor symptoms have been attributed to the accumulation of mutant AR in the nucleus of lower motor neurons, which is more profound in patients with a longer CAG repeat. We examined nerve conduction properties including F-waves in a total of 106 patients with genetically confirmed SBMA (mean age at data collection = 53.8 years; range = 31-75 years) and 85 control subjects. Motor conduction velocities (MCV), compound muscle action potentials (CMAP), sensory conduction velocities (SCV) and sensory nerve action potentials (SNAP) were significantly decreased in all nerves examined in the SBMA patients compared with that in the normal controls, indicating that axonal degeneration is the primary process in both motor and sensory nerves. More profound abnormalities were observed in the nerves of the upper limbs than in those of the lower limbs. F-waves in the median nerve were absent in 30 of 106 cases (28.3%), but no cases of absent F-waves were observed in the tibial nerve. From an analysis of the relationship between CMAPs and SNAPs, patients were identified with different electrophysiological phenotypes: motor-dominant, sensory-dominant and non-dominant phenotypes. The CAG repeat size and the age at onset were significantly different among the patients with motor- and sensory-dominant phenotypes, indicating that a longer CAG repeat is more closely linked to the motor-dominant phenotype and a shorter CAG repeat is more closely linked to the sensory-dominant phenotype. Furthermore, when we classified the patients by CAG repeat size, CMAP values showed a tendency to be decreased in patients with a longer CAG repeat (> or =47), while SNAPs were significantly decreased in patients with a shorter CAG repeat (<47). In addition, we found that the frequency of aggregation in the sensory neuron cytoplasm tended to inversely correlate with the CAG repeat size in the autopsy study, supporting the view that the CAG repeat size differentially correlates with motor- and sensory-dominant phenotypes. In conclusion, our results suggest that there are unequivocal electrophysiological phenotypes influenced by CAG repeat size in SBMA.

    PubMed

    researchmap

  • Activin a causes cancer cell aggressiveness in esophageal squamous cell carcinoma cells. 査読 国際誌

    Yoshinaga K, Yamashita K, Mimori K, Tanaka F, Inoue H, Mori M

    Annals of surgical oncology   15 ( 1 )   96 - 103   2008年1月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.1245/s10434-007-9631-1

    PubMed

    researchmap

  • 球脊髄性筋萎縮症の筋病変

    勝野 雅央, 足立 弘明, 南山 誠, 和座 雅浩, 徳井 啓介, 坂野 晴彦, 鈴木 啓介, 竹内 優, 田中 章景, 道勇 学, 祖父江 元

    臨床神経学   47 ( 12 )   1095 - 1095   2007年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • Nonmyelinating Schwann cell involvement with well-preserved unmyelinated axons in Charcot-Marie-Tooth disease type 1A. 国際誌

    Haruki Koike, Masahiro Iijima, Keiko Mori, Masahiko Yamamoto, Naoki Hattori, Masahisa Katsuno, Fumiaki Tanaka, Hirohisa Watanabe, Manabu Doyu, Hiroo Yoshikawa, Gen Sobue

    Journal of neuropathology and experimental neurology   66 ( 11 )   1027 - 36   2007年11月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Electron microscopic examination was performed to compare morphologic changes of nonmyelinating Schwann cells and unmyelinated axons in patients with Charcot-Marie-Tooth disease type 1A (CMT1A) with peripheral myelin protein 22 duplication (n = 27) and normal control individuals (n = 14). Complete transverse sural nerve cross-sections were obtained in 16 patients and the total number of axons and Schwann cells in each cross-section was estimated. In patients with CMT1A, the number of myelinated axons was significantly decreased, whereas unmyelinated axons were well-preserved and did not show any marked changes. The numbers of nuclei, subunits, and profiles of nonmyelinating Schwann cells were all increased significantly in patients with CMT1A, whereas the numbers of axons per unmyelinated axon-containing subunit were significantly decreased. Schwann cell subunits consisted of layers of flattened cytoplasmic profiles wrapped around unmyelinated axons in the patient with CMT1A. The numbers of nonmyelinating Schwann cell profiles were increased and the numbers of axons per unmyelinated axon-containing subunit were reduced even in young patients with well-preserved myelinated fibers. In conclusion, there is marked alteration of the population and morphology of nonmyelinating Schwann cells, and axon-Schwann cell interactions seem to be regulated differently between myelinated and unmyelinated fibers in CMT1A.

    PubMed

    researchmap

  • Clinical significance of growth differentiation factor 11 in colorectal cancer. 査読

    Yokoe T, Ohmachi T, Inoue H, Mimori K, Tanaka F, Kusunoki M, Mori M

    International journal of oncology   31 ( 5 )   1097 - 1101   2007年11月

     詳細を見る

  • Therapeutic strategies for spinal and bulbar muscular atrophy (SBMA) 査読

    Masahisa Katsuno, Haruhiko Banno, Keisuke Suzuki, Yu Takeuchi, Makoto Minamiyama, Masahiro Waza, Hiroaki Adachi, Fumiaki Tanaka, Gen Sobue

    DRUGS OF THE FUTURE   32 ( 10 )   907 - 917   2007年10月

     詳細を見る

    記述言語:英語   出版者・発行元:PROUS SCIENCE, SA  

    Spinal and bulbar muscular atrophy (SBMA) is an adult-onset neurodegenerative disease characterized by slowly progressive weakness, atrophy of bulbar, facial and limb muscles, and mild androgen insensitivity. The cause of this disease is expansion of a trinucleotide CAG repeat which encodes the polyglutamine tract within the first exon of the androgen receptor (AR) gene. SBMA occurs exclusively in adult males, whereas both heterozygous and homozygous females are usually asymptomatic. Lower motor neurons in the anterior horn of the spinal cord and those in the brainstem motor nuclei are predominantly affected in SBMA, and other neuronal and non-neuronal tissues are also widely involved to a lesser extent. SBMA is considered an intractable disease, but several therapeutic approaches have been developed based on new insight into the pathogenesis. There are several lines of evidence indicating that testosterone, the ligand for ARs, plays a crucial role in the pathogenesis of neurodegeneration in SBMA, leading to clinical trials of androgen deprivation therapies. Moreover, animal studies have revealed other key molecules in the pathogenesis of SBMA, such as heat shock proteins (HSPs), transcriptional co-activators and axon motors, suggesting additional therapeutic targets.

    DOI: 10.1358/dot.2007.032.10.1131451

    Web of Science

    Scopus

    researchmap

    その他リンク: http://orcid.org/0000-0002-9302-4663

  • [Gene expression profile of spinal ventral horn in ALS]. 査読

    Masahiko Yamamoto, Fumiaki Tanaka, Gen Sobue

    Brain and nerve = Shinkei kenkyu no shinpo   59 ( 10 )   1129 - 39   2007年10月

     詳細を見る

    記述言語:日本語   掲載種別:研究論文(学術雑誌)  

    The causative pathomechanism of sporadic amyotrophic lateral sclerosis (ALS) is not clearly understood. Using microarray technology combined with laser-captured microdissection, gene expression profiles of degenerating spinal motor neurons as well as spinal ventral horn from autopsied patients with sporadic ALS were examined. Spinal motor neurons showed a distinct gene expression profile from the whole spinal ventral horn. Three percent of genes examined were significantly downregulated, and 1% were upregulated in motor neurons. In contrast with motor neurons, the total spinal ventral horn homogenates demonstrated 0.7% and 0.2% significant upregulation and downregulation of gene expression, respectively. Downregulated genes in motor neurons included those associated with cytoskeleton/axonal transport, transcription and cell surface antigens/receptors, such as dynactin 1 (DCTN1) and early growth response 3 (EGR3). In particular, DCTN1 was markedly downregulated in most residual motor neurons prior to the accumulation of pNF-H and ubiquitylated protein. Promoters for cell death pathway, death receptor 5 (DR5), cyclins C (CCNC) and A1 (CCNA), and caspases were upregulated, whereas cell death inhibitors, acetyl-CoA transporter (ACATN) and NF-kappaB (NFKB) were also upregulated. In terms of spinal ventral horn, the expression of genes related to cell surface antigens/receptors, transcription and cell adhesion/ECM were increased. The gene expression resulting in neurodegenerative and neuroprotective changes were both present in spinal motor neurons and ventral horn. Moreover, Inflammation-related genes, such as belonging to the cytokine family were not, however, significantly upregulated in either motor neurons or ventral horn. The sequence of motor neuron-specific gene expression changes from early DCTN1 downregulation to late CCNC upregulation in sporadic ALS can provide direct information on the genes leading to neurodegeneration and neuronal death, and are helpful for developing new therapeutic strategies.

    PubMed

    researchmap

  • Disulfide bond mediates aggregation, toxicity, and ubiquitylation of familial amyotrophic lateral sclerosis-linked mutant SOD1. 国際誌

    Jun-ichi Niwa, Shin-ichi Yamada, Shinsuke Ishigaki, Jun Sone, Miho Takahashi, Masahisa Katsuno, Fumiaki Tanaka, Manabu Doyu, Gen Sobue

    The Journal of biological chemistry   282 ( 38 )   28087 - 95   2007年9月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Mutations in the Cu/Zn-superoxide dismutase (SOD1) gene cause familial amyotrophic lateral sclerosis (ALS) through the gain of a toxic function; however, the nature of this toxic function remains largely unknown. Ubiquitylated aggregates of mutant SOD1 proteins in affected brain lesions are pathological hallmarks of the disease and are suggested to be involved in several proposed mechanisms of motor neuron death. Recent studies suggest that mutant SOD1 readily forms an incorrect disulfide bond upon mild oxidative stress in vitro, and the insoluble SOD1 aggregates in spinal cord of ALS model mice contain multimers cross-linked via intermolecular disulfide bonds. Here we show that a non-physiological intermolecular disulfide bond between cysteines at positions 6 and 111 of mutant SOD1 is important for high molecular weight aggregate formation, ubiquitylation, and neurotoxicity, all of which were dramatically reduced when the pertinent cysteines were replaced in mutant SOD1 expressed in Neuro-2a cells. Dorfin is a ubiquityl ligase that specifically binds familial ALS-linked mutant SOD1 and ubiquitylates it, thereby promoting its degradation. We found that Dorfin ubiquitylated mutant SOD1 by recognizing the Cys(6)- and Cys(111)-disulfide cross-linked form and targeted it for proteasomal degradation.

    PubMed

    researchmap

  • Tripartite motif-containing 29 (TRIM29) is a novel marker for lymph node metastasis in gastric cancer. 査読

    Kosaka Y, Inoue H, Ohmachi T, Yokoe T, Matsumoto T, Mimori K, Tanaka F, Watanabe M, Mori M

    Annals of surgical oncology   14 ( 9 )   2543 - 2549   2007年9月

  • Clinical significance of the loss of MATS1 mRNA expression in colorectal cancer. 査読

    Kosaka Y, Mimori K, Tanaka F, Inoue H, Watanabe M, Mori M

    International journal of oncology   31 ( 2 )   333 - 338   2007年8月

     詳細を見る

  • Identification of overexpressed genes in hepatocellular carcinoma, with special reference to ubiquitin-conjugating enzyme E2C gene expression. 査読 国際誌

    Ieta K, Ojima E, Tanaka F, Nakamura Y, Haraguchi N, Mimori K, Inoue H, Kuwano H, Mori M

    International journal of cancer   121 ( 1 )   33 - 38   2007年7月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.1002/ijc.22605

    PubMed

    researchmap

  • Gene expressions specifically detected in motor neurons (dynactin 1, early growth response 3, acetyl-CoA transporter, death receptor 5, and cyclin C) differentially correlate to pathologic markers in sporadic amyotrophic lateral sclerosis. 国際誌

    Yue-Mei Jiang, Masahiko Yamamoto, Fumiaki Tanaka, Shinsuke Ishigaki, Masahisa Katsuno, Hiroaki Adachi, Jun-Ichi Niwa, Manabu Doyu, Mari Yoshida, Yoshio Hashizume, Gen Sobue

    Journal of neuropathology and experimental neurology   66 ( 7 )   617 - 27   2007年7月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    In a differential gene expression profile, we showed previously that dynactin 1 (DCTN1), early growth response 3 (EGR3), acetyl-CoA transporter (ACATN), death receptor 5 (DR5), and cyclin C (CCNC) were prominently up- or downregulated in motor neurons of sporadic amyotrophic lateral sclerosis (ALS). In the present study, we examined the correlation between the expression levels of these genes and the levels of pathologic markers for motor neuron degeneration (i.e. cytoplasmic accumulation of phosphorylated neurofilament H [pNF-H] and ubiquitylated protein) and the numbers of residual motor neurons in 20 autopsies of patients with sporadic ALS. DCTN1 and EGR3 were widely downregulated, and the changes in gene expression were correlated to the number of residual motor neurons. In particular, DCTN1 was markedly downregulated in most residual motor neurons before the accumulation of pNF-H, even in cases with well-preserved motor neuron populations. ACATN, DR5, and CCNC were upregulated in subpopulations of residual motor neurons, and their expression levels were well correlated with the levels of pNF-H accumulation and the number of residual motor neurons. The expressions of DCTN1, EGR3, ACATN, and DR5 were all markedly altered before ubiquitylated protein accumulation. DCTN1 downregulation appears to be an early event before the appearance of neurodegeneration markers, whereas upregulations of DR5 and CCNC are relatively later phenomena associated with pathologic markers and leading to neuronal death. The sequence of motor neuron-specific gene expression changes in sporadic ALS can be beneficial information in developing appropriate therapeutic strategies for neurodegeneration.

    PubMed

    researchmap

  • Usefulness of combined fractional anisotropy and apparent diffusion coefficient values for detection of involvement in multiple system atrophy. 国際誌

    Mizuki Ito, Hirohisa Watanabe, Yoshinari Kawai, Naoki Atsuta, Fumiaki Tanaka, Shinji Naganawa, Hiroshi Fukatsu, Gen Sobue

    Journal of neurology, neurosurgery, and psychiatry   78 ( 7 )   722 - 8   2007年7月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    OBJECTIVE: To determine whether apparent diffusion coefficient (ADC) values and fractional anisotropy (FA) values can detect early pathological involvement in multiple system atrophy (MSA), and be used to differentiate MSA-P (multiple system atrophy if parkinsonian features predominate) from Parkinson's disease (PD). METHODS: We compared ADC and FA values in the pons, cerebellum and putamen of 61 subjects (20 probable MSA patients, 21 age matched PD patients and 20 age matched healthy controls) using a 3.0 T magnetic resonance system. RESULTS: ADC values in the pons, cerebellum and putamen were significantly higher, and FA values lower in MSA than in PD or controls. These differences were prominent in MSA lacking dorsolateral putaminal hyperintensity (DPH) or hot cross bun (HCB) sign. In differentiating MSA-P from PD using FA and ADC values, we obtained equal sensitivity (70%) and higher specificity (100%) in the pons than in the putamen and cerebellum. In addition, all patients that had both significant low FA and high ADC values in each of these three areas were MSA-P cases, and those that had both normal FA and ADC values in the pons were all PD cases. Our diagnostic algorithm based on these results accurately diagnosed 90% of patients with MSA-P. CONCLUSION: FA and ADC values detected early pathological involvement prior to magnetic resonance signal changes in MSA. In particular, low FA values in the pons showed high specificity in discriminating MSA-P from PD. In addition, combined analysis of both FA and ADC values in all three areas was more useful than only one.

    PubMed

    researchmap

  • CHIP overexpression reduces mutant androgen receptor protein and ameliorates phenotypes of the spinal and bulbar muscular atrophy transgenic mouse model. 国際誌

    Hiroaki Adachi, Masahiro Waza, Keisuke Tokui, Masahisa Katsuno, Makoto Minamiyama, Fumiaki Tanaka, Manabu Doyu, Gen Sobue

    The Journal of neuroscience : the official journal of the Society for Neuroscience   27 ( 19 )   5115 - 26   2007年5月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Spinal and bulbar muscular atrophy (SBMA) is an inherited motor neuron disease caused by the expansion of a polyglutamine tract within the androgen receptor (AR). The pathologic features of SBMA are motor neuron loss in the spinal cord and brainstem and diffuse nuclear accumulation and nuclear inclusions of the mutant AR in the residual motor neurons and certain visceral organs. Many components of the ubiquitin-proteasome and molecular chaperones are also sequestered in the inclusions, suggesting that they may be actively engaged in an attempt to degrade or refold the mutant AR. C terminus of Hsc70 (heat shock cognate protein 70)-interacting protein (CHIP), a U-box type E3 ubiquitin ligase, has been shown to interact with heat shock protein 90 (Hsp90) or Hsp70 and ubiquitylates unfolded proteins trapped by molecular chaperones and degrades them. Here, we demonstrate that transient overexpression of CHIP in a neuronal cell model reduces the monomeric mutant AR more effectively than it does the wild type, suggesting that the mutant AR is more sensitive to CHIP than is the wild type. High expression of CHIP in an SBMA transgenic mouse model also ameliorated motor symptoms and inhibited neuronal nuclear accumulation of the mutant AR. When CHIP was overexpressed in transgenic SBMA mice, mutant AR was also preferentially degraded over wild-type AR. These findings suggest that CHIP overexpression ameliorates SBMA phenotypes in mice by reducing nuclear-localized mutant AR via enhanced mutant AR degradation. Thus, CHIP overexpression would provide a potential therapeutic avenue for SBMA.

    PubMed

    researchmap

  • Opa interacting protein 5 (OIP5) is a novel cancer-testis specific gene in gastric cancer. 査読 国際誌

    Nakamura Y, Tanaka F, Nagahara H, Ieta K, Haraguchi N, Mimori K, Sasaki A, Inoue H, Yanaga K, Mori M

    Annals of surgical oncology   14 ( 2 )   885 - 892   2007年2月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.1245/s10434-006-9121-x

    PubMed

    researchmap

  • [Integrated molecular medicine for neuronal and neoplastic disorders]. 査読

    Fumiaki Tanaka, Gen Sobue

    Seikagaku. The Journal of Japanese Biochemical Society   79 ( 2 )   121 - 30   2007年2月

     詳細を見る

    記述言語:日本語   掲載種別:研究論文(学術雑誌)   出版者・発行元:JAPANESE BIOCHEMICAL SOC  

    Web of Science

    PubMed

    researchmap

  • TIMP-3 and Phosphatidylinositol 3-kinase genes were found to be related to the progression of colon cancer in a comparison of pneumoperitoneum and laparotomy in a murine model. 査読

    Tanaka F, Sonoda H, Okamoto M, Mimori K, Utsunomiya T, Inoue H, Hanai T, Mori M

    Surgery today   37 ( 3 )   220 - 225   2007年

  • 球脊髄性筋萎縮症に対する酢酸リュープロレリンのプラセボ対照ランダム化比較試験

    坂野 晴彦, 勝野 雅央, 鈴木 啓介, 和座 雅浩, 山田 新一, 沖 祐美子, 高森 元子, 熱田 直樹, 伊藤 瑞規, 松尾 幸治, 南山 誠, 中村 友彦, 渡邉 宏久, 足立 弘明, 田中 章景, 道勇 学, 片山 直美, 藤本 保志, 中島 務, 祖父江 元

    臨床神経学   46 ( 12 )   1117 - 1117   2006年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • ポリグルタミン病の病変部におけるHsp70発現低下 機序および病態への関与

    勝野 雅央, 坂野 晴彦, 鈴木 啓介, 足立 弘明, 和座 雅浩, 南山 誠, 徳井 啓介, 田中 章景, 道勇 学, 祖父江 元

    臨床神経学   46 ( 12 )   1020 - 1020   2006年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 筋萎縮性側索硬化症(ALS)における感覚神経伝導

    堀 紀生, 高森 元子, 中村 友彦, 伊藤 宏樹, 熱田 直樹, 伊藤 瑞規, 渡辺 宏久, 田中 章景, 平山 正昭, 祖父江 元

    臨床神経学   46 ( 12 )   1151 - 1151   2006年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • Reversible disruption of dynactin 1-mediated retrograde axonal transport in polyglutamine-induced motor neuron degeneration. 国際誌

    Masahisa Katsuno, Hiroaki Adachi, Makoto Minamiyama, Masahiro Waza, Keisuke Tokui, Haruhiko Banno, Keisuke Suzuki, Yu Onoda, Fumiaki Tanaka, Manabu Doyu, Gen Sobue

    The Journal of neuroscience : the official journal of the Society for Neuroscience   26 ( 47 )   12106 - 17   2006年11月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Spinal and bulbar muscular atrophy (SBMA) is a hereditary neurodegenerative disease caused by an expansion of a trinucleotide CAG repeat encoding the polyglutamine tract in the androgen receptor (AR) gene. To elucidate the pathogenesis of polyglutamine-mediated motor neuron dysfunction, we investigated histopathological and biological alterations in a transgenic mouse model of SBMA carrying human pathogenic AR. In affected mice, neurofilaments and synaptophysin accumulated at the distal motor axon. A similar intramuscular accumulation of neurofilament was detected in the skeletal muscle of SBMA patients. Fluoro-gold labeling and sciatic nerve ligation demonstrated an impaired retrograde axonal transport in the transgenic mice. The mRNA level of dynactin 1, an axon motor for retrograde transport, was significantly reduced in the SBMA mice resulting from pathogenic AR-induced transcriptional dysregulation. These pathological events were observed before the onset of neurological symptoms, but were reversed by castration, which prevents nuclear accumulation of pathogenic AR. Overexpression of dynactin 1 mitigated neuronal toxicity of the pathogenic AR in a cell culture model of SBMA. These observations indicate that polyglutamine-dependent transcriptional dysregulation of dynactin 1 plays a crucial role in the reversible neuronal dysfunction in the early stage of SBMA.

    PubMed

    researchmap

  • Gene expression profiling toward understanding of ALS pathogenesis. 国際誌

    Fumiaki Tanaka, Jun-Ichi Niwa, Shinsuke Ishigaki, Masahisa Katsuno, Masahiro Waza, Masahiko Yamamoto, Manabu Doyu, Gen Sobue

    Annals of the New York Academy of Sciences   1086   1 - 10   2006年11月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Although more than 130 years have gone by since the first description in 1869 by Jean-Martin Charcot, the mechanism underlying the characteristic selective motor neuron degeneration in amyotrophic lateral sclerosis (ALS) has remained elusive. Modest advances in this research field have been achieved by the identification of copper/zinc superoxide dismutase 1 (SOD1) as one of the causative genes for rare familial ALS (FALS) and by the development and analysis of mutant SOD1 transgenic mouse models. However, in sporadic ALS (SALS) with many more patients, causative or critical genes situated upstream of the disease pathway have not yet been elucidated and no available disease models have been established. To approach genes causative or critical for ALS, gene expression profiling in tissues primarily affected by the disease has represented an attractive research strategy. We have been working on screening these genes employing and combining several new technologies such as cDNA microarray, molecular indexing, and laser capture microdissection. Many of the resultant genes are of intense interest and may provide a powerful tool for determining the molecular mechanisms of ALS. However, we have barely arrived at the starting point and are confronting an enormous number of genes whose roles remain undetermined. Challenging tasks lie ahead of us such as identifying which genes are really causative for ALS and developing a disease model of SALS with due consideration for the expression changes in those genes.

    PubMed

    researchmap

  • Alleviating neurodegeneration by an anticancer agent: an Hsp90 inhibitor (17-AAG). 国際誌

    Masahiro Waza, Hiroaki Adachi, Masahisa Katsuno, Makoto Minamiyama, Fumiaki Tanaka, Gen Sobue

    Annals of the New York Academy of Sciences   1086   21 - 34   2006年11月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Heat shock proteins (HSPs) that function mainly as molecular chaperones play an important role in the folding and quality control of proteins. Compared with these chaperones, Hsp90 is unique in that it binds to substrate proteins, called Hsp90 client proteins. Hsp90 is involved in the folding, activation, and assembly of its client proteins in association with its co-chaperones. Because numerous oncoproteins belonging to the Hsp90 client protein family are selectively degraded by Hsp90 inhibitors, 17-allylamino-17-demethoxygeldanamycin (17-AAG), a first-in-class Hsp90 inhibitor, is now under clinical trials as a novel molecular-targeted agent for a wide range of malignancies. In spinal and bulbar muscular atrophy (SBMA), the pathogenic gene product is polyglutamine (polyQ)-expanded androgen receptor (AR), which belongs to the Hsp90 client protein family and is known to be degraded by 17-AAG. We have recently demonstrated that administration of an anticancer agent 17-AAG significantly ameliorated polyQ-mediated motor neuron degeneration by reducing the total amount of mutant AR. The ability of 17-AAG to degrade mutant protein would be directly applicable to SBMA and other neurodegenerative diseases in which the disease-causing proteins also belong to the Hsp90 client protein family. Our proposed therapeutic approach using a novel anticancer agent 17-AAG has emerged as a candidate for molecular-targeted therapies for neurodegenerative diseases.

    PubMed

    researchmap

  • Efficient induction of specific cytotoxic T lymphocytes to tumor rejection peptide using functional matured 2 day-cultured dendritic cells derived from human monocytes. 査読 国際誌

    Tanaka F, Yamaguchi H, Haraguchi N, Mashino K, Ohta M, Inoue H, Mori M

    International journal of oncology   29 ( 5 )   1263 - 1268   2006年11月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    PubMed

    researchmap

  • Fatty acid binding protein 6 is overexpressed in colorectal cancer. 査読

    Ohmachi T, Inoue H, Mimori K, Tanaka F, Sasaki A, Kanda T, Fujii H, Yanaga K, Mori M

    Clinical cancer research : an official journal of the American Association for Cancer Research   12 ( 17 )   5090 - 5095   2006年9月

  • Modulation of Hsp90 function in neurodegenerative disorders: a molecular-targeted therapy against disease-causing protein. 国際誌

    Masahiro Waza, Hiroaki Adachi, Masahisa Katsuno, Makoto Minamiyama, Fumiaki Tanaka, Manabu Doyu, Gen Sobue

    Journal of molecular medicine (Berlin, Germany)   84 ( 8 )   635 - 46   2006年8月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Abnormal accumulation of disease-causing protein is a commonly observed characteristic in chronic neurodegenerative disorders such as Alzheimer's disease, Parkinson's disease, and polyglutamine (polyQ) diseases. A therapeutic approach that could selectively eliminate would be a promising remedy for neurodegenerative disorders. Spinal and bulbar muscular atrophy (SBMA), one of the polyQ diseases, is a late-onset motor neuron disease characterized by proximal muscle atrophy, weakness, contraction fasciculations, and bulbar involvement. The pathogenic gene product is polyQ-expanded androgen receptor (AR), which belongs to the heat shock protein (Hsp) 90 client protein family. 17-Allylamino-17-demethoxygeldanamycin (17-AAG), a novel Hsp90 inhibitor, is a new derivative of geldanamycin that shares its important biological activities but shows less toxicity. 17-AAG is now in phase II clinical trials as a potential anti-cancer agent because of its ability to selectively degrade several oncoproteins. We have recently demonstrated the efficacy and safety of 17-AAG in a mouse model of SBMA. The administration of 17-AAG significantly ameliorated polyQ-mediated motor neuron degeneration by reducing the total amount of mutant AR. 17-AAG accomplished the preferential reduction of mutant AR mainly through Hsp90 chaperone complex formation and subsequent proteasome-dependent degradation. 17-AAG induced Hsp70 and Hsp40 in vivo as previously reported; however, its ability to induce HSPs was limited, suggesting that the HSP induction might support the degradation of mutant protein. The ability of 17-AAG to preferentially degrade mutant protein would be directly applicable to SBMA and other neurodegenerative diseases in which the disease-causing proteins also belong to the Hsp90 client protein family. Our proposed therapeutic approach, modulation of Hsp90 function by 17-AAG treatment, has emerged as a candidate for molecular-targeted therapies for neurodegenerative diseases. This review will consider our research findings and discuss the possibility of a clinical application of 17-AAG to SBMA and other neurodegenerative diseases.

    PubMed

    researchmap

  • Pathogenesis, animal models and therapeutics in spinal and bulbar muscular atrophy (SBMA). 国際誌

    Masahisa Katsuno, Hiroaki Adachi, Masahiro Waza, Haruhiko Banno, Keisuke Suzuki, Fumiaki Tanaka, Manabu Doyu, Gen Sobue

    Experimental neurology   200 ( 1 )   8 - 18   2006年7月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Spinal and bulbar muscular atrophy (SBMA) is a hereditary neurodegenerative disease characterized by slowly progressive muscle weakness and atrophy of bulbar, facial, and limb muscles. The cause of SBMA is expansion of a trinucleotide CAG repeat, which encodes the polyglutamine tract, in the first exon of the androgen receptor (AR) gene. SBMA chiefly occurs in adult males, whereas neurological symptoms are rarely detected in females having mutant AR gene. The cardinal histopathological finding of SBMA is loss of lower motor neurons in the anterior horn of spinal cord as well as in brainstem motor nuclei. Animal models carrying human mutant AR gene recapitulate polyglutamine-mediated motor neuron degeneration, providing clues to the pathogenesis of SBMA. There is increasing evidence that testosterone, the ligand of AR, plays a pivotal role in the pathogenesis of neurodegeneration in SBMA. The striking success of androgen deprivation therapy in SBMA mouse models has been translated into clinical trials. In addition, elucidation of pathophysiology using animal models leads to emergence of candidate drugs to treat this devastating disease: HSP inducer, Hsp90 inhibitor, and histone deacetylase inhibitor. Utilizing biomarkers such as scrotal skin biopsy would improve efficacy of clinical trials to verify the results from animal studies. Advances in basic and clinical researches on SBMA are now paving the way for clinical application of potential therapeutics.

    PubMed

    researchmap

  • 【再生医学をめぐる最新の展開】神経変性疾患の治療開発 球脊髄性筋萎縮症(SBMA)を中心に

    坂野 晴彦, 勝野 雅央, 小野田 優, 鈴木 啓介, 徳井 啓介, 和座 雅浩, 南山 誠, 足立 弘明, 田中 章景, 道勇 学, 祖父江 元

    現代医学   54 ( 1 )   15 - 23   2006年7月

  • Natural history of spinal and bulbar muscular atrophy (SBMA): a study of 223 Japanese patients. 国際誌

    Naoki Atsuta, Hirohisa Watanabe, Mizuki Ito, Haruhiko Banno, Keisuke Suzuki, Masahisa Katsuno, Fumiaki Tanaka, Akiko Tamakoshi, Gen Sobue

    Brain : a journal of neurology   129 ( Pt 6 )   1446 - 55   2006年6月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Spinal and bulbar muscular atrophy (SBMA) is an adult-onset motoneuron disease caused by a CAG-repeat expansion in the androgen receptor (AR) gene and for which no curative therapy exists. However, since recent research may provide opportunities for medical treatment, information concerning the natural history of SBMA would be beneficial in planning future clinical trials. We investigated the natural course of SBMA as assessed by nine activities of daily living (ADL) milestones in 223 Japanese SBMA patients (mean age at data collection = 55.2 years; range = 30-87 years) followed from 1 to 20 years. All the patients were diagnosed by genetic analysis. Hand tremor was an early event that was noticed at a median age of 33 years. Muscular weakness occurred predominantly in the lower limbs, and was noticed at a median age of 44 years, followed by the requirement of a handrail to ascend stairs at 49, dysarthria at 50, dysphagia at 54, use of a cane at 59 and a wheelchair at 61 years. Twenty-one of the patients developed pneumonia at a median age of 62 and 15 of them died at a median age of 65 years. The most common cause of death in these cases was pneumonia and respiratory failure. The ages at onset of each ADL milestone were strongly correlated with the length of CAG repeats in the AR gene. However CAG-repeat length did not correlate with the time intervals between each ADL milestone, suggesting that although the onset age of each ADL milestone depends on the CAG-repeat length in the AR gene, the rate of disease progression does not. The levels of serum testosterone, an important triggering factor for polyglutamine-mediated motoneuron degeneration, were maintained at relatively high levels even at advanced ages. These results provide beneficial information for future clinical therapeutic trials, although further detailed prospective studies are also needed.

    PubMed

    researchmap

  • Expression of the TRAG-3 gene in human esophageal cancer: the frequent synchronous expression of MAGE-3 gene. 査読

    Ohta M, Tanaka F, Sadanaga N, Yamaguchi H, Inoue H, Mori M

    Oncology reports   15 ( 6 )   1529 - 1532   2006年6月

     詳細を見る

  • 球脊髄性筋萎縮症の自然歴 治療介入研究にむけて

    熱田 直樹, 渡邉 宏久, 伊藤 瑞規, 坂野 晴彦, 勝野 雅央, 鈴木 啓介, 田中 章景, 祖父江 元

    神経治療学   23 ( 3 )   337 - 337   2006年5月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経治療学会  

    researchmap

  • Clinical significance of TROP2 expression in colorectal cancer. 査読

    Ohmachi T, Tanaka F, Mimori K, Inoue H, Yanaga K, Mori M

    Clinical cancer research : an official journal of the American Association for Cancer Research   12 ( 10 )   3057 - 3063   2006年5月

  • Differential gene expression profiles of radioresistant pancreatic cancer cell lines established by fractionated irradiation. 査読

    Ogawa K, Utsunomiya T, Mimori K, Tanaka F, Haraguchi N, Inoue H, Murayama S, Mori M

    International journal of oncology   28 ( 3 )   705 - 713   2006年3月

     詳細を見る

  • Characterization of a side population of cancer cells from human gastrointestinal system. 査読 国際誌

    Haraguchi N, Utsunomiya T, Inoue H, Tanaka F, Mimori K, Barnard GF, Mori M

    Stem cells (Dayton, Ohio)   24 ( 3 )   506 - 513   2006年3月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.1634/stemcells.2005-0282

    PubMed

    researchmap

  • Mutant androgen receptor accumulation in spinal and bulbar muscular atrophy scrotal skin: a pathogenic marker. 査読 国際誌

    Haruhiko Banno, Hiroaki Adachi, Masahisa Katsuno, Keisuke Suzuki, Naoki Atsuta, Hirohisa Watanabe, Fumiaki Tanaka, Manabu Doyu, Gen Sobue

    Annals of neurology   59 ( 3 )   520 - 6   2006年3月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:WILEY-LISS  

    OBJECTIVE: Spinal and bulbar muscular atrophy (SBMA) is a hereditary motor neuron disease caused by the expansion of a polyglutamine tract in the androgen receptor (AR). The nuclear accumulation of mutant AR is central to the pathogenesis of SBMA. Androgen deprivation with leuprorelin inhibits mutant AR accumulation, resulting in rescue of neuronal dysfunction in a mouse model of SBMA. This study aimed to investigate whether mutant AR accumulation in the scrotal skin is an appropriate biomarker of SBMA. METHODS: Immunohistochemistry of both scrotal skin and the spinal cord was performed on five autopsied SBMA cases. Neurological severity and scrotal skin findings were studied in another 13 patients. Five other patients received subcutaneous injections of leuprorelin and underwent scrotal skin biopsy. RESULTS: The degree of mutant AR accumulation in scrotal skin epithelial cells tended to be correlated with that in the spinal motor neurons in autopsy specimens, and it was well correlated with CAG repeat length and inversely correlated with the amyotrophic lateral sclerosis functional scale. Leuprorelin treatment inhibited mutant AR protein accumulation in the scrotal skin of SBMA patients. INTERPRETATION: These observations suggest that scrotal skin biopsy findings are a potent pathogenic marker of SBMA and can be a surrogate end point in therapeutic trials.

    DOI: 10.1002/ana.20735

    Web of Science

    PubMed

    researchmap

  • Cancer stem cells in human gastrointestinal cancers. 査読

    Haraguchi N, Inoue H, Tanaka F, Mimori K, Utsunomiya T, Sasaki A, Mori M

    Human cell   19 ( 1 )   24 - 29   2006年2月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.1111/j.1749-0774.2005.00004.x

    PubMed

    researchmap

  • 球脊髄性筋萎縮症におけるsurrogate markerの探索

    道勇 学, 坂野 晴彦, 勝野 雅央, 鈴木 啓介, 足立 弘明, 和座 雅浩, 南山 誠, 熱田 直樹, 渡邉 宏久, 田中 章景, 祖父江 元

    臨床神経学   45 ( 12 )   1115 - 1115   2005年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 球脊髄性筋萎縮症(SBMA)の自然歴

    熱田 直樹, 渡邉 宏久, 伊藤 瑞規, 田中 章景, 祖父江 元

    臨床神経学   45 ( 12 )   1147 - 1147   2005年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • Pharmacological induction of heat-shock proteins alleviates polyglutamine-mediated motor neuron disease. 国際誌

    Masahisa Katsuno, Chen Sang, Hiroaki Adachi, Makoto Minamiyama, Masahiro Waza, Fumiaki Tanaka, Manabu Doyu, Gen Sobue

    Proceedings of the National Academy of Sciences of the United States of America   102 ( 46 )   16801 - 6   2005年11月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Spinal and bulbar muscular atrophy (SBMA) is an adult-onset motor neuron disease caused by the expansion of a trinucleotide CAG repeat encoding the polyglutamine tract in the first exon of the androgen receptor gene (AR). The pathogenic, polyglutamine-expanded AR protein accumulates in the cell nucleus in a ligand-dependent manner and inhibits transcription by interfering with transcriptional factors and coactivators. Heat-shock proteins (HSPs) are stress-induced chaperones that facilitate the refolding and, thus, the degradation of abnormal proteins. Geranylgeranylacetone (GGA), a nontoxic antiulcer drug, has been shown to potently induce HSP expression in various tissues, including the central nervous system. In a cell model of SBMA, GGA increased the levels of Hsp70, Hsp90, and Hsp105 and inhibited cell death and the accumulation of pathogenic AR. Oral administration of GGA also up-regulated the expression of HSPs in the central nervous system of SBMA-transgenic mice and suppressed nuclear accumulation of the pathogenic AR protein, resulting in amelioration of polyglutamine-dependent neuromuscular phenotypes. These observations suggest that, although a high dose appears to be needed for clinical effects, oral GGA administration is a safe and promising therapeutic candidate for polyglutamine-mediated neurodegenerative diseases, including SBMA.

    PubMed

    researchmap

  • The wide spectrum of clinical manifestations in Sjögren's syndrome-associated neuropathy. 査読 国際誌

    Mori K, Iijima M, Koike H, Hattori N, Tanaka F, Watanabe H, Katsuno M, Fujita A, Aiba I, Ogata A, Saito T, Asakura K, Yoshida M, Hirayama M, Sobue G

    Brain : a journal of neurology   128 ( Pt 11 )   2518 - 34   2005年11月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.1093/brain/awh605

    Web of Science

    PubMed

    researchmap

  • 17-AAG, an Hsp90 inhibitor, ameliorates polyglutamine-mediated motor neuron degeneration. 国際誌

    Masahiro Waza, Hiroaki Adachi, Masahisa Katsuno, Makoto Minamiyama, Chen Sang, Fumiaki Tanaka, Akira Inukai, Manabu Doyu, Gen Sobue

    Nature medicine   11 ( 10 )   1088 - 95   2005年10月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Heat-shock protein 90 (Hsp90) functions as part of a multichaperone complex that folds, activates and assembles its client proteins. Androgen receptor (AR), a pathogenic gene product in spinal and bulbar muscular atrophy (SBMA), is one of the Hsp90 client proteins. We examined the therapeutic effects of 17-allylamino-17-demethoxygeldanamycin (17-AAG), a potent Hsp90 inhibitor, and its ability to degrade polyglutamine-expanded mutant AR. Administration of 17-AAG markedly ameliorated motor impairments in the SBMA transgenic mouse model without detectable toxicity, by reducing amounts of monomeric and aggregated mutant AR. The mutant AR showed a higher affinity for Hsp90-p23 and preferentially formed an Hsp90 chaperone complex as compared to wild-type AR; mutant AR was preferentially degraded in the presence of 17-AAG in both cells and transgenic mice as compared to wild-type AR. 17-AAG also mildly induced Hsp70 and Hsp40. 17-AAG would thus provide a new therapeutic approach to SBMA and probably to other related neurodegenerative diseases.

    PubMed

    researchmap

  • Genomic screens for genes upregulated by demethylation in colorectal cancer: possible usefulness for clinical application. 査読

    Ogawa K, Utsunomiya T, Mimori K, Yamashita K, Okamoto M, Tanaka F, Inoue H, Ikeda Y, Saku M, Murayama S, Mori M

    International journal of oncology   27 ( 2 )   417 - 426   2005年8月

     詳細を見る

  • 球脊髄性筋萎縮症におけるsurrogate markerの探索

    坂野 晴彦, 勝野 雅央, 足立 弘明, 和座 雅浩, 南山 誠, 熱田 直樹, 渡邉 宏久, 田中 章景, 道勇 学, 祖父江 元

    神経治療学   22 ( 3 )   356 - 356   2005年5月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経治療学会  

    researchmap

  • Tuft-shaped astrocytes in Lewy body disease. 国際誌

    Nozomi Hishikawa, Yoshio Hashizume, Mari Yoshida, Jun-Ichi Niwa, Fumiaki Tanaka, Gen Sobue

    Acta neuropathologica   109 ( 4 )   373 - 80   2005年4月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    We investigated the occurrence and distribution of tuft-shaped astrocytes (TuSAs) in 60 brains from patients with Lewy body disease (LBD), which were clinically diagnosed as Parkinson's disease (PD) or dementia with Lewy bodies (DLB), and 85 brains from control subjects. TuSAs have been documented as a neuropathological hallmark of progressive supranuclear palsy (PSP). We found phosphorylated tau (p-tau)-positive and alpha-synuclein-negative TuSAs in 10 of 60 patients with LBD and 3 of 85 control cases. TuSAs were mainly located within the precentral and premotor gyri of the frontal lobe cortex. There were only few TuSAs, but the distribution pattern and morphological and immunohistological features were similar to that in PSP. Furthermore, other p-tau positive structures, including aggregates in neurons, coiled-like glial cells and threads showed a similar distribution to those in PSP; mainly in the hippocampus, striatum, subthalamic nucleus, precentral and premotor gyri, brainstem nucleus, and dentate nucleus. In these cases, however, neuronal loss and gliosis were not seen in the regions involved in PSP, such as the subthalamic nucleus, pallidum, inferior olivary, cerebellar dentate nuclei, and periaqueductal gray matter. Clinical features were indistinguishable between the LBD with and without TuSAs. The appearance of TuSAs was not related to the frequency of Lewy bodies, neurofibrillary tangles, and senile plaques, but was significantly more pronounced with advancing age in both LBD and controls. These findings suggest that in a subgroup of elderly individual cases, especially associated with LB pathology, the glial and neuronal p-tau accumulation is increased and has a distributional pattern similar to PSP.

    PubMed

    researchmap

  • Clinical significance of human kallikrein gene 6 messenger RNA expression in colorectal cancer. 査読

    Ogawa K, Utsunomiya T, Mimori K, Tanaka F, Inoue H, Nagahara H, Murayama S, Mori M

    Clinical cancer research : an official journal of the American Association for Cancer Research   11 ( 8 )   2889 - 2893   2005年4月

  • Widespread nuclear and cytoplasmic accumulation of mutant androgen receptor in SBMA patients. 国際誌

    Hiroaki Adachi, Masahisa Katsuno, Makoto Minamiyama, Masahiro Waza, Chen Sang, Yuji Nakagomi, Yasushi Kobayashi, Fumiaki Tanaka, Manabu Doyu, Akira Inukai, Mari Yoshida, Yoshio Hashizume, Gen Sobue

    Brain : a journal of neurology   128 ( Pt 3 )   659 - 70   2005年3月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Spinal and bulbar muscular atrophy (SBMA) is an inherited adult onset motor neuron disease caused by the expansion of a polyglutamine (polyQ) tract within the androgen receptor (AR), affecting only males. The characteristic pathological finding is nuclear inclusions (NIs) consisting of mutant AR with an expanded polyQ in residual motor neurons, and in certain visceral organs. We immunohistochemically examined 11 SBMA patients at autopsy with 1C2, an antibody that specifically recognizes expanded polyQ. Our study demonstrated that diffuse nuclear accumulation of mutant AR was far more frequent and extensive than NIs being distributed in a wide array of CNS nuclei, and in more visceral organs than thus far believed. Mutant AR accumulation was also present in the cytoplasm, particularly in the Golgi apparatus; nuclear or cytoplasmic predominance of accumulation was tissue specific. Furthermore, the extent of diffuse nuclear accumulation of mutant AR in motor and sensory neurons of the spinal cord was closely related to CAG repeat length. Thus, diffuse nuclear accumulation of mutant AR apparently is a cardinal pathogenetic process underlying neurological manifestations, as in SBMA transgenic mice, while cytoplasmic accumulation may also contribute to SBMA pathophysiology.

    PubMed

    researchmap

  • Gene expression profile of spinal motor neurons in sporadic amyotrophic lateral sclerosis. 国際誌

    Yue-Mei Jiang, Masahiko Yamamoto, Yasushi Kobayashi, Tsuyoshi Yoshihara, Yideng Liang, Shinichi Terao, Hideyuki Takeuchi, Shinsuke Ishigaki, Masahisa Katsuno, Hiroaki Adachi, Jun-ichi Niwa, Fumiaki Tanaka, Manabu Doyu, Mari Yoshida, Yoshio Hashizume, Gen Sobue

    Annals of neurology   57 ( 2 )   236 - 51   2005年2月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    The causative pathomechanism of sporadic amyotrophic lateral sclerosis (ALS) is not clearly understood. Using microarray technology combined with laser-captured microdissection, gene expression profiles of degenerating spinal motor neurons isolated from autopsied patients with sporadic ALS were examined. Gene expression was quantitatively assessed by real-time reverse transcription polymerase chain reaction and in situ hybridization. Spinal motor neurons showed a distinct gene expression profile from the whole spinal ventral horn. Three percent of genes examined were downregulated, and 1% were upregulated in motor neurons. Downregulated genes included those associated with cytoskeleton/axonal transport, transcription, and cell surface antigens/receptors, such as dynactin, microtubule-associated proteins, and early growth response 3 (EGR3). In contrast, cell death-associated genes were mostly upregulated. Promoters for cell death pathway, death receptor 5, cyclins A1 and C, and caspases-1, -3, and -9, were upregulated, whereas cell death inhibitors, acetyl-CoA transporter, and NF-kappaB were also upregulated. Moreover, neuroprotective neurotrophic factors such as ciliary neurotrophic factor (CNTF), Hepatocyte growth factor (HGF), and glial cell line-derived neurotrophic factor were upregulated. Inflammation-related genes, such as those belonging to the cytokine family, were not, however, significantly upregulated in either motor neurons or ventral horns. The motor neuron-specific gene expression profile in sporadic ALS can provide direct information on the genes leading to neurodegeneration and neuronal death and are helpful for developing new therapeutic strategies.

    PubMed

    researchmap

  • The high expression of Fractalkine results in a better prognosis for colorectal cancer patients. 査読

    Ohta M, Tanaka F, Yamaguchi H, Sadanaga N, Inoue H, Mori M

    International journal of oncology   26 ( 1 )   41 - 47   2005年1月

     詳細を見る

  • Design of nucleic acid sequences for DNA computing based on a thermodynamic approach. 査読

    Tanaka F, Kameda A, Yamamoto M, Ohuchi A

    Nucleic acids research   33 ( 3 )   903 - 911   2005年

  • 家族性ALS:SOD1遺伝子変異陽性および陰性例の臨床病理

    熱田 直樹, 渡辺 宏久, 伊藤 瑞規, 田中 章景, 丹羽 淳一, 道勇 学, 饗場 郁子, 吉田 眞理, 橋詰 良夫, 祖父江 元

    臨床神経学   44 ( 12 )   1028 - 1028   2004年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • Cognitive impairments in Machado-Joseph disease. 国際誌

    Yoshinari Kawai, Akinori Takeda, Yuji Abe, Yukihiko Washimi, Fumiaki Tanaka, Gen Sobue

    Archives of neurology   61 ( 11 )   1757 - 60   2004年11月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    BACKGROUND: Cognitive function of Machado-Joseph disease (MJD) patients has not been clarified. OBJECTIVES: To determine the characteristics of cognitive dysfunction in MJD patients and to assess the relationship of dysfunction to age at onset, age at examination, disease duration, education, ataxia, depression, anxiety, and CAG repeat length. DESIGN: Case-control study. SETTING: Research-oriented hospitals. PARTICIPANTS: Sixteen genetically confirmed MJD patients able to complete neuropsychological tests and 20 control subjects matched to patients by age and education. MAIN OUTCOME MEASURES: Neuropsychological tests, including general cognition, verbal and visual memory, working memory, visuospatial and constructional ability, language, executive function, depression, and anxiety. RESULTS: Machado-Joseph disease patients scored significantly lower than controls in verbal and visual memory, in visuospatial and constructional tasks, and in phonemic and semantic fluency tasks. None of these impairments correlated with CAG repeat length, age at onset, age at examination, disease duration, or education. Verbal fluency (words named in a category) correlated with the International Cooperative Ataxia Rating Scale score. CONCLUSION: Machado-Joseph disease patients have verbal and visual memory deficits, visuospatial and constructional dysfunction, and verbal fluency deficits, all unrelated to CAG repeat length.

    PubMed

    researchmap

  • Expression of cancer-testis antigen (CTA) genes in intrahepatic cholangiocarcinoma. 査読

    Utsunomiya T, Inoue H, Tanaka F, Yamaguchi H, Ohta M, Okamoto M, Mimori K, Mori M

    Annals of surgical oncology   11 ( 10 )   934 - 940   2004年10月

     詳細を見る

  • A gene-expression signature can quantify the degree of hepatic fibrosis in the rat. 査読

    Utsunomiya T, Okamoto M, Hashimoto M, Yoshinaga K, Shiraishi T, Tanaka F, Mimori K, Inoue H, Watanabe G, Barnard GF, Mori M

    Journal of hepatology   41 ( 3 )   399 - 406   2004年9月

  • Analysis of gastric cancer with cDNA microarray. 査読 国際誌

    Haraguchi N, Inoue H, Mimori K, Tanaka F, Utsunomiya T, Yoshikawa K, Mori M

    Cancer chemotherapy and pharmacology   54 Suppl 1   S21 - 4   2004年9月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.1007/s00280-004-0882-2

    PubMed

    researchmap

  • Thermodynamic parameters based on a nearest-neighbor model for DNA sequences with a single-bulge loop. 査読

    Tanaka F, Kameda A, Yamamoto M, Ohuchi A

    Biochemistry   43 ( 22 )   7143 - 7150   2004年6月

  • Spinal and bulbar muscular atrophy: ligand-dependent pathogenesis and therapeutic perspectives. 国際誌

    Masahisa Katsuno, Hiroaki Adachi, Fumiaki Tanaka, Gen Sobue

    Journal of molecular medicine (Berlin, Germany)   82 ( 5 )   298 - 307   2004年5月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Spinal and bulbar muscular atrophy (SBMA) is a late-onset motor neuron disease characterized by proximal muscle atrophy, weakness, contraction fasciculations, and bulbar involvement. SBMA exclusively affects males, while females are usually asymptomatic. The molecular basis of SBMA is the expansion of a trinucleotide CAG repeat, which encodes the polyglutamine (polyQ) tract in the first exon of the androgen receptor (AR) gene. The histopathological hallmark is the presence of nuclear inclusions containing mutant truncated ARs with expanded polyQ tracts in the residual motor neurons in the brainstem and spinal cord, as well as in some other visceral organs. The AR ligand, testosterone, accelerates AR dissociation from heat shock proteins and thus its nuclear translocation. Ligand-dependent nuclear accumulation of mutant ARs has been implicated in the pathogenesis of SBMA. Transgenic mice carrying the full-length human AR gene with an expanded polyQ tract demonstrate neuromuscular phenotypes, which are profound in males. Their SBMA-like phenotypes are rescued by castration, and aggravated by testosterone administration. Leuprorelin, an LHRH agonist that reduces testosterone release from the testis, inhibits nuclear accumulation of mutant ARs, resulting in the rescue of motor dysfunction in the male transgenic mice. However, flutamide, an androgen antagonist promoting nuclear translocation of the AR, yielded no therapeutic effect. The degradation and cleavage of the AR protein are also influenced by the ligand, contributing to the pathogenesis. Testosterone thus appears to be the key molecule in the pathogenesis of SBMA, as well as main therapeutic target of this disease.

    PubMed

    researchmap

  • Spinal and bulbar muscular atrophy: ligand-dependent pathogenesis and therapeutic perspectives 査読

    M Katsuno, H Adachi, F Tanaka, G Sobue

    JOURNAL OF MOLECULAR MEDICINE-JMM   82 ( 5 )   298 - 307   2004年5月

     詳細を見る

    記述言語:英語   出版者・発行元:SPRINGER-VERLAG  

    Spinal and bulbar muscular atrophy (SBMA) is a late-onset motor neuron disease characterized by proximal muscle atrophy, weakness, contraction fasciculations, and bulbar involvement. SBMA exclusively affects males, while females are usually asymptomatic. The molecular basis of SBMA is the expansion of a trinucleotide CAG repeat, which encodes the polyglutamine (polyQ) tract in the first exon of the androgen receptor (AR) gene. The histopathological hallmark is the presence of nuclear inclusions containing mutant truncated ARs with expanded polyQ tracts in the residual motor neurons in the brainstem and spinal cord, as well as in some other visceral organs. The AR ligand, testosterone, accelerates AR dissociation from heat shock proteins and thus its nuclear translocation. Ligand-dependent nuclear accumulation of mutant ARs has been implicated in the pathogenesis of SBMA. Transgenic mice carrying the full-length human AR gene with an expanded polyQ tract demonstrate neuromuscular phenotypes, which are profound in males. Their SBMA-like phenotypes are rescued by castration, and aggravated by testosterone administration. Leuprorelin, an LHRH agonist that reduces testosterone release from the testis, inhibits nuclear accumulation of mutant ARs, resulting in the rescue of motor dysfunction in the male transgenic mice. However, flutamide, an androgen antagonist promoting nuclear translocation of the AR, yielded no therapeutic effect. The degradation and cleavage of the AR protein are also influenced by the ligand, contributing to the pathogenesis. Testosterone thus appears to be the key molecule in the pathogenesis of SBMA, as well as main therapeutic target of this disease.

    DOI: 10.1007/s00109-004-0530-7

    Web of Science

    PubMed

    researchmap

  • Dorfin prevents cell death by reducing mitochondrial localizing mutant superoxide dismutase 1 in a neuronal cell model of familial amyotrophic lateral sclerosis. 国際誌

    Hideyuki Takeuchi, Jun-ichi Niwa, Nozomi Hishikawa, Shinsuke Ishigaki, Fumiaki Tanaka, Manabu Doyu, Gen Sobue

    Journal of neurochemistry   89 ( 1 )   64 - 72   2004年4月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Abstract Dorfin is a RING-finger type ubiquitin ligase for mutant superoxide dismutase 1 (SOD1) that enhances its degradation. Mutant SOD1s cause familial amyotrophic lateral sclerosis (FALS) through the gain of unelucidated toxic properties. We previously showed that the accumulation of mutant SOD1 in the mitochondria triggered the release of cytochrome c, followed by the activation of the caspase cascade and induction of neuronal cell death. In the present study, therefore, we investigated whether Dorfin can modulate the level of mutant SOD1 in the mitochondria and subsequent caspase activation. We showed that Dorfin significantly reduced the amount of mutant SOD1 in the mitochondria, the release of cytochrome c and the activation of the following caspase cascade, thereby preventing eventual neuronal cell death in a neuronal cell model of FALS. These results suggest that reducing the accumulation of mutant SOD1 in the mitochondria may be a new therapeutic strategy for mutant SOD1-associated FALS, and that Dorfin may play a significant role in this.

    PubMed

    researchmap

  • Identification of HLA-A24-restricted CTL epitope from cancer-testis antigen, NY-ESO-1, and induction of a specific antitumor immune response. 査読

    Yamaguchi H, Tanaka F, Ohta M, Inoue H, Mori M

    Clinical cancer research : an official journal of the American Association for Cancer Research   10 ( 3 )   890 - 896   2004年2月

     詳細を見る

  • [Advanced lung cancer of performance status 3 successfully treated by gefitinib--a case report]. 査読

    Kambayashi T, Ishibashi O, Yanagihara K, Tanaka F, Hasegawa S, Wada H

    Gan to kagaku ryoho. Cancer & chemotherapy   31 ( 2 )   223 - 226   2004年2月

     詳細を見る

  • Stimulation of CD40 inhibits Fas- or chemotherapy-mediated apoptosis and increases cell motility in human gastric carcinoma cells. 査読

    Yamaguchi H, Tanaka F, Sadanaga N, Ohta M, Inoue H, Mori M

    International journal of oncology   23 ( 6 )   1697 - 1702   2003年12月

     詳細を見る

  • 近位筋優位の脱力と自律神経障害を呈した遺伝性ニューロパチーの1家系

    曽根 淳, 伊藤 瑞規, 小池 春樹, 田中 章景, 服部 直樹, 祖父江 元

    臨床神経学   43 ( 7 )   450 - 450   2003年7月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • Platelet-derived endothelial cell growth factor mediates Rho-associated coiled-coil domain kinase messenger RNA expression and promotes cell motility. 査読

    Yoshinaga K, Inoue H, Tanaka F, Mimori K, Utsunomiya T, Mori M

    Annals of surgical oncology   10 ( 5 )   582 - 587   2003年6月

     詳細を見る

  • Natural killer, but not natural killer T, cells play a necessary role in the promotion of an innate antitumor response induced by IL-18. 査読

    Hashimoto W, Tanaka F, Robbins PD, Taniguchi M, Okamura H, Lotze MT, Tahara H

    International journal of cancer   103 ( 4 )   508 - 513   2003年2月

  • Intratumoral injection of dendritic cells after treatment of anticancer drugs induces tumor-specific antitumor effect in vivo. 査読

    Tanaka F, Yamaguchi H, Ohta M, Mashino K, Sonoda H, Sadanaga N, Inoue H, Mori M

    International journal of cancer   101 ( 3 )   265 - 269   2002年9月

  • Effective strategy of dendritic cell-based immunotherapy for advanced tumor-bearing hosts: the critical role of Th1-dominant immunity. 査読

    Mashino K, Sadanaga N, Tanaka F, Ohta M, Yamaguchi H, Mori M

    Molecular cancer therapeutics   1 ( 10 )   785 - 794   2002年8月

     詳細を見る

  • Expression of chemokine receptor CCR7 is associated with lymph node metastasis of gastric carcinoma. 査読

    Mashino K, Sadanaga N, Yamaguchi H, Tanaka F, Ohta M, Shibuta K, Inoue H, Mori M

    Cancer research   62 ( 10 )   2937 - 2941   2002年5月

     詳細を見る

  • Analysis of the gene-expression profile regarding the progression of human gastric carcinoma. 査読

    Mori M, Mimori K, Yoshikawa Y, Shibuta K, Utsunomiya T, Sadanaga N, Tanaka F, Matsuyama A, Inoue H, Sugimachi K

    Surgery   131 ( 1 Suppl )   S39 - 47   2002年1月

     詳細を見る

  • Erratum: Triggering of neuronal cell death by accumulation of activated SEK1 on nuclear polyglutamine aggregations in PML bodies (Genes to Cells 4:12) 査読

    Yasuda S, Inoue K, Hirabayashi M, Higashiyama H, Yamamoto Y, Fuyushiro H, Komure O, Tanaka F, Sobue G, Tsuchiya K, Hamada K, Sasaki H, Takeda K, Ichijo H, Kakizuka A

    Genes to Cells   5 ( 2 )   153   2000年

▼全件表示

MISC

  • Transmission experiments verify sporadic V2 prion in a patient with E200K mutation

    Hitaru Kishida, Atsushi Kobayashi, Kenta Teruya, Hiroshi Doi, Naohisa Ueda, Fumiaki Tanaka, Yoshiyuki Kuroiwa, Piero Parchi, Shirou Mohri, Tetsuyuki Kitamoto

    Acta Neuropathologica   147 ( 1 )   2024年6月

     詳細を見る

    掲載種別:速報,短報,研究ノート等(学術雑誌)  

    DOI: 10.1007/s00401-024-02738-6

    Scopus

    PubMed

    researchmap

  • 【巨匠の神経心理学】Sperryの神経心理学

    浜田 智哉, 東山 雄一, 田中 章景

    脳神経内科   98 ( 4 )   598 - 606   2023年4月

     詳細を見る

    記述言語:日本語   出版者・発行元:(有)科学評論社  

    researchmap

  • プリオン病のサーベイランスと感染予防に関する調査研究 サーベイランス調査研究の諸問題-未回収調査票と剖検率の低下-

    塚本忠, 水澤英洋, 矢部一郎, 青木正志, 村井弘之, 三條伸夫, 田中章景, 小野寺理, 山田正仁, 濱口毅, 望月秀樹, 道勇学, 山下徹, 磯部紀子, 松下拓也, 高橋良輔

    プリオン病のサーベイランスと感染予防に関する調査研究 令和4年度 総括・分担研究報告書(Web)   2023年

     詳細を見る

  • プリオン病及び遅発性ウイルス感染症に関する調査研究班 プリオン病のサーベイランス・感染予防に関する調査・研究の報告,JACOPの推進

    水澤英洋, 塚本忠, 三條伸夫, 矢部一郎, 青木正志, 小野寺理, 田中章景, 道勇学, 浜口毅, 望月秀樹, 山下徹, 村井弘之, 松下拓也, 佐藤克也, 北本哲之, 阿江竜介, 村山繁雄, 原田雅史, 齊藤延人, 太組一朗, 金谷泰宏, 黒岩義之, 高橋良輔, 田村智英子, 山田正仁, 高尾昌樹

    プリオン病及び遅発性ウイルス感染症に関する調査研究班 令和4年度 総括研究報告書(Web)   2023年

     詳細を見る

  • 原発性進行性失語症における口舌顔面失行の臨床学的特徴と責任病巣について

    森原啓介, 森原啓介, 太田祥子, 柿沼一雄, 川上暢子, 東山雄一, 菅野重範, 田中章景, 鈴木匡子

    日本神経学会学術大会プログラム・抄録集   63rd   2022年

     詳細を見る

  • 新規ビオチン標識法を用いたマルチオミクス解析によるCajal body構成因子の網羅的解析とCajal body形成メカニズムの解明

    野口慶介, 鈴木秀文, 阿部竜太, 池陽子, 井野洋子, 木村弥生, 梁明秀, 土井宏, 田中章景, 山口雄輝, 高橋秀尚

    日本分子生物学会年会プログラム・要旨集(Web)   45th   2022年

     詳細を見る

  • プリオン病及び遅発性ウイルス感染症に関する調査研究班 プリオン病のサーベイランス・感染予防に関する調査・研究の報告,JACOPの推進

    水澤英洋, 塚本忠, 三條伸夫, 矢部一郎, 青木正志, 小野寺理, 田中章景, 道勇学, 浜口毅, 望月秀樹, 山下徹, 村井弘之, 松下拓也, 佐藤克也, 北本哲之, 阿江竜介, 村山繁雄, 原田雅史, 齊藤延人, 太組一朗, 金谷泰宏, 黒岩義之, 高橋良輔, 田村智英子, 山田正仁, 高尾昌樹

    プリオン病及び遅発性ウイルス感染症に関する調査研究班 令和3年度 総括・分担研究報告書(Web)   2022年

     詳細を見る

  • 【脳神経内科診療における超音波】筋疾患診断への超音波

    渡辺 大祐, 馬場 泰尚, 田中 章景

    脳神経内科   95 ( 5 )   586 - 594   2021年11月

     詳細を見る

    記述言語:日本語   出版者・発行元:(有)科学評論社  

    researchmap

  • Medical Scope 多発性硬化症の診断マーカー研究の進歩

    田中 章景

    Pharma Medica   39 ( 11 )   67 - 70   2021年11月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)メディカルレビュー社  

    <文献概要>多発性硬化症(multiple sclerosis:MS)では,診断に加え,再発や進行を判断する確実なマーカーが存在しないことが,臨床上の課題となっている。IgGインデックスやオリゴクローナルバンドは古くから,中枢神経炎症を反映する髄液マーカーとして使われてきた。ニューロフィラメントやGFAPは髄液・血液マーカーとして,重症度や疾患進行の予測因子となりうる可能性がある。また,マイクロRNAもMS病態を反映するマーカーとしての期待が高まっている。さらに,Nogo受容体アンタゴニストのLOTUSは,再発や進行を反映するマーカーとして有望である。しかし,これらのいずれもが感度,特異度の点で確実なマーカーとはいえず,さらなるマーカー開発が望まれる。

    researchmap

    その他リンク: https://search.jamas.or.jp/index.php?module=Default&action=Link&pub_year=2021&ichushi_jid=J01750&link_issn=&doc_id=20211125160014&doc_link_id=issn%3D0289-5803%26volume%3D39%26issue%3D11%26spage%3D67&url=http%3A%2F%2Fwww.pieronline.jp%2Fopenurl%3Fissn%3D0289-5803%26volume%3D39%26issue%3D11%26spage%3D67&type=PierOnline&icon=https%3A%2F%2Fjk04.jamas.or.jp%2Ficon%2F00005_2.gif

  • IL-19欠損はALSモデルマウスの運動機能改善をもたらす

    古宮 裕泰, 竹内 英之, 小川 有紀, 小笠原 陽大, 高橋 慶太, 田中 章景

    神経免疫学   26 ( 1 )   139 - 139   2021年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経免疫学会  

    researchmap

  • 難治性ニューロパチーの新規治療への展望 脊髄性筋萎縮症の核酸・遺伝子治療(成人例を中心に)

    田中 章景

    神経治療学   38 ( 6 )   S173 - S173   2021年10月

  • フィンゴリモド治療中の多発性硬化症患者におけるCOVID-19の経過

    岸田 日帯, 木村 活生, 林 紀子, 上村 直哉, 小林 卓雄, 伊藤 知美, 山田 亮, 上田 直久, 田中 章景

    神経免疫学   26 ( 1 )   145 - 145   2021年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経免疫学会  

    researchmap

  • IVIg後に肺塞栓症を発症したギラン・バレー症候群の症例

    仲野 達, 武田 むつき, 山下 亮太郎, 田中 章景

    神経治療学   38 ( 6 )   S317 - S317   2021年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経治療学会  

    researchmap

  • パーキンソン病のdevice-aided therapy(DAT) DBS、LCIGをめぐって

    木村 活生, 田中 章景

    神経治療学   38 ( 6 )   S217 - S217   2021年10月

  • 多発性硬化症治療薬siponimodのグリア細胞における作用機序

    小笠原 陽大, 古宮 裕泰, 小川 有紀, 高橋 慶太, 竹内 英之, 田中 章景

    神経免疫学   26 ( 1 )   129 - 129   2021年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経免疫学会  

    researchmap

  • パーキンソン病患者における脊髄刺激療法施行後の運動機能・疼痛スコアの変化

    安部 克哉, 木村 活生, 柳泉 亮太, 東島 威史, 川崎 隆, 岸田 日帯, 上田 直久, 田中 章景

    パーキンソン病・運動障害疾患コングレスプログラム・抄録集   15回   95 - 95   2021年7月

     詳細を見る

    記述言語:日本語   出版者・発行元:Movement Disorder Society of Japan (MDSJ)  

    researchmap

  • 全身性舞踏運動を呈し左鎖骨下動脈拡張術により改善した84歳男性例

    伊藤 知美, 木村 活生, 礒田 将徳, 松永 祐己, 岸田 日帯, 間中 浩, 坂田 勝巳, 上田 直久, 田中 章景

    パーキンソン病・運動障害疾患コングレスプログラム・抄録集   15回   107 - 107   2021年7月

     詳細を見る

    記述言語:日本語   出版者・発行元:Movement Disorder Society of Japan (MDSJ)  

    researchmap

  • STN-DBSにおけるGuideXTを用いた刺激導入法の検討

    木村 活生, 岸田 日帯, 宮地 洋輔, 東山 雄一, 上木 英人, 土井 宏, 竹内 英之, 東島 威史, 川崎 隆, 上田 直久, 田中 章景

    パーキンソン病・運動障害疾患コングレスプログラム・抄録集   15回   94 - 94   2021年7月

     詳細を見る

    記述言語:日本語   出版者・発行元:Movement Disorder Society of Japan (MDSJ)  

    researchmap

  • Controversy レボドパカルビドパ持続経腸療法は脳深部刺激療法よりも優れている Noの立場から

    木村 活生, 岸田 日帯, 東島 威史, 川崎 隆, 上田 直久, 田中 章景

    パーキンソン病・運動障害疾患コングレスプログラム・抄録集   15回   44 - 44   2021年7月

     詳細を見る

    記述言語:日本語   出版者・発行元:Movement Disorder Society of Japan (MDSJ)  

    researchmap

  • 臨床で進行性核上性麻痺とParkinson病の合併が疑われ、病理学的に確認された87歳女性例

    古泉 龍一, 守吉 秀行, 矢端 博行, 安藤 孝志, 赤木 明生, 陸 雄一, 宮原 弘明, 田中 章景, 吉田 眞理, 岩崎 靖

    パーキンソン病・運動障害疾患コングレスプログラム・抄録集   15回   98 - 98   2021年7月

     詳細を見る

    記述言語:日本語   出版者・発行元:Movement Disorder Society of Japan (MDSJ)  

    researchmap

  • Movement disorderの救急 コンサルト症例から学ぶ救急現場でのmovement disorder emergency対応

    木村 活生, 岸田 日帯, 北澤 悠, 東山 雄一, 宮地 洋輔, 上木 英人, 土井 宏, 竹内 英之, 上田 直久, 田中 章景

    Journal of Japan Society of Neurological Emergencies & Critical Care   34 ( 1 )   45 - 45   2021年6月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)へるす出版  

    researchmap

  • 難治性てんかん、幻覚症状で再発した脳炎の若年男性例

    堀口 遼平, 岸田 日帯, 山下 亮太郎, 萩原 真斗, 木村 活生, 上田 直久, 田中 章景

    臨床神経学   61 ( 1 )   62 - 62   2021年1月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • プリオン病及び遅発性ウイルス感染症に関する調査研究班 プリオン病のサーベイランス・感染予防に関する調査・研究の報告,JACOPの推進

    水澤英洋, 塚本忠, 三條伸夫, 矢部一郎, 青木正志, 小野寺理, 田中章景, 道勇学, 望月秀樹, 阿部康二, 村井弘之, 松下拓也, 佐藤克也, 北本哲之, 阿江竜介, 村山繁雄, 黒岩義之, 原田雅史, 齊藤延人, 太組一朗, 金谷泰宏, 田村智英子, 山田正仁, 高尾昌樹

    プリオン病及び遅発性ウイルス感染症に関する調査研究班 令和2年度 総括・分担研究報告書(Web)   2021年

     詳細を見る

  • 末梢神経疾患と脊椎・脊髄疾患の接点 脊髄性筋萎縮症(SMA)の遺伝子・核酸治療

    田中 章景

    末梢神経   31 ( 2 )   219 - 222   2020年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本末梢神経学会  

    脊髄性筋萎縮症(SMA)はSMN1遺伝子の欠失・変異によるSMNタンパク質の不足が原因となる下位運動ニューロン疾患である。患者ではSMN1遺伝子のパラログであるSMN2遺伝子からSMNタンパク質が作られるが、スプライシング過程の障害により産生量はわずかである。この過程を修復しSMNタンパク質を産生する核酸薬のnusinersenや低分子化合物のrisdiplamが開発されている。特にnusinerseは実臨床における治療成績が集積されてきている。罹病期間の長い成人例においても臨床スコアの改善がみられており、SMA診療は大きく変貌した。Risdiplamは経口投与という利点を有し、2020年にFDAの認可を受けた。また、ウイルスベクターを用いSMNタンパク質を産生させる遺伝子治療として、onasemnogeneが2歳未満の患者に2020年より使用可能となり、重症例の大幅な予後改善が期待されている。その他、SMNタンパク質に依存しない治療薬の開発も行われている。SMA治療は、神経変性疾患に対する治療の代表的成功例であり、今後の難治性疾患の治療開発に大きな影響を与えると考えられる。(著者抄録)

    researchmap

  • combination techniqueによる血栓回収時におけるデバイスの相性

    山本 良央, 天野 悠, 岸本 真雄, 甘利 和光, 中居 康展, 城倉 健, 田中 章景

    脳血管内治療   5 ( Suppl. )   68 - 68   2020年11月

     詳細を見る

    記述言語:日本語   出版者・発行元:(NPO)日本脳神経血管内治療学会  

    researchmap

  • パーキンソン病患者の便秘に対するエロビキシバットの有効性

    中江 啓晴, 吉田 環, 竹井 暖, 古谷 正幸, 田中 章景

    臨床神経学   60 ( Suppl. )   S430 - S430   2020年11月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 橋に限局する急性期脳卒中患者のベッドサイドでの眼球運動評価(第2報)

    工藤 洋祐, 菅原 恵梨子, 奈良 典子, 大瀧 浩之, 天野 悠, 山本 良央, 山本 正博, 甘利 和光, 高橋 幸治, 田中 理, 田中 章景, 城倉 健

    臨床神経学   60 ( Suppl. )   S423 - S423   2020年11月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • パーキンソン病における血圧日内変動と非運動症状との相関

    上木 英人, 宮地 洋輔, 北澤 悠, 木村 活生, 岸田 日帯, 上田 直久, 土井 宏, 児矢野 繁, 竹内 英之, 田中 章景

    臨床神経学   60 ( Suppl. )   S447 - S447   2020年11月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 集学的治療により発作症状の軽減が得られた成人発症型Rasmussen症候群の一例

    北澤 悠, 萩原 真斗, 宮城 哲哉, 岡本 智子, 太組 一朗, 木村 活生, 岸田 日帯, 上木 英人, 土井 宏, 竹内 英之, 上田 直久, 田中 章景

    臨床神経学   60 ( Suppl. )   S439 - S439   2020年11月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • めまいと消化器症状の関連

    菅原 恵梨子, 奈良 典子, 工藤 洋祐, 田中 章景, 城倉 健

    臨床神経学   60 ( Suppl. )   S419 - S419   2020年11月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 特発性正常圧水頭症患者におけるシャント術後の転帰不良因子の同定

    小林 絵礼奈, 菅野 重範, 成田 渉, 田中 章景, 鈴木 匡子

    臨床神経学   60 ( Suppl. )   S403 - S403   2020年11月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 頭蓋内大血管閉塞症例における、bright vessel appearanceの意義

    山本 良央, 大瀧 浩之, 菅原 恵梨子, 奈良 典子, 天野 悠, 工藤 洋祐, 岸本 真雄, 甘利 和光, 中居 康展, 田中 章景, 城倉 健

    臨床神経学   60 ( Suppl. )   S374 - S374   2020年11月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • ジストニアにおけるドパミン産生機能の画像的検討

    池澤 淳, 横地 房子, 沖山 亮一, 熊田 聡子, 戸島 麻耶, 上山 勉, 花川 隆, 松田 博史, 田中 章景, 中田 安浩, 磯崎 英治

    臨床神経学   60 ( Suppl. )   S307 - S307   2020年11月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 神経変性疾患の分子生物学的病態解明

    田中 章景

    臨床神経学   60 ( Suppl. )   S283 - S283   2020年11月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • E200K遺伝性CJD 60例の臨床的特徴

    岸田 日帯, 工藤 洋祐, 児矢野 繁, 黒岩 義之, 溝口 功一, 瀧山 嘉久, 木村 活生, 上木 英人, 土井 宏, 竹内 英之, 上田 直久, 田中 章景

    臨床神経学   60 ( Suppl. )   S343 - S343   2020年11月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • パーキンソン病における運動および知的学習の転移効果

    上田 直久, 森原 啓介, 北澤 悠, 木村 活生, 上木 英人, 土井 宏, 岸田 日帯, 竹内 英之, 児矢野 繁, 田中 章景

    臨床神経学   60 ( Suppl. )   S339 - S339   2020年11月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 新型コロナ感染症現場における脳神経内科医の挑戦 新型コロナウィルス感染症を発症したクルーズ船内発症脳梗塞患者における治療上の問題点

    木村 活生, 麥田 積司, 横山 尚佑, 萩原 真斗, 岸田 日帯, 工藤 誠, 比嘉 令子, 築地 淳, 上田 直久, 田中 章景

    臨床神経学   60 ( Suppl. )   S262 - S262   2020年11月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 手根管症候群の新しい重症度分類の提唱

    宮地 洋輔, 大石 知瑞子, 田中 章景, 園生 雅弘

    臨床神経生理学   48 ( 5 )   554 - 554   2020年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本臨床神経生理学会  

    researchmap

  • ALSモデルマウスの病勢進行に伴ったCCR2の中枢神経における細胞局在変化

    古宮 裕泰, 竹内 英之, 小川 有紀, 高橋 慶太, 勝元 敦子, 國井 美紗子, 多田 美紀子, 土井 宏, 田中 章景

    神経免疫学   25 ( 1 )   110 - 110   2020年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経免疫学会  

    researchmap

  • たこつぼ型心筋症を合併したBickerstaff脳幹脳炎の68歳女性例

    木村 瑞希, 橋口 俊太, 田中 健一, 高橋 慶太, 宮地 洋輔, 上木 英人, 土井 宏, 竹内 英之, 田中 章景

    神経治療学   37 ( 6 )   S248 - S248   2020年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経治療学会  

    researchmap

  • 精神神経科・脳神経内科で協力して行う認知症検査入院の試み

    仲野 達, 古田 龍太郎, 齊藤 菜穂, 安部 克哉, 武田 むつき, 山下 亮太郎, 田中 章景

    Dementia Japan   34 ( 4 )   501 - 501   2020年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本認知症学会  

    researchmap

  • 緑膿菌感染による肥厚性硬膜炎に伴い硬膜下水腫を呈した1例

    國井 美紗子, 岡本 光生, 竹井 暖, 窪田 瞬, 中村 治子, 田中 章景

    臨床神経学   60 ( 8 )   538 - 542   2020年8月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    78歳女性.右眼窩先端症候群・両側真菌性副鼻腔炎に対する内視鏡下右視神経管開放術・副鼻腔手術施行2ヶ月後,精神症状,異常行動が出現した.当初右慢性硬膜下血腫の診断であったが,穿頭ドレナージ術により高蛋白の滲出液貯留が確認された.原因は不明であり,10日後に液体再貯留と硬膜肥厚を認めた.硬膜生検による組織培養にて初めて緑膿菌が検出され,レボフロキサシンの内服により軽快した.局所の緑膿菌感染に続発する肥厚性硬膜炎は,疼痛を初発症状とし進行すると脳神経麻痺などを呈する経過が典型的であるが,疼痛なしに硬膜下水腫を伴い亜急性の精神症状でのみ発症した症例は報告されておらず,本例は稀な症例と考えられた.(著者抄録)

    researchmap

    その他リンク: https://search.jamas.or.jp/index.php?module=Default&action=Link&pub_year=2020&ichushi_jid=J01550&link_issn=&doc_id=20200820280010&doc_link_id=130007885759&url=https%3A%2F%2Fci.nii.ac.jp%2Fnaid%2F130007885759&type=CiNii&icon=https%3A%2F%2Fjk04.jamas.or.jp%2Ficon%2F00003_1.gif

  • 経時的画像を追跡しえた神経核内封入体病の52歳男性例

    佐々木 芽衣, 宮地 洋輔, 草間 香里, 小笠原 陽大, 上木 英人, 土井 宏, 竹内 英之, 田中 章景

    臨床神経学   60 ( 5 )   381 - 381   2020年5月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 臨床に役立つ針筋電図検査の実際

    宮地 洋輔, 田中 章景, 園生 雅弘

    神経治療学   37 ( 3 )   291 - 293   2020年5月

  • 合併した二次性水頭症により抗結核治療の有効性判断に苦慮した髄膜炎の1例

    萩原 真斗, 岸田 日帯, 堀口 遼平, 山下 亮太郎, 木村 活生, 上田 直久, 田中 章景

    NEUROINFECTION   25 ( 1 )   139 - 145   2020年5月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本神経感染症学会  

    症例は44歳男性。8ヵ月前から亜急性に頭痛、微熱、物忘れ等の症状が出現、慢性的に経過し、さらに異常言動、意識障害を認めたため入院した。意識障害、項部硬直から髄膜炎が疑われ、背景としての易感染性、長期間続く症状、画像所見、脳脊髄液所見から、結核性髄膜炎と考えた。しかし各種培養検査・Nested PCR・細胞診、生検でも病原体の同定にいたらなかった。抗結核治療で脳脊髄液細胞数は減少したが、意識障害等の改善は乏しく、水頭症に対するVPシャント術施行後に徐々に症状は改善した。診断・治療に苦慮した髄膜炎である本症例を提示し、二次性水頭症合併下で、結核菌を同定できていない段階での抗結核治療効果判定とその問題点について考察する。(著者抄録)

    researchmap

  • Long-read Sequencing Identifies GGC Repeat Expansions in NOTCH2NLC as the Cause of Neuronal Intranuclear Inclusion Disease

    Jun Sone, Satomi Mitsuhashi, Atsushi Fujita, Hiroshi Takashima, Hiroshi Sugiyama, Yoshihisa Takiyama, Kengo Maeda, Fumiaki Tanaka, Yasushi Iwasaki, Mari Yoshida, Naomichi Matsumoto, Gen Sobue

    NEUROLOGY   94 ( 15 )   2020年4月

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:LIPPINCOTT WILLIAMS & WILKINS  

    Web of Science

    researchmap

  • 2-ヒドロキシグルタル酸尿症による成人白質ジストロフィーの1例

    古田 恭寛, 邦武 克彦, 稲垣 良輔, 鈴木 淳一郎, 中井 紀嘉, 西田 卓, 伊藤 泰広, 國井 美紗子, 土井 宏, 田中 章景

    臨床神経学   60 ( 4 )   298 - 298   2020年4月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 神経核内封入体病(NIID)の病態解明および原因遺伝子同定

    曽根 淳, 吉田 眞理, 田中 章景, 南山 誠

    大和証券ヘルス財団研究業績集   ( 43 )   89 - 94   2020年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(公財)大和証券ヘルス財団  

    神経核内封入体病(NIID)の病態および原因の解明と治療法の開発のため、NIIDの原因遺伝子探索研究に着手した。ショートリード型の次世代シークエンサーを用いて全エクソンおよび全ゲノム解析を行い、主に一塩基多型の検索を網羅的に行ったが、NIID患者にのみ共通して認められる一塩基変異あるいは挿入、欠失は認められず、原因遺伝子同定には至らなかった。NIIDの原因は一塩基変異ではないと考え、ロングリード型次世代シークエンサーを用いて解析を行った。その結果、NOTCH2NLC遺伝子のGGCリピート配列が、NIID発症者のサンプルでのみ延長していることが明らかとなった。さらに、CRISPER-Cas9システムを用いて、NOTCH2NLC遺伝子のGGCリピート配列の周辺に領域をしぼって、ロングリード型次世代シークエンサーでさらに詳細に解析をしたところ、GGCリピートの延長に加えて一部GGAリピート配列も含まれていることが明らかとなった。さらに、家族性NIIDに加えて、孤発性NIIDに関してもNOTCH2NLC遺伝子のGGCリピート配列について検討したところ、40例についても、家族性NIID同様にGGCリピートの延長を認めた。また、正常コントロールサンプルではリピート配列の延長は認められなかったため、NOTCH2NLC遺伝子のGGCリピート配列がNIIDの原因遺伝子であると結論した。また、GGCリピートの延長数について検討してみたが、家族性NIIDと孤発性NIIDの間で有意なリピート数の差は認められなかった。

    researchmap

  • 【脳神経疾患のバイオマーカー】バイオマーカーとしての神経・筋超音波検査 神経・筋疾患への応用

    渡辺 大祐, 馬場 泰尚, 田中 章景

    脳神経内科   92 ( 2 )   165 - 171   2020年2月

     詳細を見る

    記述言語:日本語   出版者・発行元:(有)科学評論社  

    researchmap

  • ミオキミー放電により診断した放射線照射後ニューロパチーによる首下がり症候群の66歳女性例

    宮地 洋輔, 中村 治子, 寺師 綾子, 土井 宏, 竹内 英之, 園生 雅弘, 田中 章景

    臨床神経学   60 ( 1 )   91 - 91   2020年1月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 脳神経の有痛性病変およびその他の顔面痛に対する漢方処方

    中江 啓晴, 田中 章景

    日本頭痛学会誌   47 ( 1 )   167 - 172   2020年

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本頭痛学会  

    researchmap

  • 研究者の最新動向 脊髄小脳失調症新規モデルマウスを用いた病態解析

    土井 宏, 橋口 俊太, 中村 行宏, 石川 太郎, 田中 章景

    Precision Medicine   2 ( 13 )   1260 - 1266   2019年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)北隆館  

    常染色体優性遺伝性脊髄小脳失調症42型はT型カルシウムチャネルCaV3.1をコードするCACNA1Gのミスセンス変異によって発症する疾患である。我々はCRISPR/Cas9システムを用いてCacna1g遺伝子にヒトで発見された変異を導入したモデルマウスを作成し、その結果、運動失調、プルキンエ細胞変性を再現することに成功した。また小脳・脳幹急性スライスにおいてプルキンエ細胞および下オリーブ核神経細胞の電気生理学的異常を検出した。今後本モデルマウスを用いた治療法を開発していく予定である。(著者抄録)

    researchmap

  • DBSの新規刺激条件による治療効果の異同 ディレクショナルモードを使用したパーキンソン病に対するSTN-DBSの長期予後

    木村 活生, 岸田 日帯, 川崎 隆, 上田 直久, 田中 章景

    日本定位・機能神経外科学会プログラム・抄録集   59回   94 - 94   2019年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本定位・機能神経外科学会  

    researchmap

  • 手根管症候群の感覚神経伝導検査の比較法におけるonset潜時とpeak潜時の比較

    宮地 洋輔, 大石 知瑞子, 神谷 久雄, 田中 章景, 園生 雅弘

    臨床神経学   59 ( Suppl. )   S240 - S240   2019年11月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 3次元構造可視化ソフト(AVIZO)で動眼神経肥厚を証明した再発性有痛性眼筋麻痺性ニューロパチー

    黒川 隆史, 中川 大地, 中村 昭子, 中西 直子, 田中 章景

    日本頭痛学会誌   46 ( 2 )   478 - 478   2019年11月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本頭痛学会  

    researchmap

  • 中枢性めまいに対する新しい治療戦略

    城倉 健, 工藤 洋祐, 菅原 恵梨子, 奈良 典子, 山本 良央, 山本 正博, 甘利 和光, 田中 章景, 高橋 幸治, 田中 理

    臨床神経学   59 ( Suppl. )   S319 - S319   2019年11月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 脳卒中後慢性疼痛に対するMRIナビゲーション反復経頭蓋磁気刺激の効果(第2報)

    工藤 洋祐, 菅原 恵梨子, 天野 悠, 奈良 典子, 山本 良央, 甘利 和光, 高橋 幸治, 田中 理, 田中 章景, 城倉 健

    臨床神経学   59 ( Suppl. )   S318 - S318   2019年11月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 頭痛を主訴として神経内科外来を受診する患者の特徴

    中江 啓晴, 川口 優花, 古谷 正幸, 吉田 環, 田中 章景

    臨床神経学   59 ( Suppl. )   S317 - S317   2019年11月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 急性期病棟でのせん妄予防の試み(第2報)

    菅原 恵梨子, 南里 千春, 下川 友貴乃, 工藤 洋祐, 中溝 知樹, 田中 章景, 城倉 健

    臨床神経学   59 ( Suppl. )   S290 - S290   2019年11月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 脳梗塞に対する再開通療法において,来院時BNP値は3ヵ月後のmRSと相関する

    山本 良央, 麥田 積司, 菅原 恵梨子, 奈良 典子, 天野 悠, 工藤 洋祐, 小島 昭雄, 甘利 和光, 田中 章景, 城倉 健

    臨床神経学   59 ( Suppl. )   S263 - S263   2019年11月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • ジストニアと黒質のメラニン沈着

    池澤 淳, 横地 房子, 沖山 亮一, 熊田 聡子, 戸島 麻耶, 上山 勉, 花川 隆, 松田 博史, 田中 章景, 中田 安浩, 磯崎 英治

    臨床神経学   59 ( Suppl. )   S302 - S302   2019年11月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 進行期パーキンソン病治療におけるロチゴチンの有効な使用法についての検討

    岡田 雅仁, 児矢野 繁, 田中 章景

    臨床神経学   59 ( Suppl. )   S300 - S300   2019年11月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 全身麻酔下でMoMa+GuardWireダブルプロテクションで施行した頸動脈ステント留置術後のDWI陽性病変出現に関する予測因子

    山本 良央, 天野 悠, 岸本 真雄, 甘利 和光, 中居 康展, 城倉 健, 田中 章景

    脳血管内治療   4 ( Suppl. )   S282 - S282   2019年11月

     詳細を見る

    記述言語:日本語   出版者・発行元:(NPO)日本脳神経血管内治療学会  

    researchmap

  • Branch Atheromatous Diseaseにおける入院初期安静と予後に関する検討

    渡辺 大祐, 上村 直哉, 淺野 敬一郎, 土橋 裕一, 小島 麻里, 田中 章景, 高橋 竜哉

    臨床神経学   59 ( Suppl. )   S261 - S261   2019年11月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 当院におけるatrial fibrillation detected after stroke(AFDAS)症例の検討

    桃尾 隆之, 山浦 弦平, 伊東 毅, 麥田 積司, 田中 章景

    臨床神経学   59 ( Suppl. )   S325 - S325   2019年11月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 充電型デバイスを用いたDBS施行後のPD患者に対する退院指導の取り組みと効果の検討

    加藤 幸恵, 浦下 美咲, 伊丹 絢香, 菅野 裕加里, 高宮 優香子, 竹谷 有咲子, 木村 活生, 岸田 日帯, 松島 昌秀, 田中 章景, 上田 直久

    臨床神経学   59 ( Suppl. )   S450 - S450   2019年11月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • フマル酸ジメチルへの薬剤変更後に抗MOG抗体陽性が顕在化した視神経脊髄炎関連疾患の3症例

    高橋 慶太, 中村 治子, 三宅 綾子, 高橋 利幸, 土井 宏, 竹内 英之, 田中 章景

    神経治療学   36 ( 6 )   S271 - S271   2019年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経治療学会  

    researchmap

  • Neuronal intranuclear inclusion disease(神経核内封入体病)の原因遺伝子同定

    曽根 淳, 三橋 里美, 藤田 京志, 森 恵子, 小池 春樹, 高嶋 博, 杉山 博, 河野 豊, 瀧山 嘉久, 前田 健吾, 土井 宏, 幸原 伸夫, 勝野 雅央, 岩崎 靖, 鈴木 郁夫, 吉田 眞理, 田中 章景, 松本 直通, 祖父江 元

    Dementia Japan   33 ( 4 )   513 - 513   2019年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本認知症学会  

    researchmap

  • 手根管症候群診断のための感覚神経伝導検査の比較法におけるonset潜時とpeak潜時の比較

    宮地 洋輔, 大石 知瑞子, 神谷 久雄, 田中 章景, 園生 雅弘

    臨床神経生理学   47 ( 5 )   444 - 444   2019年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本臨床神経生理学会  

    researchmap

  • 発症前のMRI異常病変の出現時期を推定できたV180I遺伝性Creutzfeldt-Jakob病の65歳女性の一例

    麥田 積司, 岸田 日帯, 古泉 龍一, 横山 尚佑, 木村 活生, 上田 直久, 田中 章景

    臨床神経学   59 ( 9 )   612 - 612   2019年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • フマル酸ジメチルへの薬剤変更後に抗MOG抗体陽性が顕在化した視神経脊髄炎関連疾患の3症例

    高橋 慶太, 中村 治子, 三宅 綾子, 高橋 利幸, 土井 宏, 竹内 英之, 田中 章景

    神経免疫学   24 ( 1 )   142 - 142   2019年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経免疫学会  

    researchmap

  • 充電型デバイスを用いた脳深部刺激療法施行後のパーキンソン病患者に対する退院指導の取り組みと効果の検討

    浦下 美咲, 加藤 幸恵, 伊丹 絢香, 高宮 優香子, 竹谷 有咲子, 木村 活生, 岸田 日帯, 松島 昌秀, 田中 章景, 上田 直久

    パーキンソン病・運動障害疾患コングレスプログラム・抄録集   13回   121 - 121   2019年7月

     詳細を見る

    記述言語:日本語   出版者・発行元:Movement Disorder Society of Japan (MDSJ)  

    researchmap

  • 姿勢異常に起因する胃瘻周囲炎のため胃瘻抜去、内視鏡的胃瘻閉鎖を行ったパーキンソン病症例

    古泉 龍一, 木村 活生, 萩原 真斗, 岸田 日帯, 上田 直久, 田中 章景

    パーキンソン病・運動障害疾患コングレスプログラム・抄録集   13回   97 - 97   2019年7月

     詳細を見る

    記述言語:日本語   出版者・発行元:Movement Disorder Society of Japan (MDSJ)  

    researchmap

  • ジストニアと黒質メラニン沈着

    池澤 淳, 横地 房子, 沖山 亮一, 熊田 聡子, 戸島 麻耶, 上山 勉, 花川 隆, 松田 博史, 田中 章景, 中田 安浩, 磯崎 英治

    パーキンソン病・運動障害疾患コングレスプログラム・抄録集   13回   122 - 122   2019年7月

     詳細を見る

    記述言語:日本語   出版者・発行元:Movement Disorder Society of Japan (MDSJ)  

    researchmap

  • 悪性リンパ腫に対して行ったR-CHOP療法が著効した抗SRP抗体陽性壊死性ミオパチーの71歳男性例

    竹井 暖, 岡本 光生, 古宮 裕泰, 國井 美紗子, 多田 美紀子, 土井 宏, 竹内 英之, 田中 章景

    臨床神経学   59 ( 5 )   304 - 304   2019年5月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 軸索関連分子LOTUSを応用した多発性硬化症の診断バイオマーカー

    高橋 慶太, 竹内 英之, 竹居 光太郎, 田中 章景

    BIO Clinica   34 ( 5 )   516 - 520   2019年5月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)北隆館  

    多発性硬化症は早期の診断・治療により予後の改善が期待できることから、病勢の悪化・進行を迅速に評価可能な汎用性に優れた診断バイオマーカーの開発が喫緊の課題となっている。多発性硬化症の病態形成において、NogoとNogo受容体を中心とした軸索関連分子が重要な役割を果たしているが、我々はNogo受容体の内在性アンタゴニストであるLOTUSの髄液中濃度が病勢と一致して変動することを見出してきた。本稿では軸索関連分子の多発性硬化症病態への関わりと診断バイオマーカーへの応用について、LOTUSを中心にこれまでの知見を解説する。(著者抄録)

    researchmap

  • 劇症型G群溶血性連鎖球菌による髄膜炎の成人例

    栗田 悠輔, 小笠原 陽大, 澁谷 真弘, 城村 裕司, 田中 章景, 児矢野 繁

    臨床神経学   59 ( 5 )   300 - 300   2019年5月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 専門医に求められる最新の知識 機能外科 脳深部刺激療法(deep brain stimulation:DBS) デバイスの進歩

    木村 活生, 田中 章景

    脳神経外科速報   29 ( 5 )   506 - 512   2019年5月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)メディカ出版  

    脳深部刺激療法は約30年の歴史をもち、本邦でも1万例以上に施行されている治療である。長期効果は確立しており、運動合併症を有する進行期パーキンソン病、難治性振戦、全身性ジストニアなどに対して強力な治療効果を有す。使用されるデバイスの改良も進んでおり、脳内留置電極には従来型の電極だけでなく、刺激の方向性を規定できるディレクショナルリードが登場している。刺激発生装置についても、長期間使用できる充電式デバイス、独立定電流設定の可能なデバイスなどが登場し、今後さらなる予後改善、刺激誘発性の有害事象の軽減が期待される。(著者抄録)

    researchmap

    その他リンク: https://search.jamas.or.jp/index.php?module=Default&action=Link&pub_year=2019&ichushi_jid=J03120&link_issn=&doc_id=20190515120004&doc_link_id=issn%3D0917-1495%26volume%3D29%26issue%3D5%26spage%3D506&url=http%3A%2F%2Fwww.pieronline.jp%2Fopenurl%3Fissn%3D0917-1495%26volume%3D29%26issue%3D5%26spage%3D506&type=PierOnline&icon=https%3A%2F%2Fjk04.jamas.or.jp%2Ficon%2F00005_2.gif

  • TUBB4A遺伝子変異をみとめた大脳白質形成不全症の1例

    鈴木 淳一郎, 伊藤 泰広, 宮武 聡子, 土井 宏, 田中 章景

    臨床神経学   59 ( 5 )   322 - 322   2019年5月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 声帯麻痺を呈したSlow Channel Congenital Myasthenic Syndrome(SCCMS)の52歳男性例

    中村 治子, 國井 美紗子, 古宮 裕泰, 多田 美紀子, 上木 英人, 土井 宏, 竹内 英之, 田中 章景

    臨床神経学   59 ( 4 )   224 - 224   2019年4月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • LOTUS as a novel biomarker of multiple sclerosis

    Keita Takahashi, Fumiaki Tanaka

    Clinical and Experimental Neuroimmunology   10 ( 1 )   27 - 32   2019年2月

     詳細を見る

    記述言語:英語   掲載種別:書評論文,書評,文献紹介等   出版者・発行元:Wiley-Blackwell  

    Multiple sclerosis (MS) is considered to be an autoimmune demyelinating disorder, but recent studies showed that axonal degeneration is also an important pathological feature of MS. Indeed, Nogo receptor-1 and its ligands have been identified as key molecules for axonal degeneration in various neurological disorders, including MS. Lateral olfactory tract usher substance, an endogenous Nogo receptor-1 antagonist, promotes axonal growth and regeneration by blocking Nogo receptor-1 signaling. We found that the lateral olfactory tract usher substance level in cerebrospinal fluid was inversely correlated with MS disease activity. Here, we review the association between the key molecules in axonal degeneration/regeneration and MS, and discuss the potential application of lateral olfactory tract usher substance as a biomarker and therapeutic target of MS.

    DOI: 10.1111/cen3.12493

    Scopus

    researchmap

  • 神経難病と呼吸器疾患の管理

    釘本 千春, 山口 滋紀, 田中 章景

    呼吸器内科   35 ( 2 )   184 - 189   2019年2月

     詳細を見る

    記述言語:日本語   出版者・発行元:(有)科学評論社  

    researchmap

  • 【Glymphatic system-脳のゴミ処理とその異常】免疫とglymphatic system

    勝元 敦子, 田中 章景, 山村 隆

    Clinical Neuroscience   37 ( 1 )   29 - 32   2019年1月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)中外医学社  

    researchmap

  • 起立性低血圧による失神に対する抗てんかん薬の処方 (特集 見逃してはいけない! 間違いやすい抗てんかん薬処方) -- (そもそもてんかんではなかった!)

    北澤 悠, 神 一敬, 田中 章景, 中里 信和

    月刊薬事 = The pharmaceuticals monthly   61 ( 1 )   25 - 27   2019年1月

     詳細を見る

    記述言語:日本語   出版者・発行元:じほう  

    CiNii Books

    researchmap

  • プリオン病及び遅発性ウイルス感染症に関する調査研究 プリオン病のサーベイランス・感染予防に関する調査・研究の報告,JACOPの推進

    水澤英洋, 塚本忠, 三條伸夫, 佐々木秀直, 青木正志, 小野寺理, 田中章景, 道勇学, 望月秀樹, 阿部康二, 村井弘之, 松下拓也, 佐藤克也, 北本哲之, 中村好一, 村山繁雄, 黒岩義之, 原田雅史, 齊藤延人, 太組一朗, 金谷泰宏, 田村智英子, 山田正仁, 桑田一夫

    プリオン病及び遅発性ウイルス感染症に関する調査研究 平成30年度 総括・分担研究報告書(Web)   2019年

     詳細を見る

  • 脂肪酸伸長酵素ELOVL4の変異による脊髄小脳失調症34型

    尾崎心, 尾崎心, 安斉綾香, 延原幸嗣, 荒木俊彦, 久保寺隆行, 石井俊, 東美和, 曽我一将, 曽我一将, 入岡隆, 三井純, 石浦浩之, 辻省次, 馬嶋貴正, 土井宏, 岡崎康司, 田中章景, 水澤英洋, 石川欽也, 横田隆徳

    日本人類遺伝学会大会プログラム・抄録集   64th   2019年

     詳細を見る

  • 【SCDの最新の治療と研究】[第4部]治るかもしれない二次性小脳失調症 鑑別診断の重要性

    岡本 光生, 土井 宏, 田中 章景

    難病と在宅ケア   24 ( 9 )   21 - 25   2018年12月

  • 分枝粥腫病における機能予後の予測 脳血流SPECTによる検討

    高橋 竜哉, 多賀須 むつき, 小林 絵礼奈, 小島 麻里, 田中 章景, 渡辺 大祐

    臨床神経学   58 ( Suppl. )   S338 - S338   2018年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 急性期病棟でのせん妄予防の試み

    菅原 恵梨子, 南里 千春, 下川 友貴乃, 工藤 洋祐, 永井 徹, 原 弘士, 中溝 知樹, 田中 章景, 城倉 健

    臨床神経学   58 ( Suppl. )   S276 - S276   2018年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • SCA21の1家系の臨床的特徴と病理所見

    矢彦沢 裕之, 宮武 聡子, 酒井 寿明, 上原 剛, 山田 光則, 羽生 憲直, 二木 保博, 土井 宏, 児矢野 繁, 田中 章景, 鈴木 厚, 松本 直通, 吉田 邦広

    臨床神経学   58 ( Suppl. )   S266 - S266   2018年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • パーキンソン病治療におけるロチゴチン処方の特徴

    岡田 雅仁, 児矢野 繁, 田中 章景

    臨床神経学   58 ( Suppl. )   S316 - S316   2018年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 脳出血患者において,βブロッカーの使用は感染症を抑制しうるか?

    山本 良央, 麥田 積司, 中澤 謙介, 桃尾 隆之, 田中 章景

    臨床神経学   58 ( Suppl. )   S279 - S279   2018年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 脳卒中発症時の嘔吐と頭痛・めまいの関連についての検討

    中江 啓晴, 萩原 真斗, 小泉 寛之, 吉田 環, 田中 章景

    臨床神経学   58 ( Suppl. )   S252 - S252   2018年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 手根管症候群の神経伝導検査は「感覚優位の障害」ではない 適正な重症度分類について

    宮地 洋輔, 大石 知瑞子, 溝井 令一, 田中 章景, 園生 雅弘

    臨床神経学   58 ( Suppl. )   S231 - S231   2018年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • FSL-FIRSTを用いた,片頭痛における頭痛頻度と皮質下構造物の容積の検討

    黒川 隆史, 藤野 公裕, 黒岩 義之, 馬場 泰尚, 田中 章景

    臨床神経学   58 ( Suppl. )   S206 - S206   2018年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 出血性梗塞によりCharles-Bonnet症候群を生じた78歳男性例

    古泉 龍一, 池田 拓也, 木村 活生, 岸田 日帯, 上田 直久, 田中 章景

    臨床神経学   58 ( 12 )   779 - 779   2018年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 手根管症候群の神経伝導検査による既存の重症度分類における問題点 手根管症候群は「感覚神経優位の障害」とは限らない

    宮地 洋輔, 大石 知瑞子, 溝井 令一, 田中 章景, 園生 雅弘

    末梢神経   29 ( 2 )   259 - 259   2018年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本末梢神経学会  

    researchmap

  • 筋萎縮性側索硬化症の合併が疑われた頸椎症性脊髄症の1例

    宮地 洋輔, 山崎 啓史, 角谷 真人, 海田 賢一, 田中 章景, 園生 雅弘

    神経治療学   35 ( 6 )   S230 - S230   2018年11月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経治療学会  

    researchmap

  • 血管内大細胞性B細胞リンパ腫を併発し、R-CHOP療法で劇的な改善を認めた抗SRP抗体陽性筋炎の1例

    古宮 裕泰, 児矢野 繁, 土井 宏, 西野 一三, 竹内 英之, 田中 章景

    神経治療学   35 ( 6 )   S259 - S259   2018年11月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経治療学会  

    researchmap

  • 姿勢異常に起因する胃瘻トラブルのため胃瘻閉鎖に至った進行期パーキンソン病の1例

    古泉 龍一, 木村 活生, 萩原 真斗, 岸田 日帯, 上田 直久, 田中 章景

    神経治療学   35 ( 6 )   S256 - S256   2018年11月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経治療学会  

    researchmap

  • 血栓回収術後3ヵ月の機能予後は搬送時BNP値と相関する

    山本 良央, 麥田 積司, 小島 昭雄, 甘利 和光, 城倉 健, 田中 章景

    脳血管内治療   3 ( Suppl. )   S241 - S241   2018年11月

     詳細を見る

    記述言語:日本語   出版者・発行元:(NPO)日本脳神経血管内治療学会  

    researchmap

  • 手根管症候群の重症度分類の問題点 「感覚優位の障害」ではない

    宮地 洋輔, 田中 章景, 園生 雅弘

    神経治療学   35 ( 6 )   S226 - S226   2018年11月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経治療学会  

    researchmap

  • 【中枢神経疾患における末梢神経障害】有棘赤血球舞踏病における末梢神経障害

    土井 宏, 田中 章景

    神経内科   89 ( 5 )   457 - 462   2018年11月

     詳細を見る

    記述言語:日本語   出版者・発行元:(有)科学評論社  

    researchmap

  • POLR3A関連白質ジストロフィーにおける重症骨粗鬆症とその予防策

    古川 宗磨, 鈴木 淳一郎, 西田 卓, 國井 美紗子, 土井 宏, 田中 章景, 伊藤 泰広

    神経治療学   35 ( 6 )   S216 - S216   2018年11月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経治療学会  

    researchmap

  • ギラン・バレー症候群の頸部神経根超音波画像(長軸像)における腫大部位の検討

    渡辺 大祐, 上村 直哉, 淺野 敬一郎, 土橋 裕一, 塚本 浩, 阿部 達哉, 小森 哲夫, 高橋 竜哉, 田中 章景

    臨床神経生理学   46 ( 5 )   487 - 487   2018年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本臨床神経生理学会  

    researchmap

  • 劇症型G群溶血性連鎖球菌による髄膜炎の成人例

    栗田 悠輔, 城村 祐司, 澁谷 真弘, 小笠原 陽大, 田中 章景, 児矢野 繁

    NEUROINFECTION   23 ( 2 )   203 - 203   2018年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本神経感染症学会  

    researchmap

  • 神経診察と神経伝導検査で局在診断しえた胸骨正中切開術後C8腕神経叢障害の1例

    竹井 暖, 宮地 洋輔, 森原 啓介, 岩橋 幸子, 園生 雅弘, 田中 章景

    臨床神経生理学   46 ( 5 )   538 - 538   2018年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本臨床神経生理学会  

    researchmap

  • 亜急性進行性認知機能障害と多彩な白質病変を呈した神経梅毒の1例

    國井 美紗子, 伊東 毅, 川口 優花, 中村 治子, 勝元 敦子, 多田 美紀子, 岡本 光生, 玉澤 彰英, 土井 宏, 竹内 英之, 田中 章景

    NEUROINFECTION   23 ( 2 )   232 - 232   2018年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本神経感染症学会  

    researchmap

  • CTS診断update CTSの電気生理

    宮地 洋輔, 田中 章景, 園生 雅弘

    臨床神経生理学   46 ( 5 )   345 - 345   2018年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本臨床神経生理学会  

    researchmap

  • 舌癌に対する放射線治療後に首下がりを呈し、針筋電図でミオキミー発射が認められた一例

    寺師 綾子, 宮地 洋輔, 中村 治子, 園生 雅弘, 田中 章景

    臨床神経生理学   46 ( 5 )   535 - 535   2018年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本臨床神経生理学会  

    researchmap

  • 若年ミオクロニーてんかんの多剤併用療法における薬剤選択

    北澤悠, 神一敬, 柿坂庸介, 藤川真由, 中里信和, 田中章景

    てんかん研究   36 ( 2 )   570 - 570   2018年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本てんかん学会  

    J-GLOBAL

    researchmap

  • 神経核内封入体病に橋本脳症を合併した64歳男性

    岸田 日帯, 池田 拓也, 鈴木 聡, 土橋 裕一, 木村 活生, 上田 直久, 米田 誠, 田中 章景

    神経免疫学   23 ( 1 )   119 - 119   2018年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経免疫学会  

    researchmap

  • 【もっとうまくいく!病診連携の「伝え方」 わかりやすく伝えるための診療情報提供書作成のコツ】第II章<診療科別>コンサルトのポイント E. 脳神経内科へのコンサルト 歩行障害

    土井宏, 田中章景

    臨床雑誌 内科   122 ( 3 )   564 - 566   2018年9月

     詳細を見る

    記述言語:日本語  

    researchmap

  • 標準的神経治療 Parkinson病のdevice aided therapy デュオドパと脳深部刺激療法の詳細がわかる標準的神経治療

    服部 信孝, 杉村 容子, 武田 篤, 村田 美穂, 深谷 親, 波田野 琢, 大山 彦光, 下 泰司, 木村 活生, 岸田 日帯, 上田 直久, 田中 章景, 日本神経治療学会治療指針作成委員会

    神経治療学   35 ( 5 )   641 - 660   2018年9月

  • けいれん発作で発症し、数年の経過後に脳幹病変を呈した抗MOG抗体陽性男性例

    仲野 達, 高橋 竜哉, 多賀須 むつき, 松永 祐己, 金子 仁彦, 高橋 利幸, 竹内 英之, 田中 章景

    神経免疫学   23 ( 1 )   116 - 116   2018年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経免疫学会  

    researchmap

  • 血管内大細胞性B細胞リンパ腫を併発し、R-CHOP療法で劇的な改善を認めた抗SRP抗体陽性筋炎の1例

    古宮 裕泰, 児矢野 繁, 土井 宏, 西野 一三, 竹内 英之, 田中 章景

    神経免疫学   23 ( 1 )   154 - 154   2018年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経免疫学会  

    researchmap

  • MERRF様の臨床経過を呈し巣状糸球体硬化症を合併したミトコンドリア病の33歳女性

    栗田 悠輔, 草間 香里, 森下 良志, 土橋 裕一, 木村 活生, 岸田 日帯, 上田 直久, 田中 章景

    臨床神経学   58 ( 8 )   528 - 528   2018年8月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 運動失調で発症し亜急性に認知症を呈したCreutzfeldt-Jakob病の73歳男性例

    川口 優花, 中村 治子, 國井 美紗子, 勝元 敦子, 多田 美紀子, 岡本 光生, 土井 宏, 田中 章景

    臨床神経学   58 ( 8 )   531 - 531   2018年8月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • PLA2G6変異を有するPARK14に対する脳深部刺激療法の長期予後

    草間 香里, 木村 活生, 岸田 日帯, 東山 雄一, 岡本 光生, 上木 英人, 土井 宏, 竹内 英之, 濱田 幸一, 川崎 隆, 上田 直久, 田中 章景

    パーキンソン病・運動障害疾患コングレスプログラム・抄録集   12回   94 - 94   2018年7月

     詳細を見る

    記述言語:日本語   出版者・発行元:Movement Disorder Society of Japan (MDSJ)  

    researchmap

  • Directional Leadをもちいた視床中間腹側核脳深部刺激療法(VIM-DBS)の有用性

    池田 拓也, 木村 活生, 岸田 日帯, 上田 直久, 濱田 幸一, 川崎 隆, 東山 雄一, 岡本 光生, 上木 英人, 土井 宏, 竹内 英之, 田中 章景

    パーキンソン病・運動障害疾患コングレスプログラム・抄録集   12回   96 - 96   2018年7月

     詳細を見る

    記述言語:日本語   出版者・発行元:Movement Disorder Society of Japan (MDSJ)  

    researchmap

  • 脳深部刺激療法後パーキンソン病患者のすくみ足

    岸田 日帯, 木村 活生, 土橋 裕一, 鈴木 聡, 池田 拓也, 岡村 泰, 樋口 優理子, 濱田 幸一, 川崎 隆, 上田 直久, 田中 章景

    パーキンソン病・運動障害疾患コングレスプログラム・抄録集   12回   95 - 95   2018年7月

     詳細を見る

    記述言語:日本語   出版者・発行元:Movement Disorder Society of Japan (MDSJ)  

    researchmap

  • ディレクショナルリードをもちいたSTN-DBSにおける簡便な刺激導入法の検討

    木村 活生, 岸田 日帯, 東山 雄一, 岡本 光生, 上木 英人, 土井 宏, 竹内 英之, 濱田 幸一, 川崎 隆, 上田 直久, 田中 章景

    パーキンソン病・運動障害疾患コングレスプログラム・抄録集   12回   94 - 94   2018年7月

     詳細を見る

    記述言語:日本語   出版者・発行元:Movement Disorder Society of Japan (MDSJ)  

    researchmap

  • 心臓ペースメーカー埋込後のPD症例に対する脳深部刺激療法施行時の配慮

    森下 良志, 木村 活生, 岸田 日帯, 東山 雄一, 岡本 光生, 上木 英人, 土井 宏, 竹内 英之, 濱田 幸一, 川崎 隆, 上田 直久, 田中 章景

    パーキンソン病・運動障害疾患コングレスプログラム・抄録集   12回   83 - 83   2018年7月

     詳細を見る

    記述言語:日本語   出版者・発行元:Movement Disorder Society of Japan (MDSJ)  

    researchmap

  • 同時失認における視覚提示時間の影響Navon図形を用いた症例検討

    森原 啓介, 東山 雄一, 浅野 史織, 松永 祐己, 三宅 綾子, 高橋 慶太, 上木 英人, 竹内 英之, 田中 章景

    日本神経心理学会総会プログラム・予稿集   42回   127 - 127   2018年6月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本神経心理学会  

    researchmap

  • 【パーキンソン病(第2版)-基礎・臨床研究のアップデート-】 治療 機器装着治療 脳深部刺激療法術後の調整(問題点、フォローアップ)

    木村 活生, 岸田 日帯, 東山 雄一, 岡本 光生, 上木 英人, 土井 宏, 竹内 英之, 上田 直久, 田中 章景

    日本臨床   76 ( 増刊4 パーキンソン病 )   515 - 521   2018年5月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)日本臨床社  

    researchmap

  • 純粋運動失調を呈したランバート・イートン症候群の67歳男性例

    浅野 史織, 東山 雄一, 森原 啓介, 高橋 慶太, 田中 健一, 上木 英人, 竹内 英之, 田中 章景

    臨床神経学   58 ( 4 )   254 - 254   2018年4月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 純粋運動失調を呈したランバート・イートン症候群の67歳男性例

    浅野 史織, 東山 雄一, 森原 啓介, 高橋 慶太, 田中 健一, 上木 英人, 竹内 英之, 田中 章景

    臨床神経学   58 ( 4 )   254 - 254   2018年4月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • レボドパ-カルビドパ経腸用ゲル投与により首下がりが改善したパーキンソン病の70歳女性例

    池田 拓也, 木村 活生, 鈴木 聡, 岸田 日帯, 上田 直久, 田中 章景

    臨床神経学   58 ( 4 )   257 - 257   2018年4月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 【ニューロジェネティクス新時代 次世代シークエンサーが拓く新しい世界】 筋疾患・神経疾患のジェネティクス 筋萎縮性側索硬化症

    土井 宏, 田中 章景

    Clinical Neuroscience   36 ( 2 )   206 - 209   2018年2月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)中外医学社  

    researchmap

  • プリオン病のサーベイランスと感染予防に関する調査研究:JACOP自然歴調査との統合によるサーベイランスの発展

    水澤英洋, 塚本忠, 三條伸夫, 佐々木秀直, 青木正志, 小野寺理, 田中章景, 道勇学, 望月秀樹, 阿部康二, 村井弘之, 松下拓也, 佐藤克也, 北本哲之, 中村好一, 村山繁雄, 黒岩義之, 原田雅史, 齊藤延人, 太組一朗, 金谷泰宏, 田村智英子, 山田正仁, 桑田一夫

    プリオン病及び遅発性ウイルス感染症に関する調査研究 平成29年度 総括・分担研究報告書(Web)   2018年

     詳細を見る

  • 手根管症候群の神経伝導検査は「感覚神経優位の障害」ではない 正中神経分枝ごとの障害されやすさについて

    宮地 洋輔, 大石 知瑞子, 溝井 令一, 田中 章景, 園生 雅弘

    末梢神経   28 ( 2 )   309 - 309   2017年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本末梢神経学会  

    researchmap

  • 成長ホルモン投与により一定期間、高次脳機能・ADLを維持し得た4H症候群の1例

    釘本 千春, 多賀須 むつき, 古宮 裕泰, 酒井 竜一郎, 多田 美紀子, 上木 英人, 児矢野 繁, 城倉 健, 土井 宏, 田中 章景

    神経治療学   34 ( 6 )   S227 - S227   2017年11月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本神経治療学会  

    researchmap

  • 成長ホルモン投与により一定期間、高次脳機能・ADLを維持し得た4H症候群の1例

    釘本 千春, 多賀須 むつき, 古宮 裕泰, 酒井 竜一郎, 多田 美紀子, 上木 英人, 児矢野 繁, 城倉 健, 土井 宏, 田中 章景

    神経治療学   34 ( 6 )   S227 - S227   2017年11月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経治療学会  

    researchmap

  • パーキンソン病患者の便秘症状に対するルビプロストンの効果

    山口 滋紀, 林 竜一郎, 金塚 陽一, 大杉 静花, 山浦 弦平, 小笠原 陽大, 伊東 毅, 田中 章景

    神経治療学   34 ( 6 )   S218 - S218   2017年11月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経治療学会  

    researchmap

  • FSL-FIRSTを用いた、片頭痛発作頻度と皮質下構造物容積の関連性の検討

    黒川 隆史, 藤野 公裕, 黒岩 義之, 馬場 泰尚, 田中 章景

    日本頭痛学会誌   44 ( 2 )   355 - 355   2017年11月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本頭痛学会  

    researchmap

  • Clinical presentation and diagnosis of neuronal intranuclear inclusion disease

    Sone J, Mori K, Haruki K, Nakamura T, Masuda M, Yoshida M, Iwasaki Y, Tanaka F, Katsuno M, Sobue G

    JOURNAL OF THE NEUROLOGICAL SCIENCES   381   1017-1017   2017年10月

     詳細を見る

    記述言語:英語   掲載種別:速報,短報,研究ノート等(学術雑誌)  

    DOI: 10.1016/j.jns.2017.08.2869

    researchmap

  • GAP junction/hemichannel blockers ameliorate the disease progression of FTLD/ALS mice

    Takeuchi H, Mizoguchi H, Tanaka F, Suzumura A

    JOURNAL OF THE NEUROLOGICAL SCIENCES   381   714-715   2017年10月

     詳細を見る

    記述言語:英語   掲載種別:速報,短報,研究ノート等(学術雑誌)  

    DOI: 10.1016/j.jns.2017.08.2013

    researchmap

  • DBS周術期にせん妄をおこすリスクについての検討

    岸田 日帯, 木村 活生, 濱田 幸一, 川崎 隆, 小座野 いずみ, 岡村 泰, 樋口 優理子, 坂田 勝巳, 上田 直久, 田中 章景

    パーキンソン病・運動障害疾患コングレスプログラム・抄録集   11回   91 - 91   2017年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:Movement Disorder Society of Japan (MDSJ)  

    researchmap

  • MS・NMO2 神経機能分子LOTUSはNogo receptor-1非依存的に実験的自己免疫性脳炎を増悪させる

    高橋 慶太, 竹内 英之, 栗原 裕司, 竹居 光太郎, 田中 章景

    神経免疫学   22 ( 1 )   111 - 111   2017年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経免疫学会  

    researchmap

  • 8極リード・MICC技術対応IPGを用いた淡蒼球内節脳深部刺激療法(GPi-DBS)の長期予後

    木村 活生, 岸田 日帯, 川崎 隆, 濱田 幸一, 岡村 泰, 池西 優理子, 上田 直久, 田中 章景

    パーキンソン病・運動障害疾患コングレスプログラム・抄録集   11回   104 - 104   2017年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:Movement Disorder Society of Japan (MDSJ)  

    researchmap

  • 抗パ薬による薬剤性間質性肺炎のため十分な治療が行えず、STN-DBSを施行した67歳パーキンソン病女性例

    澁谷 真弘, 木村 活生, 浅野 敬一郎, 岸田 日帯, 土井 宏, 川崎 隆, 濱田 幸一, 岡村 泰, 池西 優理子, 上田 直久, 田中 章景

    パーキンソン病・運動障害疾患コングレスプログラム・抄録集   11回   103 - 103   2017年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:Movement Disorder Society of Japan (MDSJ)  

    researchmap

  • 神経フェリチン症に対する脳深部刺激療法の効果(第2報) 病理組織検討

    鈴木 聡, 木村 活生, 多田 美紀子, 岸田 日帯, 土井 宏, 上田 直久, 川崎 隆, 濱田 幸一, 岡村 泰, 池西 優理子, 田中 章景

    パーキンソン病・運動障害疾患コングレスプログラム・抄録集   11回   102 - 102   2017年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:Movement Disorder Society of Japan (MDSJ)  

    researchmap

  • 抗パーキンソン病薬投与により間質性肺炎が増悪し十分な治療が行えないためSTN-DBSを施行し症状を改善し得た67歳パーキンソン病女性例

    澁谷 真弘, 木村 活生, 浅野 敬一郎, 岸田 日帯, 土井 宏, 上田 直久, 田中 章景

    臨床神経学   57 ( 10 )   635 - 635   2017年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • DBS Emergencies IPG電池切れにともなうパーキンソン病症状悪化についての検討

    小笠原 陽大, 木村 活生, 岸田 日帯, 川崎 隆, 濱田 幸一, 岡村 泰, 池西 優理子, 上田 直久, 田中 章景

    パーキンソン病・運動障害疾患コングレスプログラム・抄録集   11回   92 - 92   2017年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:Movement Disorder Society of Japan (MDSJ)  

    researchmap

  • 再発性髄膜炎を呈し、髄液ACE、リゾチームが診断に有用であった限局性中枢神経サルコイドーシスの1例

    森原 啓介, 仲野 達, 多田 美紀子, 田中 章景

    神経免疫学   22 ( 1 )   124 - 124   2017年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経免疫学会  

    researchmap

  • 手根管症候群の神経伝導検査は「感覚神経優位の障害」ではない 正中神経分枝ごとの障害されやすさについて

    宮地 洋輔, 大石 知瑞子, 溝井 令一, 田中 章景, 園生 雅弘

    臨床神経生理学   45 ( 5 )   410 - 410   2017年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本臨床神経生理学会  

    researchmap

  • 多発性硬化症治療薬候補ラキニモドのミエロイド細胞を介した炎症抑制機序

    勝元 敦子, Aline Miranda, Zain Fanek, Teixeira Antonio, 竹内 英之, 田中 章景, Butovsky Oleg, Ransohoff Richard, Lamb Bruce

    神経免疫学   22 ( 1 )   139 - 139   2017年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経免疫学会  

    researchmap

  • Lewy小体型認知症、認知症を伴うParkinson病、Alzheimer型認知症におけるMRI白質病変

    上木 英人, 東山 雄一, 土井 宏, 木村 活生, 岸田 日帯, 上田 直久, 仲野 達, 高橋 竜哉, 児矢野 繁, 竹内 英之, 田中 章景

    パーキンソン病・運動障害疾患コングレスプログラム・抄録集   11回   85 - 85   2017年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:Movement Disorder Society of Japan (MDSJ)  

    researchmap

  • 手根管症候群の神経伝導検査は「感覚優位の障害」ではない 適正な重症度分類の提唱

    宮地 洋輔, 大石 知瑞子, 溝井 令一, 田中 章景, 園生 雅弘

    臨床神経生理学   45 ( 5 )   410 - 410   2017年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本臨床神経生理学会  

    researchmap

  • DBSにおけるSTN/GPi dual stimulationの治療効果

    浅野 敬一郎, 木村 活生, 岸田 日帯, 川崎 隆, 濱田 幸一, 岡村 泰, 池西 優理子, 上田 直久, 田中 章景

    パーキンソン病・運動障害疾患コングレスプログラム・抄録集   11回   104 - 104   2017年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:Movement Disorder Society of Japan (MDSJ)  

    researchmap

  • Directional Leadを用いた両側視床下核脳深部刺激療法(STN DBS)の予後

    木村 活生, 澁谷 真弘, 浅野 敬一郎, 岸田 日帯, 川崎 隆, 濱田 幸一, 岡村 泰, 池西 優理子, 上田 直久, 田中 章景

    パーキンソン病・運動障害疾患コングレスプログラム・抄録集   11回   104 - 104   2017年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:Movement Disorder Society of Japan (MDSJ)  

    researchmap

  • 閉塞性尿路感染症により意識障害を呈した74歳男性例

    松永 祐己, 大瀧 浩之, 東山 雄一, 高橋 慶太, 國井 美紗子, 上木 英人, 土井 宏, 竹内 英之, 田中 章景

    臨床神経学   57 ( 10 )   631 - 631   2017年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 神経機能分子LOTUSの髄液中濃度は中枢神経感染症の炎症病勢と逆相関する

    高橋 慶太, 竹内 英之, 栗原 裕司, 國井 美沙子, 田中 健一, 多田 美紀子, 竹居 光太郎, 田中 章景

    NEUROINFECTION   22 ( 2 )   260 - 260   2017年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本神経感染症学会  

    researchmap

  • 【自律神経系の基礎科学的研究update】 報酬系と行動障害

    東山 雄一, 上田 直久, 田中 章景

    神経内科   87 ( 1 )   67 - 75   2017年7月

     詳細を見る

    記述言語:日本語   出版者・発行元:(有)科学評論社  

    researchmap

  • Eight contacts with multiple-source current steering in pallidal Deep Brain Stimulation for Parkinson's disease: a non-randomized, single center, open-lavel study

    K. Kimura, H. Kishida, N. Ueda, T. Kawasaki, K. Hamada, F. Tanaka

    MOVEMENT DISORDERS   32   2017年6月

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:WILEY  

    Web of Science

    researchmap

  • 失語症者の保続症状に対するTAP(Treatment of Aphasic Perseveration)の効果

    浜田 智哉, 田中 果南, 今井 友城, 東山 雄一, 田中 章景

    高次脳機能研究   37 ( 2 )   228 - 235   2017年6月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本高次脳機能障害学会  

    失語症臨床において保続を観察する機会は多いが、保続は失語症評価訓練の阻害要因の1つとしても知られている。今回、発症から6ヵ月経過し、保続が主症状の1つであった失語症者に対してTAP(Treatment of Aphasic Perseveration)を参考に保続の減少を目的とした訓練を約1ヵ月間施行した。訓練手続きはTAPのエラーコントロールメソッドを取り入れ、さらに訓練中に表出された保続の種類の質的な分析を行うことで、保続に対するTAPの作用機序を明らかにしようと試みた。結果として、TAPによる保続の減少は訓練語以外へも汎化し、さらに実生活での言語表出能力をも向上させたことがわかった。一方、保続の質的分析の結果からは、TAPは主に直後型保続の減少に寄与していることが明らかとなった。(著者抄録)

    researchmap

  • 四肢筋力低下で発症したMcLeod症候群の55歳男性例

    多賀須 むつき, 古宮 裕泰, 多田 美紀子, 植松 絵里, 田中 健一, 上木 英人, 児矢野 繁, 田中 章景

    臨床神経学   57 ( 6 )   332 - 332   2017年6月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 脳幹梗塞により開口障害を生じた70歳女性例

    安部 克哉, 大久保 正紀, 吉田 環, 城村 裕司, 田中 章景

    臨床神経学   57 ( 6 )   328 - 328   2017年6月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 頭痛を契機に診断された高齢発症のCreutzfeldt-Jakob病の女性例

    浅野 敬一郎, 山浦 弦平, 中澤 謙介, 木村 活生, 岡本 光生, 岸田 日帯, 上田 直久, 田中 章景

    臨床神経学   57 ( 6 )   338 - 338   2017年6月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 動眼神経単独麻痺を呈した下垂体卒中の77歳男性例

    鈴木 聡, 小泉 寛之, 石戸 淳一, 桃尾 隆之, 岩田 盾也, 高山 裕太郎, 小島 昭雄, 田中 章景

    臨床神経学   57 ( 6 )   333 - 333   2017年6月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 無菌性髄膜炎患者の初回腰椎穿刺による硬膜穿刺後頭痛

    山本 良央, 桃尾 隆之, 鈴木 聡, 土橋 裕一, 菅原 恵梨子, 中江 啓晴, 田中 章景

    日本頭痛学会誌   43 ( 3 )   363 - 366   2017年4月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本頭痛学会  

    対象は無菌性髄膜炎の入院患者39例で、初回腰椎穿刺による硬膜穿刺後頭痛につき検討した。7例(17.9%)で発症した。硬膜穿刺後頭痛あり群は、硬膜穿刺後頭痛なし群と比較し、有意に若かった(24.86±4.88歳対37.09±13.75歳、P=0.0088)。また、硬膜穿刺後頭痛あり群で髄膜炎発症から腰椎穿刺までの期間が短い傾向にあった(P=0.061)。性別やBMI、髄液検査所見は差がなかった。髄膜炎患者では、他の背景を有する患者の硬膜穿刺に比べ頭痛が起こりにくいと考えられた。また、発症早期の穿刺による短期間での頭蓋内圧の変動が髄膜炎患者の硬膜穿刺後頭痛の発症にかかわっている可能性が想定される。(著者抄録)

    researchmap

  • 神経生検でアミロイド様の沈着物質が認められたMGUSニューロパチーの68歳男性例

    春日井 裕美, 岡本 光生, 岸田 日帯, 小笠原 陽大, 川頭 祐一, 祖父江 元, 上田 直久, 田中 章景

    臨床神経学   57 ( 4 )   199 - 199   2017年4月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 産褥期の低髄液圧症候群を契機に発症したと思われた脳静脈血栓症の36歳女性例

    大瀧 浩之, 高橋 慶太, 石田 匡宏, 國井 美紗子, 東山 雄一, 土井 宏, 竹内 英之, 田中 章景

    臨床神経学   57 ( 4 )   187 - 187   2017年4月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • Diagnostic flowchart of adult-onset neuronal intranuclear inclusion disease

    Jun Sone, Keiko Mori, Haruki Koike, Tomohiko Nakamura, Michihito Masuda, Mari Yoshida, Yasushi Iwasaki, Fumiaki Tanaka, Masahisa Katsuno, Gen Sobue

    NEUROLOGY   88   2017年4月

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:LIPPINCOTT WILLIAMS & WILKINS  

    Web of Science

    researchmap

  • 繰り返す視力障害を呈した神経核内封入体病の66歳女性例

    中澤 謙介, 小林 絵礼奈, 小島 麻里, 川端 雄一, 児矢野 繁, 田中 章景, 高橋 竜哉

    臨床神経学   57 ( 4 )   185 - 185   2017年4月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 小脳障害によるPoggendorff錯視の知覚変化についての検討

    黒木 美百, 東山 雄一, 齊藤 麻美, 工藤 洋祐, 上木 英人, 釘本 千春, 土井 宏, 児矢野 繁, 城倉 健, 田中 章景

    高次脳機能研究   37 ( 1 )   101 - 102   2017年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本高次脳機能障害学会  

    researchmap

  • 【医原性精神症状】 受容体刺激薬による精神症状

    宮地 洋輔, 田中 章景

    神経内科   86 ( 2 )   240 - 244   2017年2月

     詳細を見る

    記述言語:日本語   出版者・発行元:(有)科学評論社  

    researchmap

  • 【神経疾患の早期診断】 孤発性ALSの早期診断

    土井 宏, 田中 章景

    神経内科   86 ( 1 )   9 - 16   2017年1月

     詳細を見る

    記述言語:日本語   出版者・発行元:(有)科学評論社  

    researchmap

  • プリオン病のサーベイランスと感染予防に関する調査研究 サーベイランスデータに基づくわが国のプリオン病の疫学像(1999‐2016年データ)

    水澤英洋, 中村好一, 山田正仁, 齊藤延人, 北本哲之, 金谷泰宏, 村山繁雄, 佐藤克也, 原田雅史, 太組一朗, 佐々木秀直, 青木正志, 小野寺理, 田中章景, 犬塚貴, 望月秀樹, 阿部康二, 村井弘之, 古賀雄一, 黒岩義之, 桑田一夫, 三條伸夫, 塚本忠

    プリオン病のサーベイランスと感染予防に関する調査研究 平成28年度 総括・分担研究報告書(Web)   25‐40 (WEB ONLY)   2017年

     詳細を見る

    記述言語:日本語  

    J-GLOBAL

    researchmap

  • 多小脳回患者で認められた正中神経刺激体性感覚誘発反応における異常ダイポール回転現象

    北澤 悠, 菅野 彰剛, 神 一敬, 石田 誠, 柿坂 庸介, 田中 章景, 中里 信和

    日本生体磁気学会誌   30 ( 1 )   122 - 123   2017年

     詳細を見る

    記述言語:日本語   出版者・発行元:日本生体磁気学会  

    J-GLOBAL

    researchmap

  • 運動失調症の医療基盤に関する調査研究 脊髄小脳失調症6型(SCA6),同34型(SCA34),同36型(SCA36)の診断基準,疾患頻度,重症度判定についての研究

    石川欽也, 大林正人, 佐藤望, 尾崎心, 曽我一將, 土井宏, 三井純, 飯國洋一郎, 馬嶋貴正, 山根清美, 入岡隆, 石浦浩之, 土井晃一郎, 森下真一, 東美和, 関口輝彦, 小山主夫, 上田直久, 三浦義治, 宮武聡子, 松本直通, 田中章景, 辻省次, 水澤英洋, 水澤英洋, 古屋徳郎, 飯田忠恒, 飯田忠恒, 山田哲夫, 山田哲夫, 安藤登, 太田浄文, 岡田(菅野)宏美, 岡田(菅野, 宏美, 田中伸哉, 新宅雅幸, 江石義信, 横田隆徳

    運動失調症の医療基盤に関する調査研究班 平成26-28年度 総合研究報告書(Web)   11‐17 (WEB ONLY)   2017年

     詳細を見る

    記述言語:日本語  

    J-GLOBAL

    researchmap

  • プリオン病及び遅発性ウイルス感染症に関する調査研究 プリオン病のサーベイランスと感染予防に関する調査研究:JACOP自然歴調査との統合によるサーベイランスの発展

    水澤英洋, 塚本忠, 三條伸夫, 佐々木秀直, 青木正志, 小野寺理, 田中章景, 犬塚貴, 望月秀樹, 阿部康二, 村井弘之, 佐藤克也, 北本哲之, 中村好一, 村山繁雄, 黒岩義之, 原田雅史, 齊藤延人, 太組一朗, 金谷泰宏, 田村智英子, 山田正仁, 桑田一夫

    プリオン病及び遅発性ウイルス感染症に関する調査研究 平成28年度 総括・分担研究報告書(Web)   15‐17 (WEB ONLY)   2017年

     詳細を見る

    記述言語:日本語  

    J-GLOBAL

    researchmap

  • 外傷性皮質病変と海馬硬化を伴う内側側頭葉てんかんの1手術例

    北澤悠, 北澤悠, 神一敬, 岩崎真樹, 鈴木博義, 田中章景, 中里信和

    臨床神経学(Web)   57 ( 11 )   2017年

     詳細を見る

  • プリオン病及び遅発性ウイルス感染症に関する調査研究 プリオン病のサーベイランス,感染予防,および臨床研究コンソーシアムJACOPの推進

    水澤英洋, 塚本忠, 三條伸夫, 森若文雄, 佐々木秀直, 青木正志, 西澤正豊, 小野寺理, 田中章景, 犬塚貴, 武田雅俊, 望月秀樹, 阿部康二, 村井弘之, 佐藤克也, 北本哲之, 中村好一, 村山繁雄, 黒岩義之, 原田雅史, 齊藤延人, 太組一朗, 金谷泰宏, 田村智英子, 山田正仁

    プリオン病及び遅発性ウイルス感染症に関する調査研究 平成26-28年度 総合研究報告書(Web)   72‐77 (WEB ONLY)   2017年

     詳細を見る

    記述言語:日本語  

    J-GLOBAL

    researchmap

  • 不安定可動性プラークに対して安全にCASを施行した79歳男性例

    小笠原 陽大, 岡本 光生, 春日井 裕美, 岸田 日帯, 下吹越 航, 間中 浩, 上田 直久, 田中 章景

    臨床神経学   56 ( 12 )   875 - 875   2016年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 脳梗塞および脳出血患者における、推定食塩摂取量についての検討

    山本 良央, 鈴木 聡, 菅原 恵梨子, 桃尾 隆之, 田中 章景

    臨床神経学   56 ( Suppl. )   S511 - S511   2016年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • てんかん重積治療におけるレベチラセタム投与の有効性の検討

    桃尾 隆之, 鈴木 聡, 菅原 恵梨子, 山本 良央, 田中 章景

    臨床神経学   56 ( Suppl. )   S503 - S503   2016年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 脳梗塞における言語聴覚士の早期介入の影響

    浅野 徹也, 小林 絵礼奈, 遠藤 雅直, 田中 章景, 高橋 竜哉

    臨床神経学   56 ( Suppl. )   S537 - S537   2016年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 90歳以上の高齢脳梗塞患者の退院後転帰

    小林 絵礼奈, 浅野 徹也, 遠藤 雅直, 田中 章景, 高橋 竜哉

    臨床神経学   56 ( Suppl. )   S512 - S512   2016年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 神経フェリチン症のパーキンソニズム、不随意運動に対する治療の検討

    中澤 謙介, 木村 活生, 山浦 弦平, 岸田 日帯, 上木 英人, 釘本 千春, 中江 啓晴, 土井 宏, 児矢野 繁, 上田 直久, 田中 章景

    臨床神経学   56 ( Suppl. )   S495 - S495   2016年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • POLR3A関連白質ジストロフィーの姉妹例

    古川 宗磨, 鈴木 淳一郎, 中井 紀嘉, 西田 卓, 國井 美紗子, 土井 宏, 田中 章景, 伊藤 泰広

    臨床神経学   56 ( Suppl. )   S494 - S494   2016年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 複雑幻視を呈した非痙攣性てんかん重積状態の2例

    山崎 舞子, 金塚 陽一, 林 竜一郎, 田中 章景, 山口 滋紀

    臨床神経学   56 ( Suppl. )   S501 - S501   2016年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 広範な右中大脳動脈領域の脳梗塞における重症度関連因子

    高橋 竜哉, 浅野 徹也, 小林 絵礼奈, 田中 章景, 遠藤 雅直

    臨床神経学   56 ( Suppl. )   S482 - S482   2016年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 急性期脳卒中患者のベッドサイドでの眼球運動評価(第2報)

    工藤 洋祐, 天野 悠, 渡邊 耕介, 桔梗 英幸, 今関 良子, 山本 正博, 甘利 和光, 田中 理, 高橋 幸治, 田中 章景, 城倉 健

    臨床神経学   56 ( Suppl. )   S478 - S478   2016年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 多系統萎縮症と尿酸との関連(病型別の検討)

    児矢野 繁, 上田 直久, 土井 宏, 岸田 日帯, 釘本 千春, 上木 英人, 中江 啓晴, 木村 活生, 東山 雄一, 齊藤 麻美, 田中 章景

    臨床神経学   56 ( Suppl. )   S484 - S484   2016年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 病前の独居は脳梗塞患者の受診行動、退院に影響する

    菅原 恵梨子, 鈴木 聡, 山本 良央, 桃尾 隆之, 田中 章景

    臨床神経学   56 ( Suppl. )   S483 - S483   2016年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 認知症を伴うパーキンソン病における臨床的特徴とMRI白質病変の検討

    上木 英人, 東山 雄一, 中江 啓晴, 齊藤 麻美, 釘本 千春, 土井 宏, 木村 活生, 岸田 日帯, 上田 直久, 仲野 達, 高橋 竜哉, 児矢野 繁, 田中 章景

    臨床神経学   56 ( Suppl. )   S448 - S448   2016年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • ポリオ罹患者の神経筋超音波所見の検討(下肢)

    渡辺 大祐, 蜂須賀 明子, 塚本 浩, 阿部 達哉, 佐伯 覚, 田中 章景, 小森 哲夫

    臨床神経学   56 ( Suppl. )   S476 - S476   2016年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 慢性活動性EBウイルス感染症に合併した末梢神経障害の臨床的特徴

    天野 永一朗, 大久保 卓哉, 服部 高明, 齊藤 麻美, 東山 雄一, 児矢野 繁, 田中 章景, 新井 文子, 三浦 修, 横田 隆徳

    臨床神経学   56 ( Suppl. )   S468 - S468   2016年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • ALSの進行予測におけるカプノグラフィー(経皮的炭酸ガス連続測定装置)の有用性

    釘本 千春, 岩橋 幸子, 土橋 裕一, 平馬 紀子, 石戸 淳一, 三宅 綾子, 多田 美紀子, 東山 雄一, 中江 啓晴, 木村 活生, 岸田 日帯, 上田 直久, 土井 宏, 児矢野 繁, 田中 章景

    臨床神経学   56 ( Suppl. )   S289 - S289   2016年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 大柴胡湯が奏効した耳鳴の1例

    中江 啓晴, 小菅 孝明, 熊谷 由紀絵, 田中 章景

    日本東洋心身医学研究   31 ( 1-2 )   50,iv - 53,iv   2016年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本東洋心身医学研究会  

    耳鳴は感じ方や苦痛度の個人差が大きい自覚的症状で、他覚的検査法も確立されておらず、治療には難渋することが多い。患者は60歳男性、主訴は耳鳴。40歳代前半から耳鳴がするようになった。年々耳鳴は悪化して一日中するようになり、夜にはジェット機が飛んでいるような音がするようになったため当科を受診した。腹診所見から大柴胡湯を開始したところ、内服1ヵ月後には耳鳴で感じる音量が減少、内服4ヵ月後には耳鳴はほぼ消失した。漢方医学において、腹診は慢性的な疾患に対して客観的な所見を把握することができるとされる。大柴胡湯の処方決定には腹診が有用とされ、『腹證奇覧』によれば、大柴胡湯の腹証としては胸協苦満と実満が重要とされる。本症例では腹診所見を重視して大柴胡湯を選択し、改善が得られた。腹診で証があえば大柴胡湯は耳鳴に対しても有効な可能性がある。(著者抄録)

    researchmap

  • パーキンソン病における運動学習とギャンブリング課題との関連性

    上田 直久, 東山 雄一, 齊藤 麻美, 岸田 日帯, 上木 英人, 木村 活生, 釘本 千春, 中江 啓晴, 土井 宏, 児矢野 繁, 田中 章景

    臨床神経学   56 ( Suppl. )   S407 - S407   2016年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 急性期内包梗塞患者に対する反復経頭蓋磁気刺激の効果

    渡邊 耕介, 工藤 洋祐, 天野 悠, 今関 良子, 桔梗 英幸, 甘利 和光, 田中 理, 高橋 幸治, 山本 正博, 田中 章景, 城倉 健

    臨床神経学   56 ( Suppl. )   S316 - S316   2016年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 長時間のホルン演奏後に痛みを伴う麻痺を発症したが、2年前の外傷による手首部尺骨神経損傷とfunctional overlayと診断した14歳女性例

    宮地 洋輔, 大石 知瑞子, 神谷 久雄, 田中 章景, 園生 雅弘

    末梢神経   27 ( 2 )   351 - 351   2016年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本末梢神経学会  

    researchmap

  • IgG4関連ニューロパチーと鑑別を要した家族性アミロイドポリニューロパチー(ATTR-FAP)の71歳男性例

    古宮 裕泰, 多田 美紀子, 石戸 淳一, 多賀須 むつき, 田中 健一, 上木 英人, 児矢野 繁, 田中 章景

    臨床神経学   56 ( 12 )   886 - 886   2016年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • Neuronal intranuclear inclusion disease(NIID)の臨床症候

    曽根 淳, 稲垣 智則, 勝又 竜, 高木 伸之介, 森 恵子, 荒木 邦彦, 大嶽 れい子, 田中 康博, 桝田 道人, 中村 友彦, 岩崎 靖, 田中 章景, 勝野 雅央, 吉田 眞理, 祖父江 元

    臨床神経学   56 ( Suppl. )   S287 - S287   2016年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • ELOVL4における新規変異の同定とSCA34の臨床的スペクトラムの拡張

    尾崎 心, 土井 宏, 三井 純, 佐藤 望, 山根 清美, 入岡 隆, 石浦 浩之, 土井 晃一郎, 森下 真一, 小山 主夫, 三浦 義治, 松本 直通, 横田 隆徳, 田中 章景, 辻 省次, 水澤 英洋, 石川 欽也

    臨床神経学   56 ( Suppl. )   S81 - S81   2016年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 中大脳動脈閉塞症に対する再開通療法後にforeign body granulomaを来たした1例

    甘利 和光, 工藤 洋祐, 天野 悠, 渡邊 耕介, 大澤 成之, 児矢野 繁, 田中 章景, 城倉 健

    脳血管内治療   1 ( Suppl. )   S283 - S283   2016年11月

     詳細を見る

    記述言語:日本語   出版者・発行元:(NPO)日本脳神経血管内治療学会  

    researchmap

  • 当院における横浜市難病患者一次入院事業利用患者の実態と課題

    山口 滋紀, 林 竜一郎, 金塚 陽一, 山浦 弦平, 伊東 毅, 小高 律子, 田中 章景

    日本難病医療ネットワーク学会機関誌   4 ( 1 )   58 - 58   2016年11月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本難病医療ネットワーク学会  

    researchmap

  • 球脊髄性筋萎縮症における頸部神経根と末梢神経の超音波所見

    渡辺 大祐, 塚本 浩, 阿部 達哉, 田中 章景, 小森 哲夫

    臨床神経生理学   44 ( 5 )   425 - 425   2016年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本臨床神経生理学会  

    researchmap

  • 成人発症Neuronal intranuclear inclusion disease(NIID)の臨床症候

    曽根 淳, 森 恵子, 桝田 道人, 中村 友彦, 岩崎 靖, 田中 章景, 勝野 雅央, 吉田 眞理, 祖父江 元

    Dementia Japan   30 ( 4 )   541 - 541   2016年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本認知症学会  

    researchmap

  • 神経フェリチン症の不随意運動に対する両側淡蒼球DBSの効果

    岡村 泰, 木村 活生, 岸田 日帯, 上田 直久, 川崎 隆, 濱田 幸一, 樋口 優理子, 田中 章景

    パーキンソン病・運動障害疾患コングレスプログラム・抄録集   10回   90 - 90   2016年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:Movement Disorder Society of Japan (MDSJ)  

    researchmap

  • 片頭痛患者におけるFSL-FIRSTを用いた皮質下構造物の容積の検討

    黒川 隆史, 池田 拓也, 藤野 公裕, 黒岩 義之, 馬場 泰尚, 田中 章景

    日本頭痛学会誌   43 ( 2 )   274 - 274   2016年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本頭痛学会  

    researchmap

  • STN-DBS後にGPi-DBSの追加施行を必要としたパーキンソン病症例の検討

    森原 啓介, 木村 活生, 岸田 日帯, 川崎 隆, 濱田 幸一, 樋口 優理子, 岡村 泰, 上田 直久, 田中 章景

    パーキンソン病・運動障害疾患コングレスプログラム・抄録集   10回   86 - 86   2016年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:Movement Disorder Society of Japan (MDSJ)  

    researchmap

  • 脳深部刺激療法長期経過後における非充電式刺激発生装置から充電式刺激発生装置への交換の経験

    木村 活生, 岸田 日帯, 澁谷 真弘, 川崎 隆, 濱田 幸一, 樋口 優理子, 岡村 泰, 上田 直久, 田中 章景

    パーキンソン病・運動障害疾患コングレスプログラム・抄録集   10回   86 - 86   2016年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:Movement Disorder Society of Japan (MDSJ)  

    researchmap

  • 低パルス幅刺激はSTN-DBS後のICD/DDSを誘発しにくい

    岸田 日帯, 木村 活生, 川崎 隆, 濱田 幸一, 樋口 優理子, 岡村 泰, 古宮 裕泰, 澁谷 真弘, 森原 啓介, 坂田 勝巳, 上田 直久, 田中 章景

    パーキンソン病・運動障害疾患コングレスプログラム・抄録集   10回   87 - 87   2016年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:Movement Disorder Society of Japan (MDSJ)  

    researchmap

  • STN-DBS後の発声障害に対し30μ秒の低パルス幅設定は症状を改善しうる

    古宮 裕泰, 木村 活生, 岸田 日帯, 森原 啓介, 川崎 隆, 濱田 幸一, 池西 優理子, 岡村 泰, 上田 直久, 田中 章景

    パーキンソン病・運動障害疾患コングレスプログラム・抄録集   10回   86 - 86   2016年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:Movement Disorder Society of Japan (MDSJ)  

    researchmap

  • 淡蒼球内節をターゲットとした脳深部刺激療法(GPi-DBS)における低パルス幅刺激の有用性

    木村 活生, 岸田 日帯, 澁谷 真弘, 川崎 隆, 濱田 幸一, 樋口 優理子, 岡村 泰, 上田 直久, 田中 章景

    パーキンソン病・運動障害疾患コングレスプログラム・抄録集   10回   86 - 86   2016年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:Movement Disorder Society of Japan (MDSJ)  

    researchmap

  • DBS施行後に残るオフ症状に対し、アポモルフィンの皮下投与は精神症状を悪化させずにオフ症状を緩和できる

    澁谷 真弘, 木村 活生, 岸田 日帯, 川崎 隆, 濱田 幸一, 池西 優理子, 岡村 泰, 上田 直久, 田中 章景

    パーキンソン病・運動障害疾患コングレスプログラム・抄録集   10回   72 - 72   2016年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:Movement Disorder Society of Japan (MDSJ)  

    researchmap

  • 超急性期脳梗塞に対する血行再建術後に白質脳症を合併した73歳女性例

    工藤 洋祐, 甘利 和光, 天野 悠, 渡邊 耕介, 大澤 成之, 児矢野 繁, 田中 章景, 城倉 健

    臨床神経学   56 ( 9 )   645 - 645   2016年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 初発から10年後に再発した可逆性脳梁膨大部ならびに皮質下白質病変を伴う脳症の23歳男性例

    仲野 達, 森原 啓介, 上木 英人, 田中 章景

    神経免疫学   21 ( 1 )   154 - 154   2016年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経免疫学会  

    researchmap

  • 高齢の重症筋無力症患者の特徴(2015年度)

    岸田 日帯, 岡本 光生, 木村 活生, 春日井 裕美, 澁谷 真弘, 小笠原 陽大, 上田 直久, 田中 章景

    神経免疫学   21 ( 1 )   150 - 150   2016年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経免疫学会  

    researchmap

  • 23価肺炎球菌ワクチン接種後に血清型34による肺炎球菌性髄膜炎をきたした1例

    浅野 徹也, 國井 美紗子, 大瀧 浩之, 小川 有紀, 高橋 慶太, 東山 雄一, 土井 宏, 竹内 英之, 田中 章景

    NEUROINFECTION   21 ( 2 )   208 - 208   2016年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本神経感染症学会  

    researchmap

  • FASCICULATION POTENTIALS AND DECREMENTAL RESPONSES IN AMYOTROPHIC LATERAL SCLEROSIS

    Yosuke Miyaji, Yuki Hatanaka, Mana Higashihara, Tomoko Iwanami, Takamichi Kanbayashi, Fumiaki Tanaka, Masahiro Sonoo

    MUSCLE & NERVE   54 ( 3 )   607 - 607   2016年9月

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:WILEY-BLACKWELL  

    Web of Science

    researchmap

  • 神経機能分子LOTUSは実験的自己免疫性脳炎の免疫病態にも関与する

    高橋 慶太, 栗原 裕司, 竹内 英之, 竹居 光太郎, 田中 章景

    神経免疫学   21 ( 1 )   112 - 112   2016年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経免疫学会  

    researchmap

  • 著しい妄想を呈したパーキンソン病に対し、安全に脳深部刺激療法をしえた一例

    小笠原 陽大, 木村 活生, 岸田 日帯, 川崎 隆, 濱田 幸一, 坂田 勝巳, 上田 直久, 田中 章景

    臨床神経学   56 ( 9 )   654 - 654   2016年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • RNF213多型を認め、中大脳動脈領域に広範囲の脳梗塞を生じた39歳男性例

    浅野 敬一郎, 三宅 綾子, 中江 啓晴, 田中 健一, 多田 美紀子, 土井 宏, 児矢野 繁, 田中 章景

    臨床神経学   56 ( 9 )   645 - 645   2016年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 特発性肥厚性硬膜炎に脳静脈洞血栓症を合併した41歳男性例

    橋口 俊太, 川本 裕子, 城村 裕司, 岡田 雅仁, 田中 章景

    脳卒中   38 ( 4 )   272 - 275   2016年7月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本脳卒中学会  

    症例は41歳男性。亜急性に進行した頭痛と行動異常が認められ緊急入院となった。入院時は、意識清明だが高揚感があり、軽度認知機能障害と項部硬直を認めた。脳MRIで硬膜が肥厚しており、上矢状静脈洞にdelta signも認めていたため、MRVを追加したところ上矢状静脈洞と右横静脈洞が描出不良であった。肥厚性硬膜炎に脳静脈洞血栓症を合併した病態と考え、ヘパリンを併用しながら大量ステロイド療法を施行した。臨床症状が改善したため、ステロイド剤と抗凝固薬の内服に切り替え、自宅退院となった。肥厚性硬膜炎の原因として明らかなものは認められず、特発性と診断した。脳静脈洞血栓症については、凝固亢進状態を来しうる先天性もしくは後天性の素因も認めず、硬膜肥厚により二次的な静脈洞の閉塞と還流障害が生じたものと考えた。両者の合併は稀であるが、脳静脈洞血栓症の原因として肥厚性硬膜炎も鑑別に挙げておく必要がある。(著者抄録)

    researchmap

    その他リンク: https://search.jamas.or.jp/index.php?module=Default&action=Link&pub_year=2016&ichushi_jid=J01786&link_issn=&doc_id=20160809260010&doc_link_id=%2Fdh3strok%2F2016%2F003804%2F010%2F0272-0275%26dl%3D0&url=https%3A%2F%2Fwww.medicalonline.jp%2Fjamas.php%3FGoodsID%3D%2Fdh3strok%2F2016%2F003804%2F010%2F0272-0275%26dl%3D0&type=MedicalOnline&icon=https%3A%2F%2Fjk04.jamas.or.jp%2Ficon%2F00004_2.gif

  • 小脳に限局したtumefactive lesionを呈したPrimary angiitis of the central nervous systemの一例

    池澤 淳, 岸田 日帯, 木村 活生, 竪月 順也, 川崎 隆, 坂田 勝巳, 上田 直久, 田中 章景

    臨床神経学   56 ( 7 )   516 - 516   2016年7月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 再発性多発軟骨炎による脳症と診断した72歳男性例

    澁谷 真弘, 國井 美紗子, 東山 雄一, 齊藤 麻美, 川本 裕子, 田中 健一, 上木 英人, 田中 章景

    臨床神経学   56 ( 7 )   514 - 514   2016年7月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 小脳性運動学習障害 招待

    上田直久, 田中章景

    神経内科   85 ( 1 )   41 - 45   2016年7月

     詳細を見る

    記述言語:日本語   掲載種別:記事・総説・解説・論説等(商業誌、新聞、ウェブメディア)  

    researchmap

  • 本邦でみられる常染色体劣性遺伝性脊髄小脳変性症

    田中 章景, 土井 宏, 國井 美紗子

    臨床神経学   56 ( 6 )   395 - 399   2016年6月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    近年のゲノムシークエンス技術の進歩により、常染色体劣性遺伝性脊髄小脳変性症の新たな責任遺伝子が次々と明らかになってきている。しかし、同じような表現型を示していても責任遺伝子が全く異なる場合や、逆に同じ責任遺伝子であっても発症年齢、症状、疾患進行が大きく異なる場合があり、診断は容易ではない。また、欧米の特に小児期発症例において同定された遺伝子変異が、本邦の成人発症例においてもみられるのかどうかは、今後も引き続き検討が必要な課題である。本稿では、主として近年本邦でも存在が確認された比較的まれと考えられる劣性遺伝性脊髄小脳変性症について概説する。(著者抄録)

    researchmap

    その他リンク: https://search.jamas.or.jp/index.php?module=Default&action=Link&pub_year=2016&ichushi_jid=J01550&link_issn=&doc_id=20160728260001&doc_link_id=130005158857&url=https%3A%2F%2Fci.nii.ac.jp%2Fnaid%2F130005158857&type=CiNii&icon=https%3A%2F%2Fjk04.jamas.or.jp%2Ficon%2F00003_1.gif

  • 呉茱萸湯が有効性を示す片頭痛患者の臨床的特徴

    黒川 隆史, 田中 麻衣子, 藤野 公裕, 黒岩 義之, 馬場 泰尚, 田中 章景

    痛みと漢方   26   46 - 51   2016年5月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本疼痛漢方研究会  

    呉茱萸湯を投与した片頭痛症例をresponder群、non-responder群に分けて、患者背景の違いについて後方視的に検討した。対象は38人、年齢39.6±15.3歳、男性10人、女性28人、前兆を伴う片頭痛14人、前兆を伴わない片頭痛24人であった。呉茱萸湯の苦みのため内服できなかった2名は解析から除外した。responder群16人、non-responder群20人であった。単変量解析ではresponder群は視覚前兆、冷えが有意に多く、治療前の4週あたりの頭痛日数が有意に少なかった。とくに呉茱萸湯が著効する症例はいずれも視覚前兆を伴った。多変量解析では視覚前兆が唯一のresponderの有意な危険因子であった。視覚前兆を伴う片頭痛に呉茱萸湯を積極的に投与する価値があると考えられた。(著者抄録)

    researchmap

  • 視床の脳梗塞後に持続した舌のしびれに対して柴胡加竜骨牡蛎湯と抑肝散が奏効した1症例

    中江 啓晴, 小菅 孝明, 熊谷 由紀絵, 宮原 桂, 田中 章景

    痛みと漢方   26   128 - 131   2016年5月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本疼痛漢方研究会  

    患者は60歳男性、主訴は舌のしびれ。左手、頬の左側、舌の左側、口腔内の左側のしびれで右視床のラクナ梗塞を発症し入院となった。点滴、内服加療を行い退院となったが、退院後も舌と口腔内の左側のしびれは残存した。発症から半年間経過したが改善しないため神経内科を受診した。柴胡加竜骨牡蛎湯を開始したところしびれは5/10まで改善、その後抑肝散に変方したところ3/10まで改善した。脳卒中は東洋医学的には中風と言われている。中風の治療法としては肝陽上亢に対応する治法となる疏肝が考えられる。本例では肝陽上亢を中心に処方選択を行い、柴胡加竜骨牡蛎湯、抑肝散のいずれもが有効であった。脳梗塞後遺症によるしびれに対して柴胡加竜骨牡蛎湯と抑肝散は治療選択肢になりうると考えられた。(著者抄録)

    researchmap

  • Clinical Manifestations of Adult Onset Neuronal Intranuclear Inclusion Disease Cases Presenting Leukoencephalopathy

    Jun Sone, Tomonori Inagaki, Keiko Mori, Kunihiko Araki, Michihito Masuda, Mari Yoshida, Yasushi Iwasaki, Fumiaki Tanaka, Masahisa Katsuno, Gen Sobue

    NEUROLOGY   86   2016年4月

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:LIPPINCOTT WILLIAMS & WILKINS  

    Web of Science

    researchmap

  • パーキンソン病の便秘に対する麻子仁丸の有効性

    中江 啓晴, 小菅 孝明, 熊谷 由紀絵, 田中 章景

    日本東洋医学雑誌   67 ( 2 )   131 - 136   2016年4月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本東洋医学会  

    パーキンソン病患者の便秘に対する麻子仁丸の有効性を検討した。対象は便秘のあるパーキンソン病患者23例。麻子仁丸を投与し1ヵ月後に効果の有無を確認した。効果判定は排便の頻度で行い、排便の頻度が増加したものを有効、変化がなかったものを無効、低下したものを悪化とした。以前から下剤を内服していたものについては麻子仁丸に切り替え、同様に判定した。有効率は全体では78.3%、悪化例はなかった。副作用を認めたものは13.0%でいずれも下痢であった。以前に下剤を内服していなかった15例では有効率86.7%、以前から下剤を内服していた8例では有効率62.5%であった。麻子仁丸は下剤を内服していなかった患者に対して高い有効率を示し、また以前から下剤を内服しているが効果が不十分な患者に対して便秘を悪化させることなく切り替えることが可能であった。麻子仁丸はパーキンソン病の便秘に対して適切な処方の一つと考えられた。(著者抄録)

    researchmap

    その他リンク: https://search.jamas.or.jp/index.php?module=Default&action=Link&pub_year=2016&ichushi_jid=J01600&link_issn=&doc_id=20160608460004&doc_link_id=10.3937%2Fkampomed.67.131&url=https%3A%2F%2Fdoi.org%2F10.3937%2Fkampomed.67.131&type=J-STAGE&icon=https%3A%2F%2Fjk04.jamas.or.jp%2Ficon%2F00007_3.gif

  • ニューロサイエンスの最新情報 多発性硬化症の新規病勢診断マーカー

    高橋 慶太, 田中 章景, 竹居 光太郎

    Clinical Neuroscience   34 ( 4 )   484 - 485   2016年4月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)中外医学社  

    researchmap

  • Clinical Manifestations of Adult Onset Neuronal Intranuclear Inclusion Disease Cases Presenting Leukoencephalopathy

    Jun Sone, Tomonori Inagaki, Keiko Mori, Kunihiko Araki, Michihito Masuda, Mari Yoshida, Yasushi Iwasak, Fumiaki Tanaka, Masahisa Katsuno, Gen Sobue

    NEUROLOGY   86   2016年4月

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:LIPPINCOTT WILLIAMS & WILKINS  

    Web of Science

    researchmap

  • 【プリオン病ならびに遅発性ウイルス感染症-最近の知見】プリオン病の感染予防 洗浄・滅菌法を中心に

    岸田 日帯, 児矢野 繁, 田中 章景

    神経内科   84 ( 3 )   273 - 279   2016年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(有)科学評論社  

    researchmap

  • Mice lacking collapsin response mediator protein 2 manifest hyperactivity, impaired emotional behavior and reduced social interaction

    Haruko Nakamura, Naoya Yamashita, Hiroshi Kiyonari, Go Shioi, Fumiaki Tanaka, Yoshio Goshima

    JOURNAL OF PHARMACOLOGICAL SCIENCES   130 ( 3 )   S231 - S231   2016年3月

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:JAPANESE PHARMACOLOGICAL SOC  

    Web of Science

    researchmap

  • Collapsin response mediator protein 1 (CRMP1) and CRMP2 mediate Semaphorin3A signaling through distinct pathway in vivo

    Hiroko Makihara, Shiori Nakai, Aoi Jitsuki-Takahashi, Haruko Nakamura, Naoya. Yamashita, Hiroshi Kiyonari, Go Shioi, Fumio Nakamura, Fumiaki Tanaka, Yoshio Goshima

    JOURNAL OF PHARMACOLOGICAL SCIENCES   130 ( 3 )   S155 - S155   2016年3月

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:JAPANESE PHARMACOLOGICAL SOC  

    Web of Science

    researchmap

  • 多発性硬化症を合併した神経線維腫症1型の35歳男性例

    平馬 紀子, 中江 啓晴, 土橋 裕一, 石戸 淳一, 多田 美紀子, 釘本 千春, 土井 宏, 田中 章景

    臨床神経学   56 ( 3 )   212 - 212   2016年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 歩行障害に続き四分盲を呈した神経核内封入体病の80歳女性例

    野元 祥平, 飯塚 奈都子, 岩波 弘明, 井上 学, 多田 美紀子, 児矢野 繁, 田中 章景, 市川 博雄

    臨床神経学   56 ( 3 )   208 - 208   2016年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 椎骨動脈解離に合併した突発性難聴の34歳男性例

    菅原 恵梨子, 鈴木 聡, 山本 良央, 桃尾 隆之, 池宮城 秀崇, 田中 章景

    臨床神経学   56 ( 3 )   213 - 213   2016年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 両側声帯麻痺を来した神経線維腫症II型の28歳男性例

    池田 拓也, 森原 啓介, 小泉 寛之, 池澤 淳, 木村 活生, 岸田 日帯, 上田 直久, 田中 章景

    臨床神経学   56 ( 3 )   212 - 212   2016年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 【プリオン病ならびに遅発性ウイルス感染症-最近の知見】プリオン病の脳波検査

    黒岩 義之, 太組 一朗, 田中 章景, 山田 正仁, 水澤 英洋

    神経内科   84 ( 3 )   236 - 245   2016年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(有)科学評論社  

    researchmap

  • 【プリオン病ならびに遅発性ウイルス感染症-最近の知見】遺伝性(家族性)プリオン病の臨床病型と診断

    児矢野 繁, 岸田 日帯, 田中 章景

    神経内科   84 ( 3 )   224 - 230   2016年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(有)科学評論社  

    researchmap

  • 左後大脳動脈単独梗塞から発見されたもやもや病の1例

    古宮 裕泰, 春日井 裕美, 横山 睦美, 田中 章景, 小山 主夫

    臨床神経学   56 ( 2 )   121 - 121   2016年2月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 【脳卒中はこう診る-新ガイドラインで何が変わったか】 押さえておくべき脳卒中のトピックス 脳卒中の高次脳機能障害

    東山 雄一, 田中 章景

    Medicina   53 ( 2 )   322 - 326   2016年2月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)医学書院  

    <ポイント>高次脳機能障害は,日常生活に多大な障害をもたらす一方で病識が欠けることもあるため,正しい知識と診察技術をもって,検者が積極的に診察しなければならない.失語症は,自発話,物品呼称,聴理解,復唱,読み,書きを評価し,構音障害などとの鑑別や病型分類を行う.半側空間無視は,線分二等分試験や線分抹消試験,図形の模写試験で検出できる.失行症は,パントマイムや実物品の使用を行わせる.記憶検査は様々あるが,MMSEやHDS-Rの遅延再生課題が簡便に用いられる.(著者抄録)

    researchmap

  • 不随意運動のコントロールに難渋したNiemann-Pick disease type Cの27歳男性例

    小泉 寛之, 岸田 日帯, 木村 活生, 池澤 淳, 森原 啓介, 遠藤 雅直, 上田 直久, 田中 章景

    臨床神経学   56 ( 2 )   134 - 134   2016年2月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 慢性活動性EBV感染症による末梢神経障害の18歳女性例

    齊藤 麻美, 草間 香里, 東山 雄一, 國井 美紗子, 田中 健一, 上木 英人, 児矢野 繁, 田中 章景

    臨床神経学   56 ( 2 )   129 - 129   2016年2月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 軸索再生関連分子の多発性硬化症診断マーカーへの応用

    高橋 慶太, 田中 章景, 竹居 光太郎

    BRAIN and NERVE: 神経研究の進歩   68 ( 1 )   82 - 89   2016年1月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)医学書院  

    近年,多発性硬化症の病態に係る新たな診断マーカーとして軸索再生関連分子が注目されている。これらの分子は神経系に加え免疫系においても重要な機能を有する。多発性硬化症の病態には神経系と免疫系の異常が関与することから,これらが新たな診断マーカーとして検討されている。その代表的な分子として,われわれが発見したLOTUSやRGMaやセマホリンなどについて,多発性硬化症の病態との関連や診断マーカーへの応用について概説する。(著者抄録)

    researchmap

    その他リンク: https://search.jamas.or.jp/index.php?module=Default&action=Link&pub_year=2016&ichushi_jid=J04871&link_issn=&doc_id=20160127370014&doc_link_id=40020711603&url=https%3A%2F%2Fci.nii.ac.jp%2Fnaid%2F40020711603&type=CiNii&icon=https%3A%2F%2Fjk04.jamas.or.jp%2Ficon%2F00003_1.gif

  • 看護専門学校生の漢方と神経内科に対する意識調査

    中江 啓晴, 熊谷 由紀絵, 小菅 孝明, 田中 章景

    神奈川医学会雑誌   43 ( 1 )   190 - 190   2016年1月

     詳細を見る

    記述言語:日本語   出版者・発行元:神奈川県医師会  

    researchmap

  • プリオン病及び遅発性ウイルス感染症に関する調査研究 プリオン病のサーベイランス,感染予防,および臨床研究コンソーシアムJACOPの推進

    水澤英洋, 塚本忠, 三條伸夫, 森若文雄, 青木正志, 西澤正豊, 田中章景, 犬塚貴, 武田雅俊, 阿部康二, 村井弘之, 佐藤克也, 北本哲之, 中村好一, 村山繁雄, 黒岩義之, 原田雅史, 齊藤延人, 太組一朗, 金谷泰宏, 田村智英子, 山田正仁

    プリオン病及び遅発性ウイルス感染症に関する調査研究 平成27年度 総括・分担研究報告書   2016年

     詳細を見る

  • Association of multiple sclerosis with lateral olfactory tract usher substance (LOTUS), a possible endogenous inhibitor of axonal degeneration

    Keita Takahashi, Kohtaro Takei, Fumiaki Tanaka

    Clinical and Experimental Neuroimmunology   6   64 - 69   2015年12月

     詳細を見る

    記述言語:英語   掲載種別:書評論文,書評,文献紹介等   出版者・発行元:Wiley-Blackwell  

    Neuronal regeneration in the adult mammalian central nervous system (CNS) is restricted after brain injury, and some of myelin components and their common receptor, Nogo receptor-1 (NgR1), have been identified as the key molecules for limiting axonal regeneration in the CNS. They have been widely studied as therapeutic targets to overcome the limitation of neuronal regeneration, and strategies using antagonism to NgR1 are expected for the development of the most promising therapies. Recently signaling through NgR1 was shown to be an underlying mechanism of axonal degeneration in multiple sclerosis (MS). Although MS is generally considered an autoimmune demyelinating disorder, axonal degeneration has recently attracted attention as an important pathological feature and one of the mechanisms leading to progressive neurological disability. These pathological and clinical features of MS suggest that molecules involved in limitation of axonal growth can be potential candidates for MS biomarker and therapeutic target, and recent studies have supported these hypotheses. We have previously identified a novel endogenous NgR1 antagonist and named it lateral olfactory tract usher substance (LOTUS). Our data showed that LOTUS promotes axonal growth through blocking of NgR1 signaling, suggesting that LOTUS could be an endogenous inhibitor of axonal degeneration. Furthermore, our recent study demonstrated an interesting variation of LOTUS level in the cerebrospinal fluid of MS patients that was well correlated with disease activity. Here, we review the association of MS with the molecules related to axonal growth including LOTUS, and discuss the clinical application of LOTUS as a promising biomarker and therapeutic target.

    DOI: 10.1111/cen3.12272

    Scopus

    researchmap

  • Lewy小体型認知症/認知症を伴うParkinson病におけるMRI大脳白質病変の検討(第2報)

    上木 英人, 東山 雄一, 中江 啓晴, 釘本 千春, 児矢野 繁, 仲野 達, 高橋 竜哉, 田中 章景

    臨床神経学   55 ( Suppl. )   S432 - S432   2015年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 脊髄小脳変性症における運動学習障害の評価

    上田 直久, 児矢野 繁, 釘本 千春, 土井 宏, 岸田 日帯, 上木 英人, 遠藤 雅直, 中江 啓晴, 木村 活生, 東山 雄一, 黒岩 義之, 田中 章景

    臨床神経学   55 ( Suppl. )   S319 - S319   2015年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 【神経心理学におけるディベート】 失語における流暢性の概念 有用である

    東山 雄一, 浜田 智哉, 斉藤 麻美, 田中 章景

    神経内科   83 ( 6 )   449 - 456   2015年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(有)科学評論社  

    researchmap

  • 抗neurofascin 155抗体陽性CIDPの臨床的特徴

    緒方 英紀, 山崎 亮, 樋渡 昭雄, 岡 伸幸, 河村 信利, 松瀬 大, 桑原 基, 鈴木 秀和, 楠 進, 池添 浩二, 岸田 日帯, 田中 章景, 松下 拓也, 村井 弘之, 吉良 潤一

    末梢神経   26 ( 2 )   306 - 306   2015年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本末梢神経学会  

    researchmap

  • 葉酸欠乏性ニューロパチーの臨床病理学的特徴

    小池 春樹, 池田 昇平, 高橋 美江, 川頭 祐一, 飯島 正博, 土井 宏, 田中 章景, 祖父江 元

    末梢神経   26 ( 2 )   279 - 279   2015年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本末梢神経学会  

    researchmap

  • 手根管症候群の種々の電気診断手技の感度特異度の比較 偽陽性例の適切な扱いを含めて

    宮地 洋輔, 大石 知瑞子, 神谷 久雄, 田中 章景, 園生 雅弘

    末梢神経   26 ( 2 )   318 - 318   2015年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本末梢神経学会  

    researchmap

  • 新規ホモ接合性DDHD2変異と関連する遅発性痙性運動失調の表現型(Late-onset spastic ataxia phenotype related to a novel homozygous DDHD2 mutation)

    土井 宏, 吉田 邦広, 牛山 雅夫, 谷 佳津子, 松本 直通, 田中 章景

    臨床神経学   55 ( Suppl. )   S442 - S442   2015年12月

     詳細を見る

    記述言語:英語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • ALSの病状評価と予後予測における横隔神経M波振幅の有用性

    釘本 千春, 春日井 裕美, 平馬 紀子, 多田 美紀子, 大久保 正紀, 中江 啓晴, 岩橋 幸子, 田中 章景

    臨床神経学   55 ( Suppl. )   S437 - S437   2015年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 当院にて入院加療した悪性症候群の臨床的検討

    橋口 俊太, 小島 麻里, 植松 絵里, 田中 章景

    臨床神経学   55 ( Suppl. )   S457 - S457   2015年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 新規TTC19変異によって生じたCIII欠損症の日本人姉弟2例(Two Japanese siblings with CIII deficiency caused by a novel TTC19 mutation)

    國井 美紗子, 土井 宏, 東山 雄一, 釘本 千春, 松本 直通, 田中 章景

    臨床神経学   55 ( Suppl. )   S452 - S452   2015年12月

     詳細を見る

    記述言語:英語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 表情定量解析を用いたパーキンソン病の仮面様顔貌の検討

    東山 雄一, 中江 啓晴, 上木 英人, 釘本 千春, 土井 宏, 児矢野 繁, 田中 章景

    臨床神経学   55 ( Suppl. )   S428 - S428   2015年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 呉茱萸湯が奏効する片頭痛患者の臨床的特徴

    黒川 隆史, 田中 麻衣子, 藤野 公裕, 黒岩 義之, 馬場 泰尚, 田中 章景

    臨床神経学   55 ( Suppl. )   S396 - S396   2015年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 小脳梗塞におけるmass effectによる減圧開頭術あるいは死亡に至る因子の検討

    仲野 達, 川端 雄一, 関 俊輔, 森 健太郎, 上出 智也, 玉瀬 玲, 野村 素弘, 田中 章景, 北村 佳久

    臨床神経学   55 ( Suppl. )   S300 - S300   2015年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 画像所見に乏しいmyelopathyの症例検討

    森原 啓介, 山崎 舞子, 岡本 光生, 田中 章景, 高橋 竜哉

    臨床神経学   55 ( Suppl. )   S323 - S323   2015年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • パーキンソン病に対する脳深部刺激療法手術を行わなかった症例について

    岸田 日帯, 木村 活生, 古宮 裕泰, 小泉 寛之, 濱田 幸一, 川崎 隆, 上田 直久, 田中 章景

    臨床神経学   55 ( Suppl. )   S315 - S315   2015年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 片頭痛患者の臨床的特徴と領域別QOL阻害の検討

    田中 麻衣子, 黒川 隆史, 藤野 公裕, 黒岩 義之, 馬場 泰尚, 田中 章景

    臨床神経学   55 ( Suppl. )   S395 - S395   2015年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 痙攣患者の血中アンモニア値 クレアチンキナーゼ値との比較(第二報)

    土橋 裕一, 菅原 恵梨子, 山本 良央, 桃尾 隆之, 田中 章景

    臨床神経学   55 ( Suppl. )   S329 - S329   2015年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 脳卒中ホットラインの導入の効果

    岡本 光生, 森原 啓介, 山崎 舞子, 田中 章景, 高橋 竜哉

    臨床神経学   55 ( Suppl. )   S282 - S282   2015年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 当科外来におけるパーキンソン病患者の薬物治療動向と睡眠障害改善効果の検討

    山口 滋紀, 金塚 陽一, 石戸 惇一, 田中 章景

    臨床神経学   55 ( Suppl. )   S311 - S311   2015年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 桂枝湯が奏効した"ほてり"の2例

    中江 啓晴, 小菅 孝明, 熊谷 由紀絵, 田中 章景

    日本東洋心身医学研究   30 ( 1-2 )   22,i - 24,i   2015年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本東洋心身医学研究会  

    "ほてり"は西洋医学的には原因が明らかでない場合が多く、また効果的な治療法も少ないため治療に難渋することが多い。症例1は70歳、男性。3週間持続するほてりに対して苓桂朮甘湯を2週間投与し無効であったが、桂枝湯へ変方したところ2週間の内服で改善した。症例2は69歳、女性。経過12年のほてりに対して桂枝湯を開始したところ、6週間の内服で改善傾向となった。吉益東洞の『薬徴』には「桂枝(現在の桂皮)は衝逆を主治するなり、傍ら奔豚、頭痛、発熱、悪風、汗出でて身痛するを治す」とあり、桂皮を含む方剤は気が上衝して起こる症状が使用目標になる。今回、桂枝湯の君薬である桂皮が衝逆を主治することで、上衝の症状であるほてりを改善したと考えた。桂枝湯を他の処方と合方しない場合、感冒以外の疾患に応用した報告は少ない。桂枝湯は感冒以外の疾患にも応用可能であり、特に上衝の症状に対して有効であることが示唆された。(著者抄録)

    researchmap

  • 葉酸欠乏性ニューロパチーの臨床病理学的検討

    小池 春樹, 高橋 美江, 大山 健, 川頭 祐一, 飯島 正博, 土井 宏, 田中 章景, 祖父江 元

    臨床神経学   55 ( Suppl. )   S273 - S273   2015年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 意識障害を主症状に救急搬送された患者における脳卒中

    高橋 竜哉, 山崎 舞子, 森原 啓介, 田中 章景, 岡本 光生

    臨床神経学   55 ( Suppl. )   S225 - S225   2015年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 若手神経内科医にとっての行動神経学

    東山 雄一, 田中 章景

    臨床神経学   55 ( Suppl. )   S164 - S164   2015年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 当院におけるドパミントランスポーターシンチグラフィの有用性の検討

    山崎 舞子, 森原 啓介, 岡本 光生, 田中 章景, 高橋 竜哉

    臨床神経学   55 ( Suppl. )   S250 - S250   2015年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 脳梗塞患者における尿酸値の検討(第二報)

    山本 良央, 土橋 裕一, 菅原 恵梨子, 桃尾 隆之, 田中 章景

    臨床神経学   55 ( Suppl. )   S243 - S243   2015年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 脳脊髄液抗ガラクトースIgG抗体が陽性であった関節リウマチ未発症の無菌性髄膜炎の1例

    川端 雄一, 宮地 洋輔, 仲野 達, 上木 英人, 田中 章景

    臨床神経学   55 ( 12 )   904 - 908   2015年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    症例は失行、右上下肢麻痺、痙攣で発症し、関節リウマチ症状を認めない69歳女性。脳MRIで両側頭頂葉、左前頭葉の脳表に沿った限局性病変を認め、血中抗CCP抗体、抗ガラクトース欠損IgG抗体、MMP-3、脳脊髄液中抗ガラクトース欠損IgG抗体陽性であり病態的にリウマチ性髄膜炎が疑われた。ステロイド治療に反応し、診断と病勢の指標に抗体価指数(脳脊髄液中抗ガラクトース欠損IgG抗体価/血清抗ガラクトース欠損IgG抗体価)/(脳脊髄液中IgG/血清IgG)が有用であった。本症例は関節リウマチ未発症である点、脳脊髄液中抗ガラクトースIgG抗体を測定した点が初報告であり、貴重な症例と考えられた。(著者抄録)

    researchmap

    その他リンク: https://search.jamas.or.jp/index.php?module=Default&action=Link&pub_year=2015&ichushi_jid=J01550&link_issn=&doc_id=20160222310003&doc_link_id=130005116929&url=https%3A%2F%2Fci.nii.ac.jp%2Fnaid%2F130005116929&type=CiNii&icon=https%3A%2F%2Fjk04.jamas.or.jp%2Ficon%2F00003_1.gif

  • 呉茱萸湯が奏効する片頭痛患者の臨床的特徴

    黒川 隆史, 田中 麻衣子, 藤野 公裕, 黒岩 義之, 馬場 泰尚, 田中 章景

    日本頭痛学会誌   42 ( 2 )   128 - 128   2015年11月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本頭痛学会  

    researchmap

  • 脂質異常を伴う片頭痛患者に対するω3系脂肪酸製剤の治療効果

    黒川 隆史, 浜田 裕子, 浜田 恭子, 田中 麻衣子, 藤野 公裕, 黒岩 義之, 馬場 泰尚, 田中 章景

    日本頭痛学会誌   42 ( 2 )   161 - 161   2015年11月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本頭痛学会  

    researchmap

  • 病初期に臨床所見と画像所見が乖離した神経核内封入体病の45歳女性例

    秋田 怜香, 工藤 洋祐, 甘利 和光, 山本 正博, 児矢野 繁, 三村 將, 田中 章景, 城倉 健

    臨床神経学   55 ( 10 )   770 - 770   2015年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • PROPER TREATMENT OF "FALSE-POSITIVE" CASES IN COMPARING THE DIAGNOSTIC YIELDS OF VARIOUS NERVE CONDUCTION TECHNIQUES TO DIAGNOSE CARPAL TUNNEL SYNDROME

    Yosuke Miyaji, Chizuko Oishi, Hisao Kamiya, Yuki Hatanaka, Fumiaki Tanaka, Masahiro Sonoo

    MUSCLE & NERVE   52   S98 - S98   2015年10月

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:WILEY-BLACKWELL  

    Web of Science

    researchmap

  • 抗PL-12抗体陽性多発筋炎の65歳女性

    中澤 謙介, 齊藤 麻美, 山浦 弦平, 小林 絵礼奈, 木村 活生, 遠藤 雅直, 上田 直久, 田中 章景

    臨床神経学   55 ( 10 )   778 - 778   2015年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 脳生検で診断しえた非HIV進行性多巣性白質脳症の62歳男性例

    土橋 裕一, 中江 啓晴, 大久保 正紀, 多田 美紀子, 土井 宏, 日比谷 孝志, 宍戸 由紀子[原], 田中 章景

    臨床神経学   55 ( 10 )   777 - 777   2015年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • IgG4 Neurofascin 155 Antibody-Positive Hypertrophic Demyelinating Polyneuropathy

    Hidenori Ogata, Ryo Yamasaki, Akio Hiwatashi, Nobuyuki Oka, Nobutoshi Kawamura, Dai Matsuse, Motoi Kuwahara, Hidekazu Suzuki, Susumu Kusunoki, Yuichi Fujimoto, Koji Ikezoe, Hitaru Kishida, Fumiaki Tanaka, Takuya Matsushita, Hiroyuki Murai, Jun-ichi Kira

    ANNALS OF NEUROLOGY   78   S79 - S79   2015年10月

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:WILEY-BLACKWELL  

    Web of Science

    researchmap

  • ポリオ罹患者の神経筋超音波所見の検討(下肢)(第1報)

    渡辺 大祐, 蜂須賀 明子, 塚本 浩, 阿部 達哉, 佐伯 覚, 田中 章景, 小森 哲夫

    臨床神経生理学   43 ( 5 )   457 - 457   2015年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本臨床神経生理学会  

    researchmap

  • 遺伝性パーキンソン病(PARK14)に対するGPi-DBSにおける細胞活動の特徴

    木村 活生, 岸田 日帯, 山浦 弦平, 中澤 謙介, 古宮 裕泰, 小泉 寛之, 上田 直久, 川崎 隆, 濱田 幸一, 田中 章景

    パーキンソン病・運動障害疾患コングレスプログラム・抄録集   9回   82 - 82   2015年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:Movement Disorder Society of Japan (MDSJ)  

    researchmap

  • 神経ベーチェット病が疑われていたが抗GAD抗体陽性小脳失調症の54歳男性例

    春日井 裕美, 古宮 裕泰, 横山 睦美, 小山 主夫, 田中 章景, 池澤 淳

    臨床神経学   55 ( 10 )   771 - 771   2015年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 迅速な卵巣奇形腫摘出術により速やかに回復した抗NMDA受容体脳炎の17歳女性

    古宮 裕泰, 岸田 日帯, 木村 活生, 小泉 寛之, 上田 直久, 下向 麻由, 大谷 方子, 小山 主夫, 田中 章景

    神経免疫学   20 ( 1 )   132 - 132   2015年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経免疫学会  

    researchmap

  • 間欠的後頸部痛で発症しC2/3脊髄神経領域帯状疱疹に同側顔面神経麻痺を呈した不全型Ramsay-Hunt症候群の62歳男性例

    川端 雄一, 仲野 達, 田中 章景

    NEUROINFECTION   20 ( 2 )   158 - 158   2015年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本神経感染症学会  

    researchmap

  • dynactin-1ノックアウトマウスにおける進行性運動機能障害

    河合 香里, 池中 建介, 勝野 雅央, 井口 洋平, 田中 章景, 祖父江 元

    神経治療学   32 ( 5 )   839 - 839   2015年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経治療学会  

    researchmap

  • 尋常性乾癬に対してシクロスポリン内服中に発症した多発性硬化症の56歳男性例

    仲野 達, 川端 雄一, 上木 英人, 田中 章景

    神経免疫学   20 ( 1 )   111 - 111   2015年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本神経免疫学会  

    researchmap

  • 脳損傷周辺領域に可塑的変化を誘導しリハビリテーション効果を促進する低分子化合物の同定

    阿部 弘基, 実木 亨, 小森 隆司, 荒 若菜, 水口 愛香, 佐野 亜加根, 須山 紅美子, 奥田 智博, 田中 章景, 高橋 琢哉

    神経治療学   32 ( 5 )   832 - 832   2015年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経治療学会  

    researchmap

  • HIV感染症のART療法中に感染源不明の白質脳症を伴う免疫再構築症候群をきたした1例

    三宅 綾子, 中江 啓晴, 土井 宏, 岸田 日帯, 上田 直久, 児矢野 繁, 田中 章景

    神経治療学   32 ( 5 )   838 - 838   2015年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経治療学会  

    researchmap

  • 細菌性髄膜炎、多発脳膿瘍の治療中に眼内炎を併発した67歳男性例

    平馬 紀子, 山本 良央, 工藤 洋祐, 中江 啓晴, 田中 章景

    神経治療学   32 ( 5 )   836 - 836   2015年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経治療学会  

    researchmap

  • 灼熱痛にmexiletine投与が有効であった自律神経障害を伴う筋萎縮性硬化症の1例

    渡辺 大祐, 大熊 彩, 阿部 達哉, 田中 章景, 小森 哲夫

    神経治療学   32 ( 5 )   823 - 823   2015年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経治療学会  

    researchmap

  • 関節リウマチ未発症で髄液抗ガラクトースIgG抗体が病態に関与していると考えられた髄膜炎の1例

    川端 雄一, 仲野 達, 田中 章景

    神経治療学   32 ( 5 )   817 - 817   2015年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経治療学会  

    researchmap

  • 新規経口抗凝固薬内服中に発症した脳出血症例の検討

    仲野 達, 川端 雄一, 飯田 悠, 森 健太郎, 玉瀬 玲, 野村 素弘, 田中 章景, 北村 佳久

    神経治療学   32 ( 5 )   832 - 832   2015年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経治療学会  

    researchmap

  • 治療に難渋した成人発症Niemann-Pick病C型の男性例

    小泉 寛之, 岸田 日帯, 遠藤 雅直, 小林 絵礼奈, 齊藤 麻美, 木村 活生, 上田 直久, 田中 章景

    神経治療学   32 ( 5 )   828 - 828   2015年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経治療学会  

    researchmap

  • 神経筋疾患の夜間NPPV導入における、カプノグラフィー(経皮的PCO2連続測定)の有用性

    釘本 千春, 中江 啓晴, 多田 美紀子, 平馬 紀子, 石戸 淳一, 土橋 祐一, 土井 宏, 田中 章景

    神経治療学   32 ( 5 )   810 - 810   2015年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経治療学会  

    researchmap

  • 孤発性Neuronal intranuclear inclusion diseaseの臨床症候

    曽根 淳, 稲垣 智則, 勝又 竜, 高木 伸之介, 森 恵子, 荒木 邦彦, 岩崎 靖, 吉田 眞理, 田中 章景, 祖父江 元

    神経治療学   32 ( 5 )   753 - 753   2015年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経治療学会  

    researchmap

  • 続発性副腎皮質機能低下症に伴った多発性ニューロパチーの1例

    石戸 淳一, 金塚 陽一, 林 竜一郎, 今井 孝俊, 田中 章景, 山口 滋紀

    神経治療学   32 ( 5 )   815 - 815   2015年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経治療学会  

    researchmap

  • 葉酸欠乏性ニューロパチーの臨床病理学的特徴と食事および補充療法の反応性

    小池 春樹, 池田 昇平, 高橋 美江, 川頭 祐一, 飯島 正博, 土井 宏, 田中 章景, 祖父江 元

    神経治療学   32 ( 5 )   814 - 814   2015年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経治療学会  

    researchmap

  • 脳炎後難治性てんかんの意識消失発作に対し免疫療法が有効で抗NMDAR抗体の関与が示唆された症例

    國井 美紗子, 田中 健一, 多田 美紀子, 窪田 瞬, 東山 雄一, 上木 英人, 児矢野 繁, 高橋 幸利, 田中 章景

    神経免疫学   20 ( 1 )   133 - 133   2015年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経免疫学会  

    researchmap

  • E200K変異、コドン129MV多型を有する家族性クロイツフェルト・ヤコブ病

    徳永 雅彦, 岸田 日帯, 古宮 裕泰, 小泉 寛之, 木村 活生, 上田 直久, 田中 章景

    臨床神経学   55 ( 8 )   614 - 614   2015年8月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 血管炎性ニューロパチーと診断したB型肝炎ウイルスキャリアの33歳女性例

    草間 香里, 東山 雄一, 山浦 弦平, 國井 美紗子, 田中 健一, 上木 英人, 児矢野 繁, 田中 章景

    臨床神経学   55 ( 8 )   617 - 617   2015年8月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 甲状腺クリーゼに伴う急性の頸部・四肢筋力低下をきたした53歳男性例

    菅原 恵梨子, 土橋 裕一, 山本 良央, 川上 直樹, 桃尾 隆之, 田中 章景

    臨床神経学   55 ( 8 )   616 - 616   2015年8月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • Age-dependent distribution change of amyloid-beta protein in macaque brains

    K. Kimura, K. Inoue, F. Tanaka, M. Takada

    MOVEMENT DISORDERS   30   S496 - S496   2015年6月

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:WILEY-BLACKWELL  

    Web of Science

    researchmap

  • 大量の小児用かぜ薬シロップによる低カリウム血性ミオパチー

    武市 瑛子, 澁谷 真弘, 山浦 弦平, 城村 裕司, 田中 章景

    神経内科   82 ( 6 )   623 - 625   2015年6月

     詳細を見る

    記述言語:日本語   出版者・発行元:(有)科学評論社  

    51歳女。以前よりインターネット上で感冒様症状に対し市販の小児かぜ薬シロップの一気飲みが効果的であるという記事を見ており、それを実践していた。小児用かぜ薬シロップは1回につき1本ずつ、体調が回復するまでおよそ3日間にわたり1日あたり2〜3本を服用していた。咽頭痛や鼻汁などの感冒様症状に対し小児用かぜ薬シロップを服用し、症状の改善を認めた。両上肢と両下肢大腿部に脱力感を自覚し、感冒によるものかと考え小児用かぜ薬シロップを連日服用したところ、脱力がさらに進行した。自力では、立位もとれなくなったため救急要請した。カリウムの補充を行ったところ筋力は速やかに回復し、低カリウム血症ミオパチーと診断した。第8病日に自宅退院とした。

    researchmap

  • 脊髄小脳失調症up-to-date 劣性遺伝性疾患を中心に

    田中 章景

    臨床神経学   55 ( 5 )   365 - 365   2015年5月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 視神経脊髄炎関連疾患のしびれに対して牛車腎気丸合大建中湯が奏効した1症例

    中江 啓晴, 小菅 孝明, 熊谷 由紀絵, 田中 章景

    痛みと漢方   25   68 - 71   2015年5月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本疼痛漢方研究会  

    患者は52歳女性、主訴は足のしびれ。47歳時に視神経脊髄炎関連疾患を発症し、X年7月に両脇腹の痛み、足先のしびれで再発したため入院となった。ステロイドパルス療法で両脇腹の痛みは徐々に改善傾向となったが、しびれは改善しなかった。第26病日から牛車腎気丸合大建中湯を開始したところ下肢のしびれは徐々に改善し、内服7日後には8/10に、内服2ヵ月後には5/10に、内服6ヵ月後には1/10に改善した。牛車腎気丸はしびれに対してしばしば使用されるが、検索しえた限りでは脊髄炎によるしびれに対して牛車腎気丸の有効性を示した報告はない。一方、大建中湯は疼痛に対して使用されることもあり、しびれの改善に関与していた可能性も考えられる。今後、両薬の単独使用の効果を検証する必要はあるが、視神経脊髄炎関連疾患の感覚障害に対して漢方薬は有効な可能性があり、治療の選択肢に加えるべきと考えられた。(著者抄録)

    researchmap

  • non-paralytic pontine exotropiaと回旋性眼振を同時に認めたMLF症候群の68歳男性例

    山本 良央, 土橋 裕一, 菅原 恵梨子, 桃尾 隆之, 田中 章景

    臨床神経学   55 ( 4 )   277 - 277   2015年4月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 味覚障害を呈したFisher症候群の一例

    池澤 淳, 横山 睦美, 張 寧, 田中 章景, 小山 主夫

    臨床神経学   55 ( 4 )   285 - 285   2015年4月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • Combined central and peripheral demyelination(CCPD)の16歳男性例

    小泉 寛之, 古宮 裕泰, 木村 活生, 岸田 日帯, 上田 直久, 田中 章景

    臨床神経学   55 ( 4 )   280 - 280   2015年4月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 高度の脱髄・軸索障害を呈した抗Hu抗体陽性Painful and Sensory Ataxic Neuropathyの64歳女性例

    大久保 正紀, 中江 啓晴, 春日井 裕美, 平馬 紀子, 多田 美紀子, 釘本 千春, 土井 宏, 田中 章景

    臨床神経学   55 ( 4 )   281 - 281   2015年4月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 選択的タイプライティング障害を呈した左前頭葉梗塞の78歳男性例

    東山 雄一, 山浦 弦平, 草間 香里, 國井 美紗子, 田中 健一, 上木 英人, 田中 章景

    高次脳機能研究   35 ( 1 )   90 - 90   2015年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本高次脳機能障害学会  

    researchmap

  • 半夏白朮天麻湯が奏効した耳鳴の2症例

    中江 啓晴, 小菅 孝明, 熊谷 由紀絵, 田中 章景

    漢方の臨床   62 ( 2 )   289 - 293   2015年2月

     詳細を見る

    記述言語:日本語   出版者・発行元:東亜医学協会  

    症例1(63歳男性)。急に耳鳴が出現し近医の耳鼻咽喉科を受診、聴力検査では異常はなかったが、脳神経系障害の可能性を指摘され、発症から2週間後に著者らの施設へ紹介となった。西洋医学的所見では一般内科的、神経学的に異常所見や聴力の明らかな低下は認められなかったが、漢方医学的所見では水滞による耳鳴と考え、六君子湯エキス顆粒(7.5g/分3)の1週間投与が行われた。その結果、3日目から耳鳴の音は小さくなったが1日中続いたままであった。そこで、以前からのめまいの訴えも踏まえ、半夏白朮天麻湯エキス顆粒(7.5g/分3)に変方したところ、1週間の内服で耳鳴は改善し廃薬となった。症例2(32歳女性)。第1病日朝にめまいが出現し直ぐに治まったが、昼にもめまいが再発、夕方にはめまいが持続し、まっすぐ歩けなくなり、耳鳴も出現したため第2病日目に受診となった。西洋医学的所見では一般内科的、神経学的に異常所見はなく、聴力にも明らかな低下は認められなかったが、漢方医学的所見から水滞による耳鳴と考え、半夏白朮天麻湯エキス顆粒(7.5g/分3)を7日間投与したところ、めまいは消失、9日目の内服後は耳鳴も消失した。そのため内服14日間で廃薬とした。以上より、西洋医学的に診断のつかない耳鳴に対して半夏白朮天麻湯は治療選択肢の1つとなり得ると考えられた。

    researchmap

  • 骨髄腫細胞に関連し、良好な経過を呈した脳炎の一例

    松下 ゆり, 田中 章景

    日本内科学会雑誌   104 ( Suppl. )   272 - 272   2015年2月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本内科学会  

    researchmap

  • 【自己免疫性脳炎-抗原・抗体は何をしている?】Collapsin response mediator proteins Collapsin response mediator proteinの機能

    中村 治子, 田中 章景, 五嶋 良郎

    Clinical Neuroscience   33 ( 1 )   90 - 93   2015年1月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)中外医学社  

    researchmap

  • 脊髄小脳変性症(SCD)症例の構音動態の検討

    生井 友紀子, 持田 岳美, 五味 裕章, 児矢野 繁, 田中 章景, 廣瀬 肇, 折舘 伸彦

    音声言語医学   56 ( 1 )   74 - 74   2015年1月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本音声言語医学会  

    researchmap

  • 真武湯が奏功しためまいの5症例

    中江 啓晴, 小菅 孝明, 熊谷 由紀恵, 田中 章景

    神奈川医学会雑誌   42 ( 1 )   160 - 160   2015年1月

     詳細を見る

    記述言語:日本語   出版者・発行元:神奈川県医師会  

    researchmap

  • 多発脳病変をきたしステロイドが有効であった45歳女性例

    菅原 恵梨子, 土橋 裕一, 山本 良央, 桃尾 隆之, 竹本 安範, 中江 啓晴, 田中 章景

    臨床神経学   55 ( 1 )   73 - 73   2015年1月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • サーフィン後に異常行動で発症し、多発脳梗塞、両側椎骨動脈解離を認めた39歳男性例

    仲野 達, 山浦 弦平, 横山 睦美, 田中 章景, 小山 主夫

    脳卒中   37 ( 1 )   47 - 49   2015年1月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本脳卒中学会  

    症例は39歳男性。サーフィン後に他人の自転車を乗っていこうとする異常行動のあとに意識障害が進行したため救急搬送された。MRIでは両側小脳、両側視床に新規脳梗塞を認め、MR angiography(MRA)では頭蓋外から頭蓋内への移行部に両側で椎骨動脈解離を認めた。MRAで経時的に観察を行い、両側で同様な解離腔の信号変化を呈したことから両側同時に解離が生じたものと判断した。保存的治療で意識状態は改善したが、見当識障害、記銘力障害が残存した。外的要因で椎骨動脈解離が生じることは知られているが、サーフィンも例外ではない。また、両側椎骨動脈解離を認める症例は少なく、発症機序を考察する上でも貴重な症例と考えた。(著者抄録)

    researchmap

    その他リンク: https://search.jamas.or.jp/index.php?module=Default&action=Link&pub_year=2015&ichushi_jid=J01786&link_issn=&doc_id=20150130510010&doc_link_id=%2Fdh3strok%2F2015%2F003701%2F010%2F0047-0049%26dl%3D0&url=https%3A%2F%2Fwww.medicalonline.jp%2Fjamas.php%3FGoodsID%3D%2Fdh3strok%2F2015%2F003701%2F010%2F0047-0049%26dl%3D0&type=MedicalOnline&icon=https%3A%2F%2Fjk04.jamas.or.jp%2Ficon%2F00004_2.gif

  • 【瞳孔の神経学】一側性Horner症候群の診断と瞳孔の診察

    黒岩 義之, 井手 恵子, 馬場 泰尚, 田中 章景

    神経内科   82 ( 1 )   35 - 38   2015年1月

     詳細を見る

    記述言語:日本語   出版者・発行元:(有)科学評論社  

    researchmap

  • IgA腎症を合併したCADASILの37歳男性例

    春日井 裕美, 草間 香里, 山浦 弦平, 國井 美紗子, 東山 雄一, 土井 宏, 鈴木 ゆめ, 田中 章景

    臨床神経学   55 ( 1 )   65 - 65   2015年1月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 開眼困難で発症したパーキンソン病の79歳男性例

    齊藤 麻美, 遠藤 雅直, 小林 絵礼奈, 木村 活生, 岸田 日帯, 上田 直久, 田中 章景

    臨床神経学   55 ( 1 )   64 - 64   2015年1月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 重症頭部外傷の既往がある海馬硬化症に伴う内側側頭葉てんかんの一手術例

    北澤悠, 神一敬, 加藤量広, 柿坂庸介, 藤川真由, 中里信和, 岩崎真樹, 田中章景

    臨床神経学(Web)   55 ( 1 )   2015年

     詳細を見る

  • 症例報告 急性期脳梗塞患者で発見された慢性硬膜下血腫に対して柴苓湯が奏効した1例

    中江 啓晴, 小菅 孝明, 熊谷 由紀絵, 田中 章景

    脳神経外科と漢方 = Journal of neurosurgery and kampo medicine : 日本脳神経外科漢方医学会機関誌   1   78 - 81   2015年

     詳細を見る

    記述言語:日本語   出版者・発行元:日本脳神経外科漢方医学会  

    CiNii Books

    researchmap

  • プリオン病及び遅発性ウイルス感染症の分子病態解明・治療法開発に関する研究 遺伝性プリオン病患者登録・評価・介入ユニット(trial unit)の構築

    水澤英洋, 塚本忠, 三條伸夫, 森若文雄, 青木正志, 西澤正豊, 田中章景, 犬塚貴, 武田雅俊, 阿部康二, 村井弘之, 佐藤克也, 北本哲之, 中村好一, 村山繁雄, 黒岩義之, 原田雅史, 齊藤延人, 太組一朗, 金谷泰宏, 田村智英子, 山田正仁, 桑田一夫

    プリオン病及び遅発性ウイルス感染症の分子病態解明・治療法開発に関する研究 平成26年度 委託業務成果報告書   2015年

     詳細を見る

  • バルプロ酸・ラモトリギン・レベチラセタムの3剤併用で発作消失に至った難治性若年ミオクロニーてんかんの3例

    北澤悠, 神一敬, 柿坂庸介, 藤川真由, 中里信和, 加藤量広, 岩崎真樹, 田中章景

    臨床神経学(Web)   55 ( 7 )   2015年

     詳細を見る

  • プリオン病及び遅発性ウイルス感染症に関する調査研究 わが国のプリオン病サーベイランスの状況と治験に向けたプリオン病コンソーシアム(JACOP)との協力体制

    水澤英洋, 塚本忠, 三條伸夫, 森若文雄, 青木正志, 西澤正豊, 田中章景, 犬塚貴, 武田雅俊, 阿部康二, 村井弘之, 佐藤克也, 北本哲之, 中村好一, 村山繁雄, 黒岩義之, 原田雅史, 齊藤延人, 太組一朗, 金谷泰宏, 田村智英子, 山田正仁

    プリオン病及び遅発性ウイルス感染症に関する調査研究 平成26年度 総括・分担研究報告書   2015年

     詳細を見る

  • fMRIを用いたタイプライティングの神経基盤の検討

    東山 雄一, 染谷 芳明, 武田 克彦, 黒岩 義之, 田中 章景

    臨床神経学   54 ( Suppl. )   S176 - S176   2014年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 年齢別に検討した脳梗塞の臨床的特徴

    仲野 達, 横山 睦美, 山浦 弦平, 田中 章景, 小山 主夫

    臨床神経学   54 ( Suppl. )   S230 - S230   2014年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • ネマリンミオパチー3症例の長期経過の検討

    鈴木 ゆめ, 土井 宏, 釘本 千春, 松本 直通, 田中 章景

    臨床神経学   54 ( Suppl. )   S211 - S211   2014年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 脳梗塞患者における尿酸値の検討

    山本 良央, 土橋 裕一, 中江 啓晴, 田中 章景, 城倉 健

    臨床神経学   54 ( Suppl. )   S179 - S179   2014年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 脳梗塞急性期のEPA/AA比

    横山 睦美, 山浦 弦平, 仲野 達, 田中 章景, 小山 主夫

    臨床神経学   54 ( Suppl. )   S179 - S179   2014年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • カルシウムシグナリングからみたポリグルタミン病の神経病理学的検討

    児矢野 繁, 柳下 三郎, 田中 章景

    臨床神経学   54 ( Suppl. )   S197 - S197   2014年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • Lewy小体型認知症、および認知症を伴うParkinson病におけるMRI上の大脳白質病変の検討

    上木 英人, 工藤 洋祐, 東山 雄一, 釘本 千春, 上田 直久, 児矢野 繁, 鈴木 ゆめ, 田中 章景

    臨床神経学   54 ( Suppl. )   S196 - S196   2014年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 慢性片頭痛と非慢性片頭痛における疼痛感作の違い 線維筋痛症圧痛点を用いた評価

    黒川 隆史, 藤野 公裕, 黒岩 義之, 馬場 泰尚, 田中 章景

    臨床神経学   54 ( Suppl. )   S170 - S170   2014年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • レベチラセタム新規投与例についての検討(単剤療法群を含めて)

    中江 啓晴, 土橋 裕一, 山本 良央, 田中 章景, 城倉 健

    臨床神経学   54 ( Suppl. )   S161 - S161   2014年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 脳梗塞急性期における「Narrow window CT」の有用性

    川端 雄一, 宮地 洋輔, 田中 章景

    臨床神経学   54 ( Suppl. )   S177 - S177   2014年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 【健康寿命の延伸を目指して-高齢社会における予防医学-】認知症の現状と今後の課題 DSM-5における「認知症」から

    鈴木 ゆめ, 田中 章景

    予防医学   ( 56 )   65 - 69   2014年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(公財)神奈川県予防医学協会  

    researchmap

  • 若年発症の筋萎縮性側索硬化症におけるスポーツ歴

    城村 裕司, 川本 裕子, 橋口 俊太, 田中 章景

    臨床神経学   54 ( Suppl. )   S147 - S147   2014年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • Parkinson病における知覚伝導閾値とMIBG心筋シンチグラフィーの関係

    池田 真悟, 大久保 正紀, 遠藤 雅直, 岸田 日帯, 島村 めぐみ, 田中 章景

    臨床神経学   54 ( Suppl. )   S141 - S141   2014年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 痙攣患者の血中アンモニア値 クレアチンキナーゼ値との比較

    土橋 裕一, 中江 啓晴, 山本 良央, 田中 章景, 城倉 健

    臨床神経学   54 ( Suppl. )   S161 - S161   2014年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • パーキンソニズムを呈した筋萎縮性側索硬化症の臨床病理学的検討

    多田 美紀子, 児矢野 繁, 土井 宏, 鈴木 ゆめ, 田中 章景

    臨床神経学   54 ( Suppl. )   S99 - S99   2014年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • REEP1にp.Lys32Asn変異を認めた遺伝性痙性対麻痺の2家系例

    土井 宏, 吉田 環, 釘本 千春, 松本 直通, 田中 章景

    臨床神経学   54 ( Suppl. )   S96 - S96   2014年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 精神疾患患者における脳梗塞診断困難例の特徴

    國井 美紗子, 古宮 裕泰, 岡本 光生, 田中 章景, 高橋 竜哉

    臨床神経学   54 ( Suppl. )   S130 - S130   2014年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • dynactin-1ノックアウトマウスを用いた孤発性ALSの病態解析

    河合 香里, 池中 建介, 勝野 雅央, 井口 洋平, 勝又 竜, 田中 章景, 祖父江 元

    臨床神経学   54 ( Suppl. )   S100 - S100   2014年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 脳出血におけるEPA/AA比の検討

    岡本 光生, 古宮 裕泰, 國井 美紗子, 田中 章景, 高橋 竜哉

    臨床神経学   54 ( Suppl. )   S75 - S75   2014年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 脳卒中患者における回復期リハビリテーション病院からの退院先

    高橋 竜哉, 高瀬 昌浩, 古宮 裕泰, 國井 美紗子, 岡本 光生, 田中 章景

    臨床神経学   54 ( Suppl. )   S79 - S79   2014年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • t-PA治療後の症候性頭蓋内出血例の検討

    島村 めぐみ, 池田 真悟, 菅原 恵理子, 遠藤 雅直, 桃尾 隆之, 岸田 日帯, 田中 章景

    臨床神経学   54 ( Suppl. )   S75 - S75   2014年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 皮膚生検により診断したNeuronal intranuclear inclusion disease 18例の臨床学的特徴

    曽根 淳, 北川 尚之, 菅原 恵梨子, 違口 正明, 稲垣 智則, 吉村 元, 石井 淳子, 川本 未知, 森 恵子, 岩崎 靖, 吉田 眞理, 田中 章景, 祖父江 元

    臨床神経学   54 ( Suppl. )   S63 - S63   2014年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 同種骨髄移植後に視神経、大脳白質、脊髄病変を示した36歳男性例

    林 紀子, 池澤 淳, 窪田 瞬, 田中 健一, 多田 美紀子, 工藤 洋祐, 山本 渉, 立花 崇孝, 鈴木 ゆめ, 田中 章景

    臨床神経学   54 ( Suppl. )   S17 - S17   2014年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 初期診断が困難であった延髄外側梗塞の特徴

    菅原 恵梨子, 島村 めぐみ, 高橋 竜哉, 田中 章景

    臨床神経学   54 ( Suppl. )   S73 - S73   2014年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 方向交代性上向性眼振の鑑別 小脳病変と良性発作性頭位めまい症の違い

    城倉 健, 中江 啓晴, 山本 良央, 土橋 裕一, 田中 章景

    臨床神経学   54 ( Suppl. )   S68 - S68   2014年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 【神経症候群(第2版)-その他の神経疾患を含めて-】てんかん症候群 その他の重要な病態 進行性ミオクローヌスてんかんを示す疾患 神経セロイドリポフスチン症 Kufs病

    島村 めぐみ, 田中 章景

    日本臨床   別冊 ( 神経症候群VI )   334 - 338   2014年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)日本臨床社  

    researchmap

  • 中枢性脱髄を呈したCharcot-Marie-Tooth 1Aの22歳女性例

    小林 絵礼奈, 齋藤 麻美, 遠藤 雅直, 上田 直久, 田中 章景

    末梢神経   25 ( 2 )   414 - 414   2014年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本末梢神経学会  

    researchmap

  • Parkinson病外来患者における栄養状態の評価(第2報)

    工藤 洋祐, 中村 治子, 東山 雄一, 上木 英人, 児矢野 繁, 田中 章景

    臨床神経学   54 ( Suppl. )   S237 - S237   2014年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 脊髄小脳変性症における構音動態の検討

    生井 友紀子, 廣瀬 肇, 折舘 伸彦, 持田 岳美, 五味 裕章, 児矢野 繁, 田中 章景

    臨床神経学   54 ( Suppl. )   S245 - S245   2014年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • パーキンソン病の夜間症状 PDSS-2日本語版の有用性

    宮地 洋輔, 川端 雄一, 上木 英人, 田中 章景

    臨床神経学   54 ( Suppl. )   S86 - S86   2014年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 当院における一過性意識消失にて神経内科を紹介受診された患者の診療と診断

    山浦 弦平, 仲野 達, 横山 睦美, 田中 章景, 小山 主夫

    臨床神経学   54 ( Suppl. )   S263 - S263   2014年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 脳脊髄液抗GAD抗体測定の有用性の検討

    古宮 裕泰, 國井 美紗子, 岡本 光生, 田中 章景, 高橋 竜哉

    臨床神経学   54 ( Suppl. )   S251 - S251   2014年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 脊髄小脳変性症における運動学習障害の評価

    上田 直久, 波木井 靖人, 児矢野 繁, 釘本 千春, 土井 宏, 岸田 日帯, 上木 英人, 工藤 洋祐, 東山 雄一, 鈴木 ゆめ, 黒岩 義之, 田中 章景

    臨床神経学   54 ( Suppl. )   S32 - S32   2014年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • キャリーオーバー患者の受け入れの現状

    小山 主夫, 横山 睦美, 仲野 達, 山浦 弦平, 出井 ふみ, 田中 章景

    臨床神経学   54 ( Suppl. )   S265 - S265   2014年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • ALSの呼吸機能評価における横隔膜エコーと横隔神経M波振幅の組み合わせの有用性

    釘本 千春, 岩橋 幸子, 小林 絵礼奈, 斎藤 麻美, 山崎 舞子, 東山 雄一, 上木 英人, 田中 章景

    臨床神経学   54 ( Suppl. )   S247 - S247   2014年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 慢性片頭痛と反復性片頭痛における疼痛感作の違い 線維筋痛症圧痛点を用いた評価

    黒川 隆史, 小泉 寛之, 中村 昭子, 藤野 公裕, 黒岩 義之, 馬場 泰尚, 田中 章景

    日本頭痛学会誌   41 ( 2 )   258 - 258   2014年11月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本頭痛学会  

    researchmap

  • 無菌性髄膜炎患者の初回腰椎穿刺による硬膜穿刺後頭痛

    山本 良央, 土橋 裕一, 菅原 恵梨子, 桃尾 隆之, 田中 章景

    日本頭痛学会誌   41 ( 2 )   321 - 321   2014年11月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本頭痛学会  

    researchmap

  • 筋電図でMytonic dischargeを認めた中心核ミオパチーの39歳男性例

    山浦 弦平, 小林 絵礼奈, 東山 雄一, 上木 英人, 岩橋 幸子, 土井 宏, 鈴木 ゆめ, 田中 章景

    臨床神経学   54 ( 10 )   844 - 844   2014年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 脊髄小脳変性症における運動学習障害の評価

    上田 直久, 波木井 靖人, 釘本 千春, 上木 英人, 工藤 洋祐, 東山 雄一, 黒岩 義之, 田中 章景

    Dementia Japan   28 ( 4 )   510 - 510   2014年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本認知症学会  

    researchmap

  • 皮膚生検により診断したNeuronal intranuclear inclusion disease 10例の検討

    曽根 淳, 荒木 邦彦, 藤岡 祐介, 稲垣 智則, 桝田 道人, 岩崎 靖, 吉田 眞理, 田中 章景, 祖父江 元

    Dementia Japan   28 ( 4 )   509 - 509   2014年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本認知症学会  

    researchmap

  • アルツハイマー病のBPSDに対するガランタミンの効果

    中江 啓晴, 東山 雄一, 児矢野 繁, 城倉 健, 田中 章景

    Dementia Japan   28 ( 4 )   488 - 488   2014年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本認知症学会  

    researchmap

  • 脊髄硬膜外膿瘍の髄液検査所見

    宮地 洋輔, 宮崎 秀健, 張 寧, 渡邉 大祐, 田中 章景

    横浜医学   65 ( 4 )   537 - 544   2014年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:横浜市立大学医学会  

    脊髄硬膜外膿瘍患者で、頭痛や意識障害などを伴い、膿瘍の浸潤などを原因とした細菌性髄膜炎の合併が疑われた場合、その合併は予後不良因子とされ、合併有無の診断は抗菌薬の選択など治療方針決定に際し重要である。脊髄硬膜外膿瘍の髄液検査所見は、教科書的には、多型核球優位の細胞数増多、蛋白高値、糖正常が特徴とされているが、疾患の希少性も手伝い、多数例での検討は乏しい。今回、2012年までに報告された脊髄硬膜外膿瘍の症例に関する日本国内の施設からの症例報告を参照し、髄液検査所見に関する具体的記載があった83報告、89例に、明らかな髄膜炎の徴候を伴わないものの髄液検査から当初細菌性髄膜炎の合併を否定できなかった脊髄硬膜外膿瘍の自験1例を加えた計90例を対象とし、本文中の記載に基づき、髄膜炎合併の記載のある18例と記載のない72例について比較検討した。結果としては、髄膜炎非合併例で、多形核球優位の細胞数増多が多数を占め、全例で蛋白は上昇していたのみならず、髄液糖の低下も35例中17例(49%)にみられた。また、発熱と項部硬直は陽性のものが多く、意識障害を認めた例も僅かながらあった(4/65例)。頭痛は37%(13/35例)にみられた。以上から、細菌性髄膜炎合併の有無を髄液検査により判断することは極めて困難であり、細菌性髄膜炎を伴わずとも髄液糖低下をきたしうることに留意する必要がある。(著者抄録)

    CiNii Books

    researchmap

    その他リンク: http://search.jamas.or.jp/link/ui/2015359978

  • 両側視床下核脳深部刺激術(STN-DBS)後、刺激変更により、気管支喘息が改善した若年性Parkinson病の1例

    古宮 裕泰, 田中 麻衣子, 小林 絵礼奈, 齊藤 麻美, 木村 活生, 遠藤 雅直, 岸田 日帯, 上田 直久, 田中 章景

    パーキンソン病・運動障害疾患コングレスプログラム・抄録集   8回   88 - 88   2014年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:Movement Disorder Society of Japan (MDSJ)  

    researchmap

  • 眼で見る神経内科 多発微小脳出血を合併した顕微鏡的多発血管炎

    橋口 俊太, 工藤 洋祐, 上田 直久, 黒岩 義之, 田中 章景

    神経内科   81 ( 4 )   460 - 462   2014年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:(有)科学評論社  

    researchmap

  • RNA病からみた認知症関連疾患 C9orf72遺伝子変異と前頭側頭葉変性症

    田中 章景

    Dementia Japan   28 ( 4 )   453 - 453   2014年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本認知症学会  

    researchmap

  • 両側視床下核脳深部刺激療法を施行したパーキンソン病の剖検例における、電極留置部位と刺激効果の検討

    木村 活生, 岸田 日帯, 古宮 裕泰, 田中 麻衣子, 上田 直久, 川崎 隆, 濱田 幸一, 田中 章景

    パーキンソン病・運動障害疾患コングレスプログラム・抄録集   8回   89 - 89   2014年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:Movement Disorder Society of Japan (MDSJ)  

    researchmap

  • MRI T2*WI、DWIが診断に有用であった深部脳静脈血栓症の86歳女性例

    堤 勝彦, 仲野 達, 山浦 弦平, 横山 睦美, 田中 章景, 小山 主夫

    臨床神経学   54 ( 10 )   839 - 839   2014年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 【神経細胞変性のメカニズム】蛋白質凝集と神経変性

    土井 宏, 田中 章景

    Brain Medical   26 ( 3 )   265 - 271   2014年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)メディカルレビュー社  

    神経組織への凝集蛋白質の沈着は、多くの神経変性疾患に共通して認められる現象であり、その種類、形態、分布を明らかにすることが、各疾患の病理学的診断に不可欠な要素となっている。蛋白質凝集は神経変性疾患の病態の中核をなすものであり、多方面から研究が行われている。本稿では、in vitroにおけるアミロイド線維形成の動態、代表的な凝集体形成疾患であるプリオン病における蛋白質凝集、蛋白質凝集の生理学的な意味、二次的な蛋白質凝集について解説する。(著者抄録)

    researchmap

  • マカクザル脳における加齢に伴うアミロイドβ蛋白の蓄積変化 査読

    木村活生, 井上謙一, 田中章景, 高田昌彦

    第37回日本神経科学大会(2014/9/11-13, 横浜)   2014年9月

     詳細を見る

    記述言語:日本語  

    researchmap

  • 内包後脚に再発を繰り返した低血糖性片麻痺の1例

    窪田 瞬, 平田 順一, 小島 麻里, 國井 美紗子, 冨田 敦子, 釘本 千春, 土井 宏, 上田 直久, 田中 章景

    脳卒中   36 ( 5 )   370 - 373   2014年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本脳卒中学会  

    症例は79歳男性。糖尿病で内服加療を行っていたが、突然発症の右不全片麻痺を来し当院に救急搬送された。頭部MRI拡散強調画像で左内包後脚に高信号を認めた。血糖が30mg/dlと著明に低下しており50%グルコースを静注したところ症状は速やかに消失し、片麻痺の原因は低血糖によるものと考えられた。患者は過去にも低血糖による内包後脚のMRI異常信号を呈し、右不全片麻痺を発症していた。低血糖発作による脳卒中様の片麻痺は過去にも報告がみられるが、同一部位に繰り返しMRI異常信号を認めた例はこれまでにない。内包後脚が低血糖への脆弱性が高い脳組織の一つであることが示された。(著者抄録)

    researchmap

    その他リンク: https://search.jamas.or.jp/index.php?module=Default&action=Link&pub_year=2014&ichushi_jid=J01786&link_issn=&doc_id=20141003400010&doc_link_id=%2Fdh3strok%2F2014%2F003605%2F010%2F0370-0373%26dl%3D0&url=https%3A%2F%2Fwww.medicalonline.jp%2Fjamas.php%3FGoodsID%3D%2Fdh3strok%2F2014%2F003605%2F010%2F0370-0373%26dl%3D0&type=MedicalOnline&icon=https%3A%2F%2Fjk04.jamas.or.jp%2Ficon%2F00004_2.gif

  • 同種骨髄移植後に中枢神経病変を呈し、大量免疫グロブリン療法が有効であった1例

    平馬 紀子, 多田 美紀子, 工藤 洋祐, 中江 啓晴, 田中 章景

    神経治療学   31 ( 5 )   659 - 659   2014年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経治療学会  

    researchmap

  • 皮膚生検によるNeuronal intranuclear inclusion diseaseの診断について

    曽根 淳, 北川 尚之, 稲垣 智則, 岩崎 靖, 吉田 眞理, 田中 章景, 祖父江 元

    神経治療学   31 ( 5 )   650 - 650   2014年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経治療学会  

    researchmap

  • 【血管支配からみた高次脳機能障害】 右中大脳動脈病変による高次脳機能障害

    東山 雄一, 田中 章景

    神経内科   81 ( 3 )   306 - 314   2014年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(有)科学評論社  

    researchmap

  • Clinical feature of 19 cases of neuronal intranuclear inclusion disease diagnosed by skin biopsy

    J. Sone, N. Kitagawa, E. Sugawara, M. Iguchi, T. Inagaki, H. Yoshimura, J. Ishii, M. Kawamoto, K. Mori, K. Araki, M. Masuda, M. Yoshida, Y. Iwasaki, F. Tanaka, G. Sobue

    BRAIN PATHOLOGY   24   64 - 64   2014年9月

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:WILEY-BLACKWELL  

    Web of Science

    researchmap

  • メトロニダゾール追加投与が奏効したKlebsiella pneumoniaeによる多発脳膿瘍の46歳男性例

    仲野 達, 山浦 弦平, 横山 睦美, 田中 章景, 小山 主夫

    神経免疫学   19 ( 1 )   148 - 148   2014年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経免疫学会  

    researchmap

  • 多発性硬化症様の中枢神経病変を呈したCharcot-Marie-Tooth 1Aの22歳女性例

    小林 絵礼奈, 齊藤 麻美, 遠藤 雅直, 上田 直久, 田中 章景

    神経治療学   31 ( 5 )   639 - 639   2014年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経治療学会  

    researchmap

  • 各種難病の最新治療情報 神経変性疾患患者の脳MRIにおける年間萎縮率"Annual Atrophic Rate(AAR)"

    黒岩 義之, 田中 章景, 藤野 公裕, 黒川 隆史, 馬場 泰尚

    難病と在宅ケア   20 ( 5 )   62 - 65   2014年8月

  • メトロニダゾール追加投与が奏効したKlebsiella pneumoniaeによる多発脳膿瘍の46歳男性例

    仲野 達, 山浦 弦平, 横山 睦美, 田中 章景, 小山 主夫

    NEUROINFECTION   19 ( 2 )   212 - 212   2014年8月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本神経感染症学会  

    researchmap

  • 【神経疾患の性差をみる】Parkinson病と性差

    黒岩 義之, 馬場 泰尚, 川端 雄一, 橋口 俊太, 田中 章景

    神経内科   81 ( 2 )   145 - 148   2014年8月

     詳細を見る

    記述言語:日本語   出版者・発行元:(有)科学評論社  

    researchmap

  • Intravascular lymphomatosisの現況 (特集 神経系の悪性リンパ腫 update)

    児矢野 繁, 橋口 俊太, 田中 章景

    Brain and nerve : 神経研究の進歩   66 ( 8 )   927 - 946   2014年8月

     詳細を見る

    記述言語:日本語   出版者・発行元:医学書院  

    CiNii Books

    researchmap

    その他リンク: http://search.jamas.or.jp/link/ui/2014315383

  • くも膜嚢胞を伴う常染色体劣性遺伝性痙性失調症(Charlevoix-Saguenay型)の男性例

    池田 真悟, 岸田 日帯, 大久保 正紀, 遠藤 雅直, 島村 めぐみ, 土井 宏, 田中 章景

    臨床神経学   54 ( 8 )   694 - 694   2014年8月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • Tumefactive lesionを呈したPrimary angiitis of the central nervous systemの46歳女性例

    池澤 淳, 工藤 洋祐, 多田 美紀子, 児矢野 繁, 鈴木 ゆめ, 田中 章景, 加藤 依子, 宇高 直子

    臨床神経学   54 ( 8 )   686 - 686   2014年8月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 【神経疾患の性差をみる】片頭痛・群発頭痛・三叉神経痛 性差をみる

    黒川 隆史, 黒岩 義之, 馬場 泰尚, 田中 章景

    神経内科   81 ( 2 )   123 - 129   2014年8月

     詳細を見る

    記述言語:日本語   出版者・発行元:(有)科学評論社  

    researchmap

  • 髄膜炎改善後に多発脳膿瘍の画像的増悪を認めたKlebsiella pneumoniae Renal Abscess Syndromeの46歳男性例

    仲野 達, 山浦 弦平, 横山 睦美, 田中 章景, 小山 主夫

    臨床神経学   54 ( 8 )   696 - 696   2014年8月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 初発症状として低体温、記銘力障害を呈し、MRIで間脳のみに病変をみとめた抗アクアポリン抗体関連疾患の69歳女性例

    仲野 達, 出井 ふみ, 川本 裕子, 高橋 利幸, 田中 章景, 小山 主夫

    臨床神経学   54 ( 8 )   653 - 656   2014年8月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    症例は69歳女性である。約1ヵ月の経過で日中の眠気、もの忘れが徐々に進行した。入院時は徐脈(55回/分)、低体温(32.5℃)が存在し、記銘力障害、軽度の構音障害、動作緩慢をみとめた。脳MRI FLAIR画像では側脳室、第三脳室に接する領域で高信号域がみとめられ、血清抗アクアポリン4(Aquaporin 4;AQP4)抗体が陽性であった。視神経炎、脊髄炎の既往・所見はなく、抗AQP4抗体関連疾患と診断した。視神経脊髄炎(neuromyelitis optica;NMO)で初発として間脳病変や間脳症状を呈した症例の報告はまれである。第三脳室に接する病変あるいは間脳症状がみとめられたばあいは抗AQP4抗体関連疾患を鑑別する必要がある。(著者抄録)

    researchmap

    その他リンク: https://search.jamas.or.jp/index.php?module=Default&action=Link&pub_year=2014&ichushi_jid=J01550&link_issn=&doc_id=20140813210004&doc_link_id=130004679008&url=https%3A%2F%2Fci.nii.ac.jp%2Fnaid%2F130004679008&type=CiNii&icon=https%3A%2F%2Fjk04.jamas.or.jp%2Ficon%2F00003_1.gif

  • 左同名性半盲に対してPCを用いた視機能回復訓練を施行した脳出血の24歳男性例

    東山 雄一, 津本 学, 田中 章景, 武田 克彦

    認知神経科学   16 ( 2 )   131 - 131   2014年6月

     詳細を見る

    記述言語:日本語   出版者・発行元:認知神経科学会  

    researchmap

  • 高CK血症、間質性肺炎にて発症したNMO spectrum disorderの67歳男性例

    山浦 弦平, 仲野 達, 横山 睦美, 田中 章景, 小山 主夫

    臨床神経学   54 ( 5 )   452 - 452   2014年5月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 口蓋振戦を合併したFahr病の37歳女性例

    小林 絵礼奈, 齊藤 麻美, 山崎 舞子, 東山 雄一, 上木 英人, 上田 直久, 鈴木 ゆめ, 田中 章景

    臨床神経学   54 ( 5 )   460 - 460   2014年5月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 片側Wallenberg症候群により亜急性期に中枢性低換気をきたした1例

    菅原 恵梨子, 齊藤 麻美, 岡本 光生, 田中 章景, 高橋 竜哉

    臨床神経学   54 ( 4 )   303 - 307   2014年4月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    症例は46歳男性である。頭痛、嘔気を訴え脳MRIで右延髄外側に右椎骨動脈解離による梗塞巣をみとめた。第3病日当院への転院時、右Wallenberg症候群を呈しており、誤嚥性肺炎をきたしていたものの意識清明であった。その後不穏となり第9病日にCO2ナルコーシスのため人工呼吸器管理となった。第10病日に抜管後も同様のエピソードがあり、気管切開が実施された。第39病日に人工呼吸器離脱した。画像上で梗塞巣の拡大はみとめなかった。本例同様にWallenberg症候群の亜急性期に中枢性低換気を呈するものは少ないながら報告されており、亜急性期をふくめ注意深いバイタルサイン観察が必要である。(著者抄録)

    researchmap

    その他リンク: https://search.jamas.or.jp/index.php?module=Default&action=Link&pub_year=2014&ichushi_jid=J01550&link_issn=&doc_id=20140409340003&doc_link_id=130004921250&url=https%3A%2F%2Fci.nii.ac.jp%2Fnaid%2F130004921250&type=CiNii&icon=https%3A%2F%2Fjk04.jamas.or.jp%2Ficon%2F00003_1.gif

  • 脳卒中急性期における原発性アルドステロン症のスクリーニング

    宮地 洋輔, 山田 昌代, 中口 裕達, 南 太一, 角田 哲治, 佐々木 真由子, 川端 雄一, 関 俊輔, 森 健太郎, 上出 智也, 玉瀬 玲, 野村 素弘, 北村 佳久, 田中 章景

    日本内分泌学会雑誌   90 ( 1 )   326 - 326   2014年4月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本内分泌学会  

    researchmap

  • サーフィン後に異常行動で発症し両側椎骨動脈解離を認めた39歳男性例

    山浦 弦平, 仲野 達, 横山 睦美, 田中 章景, 小山 主夫

    臨床神経学   54 ( 3 )   254 - 254   2014年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 顔面の痙攣を伴った器質化慢性硬膜下血腫の74歳男性例

    大久保 正紀, 池田 真悟, 遠藤 雅直, 岸田 日帯, 島村 めぐみ, 篠原 禎雄, 間中 浩, 田中 章景

    臨床神経学   54 ( 3 )   252 - 252   2014年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 各種疾患 変性疾患 小脳障害と構音障害

    生井 友紀子, 田中 章景

    Annual Review神経   2014   199 - 205   2014年1月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)中外医学社  

    小脳障害症例における構音障害は,運動失調性構音(ataxic speech)とされ,患者のQOLに大きく関係する症状の一つである.構音機能の局在については未だ結論が得られていない.構音障害の特徴の検討は,他の神経疾患との鑑別や,障害の重症度の判定に役立つと考えられ,従来,発話の聴覚印象での評価が主に行われてきた.構音の異常の程度と発話の明瞭性(ことばの伝わり方)の程度が評価されるが,共にカテゴリー段階評価であり,評価者の熟練も必要である.近年発話の客観的評価として,音響分析や動作解析が試みられてきた.主に,単音節の反復繰り返し検査(oral diadochokinesis test:ODKT)の解析が中心である.しかし構音とは,コミュニケーションを前提としたものであり,言語により音もリズムも異なる.最近では文の発話についての詳細な音響解析も行われつつある.今後も構音の客観的評価によって小脳の機能や病態の研究に新たな展開が見られていくことが期待される.(著者抄録)

    researchmap

  • パーキンソン病患者の発声機能の検討

    生井 友紀子, 佐野 大佑, 百束 紘, 中村 治子, 東山 雄一, 田中 章景, 廣瀬 肇, 折舘 伸彦

    音声言語医学   55 ( 1 )   67 - 67   2014年1月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本音声言語医学会  

    researchmap

  • Neuronal intranuclear inclusion diseaseの生前診断

    曽根 淳, 北川 尚之, 岩崎 靖, 吉田 眞理, 田中 章景, 祖父江 元

    末梢神経   24 ( 2 )   428 - 428   2013年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本末梢神経学会  

    researchmap

  • SCARB2遺伝子に変異を認めた高齢発症の進行性ミオクローヌてんかん兄妹例

    東山 雄一, 土井 宏, 阿部 弘基, 中村 治子, 工藤 洋祐, 上木 英人, 児矢野 繁, 鈴木 ゆめ, 黒岩 義之, 松本 直通, 田中 章景

    臨床神経学   53 ( 12 )   1641 - 1641   2013年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • バクロフェン持続髄注療法4症例の検討

    島村 めぐみ, 岸田 日帯, 桃尾 隆之, 濱田 幸一, 菊地 尚久, 吉野 浩代, 田中 章景

    臨床神経学   53 ( 12 )   1635 - 1635   2013年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • パーキンソン病の発声障害と高次脳機能障害についての検討

    中村 治子, 生井 友紀子, 佐野 大佑, 東山 雄一, 工藤 洋祐, 上木 英人, 上田 直久, 児矢野 繁, 鈴木 ゆめ, 田中 章景

    臨床神経学   53 ( 12 )   1493 - 1493   2013年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • パーキンソン病患者における小脳体積の左右差について

    川本 裕子, 仲野 達, 田中 章景, 小山 主夫

    臨床神経学   53 ( 12 )   1615 - 1615   2013年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 病前スケールにより抽出される脳卒中部位の左右差と失語症

    川端 雄一, 山本 良央, 中江 啓晴, 田中 章景, 城倉 健

    臨床神経学   53 ( 12 )   1604 - 1604   2013年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 腹部CTによる内臓脂肪量と脳梗塞の発症機序との関連の検討

    桃尾 隆之, 橋口 俊太, 室橋 洋子, 遠藤 雅直, 島村 めぐみ, 田中 章景

    臨床神経学   53 ( 12 )   1600 - 1600   2013年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 急性期脳梗塞における経口抗血小板薬の出血合併症

    高橋 竜哉, 菅原 恵梨子, 齊藤 麻美, 田中 章景, 岡本 光生

    臨床神経学   53 ( 12 )   1598 - 1598   2013年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 多系統萎縮症の睡眠時呼吸に対するramelteon(melatonin受容体agonist)の安全性の検討

    釘本 千春, 窪田 瞬, 冨田 敦子, 平田 順一, 上田 直久, 土井 宏, 鈴木 ゆめ, 田中 章景

    臨床神経学   53 ( 12 )   1564 - 1564   2013年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 急性期脳卒中予後予測における上腕動脈血圧左右差の有用性

    池田 真悟, 杉山 美紀子, 岸田 日帯, 島村 めぐみ, 田中 章景

    臨床神経学   53 ( 12 )   1600 - 1600   2013年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 脳梗塞発症部位と脳梗塞急性期の不穏行動

    小山 主夫, 仲野 達, 川本 裕子, 出井 ふみ, 田中 章景

    臨床神経学   53 ( 12 )   1598 - 1598   2013年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 後方循環系梗塞に先行するTIAとめまい

    中江 啓晴, 川端 雄一, 山本 良央, 田中 章景, 城倉 健

    臨床神経学   53 ( 12 )   1524 - 1524   2013年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 脳卒中後のlate seizureの臨床像とMRIのarterial spin labelingの有用性

    宮地 洋輔, 三富 睦美, 田中 章景

    臨床神経学   53 ( 12 )   1513 - 1513   2013年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 多系統萎縮症と尿酸との関連性

    児矢野 繁, 鈴木 ゆめ, 田中 章景

    臨床神経学   53 ( 12 )   1564 - 1564   2013年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • Parkinson病外来患者における栄養状態の評価

    工藤 洋祐, 中村 治子, 上木 英人, 児矢野 繁, 田中 章景

    臨床神経学   53 ( 12 )   1561 - 1561   2013年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 多発性硬化症における脳脊髄液バイオマーカーの経時的変化

    高橋 慶太, 冨田 敦子, 土井 宏, 鈴木 ゆめ, 田中 章景

    臨床神経学   53 ( 12 )   1503 - 1503   2013年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 多発性硬化症におけるオリゴクローナルバンドの陰性例と陽性例の解析

    鈴木 ゆめ, 高橋 慶太, 冨田 敦子, 土井 宏, 田中 章景

    臨床神経学   53 ( 12 )   1503 - 1503   2013年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 髄液オリゴクローナルバンド陽性視神経脊髄炎類縁疾患の特徴

    岸田 日帯, 島村 めぐみ, 池田 真悟, 杉山 美紀子, 桃尾 隆之, 冨田 敦子, 田中 章景

    臨床神経学   53 ( 12 )   1503 - 1503   2013年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 劣性型脊髄小脳変性症・痙性対麻痺6例に対するエクソーム解析

    土井 宏, 鈴木 ゆめ, 松本 直通, 田中 章景

    臨床神経学   53 ( 12 )   1496 - 1496   2013年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • Parkinson病患者の語想起能力 Letter cue taskとCategory cus task

    菅原 恵梨子, 齊藤 麻美, 岡本 光生, 田中 章景, 高橋 竜哉

    臨床神経学   53 ( 12 )   1492 - 1492   2013年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • dynactin-1ノックアウトによる孤発性ALSモデルマウスの作成と病態解析

    河合 香里, 池中 建介, 勝野 雅央, 井口 洋平, 勝又 竜, 田中 章景, 祖父江 元

    臨床神経学   53 ( 12 )   1500 - 1500   2013年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 運動ニューロン特異的TDP-43ノックアウトマウスの病理学的検討

    井口 洋平, 勝野 雅央, 丹羽 淳一, 高木 伸之介, 山中 宏二, 三澤 日出巳, 高橋 良輔, 佐々木 彰一, 田中 章景, 祖父江 元

    臨床神経学   53 ( 12 )   1500 - 1500   2013年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 上部消化管悪性腫瘍を合併した脳血管障害の臨床的検討

    林 紀子, 田中 健一, 城村 裕司, 田中 章景, 岡田 雅仁

    臨床神経学   53 ( 12 )   1475 - 1475   2013年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 一過性脳虚血発作の可能性が小さいにもかかわらず抗血小板薬が中止できない症例の検討

    城村 裕司, 林 紀子, 田中 健一, 岡本 光生, 亀田 知明, 木村 活生, 中江 啓晴, 上田 直久, 田中 章景, 岡田 雅仁

    臨床神経学   53 ( 12 )   1474 - 1474   2013年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 神経疾患における視覚的感覚記憶の検討(予備研究)

    岡本 光生, 齊藤 麻美, 菅原 恵梨子, 田中 章景, 高橋 竜哉

    臨床神経学   53 ( 12 )   1486 - 1486   2013年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 脳梗塞患者におけるEPA/AA比と白質病変、microbleedsとの関連

    仲野 達, 川本 裕子, 田中 章景, 小山 主夫

    臨床神経学   53 ( 12 )   1478 - 1478   2013年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • シロスタゾール投与患者に対するアセトアミノフェン併用の有効性

    山本 良央, 川端 雄一, 中江 啓晴, 田中 章景, 城倉 健

    臨床神経学   53 ( 12 )   1474 - 1474   2013年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • CIDP、GBSにおける免疫グロブリン大量静注療法前後での電流知覚閾値(CPT)測定の有用性

    橋口 俊太, 室橋 洋子, 遠藤 雅直, 桃尾 隆之, 島村 めぐみ, 田中 章景

    臨床神経学   53 ( 12 )   1459 - 1459   2013年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • Branch atheromatous diseaseの治療法の検討

    田中 健一, 城村 裕司, 林 紀子, 田中 章景, 岡田 雅仁

    臨床神経学   53 ( 12 )   1474 - 1474   2013年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 渦巻き描記を用いた小脳性運動失調の他覚的評価法(第7報)

    上田 直久, 波木井 靖人, 黒岩 義之, 田中 章景

    臨床神経学   53 ( 12 )   1436 - 1436   2013年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • パーキンソン病における声の音声言語医学的解析

    生井 友紀子, 中村 治子, 東山 雄一, 佐野 大佑, 廣瀬 肇, 田中 章景

    臨床神経学   53 ( 12 )   1432 - 1432   2013年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • てんかんで入院加療をおこなった患者の臨床的特徴

    齊藤 麻美, 菅原 恵梨子, 岡本 光生, 田中 章景, 高橋 竜哉

    臨床神経学   53 ( 12 )   1453 - 1453   2013年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 神経変性疾患患者の脳MRIにおける年間萎縮率Annual Atrophic Rate(AAR)

    黒岩 義之, 堀 寛子, 川端 雄一, 橋口 俊太, 田中 章景, 児矢野 繁, 鈴木 ゆめ, 上田 直久, 上木 英人, 東山 雄一, 藤野 公裕, 黒川 隆史, 馬場 泰尚

    臨床神経学   53 ( 12 )   1437 - 1437   2013年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 悪性腫瘍を合併した脳梗塞の臨床的検討

    窪田 瞬, 高橋 慶太, 冨田 敦子, 平田 順一, 釘本 千春, 土井 宏, 上田 直久, 児矢野 繁, 鈴木 ゆめ, 田中 章景

    臨床神経学   53 ( 12 )   1417 - 1417   2013年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • Lewy小体型認知症および認知症を伴うParkinson病における脳MRI上の脳血管病変の検討

    上木 英人, 工藤 洋祐, 東山 雄一, 中村 治子, 児矢野 繁, 田中 章景

    臨床神経学   53 ( 12 )   1421 - 1421   2013年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 小脳障害により出現する方向固定性水平性眼振と方向交代性上向性眼振

    城倉 健, 中江 啓晴, 山本 良央, 川端 雄一, 田中 章景

    臨床神経学   53 ( 12 )   1420 - 1420   2013年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • Pseudoabducens palsyを伴ったplus-minus lid syndrome

    工藤 洋祐, 小島 昭雄, 黒岩 義之, 田中 章景, 城倉 健

    神経内科   79 ( 6 )   757 - 759   2013年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(有)科学評論社  

    症例は67歳女性で、トイレで動けなくなっているところを発見され、呂律が回らず左眼瞼が下がっており、救急外来を受診した。血圧は145/71mmHgで、心電図で心房細動を認めた。左眼は眼瞼下垂、瞳孔散大、内転・上転・不全下転障害を認め、核下動眼神経麻痺と診断した。右眼には眼瞼後退と上転障害を認め、眼瞼後退は左眼の眼瞼を用手的に挙上しても変化がなかった。正面視で軽度内転し、視標追試検査で外転障害を認めたが、前庭動眼反射を用いると外転した。他に軽度の構音障害と右不全麻痺を認めた。脳MRIでは拡散強調画像水平断で左中脳腹側および右後頭葉皮質に高信号を認め、冠状断で梗塞巣は左中脳から視床内部に及んでいた。心房細動による心原性脳塞栓、脳底動脈先端部症候群と診断し、エダラボン併用の抗凝固療法を施行した。第19病日に回復期リハビリテーション病院へ転院し、左動眼神経麻痺、右眼瞼後退、右外転制限、右不全片麻痺が残存していた。

    researchmap

  • 脳梗塞発症前に抗凝固療法を行われていた心房細動患者の特徴

    三富 睦美, 宮地 洋輔, 田中 章景

    臨床神経学   53 ( 12 )   1416 - 1416   2013年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 妊娠を契機に増悪した抗MuSK抗体陽性重症筋無力症患者には血液浄化療法が有効である

    池田 真悟, 吉田 日帯, 遠藤 雅直, 大久保 正紀, 島村 めぐみ, 田中 章景

    神経免疫学   18 ( 1 )   148 - 148   2013年11月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経免疫学会  

    researchmap

  • Corticobasal Syndrome CBSと関連する遺伝子変異

    土井 宏, 田中 章景

    臨床神経学   53 ( 11 )   1026 - 1028   2013年11月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    CBSの病理学的診断は多彩であり、遺伝学的背景も多彩である。病理学的には前頭側頭葉変性症(FTLD)である頻度がもっとも高く、他にAlzheimer病、Creutzfeldt-Jakob病、Parkinson病/Lewy小体型認知症などが挙げられる。FTLDの原因として頻度の高いMAPT、GRN、C9orf72変異やTARDBP、FUS、LRRK2、CSF1R変異例では臨床的にCBSを呈する可能性があることが欧米を中心に知られている。しかし日本人のCBS発症に関与する遺伝子については、単一遺伝子異常、疾患感受性遺伝子ともにまったくわかっておらず、今後多施設間で症例を集積、解析していく必要がある。(著者抄録)

    researchmap

    その他リンク: https://search.jamas.or.jp/index.php?module=Default&action=Link&pub_year=2013&ichushi_jid=J01550&link_issn=&doc_id=20140331470043&doc_link_id=130004505325&url=https%3A%2F%2Fci.nii.ac.jp%2Fnaid%2F130004505325&type=CiNii&icon=https%3A%2F%2Fjk04.jamas.or.jp%2Ficon%2F00003_1.gif

  • 片頭痛において疼痛過敏性を来す因子の検討 線維筋痛症圧痛点を用いた評価

    黒川 隆史, 藤野 公裕, 黒岩 義之, 馬場 泰尚, 田中 章景

    日本頭痛学会誌   40 ( 2 )   389 - 389   2013年11月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本頭痛学会  

    researchmap

  • 経静脈的免疫グロブリン療法を繰り返し行うも改善が乏しかった重症ギラン・バレー症候群の46歳男性例

    仲野 達, 山浦 弦平, 横山 睦美, 田中 章景, 小山 主夫

    神経免疫学   18 ( 1 )   150 - 150   2013年11月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経免疫学会  

    researchmap

  • Age-dependent alterations in the distribution of neurons expressing alpha-synuclein in macaque monkeys. 査読

    Kimura K, Inoue K, Tanaka F, Takada M

    Neuroscience 2013 (2013/11/9-11/13, San Diego, USA).   2013年11月

     詳細を見る

    記述言語:英語  

    researchmap

  • 下顎歯肉癌に対する超選択的動注療法後に失語症を呈した84歳男性例

    國井 美紗子, 工藤 洋祐, 冨田 敦子, 鈴木 ゆめ, 田中 章景

    臨床神経学   53 ( 10 )   852 - 852   2013年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 中大脳動脈水平部血管攣縮に対して塩酸ファスジル選択的動注療法が奏功した38歳女性例

    池田 真悟, 桃尾 隆之, 室橋 洋子, 島村 めぐみ, 間中 浩, 田中 章景

    臨床神経学   53 ( 10 )   874 - 874   2013年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 外傷を契機に亜急性に症状が出現した免疫介在性ニューロパチーの37歳男性例

    川本 裕子, 田丸 智彦, 仲野 達, 田中 章景, 小山 主夫

    臨床神経学   53 ( 10 )   863 - 863   2013年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 急性外眼筋麻痺の9年後にBickerstaff脳幹脳炎を発症した24歳男性例

    齊藤 麻美, 中村 治子, 東山 雄一, 工藤 洋祐, 上木 英人, 児矢野 繁, 鈴木 ゆめ, 田中 章景

    臨床神経学   53 ( 10 )   885 - 885   2013年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • ステロイド反応性の両側顔面神経麻痺と大血管壁肥厚を認めたCogan症候群の63歳男性例

    草間 香里, 川本 裕子, 仲野 達, 山浦 弦平, 三富 睦美, 田中 章景, 小山 主夫

    臨床神経学   53 ( 10 )   882 - 882   2013年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 抗SGPG IgG抗体陽性、抗MAG/SGPG IgM抗体陰性のIgM M蛋白血症にともなう多発ニューロパチーの1例

    中村 治子, 遠藤 雅直, 菅原 恵梨子, 桑原 基, 楠 進, 田中 章景, 高橋 竜哉

    臨床神経学   53 ( 10 )   799 - 802   2013年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    症例は84歳男性である。左顔面、四肢遠位優位の感覚障害を呈した。神経伝導検査上遠位潜時の延長がめだたないが、CMAP、SNAPの振幅が低下していた。血液検査でIgM型M蛋白血症、抗SGPG IgG抗体をみとめ、抗SGPG抗体関連ニューロパチーと診断した。抗MAG IgG、IgM抗体、抗SGPG IgM抗体陰性である点が、既報告の抗MAG/SGPG IgM抗体陽性の多発ニューロパチーと異なった。IgM型M蛋白血症における抗MAG活性を持たない抗SGPG IgG抗体陽性の多発ニューロパチーの報告はなく貴重な症例と考えられた。(著者抄録)

    researchmap

    その他リンク: https://search.jamas.or.jp/index.php?module=Default&action=Link&pub_year=2013&ichushi_jid=J01550&link_issn=&doc_id=20131007350001&doc_link_id=40019827649&url=https%3A%2F%2Fci.nii.ac.jp%2Fnaid%2F40019827649&type=CiNii&icon=https%3A%2F%2Fjk04.jamas.or.jp%2Ficon%2F00003_1.gif

  • 副腎皮質ステロイド不応性で多発白質病変を認めた中枢神経原発悪性リンパ腫の71歳男性例

    橋口 俊太, 桃尾 隆之, 室橋 洋子, 遠藤 雅直, 島村 めぐみ, 川崎 隆, 田中 章景

    臨床神経学   53 ( 10 )   855 - 855   2013年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 【認知症と高次脳機能】認知症と視覚機能

    黒岩 義之, 藤野 公裕, 黒川 隆史, 馬場 泰尚, 田中 章景

    神経眼科   30 ( 3 )   242 - 252   2013年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本神経眼科学会  

    認知症を伴う神経変性疾患には、アルツハイマー病(AD)、Lewy小体型認知症(DLB)、Parkinson病(PD)、前頭側頭型認知症(FTD)、Machado-Joseph病、進行性核上性麻痺(PSP)、大脳皮質基底核変性症(CBD)などがある。それらの典型例は、それぞれ特徴的な症状を呈する。ADでは記銘力障害、視空間認知障害、遂行機能障害、視覚型ADの視覚性注意障害、DLBでは変動する意欲低下、鮮やかな幻視や錯視、色覚や錯綜図認知の障害、PDでは幻視や視覚性疲労、FTDでは人格障害や情緒障害、人物や物品の意味記憶障害、意味性認知症、PSPでは核上性の下方視障害のための二次的視野狭窄、CBDでは半側空間無視、構成障害、着衣障害などの空間性操作障害に加え、失語症や非対称性のパーキンソニズムが特徴的な症状である。頭部外傷、進行麻痺、脳血管障害、脳腫瘍、Creutzfeldt-Jakob病、側頭葉てんかんなど神経変性疾患以外の疾患でも認知症は出現する。血管性認知症では、アパシー、抑うつが高頻度にみられ、ADに比較して妄想は少ない。アルコール中毒でも幻視が見られる。幻視、皮膚症状、振戦、眼球運動異常、精神症状が見られる場合はナイアシン欠乏症、すなわちペラグラ脳症を考える。ニコチン酸投与で改善する。シャルル・ボネ症候群は、それまで精神的に問題のなかった高齢者に、白内障などによる長期的な視力低下の後、人物や動物、建物や景色等の幻がありありと見える症状を呈する。シャルル・ボネ症候群には認知症への移行例もある。視覚機能障害は感覚系視覚機能障害(sensory visual dysfunction)、知覚系視覚機能障害(perceptive visual dysfunction)、認知・情動系視覚機能障害(cognitive/emotional visual dysfunction)の3つに分けられる。脳波と視覚刺激に対する中枢神経系の電気的反応である「視覚誘発電位(visual evoked potentials;VEPs)」は、認知症患者の視覚機能を非侵襲的に評価する上で有用である。VEPsは感覚系視覚誘発電位(sensory VEPs)、知覚系視覚誘発電位(perceptive VEPs)、認知・情動系視覚誘発電位(cognitive/emotional VEPs)の3つに分類できる。感覚系VEPsには網膜電図のa/b波(30〜60ms;起源は光受容体細胞や網膜神経節細胞)や大脳誘発電位のC1(50〜90ms;起源はV1)が含まれ、これらは"non-attentional components"である。知覚系VEPsには大脳誘発電位のP1/N1(80〜190ms;起源はextrastriate cortex・V1)やN2(240〜320ms;起源はV4・V8)が含まれる。P1/N1は"visuospatial attention"や"depth perception"と関わり、N2は"non-spatial attention"や"feature-specific channels(色、動き、空間周波数など)"と関わる。認知・情動系VEPsにはmiss match negativityや事象関連電位のP3(300〜450ms;起源はbitemporal cortex)が含まれ、"attentional resources"と関わる。画像検査は認知症患者の視覚機能障害の責任病巣を評価する上で有用であり、MRIによる形態画像と脳血流SPECTによる機能画像がある。MRI上、形態的にADでは海馬、FTDでは前頭葉や側頭葉が萎縮するが、PDやDLBでは明らかな萎縮を認めない傾向にある。ADにおける血流低下は後部帯状回あるいは楔前部に始まり、認知機能の低下と共に側頭頭頂連合野に及ぶ。DLBにおける血流低下は後頭葉の視覚野あるいは視覚連合野に、FTDにおける血流低下は前頭葉や側頭葉に認められる。結論として、視覚情報処理は大脳皮質の広範な部位で行われており、認知症患者ではその障害されるパターンにより、様々な特徴を備えた視覚機能障害がみられ、これらを評価することが重要といえる。(著者抄録)

    researchmap

  • MEPM耐性PRSPに対し集学的治療を行い救命し得た1例

    山浦 弦平, 仲野 達, 横山 睦美, 田中 章景, 小山 主夫

    NEUROINFECTION   18 ( 2 )   180 - 180   2013年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本神経感染症学会  

    researchmap

  • 皮膚生検により診断したneuronal intranuclear inclusion diseaseの症例

    曽根 淳, 祖父江 元, 北川 尚之, 田中 章景, 岩崎 靖, 吉田 眞理

    臨床神経学   53 ( 9 )   762 - 762   2013年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 【プリオン病-up to date】ヒトのプリオン病 洗浄・滅菌法の現状と展望

    岸田 日帯, 黒岩 義之, 田中 章景

    Clinical Neuroscience   31 ( 9 )   1041 - 1043   2013年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)中外医学社  

    researchmap

  • ブリオン病の最近の進歩 プリオン病の感染予防

    岸田 日帯, 田中 章景, 黒岩 義之

    NEUROINFECTION   18 ( 1 )   48 - 53   2013年8月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本神経感染症学会  

    researchmap

  • 横浜市立大学における学生症例検討会(学生CPC)の経験

    長嶋 洋治, 青木 一郎, 大橋 健一, 石ヶ坪 良明, 梅村 敏, 寺内 康夫, 前田 慎, 田中 章景, 益田 宗孝, 遠藤 格, 後藤 英司

    医学教育   44 ( Suppl. )   150 - 150   2013年7月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本医学教育学会  

    researchmap

  • 【Depressionの神経学】セロトニン神経系とdepression Parkinson病におけるうつを中心に

    中村 昭子, 島村 めぐみ, 田中 章景

    神経内科   79 ( 1 )   18 - 23   2013年7月

     詳細を見る

    記述言語:日本語   出版者・発行元:(有)科学評論社  

    researchmap

  • 小脳症状単独で発症しcodon M232R変異を認めたCreutzfeldt-Jakob病の66歳男性例

    橋口 俊太, 桃尾 隆之, 遠藤 雅直, 島村 めぐみ, 田中 章景

    臨床神経学   53 ( 6 )   493 - 493   2013年6月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • マカクザルにおけるアルファシヌクレイン発現ニューロンの加齢による分布変化 査読

    木村活生, 井上謙一, 黒田呈子, 田中章景, 高田昌彦

    第36回日本神経科学大会(2013/6/20-23, 京都)   2013年6月

     詳細を見る

    記述言語:日本語  

    researchmap

  • 【小脳の神経学】 小脳と高次脳機能

    東山 雄一, 田中 章景

    神経内科   78 ( 6 )   667 - 673   2013年6月

     詳細を見る

    記述言語:日本語   出版者・発行元:(有)科学評論社  

    researchmap

  • SCARB2遺伝子に変異を認めた進行性ミオクローヌスてんかんの58歳女性例

    東山 雄一, 土井 宏, 上木 英人, 黒岩 義之, 田中 章景

    臨床神経学   53 ( 6 )   497 - 497   2013年6月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • けいれん重積で発症し、123I-iomazenil(IMZ)SPECTで左大脳半球広範に集積低下を認め、髄液抗GluR抗体陽性であった73歳女性例

    仲野 達, 川本 裕子, 小山 主夫, 高橋 幸利, 田中 章景

    臨床神経学   53 ( 6 )   494 - 494   2013年6月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 【小脳の神経学】小脳・橋の年間脳萎縮率 多系統萎縮症患者でのMRI計測から

    黒岩 義之, 堀 寛子, 川端 雄一, 橋口 俊太, 田中 章景

    神経内科   78 ( 6 )   695 - 699   2013年6月

     詳細を見る

    記述言語:日本語   出版者・発行元:(有)科学評論社  

    researchmap

  • 【小脳の神経学】小脳性運動失調の他覚的評価法

    上田 直久, 田中 章景

    神経内科   78 ( 6 )   683 - 686   2013年6月

     詳細を見る

    記述言語:日本語   出版者・発行元:(有)科学評論社  

    researchmap

  • 孤発性ALS新規疾患モデルの作成と軸索輸送・オートファジーを標的とした治療法開発

    田中 章景

    横浜医学   64 ( 2 )   73 - 78   2013年4月

     詳細を見る

    記述言語:日本語   出版者・発行元:横浜市立大学医学会  

    CiNii Books

    researchmap

    その他リンク: http://search.jamas.or.jp/link/ui/2014062222

  • 【次世代シーケンサーによる神経変性疾患の解析と展望】ALSのパーソナルゲノム解析

    田中 章景, 曽根 淳, 熱田 直樹, 中村 亮一, 土井 宏, 児矢野 繁, 祖父江 元

    BRAIN and NERVE: 神経研究の進歩   65 ( 3 )   257 - 265   2013年3月

  • 【Corticobasal Syndrome】 CBSと関連する遺伝子変異

    土井 宏, 田中 章景

    BRAIN and NERVE: 神経研究の進歩   65 ( 1 )   19 - 30   2013年1月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)医学書院  

    大脳皮質基底核症候群(CBS)を呈する個々の疾患、特に主たる原因疾患である前頭側頭葉変性症(FTLD)を中心に、遺伝的背景について概説した。FTLDは蓄積タンパク質からFTLD-tau、FTLD-TDP、FTLD-UPSなどに分類される。FTLD-tauではMAPT、FTLD-TDPではGRN、C9orf72、VCP、FTLD-UPSではCHMP2Bなどの遺伝子変異が報告されている。アルツハイマー病、パーキンソン病/レビー小体型認知症、クロイツフェルト・ヤコブ病についても述べた。

    researchmap

  • 病態に根ざしたALSの新規治療法開発 TDP-43の機能変調による運動神経変性機序の解明

    山中宏二, 築地仁美, 渡辺祥司, 金子貢巳, 古屋亜佐子, 井口洋平, 熱田直樹, 田中章景, 祖父江元, 初田裕幸, 村山繁雄, 赤津博康, 橋詰良夫

    神経変性疾患に関する調査研究班分科班「病態に根ざしたALSの新規治療法開発」 平成24年度 研究報告書   2013年

     詳細を見る

  • Translational research on disease-modifying therapies for neurodegenerative diseases. 招待 査読

    Katsuno M, Watanabe H, Tanaka F, Sobue G

    Neurology and Clinical Neuroscience   1   3-10   2013年

     詳細を見る

    記述言語:英語   掲載種別:記事・総説・解説・論説等(学術雑誌)  

    DOI: 10.1002/ncn3.7

    researchmap

  • 病態に根ざしたALSの新規治療法開発 変異SOD1(G93A)マウスにおけるc‐Abl阻害剤の治療効果

    祖父江元, 勝又竜, 石垣診祐, 勝野雅央, 河合香織, 曽根淳, 足立弘明, 田中章景

    神経変性疾患に関する調査研究班分科班「病態に根ざしたALSの新規治療法開発」 平成24年度 研究報告書   18 - 21   2013年

     詳細を見る

    記述言語:日本語  

    J-GLOBAL

    researchmap

  • Dementia and visual function

    Yoshiyuki Kuroiwa, Kimihiro Fujino, Takashi Kurokawa, Yasuhisa Baba, Fumiaki Tanaka

    Neuro-Ophthalmology Japan   30 ( 3 )   242 - 252   2013年

     詳細を見る

    記述言語:日本語   掲載種別:書評論文,書評,文献紹介等  

    Neurodegenerative diseases with dementia include Alzheimer's disease (AD), dementia with Lewy body (DLB), Parkinson's disease (PD), frontotemporal dementia (FTD), Machado-Joseph disease (MJD), progressive supranuclear palsy (PSP), and corticobasal degeneration (CBD). These dementias are often associated with visual symptoms. Characteristic occurrences of visual dysfunctions are recognized as visual attention impairment in AD, vivid hallucination in DLB and PD, narrowed visual fields secondary to supranuclear downward gaze palsy in PSP, and hemispatial neglect in CBD. Dementia due to non-degenerative diseases of the brain is also often associated with visual symptoms, for example in head injury, neurosyphilis, stroke, brain tumor, and temporal lobe epilepsy. Visual hallucination is also seen in excessive alcohol drinking, and in pellagra. Visual symptoms are often an initial sign of progressive dementia in Creutzfeldt-Jakob disease. Visual dysfunctions are classified into three categories
    impaired sensory visual function, impaired perceptive visual function, and impaired cognitive/emotional visual function. Non-invasive measurements of electroencephalograms, and visual evoked potentials (VEPs) are useful for evaluating attentional or cognitive functions in patients with dementia. VEPs are classified into three categories
    sensory VEPs, perceptive VEPs, and cognitive/emotional VEPs. Sensory VEPs are related to non-attentional visual function. Sensory VEPs are a/b waves of eletroretinograms (30-60ms) originated from photoreceptor cells and retinal ganglion cells, and Cl wave (50-90ms) originated from V1 cortex. Perceptive VEPs are P1/N1 waves (80-190ms) originated from extrastriate and V1 cortex, and N2 wave (240-320ms) originated from V4 and V8 cortex. P1/N1 waves are related to visuospatial attention and depth perception, while N2 wave is related to non-spatial attention and feature-specific channels. Cognitive/emotional VEPs are related to attentional resources, and are miss match negativity and P3 wave of event-related potentials (300-450ms) originated from bitemporal cortex. Neuroimaging tests are useful for evaluating cerebral lesions which are responsible for visual dysfunctions in patients with dementia, and consist of structural (MRI) and functional (SPECT) imaging studies. MRI shows brain atrophy at the hippocampus in AD, and at the frontotemporal lobes in FTD, while brain atrophy is usually not apparent in DLB and PD. SPECT shows reduced cerebral blood flow (CBF) initially at the posterior cingulated gyrus, and at the precuneus, and later at the temporoparietal association cortex. CBF is often reduced at the visual cortex or the visual association cortex in DLB, and at the frontotemporal lobes in FTD. In conclusion, it is important for clinicians to evaluate visual dysfunctions resulting from impaired visual information processing of the brain in patients with dementia.

    Scopus

    researchmap

  • Neuronal intranuclear inclusion diseaseの原因遺伝子探索

    曽根淳, 田中章景, 北川尚之, 鈴木穣, 菅野純夫, 森下真一, 祖父江元

    日本神経学会学術大会プログラム・抄録集   54th ( 12 )   381 - 1495   2013年

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    J-GLOBAL

    researchmap

  • ナラトリプタンは球脊髄性筋萎縮症(SBMA)の病態を改善する

    南山 誠, 勝野 雅央, 足立 弘明, 土井 英樹, 近藤 直英, 田中 章景, 祖父江 元, 栗原 裕基

    臨床神経学   52 ( 12 )   1447 - 1447   2012年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • GJB1変異を伴うCMTX25例の検討

    樋口 雄二郎, 中村 友紀, 橋口 昭大, 徳永 章子, 岡本 裕嗣, 高嶋 博, 小池 春樹, 田中 章景, 祖父江 元

    臨床神経学   52 ( 12 )   1618 - 1618   2012年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • ALSにおけるFUS/TLSの質的機能喪失と病態 FUS/TLSの核内高分子複合体の機能解析から

    石垣 診祐, 藤岡 祐介, 田中 章景, 祖父江 元

    臨床神経学   52 ( 12 )   1603 - 1603   2012年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 多施設共同ALS患者コホートにおける上位運動ニューロン症候を呈さない例の臨床像

    熱田 直樹, 中村 亮一, 渡辺 はづき, 渡辺 宏久, 伊藤 瑞規, 千田 譲, 田中 章景, 梶 龍兒, 森田 光哉, 和泉 唯信, 青木 正志, 溝口 功一, 谷口 彰, 岡本 幸市, 饗場 郁子, 川田 明広, 長谷川 一子, 大垣 光太郎, 中野 今治, 祖父江 元

    臨床神経学   52 ( 12 )   1483 - 1483   2012年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • ALS患者の縦断像 JaCALSからの解析

    中村 亮一, 熱田 直樹, 渡辺 はづき, 千田 譲, 伊藤 瑞規, 渡辺 宏久, 田中 章景, 梶 龍兒, 和泉 唯信, 森田 光哉, 青木 正志, 溝口 功一, 谷口 彰, 岡本 幸市, 饗場 郁子, 川田 明広, 長谷川 一子, 大垣 光太郎, 中野 今治, 祖父江 元

    臨床神経学   52 ( 12 )   1519 - 1519   2012年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • dynactin-1ノックアウトによる孤発性ALSモデルマウスの作成と病態解析

    河合 香里, 池中 建介, 勝又 竜, 井口 洋平, 勝野 雅央, 田中 章景, 祖父江 元

    臨床神経学   52 ( 12 )   1519 - 1519   2012年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 筋萎縮性側索硬化症、及びそのモデルマウスの腰髄におけるリン酸化Cofilinの評価

    勝又 竜, 勝野 雅央, 田中 章景, 祖父江 元

    臨床神経学   52 ( 12 )   1518 - 1518   2012年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 孤発性筋萎縮性側索硬化症患者ゲノムのCNV(copy number variation)解析(第5報)

    佐藤 秀則, 加藤 丈夫, 江見 充, 小山 信吾, 荒若 繁樹, 和田 学, 川並 透, 片桐 忠, 圓谷 建治, 豊島 至, 田中 章景, 祖父江 元, 松原 謙一

    臨床神経学   52 ( 12 )   1602 - 1602   2012年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • miR-196aはSBMAにおいて異常AR mRNAの不安定化を促進し表現型を有意に改善させる

    宮崎 雄, 足立 弘明, 勝野 雅央, 南山 誠, 蒋 月梅, 土井 英樹, 松本 慎二郎, 近藤 直英, 飯田 円, 藤内 玄規, 田中 章景, 村松 慎一, 祖父江 元

    臨床神経学   52 ( 12 )   1483 - 1483   2012年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • TDP-43の凝集体形成におけるRNA結合障害の関与

    高木 伸之介, 井口 洋平, 石垣 診祐, 勝野 雅央, 田中 章景, 祖父江 元

    臨床神経学   52 ( 12 )   1448 - 1448   2012年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 球脊髄性筋萎縮症におけるFK506 binding protein 1a(FKBP12)の病態への関与

    足立 弘明, 土井 英樹, 勝野 雅央, 南山 誠, 松本 慎二郎, 近藤 直英, 宮崎 雄, 飯田 円, 藤内 玄規, 田中 章景, 祖父江 元

    臨床神経学   52 ( 12 )   1518 - 1518   2012年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 運動ニューロン特異的TDP-43ノックアウトマウスの病態解析

    井口 洋平, 勝野 雅央, 丹羽 淳一, 高木 伸之介, 田中 章景, 祖父江 元

    臨床神経学   52 ( 12 )   1518 - 1518   2012年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 球脊髄性筋萎縮症の病態におけるCDKの関与

    勝野 雅央, 足立 弘明, 南山 誠, 土井 英樹, 近藤 直英, 松本 慎二郎, 宮崎 雄, 飯田 円, 田中 章景, 祖父江 元

    臨床神経学   52 ( 12 )   1447 - 1447   2012年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • Hsf-1は球脊髄性筋萎縮症の病変分布に影響を及ぼす

    近藤 直英, 勝野 雅央, 足立 弘明, 南山 誠, 土井 英樹, 松本 慎二郎, 宮崎 雄, 飯田 円, 田中 章景, 祖父江 元

    臨床神経学   52 ( 12 )   1447 - 1447   2012年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 球脊髄性筋萎縮症モデルにおけるp62の役割

    土井 英樹, 足立 弘明, 勝野 雅央, 南山 誠, 松本 慎二郎, 近藤 直英, 宮崎 雄, 飯田 円, 藤内 玄規, 田中 章景, 祖父江 元

    臨床神経学   52 ( 12 )   1447 - 1447   2012年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 医食農同源の取組み 生活習慣病対策と食育(食事) 認知症の治療と予防

    田中 章景

    神奈川県公衆衛生学会誌   ( 58 )   10 - 10   2012年11月

     詳細を見る

    記述言語:日本語   出版者・発行元:神奈川県公衆衛生協会  

    researchmap

  • CGRP1 is the new therapeutic target for SBMA (Spinal and Bulbar Muscular Atrophy)

    M. Minamiyama, M. Katsuno, H. Adachi, H. Doi, N. Kondo, M. Iida, S. Ishigaki, Y. Fujioka, S. Matsumoto, Y. Miyazaki, F. Tanaka, H. Kurihara, G. Sobue

    JOURNAL OF NEUROCHEMISTRY   123   106 - 106   2012年10月

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:WILEY-BLACKWELL  

    Web of Science

    researchmap

  • 神経変性疾患のトランスレーショナルリサーチ

    勝野 雅央, 坂野 晴彦, 鈴木 啓介, 橋詰 淳, 足立 弘明, 田中 章景, 祖父江 元

    日本内科学会雑誌   101 ( 9 )   2533 - 2538   2012年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:The Japanese Society of Internal Medicine  

    DOI: 10.2169/naika.101.2533

    CiNii Books

    researchmap

  • 神経疾患治療の進歩2011年 運動ニューロン疾患の治療の進歩

    田中章景, 井口洋平, 池中建介, 石垣診祐, 勝野雅央, 祖父江元

    神経治療学   29 ( 4 )   401-403   2012年7月

     詳細を見る

    記述言語:日本語  

    J-GLOBAL

    researchmap

  • 各種病態モデルと創薬研究 1.神経疾患 5)球脊髄性筋萎縮症(SBMA)モデルマウスを用いた抗アンドロゲン療法の開発

    勝野雅央, 坂野晴彦, 鈴木啓介, 足立弘明, 田中章景, 祖父江元

    遺伝子医学MOOK   ( 22 )   87-92,12   2012年7月

     詳細を見る

    記述言語:日本語  

    J-GLOBAL

    researchmap

  • Microarray Analysis in Spinal Cords of Sporadic ALS Patients with Cell-Type Specific Transcriptome

    Hirofumi Yamashita, Noriko Fujimori, Hidefumi Ito, Yohei Iguchi, Naoki Atsuta, Fumiaki Tanaka, Gen Sobue, Ryosuke Takahashi, Koji Yamanaka

    NEUROLOGY   78   2012年4月

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:LIPPINCOTT WILLIAMS & WILKINS  

    Web of Science

    researchmap

  • Differential change of clinical outcome measures in spinal and bulbar muscular atrophy: comparison of natural history with placebo-treated group. 査読

    Hashizume A, Katsuno M, Banno H, Suzuki K, Suga N, Tanaka F, Sobue G

    J Neurol.   259   712-719   2012年

     詳細を見る

    記述言語:英語   掲載種別:速報,短報,研究ノート等(学術雑誌)  

    researchmap

  • Current Status of Treatment of Spinal and Bulbar Muscular Atrophy

    Fumiaki Tanaka, Masahisa Katsuno, Haruhiko Banno, Keisuke Suzuki, Hiroaki Adachi, Gen Sobue

    NEURAL PLASTICITY   2012年

     詳細を見る

    記述言語:英語   掲載種別:書評論文,書評,文献紹介等   出版者・発行元:HINDAWI PUBLISHING CORPORATION  

    Spinal and bulbar muscular atrophy (SBMA) is the first member identified among polyglutamine diseases characterized by slowly progressive muscle weakness and atrophy of the bulbar, facial, and limb muscles pathologically associated with motor neuron loss in the spinal cord and brainstem. Androgen receptor (AR), a disease-causing protein of SBMA, is a well-characterized ligand-activated transcription factor, and androgen binding induces nuclear translocation, conformational change and recruitment of coregulators for transactivation of AR target genes. Some therapeutic strategies for SBMA are based on these native functions of AR. Since ligand-induced nuclear translocation of mutant AR has been shown to be a critical step in motor neuron degeneration in SBMA, androgen deprivation therapies using leuprorelin and dutasteride have been developed and translated into clinical trials. Although the results of these trials are inconclusive, renewed clinical trials with more sophisticated design might prove the effectiveness of hormonal intervention in the near future. Furthermore, based on the normal function of AR, therapies targeted for conformational changes of AR including amino-terminal (N) and carboxy-terminal (C) (N/C) interaction and transcriptional coregulators might be promising. Other treatments targeted for mitochondrial function, ubiquitin-proteasome system (UPS), and autophagy could be applicable for all types of polyglutamine diseases.

    DOI: 10.1155/2012/369284

    Web of Science

    researchmap

  • NIID(エオジン好性核内封入体病)の核内封入体に関する検討

    曽根 淳, 田中 章景, 祖父江 元, 吉田 眞理

    臨床神経学   51 ( 12 )   1359 - 1359   2011年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • MPZ変異を伴うCMT11例の検討

    中村 友紀, 橋口 昭大, 徳永 章子, 岡本 裕嗣, 高嶋 博, 小池 春樹, 田中 章景, 祖父江 元

    臨床神経学   51 ( 12 )   1455 - 1455   2011年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 孤発性ALSにおけるFUSの病理学的特徴

    高木 伸之介, 井口 洋平, 勝野 雅央, 田中 章景, 祖父江 元

    臨床神経学   51 ( 12 )   1444 - 1444   2011年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • CIDPにおける無髄線維に関連したSchwann細胞の形態の検討

    両角 佐織, 小池 春樹, 橋本 里奈, 冨田 稔, 川頭 祐一, 飯島 正博, 山本 正彦, 田中 章景, 祖父江 元

    臨床神経学   51 ( 12 )   1457 - 1457   2011年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • GJB1変異を伴うCMTX17例の検討

    樋口 雄二郎, 橋口 昭大, 岡本 裕嗣, 高嶋 博, 小池 春樹, 田中 章景, 祖父江 元

    臨床神経学   51 ( 12 )   1456 - 1456   2011年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 球脊髄性筋萎縮症モデルマウスにおける異常蛋白凝集の病理学的分布はHsf-1の影響を受ける

    近藤 直英, 勝野 雅央, 足立 弘明, 南山 誠, 土井 英樹, 松本 慎二郎, 宮崎 雄, 田中 章景, 祖父江 元

    臨床神経学   51 ( 12 )   1440 - 1440   2011年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 球脊髄性筋萎縮症モデルにおけるペオニ抽出物の治療効果

    藤内 玄規, 足立 弘明, 勝野 雅央, 南山 誠, 土井 英樹, 松本 慎二郎, 近藤 直英, 宮崎 雄, 田中 章景, 大塚 健三, 祖父江 元

    臨床神経学   51 ( 12 )   1440 - 1440   2011年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 球脊髄性筋萎縮症(SBMA)病態関連遺伝子CGRP1の分子機構

    南山 誠, 勝野 雅央, 足立 弘明, 土井 英樹, 近藤 直英, 田中 章景, 祖父江 元, 栗原 裕基

    臨床神経学   51 ( 12 )   1440 - 1440   2011年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 球脊髄性筋萎縮症モデルにおけるp62の役割

    土井 英樹, 足立 弘明, 勝野 雅央, 南山 誠, 松本 慎二郎, 近藤 直英, 宮崎 雄, 田中 章景, 祖父江 元

    臨床神経学   51 ( 12 )   1440 - 1440   2011年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • c-Abl阻害剤によるG93A-mouseでの治療効果の検討

    勝又 竜, 田中 章景, 祖父江 元

    臨床神経学   51 ( 12 )   1439 - 1439   2011年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • dynactin-1ノックダウンによる孤発性ALS線虫モデルの作成と病態解析

    池中 建介, 河合 香里, 黄 哲, 蒋 月梅, 勝又 竜, 勝野 雅央, 田中 章景, 祖父江 元

    臨床神経学   51 ( 12 )   1361 - 1361   2011年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 非集積地の高齢発症型FAP ATTR Val30Metの自然歴に関する検討

    小池 春樹, 橋本 里奈, 冨田 稔, 両角 佐織, 川頭 祐一, 飯島 正博, 山本 正彦, 田中 章景, 祖父江 元

    末梢神経   22 ( 2 )   334 - 335   2011年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本末梢神経学会  

    researchmap

  • 運動ニューロンにおけるALS関連変異FUS/TLSの機能障害

    石垣 診祐, 藤岡 祐介, 田中 章景, 祖父江 元

    臨床神経学   51 ( 12 )   1315 - 1315   2011年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 家族歴を認めないFAP ATTR Val30Metの臨床病理の検討

    小池 春樹, 橋本 里奈, 冨田 稔, 両角 佐織, 川頭 祐一, 飯島 正博, 山本 正彦, 田中 章景, 祖父江 元

    臨床神経学   51 ( 12 )   1305 - 1305   2011年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • SCA1モデルマウスにおける17-DMAGの病態抑止と効果のおよびその機序の検討

    松本 慎二郎, 足立 弘明, 勝野 雅央, 南山 誠, 土井 英樹, 近藤 直英, 藤内 玄規, 宮崎 雄, 田中 章景, 祖父江 元

    臨床神経学   51 ( 12 )   1358 - 1358   2011年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 球脊髄性筋萎縮症モデルのHGF単独療法と抗アンドロゲン療法との混合療法

    足立 弘明, 勝野 雅央, 南山 誠, 土井 英樹, 松本 慎二郎, 近藤 直英, 宮崎 雄, 藤内 玄規, 田中 章景, 船越 洋, 祖父江 元

    臨床神経学   51 ( 12 )   1317 - 1317   2011年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 孤発性筋萎縮性側索硬化症(SALS)におけるIDI1/2遺伝子領域のコピー数変化

    加藤 丈夫, 江見 充, 佐藤 秀則, 荒若 繁樹, 和田 学, 川並 透, 片桐 忠, 圓谷 建治, 豊島 至, 田中 章景, 祖父江 元, 松原 謙一

    臨床神経学   51 ( 12 )   1227 - 1227   2011年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 細胞特異的トランスクリプトームを用いた、孤発性ALS患者脊髄のDNAマイクロアレイによる解析

    山下 博史, 藤森 典子, 片岡 礼音, 井口 洋平, 熱田 直樹, 田中 章景, 祖父江 元, 山中 宏二

    臨床神経学   51 ( 12 )   1226 - 1226   2011年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 非集積地の高齢発症FAP ATTR Val30Metの腓腹神経病理所見

    沖 祐美子, 小池 春樹, 橋本 里奈, 冨田 稔, 両角 佐織, 川頭 祐一, 飯島 正博, 山本 正彦, 田中 章景, 祖父江 元

    臨床神経学   51 ( 12 )   1290 - 1290   2011年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 非集積地の高齢発症型FAP ATTR Val30Metの自然歴に関する検討

    杉浦 真, 小池 春樹, 橋本 里奈, 冨田 稔, 両角 佐織, 川頭 祐一, 飯島 正博, 山本 正彦, 田中 章景, 祖父江 元

    臨床神経学   51 ( 12 )   1290 - 1290   2011年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 神経内科領域における前方向的コホート研究から見えてきたもの JaCALS ALSの進行、予後規定因子

    熱田 直樹, 中村 亮一, 渡辺 はづき, 渡辺 宏久, 伊藤 瑞規, 千田 譲, 田中 章景, 祖父江 元

    臨床神経学   51 ( 11 )   903 - 905   2011年11月

  • 運動ニューロン疾患の分子病態の解明と治療法開発への展望 ALSにおける軸索輸送の役割 dynactin-1を標的とした孤発性ALSモデルの開発

    田中 章景, 池中 建介, 祖父江 元

    臨床神経学   51 ( 11 )   1189 - 1191   2011年11月

  • ダイナクチンノックダウン線虫を用いた孤発性ALS軸索輸送障害モデルの作成と解析(Dynactin-1 knock-down C.elegans is a novel sporadic amyotrophic lateral sclerosis (SALS) model simulating axonal transport defect and motor neuron degeneration)

    池中 建介, 河合 香里, 黄 哲, 蒋 月梅, 勝野 雅央, 田中 章景, 祖父江 元

    神経化学   50 ( 2-3 )   171 - 171   2011年9月

     詳細を見る

    記述言語:英語   出版者・発行元:日本神経化学会  

    researchmap

  • DIAGNOSIS OF SPORADIC TRANSTHYRETIN VAL30MET FAMILIAL AMYLOIND POLNEUROPATHY: A PRACTICAL ANALYSIS

    H. Koike, R. Hashimoto, M. Tomita, Y. Kawagashira, M. Iijima, F. Tanaka, G. Sobue

    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM   16   S69 - S69   2011年9月

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:WILEY-BLACKWELL  

    Web of Science

    researchmap

  • GENE EXPRESSION ANALYSIS OF BIOPSIED NERVES IN JAPANESE CHRONIC INFLAMMATORY DEMYELINATING POLYNEURPATHY PATIENTS

    M. Iijima, H. Koike, Y. Kawagashira, M. Tomita, R. Hashimoto, F. Tanaka, G. Sobue

    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM   16   S59 - S59   2011年9月

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:WILEY-BLACKWELL  

    Web of Science

    researchmap

  • ELECTRON MICROSCOPIC FINDINGS OF POEMS SYNDROME: ANALYSIS OF LONGITUDINAL SECTIONS

    R. Hashimoto, M. Tomita, Y. Kawagashira, M. Iijima, H. Koike, F. Tanaka, G. Sobue

    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM   16   S53 - S53   2011年9月

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:WILEY-BLACKWELL  

    Web of Science

    researchmap

  • 神経疾患治療の進歩2010年 運動ニューロン疾患の治療の進歩

    田中章景, 井口洋平, 石垣診祐, 勝野雅央, 祖父江元

    神経治療学   28 ( 4 )   367-369 - 369   2011年7月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経治療学会  

    筋萎縮性側索硬化症に対する治療はリルゾールの有効性が示されて以来、新たな治療法は確立されていないが、治療標的の候補が次々と明らかになり多くの臨床試験が進行中である。その一部を紹介した。1)グルタミン酸を標的とする治療法、2)熱ショック蛋白質を標的とする治療法、3)免疫療法、4)RNAを標的とする治療法、5)ミトコンドリアを標的とする治療法、6)神経栄養因子を標的とする治療法、7)幹細胞治療。

    J-GLOBAL

    researchmap

  • シャルコー・マリー・トゥース病200例のマイクロアレイDNAチップによる遺伝子診断

    橋口 昭大, 徳永 章子, 中村 友紀, 岡本 裕嗣, 有村 公良, 小池 春樹, 田中 章景, 祖父江 元, 高嶋 博

    末梢神経 = Peripheral nerve   22 ( 1 )   64 - 71   2011年6月

     詳細を見る

    記述言語:日本語  

    CiNii Books

    researchmap

  • 家族性アミロイドポリニューロパチー自験3例の検討

    酒井 竜一郎, 出井 里佳, 岩井 克成, 杢野 謙次, 冨田 稔, 飯島 正博, 小池 春樹, 田中 章景, 祖父江 元

    臨床神経学   51 ( 4 )   293 - 293   2011年4月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • Oxidative stress induced by glutathione depletion reproduces pathological modifications of TDP-43

    Yohei Iguchi, Masahisa Katsuno, Shinnosuke Takagi, Fumiaki Tanaka, Gen Sobue

    NEUROSCIENCE RESEARCH   71   E192 - E193   2011年

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:ELSEVIER IRELAND LTD  

    DOI: 10.1016/j.neures.2011.07.832

    Web of Science

    researchmap

  • Endoscopic third ventriculotomy improves Parkinsonism following a ventriculo-peritoneal shunt in a patient with non communicating hydrocephalus secondary to idiopathic aqueduct stenosis 査読

    Hashizume, A., Watanabe, H., Matsuo, K., Katsuno, M., Tanaka, F., Nagatani, T., Sobue, G.

    Journal of the Neurological Sciences   309 ( 1-2 )   148-50   2011年

     詳細を見る

  • Skin biopsy is useful for the antemortem diagnosis of neuronal intranuclear inclusion disease 査読

    Sone, J., Tanaka, F., Koike, H., Inukai, A., Katsuno, M., Yoshida, M., Watanabe, H., Sobue, G.

    Neurology   76 ( 16 )   1372-6   2011年

     詳細を見る

  • Molecular pathology of SBMA (spinal and bulbar muscular atrophy) related gene CGRP1

    Makoto Minamiyama, Masahisa Katsuno, Hiroaki Adachi, Hideki Doi, Naohide Kondou, Fumiaki Tanaka, Gen Sobue, Hiroki Kurihara

    NEUROSCIENCE RESEARCH   71   E292 - E292   2011年

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:ELSEVIER IRELAND LTD  

    DOI: 10.1016/j.neures.2011.07.1275

    Web of Science

    researchmap

  • Medical induction of stress response alleviates polyglutamine-mediated motor neuron disease

    Genki Tohnai, Hiroaki Adachi, Masahisa Katsuno, Makoto Minamiyama, Hideki Doi, Shinjiro Matsumoto, Naohide Kondo, Fumiaki Tanaka, Kenzo Ohtsuka, Gen Sobue

    NEUROSCIENCE RESEARCH   71   E293 - E293   2011年

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:ELSEVIER IRELAND LTD  

    DOI: 10.1016/j.neures.2011.07.1278

    Web of Science

    researchmap

  • Central nervous system involvement in n-hexane polyneuropathy demonstrated by MRI and proton MR spectroscopy 査読

    Hashizume, A., Koike, H., Kawagashira, Y., Banno, H., Suzuki, K., Ito, M., Katsuno, M., Watanabe, H., Tanaka, F., Naganawa, S., Kaneko, R., Ishii, A., Sobue, G.

    Clinical Neurology and Neurosurgery   113 ( 6 )   493-5   2011年

     詳細を見る

  • Overexpression of HGF exerts symptom-relief therapeutic effects in the SBMA transgenic mice treated with an anti-androgen therapy

    Hiroaki Adachi, Masahisa Katsuno, Makoto Minamiyama, Hideki Doi, Shinjiro Matsumoto, Naohide Kondo, Yu Miyazaki, Genki Tohnai, Fumiaki Tanaka, Hiroshi Funakoshi, Gen Sobue

    NEUROSCIENCE RESEARCH   71   E193 - E194   2011年

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:ELSEVIER IRELAND LTD  

    DOI: 10.1016/j.neures.2011.07.837

    Web of Science

    researchmap

  • Dynactin-1 knock-down C. elegans model of sporadic ALS

    Kensuke Ikenaka, Kaori Kawai, Zhe Huang, Yue-Mei Jiang, Masahiro Katsuno, Fumiaki Tanaka, Gen Sobue

    NEUROSCIENCE RESEARCH   71   E118 - E118   2011年

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:ELSEVIER IRELAND LTD  

    DOI: 10.1016/j.neures.2011.07.504

    Web of Science

    researchmap

  • Microarray analysis in spinal cords of sporadic ALS patients with cell-type specific transcriptome

    Hirofumi Yamashita, Noriko Fujimori, Ayane Kataoka, Yohei Iguchi, Naoki Atsuta, Fumiaki Tanaka, Gen Sobue, Hidefumi Ito, Ryosuke Takahashi, Koji Yamanaka

    NEUROSCIENCE RESEARCH   71   E292 - E292   2011年

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:ELSEVIER IRELAND LTD  

    DOI: 10.1016/j.neures.2011.07.1276

    Web of Science

    researchmap

  • Cell cycle dysregulation in spinal and bulbar muscular atrophy (SBMA)

    Masahisa Katsuno, Hiroaki Adachi, Makoto Minamiyama, Naohide Kondo, Hideki Doi, Shin-jiro Matsumoto, Yu Miyazaki, Fumiaki Tanaka, Gen Sobue

    NEUROSCIENCE RESEARCH   71   E292 - E293   2011年

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:ELSEVIER IRELAND LTD  

    DOI: 10.1016/j.neures.2011.07.1277

    Web of Science

    researchmap

  • Heat shock factor-1 (Hsf-1) influences distribution of pathogenic androgen receptor aggregations in model mouse of spinal and bulbar muscular atrophy (SBMA)

    Naohide Kondo, Masahisa Katsuno, Hiroaki Adachi, Makoto Minamiyama, Hideki Doi, Shinjiro Matsumoto, Yu Miyazaki, Madoka Iida, Fumiaki Tanaka, Gen Sobue

    NEUROSCIENCE RESEARCH   71   E293 - E294   2011年

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:ELSEVIER IRELAND LTD  

    DOI: 10.1016/j.neures.2011.07.1281

    Web of Science

    researchmap

  • 家族歴を認めないFAP ATTR Val30 Metの臨床病理の検討

    小池 春樹, 橋本 里奈, 冨田 稔, 両角 佐織, 川頭 祐一, 飯島 正博, 山本 正彦, 田中 章景, 祖父江 元

    末梢神経   21 ( 2 )   346 - 347   2010年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本末梢神経学会  

    researchmap

  • 球脊髄性筋萎縮症モデルにおける抗アンドロゲン療法とHGF高発現の混合療法の効果

    松本 慎二郎, 足立 弘明, 勝野 雅央, 南山 誠, 土井 英樹, 近藤 直英, 田中 章景, 船越 洋, 祖父江 元

    臨床神経学   50 ( 12 )   1232 - 1232   2010年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 球脊髄性筋萎縮症モデルにおけるペオニ抽出物の治療効果

    足立 弘明, 藤内 玄規, 勝野 雅央, 南山 誠, 土井 英樹, 松本 慎二郎, 近藤 直英, 田中 章景, 大塚 健三, 祖父江 元

    臨床神経学   50 ( 12 )   1232 - 1232   2010年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 肥厚型CIDPの臨床的特徴 病理所見、治療反応性の検討

    両角 佐織, 冨田 稔, 川頭 祐一, 飯島 正博, 小池 春樹, 田中 章景, 祖父江 元

    臨床神経学   50 ( 12 )   1204 - 1204   2010年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 神経細胞におけるTDP-43のloss-of-functionの検討

    井口 洋平, 勝野 雅央, 丹羽 淳一, 高木 伸之介, 足立 弘明, 田中 章景, 貝淵 弘三, 祖父江 元

    臨床神経学   50 ( 12 )   1199 - 1199   2010年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 神経変性疾患におけるdynactin-1と細胞周期関連分子の発現解析

    池中 建介, 蒋 月梅, 田中 章景, 勝又 竜, 河合 香里, 黄 哲, 勝野 雅央, 山本 正彦, 祖父江 元

    臨床神経学   50 ( 12 )   1160 - 1160   2010年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 球脊髄性筋萎縮症(SBMA)の病態関連遺伝子CGRP1の解析と治療標的検討

    南山 誠, 勝野 雅央, 足立 弘明, 和座 雅浩, 土井 英樹, 松本 慎二郎, 近藤 直英, 田中 章景, 祖父江 元, 栗原 裕基

    臨床神経学   50 ( 12 )   1160 - 1160   2010年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 家族性NIHID(エオジン好性核内封入体病)の生前診断に関する検討

    曽根 淳, 田中 章景, 祖父江 元, 吉田 眞理, 橋詰 良夫

    臨床神経学   50 ( 12 )   1195 - 1195   2010年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • マイクロアレイDNAチップによるCharcot-Marie-Tooth病の遺伝子診断

    徳永 章子, 橋口 昭大, 岡本 裕嗣, 中村 友紀, 有村 公良, 高嶋 博, 祖父江 元, 小池 春樹, 田中 章景, 山本 正彦, 中川 正法

    臨床神経学   50 ( 12 )   1165 - 1165   2010年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • Dynactin-1ノックダウン線虫における神経変性

    田中 章景, 黄 哲, 勝又 竜, 池中 建介, 河合 香里, 蒋 月梅, 和座 雅浩, 勝野 雅央, 祖父江 元

    臨床神経学   50 ( 12 )   1127 - 1127   2010年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • FAP ATTR Val30Met孤発例の臨床病理の検討

    小池 春樹, 冨田 稔, 両角 佐織, 川頭 祐一, 飯島 正博, 山本 正彦, 田中 章景, 祖父江 元

    臨床神経学   50 ( 12 )   1086 - 1086   2010年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 球脊髄性筋萎縮症モデルにおけるp62の役割

    土井 英樹, 足立 弘明, 勝野 雅央, 南山 誠, 松本 慎二郎, 近藤 直英, 田中 章景, 祖父江 元

    臨床神経学   50 ( 12 )   1128 - 1128   2010年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 球脊髄性筋萎縮症(SBMA)モデルマウスにおけるHsf-1の組織分布

    近藤 直英, 勝野 雅央, 足立 弘明, 南山 誠, 土井 英樹, 松本 慎二郎, 田中 章景, 祖父江 元

    臨床神経学   50 ( 12 )   1127 - 1127   2010年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • Segmental copy-number gain within the region of isopentenyl diphosphate isomerase genes in sporadic amyotrophic lateral sclerosis. 国際誌

    Takeo Kato, Mitsuru Emi, Hidenori Sato, Shigeki Arawaka, Manabu Wada, Toru Kawanami, Tadashi Katagiri, Kenji Tsuburaya, Itaru Toyoshima, Fumiaki Tanaka, Gen Sobue, Kenichi Matsubara

    Biochemical and biophysical research communications   402 ( 2 )   438 - 42   2010年11月

     詳細を見る

    記述言語:英語   出版者・発行元:ACADEMIC PRESS INC ELSEVIER SCIENCE  

    AIMS: Sporadic amyotrophic lateral sclerosis (SALS) seems to be a multifactorial disease, the pathogenesis of which may involve both genetic and environmental factors. The present study aims at identifying a possible genetic change that confers risk for SALS. METHODS: We performed whole-genome screening of a copy-number variation (CNV) using a CNV beadchip, followed by real-time quantitative polymerase chain reaction (qPCR) and region-targeted high-density oligonucleotide tiling microarray. RESULTS: Within the 40-kb region on 10p15.3 subtelomere, which harbours two genes encoding isopentenyl diphosphate isomerase 1 (IDI1) and IDI2, we found a segmental copy-number gain in a large proportion of SALS patients. qPCR analysis demonstrated the copy-number gain in 46 out of 83 SALS patients, as compared with 10 out of 99 controls (p=4.86×10(-11), Odds Ratio 10.8); subsequent tiling microarray validated qPCR results and elucidated the fine structure of segmental gains. CONCLUSIONS: A segmental copy-number gain in the IDI1/IDI2 gene region may play a significant role in the pathogenesis of SALS.

    DOI: 10.1016/j.bbrc.2010.10.056

    Web of Science

    PubMed

    researchmap

  • Morphological Progression of Myelin Abnormalities in IgM-Monoclonal Gammopathy of Undetermined Significance Anti-Myelin-Associated Glycoprotein Neuropathy

    Yuichi Kawagashira, Haruki Koike, Minoru Tomita, Saori Morozumi, Masahiro Iijima, Tomohiko Nakamura, Masahisa Katsuno, Fumiaki Tanaka, Gen Sobue

    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY   69 ( 11 )   1143 - 1157   2010年11月

     詳細を見る

    記述言語:英語   出版者・発行元:LIPPINCOTT WILLIAMS & WILKINS  

    To characterize the morphological progression of neuropathy associated with immunoglobulin M-monoclonal gammopathy of undetermined significance with anti-myelin-associated glycoprotein antibody, we assessed histopathologic features of sural nerve specimens from 15 patients, emphasizing widely spaced myelin (WSM), demyelination, and tomaculous changes. The frequency of WSM correlated with that of demyelination and tomaculous appearance in teased-fiber preparations. In longitudinal sections at nodes of Ranvier and paranodal regions, the spaces between terminal myelin loops, particularly those adjacent to the node of Ranvier, were widened, indicating an early change before demyelination, and there was concomitant swelling of terminal myelin loops. Some conspicuously swollen terminal myelin loops were detached from the paranodal axolemma, thereby widening the nodes of Ranvier. Tomacula coexisted frequently with redundant myelin loops and WSM, particularly in the outermost layer of myelin sheaths, suggesting that loosening of the outer layers contributes to their formation. By immunofluorescence microscopy, immunoglobulin M and myelin-associated glycoprotein were colocalized in paranodal regions and Schmidt-Lanterman incisures. Confocal analysis revealed colocalization of immunoglobulin M and complement product C3d corresponding to the area of WSM. Thus, morphological changes in terminal myelin loops, formation of WSM at paranodes, and subsequent dissociation from paranodal axolemma (which may be associated with activation of the complement pathway) likely contribute to demyelination in this condition. Loosening of compact myelin seems to contribute to tomacula formation.

    DOI: 10.1097/NEN.0b013e3181fa44af

    Web of Science

    researchmap

  • Morphological progression of myelin abnormalities in IgM-monoclonal gammopathy of undetermined significance anti-myelin-associated glycoprotein neuropathy. 国際誌

    Yuichi Kawagashira, Haruki Koike, Minoru Tomita, Saori Morozumi, Masahiro Iijima, Tomohiko Nakamura, Masahisa Katsuno, Fumiaki Tanaka, Gen Sobue

    Journal of neuropathology and experimental neurology   69 ( 11 )   1143 - 57   2010年11月

     詳細を見る

    記述言語:英語   出版者・発行元:LIPPINCOTT WILLIAMS & WILKINS  

    To characterize the morphological progression of neuropathy associated with immunoglobulin M-monoclonal gammopathy of undetermined significance with anti-myelin-associated glycoprotein antibody, we assessed histopathologic features of sural nerve specimens from 15 patients, emphasizing widely spaced myelin (WSM), demyelination, and tomaculous changes. The frequency of WSM correlated with that of demyelination and tomaculous appearance in teased-fiber preparations. In longitudinal sections at nodes of Ranvier and paranodal regions, the spaces between terminal myelin loops, particularly those adjacent to the node of Ranvier, were widened, indicating an early change before demyelination, and there was concomitant swelling of terminal myelin loops. Some conspicuously swollen terminal myelin loops were detached from the paranodal axolemma, thereby widening the nodes of Ranvier. Tomacula coexisted frequently with redundant myelin loops and WSM, particularly in the outermost layer of myelin sheaths, suggesting that loosening of the outer layers contributes to their formation. By immunofluorescence microscopy, immunoglobulin M and myelin-associated glycoprotein were colocalized in paranodal regions and Schmidt-Lanterman incisures. Confocal analysis revealed colocalization of immunoglobulin M and complement product C3d corresponding to the area of WSM. Thus, morphological changes in terminal myelin loops, formation of WSM at paranodes, and subsequent dissociation from paranodal axolemma (which may be associated with activation of the complement pathway) likely contribute to demyelination in this condition. Loosening of compact myelin seems to contribute to tomacula formation.

    DOI: 10.1097/NEN.0b013e3181fa44af

    Web of Science

    PubMed

    researchmap

  • Segmental copy-number gain within the region of isopentenyl diphosphate isomerase genes in sporadic amyotrophic lateral sclerosis

    Takeo Kato, Mitsuru Emi, Hidenori Sato, Shigeki Arawaka, Manabu Wada, Toru Kawanami, Tadashi Katagiri, Kenji Tsuburaya, Itaru Toyoshima, Fumiaki Tanaka, Gen Sobue, Kenichi Matsubara

    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS   402 ( 2 )   438 - 442   2010年11月

     詳細を見る

    記述言語:英語   出版者・発行元:ACADEMIC PRESS INC ELSEVIER SCIENCE  

    Aims: Sporadic amyotrophic lateral sclerosis (SALS) seems to be a multifactorial disease, the pathogenesis of which may involve both genetic and environmental factors. The present study aims at identifying a possible genetic change that confers risk for SALS. Methods: We performed whole-genome screening of a copy-number variation (CNV) using a CNV beadchip, followed by real-time quantitative polymerase chain reaction (qPCR) and region-targeted high-density oligonucleotide tiling microarray. Results: Within the 40-kb region on 10p15.3 subtelomere, which harbours two genes encoding isopentenyl diphosphate isomerase 1 (IDI1) and IDI2, we found a segmental copy-number gain in a large proportion of SALS patients. qPCR analysis demonstrated the copy-number gain in 46 out of 83 SALS patients, as compared with 10 out of 99 controls (p =4.86 x 10(-11), Odds Ratio 10.8); subsequent tiling microarray validated qPCR results and elucidated the fine structure of segmental gains. Conclusions: A segmental copy-number gain in the IDI1/IDI2 gene region may play a significant role in the pathogenesis of SALS. (C) 2010 Elsevier Inc. All rights reserved.

    DOI: 10.1016/j.bbrc.2010.10.056

    Web of Science

    PubMed

    researchmap

  • Putaminal magnetic resonance imaging features at various magnetic field strengths in multiple system atrophy. 国際誌

    Hirohisa Watanabe, Mizuki Ito, Hiroshi Fukatsu, Jo Senda, Naoki Atsuta, Tomotsugu Kaga, Shigetaka Kato, Masahisa Katsuno, Fumiaki Tanaka, Masaaki Hirayama, Shinji Naganawa, Gen Sobue

    Movement disorders : official journal of the Movement Disorder Society   25 ( 12 )   1916 - 23   2010年9月

     詳細を見る

    記述言語:英語   出版者・発行元:WILEY-LISS  

    We delineated the effects of magnetic field strength on signal intensities to facilitate the specific findings of multiple system atrophy (MSA). Fifteen patients with probable MSA were imaged by 0.35T fast spin-echo (FSE), 1.5T FSE, and 3.0T FSE using a consistent protocol, testing all field strengths on the same day. Sixty patients with probable Parkinson's disease (PD) also underwent imaging. Moderate or marked hyperintensity at the dorsolateral outer putaminal margin, hyperintensity of the putaminal body, hypointensity relative to the globus pallidus at the dorsolateral putaminal margin, and infratentorial signal changes were evaluated as specific findings for MSA. As the field strength increased, the occurrence of hyperintensity both at the dorsolateral outer putaminal margin and of the putaminal body decreased, while the occurrence of hypointensity at the dorsolateral putaminal margin increased in MSA. The occurrence of uniform mild hyperintensity of the outer putaminal margin was evident in 7% at 0.35T, 40% at 1.5T, and 47% at 3.0T in MSA and in 5% at 0.35T, 60% at 1.5T, and 75% at 3.0T in PD. However, no PD patients showed hyperintensity at the dorsolateral outer putaminal margin and that of the putaminal body. Putaminal magnetic resonance imaging (MRI) findings in MSA were altered considerably by magnetic field strength. The severity and distribution of signal changes are important for assessing putaminal MRI findings in MSA.

    DOI: 10.1002/mds.23196

    Web of Science

    PubMed

    researchmap

  • Skin biopsy is available tool for antemortem diagnosis of Neuronal intranuclear hyaline inclusion disease

    J. Sone, F. Tanaka, G. Sobue

    BRAIN PATHOLOGY   20   96 - 96   2010年9月

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:WILEY-BLACKWELL PUBLISHING, INC  

    Web of Science

    researchmap

  • Putaminal Magnetic Resonance Imaging Features at Various Magnetic Field Strengths in Multiple System Atrophy

    Hirohisa Watanabe, Mizuki Ito, Hiroshi Fukatsu, Jo Senda, Naoki Atsuta, Tomotsugu Kaga, Shigetaka Kato, Masahisa Katsuno, Fumiaki Tanaka, Masaaki Hirayama, Shinji Naganawa, Gen Sobue

    MOVEMENT DISORDERS   25 ( 12 )   1916 - 1923   2010年9月

     詳細を見る

    記述言語:英語   出版者・発行元:WILEY-LISS  

    We delineated the effects of magnetic field strength on signal intensities to facilitate the specific findings of multiple system atrophy (MSA). Fifteen patients with probable MSA were imaged by 0.35T fast spin-echo (FSE), 1.5T FSE, and 3.0T FSE using a consistent protocol, testing all field strengths on the same day. Sixty patients with probable Parkinson&apos;s disease (PD) also underwent imaging. Moderate or marked hyperintensity at the dorsolateral outer putaminal margin, hyperintensity of the putaminal body, hypointensity relative to the globus pallidus at the dorsolateral putaminal margin, and infratentorial signal changes were evaluated as specific findings for MSA. As the field strength increased, the occurrence of hyperintensity both at the dorsolateral outer putaminal margin and of the putaminal body decreased, while the occurrence of hypointensity at the dorsolateral putaminal margin increased in MSA. The occurrence of uniform mild hyperintensity of the outer putaminal margin was evident in 7% at 0.35T, 40% at 1.5T, and 47% at 3.0T in MSA and in 5% at 0.35T, 60% at 1.5T, and 75% at 3.0T in PD. However, no PD patients showed hyperintensity at the dorsolateral outer putaminal margin and that of the putaminal body. Putaminal magnetic resonance imaging (MRI) findings in MSA were altered considerably by magnetic field strength. The severity and distribution of signal changes are important for assessing putaminal MRI findings in MSA. (C) 2010 Movement Disorder Society

    DOI: 10.1002/mds.23196

    Web of Science

    researchmap

  • Efficacy and safety of leuprorelin in patients with spinal and bulbar muscular atrophy (JASMITT study): a multicentre, randomised, double-blind, placebo-controlled trial. 国際誌

    Masahisa Katsuno, Haruhiko Banno, Keisuke Suzuki, Yu Takeuchi, Motoshi Kawashima, Ichiro Yabe, Hidenao Sasaki, Masashi Aoki, Mitsuya Morita, Imaharu Nakano, Kazuaki Kanai, Shoichi Ito, Kinya Ishikawa, Hidehiro Mizusawa, Tomotaka Yamamoto, Shoji Tsuji, Kazuko Hasegawa, Takayoshi Shimohata, Masatoyo Nishizawa, Hiroaki Miyajima, Fumio Kanda, Yasuhiro Watanabe, Kenji Nakashima, Akira Tsujino, Taro Yamashita, Makoto Uchino, Yasushi Fujimoto, Fumiaki Tanaka, Gen Sobue

    The Lancet. Neurology   9 ( 9 )   875 - 84   2010年9月

     詳細を見る

    記述言語:英語   出版者・発行元:ELSEVIER SCIENCE INC  

    BACKGROUND: Spinal and bulbar muscular atrophy is a hereditary motor neuron disease caused by the expansion of a polyglutamine tract in the androgen receptor. At present there are no treatments for spinal and bulbar muscular atrophy, although leuprorelin suppressed the accumulation of pathogenic androgen receptors in a phase 2 trial. We aimed to assess the efficacy and safety of leuprorelin for spinal and bulbar muscular atrophy. METHODS: The Japan SBMA Interventional Trial for TAP-144-SR (JASMITT) was a 48-week, randomised, double-blind, placebo-controlled trial done at 14 hospitals between August, 2006, and March, 2008. Patients with spinal and bulbar muscular atrophy were randomly assigned (1:1) by minimisation to subcutaneous 11.25 mg leuprorelin or identical placebo every 12 weeks. Patients and investigators were masked to treatment allocation. The primary endpoint was pharyngeal barium residue, which indicates incomplete bolus clearance, measured at week 48 by videofluorography. All patients who were randomly assigned and who were assessed with videofluorography at least once were included in the analyses. This study is registered with the JMACCT clinical trials registry, number JMA-IIA00009, and the UMIN clinical trials registry, number UMIN000000465. FINDINGS: 204 patients were randomly assigned and 199 started treatment: 100 with leuprorelin and 99 with placebo. At week 48, the pharyngeal barium residue after initial swallowing had changed by -5.1% (SD 21.0) in the leuprorelin group and by 0.2% (18.2) in the placebo group (difference between groups -5.3%; 95% CI -10.8 to 0.3; p=0.063). The mean difference in pharyngeal barium residue after piecemeal deglutition at week 48 was -3.2% (-6.4 to 0.0; p=0.049), but there was no significant difference between the groups after covariate adjustment for the baseline data (-4.1 to 1.6; p=0.392). In a predefined subgroup analysis, leuprorelin treatment was associated with a greater reduction in barium residue after initial swallowing than was placebo in patients with a disease duration less than 10 years (difference between groups -9.8, -17.1 to -2.5; p=0.009). There were no significant differences in the number of drug-related adverse events between groups (57 of 100 in the leuprorelin group and 54 of 99 in the placebo group; p=0.727). INTERPRETATION: 48 weeks of treatment with leuprorelin did not show significant effects on swallowing function in patients with spinal and bulbar muscular atrophy, although it was well tolerated. Disease duration might influence the efficacy of leuprorelin and thus further clinical trials with sensitive outcome measures should be done in subpopulations of patients. FUNDING: Large Scale Clinical Trial Network Project, Japan and Takeda Pharmaceuticals.

    DOI: 10.1016/S1474-4422(10)70182-4

    Web of Science

    PubMed

    researchmap

  • IgM MGUS anti-MAG neuropathy with predominant muscle weakness and extensive muscle atrophy. 国際誌

    Yuichi Kawagashira, Naohide Kondo, Naoki Atsuta, Masahiro Iijima, Haruki Koike, Masahisa Katsuno, Fumiaki Tanaka, Susumu Kusunoki, Gen Sobue

    Muscle & nerve   42 ( 3 )   433 - 5   2010年9月

     詳細を見る

    記述言語:英語   出版者・発行元:JOHN WILEY & SONS INC  

    We report a patient with anti-myelin-associated glycoprotein (MAG) neuropathy, predominantly exhibiting severe motor symptoms, accompanied by extensive muscle atrophy mimicking Charcot-Marie-Tooth disease. Nerve conduction studies revealed mild retardation of motor conduction velocities and significant prolongation of distal latency. Sural nerve biopsy revealed widely spaced myelin and positive staining of myelinated fibers with an IgM antibody. Predominant motor symptoms with muscle atrophy can be one of the clinical manifestations of anti-MAG neuropathy.

    DOI: 10.1002/mus.21741

    Web of Science

    PubMed

    researchmap

  • IgM MGUS ANTI-MAG NEUROPATHY WITH PREDOMINANT MUSCLE WEAKNESS AND EXTENSIVE MUSCLE ATROPHY

    Yuichi Kawagashira, Naohide Kondo, Naoki Atsuta, Masahiro Iijima, Haruki Koike, Masahisa Katsuno, Fumiaki Tanaka, Susumu Kusunoki, Gen Sobue

    MUSCLE & NERVE   42 ( 3 )   433 - 435   2010年9月

     詳細を見る

    記述言語:英語   出版者・発行元:JOHN WILEY & SONS INC  

    We report a patient with anti-myelin-associated glycoprotein (MAG) neuropathy, predominantly exhibiting severe motor symptoms, accompanied by extensive muscle atrophy mimicking Charcot-Marie-Tooth disease. Nerve conduction studies revealed mild retardation of motor conduction velocities and significant prolongation of distal latency. Sural nerve biopsy revealed widely spaced myelin and positive staining of myelinated fibers with an IgM antibody. Predominant motor symptoms with muscle atrophy can be one of the clinical manifestations of anti-MAG neuropathy. Muscle Nerve 42: 433-435, 2010

    DOI: 10.1002/mus.21741

    Web of Science

    researchmap

  • Efficacy and safety of leuprorelin in patients with spinal and bulbar muscular atrophy (JASMITT study): a multicentre, randomised, double-blind, placebo-controlled trial

    Masahisa Katsuno, Haruhiko Banno, Keisuke Suzuki, Yu Takeuchi, Motoshi Kawashima, Ichiro Yabe, Hidenao Sasaki, Masashi Aoki, Mitsuya Morita, Imaharu Nakano, Kazuaki Kanai, Shoichi Ito, Kinya Ishikawa, Hidehiro Mizusawa, Tomotaka Yamamoto, Shoji Tsuji, Kazuko Hasegawa, Takayoshi Shimohata, Masatoyo Nishizawa, Hiroaki Miyajima, Fumio Kanda, Yasuhiro Watanabe, Kenji Nakashima, Akira Tsujino, Taro Yamashita, Makoto Uchino, Yasushi Fujimoto, Fumiaki Tanaka, Gen Sobue

    LANCET NEUROLOGY   9 ( 9 )   875 - 884   2010年9月

     詳細を見る

    記述言語:英語   出版者・発行元:ELSEVIER SCIENCE INC  

    Background Spinal and bulbar muscular atrophy is a hereditary motor neuron disease caused by the expansion of a polyglutamine tract in the androgen receptor. At present there are no treatments for spinal and bulbar muscular atrophy, although leuprorelin suppressed the accumulation of pathogenic androgen receptors in a phase 2 trial. We aimed to assess the efficacy and safety of leuprorelin for spinal and bulbar muscular atrophy.
    Methods The Japan SBMA Interventional Trial for TAP-144-SR (JASMITT) was a 48-week, randomised, double-blind, placebo-controlled trial done at 14 hospitals between August, 2006, and March, 2008. Patients with spinal and bulbar muscular atrophy were randomly assigned (1:1) by minimisation to subcutaneous 11.25 mg leuprorelin or identical placebo every 12 weeks. Patients and investigators were masked to treatment allocation. The primary endpoint was pharyngeal barium residue, which indicates incomplete bolus clearance, measured at week 48 by videofluorography. All patients who were randomly assigned and who were assessed with videofluorography at least once were included in the analyses. This study is registered with the JMACCT clinical trials registry, number JMA-IIA00009, and the UMIN clinical trials registry, number UMIN000000465.
    Findings 204 patients were randomly assigned and 199 started treatment: 100 with leuprorelin and 99 with placebo. At week 48, the pharyngeal barium residue after initial swallowing had changed by -5.1% (SD 21.0) in the leuprorelin group and by 0.2% (18.2) in the placebo group (difference between groups -5.3%; 95% CI -10.8 to 0.3; p=0.063). The mean difference in pharyngeal barium residue after piecemeal deglutition at week 48 was -3.2% (-6.4 to 0.0; p=0.049), but there was no significant difference between the groups after covariate adjustment for the baseline data (-4.1 to 1.6; p=0.392). In a predefined subgroup analysis, leuprorelin treatment was associated with a greater reduction in barium residue after initial swallowing than was placebo in patients with a disease duration less than 10 years (difference between groups -9.8, -17.1 to -2.5; p=0.009). There were no significant differences in the number of drug-related adverse events between groups (57 of 100 in the leuprorelin group and 54 of 99 in the placebo group; p=0.727).
    Interpretation 48 weeks of treatment with leuprorelin did not show significant effects on swallowing function in patients with spinal and bulbar muscular atrophy, although it was well tolerated. Disease duration might influence the efficacy of leuprorelin and thus further clinical trials with sensitive outcome measures should be done in subpopulations of patients.

    DOI: 10.1016/S1474-4422(10)70182-4

    Web of Science

    researchmap

  • SBMAモデルにおけるペオニ抽出物の治療効果(A peony extract alleviates polyglutamine-mediated motor neuron disease)

    藤内 玄規, 足立 弘明, 勝野 雅央, 南山 誠, 和座 雅浩, 土井 英樹, 田中 章景, 大塚 健三, 祖父江 元

    神経化学   49 ( 2-3 )   671 - 671   2010年8月

     詳細を見る

    記述言語:英語   出版者・発行元:日本神経化学会  

    researchmap

  • 球脊髄性筋萎縮症(SBMA)モデルマウスの病変分布はHsf-1の影響を受ける(Distribution of pathogenic androgen receptor aggregations is influenced by heat shock factor-1 in model mouse of spinal and bulbar muscle atrophy (SBMA))

    近藤 直英, 勝野 雅央, 足立 弘明, 南山 誠, 土井 英樹, 松本 慎二郎, 田中 章景, 祖父江 元

    神経化学   49 ( 2-3 )   672 - 672   2010年8月

     詳細を見る

    記述言語:英語   出版者・発行元:日本神経化学会  

    researchmap

  • 【神経疾患治療の進歩2009年】運動ニューロン疾患の治療の進歩

    田中 章景, 井口 洋平, 熱田 直樹, 勝野 雅央, 祖父江 元

    神経治療学   27 ( 4 )   521 - 524   2010年7月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経治療学会  

    researchmap

  • 【内科疾患の診断基準 病型分類・重症度】診断メモ 脊髄性筋萎縮症

    田中 章景, 祖父江 元

    内科   105 ( 6 )   1393 - 1393   2010年6月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)南江堂  

    researchmap

  • 【内科疾患の診断基準 病型分類・重症度】神経・筋 運動ニューロン疾患

    田中 章景, 熱田 直樹, 祖父江 元

    内科   105 ( 6 )   1348 - 1351   2010年6月

  • The profile of motor unit number estimation (MUNE) in spinal and bulbar muscular atrophy

    Keisuke Suzuki, Masahisa Katsuno, Haruhiko Banno, Yu Takeuchi, Motoshi Kawashima, Noriaki Suga, Atsushi Hashizume, Tetsuo Hama, Kei Uchida, Fumitada Yamashita, Tomohiko Nakamura, Masaaki Hirayama, Fumiaki Tanaka, Gen Sobue

    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY   81 ( 5 )   567 - 571   2010年5月

     詳細を見る

    記述言語:英語   出版者・発行元:B M J PUBLISHING GROUP  

    Objective Spinal and bulbar muscular atrophy (SBMA) is a lower motor neuron disease caused by the expansion of a trinucleotide CAG repeat in the androgen receptor (AR) gene. The fundamental histopathological finding of this disease is an extensive loss of lower motor neurons in the spinal cord and brainstem. It is, however, difficult to evaluate clinically the degree of motor neuron degeneration, which stresses the need for biomarkers to detect the remaining neuronal function.
    Methods The authors performed motor unit number estimation (MUNE) in 52 patients with SBMA, to investigate whether this method could be a potential biomarker of SBMA, and re-evaluated MUNE 1 year later in a subgroup of the patients.
    Results The number of functioning motor units was remarkably reduced in patients with SBMA compared with controls, and was correlated with both ipsilateral grip power and disease duration. A longitudinal analysis demonstrated a further reduction in motor units within 1 year.
    Conclusions The results suggest that MUNE is an electrophysiological parameter that reflects the severity and progression of motor neuron degeneration in patients with SBMA.

    DOI: 10.1136/jnnp.2009.190462

    Web of Science

    PubMed

    researchmap

  • The profile of motor unit number estimation (MUNE) in spinal and bulbar muscular atrophy. 国際誌

    Keisuke Suzuki, Masahisa Katsuno, Haruhiko Banno, Yu Takeuchi, Motoshi Kawashima, Noriaki Suga, Atsushi Hashizume, Tetsuo Hama, Kei Uchida, Fumitada Yamashita, Tomohiko Nakamura, Masaaki Hirayama, Fumiaki Tanaka, Gen Sobue

    Journal of neurology, neurosurgery, and psychiatry   81 ( 5 )   567 - 71   2010年5月

     詳細を見る

    記述言語:英語   出版者・発行元:B M J PUBLISHING GROUP  

    OBJECTIVE: Spinal and bulbar muscular atrophy (SBMA) is a lower motor neuron disease caused by the expansion of a trinucleotide CAG repeat in the androgen receptor (AR) gene. The fundamental histopathological finding of this disease is an extensive loss of lower motor neurons in the spinal cord and brainstem. It is, however, difficult to evaluate clinically the degree of motor neuron degeneration, which stresses the need for biomarkers to detect the remaining neuronal function. METHODS: The authors performed motor unit number estimation (MUNE) in 52 patients with SBMA, to investigate whether this method could be a potential biomarker of SBMA, and re-evaluated MUNE 1 year later in a subgroup of the patients. RESULTS: The number of functioning motor units was remarkably reduced in patients with SBMA compared with controls, and was correlated with both ipsilateral grip power and disease duration. A longitudinal analysis demonstrated a further reduction in motor units within 1 year. CONCLUSIONS: The results suggest that MUNE is an electrophysiological parameter that reflects the severity and progression of motor neuron degeneration in patients with SBMA.

    DOI: 10.1136/jnnp.2009.190462

    Web of Science

    PubMed

    researchmap

  • Disrupted transforming growth factor-beta signaling in spinal and bulbar muscular atrophy. 国際誌

    Masahisa Katsuno, Hiroaki Adachi, Makoto Minamiyama, Masahiro Waza, Hideki Doi, Naohide Kondo, Hiroyuki Mizoguchi, Atsumi Nitta, Kiyofumi Yamada, Haruhiko Banno, Keisuke Suzuki, Fumiaki Tanaka, Gen Sobue

    The Journal of neuroscience : the official journal of the Society for Neuroscience   30 ( 16 )   5702 - 12   2010年4月

     詳細を見る

    記述言語:英語   出版者・発行元:SOC NEUROSCIENCE  

    Spinal and bulbar muscular atrophy (SBMA) is a late-onset lower motor neuron disease caused by the expansion of a trinucleotide CAG repeat, which encodes a polyglutamine tract in androgen receptor (AR). Although it is commonly held that the pathogenic polyglutamine proteins accumulate in neurons and thereby induce transcriptional dysregulation, the downstream molecular events have remained elusive. Here, we examined whether TGF-beta signaling is dysregulated in SBMA. Nuclear translocation of phosphorylated Smad2/3, a key step in TGF-beta signaling, is suppressed in the spinal motor neurons of male transgenic mice carrying the mutant human AR. A similar finding was also observed in the motor neurons, but not in Purkinje cells, of SBMA patients. The pathogenic AR, the causative protein of SBMA, inhibits the transcription of TGF-beta receptor type II (TbetaRII) via abnormal interactions with NF-Y and p300/CBP-associated factor. Furthermore, overexpression of TbetaRII dampens polyglutamine-induced cytotoxicity in a neuroblastoma cell line expressing the pathogenic AR. The present study thus indicates that disruption of TGF-beta due to the transcriptional dysregulation of TbetaRII is associated with polyglutamine-induced motor neuron damage in SBMA.

    DOI: 10.1523/JNEUROSCI.0388-10.2010

    Web of Science

    PubMed

    researchmap

  • Disrupted Transforming Growth Factor-beta Signaling in Spinal and Bulbar Muscular Atrophy

    Masahisa Katsuno, Hiroaki Adachi, Makoto Minamiyama, Masahiro Waza, Hideki Doi, Naohide Kondo, Hiroyuki Mizoguchi, Atsumi Nitta, Kiyofumi Yamada, Haruhiko Banno, Keisuke Suzuki, Fumiaki Tanaka, Gen Sobue

    JOURNAL OF NEUROSCIENCE   30 ( 16 )   5702 - 5712   2010年4月

     詳細を見る

    記述言語:英語   出版者・発行元:SOC NEUROSCIENCE  

    Spinal and bulbar muscular atrophy (SBMA) is a late-onset lower motor neuron disease caused by the expansion of a trinucleotide CAG repeat, which encodes a polyglutamine tract in androgen receptor (AR). Although it is commonly held that the pathogenic polyglutamine proteins accumulate in neurons and thereby induce transcriptional dysregulation, the downstream molecular events have remained elusive. Here, we examined whether TGF-beta signaling is dysregulated in SBMA. Nuclear translocation of phosphorylated Smad2/3, a key step in TGF-beta signaling, is suppressed in the spinal motor neurons of male transgenic mice carrying the mutant human AR. A similar finding was also observed in the motor neurons, but not in Purkinje cells, of SBMA patients. The pathogenic AR, the causative protein of SBMA, inhibits the transcription of TGF-beta receptor type II (T beta RII) via abnormal interactions with NF-Y and p300/CBP-associated factor. Furthermore, overexpression of T beta RII dampens polyglutamine-induced cytotoxicity in a neuroblastoma cell line expressing the pathogenic AR. The present study thus indicates that disruption of TGF-beta due to the transcriptional dysregulation of T beta RII is associated with polyglutamine-induced motor neuron damage in SBMA.

    DOI: 10.1523/JNEUROSCI.0388-10.2010

    Web of Science

    PubMed

    researchmap

  • Dorfin ameliorates phenotypes in a transgenic mouse model of amyotrophic lateral sclerosis. 国際誌

    Jun Sone, Jun-ichi Niwa, Kaori Kawai, Shinsuke Ishigaki, Shin-ichi Yamada, Hiroaki Adachi, Masahisa Katsuno, Fumiaki Tanaka, Manabu Doyu, Gen Sobue

    Journal of neuroscience research   88 ( 1 )   123 - 35   2010年1月

     詳細を見る

    記述言語:英語   出版者・発行元:WILEY-LISS  

    Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease that is characterized by progressive motor neuron degeneration and leads to death within a few years of diagnosis. One of the pathogenic mechanisms of ALS is proposed to be a dysfunction in the protein quality-control machinery. Dorfin has been identified as a ubiquitin ligase (E3) that recognizes and ubiquitinates mutant SOD1 proteins, thereby accelerating their degradation and reducing their cellular toxicity. We examined the effects of human Dorfin overexpression in G93A mutant SOD1 transgenic mice, a mouse model of familial ALS. In addition to causing a decrease in the amount of mutant SOD1 protein in the spinal cord, Dorfin overexpression ameliorated neurological phenotypes and motor neuron degeneration. Our results indicate that Dorfin overexpression or the activation or induction of E3 may be a therapeutic avenue for mutant SOD1-associated ALS.

    DOI: 10.1002/jnr.22175

    Web of Science

    PubMed

    researchmap

  • Dorfin Ameliorates Phenotypes in a Transgenic Mouse Model of Amyotrophic Lateral Sclerosis

    Jun Sone, Jun-ichi Niwa, Kaori Kawai, Shinsuke Ishigaki, Shin-ichi Yamada, Hiroaki Adachi, Masahisa Katsuno, Fumiaki Tanaka, Manabu Doyu, Gen Sobue

    JOURNAL OF NEUROSCIENCE RESEARCH   88 ( 1 )   123 - 135   2010年1月

     詳細を見る

    記述言語:英語   出版者・発行元:WILEY-LISS  

    Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease that is characterized by progressive motor neuron degeneration and leads to death within a few years of diagnosis. One of the pathogenic mechanisms of ALS is proposed to be a dysfunction in the protein quality-control machinery. Dorfin has been identified as a ubiquitin ligase (D) that recognizes and ubiquitinates mutant SOD1 proteins, thereby accelerating their degradation and reducing their cellular toxicity. We examined the effects of human Dorfin overexpression in G93A mutant SOD1 transgenic mice, a mouse model of familial ALS. In addition to causing a decrease in the amount of mutant SOD1 protein in the spinal cord, Dorfin overexpression ameliorated neurological phenotypes and motor neuron degeneration. Our results indicate that Dorfin overexpression or the activation or induction of E3 may be a therapeutic avenue for mutant SOD1-associated ALS. (C) 2009 Wiley-Liss, Inc.

    DOI: 10.1002/jnr.22175

    Web of Science

    PubMed

    researchmap

  • 多彩な神経所見と著明な神経肥厚を呈した慢性炎症性脱髄性多発神経炎(CIDP)

    辻本 昌史, 松尾 幸治, 両角 佐織, 飯島 正博, 小池 春樹, 服部 直樹, 田中 章景, 祖父江 元

    臨床神経学   50 ( 1 )   43 - 43   2010年1月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • V-P shunt術後に、高度な眼球運動障害・錐体路徴候・パーキンソニズムを呈した、中脳水道狭窄による非交通性水頭症の1例

    橋詰 淳, 松尾 幸治, 渡邉 宏久, 服部 直樹, 田中 章景, 祖父江 元

    臨床神経学   50 ( 1 )   47 - 47   2010年1月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • Clinical Features and Molecular Mechanisms of Spinal and Bulbar Muscular Atrophy (SBMA)

    Masahisa Katsuno, Haruhiko Banno, Keisuke Suzuki, Hiroaki Adachi, Fumiaki Tanaka, Gen Sobue

    DISEASES OF DNA REPAIR   685   64 - 74   2010年

     詳細を見る

    記述言語:英語   出版者・発行元:SPRINGER-VERLAG BERLIN  

    Spinal and bulbar muscular atrophy (SBMA) is an adult-onset neurodegenerative disease characterized by slowly progressive muscle weakness and atrophy. The cause of this disease is the expansion of a trinucleotide GAG repeat, which encodes the polyglutamine tract, within the first exon of the androgen receptor (AR) gene. SBMA exclusively occurs in adult males, whereas both heterozygous and homozygous females are usually asymptomatic. Lower motor neurons in the anterior horn of the spinal cord and those in the brainstem motor nuclei are predominantly affected in SBMA, and other neuronal and nonneuronal tissues are also widely involved to some extent. Testosterone-dependent nuclear accumulation of the pathogenic AR protein has been considered to be a fundamental step of neurodegenerative process, which is followed by several molecular events such as transcriptional dysregulation, axonal transport disruption and mitochondrial dysfunction. Results of animal studies suggest that androgen deprivation and activation of protein quality control systems are potential therapies for SBMA.

    DOI: 10.1007/978-1-4419-6448-9_6

    Web of Science

    researchmap

  • Familial Amyotrophic Lateral Sclerosis with a Novel G85S Mutation of Superoxide Dismutase 1 Gene: Clinical Features of Lower Motor Neuron Disease

    Takanori Takazawa, Ken Ikeda, Takehisa Hirayama, Kiyokazu Kawabe, Yoshikazu Nakamura, Hirono Ito, Osamu Kano, Yasuhiro Yoshii, Fumiaki Tanaka, Gen Sobue, Yasuo Iwasaki

    INTERNAL MEDICINE   49 ( 2 )   183 - 186   2010年

     詳細を見る

    記述言語:英語   出版者・発行元:JAPAN SOC INTERNAL MEDICINE  

    Amyotrophic lateral sclerosis (ALS) is a devastating disease characterized by upper and lower motor neuron damage. Mutations of Cu/Zn superoxide dismutase gene (SOD1) account for 20% of familial ALS (FALS). We report a unique clinicogenotype of a Japanese family with a novel SOD 1 mutation. A 37-year-old woman (the proband) noticed muscle weakness in the left lower limb. Her mother had developed progressive lower motor neuron signs in four extremities at 38 years of age. Subsequently she was diagnosed as ALS and died of respiratory failure at 15 months after clinical onset. Neurological examination of the proband showed absent muscle stretch reflexes in the let knee and the left ankle without Babinski signs. Mild to moderate degree of muscle weakness existed in the left lower extremity. Muscle atrophy was presented in the left thigh. Initial pulmonary function revealed forced vital capacity of 91.1%. Electromyography disclosed ongoing denervation muscle potentials in the left lower extremity. SOD1 analysis demonstrated amino acid substitution of glycine by serine at codon 85 (G85S) in exon 4. Six months later, marked muscle weakness and atrophy expanded to four extremities. All muscle stretch reflexes were absent. Three months later, ventilator support with a tracheostomy was needed. The patient died at 18 months after clinical onset. Clinical hallmarks of this FALS family indicate that G85S mutation of SOD1 may cause rapidly progressive form of pure lower motor neuron signs.

    DOI: 10.2169/internalmedicine.49.2720

    Web of Science

    researchmap

  • Expression pattern of sodium channels is dysregulated in spinal and bulbar musclar atrophy (SBMA)

    Masahisa Katsuno, Hiroaki Adachi, Makoto Minamiyama, Hideki Doi, Naohide Kondo, Shinjiro Matsumoto, Haruhiko Banno, Keisuke Suzuki, Fumiaki Tanaka, Gen Sobue

    NEUROSCIENCE RESEARCH   68   E195 - E195   2010年

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:ELSEVIER IRELAND LTD  

    DOI: 10.1016/j.neures.2010.07.2435

    Web of Science

    researchmap

  • Distribution of pathogenic androgen receptor aggregations is influenced by heat shock factor-1 in model mouse of spinal and bulbar muscle atrophy (SBMA)

    Naohide Kondo, Masahisa Katsuno, Hiroaki Adachi, Makoto Minamiyama, Hideki Doi, Shin-jiro Matsumoto, Fumiaki Tanaka, Gen Sobue

    NEUROSCIENCE RESEARCH   68   E310 - E311   2010年

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:ELSEVIER IRELAND LTD  

    DOI: 10.1016/j.neures.2010.07.1379

    Web of Science

    researchmap

  • A peony extract alleviates polyglutamine-mediated motor neuron disease

    Genki Tohnai, Hiroaki Adachi, Masahisa Katsuno, Makoto Minamiyama, Masahiro Waza, Hideki Doi, Fumiaki Tanaka, Kenzo Ohtsuka, Gen Sobue

    NEUROSCIENCE RESEARCH   68   E310 - E310   2010年

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:ELSEVIER IRELAND LTD  

    DOI: 10.1016/j.neures.2010.07.1378

    Web of Science

    researchmap

  • Familial amyotrophic lateral sclerosis with a novel G85S mutation of superoxide dismutase 1 gene: clinical features of lower motor neuron disease.

    Takanori Takazawa, Ken Ikeda, Takehisa Hirayama, Kiyokazu Kawabe, Yoshikazu Nakamura, Hirono Ito, Osamu Kano, Yasuhiro Yoshii, Fumiaki Tanaka, Gen Sobue, Yasuo Iwasaki

    Internal medicine (Tokyo, Japan)   49 ( 2 )   183 - 6   2010年

     詳細を見る

    記述言語:英語   出版者・発行元:JAPAN SOC INTERNAL MEDICINE  

    Amyotrophic lateral sclerosis (ALS) is a devastating disease characterized by upper and lower motor neuron damage. Mutations of Cu/Zn superoxide dismutase gene (SOD1) account for 20% of familial ALS (FALS). We report a unique clinicogenotype of a Japanese family with a novel SOD 1 mutation. A 37-year-old woman (the proband) noticed muscle weakness in the left lower limb. Her mother had developed progressive lower motor neuron signs in four extremities at 38 years of age. Subsequently she was diagnosed as ALS and died of respiratory failure at 15 months after clinical onset. Neurological examination of the proband showed absent muscle stretch reflexes in the left knee and the left ankle without Babinski signs. Mild to moderate degree of muscle weakness existed in the left lower extremity. Muscle atrophy was presented in the left thigh. Initial pulmonary function revealed forced vital capacity of 91.1%. Electromyography disclosed ongoing denervation muscle potentials in the left lower extremity. SOD1 analysis demonstrated amino acid substitution of glycine by serine at codon 85 (G85S) in exon 4. Six months later, marked muscle weakness and atrophy expanded to four extremities. All muscle stretch reflexes were absent. Three months later, ventilator support with a tracheostomy was needed. The patient died at 18 months after clinical onset. Clinical hallmarks of this FALS family indicate that G85S mutation of SOD1 may cause rapidly progressive form of pure lower motor neuron signs.

    DOI: 10.2169/internalmedicine.49.2720

    Web of Science

    PubMed

    researchmap

  • Clinical features and molecular mechanisms of spinal and bulbar muscular atrophy (SBMA). 国際誌

    Masahisa Katsuno, Haruhiko Banno, Keisuke Suzuki, Hiroaki Adachi, Fumiaki Tanaka, Gen Sobue

    Advances in experimental medicine and biology   685   64 - 74   2010年

     詳細を見る

    記述言語:英語  

    Spinal and bulbar muscular atrophy (SBMA) is an adult-onset neurodegenerative disease characterized by slowly progressive muscle weakness and atrophy. The cause of this disease is the expansion of a trinucleotide CAG repeat, which encodes the polyglutamine tract, within the first exon of the androgen receptor (AR) gene. SBMA exclusively occurs in adult males, whereas both heterozygous and homozygous females are usually asymptomatic. Lower motor neurons in the anterior horn of the spinal cord and those in the brainstem motor nuclei are predominantly affected in SBMA, and other neuronal and nonneuronal tissues are also widely involved to some extent. Testosterone-dependent nuclear accumulation of the pathogenic AR protein has been considered to be a fundamental step of neurodegenerative process, which is followed by several molecular events such as transcriptional dysregulation, axonal transport disruption and mitochondrial dysfunction. Results of animal studies suggest that androgen deprivation and activation of protein quality control systems are potential therapies for SBMA.

    DOI: 10.1007/978-1-4419-6448-9_6

    Scopus

    PubMed

    researchmap

  • 抗MAG抗体陽性IgM-MGUSニューロパチーの脱髄機転と軸索障害

    川頭 祐一, 冨田 稔, 両角 佐織, 飯島 正博, 小池 春樹, TANAKA Fumiaki, 祖父江 元

    末梢神経 = Peripheral nerve   20 ( 2 )   234 - 235   2009年12月

     詳細を見る

    記述言語:日本語  

    CiNii Books

    researchmap

  • Heat shock proteins in neurodegenerative diseases: pathogenic roles and therapeutic implications. 国際誌

    Hiroaki Adachi, Masahisa Katsuno, Masahiro Waza, Makoto Minamiyama, Fumiaki Tanaka, Gen Sobue

    International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group   25 ( 8 )   647 - 54   2009年12月

     詳細を見る

    記述言語:英語   出版者・発行元:INFORMA HEALTHCARE  

    Neurodegenerative diseases including amyotrophic lateral sclerosis, Parkinson's disease, Alzheimer's disease, and polyglutamine (polyQ) diseases are thought to be caused by protein misfolding. Heat shock proteins (HSPs), which function mainly as molecular chaperones, play an important role in the folding and quality control of proteins. The histopathological hallmark of neurodegenerative diseases is accumulation and/or inclusions of the disease-causing proteins in residual neurons in targeted regions of the nervous system. The inclusions combine with many components of molecular chaperone pathways and ubiquitin-proteasome, raising the possibility that misfolding and altered degradation of mutant proteins may be involved in the pathogenesis of neurodegenerative diseases. Overexpression of HSPs has been reported to reduce the number and size of inclusions and accumulation of disease-causing proteins, and ameliorate the phenotypes in neuronal cell and mouse models. Hsp90 inhibitors also exert therapeutic effects through selective proteasome degradation of its client proteins. Elucidation of its pathophysiology using animal models has led to the development of disease-modifying drugs, i.e., Hsp90 inhibitor and HSP inducer, which inhibit the pathogenic process of neuronal degeneration. These findings may provide the basis for development of an HSP-related therapy for neurodegenerative diseases.

    DOI: 10.3109/02656730903315823

    Web of Science

    PubMed

    researchmap

  • Dynactin-1ノックダウン線虫モデル

    和座 雅浩, 田中 章景, 蒋 月梅, 黄 哲, 勝野 雅央, 足立 弘明, 山本 正彦, 祖父江 元

    臨床神経学   49 ( 12 )   1018 - 1018   2009年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • CIDPにおける軸索関連分子TAG-1の治療反応性への関与

    飯島 正博, 冨田 稔, 両角 佐織, 川頭 祐一, 小池 春樹, 服部 直樹, 田中 章景, 山本 正彦, 祖父江 元

    臨床神経学   49 ( 12 )   1128 - 1128   2009年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 球脊髄性筋萎縮症の病態関連遺伝子の解析

    南山 誠, 勝野 雅央, 足立 弘明, 和座 雅浩, 徳井 啓介, 土井 英樹, 田中 章景, 祖父江 元, 栗原 裕基

    臨床神経学   49 ( 12 )   1099 - 1099   2009年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • CIDPにおける軸索関連分子TAG-1の治療反応性への関与

    飯島 正博, 冨田 稔, 両角 佐織, 川頭 祐一, 小池 春樹, 田中 章景, 祖父江 元

    末梢神経   20 ( 2 )   256 - 257   2009年12月

  • 肥厚型chronic inflammatory demyelinating polyradiculoneuropathy 8例における臨床、病理所見、治療反応性の検討

    両角 佐織, 冨田 稔, 川頭 祐一, 飯島 正博, 小池 春樹, 服部 直樹, 田中 章景, 祖父江 元

    末梢神経   20 ( 2 )   195 - 196   2009年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本末梢神経学会  

    researchmap

  • 球脊髄性筋萎縮症モデルにおける抗アンドロゲン療法とHGF高発現の混合療法の効果

    足立 弘明, 徳井 啓介, 和座 雅浩, 勝野 雅央, 南山 誠, 土井 英樹, 田中 章景, 船越 洋, 祖父江 元

    臨床神経学   49 ( 12 )   1099 - 1099   2009年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • TDP-43による神経細胞障害 loss of functionの検討

    井口 洋平, 勝野 雅央, 丹羽 淳一, 曽根 淳, 和座 雅浩, 足立 弘明, 田中 章景, 貝淵 弘三, 祖父江 元

    臨床神経学   49 ( 12 )   1055 - 1055   2009年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 球脊髄性筋萎縮症モデルにおけるimmunophilin高発現の効果

    土井 英樹, 足立 弘明, 徳井 啓介, 和座 雅浩, 南山 誠, 勝野 雅央, 田中 章景, 祖父江 元

    臨床神経学   49 ( 12 )   1099 - 1099   2009年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • SBMAモデルマウスにおけるプロテアソーム機能解析と17-DMAGの効果

    徳井 啓介, 足立 弘明, 和座 雅浩, 勝野 雅央, 南山 誠, 土井 英樹, 田中 章景, 祖父江 元

    臨床神経学   49 ( 12 )   1099 - 1099   2009年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 家族性NIHID(エオジン好性核内封入体病)家系に関する検討

    曽根 淳, 田中 章景, 小池 春樹, 菱川 望, 祖父江 元, 吉田 眞理, 橋詰 良夫, 山田 英二, 今村 久司, 渡辺 俊之, 小牟禮 修

    臨床神経学   49 ( 12 )   1036 - 1036   2009年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • ALS治療法開発の将来 孤発性ALS疾患モデルによる病態解明と治療法開発

    田中 章景, 和座 雅浩, 山本 正彦, 祖父江 元

    臨床神経学   49 ( 11 )   811 - 813   2009年11月

  • Single nucleotide polymorphism of TAG-1 influences IVIg responsiveness of Japanese patients with CIDP

    M. Iijima, M. Tomita, S. Morozumi, Y. Kawagashira, T. Nakamura, H. Koike, M. Katsuno, N. Hattori, F. Tanaka, M. Yamamoto, G. Sobue

    NEUROLOGY   73 ( 17 )   1348 - 1352   2009年10月

     詳細を見る

    記述言語:英語   出版者・発行元:LIPPINCOTT WILLIAMS & WILKINS  

    Objective: Chronic inflammatory demyelinating polyneuropathy (CIDP) is characterized by immune-mediated peripheral demyelination. Although corticosteroid, IV immunoglobulin (IVIg) and plasma exchange have been established as the most effective therapeutics, subpopulations of patients show little or no response to either of these therapies. In this study, we examined whether particular genetic factors influence the therapeutic responsiveness of patients with CIDP.
    Methods: One hundred Japanese patients categorized as responders or nonresponders to IVIg therapy participated in our study. We performed an association analysis with single nucleotide polymorphisms (SNPs) and haplotype studies between the IVIg responders and nonresponders.
    Results: Two separate SNPs, corresponding to TAG-1 (transient axonal glycoprotein 1) and CLEC10A (C-type lectin domain family 10, member A), showed strong significant differences between responders and nonresponders. Haplotype analysis of a series of expanded SNPs, from TAG-1 or CLEC10A, showed that only TAG-1 included a significant haplotype within 1 linkage disequilibrium block, which accommodates IVIg responsiveness. Diplotype analysis of TAG-1 also supported this observation.
    Conclusions: Transient axonal glycoprotein 1 is a crucial molecule involved in IV immunoglobulin responsiveness in Japanese patients with chronic inflammatory demyelinating polyneuropathy. Neurology (R) 2009; 73: 1348-1352

    DOI: 10.1212/WNL.0b013e3181bd1139

    Web of Science

    researchmap

  • TDP-43 depletion induces neuronal cell damage through dysregulation of Rho family GTPases. 国際誌

    Yohei Iguchi, Masahisa Katsuno, Jun-ichi Niwa, Shin-ichi Yamada, Jun Sone, Masahiro Waza, Hiroaki Adachi, Fumiaki Tanaka, Koh-ichi Nagata, Nariko Arimura, Takashi Watanabe, Kozo Kaibuchi, Gen Sobue

    The Journal of biological chemistry   284 ( 33 )   22059 - 66   2009年8月

     詳細を見る

    記述言語:英語   出版者・発行元:AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC  

    The 43-kDa TAR DNA-binding protein (TDP-43) is known to be a major component of the ubiquitinated inclusions characteristic of amyotrophic lateral sclerosis and frontotemporal lobar degeneration with ubiquitin-positive inclusions. Although TDP-43 is a nuclear protein, it disappears from the nucleus of affected neurons and glial cells, implicating TDP-43 loss of function in the pathogenesis of neurodegeneration. Here we show that the knockdown of TDP-43 in differentiated Neuro-2a cells inhibited neurite outgrowth and induced cell death. In knockdown cells, the Rho family members RhoA, Rac1, and Cdc42 GTPases were inactivated, and membrane localization of these molecules was reduced. In addition, TDP-43 depletion significantly suppressed protein geranylgeranylation, a key regulating factor of Rho family activity and intracellular localization. In contrast, overexpression of TDP-43 mitigated the cellular damage caused by pharmacological inhibition of geranylgeranylation. Furthermore administration of geranylgeranyl pyrophosphate partially restored cell viability and neurite outgrowth in TDP-43 knockdown cells. In summary, our data suggest that TDP-43 plays a key role in the maintenance of neuronal cell morphology and survival possibly through protein geranylgeranylation of Rho family GTPases.

    DOI: 10.1074/jbc.M109.012195

    Web of Science

    PubMed

    researchmap

  • TDP-43 Depletion Induces Neuronal Cell Damage through Dysregulation of Rho Family GTPases

    Yohei Iguchi, Masahisa Katsuno, Jun-ichi Niwa, Shin-ichi Yamada, Jun Sone, Masahiro Waza, Hiroaki Adachi, Fumiaki Tanaka, Koh-ichi Nagata, Nariko Arimura, Takashi Watanabe, Kozo Kaibuchi, Gen Sobue

    JOURNAL OF BIOLOGICAL CHEMISTRY   284 ( 33 )   22059 - 22066   2009年8月

     詳細を見る

    記述言語:英語   出版者・発行元:AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC  

    The 43-kDa TAR DNA-binding protein (TDP-43) is known to be a major component of the ubiquitinated inclusions characteristic of amyotrophic lateral sclerosis and frontotemporal lobar degeneration with ubiquitin-positive inclusions. Although TDP-43 is a nuclear protein, it disappears from the nucleus of affected neurons and glial cells, implicating TDP-43 loss of function in the pathogenesis of neurodegeneration. Here we show that the knockdown of TDP-43 in differentiated Neuro-2a cells inhibited neurite outgrowth and induced cell death. In knockdown cells, the Rho family members RhoA, Rac1, and Cdc42 GTPases were inactivated, and membrane localization of these molecules was reduced. In addition, TDP-43 depletion significantly suppressed protein geranylgeranylation, a key regulating factor of Rho family activity and intracellular localization. In contrast, overexpression of TDP-43 mitigated the cellular damage caused by pharmacological inhibition of geranylgeranylation. Furthermore administration of geranylgeranyl pyrophosphate partially restored cell viability and neurite outgrowth in TDP-43 knockdown cells. In summary, our data suggest that TDP-43 plays a key role in the maintenance of neuronal cell morphology and survival possibly through protein geranylgeranylation of Rho family GTPases.

    DOI: 10.1074/jbc.M109.012195

    Web of Science

    PubMed

    researchmap

  • Intravenous immunoglobulin treatment for painful sensory neuropathy associated with Sjögren's syndrome 国際誌

    J Neurol Sci   279 ( 1-2 )   57 - 61   2009年4月

     詳細を見る

  • Intravenous immunoglobulin treatment for painful sensory neuropathy associated with Sjogren&apos;s syndrome

    Saori Morozumi, Yuichi Kawagashira, Masahiro Iijima, Haruki Koike, Naoki Hattori, Masahisa Katsuno, Fumiaki Tanaka, Gen Sobue

    JOURNAL OF THE NEUROLOGICAL SCIENCES   279 ( 1-2 )   57 - 61   2009年4月

     詳細を見る

    記述言語:英語   出版者・発行元:ELSEVIER SCIENCE BV  

    Background: Patients with painful sensory neuropathy associated with Sjogren&apos;s syndrome-associated neuropathy often show severe neuropathic pain which is not relieved by conventional treatments. Objective: To evaluate the effect of intravenous immunoglobulin (IVIg) therapy in the treatment of neuropathic pain associated with Sjogren&apos;s syndrome.
    Patients and methods: We examined 5 patients affected by painful sensory neuropathy associated with Sjogren&apos;s syndrome. All patients were treated with IVIg (0.4 g/kg/day for 5 days) and pain rating was assessed by the Visual Analogue Scale (VAS).
    Results: All five patients showed a remarkable improvement in neuropathic pain following IVIg therapy. Pain, assessed by the determination of mean VAS score, was reduced by 73.4% front days 2-14 following treatment. The observed clinical improvement persisted for 2 to 6 months. One patient, examined by quantitative sensory testing (QST), showed an improvement of superficial sensory deficit accompanied by pain relief.
    Conclusion: IVIg might be an effective treatment for pain in Sjogren&apos;s syndrome-associated neuropathy. Further studies should be done in a controlled, blind study. (C) 2008 Elsevier B.V. All rights reserved.

    DOI: 10.1016/j.jns.2008.12.018

    Web of Science

    researchmap

  • 17-DMAG ameliorates polyglutamine-mediated motor neuron degeneration through well-preserved proteasome function in an SBMA model mouse. 国際誌

    Keisuke Tokui, Hiroaki Adachi, Masahiro Waza, Masahisa Katsuno, Makoto Minamiyama, Hideki Doi, Keiji Tanaka, Jun Hamazaki, Shigeo Murata, Fumiaki Tanaka, Gen Sobue

    Human molecular genetics   18 ( 5 )   898 - 910   2009年3月

     詳細を見る

    記述言語:英語   出版者・発行元:OXFORD UNIV PRESS  

    The ubiquitin-proteasome system (UPS) is the principal protein degradation system that tags and targets short-lived proteins, as well as damaged or misfolded proteins, for destruction. In spinal and bulbar muscular atrophy (SBMA), the androgen receptor (AR), an Hsp90 client protein, is such a misfolded protein that tends to aggregate in neurons. Hsp90 inhibitors promote the degradation of Hsp90 client proteins via the UPS. In a transgenic mouse model of SBMA, we examined whether a functioning UPS is preserved, if it was capable of degrading polyglutamine-expanded mutant AR, and what might be the therapeutic effects of 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin (17-DMAG), an oral Hsp90 inhibitor. Ubiquitin-proteasomal function was well preserved in SBMA mice and was even increased during advanced stages when the mice developed severe phenotypes. Administration of 17-DMAG markedly ameliorated motor impairments in SBMA mice without detectable toxicity and reduced amounts of monomeric and nuclear-accumulated mutant AR. Mutant AR was preferentially degraded in the presence of 17-DMAG in both SBMA cell and mouse models when compared with wild-type AR. 17-DMAG also significantly induced Hsp70 and Hsp40. Thus, 17-DMAG would exert a therapeutic effect on SBMA via preserved proteasome function.

    DOI: 10.1093/hmg/ddn419

    Web of Science

    PubMed

    researchmap

  • 17-DMAG ameliorates polyglutamine-mediated motor neuron degeneration through well-preserved proteasome function in an SBMA model mouse

    Keisuke Tokui, Hiroaki Adachi, Masahiro Waza, Masahisa Katsuno, Makoto Minamiyama, Hideki Doi, Keiji Tanaka, Jun Hamazaki, Shigeo Murata, Fumiaki Tanaka, Gen Sobue

    HUMAN MOLECULAR GENETICS   18 ( 5 )   898 - 910   2009年3月

     詳細を見る

    記述言語:英語   出版者・発行元:OXFORD UNIV PRESS  

    The ubiquitin-proteasome system (UPS) is the principal protein degradation system that tags and targets short-lived proteins, as well as damaged or misfolded proteins, for destruction. In spinal and bulbar muscular atrophy (SBMA), the androgen receptor (AR), an Hsp90 client protein, is such a misfolded protein that tends to aggregate in neurons. Hsp90 inhibitors promote the degradation of Hsp90 client proteins via the UPS. In a transgenic mouse model of SBMA, we examined whether a functioning UPS is preserved, if it was capable of degrading polyglutamine-expanded mutant AR, and what might be the therapeutic effects of 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin (17-DMAG), an oral Hsp90 inhibitor. Ubiquitin-proteasomal function was well preserved in SBMA mice and was even increased during advanced stages when the mice developed severe phenotypes. Administration of 17-DMAG markedly ameliorated motor impairments in SBMA mice without detectable toxicity and reduced amounts of monomeric and nuclear-accumulated mutant AR. Mutant AR was preferentially degraded in the presence of 17-DMAG in both SBMA cell and mouse models when compared with wild-type AR. 17-DMAG also significantly induced Hsp70 and Hsp40. Thus, 17-DMAG would exert a therapeutic effect on SBMA via preserved proteasome function.

    DOI: 10.1093/hmg/ddn419

    Web of Science

    researchmap

  • Neuropathology and therapeutic intervention in spinal and bulbar muscular atrophy. 国際誌

    Haruhiko Banno, Masahisa Katsuno, Keisuke Suzuki, Fumiaki Tanaka, Gen Sobue

    International journal of molecular sciences   10 ( 3 )   1000 - 12   2009年3月

     詳細を見る

    記述言語:英語   出版者・発行元:MDPI AG  

    Spinal and bulbar muscular atrophy (SBMA) is a hereditary motor neuron disease caused by the expansion of a polyglutamine tract in the androgen receptor (AR). The histopathological finding in SBMA is loss of lower motor neurons in the anterior horn of the spinal cord as well as in the brainstem motor nuclei. Animal studies have revealed that the pathogenesis of SBMA depends on the level of serum testosterone, and that androgen deprivation mitigates neurodegeneration through inhibition of nuclear accumulation of the pathogenic AR. Heat shock proteins, ubiquitin-proteasome system and transcriptional regulation are also potential targets of therapy development for SBMA.

    DOI: 10.3390/ijms10031000

    Web of Science

    PubMed

    researchmap

  • Phase II Trial of Leuprorelin Acetate in Patients with Spinal and Bulbar Muscular Atrophy

    Haruhiko Banno, Masahisa Katsuno, Keisuke Suzuki, Yu Takeuchi, Motoshi Kawashima, Noriaki Suga, Mizuki Ito, Tomohiko Nakamura, Koji Matsuo, Shinichi Yamada, Yumiko Oki, Hiroaki Adachi, Makoto Minamiyama, Masahiro Waza, Naoki Atsuta, Hirohisa Watanabe, Yasushi Fujimoto, Tsutomu Nakashima, Fumiaki Tanaka, Manabu Doyu, Gen Sobue

    NEUROLOGY   72 ( 11 )   A275 - A275   2009年3月

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:LIPPINCOTT WILLIAMS & WILKINS  

    Web of Science

    researchmap

  • Neuropathology and Therapeutic Intervention in Spinal and Bulbar Muscular Atrophy

    Haruhiko Banno, Masahisa Katsuno, Keisuke Suzuki, Fumiaki Tanaka, Gen Sobue

    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES   10 ( 3 )   1000 - 1012   2009年3月

     詳細を見る

    記述言語:英語   掲載種別:書評論文,書評,文献紹介等   出版者・発行元:MDPI AG  

    Spinal and bulbar muscular atrophy (SBMA) is a hereditary motor neuron disease caused by the expansion of a polyglutamine tract in the androgen receptor (AR). The histopathological finding in SBMA is loss of lower motor neurons in the anterior horn of the spinal cord as well as in the brainstem motor nuclei. Animal studies have revealed that the pathogenesis of SBMA depends on the level of serum testosterone, and that androgen deprivation mitigates neurodegeneration through inhibition of nuclear accumulation of the pathogenic AR. Heat shock proteins, ubiquitin-proteasome system and transcriptional regulation are also potential targets of therapy development for SBMA.

    DOI: 10.3390/ijms10031000

    Web of Science

    researchmap

  • Polyglutamine-expanded androgen receptor truncation fragments activate a Bax-dependent apoptotic cascade mediated by DP5/Hrk. 国際誌

    Jessica E Young, Gwenn A Garden, Refugio A Martinez, Fumiaki Tanaka, C Miguel Sandoval, Annette C Smith, Bryce L Sopher, Amy Lin, Kenneth H Fischbeck, Lisa M Ellerby, Richard S Morrison, J Paul Taylor, Albert R La Spada

    The Journal of neuroscience : the official journal of the Society for Neuroscience   29 ( 7 )   1987 - 97   2009年2月

     詳細を見る

    記述言語:英語   出版者・発行元:SOC NEUROSCIENCE  

    Spinal and bulbar muscular atrophy (SBMA) is an inherited neuromuscular disorder caused by a polyglutamine (polyQ) repeat expansion in the androgen receptor (AR). PolyQ-AR neurotoxicity may involve generation of an N-terminal truncation fragment, as such peptides occur in SBMA patients and mouse models. To elucidate the basis of SBMA, we expressed N-terminal truncated AR in motor neuron-derived cells and primary cortical neurons. Accumulation of polyQ-AR truncation fragments in the cytosol resulted in neurodegeneration and apoptotic, caspase-dependent cell death. Using primary neurons from mice transgenic or deficient for apoptosis-related genes, we determined that polyQ-AR apoptotic activation is fully dependent on Bax. Jun N-terminal kinase (JNK) was required for apoptotic pathway activation through phosphorylation of c-Jun. Expression of polyQ-AR in DP5/Hrk null neurons yielded significant protection against apoptotic activation, but absence of Bim did not provide protection, apparently due to compensatory upregulation of DP5/Hrk or other BH3-only proteins. Misfolded AR protein in the cytosol thus initiates a cascade of events beginning with JNK and culminating in Bax-dependent, intrinsic pathway activation, mediated in part by DP5/Hrk. As apoptotic mediators are candidates for toxic fragment generation and other cellular processes linked to neuron dysfunction, delineation of the apoptotic activation pathway induced by polyQ-expanded AR may shed light on the pathogenic cascade in SBMA and other motor neuron diseases.

    DOI: 10.1523/JNEUROSCI.4072-08.2009

    Web of Science

    PubMed

    researchmap

  • Phase 2 trial of leuprorelin in patients with spinal and bulbar muscular atrophy. 国際誌

    Haruhiko Banno, Masahisa Katsuno, Keisuke Suzuki, Yu Takeuchi, Motoshi Kawashima, Noriaki Suga, Motoko Takamori, Mizuki Ito, Tomohiko Nakamura, Koji Matsuo, Shinichi Yamada, Yumiko Oki, Hiroaki Adachi, Makoto Minamiyama, Masahiro Waza, Naoki Atsuta, Hirohisa Watanabe, Yasushi Fujimoto, Tsutomu Nakashima, Fumiaki Tanaka, Manabu Doyu, Gen Sobue

    Annals of neurology   65 ( 2 )   140 - 50   2009年2月

     詳細を見る

    記述言語:英語   出版者・発行元:WILEY-BLACKWELL  

    OBJECTIVE: Spinal and bulbar muscular atrophy (SBMA) is a hereditary motor neuron disease caused by the expansion of a polyglutamine tract in the androgen receptor (AR). Animal studies have shown that the pathogenesis of SBMA is dependent on serum testosterone level. This study is aimed at evaluating the efficacy and safety of androgen deprivation by leuprorelin acetate in patients with SBMA. METHODS: Fifty SBMA patients underwent subcutaneous injections of leuprorelin acetate or placebo in a randomized, placebo-controlled trial for 48 weeks, followed by an open-label trial for an additional 96 weeks, in which 19 patients of the leuprorelin group and 15 of the placebo group received leuprorelin acetate. The patients who did not participate in the open-label trial were also followed up for the 96-week period (UMIN000000474). RESULTS: Leuprorelin acetate significantly extended the duration of cricopharyngeal opening in videofluorography and decreased mutant AR accumulation in scrotal skin biopsy. The patients treated with leuprorelin acetate for 144 weeks exhibited significantly greater functional scores and better swallowing parameters than those who received placebo. Autopsy of one patient who received leuprorelin acetate for 118 weeks suggested that androgen deprivation inhibits the nuclear accumulation or stabilization, or both, of mutant AR in the motor neurons of the spinal cord and brainstem. INTERPRETATION: These observations suggest that administration of leuprorelin acetate suppresses the deterioration of neuromuscular impairment in SBMA by inhibiting the toxic accumulation of mutant AR. The results of this phase 2 trial support the start of large-scale clinical trials of androgen deprivation for SBMA.

    DOI: 10.1002/ana.21540

    Web of Science

    PubMed

    researchmap

  • Phase 2 Trial of Leuprorelin in Patients with Spinal and Bulbar Muscular Atrophy

    Haruhiko Banno, Masahisa Katsuno, Keisuke Suzuki, Yu Takeuchi, Motoshi Kawashima, Noriaki Suga, Motoko Takamori, Mizuki Ito, Tomohiko Nakamura, Koji Matsuo, Shinichi Yamada, Yumiko Oki, Hiroaki Adachi, Makoto Minamiyama, Masahiro Waza, Naoki Atsuta, Hirohisa Watanabe, Yasushi Fujimoto, Tsutomu Nakashima, Fumiaki Tanaka, Manabu Doyu, Gen Sobue

    ANNALS OF NEUROLOGY   65 ( 2 )   140 - 150   2009年2月

     詳細を見る

    記述言語:英語   出版者・発行元:WILEY-BLACKWELL  

    Objective: Spinal and bulbar muscular atrophy (SBMA) is a hereditary motor neuron disease caused by the expansion of a polyglutamine tract in the androgen receptor (AR). Animal studies have shown that the pathogenesis of SBMA is dependent on serum testosterone level. This study is aimed at evaluating the efficacy and safety of androgen deprivation by leuprorelin acetate in patients with SBMA.
    Methods: Fifty SBMA patients underwent subcutaneous injections of leuprorelin acetate or placebo in a randomized, placebo-controlled trial for 48 weeks, followed by an open-label trial for an additional 96 weeks, in which 19 patients of the leuprorelin group and 15 of the placebo group received leuprorelin acetate. The patients who did not participate in the open-label trial were also followed up for the 96-week period (UMIN000000474).
    Results: Leuprorelin acetate significantly extended the duration of cricopharyngeal opening in videofluorography and decreased mutant AR accumulation in scrotal skin biopsy. The patients treated with leuprorelin acetate for 144 weeks exhibited significantly greater functional scores and better swallowing parameters than those who received placebo. Autopsy of one patient who received leuprorelin acetate for 118 weeks suggested that androgen deprivation inhibits the nuclear accumulation or stabilization, or both, of mutant AR in the motor neurons of the spinal cord and brainstem.
    Interpretation: These observations suggest that administration of leuprorelin acetate suppresses the deterioration of neuromuscular impairment in SBMA by inhibiting the toxic accumulation of mutant AR. The results of this phase 2 trial support the start of large-scale clinical trials of androgen deprivation for SBMA.

    DOI: 10.1002/ana.21540

    Web of Science

    researchmap

  • Polyglutamine-Expanded Androgen Receptor Truncation Fragments Activate a Bax-Dependent Apoptotic Cascade Mediated by DP5/Hrk

    Jessica E. Young, Gwenn A. Garden, Refugio A. Martinez, Fumiaki Tanaka, C. Miguel Sandoval, Annette C. Smith, Bryce L. Sopher, Amy Lin, Kenneth H. Fischbeck, Lisa M. Ellerby, Richard S. Morrison, J. Paul Taylor, Albert R. La Spada

    JOURNAL OF NEUROSCIENCE   29 ( 7 )   1987 - 1997   2009年2月

     詳細を見る

    記述言語:英語   出版者・発行元:SOC NEUROSCIENCE  

    Spinal and bulbar muscular atrophy (SBMA) is an inherited neuromuscular disorder caused by a polyglutamine (polyQ) repeat expansion in the androgen receptor (AR). PolyQ-AR neurotoxicity may involve generation of an N-terminal truncation fragment, as such peptides occur in SBMA patients and mouse models. To elucidate the basis of SBMA, we expressed N-terminal truncated AR in motor neuron-derived cells and primary cortical neurons. Accumulation of polyQ-AR truncation fragments in the cytosol resulted in neurodegeneration and apoptotic, caspase-dependent cell death. Using primary neurons from mice transgenic or deficient for apoptosis-related genes, we determined that polyQ-AR apoptotic activation is fully dependent on Bax. Jun N-terminal kinase (JNK) was required for apoptotic pathway activation through phosphorylation of c-Jun. Expression of polyQ-AR in DP5/Hrk null neurons yielded significant protection against apoptotic activation, but absence of Bim did not provide protection, apparently due to compensatory upregulation of DP5/Hrk or other BH3-only proteins. Misfolded AR protein in the cytosol thus initiates a cascade of events beginning with JNK and culminating in Bax-dependent, intrinsic pathway activation, mediated in part by DP5/Hrk. As apoptotic mediators are candidates for toxic fragment generation and other cellular processes linked to neuron dysfunction, delineation of the apoptotic activation pathway induced by polyQ-expanded AR may shed light on the pathogenic cascade in SBMA and other motor neuron diseases.

    DOI: 10.1523/JNEUROSCI.4072-08.2009

    Web of Science

    researchmap

  • B-type natriuretic peptide and cardiovalvulopathy in Parkinson disease with dopamine agonist

    H. Watanabe, M. Hirayama, A. Noda, M. Ito, N. Atsuta, J. Senda, T. Kaga, A. Yamada, M. Katsuno, T. Niwa, F. Tanaka, G. Sobue

    NEUROLOGY   72 ( 7 )   621 - 626   2009年2月

     詳細を見る

    記述言語:英語   出版者・発行元:LIPPINCOTT WILLIAMS & WILKINS  

    Objective: To elucidate the usefulness of plasma B-type natriuretic peptide (BNP) values for evaluating adverse effects of pergolide or cabergoline on cardiovalvulopathy in patients with Parkinson disease.
    Methods: Twenty-five patients treated with pergolide or cabergoline (ergot group) and 25 patients never treated with ergot derivatives (non-ergot group) were enrolled. Plasma BNP values and detailed echocardiography were evaluated. Thirty age- and gender-matched controls were similarly evaluated.
    Results: Patients with regurgitation more than grade 3 were more frequent in the ergot group than in the non-ergot group as well as control groups (24%, 0%, 3%, p = 0.001). Both composite regurgitation scores and plasma BNP values were significantly higher in the ergot group than in controls. In the ergot group, the cumulative dose correlated to both tenting area (r = 0.57, p = 0.004) and tenting distance (r = 0.62, p = 0.001). Furthermore, plasma BNP values were higher in patients with severe or multiple regurgitation groups (p &lt; 0.001), and were correlated with composite regurgitation score (r = 0.70, p &lt; 0.001). Multiple regression analyses revealed that BNP values were independently correlated with both composite regurgitation and left ventricular ejection fraction.
    Conclusion: The combination of comprehensive echocardiography and plasma B-type natriuretic peptide levels elucidates the presence of cardiac damage in patients with Parkinson disease using ergot derivative dopamine agonists. Neurology (R) 2009;72:621-626

    DOI: 10.1212/01.wnl.0000342467.47860.f2

    Web of Science

    researchmap

  • Age at onset influences on wide-ranged clinical features of sporadic amyotrophic lateral sclerosis. 国際誌

    Naoki Atsuta, Hirohisa Watanabe, Mizuki Ito, Fumiaki Tanaka, Akiko Tamakoshi, Imaharu Nakano, Masashi Aoki, Shoji Tsuji, Tatsuhiko Yuasa, Hiroki Takano, Hideaki Hayashi, Shigeki Kuzuhara, Gen Sobue

    Journal of the neurological sciences   276 ( 1-2 )   163 - 9   2009年1月

     詳細を見る

    記述言語:英語   出版者・発行元:ELSEVIER SCIENCE BV  

    PURPOSE: To profile the detailed clinical features of sporadic amyotrophic lateral sclerosis (ALS) on large-scale samples in Japan. METHODS: We assessed the clinical features of sporadic ALS patients in Japan, based on the nationwide registration system of the Ministry of Health, Labor and Welfare of Japan. We described 3,428 new cases registered cases between 2003 and 2006 to analyze initial symptoms and related clinical features, 4,202 cases registered in the single year of 2005 to describe the cross-sectional overview of the ALS patients, and a total of 2,128 cases with tracheostomy positive pressure ventilation (TPPV) from all of the registration data from 2003 to 2006 to describe the features of ALS patients with TPPV. RESULTS: The patients with an older age at onset progressed more rapidly to the TPPV stage than those with a younger age at onset. The subpopulation of patients with long-standing TPPV showed ophthalmoplegia, while its appearance rate was less in the patients with an older age at onset than in those with a younger age at onset. Furthermore, age at onset strongly influenced the frequency of initial symptoms: dysarthria, dysphagia, neck weakness and respiratory disturbance were more frequent in patients with an older age at onset, while upper or lower limb weakness was observed more frequently in patients with a younger age at onset. In addition, those initial symptoms were still the most prominent at the follow-up stage, suggesting that the initial symptoms determine the major clinical features even in advanced illness. CONCLUSIONS: Our present study demonstrated that symptomatic features of ALS are strongly influenced by the age at onset by the large scale of samples.

    DOI: 10.1016/j.jns.2008.09.024

    Web of Science

    PubMed

    researchmap

  • Age at onset influences on wide-ranged clinical features of sporadic amyotrophic lateral sclerosis

    Naoki Atsuta, Hirohisa Watanabe, Mizuki Ito, Fumiaki Tanaka, Akiko Tamakoshi, Imaharu Nakano, Masashi Aoki, Shoji Tsuji, Tatsuhiko Yuasa, Hirold Takano, Hideaki Hayashi, Shigeld Kuzuhara, Gen Sobue

    JOURNAL OF THE NEUROLOGICAL SCIENCES   276 ( 1-2 )   163 - 169   2009年1月

     詳細を見る

    記述言語:英語   出版者・発行元:ELSEVIER SCIENCE BV  

    Purpose: To profile the detailed clinical features of sporadic amyotrophic lateral sclerosis (ALS) on large-scale samples in Japan.
    Methods: We assessed the clinical features of sporadic ALS patients in Japan, based on the nationwide registration system of the Ministry of Health, Labor and Welfare of Japan. We described 3428 new cases registered cases between 2003 and 2006 to analyze initial symptoms and related clinical features, 4202 cases registered in the single year of 2005 to describe the cross-sectional overview of the ALS patients, and a total of 2128 cases with tracheostomy positive pressure ventilation (TPPV) from all of the registration data from 2003 to 2006 to describe the features of ALS patients with TPPV.
    Results: The patients with an older age at onset progressed more rapidly to the TPPV stage than those with a Younger age at onset. The subpopulation of patients with long-standing TPPV showed ophthalmoplegia, while its appearance rate was less in the patients with an older age at onset than in those with a younger age at onset. Furthermore, age at onset strongly influenced the frequency of initial symptoms: dysarthria, dysphagia, neck weakness and respiratory disturbance were more frequent in patients with an older age at onset, while upper or lower limb weakness was observed more frequently in patients with a younger age at onset. In addition, those initial symptoms were still the most prominent at the follow-up stage, Suggesting that the initial symptoms determine the major clinical features even in advanced illness.
    Conclusions: Our present study demonstrated that symptomatic features of ALS are strongly influenced by the age at onset by the large scale of samples. (C) 2008 Elsevier B.V. All rights reserved.

    DOI: 10.1016/j.jns.2008.09.024

    Web of Science

    researchmap

  • Heat shock proteins in neurodegenerative diseases: Pathogenic roles and therapeutic implications

    Hiroaki Adachi, Masahisa Katsuno, Masahiro Waza, Makoto Minamiyama, Fumiaki Tanaka, Gen Sobue

    INTERNATIONAL JOURNAL OF HYPERTHERMIA   25 ( 8 )   647 - 654   2009年

     詳細を見る

    記述言語:英語   出版者・発行元:INFORMA HEALTHCARE  

    Neurodegenerative diseases including amyotrophic lateral sclerosis, Parkinson&apos;s disease, Alzheimer&apos;s disease, and polyglutamine (polyQ) diseases are thought to be caused by protein misfolding. Heat shock proteins (HSPs), which function mainly as molecular chaperones, play an important role in the folding and quality control of proteins. The histopathological hallmark of neurodegenerative diseases is accumulation and/or inclusions of the disease-causing proteins in residual neurons in targeted regions of the nervous system. The inclusions combine with many components of molecular chaperone pathways and ubiquitin-proteasome, raising the possibility that misfolding and altered degradation of mutant proteins may be involved in the pathogenesis of neurodegenerative diseases. Overexpression of HSPs has been reported to reduce the number and size of inclusions and accumulation of disease-causing proteins, and ameliorate the phenotypes in neuronal cell and mouse models. Hsp90 inhibitors also exert therapeutic effects through selective proteasome degradation of its client proteins. Elucidation of its pathophysiology using animal models has led to the development of disease-modifying drugs, i.e., Hsp90 inhibitor and HSP inducer, which inhibit the pathogenic process of neuronal degeneration. These findings may provide the basis for development of an HSP-related therapy for neurodegenerative diseases.

    DOI: 10.3109/02656730903315823

    Web of Science

    researchmap

  • The significance of carpal tunnel syndrome in transthyretin Val30Met familial amyloid polyneuropathy

    Haruki Koike, Saori Morozumi, Yuichi Kawagashira, Masahiro Iijima, Masahiko Yamamoto, Naoki Hattori, Fumiaki Tanaka, Tomohiko Nakamura, Masaaki Hirayama, Yukio Ando, Shu-Ichi Ikeda, Gen Sobue

    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS   16 ( 3 )   142 - 148   2009年

     詳細を見る

    記述言語:英語   出版者・発行元:INFORMA HEALTHCARE  

    Carpal tunnel syndrome (CTS) is frequently reported in association with amyloidosis. We determined the significance of CTS in transthyretin Val30Met-associated familial amyloid polyneuropathy (FAP ATTR Val30Met) by comparing the electrophysiological indices of the median and ulnar nerves in 58 patients. As a whole, sensory nerve conduction velocity (SCV) was slowed and distal motor latency (DML) was prolonged to a similar extent in the median and ulnar nerves in these patients. The extent of abnormalities in the median nerve was almost similar to that in the ulnar nerve in both early-onset cases from endemic foci and late-onset cases from non-endemic areas. In age-matched idiopathic patients with CTS (20 patients, 27 hands), the slowing of SCV and the prolongation of DML in the median nerve were significant, while the slowing of motor conduction velocity was much less compared to FAP ATTR Val30Met patients. Although concomitant lesions in the ulnar nerve entrapment site at the wrist cannot be excluded, these findings indicate that CTS is not the sole distinctive feature in the majority of FAP ATTR Val30Met patients. The electrophysiological abnormality at the distal portion of the median nerve may be a consequence of polyneuropathy rather than an entrapment injury.

    DOI: 10.1080/13506120903094074

    Web of Science

    researchmap

  • The significance of carpal tunnel syndrome in transthyretin Val30Met familial amyloid polyneuropathy. 国際誌

    Haruki Koike, Saori Morozumi, Yuichi Kawagashira, Masahiro Iijima, Masahiko Yamamoto, Naoki Hattori, Fumiaki Tanaka, Tomohiko Nakamura, Masaaki Hirayama, Yukio Ando, Shu-Ichi Ikeda, Gen Sobue

    Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis   16 ( 3 )   142 - 8   2009年

     詳細を見る

    記述言語:英語   出版者・発行元:INFORMA HEALTHCARE  

    Carpal tunnel syndrome (CTS) is frequently reported in association with amyloidosis. We determined the significance of CTS in transthyretin Val30Met-associated familial amyloid polyneuropathy (FAP ATTR Val30Met) by comparing the electrophysiological indices of the median and ulnar nerves in 58 patients. As a whole, sensory nerve conduction velocity (SCV) was slowed and distal motor latency (DML) was prolonged to a similar extent in the median and ulnar nerves in these patients. The extent of abnormalities in the median nerve was almost similar to that in the ulnar nerve in both early-onset cases from endemic foci and late-onset cases from non-endemic areas. In age-matched idiopathic patients with CTS (20 patients, 27 hands), the slowing of SCV and the prolongation of DML in the median nerve were significant, while the slowing of motor conduction velocity was much less compared to FAP ATTR Val30Met patients. Although concomitant lesions in the ulnar nerve entrapment site at the wrist cannot be excluded, these findings indicate that CTS is not the sole distinctive feature in the majority of FAP ATTR Val30Met patients. The electrophysiological abnormality at the distal portion of the median nerve may be a consequence of polyneuropathy rather than an entrapment injury.

    DOI: 10.1080/13506120903094074

    Web of Science

    PubMed

    researchmap

  • Correlation between pyramidal tract degeneration and widespread white matter involvement in amyotrophic lateral sclerosis: A study with tractography and diffusion-tensor imaging

    Amyotroph Lateral Scler   Jan 29   1 - 8   2009年

     詳細を見る

  • TGF-beta signal disruption in polyglutamine disease

    Masahisa Katsuno, Hiroaki Adachi, Makoto Minamiyama, Masahiro Waza, Keisuke Tokui, Hideki Doi, Fumiaki Tanaka, Gen Sobue

    NEUROSCIENCE RESEARCH   65   S248 - S248   2009年

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:ELSEVIER IRELAND LTD  

    DOI: 10.1016/j.neures.2009.09.1408

    Web of Science

    researchmap

  • Medical induction of stress response alleviates polyglutamine-mediated motor neuron disease

    Hiroaki Adachi, Genki Tohnai, Masahisa Katsuno, Makoto Minamiyama, Masahiro Waza, Hideki Doi, Fumiaki Tanaka, Kenzo Ohtsuka, Gen Sobue

    NEUROSCIENCE RESEARCH   65   S120 - S120   2009年

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:ELSEVIER IRELAND LTD  

    DOI: 10.1016/j.neures.2009.09.567

    Web of Science

    researchmap

  • TDP-43 depletion induces neuronal cell damage through dysregulation of Rho family GTPases

    Yohei Iguchi, Masahisa Katsuno, Jun-Ichi Niwa, Jun Sone, Masahiro Waza, Hiroaki Adachi, Fumiaki Tanaka, Kozo Kaibuchi, Gen Sobue

    NEUROSCIENCE RESEARCH   65   S119 - S119   2009年

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:ELSEVIER IRELAND LTD  

    DOI: 10.1016/j.neures.2009.09.561

    Web of Science

    researchmap

  • Correlation between pyramidal tract degeneration and widespread white matter involvement in amyotrophic lateral sclerosis: A study with tractography and diffusion-tensor imaging

    Amyotroph Lateral Scler   Jan 29   1 - 8   2009年

     詳細を見る

  • Correlation between pyramidal tract degeneration and widespread white matter involvement in amyotrophic lateral sclerosis: A study with tractography and diffusion-tensor imaging

    Joe Senda, Mizuki Ito, Hirohisa Watanabe, Naoki Atsuta, Yoshinari Kawai, Masahisa Katsuno, Fumiaki Tanaka, Shinji Naganawa, Hiroshi Fukatsu, Gen Sobue

    AMYOTROPHIC LATERAL SCLEROSIS   10 ( 5-6 )   288 - 294   2009年

     詳細を見る

    記述言語:英語   出版者・発行元:INFORMA HEALTHCARE  

    Our aim was to evaluate the location and extent of white matter involvement in patients with amyotrophic lateral sclerosis (ALS) using diffusion-tensor magnetic resonance imaging (DTI). We obtained fractional anisotropy (FA) values from the internal capsule and various white matter regions of 46 patients with sporadic ALS and 19 control subjects. In ALS patients, FA values in the internal capsule, frontal white matter, genu and splenium of the corpus callosum (p&lt;0.001), parietal and temporal lobe white matter, and posterior cingulum (p&lt;0.05) were significantly lower than in controls. FA values in frontal white matter were lower than in parietal white matter (p&lt;0.001). Decreased FA values in frontal, parietal, and temporal white matter, and the genu of the corpus callosum, correlated significantly with those in the internal capsule (r = 0.66 and p&lt;0.001, r = 0.47 and p = 0.001, r = 0.33 and p = 0.021, r = 0.41 and p = 0.005, respectively). No such correlations were found for FA values in other white matter areas or in controls. Patient FA values generally were not correlated with disease duration. DTI demonstrated more widespread involvement of the cerebral white matter in ALS patients than previously believed. The severity of involvement in the frontal, temporal and parietal white matter correlated with severity in the pyramidal tract.

    DOI: 10.3109/17482960802651717

    Web of Science

    researchmap

  • 家族性NIHID(エオジン好性核内封入体病)遺伝性ニューロパチーとの鑑別について

    曽根 淳, 菱川 望, 小池 春樹, 田中 章景, 祖父江 元, 吉田 眞理, 橋詰 良夫, 今村 久司, 山田 英二, 渡辺 俊之, 小牟禮 修

    末梢神経 = Peripheral nerve   19 ( 2 )   387 - 389   2008年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本末梢神経学会  

    researchmap

  • MM2-cortical-type sporadic Creutzfeldt-Jakob disease with early stage cerebral cortical pathology presenting with a rapidly progressive clinical course. 国際誌

    Yoshiki Niimi, Yasushi Iwasaki, Toshitaka Umemura, Fumiaki Tanaka, Mari Yoshida, Yoshio Hashizume, Tetsuyuki Kitamoto, Mikio Hirayama, Gen Sobue

    Neuropathology : official journal of the Japanese Society of Neuropathology   28 ( 6 )   645 - 51   2008年12月

     詳細を見る

    記述言語:英語   出版者・発行元:WILEY-BLACKWELL  

    We report the case of a 67-year-old man with MM2-cortical-type sporadic Creutzfeldt-Jakob disease (sCJD) with a rapidly progressive clinical course of 5 months. Initial symptoms were progressive memory disturbance and dementia. MRI revealed high signal-intensity lesions on diffusion-weighted images in the bilateral frontal and occipital cortices. Myoclonus and periodic sharp-wave complexes on the electroencephalogram were observed in the early disease stage. The clinical diagnosis was typical sCJD. Neuropathologic examination at autopsy showed widespread, characteristic cerebral neocortical involvement with large confluent vacuole-type spongiform change. Spongiform degeneration was also evident in the striatum and medial thalamus. In the cerebellar cortex, slight depletion of Purkinje neurons was evident without spongiform change in the molecular layer or apparent neuron loss in the granule cell layer. The inferior olivary nucleus showed slight hypertrophic astrocytosis without neuron loss. Prion protein (PrP) immunostaining showed widespread, characteristic perivacuolar-type PrP deposits with irregular plaque-like PrP deposits in the cerebral neocortex, striatum and medial thalamus. We believe this patient showed early-stage cerebral cortical pathology of MM2-cortical-type sCJD, which may provide clues regarding the pathologic progression of this rare sCJD subtype. Although MM2-cortical-type sCJD generally shows slow progression without myoclonus or periodic sharp-wave complexes, the present patient showed a rapidly progressive clinical course similar to that of MM1-type sCJD.

    DOI: 10.1111/j.1440-1789.2008.00904.x

    Web of Science

    PubMed

    researchmap

  • MM2-cortical-type sporadic Creutzfeldt-Jakob disease with early stage cerebral cortical pathology presenting with a rapidly progressive clinical course

    Yoshiki Niimi, Yasushi Iwasaki, Toshitaka Umemura, Fumiaki Tanaka, Mari Yoshida, Yoshio Hashizume, Tetsuyuki Kitamoto, Mikio Hirayama, Gen Sobue

    NEUROPATHOLOGY   28 ( 6 )   645 - 651   2008年12月

     詳細を見る

    記述言語:英語   出版者・発行元:WILEY-BLACKWELL  

    We report the case of a 67-year-old man with MM2-cortical-type sporadic Creutzfeldt-Jakob disease (sCJD) with a rapidly progressive clinical course of 5 months. Initial symptoms were progressive memory disturbance and dementia. MRI revealed high signal-intensity lesions on diffusion-weighted images in the bilateral frontal and occipital cortices. Myoclonus and periodic sharp-wave complexes on the electroencephalogram were observed in the early disease stage. The clinical diagnosis was typical sCJD. Neuropathologic examination at autopsy showed widespread, characteristic cerebral neocortical involvement with large confluent vacuole-type spongiform change. Spongiform degeneration was also evident in the striatum and medial thalamus. In the cerebellar cortex, slight depletion of Purkinje neurons was evident without spongiform change in the molecular layer or apparent neuron loss in the granule cell layer. The inferior olivary nucleus showed slight hypertrophic astrocytosis without neuron loss. Prion protein (PrP) immunostaining showed widespread, characteristic perivacuolar-type PrP deposits with irregular plaque-like PrP deposits in the cerebral neocortex, striatum and medial thalamus. We believe this patient showed early-stage cerebral cortical pathology of MM2-cortical-type sCJD, which may provide clues regarding the pathologic progression of this rare sCJD subtype. Although MM2-cortical-type sCJD generally shows slow progression without myoclonus or periodic sharp-wave complexes, the present patient showed a rapidly progressive clinical course similar to that of MM1-type sCJD.

    DOI: 10.1111/j.1440-1789.2008.00904.x

    Web of Science

    researchmap

  • Dynactin-1ノックダウン線虫モデルの作成

    和座 雅浩, 田中 章景, 蒋 月梅, 黄 哲, 勝野 雅央, 足立 弘明, 山本 正彦, 祖父江 元

    臨床神経学   48 ( 12 )   1122 - 1122   2008年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • マイクロアレイDNAチップによるCharcot-Marie-Tooth病の遺伝子診断

    高嶋 博, 橋口 昭大, 平野 隆城, 中村 友紀, 有村 公良, 祖父江 元, 服部 直樹, 田中 章景, 中川 正法, 滋賀 健介

    末梢神経   19 ( 2 )   390 - 392   2008年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本末梢神経学会  

    researchmap

  • 球脊髄性筋萎縮症モデルにおける神経栄養因子高発現の効果

    足立 弘明, 徳井 啓介, 船越 洋, 和座 雅浩, 勝野 雅央, 南山 誠, 田中 章景, 祖父江 元

    臨床神経学   48 ( 12 )   1148 - 1148   2008年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • シェーグレン症候群に伴うpainful sensory neuropathyに対するIVIgの有効性の検討

    両角 佐織, 冨田 稔, 川頭 祐一, 飯島 正博, 小池 春樹, 服部 直樹, 渡辺 宏久, 田中 章景, 祖父江 元

    末梢神経   19 ( 2 )   483 - 484   2008年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本末梢神経学会  

    researchmap

  • 家族性NIHID(エオジン好性核内封入体病)の病態解析

    曽根 淳, 田中 章景, 小池 春樹, 菱川 望, 祖父江 元, 吉田 眞理, 橋詰 良夫, 山田 英二, 渡辺 俊之, 小牟禮 修, 今村 久司

    臨床神経学   48 ( 12 )   1121 - 1121   2008年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 経口Hsp90阻害剤は、SBMAモデルマウスの表現型を改善する

    徳井 啓介, 足立 弘明, 和座 雅浩, 勝野 雅央, 南山 誠, 田中 章景, 祖父江 元

    臨床神経学   48 ( 12 )   1121 - 1121   2008年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 球脊髄性筋萎縮症モデルマウスを用いた病態関連遺伝子群の検討

    南山 誠, 勝野 雅央, 足立 弘明, 和座 雅浩, 徳井 啓介, 土井 英樹, 田中 章景, 祖父江 元

    臨床神経学   48 ( 12 )   1148 - 1148   2008年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • ALSの研究・治療はどこまできたか 孤発性ALS病態関連分子の探索と疾患モデルの開発

    田中 章景, 和座 雅浩, 丹羽 淳一, 山本 正彦, 祖父江 元

    臨床神経学   48 ( 11 )   970 - 972   2008年11月

  • Electrophysiological features of late-onset transthyretin Met30 familial amyloid polyneuropathy unrelated to endemic foci. 国際誌

    Haruki Koike, Yuichi Kawagashira, Masahiro Iijima, Masahiko Yamamoto, Naoki Hattori, Fumiaki Tanaka, Masaaki Hirayama, Yukio Ando, Shu-ichi Ikeda, Gen Sobue

    Journal of neurology   255 ( 10 )   1526 - 33   2008年10月

     詳細を見る

    記述言語:英語   出版者・発行元:DR DIETRICH STEINKOPFF VERLAG  

    BACKGROUND: Through the development of gene diagnostic techniques, late-onset transthyretin Met30-associated familial amyloid polyneuropathy (FAP TTR Met30) has been shown to be more prevalent than is generally believed. OBJECTIVE: To examine the electrophysiological features of late-onset FAP TTR Met30 unrelated to endemic foci. METHODS: Nerve conduction findings in 44 cases with an onset of more than 50 years of age in a non-endemic area were assessed and compared with findings from 21 earlier-onset cases related to endemic foci. RESULTS: The extent of the reduction of the compound muscle action potential and, especially, the sensory nerve action potential was more profound in the late-onset group even when the decline of these indices with aging in normal control subjects was taken into account. The feature of predominant lower-limb involvement seemed to be more conspicuous in the late-onset group. Electrophysiological indices tended to be aggravated as the duration of neuropathic symptoms increased in the early-onset group, while most of these indices in the lateonset group did not show this correlation. A slowing of conduction velocity and a prolongation of distal latency, which suggests demyelination, were conspicuous in some patients. Pathologically, a predominant loss of small-fibers was not conspicuous in sural nerve biopsy specimens from late-onset patients. Large myelinated fiber density showed a negative correlation with the disease duration in early-onset cases, but not in late-onset cases. CONCLUSIONS: Electrophysiological differences between late- and early-onset cases were present, probably reflecting the different underlying pathogenic mechanisms of neuropathy. The demyelinating feature does not exclude the possibility of this disease.

    DOI: 10.1007/s00415-008-0962-z

    Web of Science

    PubMed

    researchmap

  • Electrophysiological features of late-onset transthyretin Met30 familial amyloid polyneuropathy unrelated to endemic foci

    Haruki Koike, Yuichi Kawagashira, Masahiro Iijima, Masahiko Yamamoto, Naoki Hattori, Fumiaki Tanaka, Masaaki Hirayama, Yukio Ando, Shu-ichi Ikeda, Gen Sobue

    JOURNAL OF NEUROLOGY   255 ( 10 )   1526 - 1533   2008年10月

     詳細を見る

    記述言語:英語   出版者・発行元:DR DIETRICH STEINKOPFF VERLAG  

    Through the development of gene diagnostic techniques, late-onset transthyretin Met30-associated familial amyloid polyneuropathy (FAP TTR Met30) has been shown to be more prevalent than is generally believed.
    To examine the electrophysiological features of late-onset FAP TTR Met30 unrelated to endemic foci.
    Nerve conduction findings in 44 cases with an onset of more than 50 years of age in a non-endemic area were assessed and compared with findings from 21 earlier-onset cases related to endemic foci.
    The extent of the reduction of the compound muscle action potential and, especially, the sensory nerve action potential was more profound in the late-onset group even when the decline of these indices with aging in normal control subjects was taken into account. The feature of predominant lower-limb involvement seemed to be more conspicuous in the late-onset group. Electrophysiological indices tended to be aggravated as the duration of neuropathic symptoms increased in the early-onset group, while most of these indices in the lateonset group did not show this correlation. A slowing of conduction velocity and a prolongation of distal latency, which suggests demyelination, were conspicuous in some patients. Pathologically, a predominant loss of small-fibers was not conspicuous in sural nerve biopsy specimens from late-onset patients. Large myelinated fiber density showed a negative correlation with the disease duration in early-onset cases, but not in late-onset cases.
    Electrophysiological differences between late- and early-onset cases were present, probably reflecting the different underlying pathogenic mechanisms of neuropathy. The demyelinating feature does not exclude the possibility of this disease.

    DOI: 10.1007/s00415-008-0962-z

    Web of Science

    researchmap

  • Neuropathic pain correlates with myelinated fibre loss and cytokine profile in POEMS syndrome

    H. Koike, M. Iijima, K. Mori, M. Yamamoto, N. Hattori, H. Watanabe, F. Tanaka, M. Doyu, G. Sobue

    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY   79 ( 10 )   1171 - 1179   2008年10月

     詳細を見る

    記述言語:英語   出版者・発行元:BMJ PUBLISHING GROUP  

    Objective: To reveal characteristic clinicopathological correlates of polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy and skin changes (POEMS) syndrome.
    Methods: The clinical features of 22 patients with POEMS syndrome were investigated and correlated with the histopathological features of sural nerves and serum cytokine profiles.
    Results: More than half of the patients complained of pain in the lower extremities, which is closely related to hyperalgesia. Assessment of the total nerve fibre population using complete transverse sural nerve cross-sections, excluding the marked enlargement of endoneurial areas due to intrafascicular oedema, showed that myelinated fibres, especially small myelinated fibres, were reduced, whereas unmyelinated fibres were preserved. Uncompacted myelin lamellae and segmental demyelination were seen more frequently in the small, rather than the large, myelinated fibres. The presence of hyperalgesia was electrophysiologically associated with a reduction of sensory nerve action potentials in the sural nerve (p &lt; 0.05) and histopathologically associated with myelinated fibre loss (p &lt; 0.01). Serum levels of proinflammatory cytokines (interleukin-1b, interleukin-6 and tumour necrosis factor-alpha), but not their soluble receptors, were significantly elevated in patients with hyperalgesia (p &lt; 0.05-0.01). Conclusions: Hyperalgesia seen in patients with POEMS syndrome is closely related with a reduction in the myelinated, but not unmyelinated, fibre population. Elevation of proinflammatory cytokines is also correlated with hyperalgesia. The painful symptoms in POEMS syndrome may be generated by well-preserved unmyelinated C-fibres due to the lack of inhibitory myelinated A-fibres, along with cytokine sensitisation.

    DOI: 10.1136/jnnp.2007.135681

    Web of Science

    researchmap

  • Prevalence and incidence rates of chronic inflammatory demyelinating polyneuropathy in the Japanese population

    M. Iijima, H. Koike, N. Hattori, A. Tamakoshi, M. Katsuno, F. Tanaka, M. Yamamoto, K. Arimura, G. Sobue

    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY   79 ( 9 )   1040 - 1043   2008年9月

     詳細を見る

    記述言語:英語   出版者・発行元:B M J PUBLISHING GROUP  

    Objective and methods: To characterise the epidemiological features of chronic inflammatory demyelinating polyneuropathy (CIDP) in the Japanese population, this study performed a nationwide assessment of the prevalence and incidence rates in Japan.
    Results: The prevalence rate per 100 000 was 1.61 in the total population; 2.01 in males and 1.23 in females. The age dependent prevalence rates were 0.23 in juveniles (&lt;15 years old), 1.50 in young adults (15-55 years) and 2.31 in elderly adults (&gt;55 years). The sex and age dependent prevalence rates were 0.22 in males and 0.24 in females in juveniles, 1.81 in males and 1.19 in females in young adults, and 3.12 in males and 1.64 in females in elderly adults. The annual incidence rate per 100 000 was 0.48 in the total population, 0.58 in males and 0.38 in females. The age dependent incidence rate was 0.06 in juveniles, 0.40 in young adults and 0.73 in elderly adults. The sex and age dependent incidence rate was 0.05 in males and 0.08 in females in juveniles, 0.50 in males and 0.30 in females in young adults, and 0.93 in males and 0.58 in females in elderly adults. Both the prevalence and incidence rates were very similar throughout the eight geographical areas studied, from the northern to the southern parts of Japan.
    Conclusions: The prevalence and incidence rates were similar to those reported in the Caucasian population. The pathogenic background is suggested to be common throughout the different races and geographic areas, while gender and age effects should be taken into account in the pathogenesis of CIDP.

    DOI: 10.1136/jnnp.2007.128132

    Web of Science

    researchmap

  • Fractional anisotropy values detect pyramidal tract involvement in multiple system atrophy. 国際誌

    Mizuki Ito, Hirohisa Watanabe, Naoki Atsuta, Jo Senda, Yoshinari Kawai, Fumiaki Tanaka, Shinji Naganawa, Hiroshi Fukatsu, Gen Sobue

    Journal of the neurological sciences   271 ( 1-2 )   40 - 6   2008年8月

     詳細を見る

    記述言語:英語   出版者・発行元:ELSEVIER SCIENCE BV  

    OBJECTIVE: Pathological studies have shown remarkable pyramidal tract involvement in multiple system atrophy (MSA), while clinical pyramidal signs are relatively rare. We investigated the fractional anisotropy (FA) values to assess the degree of pyramidal tract involvement in MSA, in comparison with amyotrophic lateral sclerosis (ALS) and controls. Furthermore, we compared FA values between MSA patients with or without clinical pyramidal signs and controls, and between MSA patients with or without positive conventional MRI findings and controls. METHODS: We evaluated FA values in the internal capsule, corona radiate and whole pyramidal tract using visualized tractography of 65 subjects (20 probable MSA patients, 28 age-matched ALS patients, and 17 age-matched healthy controls) using a 3.0T magnetic resonance system. RESULTS: The FA values in the internal capsule, corona radiate, and whole pyramidal tract were significantly lower in MSA patients than in controls and were at a level similar to those of ALS patients. In addition, low FA values were prominent in MSA patients, even in those with short duration of illness, lacking precentral gyrus hyperintensity in FLAIR images, and without pyramidal signs. CONCLUSION: FA values could identify pyramidal tract degeneration even in patients with early phase MSA and those without clinical pyramidal signs or abnormal MRI findings. More extensive degeneration of the pyramidal tract occurs in MSA than so far believed.

    DOI: 10.1016/j.jns.2008.03.013

    Web of Science

    PubMed

    researchmap

  • A strategy for developing effective amyotropic lateral sclerosis pharmacotherapy: from clinical trials to novel pharmacotherapeutic strategies. 国際誌

    Masahiko Yamamoto, Fumiaki Tanaka, Hiroshi Tatsumi, Gen Sobue

    Expert opinion on pharmacotherapy   9 ( 11 )   1845 - 57   2008年8月

     詳細を見る

    記述言語:英語   出版者・発行元:INFORMA HEALTHCARE  

    BACKGROUND: The pathomechanism of sporadic amyotropic lateral sclerosis is not clearly understood, although a proportion of familial amyotropic lateral sclerosis is caused by superoxide dismutase 1 mutations. Theories based on studies of human post-mortem tissue, research on animal models and in vitro work have been proposed for the pathogenesis of amyotropic lateral sclerosis, but the pathogenesis is not the same between sporadic and familial amyotropic lateral sclerosis. OBJECTIVE/METHODS: Drug candidates were tested using superoxide dismutase 1 mutant mice. Although the candidates were shown to be effective in mice, clinical trials in humans have failed to identify any truly effective pharmacotherapies in sporadic amyotropic lateral sclerosis, with only riluzole providing a modest improvement in survival. Ongoing or planned trials are exploring the value of antiglutamatergic drugs, antioxidants, neurotrophic factors, anti-inflammatory drugs and anti-aggregation drugs. RESULTS/CONCLUSIONS: A combination of drugs acting on different mechanisms is needed for effective therapy. Moreover, gene expression profiling and genome-wide association studies, together with inhibitory RNA techniques, are helpful for developing new pharmacotherapeutic strategies including gene therapy. It is also likely that the recently advanced generation of induced pluripotent stem cells will lead to the development of cell therapy for amyotropic lateral sclerosis. In addition to finding effective therapies, research is also needed in order to detect early disease markers since pharmacotherapy is most beneficial when given early in the course of sporadic amyotropic lateral sclerosis.

    DOI: 10.1517/14656566.9.11.1845

    Web of Science

    PubMed

    researchmap

  • Walking capacity evaluated by the 6-minute walk test in spinal and bulbar muscular atrophy

    Yu Takeuchi, Masahisa Katsuno, Haruhiko Banno, Keisuke Suzuki, Motoshi Kawashima, Naoki Atsuta, Mizuki Ito, Hirohisa Watanabe, Fumiaki Tanaka, Gen Sobue

    MUSCLE & NERVE   38 ( 2 )   964 - 971   2008年8月

     詳細を見る

    記述言語:英語   出版者・発行元:JOHN WILEY & SONS INC  

    Spinal and bulbar muscular atrophy (SBMA) is an adult-onset motor neuron disease caused by a CAG repeat expansion in the androgen receptor gene. Because the progression of SBMA is slow, it is plausible to identify biomarkers that monitor disease course for therapeutic development. To verify whether the 6-min walk test (6MWT) is a biomarker of SBIVIA, we performed the 6MWT in 35 genetically confirmed patients and in 29 age-matched healthy controls. The walk distance covered within 6 min (6MWD) was significantly less in SBMA than it was in controls (323.3 +/- 143.9 m and 637.6 +/- 94.2 m respectively; P &lt; 0.001). In test-retest analysis, the intraclass correlation coefficient for the 6MWD was high in SBIVIA patients (r = 0.982). In a 1-year follow-up the 6MWD significantly decreased at a rate of 11.3% per year. Our observations suggest that the 6MWT is a biomarker that can be used to monitor progression of motor impairment in SBIVIA.

    DOI: 10.1002/mus.21077

    Web of Science

    researchmap

  • Walking capacity evaluated by the 6-minute walk test in spinal and bulbar muscular atrophy. 国際誌

    Yu Takeuchi, Masahisa Katsuno, Haruhiko Banno, Keisuke Suzuki, Motoshi Kawashima, Naoki Atsuta, Mizuki Ito, Hirohisa Watanabe, Fumiaki Tanaka, Gen Sobue

    Muscle & nerve   38 ( 2 )   964 - 71   2008年8月

     詳細を見る

    記述言語:英語   出版者・発行元:JOHN WILEY & SONS INC  

    Spinal and bulbar muscular atrophy (SBMA) is an adult-onset motor neuron disease caused by a CAG repeat expansion in the androgen receptor gene. Because the progression of SBMA is slow, it is plausible to identify biomarkers that monitor disease course for therapeutic development. To verify whether the 6-min walk test (6MWT) is a biomarker of SBMA, we performed the 6MWT in 35 genetically confirmed patients and in 29 age-matched healthy controls. The walk distance covered within 6 min (6MWD) was significantly less in SBMA than it was in controls (323.3 +/- 143.9 m and 637.6 +/- 94.2 m, respectively; P < 0.001). In test-retest analysis, the intraclass correlation coefficient for the 6MWD was high in SBMA patients (r = 0.982). In a 1-year follow-up the 6MWD significantly decreased at a rate of 11.3% per year. Our observations suggest that the 6MWT is a biomarker that can be used to monitor progression of motor impairment in SBMA.

    DOI: 10.1002/mus.21077

    Web of Science

    PubMed

    researchmap

  • Fractional anisotropy values detect pyramidal tract involvement in multiple system atrophy

    Mizuki Ito, Hirohisa Watanabe, Naoki Atsuta, Jo Senda, Yoshinari Kawai, Fumiaki Tanaka, Shinji Naganawa, Hiroshi Fukatsu, Gen Sobue

    JOURNAL OF THE NEUROLOGICAL SCIENCES   271 ( 1-2 )   40 - 46   2008年8月

     詳細を見る

    記述言語:英語   出版者・発行元:ELSEVIER SCIENCE BV  

    Objective: Pathological studies have shown remarkable pyramidal tract involvement in multiple system atrophy (MSA), while clinical Pyramidal signs are relatively rare. We investigated the fractional anisotropy (FA) values to assess the degree of pyramidal tract involvement in MSA, in comparison with amyotrophic lateral sclerosis (ALS) and controls. Furthermore, we compared FA values between MSA patients with or without clinical pyramidal signs and controls, and between MSA patients with or without positive conventional MRI findings and controls.
    Methods: We evaluated FA values in the internal capsule, corona radiate and whole pyramidal tract using visualized tractography of 65 subjects (20 probable MSA patients, 28 age-matched ALS patients, and 17 age-matched healthy controls) using a 3.0T magnetic resonance system.
    Results: The FA values in the internal capsule, corona radiate, and whole pyramidal tract were significantly lower in MSA patients than in controls and were at a level similar to those of ALS patients. In addition, low FA values were prominent in MSA patients, even in those with short duration of illness, lacking precentral gyrus hyperintensity in FLAIR images, and without pyramidal signs.
    Conclusion: FA values could identify pyramidal tract degeneration even in patients with early phase MSA and those without clinical pyramidal signs or abnormal MRI findings. More extensive degeneration of the pyramidal tract occurs in MSA than so far believed. (C) 2008 Elsevier B.V. All rights reserved.

    DOI: 10.1016/j.jns.2008.03.013

    Web of Science

    researchmap

  • A strategy for developing effective amyotropic lateral sclerosis pharmacotherapy: from clinical trials to novel pharmacotherapeutic strategies

    Masahiko Yamamoto, Fumiaki Tanaka, Hiroshi Tatsumi, Gen Sobue

    EXPERT OPINION ON PHARMACOTHERAPY   9 ( 11 )   1845 - 1857   2008年8月

     詳細を見る

    記述言語:英語   掲載種別:書評論文,書評,文献紹介等   出版者・発行元:INFORMA HEALTHCARE  

    Background: The pathomechanism of sporadic amyotropic lateral sclerosis is not clearly understood, although a proportion of familial amyotropic lateral sclerosis is caused by superoxide dismutase 1 mutations. Theories based on studies of human post-mortem tissue, research on animal models and in vitro work have been proposed for the pathogenesis of amyotropic lateral sclerosis, but the pathogenesis is not the same between sporadic and familial amyotropic lateral sclerosis. Objective/methods: Drug candidates were tested using superoxide dismutase 1 mutant mice. Although the candidates were shown to be effective in mice, clinical trials in humans have failed to identify any truly effective pharmacotherapies in sporadic amyotropic lateral sclerosis, with only riluzole providing a modest improvement in survival. Ongoing or planned trials are exploring the value of anti-inflammatory glutamatergic drugs, antioxidants, neurotrophic factors, anti-inflammatory drugs and anti-aggregation drugs. Results/conclusions: A combination of drugs acting on different mechanisms is needed for effective therapy. Moreover, gene expression profiling and genome-wide association studies, together with inhibitory RNA techniques, are helpful for developing new pharmacotherapeutic strategies including gene therapy. It is also likely that the recently advanced generation of induced pluripotent stem cells will lead to the development of cell therapy for amyotropic lateral sclerosis. In addition to finding effective therapies, research is also needed in order to detect early disease markers since pharmacotherapy is most beneficial when given early in the course of sporadic amyotropic lateral sclerosis.

    DOI: 10.1517/14656560802212524

    Web of Science

    researchmap

  • Prefrontal hypoperfasion and cognitive dysfunction correlates in spinocerebellar ataxia type 6

    Y. Kawai, M. Suenaga, H. Watanabe, M. Ito, K. Kato, T. Kato, K. Ito, F. Tanaka, G. Sobue

    JOURNAL OF THE NEUROLOGICAL SCIENCES   271 ( 1-2 )   68 - 74   2008年8月

     詳細を見る

    記述言語:英語   出版者・発行元:ELSEVIER SCIENCE BV  

    Objective: The aim of this study is to evaluate the correlation between brain perfusion and cognitive dysfunction in spinocerebellar ataxia type 6 (SCA6) patients.
    Methods: Thirteen genetically confirmed SCA6 patients and 21 age- and education-matched control subjects were subjected to single photon emission computed tomography (SPECT) and neuropsychological tests. Brain perfusion was examined with SPECT analysis, while general cognition, verbal and visual memory, attention, visuospatial ability, language, executive function, depression, and anxiety were examined with the neuropsychological tests.
    Results: SCA6 patients showed prefrontal hypoperfusion, and impairments of visual memory, verbal fluency, and executive function compared to control subjects. These neuropsychological impairments in SCA6 patients were significantly correlated with a decrease in prefrontal perfusion. This relation was not correlated to other factors, such as age, education and severity of cerebellar ataxia, which are possible relevant factors associated with cognitive performance.
    Conclusions: SCA6 patients have mild cognitive impairment, and correlating prefrontal hypoperfusion. These results indicate cognitive impairment in SCA6 patients resulting from prefrontal hypoperfusion. Crown Copyright (C) 2008 Published by Elsevier B.V. All rights reserved.

    DOI: 10.1016/j.jns.2008.03.018

    Web of Science

    researchmap

  • Rapidly developing weakness mimicking Guillain-Barré syndrome in beriberi neuropathy: two case reports

    KOIKE Haruki, ITO Shinji, MOROZUMI Saori, KAWAGASHIRA Yuichi, IIJIMA Masahiro, HATTORI Naoki, TANAKA Fumiaki, SOBUE Gen

    Nutrition   24 ( 7-8 )   776 - 780   2008年7月

     詳細を見る

  • Rapidly developing weakness mimicking Guillain-Barre syndrome in beriberi neuropathy: Two case reports

    Haruki Koike, Shinji Ito, Saori Morozumi, Yuichi Kawagashira, Masahiro Iijima, Naoki Hattori, Fumiaki Tanaka, Gen Sobue

    NUTRITION   24 ( 7-8 )   776 - 780   2008年7月

     詳細を見る

    記述言語:英語   出版者・発行元:ELSEVIER SCIENCE INC  

    Objective: We examined the diagnostic difficulty in thiamine deficiency.
    Methods: We report on two patients with polyneuropathy associated with thiamine deficiency (i.e., beriberi neuropathy) that presented with acute motor symptoms mimicking Guillain-Barre syndrome.
    Results: The cause of the thiamine deficiency was associated with gastrectomy to treat cancer in a 46-y-old man and with dietary imbalance in a 33-y-old man. The thiamine deficiency was not related to alcohol intake in either patient. In both patients, the upper and lower extremities showed a rapidly progressive weakness over the course of 1 mo. Muscle weakness in the first patient progressed even after admission to the hospital, and urinary retention, Wernicke's encephalopathy, lactic acidosis, paralytic ileus, and heart failure appeared subsequently. Clinical symptoms in both patients showed improvement after initiation of thiamine administration, although some residual deficit remained.
    Conclusion: Thiamine deficiency must be actively considered as a possible cause of polyneuropathy, and variability in its clinical features should be taken into consideration. (C) 2008 Elsevier Inc. All rights reserved.

    DOI: 10.1016/j.nut.2008.02.022

    Web of Science

    PubMed

    researchmap

  • Molecular genetics and biomarkers of polyglutamine diseases

    Masahisa Katsuno, Haruhiko Banno, Keisuke Suzuki, Yu Takeuchi, Motoshi Kawashima, Fumiaki Tanaka, Hiroaki Adachi, Gen Sobue

    CURRENT MOLECULAR MEDICINE   8 ( 3 )   221 - 234   2008年5月

     詳細を見る

    記述言語:英語   掲載種別:書評論文,書評,文献紹介等   出版者・発行元:BENTHAM SCIENCE PUBL LTD  

    Polyglutamine diseases are hereditary neurodegenerative disorders caused by an abnormal expansion of a trinucleotide CAG repeat, which encodes a polyglutamine tract. To date, nine polyglutamine diseases are known: Huntington's disease (HD), spinal and bulbar muscular atrophy (SBMA), dentatorubral-pallidoluysian atrophy (DRPLA) and six forms of spinocerebellar ataxia (SCA). The diseases are inherited in an autosomal dominant fashion except for SBMA, which shows an X-linked pattern of inheritance. Although the causative gene varies with each disorder, polyglutamine diseases share salient genetic features as well as molecular pathogenesis. CAG repeat size correlates well with the age of onset in each disease, shows both somatic and germline instability, and has a strong tendency to further expand in successive generations. Aggregation of the mutant protein followed by the disruption of cellular functions, such as transcription and axonal transport, has been implicated in the etiology of neurodegeneration in polyglutamine diseases. Although animal studies have provided promising therapeutic strategies for polyglutamine diseases, it remains difficult to translate these disease-modifying therapies to the clinic. To optimize "proof of concept", the process for testing candidate therapies in humans, it is of importance to identify biomarkers which can be used as surrogate endpoints in clinical trials for polyglutamine diseases.

    DOI: 10.2174/156652408784221298

    Web of Science

    researchmap

  • Cognitive impairment in spinocerebellar ataxia type 6

    M. Suenaga, Y. Kawai, H. Watanabe, N. Atsuta, M. Ito, F. Tanaka, M. Katsuno, H. Fukatsu, S. Naganawa, G. Sobue

    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY   79 ( 5 )   496 - 499   2008年5月

     詳細を見る

    記述言語:英語   出版者・発行元:B M J PUBLISHING GROUP  

    Objective: The aim of this study was to evaluate cognitive impairment in patients with spinocerebellar ataxia type 6 (SCA6) and to verify the role of cerebellar involvement in intellectual abilities.
    Methods: Cognitive function was examined in 18 patients with genetically confirmed SCA6 and in 21 age and education matched controls using a test battery for attention, verbal and visuospatial memory, as well as executive function.
    Results: Verbal fluency and immediate visual memory task were markedly impaired in SCA6 compared with the control group (p = 0.007, 0.004 and 0.014, respectively). The results of the Rule Shift Cards Test was reduced in patients with SCA6, but the reduction was not significant. These cognitive dysfunctions did not correlated with CAG repeat length, age at onset, ataxic motor dysfunctional scale or depression.
    Conclusions: Our results demonstrate that specific cognitive deficits occur in patients with SCA6, independent of ataxic motor dysfunction. These deficits may reflect disruption of cortico-cerebellar circuits.

    DOI: 10.1136/jnnp.2007.119883

    Web of Science

    researchmap

  • Molecular genetics and biomarkers of polyglutamine diseases. 国際誌

    Masahisa Katsuno, Haruhiko Banno, Keisuke Suzuki, Yu Takeuchi, Motoshi Kawashima, Fumiaki Tanaka, Hiroaki Adachi, Gen Sobue

    Current molecular medicine   8 ( 3 )   221 - 34   2008年5月

     詳細を見る

    記述言語:英語   出版者・発行元:BENTHAM SCIENCE PUBL LTD  

    Polyglutamine diseases are hereditary neurodegenerative disorders caused by an abnormal expansion of a trinucleotide CAG repeat, which encodes a polyglutamine tract. To date, nine polyglutamine diseases are known: Huntington's disease (HD), spinal and bulbar muscular atrophy (SBMA), dentatorubral-pallidoluysian atrophy (DRPLA) and six forms of spinocerebellar ataxia (SCA). The diseases are inherited in an autosomal dominant fashion except for SBMA, which shows an X-linked pattern of inheritance. Although the causative gene varies with each disorder, polyglutamine diseases share salient genetic features as well as molecular pathogenesis. CAG repeat size correlates well with the age of onset in each disease, shows both somatic and germline instability, and has a strong tendency to further expand in successive generations. Aggregation of the mutant protein followed by the disruption of cellular functions, such as transcription and axonal transport, has been implicated in the etiology of neurodegeneration in polyglutamine diseases. Although animal studies have provided promising therapeutic strategies for polyglutamine diseases, it remains difficult to translate these disease-modifying therapies to the clinic. To optimize "proof of concept", the process for testing candidate therapies in humans, it is of importance to identify biomarkers which can be used as surrogate endpoints in clinical trials for polyglutamine diseases.

    DOI: 10.2174/156652408784221298

    Web of Science

    PubMed

    researchmap

  • Cognitive impairments in multiple system atrophy - MSA-C vs MSA-P

    Y. Kawai, M. Suenaga, A. Takeda, M. Ito, H. Watanabe, F. Tanaka, K. Kato, H. Fukatsu, S. Naganawa, T. Kato, K. Ito, G. Sobue

    NEUROLOGY   70 ( 16 )   1390 - 1396   2008年4月

     詳細を見る

    記述言語:英語   出版者・発行元:LIPPINCOTT WILLIAMS & WILKINS  

    Objective: We evaluated comprehensive neuropsychological tests and regional brain blood flow to compare cognitive dysfunction between two types of multiple system atrophy: predominant cerebellar ataxia (MSA-C) and predominant parkinsonism (MSA-P).
    Methods: Twenty-one patients with MSA-C, 14 patients with MSA-P, and 21 age-and education-matched control subjects were subjected to neuropsychological tests and SPECT. The neuropsychological tests examined general cognition, verbal and visual memory, working memory, visuospatial and constructional ability, language, executive function, depression, and anxiety, while SPECT analysis examined brain perfusion.
    Results: Patients with MSA-P showed severe involvement of visuospatial and constructional function, verbal fluency, and executive function compared with control subjects. Patients with MSA-C showed involvement only in visuospatial and constructional function compared with control subjects and a milder degree of involvement compared with patients with MSA-P. Patients with MSA-P tended toward a wide and severe impairment in cognitive function compared with patients with MSA-C. In addition, neuropsychological impairment in patients with MSA-P was significantly correlated with a decrease in prefrontal perfusion. This significant relation was not correlated to other factors such as age, education, and severity of cerebellar ataxia and parkinsonism, which are relevant factors associated with cognitive performance.
    Conclusions: Patients with multiple system atrophy-parkinsonism show more severe and more widespread cognitive dysfunctions than patients with multiple system atrophy-cerebellar ataxia. Our results also indicate that cognitive dysfunction in patients with multiple system atrophy parkinsonism may be associated with prefrontal involvement.

    DOI: 10.1212/01.wnl.0000310413.04462.6a

    Web of Science

    researchmap

  • シェーグレン症候群に伴うpainful sensory neuropathyに対するIVIgの有効性の検討

    両角 佐織, 川頭 祐一, 飯島 正博, 小池 春樹, 服部 直樹, 渡辺 宏久, 田中 章景, 祖父江 元

    臨床神経学   48 ( 4 )   290 - 290   2008年4月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 【動物モデルからみた神経変性疾患】動物モデルからみた球脊髄性筋萎縮症 病態モデルに基づいた分子標的治療法の開発

    和座 雅浩, 足立 弘明, 勝野 雅央, 田中 章景, 祖父江 元

    神経内科   68 ( 2 )   147 - 154   2008年2月

     詳細を見る

    記述言語:日本語   出版者・発行元:(有)科学評論社  

    researchmap

  • CAG repeat size correlates to electrophysiological motor and sensory phenotypes in SBMA. 国際誌

    Keisuke Suzuki, Masahisa Katsuno, Haruhiko Banno, Yu Takeuchi, Naoki Atsuta, Mizuki Ito, Hirohisa Watanabe, Fumitada Yamashita, Norio Hori, Tomohiko Nakamura, Masaaki Hirayama, Fumiaki Tanaka, Gen Sobue

    Brain : a journal of neurology   131 ( Pt 1 )   229 - 39   2008年1月

     詳細を見る

    記述言語:英語   出版者・発行元:OXFORD UNIV PRESS  

    Spinal and bulbar muscular atrophy (SBMA) is an adult-onset, lower motor neuron disease caused by an aberrant elongation of a CAG repeat in the androgen receptor (AR) gene. The main symptoms are weakness and atrophy of bulbar, facial and limb muscles, but sensory disturbances are frequently found in SBMA patients. Motor symptoms have been attributed to the accumulation of mutant AR in the nucleus of lower motor neurons, which is more profound in patients with a longer CAG repeat. We examined nerve conduction properties including F-waves in a total of 106 patients with genetically confirmed SBMA (mean age at data collection = 53.8 years; range = 31-75 years) and 85 control subjects. Motor conduction velocities (MCV), compound muscle action potentials (CMAP), sensory conduction velocities (SCV) and sensory nerve action potentials (SNAP) were significantly decreased in all nerves examined in the SBMA patients compared with that in the normal controls, indicating that axonal degeneration is the primary process in both motor and sensory nerves. More profound abnormalities were observed in the nerves of the upper limbs than in those of the lower limbs. F-waves in the median nerve were absent in 30 of 106 cases (28.3%), but no cases of absent F-waves were observed in the tibial nerve. From an analysis of the relationship between CMAPs and SNAPs, patients were identified with different electrophysiological phenotypes: motor-dominant, sensory-dominant and non-dominant phenotypes. The CAG repeat size and the age at onset were significantly different among the patients with motor- and sensory-dominant phenotypes, indicating that a longer CAG repeat is more closely linked to the motor-dominant phenotype and a shorter CAG repeat is more closely linked to the sensory-dominant phenotype. Furthermore, when we classified the patients by CAG repeat size, CMAP values showed a tendency to be decreased in patients with a longer CAG repeat (> or =47), while SNAPs were significantly decreased in patients with a shorter CAG repeat (<47). In addition, we found that the frequency of aggregation in the sensory neuron cytoplasm tended to inversely correlate with the CAG repeat size in the autopsy study, supporting the view that the CAG repeat size differentially correlates with motor- and sensory-dominant phenotypes. In conclusion, our results suggest that there are unequivocal electrophysiological phenotypes influenced by CAG repeat size in SBMA.

    DOI: 10.1093/brain/awm289

    Web of Science

    PubMed

    researchmap

  • CAG repeat size correlates to electrophysiological motor and sensory phenotypes in SBMA

    Keisuke Suzuki, Masahisa Katsuno, Haruhiko Banno, Yu Takeuchi, Naoki Atsuta, Mizuki Ito, Hirohisa Watanabe, Fumitada Yamashita, Norio Hori, Tomohiko Nakamura, Masaaki Hirayama, Fumiaki Tanaka, Gen Sobue

    BRAIN   131 ( Pt1 )   229 - 239   2008年1月

     詳細を見る

    記述言語:英語   出版者・発行元:OXFORD UNIV PRESS  

    Spinal and bulbar muscular atrophy (SBMA) is an adult-onset, lower motor neuron disease caused by an aberrant elongation of a CAG repeat in the androgen receptor (AR) gene. The main symptoms are weakness and atrophy of bulbar, facial and limb muscles, but sensory disturbances are frequently found in SBMA patients. Motor symptoms have been attributed to the accumulation of mutant AR in the nucleus of lower motor neurons, which is more profound in patients with a longer CAG repeat. We examined nerve conduction properties including F-waves in a total of 106 patients with genetically confirmed SBMA (mean age at data collection 53.8 years; range 3175 years) and 85 control subjects. Motor conduction velocities (MCV), compound muscle action potentials (CMAP), sensory conduction velocities (SCV) and sensory nerve action potentials (SNAP) were significantly decreased in all nerves examined in the SBMA patients compared with that in the normal controls, indicating that axonal degeneration is the primary process in both motor and sensory nerves. More profound abnormalities were observed in the nerves of the upper limbs than in those of the lower limbs. F-waves in the median nerve were absent in 30 of 106 cases (28.3), but no cases of absent F-waves were observed in the tibial nerve. From an analysis of the relationship between CMAPs and SNAPs, patients were identified with different electrophysiological phenotypes: motor-dominant, sensory-dominant and non-dominant phenotypes. The CAG repeat size and the age at onset were significantly different among the patients with motor- and sensory-dominant phenotypes, indicating that a longer CAG repeat is more closely linked to the motor-dominant phenotype and a shorter CAG repeat is more closely linked to the sensory-dominant phenotype. Furthermore, when we classified the patients by CAG repeat size, CMAP values showed a tendency to be decreased in patients with a longer CAG repeat (47), while SNAPs were significantly decreased in patients with a shorter CAG repeat (47). In addition, we found that the frequency of aggregation in the sensory neuron cytoplasm tended to inversely correlate with the CAG repeat size in the autopsy study, supporting the view that the CAG repeat size differentially correlates with motor- and sensory-dominant phenotypes. In conclusion, our results suggest that there are unequivocal electrophysiological phenotypes influenced by CAG repeat size in SBMA.

    DOI: 10.1093/brain/awm289

    Web of Science

    researchmap

  • Dorfin ameliorates neurological phenotypes in a transgenic mouse model of amyotrophic lateral sclerosis

    Jun Sone, Jun-ichi Niwa, Kaori Kawai, Shinsuke Ishigaki, Shin-ichi Yamada, Fumiaki Tanaka, Manabu Doyu, Gen Sobue

    NEUROSCIENCE RESEARCH   61   S205 - S205   2008年

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:ELSEVIER IRELAND LTD  

    Web of Science

    researchmap

  • Hsp90 inhibitors ameliorates polyglutamine-mediated motor neuron impairment in SBMA models

    Hiroaki Adachi, Keisuke Tokui, Masahiro Waza, Masahisa Katsuno, Makoto Minamiyama, Fumiaki Tanaka, Gen Sobue

    NEUROSCIENCE RESEARCH   61   S204 - S204   2008年

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:ELSEVIER IRELAND LTD  

    Web of Science

    researchmap

  • Myocardial involvement in spinal and bulbar muscular atrophy

    Masahisa Katsuno, Haruhiko Banno, Keisuke Suzuki, Yu Takeuchi, Motoshi Kawashima, Hiroaki Adachi, Fumiaki Tanaka, Gen Sobue

    NEUROSCIENCE RESEARCH   61   S206 - S206   2008年

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:ELSEVIER IRELAND LTD  

    Web of Science

    researchmap

  • 孤発性ALS疾患モデルの開発 dynactin1ノックダウン細胞の解析

    田中 章景, 黄 哲, 蒋 月梅, 松尾 幸治, 和座 雅浩, 山本 正彦, 道勇 学, 祖父江 元

    臨床神経学   47 ( 12 )   996 - 996   2007年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 遺伝性Neuropathyの臨床像を呈した家族性NIHIDの病理学的検討

    曽根 淳, 菱川 望, 小池 春樹, 田中 章景, 祖父江 元, 吉田 眞理, 橋詰 良夫, 渡辺 俊之, 小牟禮 修

    臨床神経学   47 ( 12 )   1158 - 1158   2007年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 球脊髄性筋萎縮症トランスジェニックマウスの病態関連遺伝子探索

    南山 誠, 勝野 雅央, 足立 弘明, 和座 雅浩, 徳井 啓介, 田中 章景, 道勇 学, 祖父江 元

    臨床神経学   47 ( 12 )   1095 - 1095   2007年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 球脊髄性筋萎縮症モデルにおけるシャペロン依存性ユビキチンリガーゼ高発現の効果

    足立 弘明, 和座 雅浩, 徳井 啓介, 勝野 雅央, 南山 誠, 田中 章景, 道勇 学, 祖父江 元

    臨床神経学   47 ( 12 )   1095 - 1095   2007年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 経口Hsp90阻害剤は、SBMAモデルマウスの表現系を改善する

    徳井 啓介, 足立 弘明, 和座 雅浩, 勝野 雅央, 南山 誠, 田中 章景, 道勇 学, 祖父江 元

    臨床神経学   47 ( 12 )   1095 - 1095   2007年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • Nonmyelinating Schwann cell involvement with well-preserved unmyelinated axons in Charcot-Marie-Tooth disease type 1A. 国際誌

    Haruki Koike, Masahiro Iijima, Keiko Mori, Masahiko Yamamoto, Naoki Hattori, Masahisa Katsuno, Fumiaki Tanaka, Hirohisa Watanabe, Manabu Doyu, Hiroo Yoshikawa, Gen Sobue

    Journal of neuropathology and experimental neurology   66 ( 11 )   1027 - 36   2007年11月

     詳細を見る

    記述言語:英語   出版者・発行元:OXFORD UNIV PRESS INC  

    Electron microscopic examination was performed to compare morphologic changes of nonmyelinating Schwann cells and unmyelinated axons in patients with Charcot-Marie-Tooth disease type 1A (CMT1A) with peripheral myelin protein 22 duplication (n = 27) and normal control individuals (n = 14). Complete transverse sural nerve cross-sections were obtained in 16 patients and the total number of axons and Schwann cells in each cross-section was estimated. In patients with CMT1A, the number of myelinated axons was significantly decreased, whereas unmyelinated axons were well-preserved and did not show any marked changes. The numbers of nuclei, subunits, and profiles of nonmyelinating Schwann cells were all increased significantly in patients with CMT1A, whereas the numbers of axons per unmyelinated axon-containing subunit were significantly decreased. Schwann cell subunits consisted of layers of flattened cytoplasmic profiles wrapped around unmyelinated axons in the patient with CMT1A. The numbers of nonmyelinating Schwann cell profiles were increased and the numbers of axons per unmyelinated axon-containing subunit were reduced even in young patients with well-preserved myelinated fibers. In conclusion, there is marked alteration of the population and morphology of nonmyelinating Schwann cells, and axon-Schwann cell interactions seem to be regulated differently between myelinated and unmyelinated fibers in CMT1A.

    DOI: 10.1097/NEN.0b013e3181598294

    Web of Science

    PubMed

    researchmap

  • 各種難病の最新治療情報 孤発性ALSの遺伝子発現プロファイル作成から疾患モデル作成と治療への展開

    田中 章景, 山本 正彦, 祖父江 元

    難病と在宅ケア   13 ( 8 )   66 - 69   2007年11月

  • Nonmyelinating Schwann cell involvement with well-preserved unmyelinated Axons in Charcot-Marie-Tooth disease type 1a

    Haruki Koike, Masahiro Iijima, Keiko Mori, Masahiko Yamamoto, Naoki Hattori, Masahisa Katsuno, Furmaki Tanaka, Hirohisa Watanabe, Manabu Doyu, Hiroo Yoshikawa, Gen Sobue

    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY   66 ( 11 )   1027 - 1036   2007年11月

     詳細を見る

    記述言語:英語   出版者・発行元:OXFORD UNIV PRESS INC  

    Electron microscopic examination was performed to compare morphologic changes of nonmyelinating Schwann cells and unmyelinated axons in patients with Charcot-Marie-Tooth disease type 1A (CMT1A) with peripheral myelin protein 22 duplication (n = 27) and normal control individuals (n = 14). Complete transverse sural nerve cross-sections were obtained in 16 patients and the total number of axons and Schwann cells in each cross-section was estimated. In patients with CMT1A, the number of myelinated axons was significantly decreased, whereas unmyelinated axons were well-preserved and did not show any marked changes. The numbers of nuclei, subunits, and profiles of nonmyelinating Schwarm cells were all increased significantly in patients with CMT1A, whereas the numbers of axons per unmyelinated axon-containing subunit were significantly decreased. Schwann cell subunits consisted of layers of flattened cytoplasmic profiles wrapped around unmyelinated axons in the patient with CMT1A. The numbers of nonmyelinating Schwann cell profiles were increased and the numbers of axons per unmyelinated axon-containing subunit were reduced even in young patients with well-preserved myelinated fibers. In conclusion, there is marked alteration of the population and morphology of nonmyelinating Schwarm cells, and axon-Schwann cell interactions seem to be regulated differently between myelinated and unmyelinated fibers in CMT1A.

    DOI: 10.1097/NEN.0b013e3181598294

    Web of Science

    researchmap

  • ALS脊髄前角の遺伝子発現プロファイル (特集 ALS--研究と診療の進歩)

    山本正彦, 田中章景, 祖父江元

    Brain and nerve   59 ( 10 )   1129 - 1139   2007年10月

     詳細を見る

    出版者・発行元:医学書院  

    researchmap

  • Gene expression profile of spinal ventral horn in ALS

    Masahiko Yamamoto, Fumiaki Tanaka, Gen Sobue

    Brain and Nerve   59 ( 10 )   1129 - 1139   2007年10月

     詳細を見る

    記述言語:日本語   掲載種別:書評論文,書評,文献紹介等  

    The causative pathomechanism of sporadic amyotrophic lateral sclerosis (ALS) is not clearly understood. Using microarray technology combined with laser-captured microdissection, gene expression profiles of degenerating spinal motor neurons as well as spinal ventral horn from autopsied patients with sporadic ALS were examined. Spinal motor neurons showed a distinct gene expression profile from the whole spinal ventral horn. Three percent of genes examined were significantly downregulated, and 1% were upregulated in motor neurons. In contrast with motor neurons, the total spinal ventral horn homogenates demonstrated 0.7% and 0.2% significant upregulation and downregulation of gene expression, respectively. Downregulated genes in motor neurons included those associated with cytoskeleton/axonal transport, transcription and cell surface antigens/receptors, such as dynactin 1 (DCTN1) and early growth response 3 (EGR3). In particular, DCTN1 was markedly downregulated in most residual motor neurons prior to the accumulation of pNF-H and ubiquitylated protein. Promoters for cell death pathway, death receptor 5 (DR5), cyclins C (CCNC) and A1 (CCNA), and caspases were upregulated, whereas cell death inhibitors, acetyl-CoA transporter (ACATN) and NF-kB (NFKB) were also upregulated. In terms of spinal ventral horn, the expression of genes related to cell surface antigens/receptors, transcription and cell adhesion/ECM were increased. The gene expression resulting in neurodegenerative and neuroprotective changes were both present in spinal motor neurons and ventral horn. Moreover, Inflammation-related genes, such as belonging to the cytokine family were not, however, significantly upregulated in either motor neurons or ventral horn. The sequence of motor neuron-specific gene expression changes from early DCTN1 downregulation to late CCNC upregulation in sporadic ALS can provide direct information on the genes leading to neurodegeneration and neuronal death, and are helpful for developing new therapeutic strategies.

    Scopus

    PubMed

    researchmap

  • Disulfide bond mediates aggregation, toxicity, and ubiquitylation of familial amyotrophic lateral sclerosis-linked mutant SOD1. 国際誌

    Jun-ichi Niwa, Shin-ichi Yamada, Shinsuke Ishigaki, Jun Sone, Miho Takahashi, Masahisa Katsuno, Fumiaki Tanaka, Manabu Doyu, Gen Sobue

    The Journal of biological chemistry   282 ( 38 )   28087 - 95   2007年9月

     詳細を見る

    記述言語:英語   出版者・発行元:AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC  

    Mutations in the Cu/Zn-superoxide dismutase (SOD1) gene cause familial amyotrophic lateral sclerosis (ALS) through the gain of a toxic function; however, the nature of this toxic function remains largely unknown. Ubiquitylated aggregates of mutant SOD1 proteins in affected brain lesions are pathological hallmarks of the disease and are suggested to be involved in several proposed mechanisms of motor neuron death. Recent studies suggest that mutant SOD1 readily forms an incorrect disulfide bond upon mild oxidative stress in vitro, and the insoluble SOD1 aggregates in spinal cord of ALS model mice contain multimers cross-linked via intermolecular disulfide bonds. Here we show that a non-physiological intermolecular disulfide bond between cysteines at positions 6 and 111 of mutant SOD1 is important for high molecular weight aggregate formation, ubiquitylation, and neurotoxicity, all of which were dramatically reduced when the pertinent cysteines were replaced in mutant SOD1 expressed in Neuro-2a cells. Dorfin is a ubiquityl ligase that specifically binds familial ALS-linked mutant SOD1 and ubiquitylates it, thereby promoting its degradation. We found that Dorfin ubiquitylated mutant SOD1 by recognizing the Cys(6)- and Cys(111)-disulfide cross-linked form and targeted it for proteasomal degradation.

    DOI: 10.1074/jbc.M704465200

    Web of Science

    PubMed

    researchmap

  • 一過性の脳神経症状を繰り返し、著明な馬尾肥厚を認めたCIDPの2症例

    両角 佐織, 井口 洋平, 飯島 正博, 小池 春樹, 服部 直樹, 田中 章景, 祖父江 元

    臨床神経学   47 ( 9 )   614 - 614   2007年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • Disulfide bond mediates aggregation, toxicity, and ubiquitylation of familial amyotrophic lateral sclerosis-linked mutant SOD1

    Jun-ichi Niwa, Shin-ichi Yamada, Shinsuke Ishigaki, Jun Sone, Miho Takahashi, Masahisa Katsuno, Fumiaki Tanaka, Manabu Doyu, Gen Sobue

    JOURNAL OF BIOLOGICAL CHEMISTRY   282 ( 38 )   28087 - 28095   2007年9月

     詳細を見る

    記述言語:英語   出版者・発行元:AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC  

    Mutations in the Cu/Zn-superoxide dismutase (SOD1) gene cause familial amyotrophic lateral sclerosis (ALS) through the gain of a toxic function; however, the nature of this toxic function remains largely unknown. Ubiquitylated aggregates of mutant SOD 1 proteins in affected brain lesions are pathological hallmarks of the disease and are suggested to be involved in several proposed mechanisms of motor neuron death. Recent studies suggest that mutant SODI readily forms an incorrect disulfide bond upon mild oxidative stress in vitro, and the insoluble SOD 1 aggregates in spinal cord of ALS model mice contain multimers cross-linked via intermolecular disulfide bonds. Here we show that a non-physiological intermolecular disulfide bond between cysteines at positions 6 and 111 of mutant SOD 1 is important for high molecular weight aggregate formation, ubliquitylation, and neurotoxicity, all of which were dramatically reduced when the pertinent cysteines were replaced in mutant SOD 1 expressed in Neuro-2a cells. Dorfin is a ubiquityl ligase that specifically binds familial ALS-linked mutant SOD 1 and ubiquitylates it, thereby promoting its degradation. We found that Dorfin ubiquitylated mutant SOD1 by recognizing the CYS6- and Cys(111)-disulfide cross-linked form and targeted it for proteasomal degradation.

    DOI: 10.1074/jbc.M704465200

    Web of Science

    PubMed

    researchmap

  • Intravenous immunoglobulin therapy markedly ameliorates muscle weakness and severe pain in proximal diabetic neuropathy

    Y. Kawagashira, H. Watanabe, Y. Oki, M. Iijima, H. Koike, N. Hattori, M. Katsuno, F. Tanaka, G. Sobue

    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY   78 ( 8 )   899 - 901   2007年8月

     詳細を見る

    記述言語:英語   出版者・発行元:BMJ PUBLISHING GROUP  

    A 57-year-old man with type 2 diabetes mellitus for 10 years showed progressive loss of muscle strength in both legs, pain and muscle atrophy in the femoral region and significant weight loss. On admission, he could not stand alone and used a wheelchair. He also complained of severe pain in the lower extremities. He was diagnosed with proximal diabetic neuropathy (PDN) by characteristic clinical and electrophysiological features. Intravenous immunoglobulin therapy (IVIg 0.4 g/kgx65 days) markedly reduced the severe pain and muscle weakness in the legs. Eventually, pain assessed by the Visual Analogue Scale was relieved by 80% and muscle strength was also well recovered, thereby enabling the patient to walk with a cane. The present case suggests that IVIg therapy may be effective for the relief of pain in PDN.

    DOI: 10.1136/jnnp.2006.111302

    Web of Science

    researchmap

  • 【脳神経疾患の分子病態と治療への展開 アルツハイマー病、パーキンソン病、発達障害、精神疾患などの発症メカニズムを分子から解く】神経難病の病態トピックス 球脊髄性筋萎縮症(SBMA)の分子病態と治療法開発

    勝野 雅央, 足立 弘明, 田中 章景, 祖父江 元

    実験医学   25 ( 13 )   1974 - 1980   2007年8月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)羊土社  

    球脊髄性筋萎縮症(SBMA)はアンドロゲン受容体(AR)遺伝子のCAG繰り返し塩基配列の異常延長を原因とする神経変性疾患である。病態として、変異ARがテストステロン依存性に核内集積し、転写障害をきたすことが知られている。マウスモデルを用いた解析により、ホルモン療法などの治療薬の効果が示されており、なかでも酢酸リュープロレリンは大規模臨床試験が進行中である。また、発症後に治療的介入を行っても効果がみられることが明らかとなっており、初期の可逆的病態メカニズムとして逆行性軸索輸送障害が示唆されている。(著者抄録)

    researchmap

  • Ataxic vs painful form of paraneoplastic neuropathy

    Y. Oki, H. Koike, M. Iijima, K. Mori, N. Hattori, M. Katsuno, T. Nakamura, M. Hirayama, F. Tanaka, M. Shiraishi, S. Yazaki, K. Nokura, H. Yamamoto, G. Sobue

    NEUROLOGY   69 ( 6 )   564 - 572   2007年8月

     詳細を見る

    記述言語:英語   出版者・発行元:LIPPINCOTT WILLIAMS & WILKINS  

    Objective: To characterize the clinicopathologic features of ataxic and painful forms of paraneoplastic neuropathy.
    Methods: Clinical, electrophysiologic, and histopathologic findings were assessed in 17 patients with paraneoplastic neuropathy.
    Results: Clinical features can be categorized into two groups: one group ( 13 patients) with predominantly deep sensory disturbance and a second group ( 4 patients) with predominantly superficial sensory disturbance. The former group showed severe sensory ataxia and predominantly large myelinated fiber loss in the sural nerve. The latter group showed marked pain, in particular, severe mechanical hyperalgesia, and predominantly small myelinated and unmyelinated fiber loss. Nerve conduction assessment indicated an axonal neuropathy pattern in both groups, while sensory action potentials were more markedly diminished in the sensory ataxic form. Anti- Hu antibodies were detected in half of the patients in both groups. Treatment for cancer was effective to improve or stabilize neuropathic symptoms in some cases from both groups. Immunotherapy was effective only for a short time.
    Conclusions: Paraneoplastic neuropathy can be characterized into two groups by the presence of sensory ataxia or severe spontaneous pain and severe mechanical hyperalgesia. Preferential small myelinated and unmyelinated fiber loss correlated to the cases of severe pain.

    DOI: 10.1212/01.wnl.0000266668.03638.94

    Web of Science

    researchmap

  • Usefulness of combined fractional anisotropy and apparent diffusion coefficient values for detection of involvement in multiple system atrophy

    Mizuki Ito, Hirohisa Watanabe, Yoshinari Kawai, Naoki Atsuta, Fumiaki Tanaka, Shinji Naganawa, Hiroshi Fukatsu, Gen Sobue

    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY   78 ( 7 )   722 - 728   2007年7月

     詳細を見る

    記述言語:英語   出版者・発行元:B M J PUBLISHING GROUP  

    Objective: To determine whether apparent diffusion coefficient ( ADC) values and fractional anisotropy ( FA) values can detect early pathological involvement in multiple system atrophy (MSA), and be used to differentiate MSA-P (multiple system atrophy if parkinsonian features predominate) from Parkinson's disease (PD).
    Methods: We compared ADC and FA values in the pons, cerebellum and putamen of 61 subjects (20 probable MSA patients, 21 age matched PD patients and 20 age matched healthy controls) using a 3.0 T magnetic resonance system.
    Results: ADC values in the pons, cerebellum and putamen were significantly higher, and FA values lower in MSA than in PD or controls. These differences were prominent in MSA lacking dorsolateral putaminal hyperintensity (DPH) or hot cross bun (HCB) sign. In differentiating MSA-P from PD using FA and ADC values, we obtained equal sensitivity (70%) and higher specificity (100%) in the pons than in the putamen and cerebellum. In addition, all patients that had both significant low FA and high ADC values in each of these three areas were MSA-P cases, and those that had both normal FA and ADC values in the pons were all PD cases. Our diagnostic algorithm based on these results accurately diagnosed 90% of patients with MSA-P.
    Conclusion: FA and ADC values detected early pathological involvement prior to magnetic resonance signal changes in MSA. In particular, low FA values in the pons showed high specificity in discriminating MSA-P from PD. In addition, combined analysis of both FA and ADC values in all three areas was more useful than only one.

    DOI: 10.1136/jnnp.2006.104075

    Web of Science

    researchmap

  • Gene expressions specifically detected in motor neurons (dynactin 1, early growth response 3, acetyl-CoA transporter, death receptor 5, and cyclin C) differentially correlate to pathologic markers in sporadic amyotrophic lateral sclerosis. 国際誌

    Yue-Mei Jiang, Masahiko Yamamoto, Fumiaki Tanaka, Shinsuke Ishigaki, Masahisa Katsuno, Hiroaki Adachi, Jun-Ichi Niwa, Manabu Doyu, Mari Yoshida, Yoshio Hashizume, Gen Sobue

    Journal of neuropathology and experimental neurology   66 ( 7 )   617 - 27   2007年7月

     詳細を見る

    記述言語:英語   出版者・発行元:LIPPINCOTT WILLIAMS & WILKINS  

    In a differential gene expression profile, we showed previously that dynactin 1 (DCTN1), early growth response 3 (EGR3), acetyl-CoA transporter (ACATN), death receptor 5 (DR5), and cyclin C (CCNC) were prominently up- or downregulated in motor neurons of sporadic amyotrophic lateral sclerosis (ALS). In the present study, we examined the correlation between the expression levels of these genes and the levels of pathologic markers for motor neuron degeneration (i.e. cytoplasmic accumulation of phosphorylated neurofilament H [pNF-H] and ubiquitylated protein) and the numbers of residual motor neurons in 20 autopsies of patients with sporadic ALS. DCTN1 and EGR3 were widely downregulated, and the changes in gene expression were correlated to the number of residual motor neurons. In particular, DCTN1 was markedly downregulated in most residual motor neurons before the accumulation of pNF-H, even in cases with well-preserved motor neuron populations. ACATN, DR5, and CCNC were upregulated in subpopulations of residual motor neurons, and their expression levels were well correlated with the levels of pNF-H accumulation and the number of residual motor neurons. The expressions of DCTN1, EGR3, ACATN, and DR5 were all markedly altered before ubiquitylated protein accumulation. DCTN1 downregulation appears to be an early event before the appearance of neurodegeneration markers, whereas upregulations of DR5 and CCNC are relatively later phenomena associated with pathologic markers and leading to neuronal death. The sequence of motor neuron-specific gene expression changes in sporadic ALS can be beneficial information in developing appropriate therapeutic strategies for neurodegeneration.

    DOI: 10.1097/nen.0b013e318093ece3

    Web of Science

    PubMed

    researchmap

  • Gene expressions specifically detected in motor neurons (Dynactin 1, early growth response 3, acetyl-CoA transporter, death receptor 5, and cyclin C) differentially correlate to Pathologic markers in sporadic amyotrophic lateral sclerosis

    Yue-Mei Jiang, Masahiko Yamamoto, Fumiaki Tanaka, Shinsuke Ishigaki, Masahisa Katsuno, Hiroaki Adachi, Jun-ichi Niwa, Manabu Doyu, Marl Yoshida, Yoshio Hashizume, Gen Sobue

    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY   66 ( 7 )   617 - 627   2007年7月

     詳細を見る

    記述言語:英語   出版者・発行元:LIPPINCOTT WILLIAMS & WILKINS  

    In a differential gene expression profile, we showed previously that dynactin 1 (DCTN1), early growth response 3 (EGR3), acetylCoA transporter (ACATN), death receptor 5 (DR5), and cyclin C (CCNC) were prominently up- or downregulated in motor neurons of sporadic amyotrophic lateral sclerosis (ALS). In the present study, we examined the correlation between the expression levels of these genes and the levels of pathologic markers for motor neuron degeneration (i.e. cytoplasmic accumulation of phosphorylated neurofilament H [pNF-H] and ubiquitylated protein) and the numbers of residual motor neurons in 20 autopsies of patients with sporadic ALS. DCTN1 and EGR3 were widely downregulated, and the changes in gene expression were correlated to the number of residual motor neurons. In particular, DCTN1 was markedly downregulated in most residual motor neurons before the accumulation of pNF-H, even in cases with well-preserved motor neuron populations. ACATN, DR5, and CCNC were upregulated in subpopulations of residual motor neurons, and their expression levels were well correlated with the levels of pNF-H accumulation and the number of residual motor neurons. The expressions of DCTN1, EGR3, ACATN, and DR5 were all markedly altered before ubiquitylated protein accumulation. DCTN1 downregulation appears to be an early event before the appearance of neurodegeneration markers, whereas upregulations of DR5 and CCNC are relatively later phenomena associated with pathologic markers and leading to neuronal death. The sequence of motor neuronspecific gene expression changes in sporadic ALS can be beneficial information in developing appropriate therapeutic strategies for neurodegeneration.

    DOI: 10.1097/nen.0b013e318093ece3

    Web of Science

    researchmap

  • Usefulness of combined fractional anisotropy and apparent diffusion coefficient values for detection of involvement in multiple system atrophy. 国際誌

    Mizuki Ito, Hirohisa Watanabe, Yoshinari Kawai, Naoki Atsuta, Fumiaki Tanaka, Shinji Naganawa, Hiroshi Fukatsu, Gen Sobue

    Journal of neurology, neurosurgery, and psychiatry   78 ( 7 )   722 - 8   2007年7月

     詳細を見る

    記述言語:英語   出版者・発行元:B M J PUBLISHING GROUP  

    OBJECTIVE: To determine whether apparent diffusion coefficient (ADC) values and fractional anisotropy (FA) values can detect early pathological involvement in multiple system atrophy (MSA), and be used to differentiate MSA-P (multiple system atrophy if parkinsonian features predominate) from Parkinson's disease (PD). METHODS: We compared ADC and FA values in the pons, cerebellum and putamen of 61 subjects (20 probable MSA patients, 21 age matched PD patients and 20 age matched healthy controls) using a 3.0 T magnetic resonance system. RESULTS: ADC values in the pons, cerebellum and putamen were significantly higher, and FA values lower in MSA than in PD or controls. These differences were prominent in MSA lacking dorsolateral putaminal hyperintensity (DPH) or hot cross bun (HCB) sign. In differentiating MSA-P from PD using FA and ADC values, we obtained equal sensitivity (70%) and higher specificity (100%) in the pons than in the putamen and cerebellum. In addition, all patients that had both significant low FA and high ADC values in each of these three areas were MSA-P cases, and those that had both normal FA and ADC values in the pons were all PD cases. Our diagnostic algorithm based on these results accurately diagnosed 90% of patients with MSA-P. CONCLUSION: FA and ADC values detected early pathological involvement prior to magnetic resonance signal changes in MSA. In particular, low FA values in the pons showed high specificity in discriminating MSA-P from PD. In addition, combined analysis of both FA and ADC values in all three areas was more useful than only one.

    DOI: 10.1136/jnnp.2006.104075

    Web of Science

    PubMed

    researchmap

  • CHIP overexpression reduces mutant androgen receptor protein and ameliorates phenotypes of the spinal and bulbar muscular atrophy transgenic mouse model. 国際誌

    Hiroaki Adachi, Masahiro Waza, Keisuke Tokui, Masahisa Katsuno, Makoto Minamiyama, Fumiaki Tanaka, Manabu Doyu, Gen Sobue

    The Journal of neuroscience : the official journal of the Society for Neuroscience   27 ( 19 )   5115 - 26   2007年5月

     詳細を見る

    記述言語:英語   出版者・発行元:SOC NEUROSCIENCE  

    Spinal and bulbar muscular atrophy (SBMA) is an inherited motor neuron disease caused by the expansion of a polyglutamine tract within the androgen receptor (AR). The pathologic features of SBMA are motor neuron loss in the spinal cord and brainstem and diffuse nuclear accumulation and nuclear inclusions of the mutant AR in the residual motor neurons and certain visceral organs. Many components of the ubiquitin-proteasome and molecular chaperones are also sequestered in the inclusions, suggesting that they may be actively engaged in an attempt to degrade or refold the mutant AR. C terminus of Hsc70 (heat shock cognate protein 70)-interacting protein (CHIP), a U-box type E3 ubiquitin ligase, has been shown to interact with heat shock protein 90 (Hsp90) or Hsp70 and ubiquitylates unfolded proteins trapped by molecular chaperones and degrades them. Here, we demonstrate that transient overexpression of CHIP in a neuronal cell model reduces the monomeric mutant AR more effectively than it does the wild type, suggesting that the mutant AR is more sensitive to CHIP than is the wild type. High expression of CHIP in an SBMA transgenic mouse model also ameliorated motor symptoms and inhibited neuronal nuclear accumulation of the mutant AR. When CHIP was overexpressed in transgenic SBMA mice, mutant AR was also preferentially degraded over wild-type AR. These findings suggest that CHIP overexpression ameliorates SBMA phenotypes in mice by reducing nuclear-localized mutant AR via enhanced mutant AR degradation. Thus, CHIP overexpression would provide a potential therapeutic avenue for SBMA.

    DOI: 10.1523/JNEUROSCI.1242-07.2007

    Web of Science

    PubMed

    researchmap

  • CHIP overexpression reduces mutant androgen receptor protein and ameliorates phenotypes of the spinal and bulbar muscular atrophy transgenic mouse model

    Hiroaki Adachi, Masahiro Waza, Keisuke Tokui, Masahisa Katsuno, Makoto Minamiyama, Fumiaki Tanaka, Manabu Doyu, Gen Sobue

    JOURNAL OF NEUROSCIENCE   27 ( 19 )   5115 - 5126   2007年5月

     詳細を見る

    記述言語:英語   出版者・発行元:SOC NEUROSCIENCE  

    Spinal and bulbar muscular atrophy (SBMA) is an inherited motor neuron disease caused by the expansion of a polyglutamine tract within the androgen receptor (AR). The pathologic features of SBMA are motor neuron loss in the spinal cord and brainstem and diffuse nuclear accumulation and nuclear inclusions of the mutant AR in the residual motor neurons and certain visceral organs. Many components of the ubiquitin-proteasome and molecular chaperones are also sequestered in the inclusions, suggesting that they may be actively engaged in an attempt to degrade or refold the mutant AR. C terminus of Hsc70 ( heat shock cognate protein 70)-interacting protein (CHIP), a U-box type E3 ubiquitin ligase, has been shown to interact with heat shock protein 90 (Hsp90) or Hsp70 and ubiquitylates unfolded proteins trapped by molecular chaperones and degrades them. Here, we demonstrate that transient overexpression of CHIP in a neuronal cell model reduces the monomeric mutant AR more effectively than it does the wild type, suggesting that the mutant AR is more sensitive to CHIP than is the wild type. High expression of CHIP in an SBMA transgenic mouse model also ameliorated motor symptoms and inhibited neuronal nuclear accumulation of the mutant AR. When CHIP was overexpressed in transgenic SBMA mice, mutant AR was also preferentially degraded over wild-type AR. These findings suggest that CHIP overexpression ameliorates SBMA phenotypes in mice by reducing nuclear-localized mutant AR via enhanced mutant AR degradation. Thus, CHIP overexpression would provide a potential therapeutic avenue for SBMA.

    DOI: 10.1523/JNEUROSCI.1242-07.2007

    Web of Science

    researchmap

  • Pathogenesis and molecular targeted therapy of spinal and bulbar muscular atrophy

    H. Adachi, M. Waza, M. Katsuno, F. Tanaka, M. Doyu, G. Sobue

    NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY   33 ( 2 )   135 - 151   2007年4月

     詳細を見る

    記述言語:英語   掲載種別:書評論文,書評,文献紹介等   出版者・発行元:BLACKWELL PUBLISHING  

    Spinal and bulbar muscular atrophy (SBMA) or Kennedy's disease is a motor neurone disease characterized by muscle atrophy, weakness, contraction fasciculations and bulbar involvement. SBMA mainly affects males, while females are usually asymptomatic. SBMA is caused by expansion of a polyglutamine (polyQ)-encoding CAG trinucleotide repeat in the androgen receptor (AR) gene. AR belongs to the heat shock protein 90 (Hsp90) client protein family. The histopathologic hallmarks of SBMA are diffuse nuclear accumulation and nuclear inclusions of the mutant AR with expanded polyQ in residual motor neurones in the brainstem and spinal cord as well as in some other visceral organs. There is increasing evidence that the ligand of AR and molecular chaperones play a crucial role in the pathogenesis of SBMA. The success of androgen deprivation therapy in SBMA mouse models has been translated into clinical trials. In addition, elucidation of its pathophysiology using animal models has led to the development of disease- modifying drugs, that is, Hsp90 inhibitor and Hsp inducer, which inhibit the pathogenic process of neuronal degeneration. SBMA is a slowly progressive disease by nature. The degree of nuclear accumulation of mutant AR in scrotal skin epithelial cells was correlated with that in spinal motor neurones in autopsy specimens; therefore, the results of scrotal skin biopsy may be used to assess the efficacy of therapeutic trials. Clinical and pathological parameters that reflect the pathogenic process of SBMA should be extensively investigated. Spinal and bulbar muscular atrophy (SBMA) or Kennedy's disease is a motor neurone disease characterized by muscle atrophy, weakness, contraction fasciculations and bulbar involvement. SBMA mainly affects males, while females are usually asymptomatic. SBMA is caused by expansion of a polyglutamine (polyQ)-encoding CAG trinucleotide repeat in the androgen receptor (AR) gene. AR belongs to the heat shock protein 90 (Hsp90) client protein family. The histopathologic hallmarks of SBMA are diffuse nuclear accumulation and nuclear inclusions of the mutant AR with expanded polyQ in residual motor neurones in the brainstem and spinal cord as well as in some other visceral organs. There is increasing evidence that the ligand of AR and molecular chaperones play a crucial role in the pathogenesis of SBMA. The success of androgen deprivation therapy in SBMA mouse models has been translated into clinical trials. In addition, elucidation of its pathophysiology using animal models has led to the development of disease-modifying drugs, that is, Hsp90 inhibitor and Hsp inducer, which inhibit the pathogenic process of neuronal degeneration. SBMA is a slowly progressive disease by nature. The degree of nuclear accumulation of mutant AR in scrotal skin epithelial cells was correlated with that in spinal motor neurones in autopsy specimens; therefore, the results of scrotal skin biopsy may be used to assess the efficacy of therapeutic trials. Clinical and pathological parameters that reflect the pathogenic process of SBMA should be extensively investigated.

    DOI: 10.1111/j.1365-2990.2007.00830.x

    Web of Science

    researchmap

  • 神経疾患・腫瘍の統合分子医学

    田中章景, 祖父江元

    生化学   79 ( 2 )   121 - 130   2007年2月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本生化学会  

    CiNii Books

    researchmap

  • 変性疾患 Neuronal intranuclear hyaline inclusion disease

    曽根 淳, 菱川 望, 田中 章景, 祖父江 元

    Annual Review神経   2007   175 - 182   2007年1月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)中外医学社  

    researchmap

  • A novel cancer testis antigen that is frequently expressed in colorectal cancer

    Takeshi Yokoe, Fumiaki Tanaka, Takahiro Omachi, Koshi Mimori, Hiroshi Inoue, Masato Kusunoki, Masaki Mori

    CLINICAL & EXPERIMENTAL METASTASIS   24 ( 4 )   286 - 287   2007年

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:SPRINGER  

    Web of Science

    researchmap

  • CHIP over-expression reduces mutant AR protein and ameliorates phenotypes of the SBMA transgenic mouse model

    Hiroaki Adachi, Masahiro Waza, Keisuke Tokui, Masahisa Katsuno, Makoto Minamiyama, Fumiaki Tanaka, Gen Sobue

    NEUROSCIENCE RESEARCH   58   S120 - S120   2007年

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:ELSEVIER IRELAND LTD  

    Web of Science

    researchmap

  • 球脊髄性筋萎縮症トランスジェニックマウスの病態関連遺伝子探索

    南山 誠, 勝野 雅央, 足立 弘明, 和座 雅浩, 徳井 啓介, 田中 章景, 道勇 学, 犬飼 晃, 祖父江 元

    臨床神経学   46 ( 12 )   1089 - 1089   2006年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • Hsp90阻害剤、17-AAGによるSBMAの治療応用

    和座 雅浩, 足立 弘明, 勝野 雅央, 南山 誠, 徳井 啓介, 田中 章景, 道勇 学, 祖父江 元

    臨床神経学   46 ( 12 )   1117 - 1117   2006年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 孤発性ALS運動ニューロン特異的病態関連分子の発現動態 神経変性過程との関連

    田中 章景, しょう 月梅, 山本 正彦, 黄 哲, 飯島 正博, 祖父江 元

    臨床神経学   46 ( 12 )   1117 - 1117   2006年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • Reversible disruption of dynactin 1-mediated retrograde axonal transport in polyglutamine-induced motor neuron degeneration. 国際誌

    Masahisa Katsuno, Hiroaki Adachi, Makoto Minamiyama, Masahiro Waza, Keisuke Tokui, Haruhiko Banno, Keisuke Suzuki, Yu Onoda, Fumiaki Tanaka, Manabu Doyu, Gen Sobue

    The Journal of neuroscience : the official journal of the Society for Neuroscience   26 ( 47 )   12106 - 17   2006年11月

     詳細を見る

    記述言語:英語   出版者・発行元:SOC NEUROSCIENCE  

    Spinal and bulbar muscular atrophy (SBMA) is a hereditary neurodegenerative disease caused by an expansion of a trinucleotide CAG repeat encoding the polyglutamine tract in the androgen receptor (AR) gene. To elucidate the pathogenesis of polyglutamine-mediated motor neuron dysfunction, we investigated histopathological and biological alterations in a transgenic mouse model of SBMA carrying human pathogenic AR. In affected mice, neurofilaments and synaptophysin accumulated at the distal motor axon. A similar intramuscular accumulation of neurofilament was detected in the skeletal muscle of SBMA patients. Fluoro-gold labeling and sciatic nerve ligation demonstrated an impaired retrograde axonal transport in the transgenic mice. The mRNA level of dynactin 1, an axon motor for retrograde transport, was significantly reduced in the SBMA mice resulting from pathogenic AR-induced transcriptional dysregulation. These pathological events were observed before the onset of neurological symptoms, but were reversed by castration, which prevents nuclear accumulation of pathogenic AR. Overexpression of dynactin 1 mitigated neuronal toxicity of the pathogenic AR in a cell culture model of SBMA. These observations indicate that polyglutamine-dependent transcriptional dysregulation of dynactin 1 plays a crucial role in the reversible neuronal dysfunction in the early stage of SBMA.

    DOI: 10.1523/JNEUROSCI.3032-06.2006

    Web of Science

    PubMed

    researchmap

  • Reversible disruption of dynactin 1-mediated retrograde axonal transport in polyglutamine-induced motor neuron degeneration

    Masahisa Katsuno, Hiroaki Adachi, Makoto Minamiyama, Masahiro Waza, Keisuke Tokui, Haruhiko Banno, Keisuke Suzuki, Yu Onoda, Fumiaki Tanaka, Manabu Doyu, Gen Sobue

    JOURNAL OF NEUROSCIENCE   26 ( 47 )   12106 - 12117   2006年11月

     詳細を見る

    記述言語:英語   出版者・発行元:SOC NEUROSCIENCE  

    Spinal and bulbar muscular atrophy (SBMA) is a hereditary neurodegenerative disease caused by an expansion of a trinucleotide CAG repeat encoding the polyglutamine tract in the androgen receptor (AR) gene. To elucidate the pathogenesis of polyglutamine-mediated motor neuron dysfunction, we investigated histopathological and biological alterations in a transgenic mouse model of SBMA carrying human pathogenic AR. In affected mice, neurofilaments and synaptophysin accumulated at the distal motor axon. A similar intramuscular accumulation of neurofilament was detected in the skeletal muscle of SBMA patients. Fluoro-gold labeling and sciatic nerve ligation demonstrated an impaired retrograde axonal transport in the transgenic mice. The mRNA level of dynactin 1, an axon motor for retrograde transport, was significantly reduced in the SBMA mice resulting from pathogenic AR-induced transcriptional dysregulation. These pathological events were observed before the onset of neurological symptoms, but were reversed by castration, which prevents nuclear accumulation of pathogenic AR. Overexpression of dynactin 1 mitigated neuronal toxicity of the pathogenic AR in a cell culture model of SBMA. These observations indicate that polyglutamine-dependent transcriptional dysregulation of dynactin 1 plays a crucial role in the reversible neuronal dysfunction in the early stage of SBMA.

    DOI: 10.1523/JNEUROSCI.3032-06.2006

    Web of Science

    researchmap

  • Alleviating neurodegeneration by an anticancer agent: an Hsp90 inhibitor (17-AAG). 国際誌

    Masahiro Waza, Hiroaki Adachi, Masahisa Katsuno, Makoto Minamiyama, Fumiaki Tanaka, Gen Sobue

    Annals of the New York Academy of Sciences   1086   21 - 34   2006年11月

     詳細を見る

    記述言語:英語   出版者・発行元:BLACKWELL PUBLISHING  

    Heat shock proteins (HSPs) that function mainly as molecular chaperones play an important role in the folding and quality control of proteins. Compared with these chaperones, Hsp90 is unique in that it binds to substrate proteins, called Hsp90 client proteins. Hsp90 is involved in the folding, activation, and assembly of its client proteins in association with its co-chaperones. Because numerous oncoproteins belonging to the Hsp90 client protein family are selectively degraded by Hsp90 inhibitors, 17-allylamino-17-demethoxygeldanamycin (17-AAG), a first-in-class Hsp90 inhibitor, is now under clinical trials as a novel molecular-targeted agent for a wide range of malignancies. In spinal and bulbar muscular atrophy (SBMA), the pathogenic gene product is polyglutamine (polyQ)-expanded androgen receptor (AR), which belongs to the Hsp90 client protein family and is known to be degraded by 17-AAG. We have recently demonstrated that administration of an anticancer agent 17-AAG significantly ameliorated polyQ-mediated motor neuron degeneration by reducing the total amount of mutant AR. The ability of 17-AAG to degrade mutant protein would be directly applicable to SBMA and other neurodegenerative diseases in which the disease-causing proteins also belong to the Hsp90 client protein family. Our proposed therapeutic approach using a novel anticancer agent 17-AAG has emerged as a candidate for molecular-targeted therapies for neurodegenerative diseases.

    DOI: 10.1196/annals.1377.012

    Web of Science

    PubMed

    researchmap

  • Gene expression profiling toward understanding of ALS pathogenesis. 国際誌

    Fumiaki Tanaka, Jun-Ichi Niwa, Shinsuke Ishigaki, Masahisa Katsuno, Masahiro Waza, Masahiko Yamamoto, Manabu Doyu, Gen Sobue

    Annals of the New York Academy of Sciences   1086   1 - 10   2006年11月

     詳細を見る

    記述言語:英語   出版者・発行元:BLACKWELL PUBLISHING  

    Although more than 130 years have gone by since the first description in 1869 by Jean-Martin Charcot, the mechanism underlying the characteristic selective motor neuron degeneration in amyotrophic lateral sclerosis (ALS) has remained elusive. Modest advances in this research field have been achieved by the identification of copper/zinc superoxide dismutase 1 (SOD1) as one of the causative genes for rare familial ALS (FALS) and by the development and analysis of mutant SOD1 transgenic mouse models. However, in sporadic ALS (SALS) with many more patients, causative or critical genes situated upstream of the disease pathway have not yet been elucidated and no available disease models have been established. To approach genes causative or critical for ALS, gene expression profiling in tissues primarily affected by the disease has represented an attractive research strategy. We have been working on screening these genes employing and combining several new technologies such as cDNA microarray, molecular indexing, and laser capture microdissection. Many of the resultant genes are of intense interest and may provide a powerful tool for determining the molecular mechanisms of ALS. However, we have barely arrived at the starting point and are confronting an enormous number of genes whose roles remain undetermined. Challenging tasks lie ahead of us such as identifying which genes are really causative for ALS and developing a disease model of SALS with due consideration for the expression changes in those genes.

    DOI: 10.1196/annals.1377.011

    Web of Science

    PubMed

    researchmap

  • Modulation of Hsp90 function in neurodegenerative disorders: a molecular-targeted therapy against disease-causing protein

    Masahiro Waza, Hiroaki Adachi, Masahisa Katsuno, Makoto Minamiyama, Fumiaki Tanaka, Manabu Doyu, Gen Sobue

    JOURNAL OF MOLECULAR MEDICINE-JMM   84 ( 8 )   635 - 646   2006年8月

     詳細を見る

    記述言語:英語   掲載種別:書評論文,書評,文献紹介等   出版者・発行元:SPRINGER  

    Abnormal accumulation of disease-causing protein is a commonly observed characteristic in chronic neurodegenerative disorders such as Alzheimer&apos;s disease, Parkinson&apos;s disease, and polyglutamine (polyQ) diseases. A therapeutic approach that could selectively eliminate would be a promising remedy for neurodegenerative disorders. Spinal and bulbar muscular atrophy (SBMA), one of the polyQ diseases, is a late-onset motor neuron disease characterized by proximal muscle atrophy, weakness, contraction fasciculations, and bulbar involvement. The pathogenic gene product is polyQ-expanded androgen receptor (AR), which belongs to the heat shock protein (Hsp) 90 client protein family. 17-Allylamino-17-demethoxygeldanamycin (17-AAG), a novel Hsp90 inhibitor, is a new derivative of geldanamycin that shares its important biological activities but shows less toxicity. 17AAG is now in phase 11 clinical trials as a potential anticancer agent because of its ability to selectively degrade several oncoproteins. We have recently demonstrated the efficacy and safety of 17-AAG in a mouse model of SBMA. The administration of 17-AAG significantly ameliorated polyQ-mediated motor neuron degeneration by reducing the total amount of mutant AR. 17-AAG accomplished the preferential reduction of mutant AR mainly through Hsp90 chaperone complex formation and subsequent proteasome-dependent degradation. 17-AAG induced Hsp70 and Hsp40 in vivo as previously reported; however, its ability to induce HSPs was limited, suggesting that the HSP induction might support the degradation of mutant protein. The ability of 17-AAG to preferentially Abnormal accumulation of disease-causing protein is a commonly observed characteristic in chronic neurodegenerative disorders such as Alzheimer&apos;s disease, Parkinson&apos;s disease, and polyglutarnine (polyQ) diseases. A therapeutic approach that could selectively eliminate would be a promising remedy for neurodegenerative disorders. Spinal and bulbar muscular atrophy (SBMA), one of the polyQ diseases, is a late-onset motor neuron disease characterized by proximal muscle atrophy, weakness, contraction fasciculations, and bulbar involvement. The pathogenic gene product is polyQ-expanded androgen receptor (AR), which belongs to the heat shock protein (Hsp) 90 client protein family. 17-Allylamino-17-demethoxygeldanamycin (17-AAG), a novel Hsp90 inhibitor, is a new derivative of geldanamycin that shares its important biological activities but shows less toxicity. 17-AAG is now in phase 11 clinical trials as a potential anticancer agent because of its ability to selectively degrade several oncoproteins. We have recently demonstrated the efficacy and safety of 17-AAG in a mouse model of SBMA. The administration of 17-AAG significantly ameliorated polyQ-mediated motor neuron degeneration by reducing the total amount of mutant AR. 17-AAG the preferential reduction of mutant AR mainly through Hsp90 chaperone complex formation and subsequent proteasome-dependent degradation. 17-AAG induced Hsp70 and Hsp40 in vivo as previously reported; however, its ability to induce HSPs was limited, suggesting that the HSP induction might support the degradation of mutant protein. The ability of 17-AAG to preferentially degrade mutant protein would be directly applicable to SBMA and other neurodegenerative diseases in which the disease-causing proteins also belong to the Hsp90 client protein family.
    Our proposed therapeutic approach, modulation of Hsp90 function by 17-AAG treatment, has emerged as a candidate for molecular-targeted therapies for neurodegenerative diseaes. This review will consider our research findings and discuss the possibility of a clinical application of 17-AAG to SBMA and other neurodegenerative diseases.

    DOI: 10.1007/s00109-006-0066-0

    Web of Science

    researchmap

  • Modulation of Hsp90 function in neurodegenerative disorders: a molecular-targeted therapy against disease-causing protein. 国際誌

    Masahiro Waza, Hiroaki Adachi, Masahisa Katsuno, Makoto Minamiyama, Fumiaki Tanaka, Manabu Doyu, Gen Sobue

    Journal of molecular medicine (Berlin, Germany)   84 ( 8 )   635 - 46   2006年8月

     詳細を見る

    記述言語:英語   出版者・発行元:SPRINGER  

    Abnormal accumulation of disease-causing protein is a commonly observed characteristic in chronic neurodegenerative disorders such as Alzheimer's disease, Parkinson's disease, and polyglutamine (polyQ) diseases. A therapeutic approach that could selectively eliminate would be a promising remedy for neurodegenerative disorders. Spinal and bulbar muscular atrophy (SBMA), one of the polyQ diseases, is a late-onset motor neuron disease characterized by proximal muscle atrophy, weakness, contraction fasciculations, and bulbar involvement. The pathogenic gene product is polyQ-expanded androgen receptor (AR), which belongs to the heat shock protein (Hsp) 90 client protein family. 17-Allylamino-17-demethoxygeldanamycin (17-AAG), a novel Hsp90 inhibitor, is a new derivative of geldanamycin that shares its important biological activities but shows less toxicity. 17-AAG is now in phase II clinical trials as a potential anti-cancer agent because of its ability to selectively degrade several oncoproteins. We have recently demonstrated the efficacy and safety of 17-AAG in a mouse model of SBMA. The administration of 17-AAG significantly ameliorated polyQ-mediated motor neuron degeneration by reducing the total amount of mutant AR. 17-AAG accomplished the preferential reduction of mutant AR mainly through Hsp90 chaperone complex formation and subsequent proteasome-dependent degradation. 17-AAG induced Hsp70 and Hsp40 in vivo as previously reported; however, its ability to induce HSPs was limited, suggesting that the HSP induction might support the degradation of mutant protein. The ability of 17-AAG to preferentially degrade mutant protein would be directly applicable to SBMA and other neurodegenerative diseases in which the disease-causing proteins also belong to the Hsp90 client protein family. Our proposed therapeutic approach, modulation of Hsp90 function by 17-AAG treatment, has emerged as a candidate for molecular-targeted therapies for neurodegenerative diseases. This review will consider our research findings and discuss the possibility of a clinical application of 17-AAG to SBMA and other neurodegenerative diseases.

    DOI: 10.1007/s00109-006-0066-0

    Web of Science

    PubMed

    researchmap

  • Pathogenesis, animal models and therapeutics in spinal and bulbar muscular atrophy (SBMA). 国際誌

    Masahisa Katsuno, Hiroaki Adachi, Masahiro Waza, Haruhiko Banno, Keisuke Suzuki, Fumiaki Tanaka, Manabu Doyu, Gen Sobue

    Experimental neurology   200 ( 1 )   8 - 18   2006年7月

     詳細を見る

    記述言語:英語   出版者・発行元:ACADEMIC PRESS INC ELSEVIER SCIENCE  

    Spinal and bulbar muscular atrophy (SBMA) is a hereditary neurodegenerative disease characterized by slowly progressive muscle weakness and atrophy of bulbar, facial, and limb muscles. The cause of SBMA is expansion of a trinucleotide CAG repeat, which encodes the polyglutamine tract, in the first exon of the androgen receptor (AR) gene. SBMA chiefly occurs in adult males, whereas neurological symptoms are rarely detected in females having mutant AR gene. The cardinal histopathological finding of SBMA is loss of lower motor neurons in the anterior horn of spinal cord as well as in brainstem motor nuclei. Animal models carrying human mutant AR gene recapitulate polyglutamine-mediated motor neuron degeneration, providing clues to the pathogenesis of SBMA. There is increasing evidence that testosterone, the ligand of AR, plays a pivotal role in the pathogenesis of neurodegeneration in SBMA. The striking success of androgen deprivation therapy in SBMA mouse models has been translated into clinical trials. In addition, elucidation of pathophysiology using animal models leads to emergence of candidate drugs to treat this devastating disease: HSP inducer, Hsp90 inhibitor, and histone deacetylase inhibitor. Utilizing biomarkers such as scrotal skin biopsy would improve efficacy of clinical trials to verify the results from animal studies. Advances in basic and clinical researches on SBMA are now paving the way for clinical application of potential therapeutics.

    DOI: 10.1016/j.expneurol.2006.01.021

    Web of Science

    PubMed

    researchmap

  • Pathogenesis, animal models and therapeutics in Spinal and bulbar muscular atrophy (SBMA)

    Masahisa Katsuno, Hiroaki Adachi, Masahiro Waza, Haruhiko Banno, Keisuke Suzuki, Fumiaki Tanaka, Manabu Doyu, Gen Sobue

    EXPERIMENTAL NEUROLOGY   200 ( 1 )   8 - 18   2006年7月

     詳細を見る

    記述言語:英語   掲載種別:書評論文,書評,文献紹介等   出版者・発行元:ACADEMIC PRESS INC ELSEVIER SCIENCE  

    Spinal and bulbar muscular atrophy (SBMA) is a hereditary neurodegenerative disease characterized by slowly progressive muscle weakness and atrophy of bulbar, facial, and limb muscles. The cause of SBMA is expansion of a trinucleotide CAG repeat, which encodes the polyglutamine tract, in the first exon of the androgen receptor (AR) gene. SBMA chiefly occurs in adult males, whereas neurological symptoms are rarely detected in females having mutant AR gene. The cardinal histopathological finding of SBMA is loss of lower motor neurons in the anterior horn of spinal cord as well as in brainstem motor nuclei. Animal models carrying human mutant AR gene recapitulate polyglutamine-mediated motor neuron degeneration, providing clues to the pathogenesis of SBMA. There is increasing evidence that testosterone, the ligand of AR, plays a pivotal role in the pathogenesis of neurodegeneration in SBMA. The striking success of androgen deprivation therapy in SBMA mouse models has been translated into clinical trials. In addition, elucidation of pathophysiology using animal models leads to emergence of candidate drugs to treat this devastating disease: HSP inducer, Hsp90 inhibitor, and histone deacetylase inhibitor. Utilizing biomarkers such as scrotal skin biopsy would improve efficacy of clinical trials to verify the results from animal studies. Advances in basic and clinical researches on SBMA are now paving the way for clinical application of potential therapeutics. (c) 2006 Elsevier Inc. All rights reserved.

    DOI: 10.1016/j.expneurol.2006.01.021

    Web of Science

    researchmap

  • Natural history of spinal and bulbar muscular atrophy (SBMA): a study of 223 Japanese patients

    N Atsuta, H Watanabe, M Ito, H Banno, K Suzuki, M Katsuno, F Tanaka, A Tamakoshi, G Sobue

    BRAIN   129 ( Pt6 )   1446 - 1455   2006年6月

     詳細を見る

    記述言語:英語   出版者・発行元:OXFORD UNIV PRESS  

    Spinal and bulbar muscular atrophy (SBMA) is an adult-onset motoneuron disease caused by a CAG-repeat expansion in the androgen receptor (AR) gene and for which no curative therapy exists. However, since recent research may provide opportunities for medical treatment, information concerning the natural history of SBMA would be beneficial in planning future clinical trials. We investigated the natural course of SBMA as assessed by nine activities of daily living (ADL) milestones in 223 Japanese SBMA patients (mean age at data collection = 55.2 years; range = 30-87 years) followed from 1 to 20 years. All the patients were diagnosed by genetic analysis. Hand tremor was an early event that was noticed at a median age of 33 years. Muscular weakness occurred predominantly in the lower limbs, and was noticed at a median age of 44 years, followed by the requirement of a handrail to ascend stairs at 49, dysarthria at 50, dysphagia at 54, use of a cane at 59 and a wheelchair at 61 years. Twenty-one of the patients developed pneumonia at a median age of 62 and 15 of them died at a median age of 65 years. The most common cause of death in these cases was pneumonia and respiratory failure. The ages at onset of each ADL milestone were strongly correlated with the length of CAG repeats in the AR gene. However CAG-repeat length did not correlate with the time intervals between each ADL milestone, suggesting that although the onset age of each ADL milestone depends on the CAG-repeat length in the AR gene, the rate of disease progression does not. The levels of serum testosterone, an important triggering factor for polyglutamine-mediated motoneuron degeneration, were maintained at relatively high levels even at advanced ages. These results provide beneficial information for future clinical therapeutic trials, although further detailed prospective studies are also needed.

    DOI: 10.1093/brain/awl096

    Web of Science

    researchmap

  • Natural history of spinal and bulbar muscular atrophy (SBMA): a study of 223 Japanese patients. 国際誌

    Naoki Atsuta, Hirohisa Watanabe, Mizuki Ito, Haruhiko Banno, Keisuke Suzuki, Masahisa Katsuno, Fumiaki Tanaka, Akiko Tamakoshi, Gen Sobue

    Brain : a journal of neurology   129 ( Pt 6 )   1446 - 55   2006年6月

     詳細を見る

    記述言語:英語   出版者・発行元:OXFORD UNIV PRESS  

    Spinal and bulbar muscular atrophy (SBMA) is an adult-onset motoneuron disease caused by a CAG-repeat expansion in the androgen receptor (AR) gene and for which no curative therapy exists. However, since recent research may provide opportunities for medical treatment, information concerning the natural history of SBMA would be beneficial in planning future clinical trials. We investigated the natural course of SBMA as assessed by nine activities of daily living (ADL) milestones in 223 Japanese SBMA patients (mean age at data collection = 55.2 years; range = 30-87 years) followed from 1 to 20 years. All the patients were diagnosed by genetic analysis. Hand tremor was an early event that was noticed at a median age of 33 years. Muscular weakness occurred predominantly in the lower limbs, and was noticed at a median age of 44 years, followed by the requirement of a handrail to ascend stairs at 49, dysarthria at 50, dysphagia at 54, use of a cane at 59 and a wheelchair at 61 years. Twenty-one of the patients developed pneumonia at a median age of 62 and 15 of them died at a median age of 65 years. The most common cause of death in these cases was pneumonia and respiratory failure. The ages at onset of each ADL milestone were strongly correlated with the length of CAG repeats in the AR gene. However CAG-repeat length did not correlate with the time intervals between each ADL milestone, suggesting that although the onset age of each ADL milestone depends on the CAG-repeat length in the AR gene, the rate of disease progression does not. The levels of serum testosterone, an important triggering factor for polyglutamine-mediated motoneuron degeneration, were maintained at relatively high levels even at advanced ages. These results provide beneficial information for future clinical therapeutic trials, although further detailed prospective studies are also needed.

    DOI: 10.1093/brain/awl096

    Web of Science

    PubMed

    researchmap

  • Mutant androgen receptor accumulation in spinal and bulbar muscular atrophy scrotal skin: A pathogenic marker

    H Banno, H Adachi, M Katsuno, K Suzuki, N Atsuta, H Watanabe, F Tanaka, M Doyu, G Sobue

    ANNALS OF NEUROLOGY   59 ( 3 )   520 - 526   2006年3月

     詳細を見る

    記述言語:英語   出版者・発行元:WILEY-LISS  

    Spinal and bulbar muscular atrophy (SBMA) is a hereditary motor neuron disease caused by the expansion of a polyglutamine tract in the androgen receptor (AR). The nuclear accumulation of mutant AR is central to the pathogenesis of SBMA. Androgen deprivation with leuprorelin inhibits mutant AR accumulation, resulting in rescue of neuronal dysfunction in a mouse model of SBMA. This study aimed to investigate whether mutant AR accumulation in the scrotal skin is an appropriate biomarker of SBMA. Methods. Immunohistochemistry of both scrotal skin and the spinal cord was performed on five autopsied SBMA cases. Neurological severity and scrotal skin findings were studied in another 13 patients. Five other patients received subcutaneous injections of leuprorelin and underwent scrotal skin biopsy. Results: The degree of mutant AR accumulation in scrotal skin epithelial cells tended to be correlated with that in the spinal motor neurons in autopsy specimens, and it was well correlated with CAG repeat length and inversely correlated with the amyotrophic lateral sclerosis functional scale. Leuprorelin treatment inhibited mutant AR protein accumulation in the scrotal skin of SBMA patients. Interpretation These observations suggest that scrotal skin biopsy findings are a potent pathogenic marker of SBMA and can be a surrogate end point in therapeutic trials.

    DOI: 10.1002/ana.20735

    Web of Science

    researchmap

  • Clinicopathologic features of nonsystemic vasculitic neuropathy and microscopic polyangiitis-associated neuropathy: A comparative study

    M Sugiura, H Koike, M Iijima, K Mori, N Hattori, M Katsuno, F Tanaka, G Sobue

    JOURNAL OF THE NEUROLOGICAL SCIENCES   241 ( 1-2 )   31 - 37   2006年2月

     詳細を見る

    記述言語:英語   出版者・発行元:ELSEVIER SCIENCE BV  

    Objective: To compare clinicopathologic findings in nonsystemic vasculitic neuropathy (NSVN) and microscopic polyangiitis-associated neuropathy (MPAN).
    Methods: Patients clinicopathologically confirmed to have NSVN (n=23) or MPAN (n=40) were compared with respect to clinical, electrophysiologic, and histopathologic features.
    Results: Clinical features of neuropathy such as initial symptoms, progression, and distribution of sensory and motor deficits were similar in both groups, while functional compromise was greater in MPAN than NSVN. Abnormalities of laboratory data including those reflecting severity and extent of inflammation such as C-reactive protein were more conspicuous in MPAN than NSVN. Perinuclear anti-neutrophil cytoplasmic antibodies (p-ANCA) were positive in two-thirds of patients with MPAN but negative in all NSVN. Electrophysiologic and histopathologic findings indicated axonal neuropathy in both groups, whereas the reduction of compound muscle action potentials in the tibial nerve and sensory nerve action potentials in the median nerve was significantly more profound in MPAN than NSVN. As for the epineurial perivascular infiltration, frequencies of cell-specific markers for T lymphocytes, macrophages, and B lymphocytes among cells infiltrating the vasculitic lesions were essentially similar between groups.
    Conclusions: Clinicopathologic profiles and vascular pathology were similar between NSVN and MPAN but the age at onset, severity, and presence of p-ANCA were clearly different. Further study is needed to clarify the pathogenesis of NSVN and its place in the vasculitic spectrum of diseases. (c) 2005 Elsevier B.V. All rights reserved.

    DOI: 10.1016/j.jns.2005.10.018

    Web of Science

    researchmap

  • 脳・神経疾患 (特集 EBMがもたらしたもの,めざすもの) -- (EBMは臨床現場を変えることができたか)

    田中 章景, 渡邉 宏久, 武田 章敬

    EBMジャ-ナル   7 ( 1 )   104 - 109   2006年1月

     詳細を見る

    記述言語:日本語   出版者・発行元:中山書店  

    CiNii Books

    researchmap

    その他リンク: http://search.jamas.or.jp/link/ui/2006126763

  • Modulation of Hsp90 function - One of molecular targeted therapy for neurodegenerative disorders

    Masahiro Waza, Hiroaki Adachi, Masahisa Katsuno, Makoto Minamiyama, Fumiaki Tanaka, Manabu Doyu, Gen Sobue

    NEUROSCIENCE RESEARCH   55   S105 - S105   2006年

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:ELSEVIER IRELAND LTD  

    Web of Science

    researchmap

  • CHIP over-expression reduces the mutant AR protein and ameliorates phenotypes of the SBMA transgenic mouse model

    Hiroaki Adachi, Masahiro Waza, Masahisa Katsuno, Makoto Minamiyama, Keisuke Tokui, Fumiaki Tanaka, Manabu Doyu, Gen Sobue

    NEUROSCIENCE RESEARCH   55   S135 - S135   2006年

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:ELSEVIER IRELAND LTD  

    Web of Science

    researchmap

  • Alleviating neurodegeneration by an anticancer agent - An Hsp90 inhibitor (17-AAG)

    Masahiro Waza, Hiroaki Adachi, Masahisa Katsuno, Makoto Minamiyama, Fumiaki Tanaka, Gen Sobue

    INTEGRATED MOLECULAR MEDICINE FOR NEURONAL AND NEOPLASTIC DISORDERS   1086   21 - 34   2006年

     詳細を見る

    記述言語:英語   出版者・発行元:BLACKWELL PUBLISHING  

    Heat shock proteins (HSPs) that function mainly as molecular chaperones play an important role in the folding and quality control of proteins. Compared with these chaperones, Hsp90 is unique in that it binds to substrate proteins, called Hsp90 client proteins. Hsp90 is involved in the folding, activation, and assembly of its client proteins in association with its co-chaperones. Because numerous oncoproteins belonging to the Hsp90 client protein family are selectively degraded by Hsp90 inhibitors, 17-allylamino-17-demethoxygeldanamycin (17-AAG), a first-in-class Hsp90 inhibitor, is now under clinical trials as a novel molecular-targeted agent for a wide range of malignancies. In spinal and bulbar muscular atrophy (SBMA), the pathogenic gene product is polyglutamine (polyQ)-expanded androgen receptor (AR), which belongs to the Hsp90 client protein family and is known to be degraded by 17-AAG. We have recently demonstrated that administration of an anticancer agent 17-AAG significantly ameliorated polyQ-mediated motor neuron degeneration by reducing the total amount of mutant AR. The ability of 17-AAG to degrade mutant protein would be directly applicable to SBMA and other neuro degenerative diseases in which the disease-causing proteins also belong to the Hsp90 client protein family. Our proposed therapeutic approach using a novel anticancer agent 17-AAG has emerged as a candidate for molecular-targeted therapies for neurodegenerative diseases.

    DOI: 10.1196/annals.1377.012

    Web of Science

    researchmap

  • Gene expression profiling toward understanding of ALS pathogenesis

    Fumiaki Tanaka, Jun-ichi Niwa, Shinsuke Ishigaki, Masahisa Katsuno, Masahiro Waza, Masahiko Yamamoto, Manabu Doyu, Gen Sobue

    INTEGRATED MOLECULAR MEDICINE FOR NEURONAL AND NEOPLASTIC DISORDERS   1086   1 - 10   2006年

     詳細を見る

    記述言語:英語   出版者・発行元:BLACKWELL PUBLISHING  

    Although more than 130 years have gone by since the first description in 1869 by Jean-Martin Charcot, the mechanism underlying the characteristic selective motor neuron degeneration in amyotrophic lateral sclerosis (ALS) has remained elusive. Modest advances in this research field have been achieved by the identification of copper/zinc superoxide dismutase I (SODI) as one of the causative genes for rare familial ALS (FALS) and by the development and analysis of mutant SODI transgenic mouse models. However, in sporadic ALS (SALS) with many more patients, causative or critical genes situated upstream of the disease pathway have not yet been elucidated and no available disease models have been established. To approach genes causative or critical for ALS, gene expression profiling in tissues primarily affected by the disease has represented an attractive research strategy. We have been working on screening these genes employing and combining several new technologies such as cDNA microarray, molecular indexing, and laser capture micro dissection. Many of the resultant genes are of intense interest and may provide a powerful tool for determining the molecular mechanisms of ALS. However, we have barely arrived at the starting point and are confronting an enormous number of genes whose roles remain undetermined. Challenging tasks lie ahead of us such as identifying which genes are really causative for ALS and developing a disease model of SALS with due consideration for the expression changes in those genes.

    DOI: 10.1196/annals.1377.011

    Web of Science

    researchmap

  • 慢性炎症性脱髄性多発ニューロパチーのIVIg治療反応性を規定するHLAアリル多型の検討

    田中 章景, 飯島 正博, 森 恵子, 小池 春樹, 服部 直樹, 山本 正彦, 祖父江 元

    臨床神経学   45 ( 12 )   1014 - 1014   2005年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 球脊髄性筋萎縮症のモデルマウスにおけるgeranylgeranylacetoneの効果

    勝野 雅央, 足立 弘明, 南山 誠, 和座 雅浩, 桑 晨, 田中 章景, 道勇 学, 祖父江 元

    臨床神経学   45 ( 12 )   1114 - 1114   2005年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 慢性炎症性脱髄性多発ニューロパチー(CIDP)の病態を規定する遺伝子背景

    飯島 正博, 森 恵子, 小池 春樹, 服部 直樹, 田中 章景, 山本 正彦, 祖父江 元

    臨床神経学   45 ( 12 )   1014 - 1014   2005年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 球脊髄性筋萎縮症トランスジェニックマウスのDNAマイクロアレイ解析

    南山 誠, 勝野 雅央, 足立 弘明, 和座 雅浩, 桑 晨, 田中 章景, 道勇 学, 犬飼 晃, 祖父江 元

    臨床神経学   45 ( 12 )   1115 - 1115   2005年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 球脊髄性筋萎縮症モデルマウスにおける逆行性軸索輸送障害

    鈴木 啓介, 勝野 雅央, 足立 弘明, 南山 誠, 和座 雅浩, 桑 晨, 田中 章景, 道勇 学, 祖父江 元

    臨床神経学   45 ( 12 )   1114 - 1114   2005年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • Pharmacological induction of heat-shock proteins alleviates polyglutamine-mediated motor neuron disease. 国際誌

    Masahisa Katsuno, Chen Sang, Hiroaki Adachi, Makoto Minamiyama, Masahiro Waza, Fumiaki Tanaka, Manabu Doyu, Gen Sobue

    Proceedings of the National Academy of Sciences of the United States of America   102 ( 46 )   16801 - 6   2005年11月

     詳細を見る

    記述言語:英語   出版者・発行元:NATL ACAD SCIENCES  

    Spinal and bulbar muscular atrophy (SBMA) is an adult-onset motor neuron disease caused by the expansion of a trinucleotide CAG repeat encoding the polyglutamine tract in the first exon of the androgen receptor gene (AR). The pathogenic, polyglutamine-expanded AR protein accumulates in the cell nucleus in a ligand-dependent manner and inhibits transcription by interfering with transcriptional factors and coactivators. Heat-shock proteins (HSPs) are stress-induced chaperones that facilitate the refolding and, thus, the degradation of abnormal proteins. Geranylgeranylacetone (GGA), a nontoxic antiulcer drug, has been shown to potently induce HSP expression in various tissues, including the central nervous system. In a cell model of SBMA, GGA increased the levels of Hsp70, Hsp90, and Hsp105 and inhibited cell death and the accumulation of pathogenic AR. Oral administration of GGA also up-regulated the expression of HSPs in the central nervous system of SBMA-transgenic mice and suppressed nuclear accumulation of the pathogenic AR protein, resulting in amelioration of polyglutamine-dependent neuromuscular phenotypes. These observations suggest that, although a high dose appears to be needed for clinical effects, oral GGA administration is a safe and promising therapeutic candidate for polyglutamine-mediated neurodegenerative diseases, including SBMA.

    DOI: 10.1073/pnas.0506249102

    Web of Science

    PubMed

    researchmap

  • Pharmacological induction of heat-shock proteins alleviates polyglutamine-mediated motor neuron disease

    M Katsuno, C Sang, H Adachi, M Minamiyama, M Waza, F Tanaka, M Doyu, G Sobue

    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA   102 ( 46 )   16801 - 16806   2005年11月

     詳細を見る

    記述言語:英語   出版者・発行元:NATL ACAD SCIENCES  

    Spinal and bulbar muscular atrophy (SBMA) is an adult-onset motor neuron disease caused by the expansion of a trinucleotide CAG repeat encoding the polyglutamine tract in the first exon of the androgen receptor gene (AR). The pathogenic, polyglutamine-expanded AR protein accumulates in the cell nucleus in a ligand-dependent manner and inhibits transcription by interfering with transcriptional factors and coactivators. Heat-shock proteins (HSPs) are stress-induced chaperones that facilitate the refolding and, thus, the degradation of abnormal proteins. Geranylgeranylacetone (GGA), a nontoxic antiulcer drug, has been shown to potently induce HSP expression in various tissues, including the central nervous system. In a cell model of SBMA, GGA increased the levels of Hsp70, Hsp90, and Hsp105 and inhibited cell death and the accumulation of pathogenic AR. Oral administration of GGA also up-regulated the expression of HSPs in the central nervous system of SBMA-transgenic mice and suppressed nuclear accumulation of the pathogenic AIR protein, resulting in amelioration of polyglutamine-dependent neuromuscular phenotypes. These observations suggest that, although a high dose appears to be needed for clinical effects, oral GGA administration is a safe and promising therapeutic candidate for polyglutamine-mediated neurodegenerative diseases, including SBMA.

    DOI: 10.1073/pnas.0506249102

    Web of Science

    PubMed

    researchmap

  • Neuronal intranuclear hyaline inclusion disease showing motor-sensory and autonomic neuropathy

    J Sone, N Hishikawa, H Koike, N Hattori, M Hirayama, M Nagamatsu, M Yamamoto, F Tanaka, M Yoshida, Y Hashizume, H Imamura, E Yamada, G Sobue

    NEUROLOGY   65 ( 10 )   1538 - 1543   2005年11月

     詳細を見る

    記述言語:英語   出版者・発行元:LIPPINCOTT WILLIAMS & WILKINS  

    Background: Neuronal intranuclear hyaline inclusion disease ( NIHID), a rare neurodegenerative disease in which eosinophilic intranuclear inclusions develop mainly in neurons, has not yet been described to present as hereditary motor- sensory and autonomic neuropathy.
    Methods: Patients in two NIHID families showing peripheral neuropathy were evaluated clinically, electrophysiologically, and histopathologically.
    Results: In both families, patients had severe muscle atrophy and weakness in limbs, limb girdle, and face; sensory impairment in the distal limbs; dysphagia, episodic intestinal pseudoobstruction with vomiting attacks; and urinary and fecal incontinence. No patients developed symptoms suggesting CNS involvement. Electrophysiologic study showed the reduced motor and sensory nerve conduction velocities and amplitudes, and also extensive denervation potentials. In sural nerve specimens, numbers of myelinated and unmyelinated fibers were decreased. In two autopsy cases, eosinophilic intranuclear inclusions were widespread, particularly in sympathetic and myenteric ganglion neurons, dorsal root ganglion neurons, and spinal motor neurons. These neurons also were decreased in number.
    Conclusion: Patients with neuronal intranuclear hyaline inclusion disease ( NIHID) can manifest symptoms limited to those of peripheral neuropathy. NIHID therefore is part of the differential diagnosis of hereditary motor- sensory neuropathy associated with autonomic symptoms. Intranuclear hyaline inclusions in Schwann cells and in the myenteric plexus may permit antemortem diagnosis of NIHID.

    DOI: 10.1212/01.wnl.0000184490.22527.90

    Web of Science

    researchmap

  • The wide spectrum of clinical manifestations in Sjogren's syndrome-associated neuropathy

    K Mori, M Iijima, H Koike, N Hattori, F Tanaka, H Watanabe, M Katsuno, A Fujita, Aiba, I, A Ogata, T Saito, K Asakura, M Yoshida, M Hirayama, G Sobue

    BRAIN   128 ( Pt11 )   2518 - 2534   2005年11月

     詳細を見る

    記述言語:英語   出版者・発行元:OXFORD UNIV PRESS  

    We assessed the clinicopathological features of 92 patients with primary Sjogren's syndrome-associated neuropathy (76 women, 16 men, 54.7 years, age at onset). The majority of patients (93%) were diagnosed with Sjogren's syndrome after neuropathic symptoms appeared. We classified these patients into seven forms of neuropathy: sensory ataxic neuropathy (n = 36), painful sensory neuropathy without sensory ataxia (n = 18), multiple mononeuropathy (n = 11), multiple cranial neuropathy (n = 5), trigeminal neuropathy (n = 15), autonomic neuropathy (n = 3) and radiculoneuropathy (n = 4), based on the predominant neuropathic symptoms. Acute or subacute onset was seen more frequently in multiple mononeuropathy and multiple cranial neuropathy, whereas chronic progression was predominant in other forms of neuropathy. Sensory symptoms without substantial motor involvement were seen predominantly in sensory ataxic, painful sensory, trigeminal and autonomic neuropathy, although the affected sensory modalities and distribution pattern varied. In contrast, motor weakness and muscle atrophy were observed in multiple mononeuropathy, multiple cranial neuropathy and radiculoneuropathy. Autonomic symptoms were often seen in all forms of neuropathy. Abnormal pupils and orthostatic hypotension were particularly frequent in sensory ataxic, painful, trigeminal and autonomic neuropathy. Unelicited somatosensory evoked potentials and spinal cord posterior column abnormalities in MRI were observed in sensory ataxic, painful and autonomic neuropathy. Sural nerve biopsy specimens (n = 55) revealed variable degrees of axon loss. Predominantly large fibre loss was observed in sensory ataxic neuropathy, whereas predominantly small fibre loss occurred in painful sensory neuropathy. Angiitis and perivascular cell invasion were seen most frequently in multiple mononeuropathy, followed by sensory ataxic neuropathy. The autopsy findings of one patient with sensory ataxic neuropathy showed severe large sensory neuron loss paralleling to dorsal root and posterior column involvement of the spinal cord, and severe sympathetic neuron loss. Degrees of neuron loss in the dorsal and sympathetic ganglion corresponded to segmental distribution of sensory and sweating impairment. Multifocal T-cell invasion was seen in the dorsal root and sympathetic ganglion, perineurial space and vessel walls in the nerve trunks. Differential therapeutic responses for corticosteroids and IVIg were seen among the neuropathic forms. These clinicopathological observations suggest that sensory ataxic, painful and perhaps trigeminal neuropathy are related to ganglioneuronopathic process, whereas multiple mononeuropathy and multiple cranial neuropathy would be more closely associated with vasculitic process.

    DOI: 10.1093/brain/awh605

    Web of Science

    researchmap

  • 17-AAG, an Hsp90 inhibitor, ameliorates polyglutamine-mediated motor neuron degeneration

    M Waza, H Adachi, M Katsuno, M Minamiyama, C Sang, F Tanaka, A Inukai, M Doyu, G Sobue

    NATURE MEDICINE   11 ( 10 )   1088 - 1095   2005年10月

     詳細を見る

    記述言語:英語   出版者・発行元:NATURE PUBLISHING GROUP  

    Heat-shock protein 90 (Hsp90) functions as part of a multichaperone complex that folds, activates and assembles its client proteins. Androgen receptor (AR), a pathogenic gene product in spinal and bulbar muscular atrophy (SBMA), is one of the Hsp90 client proteins. We examined the therapeutic effects of 17-allylamino-17-demethoxygeldanamycin (17-AAG), a potent Hsp90 inhibitor, and its ability to degrade polyglutamine-expanded mutant AR. Administration of 17-AAG markedly ameliorated motor impairments in the SBMA transgenic mouse model without detectable toxicity, by reducing amounts of monomeric and aggregated mutant AR. The mutant AR showed a higher affinity for Hsp90-p23 and preferentially formed an Hsp90 chaperone complex as compared to wild-type AR; mutant AR was preferentially degraded in the presence of 17-AAG in both cells and transgenic mice as compared to wild-type AR. 17-AAG also mildly induced Hsp70 and Hsp40. 17-AAG would thus provide a new therapeutic approach to SBMA and probably to other related neurodegenerative diseases.

    DOI: 10.1038/nm1298

    Web of Science

    PubMed

    researchmap

  • 17-AAG, an Hsp90 inhibitor, ameliorates polyglutamine-mediated motor neuron degeneration. 国際誌

    Masahiro Waza, Hiroaki Adachi, Masahisa Katsuno, Makoto Minamiyama, Chen Sang, Fumiaki Tanaka, Akira Inukai, Manabu Doyu, Gen Sobue

    Nature medicine   11 ( 10 )   1088 - 95   2005年10月

     詳細を見る

    記述言語:英語   出版者・発行元:NATURE PUBLISHING GROUP  

    Heat-shock protein 90 (Hsp90) functions as part of a multichaperone complex that folds, activates and assembles its client proteins. Androgen receptor (AR), a pathogenic gene product in spinal and bulbar muscular atrophy (SBMA), is one of the Hsp90 client proteins. We examined the therapeutic effects of 17-allylamino-17-demethoxygeldanamycin (17-AAG), a potent Hsp90 inhibitor, and its ability to degrade polyglutamine-expanded mutant AR. Administration of 17-AAG markedly ameliorated motor impairments in the SBMA transgenic mouse model without detectable toxicity, by reducing amounts of monomeric and aggregated mutant AR. The mutant AR showed a higher affinity for Hsp90-p23 and preferentially formed an Hsp90 chaperone complex as compared to wild-type AR; mutant AR was preferentially degraded in the presence of 17-AAG in both cells and transgenic mice as compared to wild-type AR. 17-AAG also mildly induced Hsp70 and Hsp40. 17-AAG would thus provide a new therapeutic approach to SBMA and probably to other related neurodegenerative diseases.

    DOI: 10.1038/nm1298

    Web of Science

    PubMed

    researchmap

  • HLA class II allele frequency and IVIG responsiveness in Japanese CIDP

    M Iijima, K Mori, H Koike, N Hattori, F Tanaka, M Yamamoto, G Sobue

    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM   10   36 - 36   2005年7月

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:BLACKWELL PUBLISHING  

    Web of Science

    researchmap

  • Tuft-shaped astrocytes in Lewy body disease. 国際誌

    Nozomi Hishikawa, Yoshio Hashizume, Mari Yoshida, Jun-Ichi Niwa, Fumiaki Tanaka, Gen Sobue

    Acta neuropathologica   109 ( 4 )   373 - 80   2005年4月

     詳細を見る

    記述言語:英語   出版者・発行元:SPRINGER  

    We investigated the occurrence and distribution of tuft-shaped astrocytes (TuSAs) in 60 brains from patients with Lewy body disease (LBD), which were clinically diagnosed as Parkinson's disease (PD) or dementia with Lewy bodies (DLB), and 85 brains from control subjects. TuSAs have been documented as a neuropathological hallmark of progressive supranuclear palsy (PSP). We found phosphorylated tau (p-tau)-positive and alpha-synuclein-negative TuSAs in 10 of 60 patients with LBD and 3 of 85 control cases. TuSAs were mainly located within the precentral and premotor gyri of the frontal lobe cortex. There were only few TuSAs, but the distribution pattern and morphological and immunohistological features were similar to that in PSP. Furthermore, other p-tau positive structures, including aggregates in neurons, coiled-like glial cells and threads showed a similar distribution to those in PSP; mainly in the hippocampus, striatum, subthalamic nucleus, precentral and premotor gyri, brainstem nucleus, and dentate nucleus. In these cases, however, neuronal loss and gliosis were not seen in the regions involved in PSP, such as the subthalamic nucleus, pallidum, inferior olivary, cerebellar dentate nuclei, and periaqueductal gray matter. Clinical features were indistinguishable between the LBD with and without TuSAs. The appearance of TuSAs was not related to the frequency of Lewy bodies, neurofibrillary tangles, and senile plaques, but was significantly more pronounced with advancing age in both LBD and controls. These findings suggest that in a subgroup of elderly individual cases, especially associated with LB pathology, the glial and neuronal p-tau accumulation is increased and has a distributional pattern similar to PSP.

    DOI: 10.1007/s00401-004-0967-3

    Web of Science

    PubMed

    researchmap

  • Clinical and electrophysiologic correlates of IVIg responsiveness in CIDP

    M Iijima, M Yamamoto, M Hirayama, F Tanaka, M Katsuno, K Mori, H Koike, N Hattori, K Arimura, M Nakagawa, H Yoshikawa, K Hayasaka, O Onodera, M Baba, H Yasuda, T Saito, M Nakazato, K Nakashima, J Kira, R Kaji, N Oka, G Sobue

    NEUROLOGY   64 ( 8 )   1471 - 1475   2005年4月

     詳細を見る

    記述言語:英語   出版者・発行元:LIPPINCOTT WILLIAMS & WILKINS  

    To identify clinical and electrophysiologic features related to IV immunoglobulin (IVIg) responsiveness in chronic inflammatory demyelinating polyneuropathy ( CIDP), the authors conducted a multicenter study on 312 patients with CIDP ( 199 responders and 113 nonresponders). Muscle atrophy and decreased compound muscle action potential were pronounced in nonresponders of IVIg. Male gender, longer disease duration, and slow progression of symptoms were also associated with IVIg unresponsiveness. Features suggesting axonal dysfunction in peripheral nerves indicated IVIg unresponsiveness in CIDP.

    Web of Science

    researchmap

  • Tuft-shaped astrocytes in Lewy body disease

    N Hishikawa, Y Hashizume, M Yoshida, J Niwa, F Tanaka, G Sobue

    ACTA NEUROPATHOLOGICA   109 ( 4 )   373 - 380   2005年4月

     詳細を見る

    記述言語:英語   出版者・発行元:SPRINGER  

    We investigated the occurrence and distribution of tuft-shaped astrocytes (TuSAs) in 60 brains from patients with Lewy body disease (LBD), which were clinically diagnosed as Parkinsons disease (PD) or dementia with Lewy bodies (DLB), and 85 brains from control subjects. TuSAs have been documented as a neuropathological hallmark of progressive supranuclear palsy (PSP). We found phosphorylated tau (p-tau)-positive and &alpha;-synuclein-negative TuSAs in 10 of 60 patients with LBD and 3 of 85 control cases. TuSAs were mainly located within the precentral and premotor gyri of the frontal lobe cortex. There were only few TuSAs, but the distribution pattern and morphological and immunohistological features were similar to that in PSP. Furthermore, other p-tau positive structures, including aggregates in neurons, coiled-like glial cells and threads showed a similar distribution to those in PSP; mainly in the hippocampus, striatum, subthalamic nucleus, precentral and premotor gyri, brainstem nucleus, and dentate nucleus. In these cases, however, neuronal loss and gliosis were not seen in the regions involved in PSP, such as the subthalamic nucleus, pallidum, inferior olivary, cerebellar dentate nuclei, and periaqueductal gray matter. Clinical features were indistinguishable between the LBD with and without TuSAs. The appearance of TuSAs was not related to the frequency of Lewy bodies, neurofibrillary tangles, and senile plaques, but was significantly more pronounced with advancing age in both LBD and controls. These findings suggest that in a subgroup of elderly individual cases, especially associated with LB pathology, the glial and neuronal p-tau accumulation is increased and has a distributional pattern similar to PSP.

    DOI: 10.1007/s00401-004-0967-3

    Web of Science

    researchmap

  • Widespread nuclear and cytoplasmic accumulation of mutant androgen receptor in SBMA patients. 国際誌

    Hiroaki Adachi, Masahisa Katsuno, Makoto Minamiyama, Masahiro Waza, Chen Sang, Yuji Nakagomi, Yasushi Kobayashi, Fumiaki Tanaka, Manabu Doyu, Akira Inukai, Mari Yoshida, Yoshio Hashizume, Gen Sobue

    Brain : a journal of neurology   128 ( Pt 3 )   659 - 70   2005年3月

     詳細を見る

    記述言語:英語   出版者・発行元:OXFORD UNIV PRESS  

    Spinal and bulbar muscular atrophy (SBMA) is an inherited adult onset motor neuron disease caused by the expansion of a polyglutamine (polyQ) tract within the androgen receptor (AR), affecting only males. The characteristic pathological finding is nuclear inclusions (NIs) consisting of mutant AR with an expanded polyQ in residual motor neurons, and in certain visceral organs. We immunohistochemically examined 11 SBMA patients at autopsy with 1C2, an antibody that specifically recognizes expanded polyQ. Our study demonstrated that diffuse nuclear accumulation of mutant AR was far more frequent and extensive than NIs being distributed in a wide array of CNS nuclei, and in more visceral organs than thus far believed. Mutant AR accumulation was also present in the cytoplasm, particularly in the Golgi apparatus; nuclear or cytoplasmic predominance of accumulation was tissue specific. Furthermore, the extent of diffuse nuclear accumulation of mutant AR in motor and sensory neurons of the spinal cord was closely related to CAG repeat length. Thus, diffuse nuclear accumulation of mutant AR apparently is a cardinal pathogenetic process underlying neurological manifestations, as in SBMA transgenic mice, while cytoplasmic accumulation may also contribute to SBMA pathophysiology.

    DOI: 10.1093/brain/awh381

    Web of Science

    PubMed

    researchmap

  • CIDPのIVIg治療反応性に関連するHLAアリル多型の検討

    飯島 正博, 森 恵子, 小池 春樹, 服部 直樹, 田中 章景, 山本 正彦, 祖父江 元

    神経免疫学   13 ( 1 )   112 - 112   2005年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本神経免疫学会  

    researchmap

  • Widespread nuclear and cytoplasmic accumulation of mutant androgen receptor in SBMA patients

    H Adachi, M Katsuno, M Minamiyama, M Waza, C Sang, Y Nakagomi, Y Kobayashi, F Tanaka, M Doyu, A Inukai, M Yoshida, Y Hashizume, G Sobue

    BRAIN   128 ( 3 )   659 - 670   2005年3月

     詳細を見る

    記述言語:英語   出版者・発行元:OXFORD UNIV PRESS  

    Spinal and bulbar muscular atrophy (SBMA) is an inherited adult onset motor neuron disease caused by the expansion of a polyglutamine (polyQ) tract within the androgen receptor (AR), affecting only males. The characteristic pathological finding is nuclear inclusions (NIs) consisting of mutant AR with an expanded polyQ in residual motor neurons, and in certain visceral organs. We immunohistochemically examined 11 SBMA patients at autopsy with 1C2, an antibody that specifically recognizes expanded polyQ. Our study demonstrated that diffuse nuclear accumulation of mutant AR was far more frequent and extensive than NIs being distributed in a wide array of CNS nuclei, and in more visceral organs than thus far believed. Mutant AR accumulation was also present in the cytoplasm, particularly in the Golgi apparatus; nuclear or cytoplasmic predominance of accumulation was tissue specific. Furthermore, the extent of diffuse nuclear accumulation of mutant AR in motor and sensory neurons of the spinal cord was closely related to CAG repeat length. Thus, diffuse nuclear accumulation of mutant AR apparently is a cardinal pathogenetic process underlying neurological manifestations, as in SBMA transgenic mice, while cytoplasmic accumulation may also contribute to SBMA pathophysiology.

    DOI: 10.1093/brain/awh381

    Web of Science

    researchmap

  • Gene expression profile of spinal motor neurons in sporadic amyotrophic lateral sclerosis. 国際誌

    Yue-Mei Jiang, Masahiko Yamamoto, Yasushi Kobayashi, Tsuyoshi Yoshihara, Yideng Liang, Shinichi Terao, Hideyuki Takeuchi, Shinsuke Ishigaki, Masahisa Katsuno, Hiroaki Adachi, Jun-ichi Niwa, Fumiaki Tanaka, Manabu Doyu, Mari Yoshida, Yoshio Hashizume, Gen Sobue

    Annals of neurology   57 ( 2 )   236 - 51   2005年2月

     詳細を見る

    記述言語:英語   出版者・発行元:WILEY-LISS  

    The causative pathomechanism of sporadic amyotrophic lateral sclerosis (ALS) is not clearly understood. Using microarray technology combined with laser-captured microdissection, gene expression profiles of degenerating spinal motor neurons isolated from autopsied patients with sporadic ALS were examined. Gene expression was quantitatively assessed by real-time reverse transcription polymerase chain reaction and in situ hybridization. Spinal motor neurons showed a distinct gene expression profile from the whole spinal ventral horn. Three percent of genes examined were downregulated, and 1% were upregulated in motor neurons. Downregulated genes included those associated with cytoskeleton/axonal transport, transcription, and cell surface antigens/receptors, such as dynactin, microtubule-associated proteins, and early growth response 3 (EGR3). In contrast, cell death-associated genes were mostly upregulated. Promoters for cell death pathway, death receptor 5, cyclins A1 and C, and caspases-1, -3, and -9, were upregulated, whereas cell death inhibitors, acetyl-CoA transporter, and NF-kappaB were also upregulated. Moreover, neuroprotective neurotrophic factors such as ciliary neurotrophic factor (CNTF), Hepatocyte growth factor (HGF), and glial cell line-derived neurotrophic factor were upregulated. Inflammation-related genes, such as those belonging to the cytokine family, were not, however, significantly upregulated in either motor neurons or ventral horns. The motor neuron-specific gene expression profile in sporadic ALS can provide direct information on the genes leading to neurodegeneration and neuronal death and are helpful for developing new therapeutic strategies.

    DOI: 10.1002/ana.20379

    Web of Science

    PubMed

    researchmap

  • Gene expression profile of spinal motor neurons in sporadic amyotrophic lateral sclerosis

    YM Jiang, M Yamamoto, Y Kobayashi, T Yoshihara, YD Liang, S Terao, H Takeuchi, S Ishigaki, M Katsuno, H Adachi, J Niwa, F Tanaka, M Doyu, M Yoshida, Y Hashizume, G Sobue

    ANNALS OF NEUROLOGY   57 ( 2 )   236 - 251   2005年2月

     詳細を見る

    記述言語:英語   出版者・発行元:WILEY-LISS  

    The causative pathomechanism of sporadic amyotrophic lateral sclerosis (ALS) is not clearly understood. Using microarray technology combined with laser-captured microdissection, gene expression profiles of degenerating spinal motor neurons isolated from autopsied patients with sporadic ALS were examined. Gene expression was quantitatively assessed by real-time reverse transcription polymerase chain reaction and in situ hybridization. Spinal motor neurons showed a distinct gene expression profile from the whole spinal ventral horn. Three percent of genes examined were downregulated, and 1% were upregulated in motor neurons. Downregulated genes included those associated with cytoskeleton/axonal transport, transcription, and cell surface antigens/receptors, such as dynactin, microtubule-associated proteins, and early growth response 3 (EGR3). In contrast, cell death-associated genes were mostly upregulated. Promoters for cell death pathway, death receptor 5, cyclins A1 and C, and caspases-1, -3, and -9, were upregulated, whereas cell death inhibitors, acetyl-CoA transporter, and NF-kappaB were also upregulated. Moreover, neuroprotective neurotrophic factors such as ciliary neurotrophic factor (CNTF), Hepatocyte growth factor (HGF), and glial cell line-derived neurotrophic factor were upregulated. Inflammation-related genes, such as those belonging to the cytokine family, were not, however, significantly upregulated in either motor neurons or ventral horns. The motor neuron-specific gene expression profile in sporadic ALS can provide direct information on the genes leading to neurodegeneration and neuronal death and are helpful for developing new therapeutic strategies.

    DOI: 10.1002/ana.20379

    Web of Science

    researchmap

  • 慢性炎症性脱髄性多発ニューロパチー(CIDP)の病態にかかわる遺伝子的背景

    飯島正博, 小池春樹, 服部直樹, 田中章景, 山本正彦, 祖父江元

    末梢神経 = Peripheral nerve   15 ( 2 )   140 - 141   2004年12月

     詳細を見る

    記述言語:日本語  

    CiNii Books

    researchmap

  • CIDPのIVIg治療反応性からみた遺伝子多型解析

    山本 正彦, 飯島 正博, 田中 章景, 服部 直樹, 祖父江 元

    臨床神経学   44 ( 12 )   1030 - 1030   2004年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • Dorfinは変異SOD1のミトコンドリア蓄積の低減を介して神経細胞死を抑制する

    田中 章景, 竹内 英之, 丹羽 淳一, 石垣 診祐, 菱川 望, 道勇 学, 祖父江 元

    臨床神経学   44 ( 12 )   1092 - 1092   2004年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 球脊髄性筋萎縮症トランスジェニックマウスに対する酪酸ナトリウムの治療効果

    南山 誠, 勝野 雅央, 足立 弘明, 和座 雅浩, 桑 晨, 小林 靖, 田中 章景, 道勇 学, 犬飼 晃, 祖父江 元

    臨床神経学   44 ( 12 )   1071 - 1071   2004年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • CIDP腓腹神経の網羅的発現遺伝子解析による病態関連因子の探索

    飯島 正博, 吉原 剛, 山本 正彦, 森 恵子, 小池 春樹, 服部 直樹, 田中 章景, 祖父江 元

    臨床神経学   44 ( 12 )   1030 - 1030   2004年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 球脊髄性筋萎縮症における逆行性軸索輸送障害とその可逆性

    勝野 雅央, 足立 弘明, 南山 誠, 和座 雅浩, 桑 晨, 小林 靖, 田中 章景, 道勇 学, 祖父江 元

    臨床神経学   44 ( 12 )   1029 - 1029   2004年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 球脊髄性筋萎縮症の培養細胞モデルにおけるGeranylgeranylacetone(GGA)の効果

    和座 雅浩, 勝野 雅央, 桑 晨, 足立 弘明, 南山 誠, 小林 靖, 田中 章景, 道勇 学, 祖父江 元

    臨床神経学   44 ( 12 )   1071 - 1071   2004年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • Cognitive impairments in Machado-Joseph disease. 国際誌

    Yoshinari Kawai, Akinori Takeda, Yuji Abe, Yukihiko Washimi, Fumiaki Tanaka, Gen Sobue

    Archives of neurology   61 ( 11 )   1757 - 60   2004年11月

     詳細を見る

    記述言語:英語   出版者・発行元:AMER MEDICAL ASSOC  

    BACKGROUND: Cognitive function of Machado-Joseph disease (MJD) patients has not been clarified. OBJECTIVES: To determine the characteristics of cognitive dysfunction in MJD patients and to assess the relationship of dysfunction to age at onset, age at examination, disease duration, education, ataxia, depression, anxiety, and CAG repeat length. DESIGN: Case-control study. SETTING: Research-oriented hospitals. PARTICIPANTS: Sixteen genetically confirmed MJD patients able to complete neuropsychological tests and 20 control subjects matched to patients by age and education. MAIN OUTCOME MEASURES: Neuropsychological tests, including general cognition, verbal and visual memory, working memory, visuospatial and constructional ability, language, executive function, depression, and anxiety. RESULTS: Machado-Joseph disease patients scored significantly lower than controls in verbal and visual memory, in visuospatial and constructional tasks, and in phonemic and semantic fluency tasks. None of these impairments correlated with CAG repeat length, age at onset, age at examination, disease duration, or education. Verbal fluency (words named in a category) correlated with the International Cooperative Ataxia Rating Scale score. CONCLUSION: Machado-Joseph disease patients have verbal and visual memory deficits, visuospatial and constructional dysfunction, and verbal fluency deficits, all unrelated to CAG repeat length.

    DOI: 10.1001/archneur.61.11.1757

    Web of Science

    PubMed

    researchmap

  • Cognitive impairments in Machado-Joseph disease

    Y Kawai, A Takeda, Y Abe, Y Washimi, F Tanaka, G Sobue

    ARCHIVES OF NEUROLOGY   61 ( 11 )   1757 - 1760   2004年11月

     詳細を見る

    記述言語:英語   出版者・発行元:AMER MEDICAL ASSOC  

    Background: Cognitive function of Machado-Joseph disease (MJD) patients has not been clarified.
    Objectives: To determine the characteristics of cognitive dysfunction in MJD patients and to assess the relationship of dysfunction to age at onset, age at examination, disease duration, education, ataxia, depression, anxiety, and CAG repeat length.
    Design: Case-control study.
    Setting: Research-oriented hospitals.
    Participants: Sixteen genetically confirmed MJD patients able to complete neuropsychological tests and 20 con trol subjects matched to patients by age and education.
    Main Outcome Measures: Neuropsychological tests, including general cognition, verbal and visual memory, working memory, visuospatial and constructional ability, language, executive function, depression, and anxiety.
    Results: Machado-Joseph disease patients scored Significantly lower than controls in verbal and visual memory, in visuospatial and constructional tasks, and in phonemic and semantic fluency tasks. None of these impairments correlated with CAG repeat length, age at onset, age at examination, disease duration, or education. Verbal fluency (words named in a category) correlated with the International Cooperative Ataxia Rating Scale score.
    Conclusion: Machado-Joseph disease patients have verbal and visual memory deficits, visuospatial and constructional dysfunction, and verbal fluency deficits, all unrelated to CAG repeat length.

    DOI: 10.1001/archneur.61.11.1757

    Web of Science

    researchmap

  • Sodium butyrate ameliorates phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy. 国際誌

    Makoto Minamiyama, Masahisa Katsuno, Hiroaki Adachi, Masahiro Waza, Chen Sang, Yasushi Kobayashi, Fumiaki Tanaka, Manabu Doyu, Akira Inukai, Gen Sobue

    Human molecular genetics   13 ( 11 )   1183 - 92   2004年6月

     詳細を見る

    記述言語:英語   出版者・発行元:OXFORD UNIV PRESS  

    Spinal and bulbar muscular atrophy (SBMA) is an inherited motor neuron disease caused by the expansion of a polyglutamine (polyQ) tract within the androgen receptor. Unifying mechanisms have been implicated in the pathogenesis of polyQ-dependent neurodegenerative diseases including SBMA, Huntington disease and spinocerebellar ataxias. It has been suggested that mutant protein containing polyQ inhibits histone acetyltransferase activity, resulting in transcriptional dysfunction and subsequent neuronal dysfunction. Histone deacetylase (HDAC) inhibitors alleviate neurological phenotypes in fly and mouse models of polyQ disease, although the therapeutic effect is limited by the toxicity of these compounds. We studied the therapeutic effects of sodium butyrate (SB), an HDAC inhibitor, in a transgenic mouse model of SBMA. Oral administration of SB ameliorated neurological phenotypes as well as increased acetylation of nuclear histone in neural tissues. These therapeutic effects, however, were seen only within a narrow range of SB dosage. Our results indicate that SB is a possible therapeutic agent for SBMA and other polyQ diseases, although an appropriate dose should be determined for clinical application.

    DOI: 10.1093/hmg/ddh131

    Web of Science

    PubMed

    researchmap

  • Sodium butyrate ameliorates phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy

    M Minamiyama, M Katsuno, H Adachi, M Waza, C Sang, Y Kobayashi, F Tanaka, M Doyu, A Inukai, G Sobue

    HUMAN MOLECULAR GENETICS   13 ( 11 )   1183 - 1192   2004年6月

     詳細を見る

    記述言語:英語   出版者・発行元:OXFORD UNIV PRESS  

    Spinal and bulbar muscular atrophy (SBMA) is an inherited motor neuron disease caused by the expansion of a polyglutamine (polyQ) tract within the androgen receptor. Unifying mechanisms have been implicated in the pathogenesis of polyQ-dependent neurodegenerative diseases including SBMA, Huntington disease and spinocerebellar ataxias. It has been suggested that mutant protein containing polyQ inhibits histone acetyltransferase activity, resulting in transcriptional dysfunction and subsequent neuronal dysfunction. Histone deacetylase (HDAC) inhibitors alleviate neurological phenotypes in fly and mouse models of polyQ disease, although the therapeutic effect is limited by the toxicity of these compounds. We studied the therapeutic effects of sodium butyrate (SB), an HDAC inhibitor, in a transgenic mouse model of SBMA. Oral administration of SB ameliorated neurological phenotypes as well as increased acetylation of nuclear histone in neural tissues. These therapeutic effects, however, were seen only within a narrow range of SB dosage. Our results indicate that SB is a possible therapeutic agent for SBMA and other polyQ diseases, although an appropriate dose should be determined for clinical application.

    DOI: 10.1093/hmg/ddh131

    Web of Science

    researchmap

  • Spinal and bulbar muscular atrophy: ligand-dependent pathogenesis and therapeutic perspectives. 国際誌

    Masahisa Katsuno, Hiroaki Adachi, Fumiaki Tanaka, Gen Sobue

    Journal of molecular medicine (Berlin, Germany)   82 ( 5 )   298 - 307   2004年5月

     詳細を見る

    記述言語:英語  

    Spinal and bulbar muscular atrophy (SBMA) is a late-onset motor neuron disease characterized by proximal muscle atrophy, weakness, contraction fasciculations, and bulbar involvement. SBMA exclusively affects males, while females are usually asymptomatic. The molecular basis of SBMA is the expansion of a trinucleotide CAG repeat, which encodes the polyglutamine (polyQ) tract in the first exon of the androgen receptor (AR) gene. The histopathological hallmark is the presence of nuclear inclusions containing mutant truncated ARs with expanded polyQ tracts in the residual motor neurons in the brainstem and spinal cord, as well as in some other visceral organs. The AR ligand, testosterone, accelerates AR dissociation from heat shock proteins and thus its nuclear translocation. Ligand-dependent nuclear accumulation of mutant ARs has been implicated in the pathogenesis of SBMA. Transgenic mice carrying the full-length human AR gene with an expanded polyQ tract demonstrate neuromuscular phenotypes, which are profound in males. Their SBMA-like phenotypes are rescued by castration, and aggravated by testosterone administration. Leuprorelin, an LHRH agonist that reduces testosterone release from the testis, inhibits nuclear accumulation of mutant ARs, resulting in the rescue of motor dysfunction in the male transgenic mice. However, flutamide, an androgen antagonist promoting nuclear translocation of the AR, yielded no therapeutic effect. The degradation and cleavage of the AR protein are also influenced by the ligand, contributing to the pathogenesis. Testosterone thus appears to be the key molecule in the pathogenesis of SBMA, as well as main therapeutic target of this disease.

    DOI: 10.1007/s00109-004-0530-7

    Scopus

    PubMed

    researchmap

  • Spinal and bulbar muscular atrophy: ligand-dependent pathogenesis and therapeutic perspectives

    M Katsuno, H Adachi, F Tanaka, G Sobue

    JOURNAL OF MOLECULAR MEDICINE-JMM   82 ( 5 )   298 - 307   2004年5月

     詳細を見る

    記述言語:英語   掲載種別:書評論文,書評,文献紹介等   出版者・発行元:SPRINGER-VERLAG  

    Spinal and bulbar muscular atrophy (SBMA) is a late-onset motor neuron disease characterized by proximal muscle atrophy, weakness, contraction fasciculations, and bulbar involvement. SBMA exclusively affects males, while females are usually asymptomatic. The molecular basis of SBMA is the expansion of a trinucleotide CAG repeat, which encodes the polyglutamine (polyQ) tract in the first exon of the androgen receptor (AR) gene. The histopathological hallmark is the presence of nuclear inclusions containing mutant truncated ARs with expanded polyQ tracts in the residual motor neurons in the brainstem and spinal cord, as well as in some other visceral organs. The AR ligand, testosterone, accelerates AR dissociation from heat shock proteins and thus its nuclear translocation. Ligand-dependent nuclear accumulation of mutant ARs has been implicated in the pathogenesis of SBMA. Transgenic mice carrying the full-length human AR gene with an expanded polyQ tract demonstrate neuromuscular phenotypes, which are profound in males. Their SBMA-like phenotypes are rescued by castration, and aggravated by testosterone administration. Leuprorelin, an LHRH agonist that reduces testosterone release from the testis, inhibits nuclear accumulation of mutant ARs, resulting in the rescue of motor dysfunction in the male transgenic mice. However, flutamide, an androgen antagonist promoting nuclear translocation of the AR, yielded no therapeutic effect. The degradation and cleavage of the AR protein are also influenced by the ligand, contributing to the pathogenesis. Testosterone thus appears to be the key molecule in the pathogenesis of SBMA, as well as main therapeutic target of this disease.

    DOI: 10.1007/s00109-004-0530-7

    Web of Science

    researchmap

  • Sodium butyrate ameliorates phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy

    M Minamiyama, M Katsuno, H Adachi, M Waza, C Sang, Y Kobayashi, F Tanaka, M Doyu, A Inukai, G Sobue

    NEUROLOGY   62 ( 7 )   A8 - A8   2004年4月

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:LIPPINCOTT WILLIAMS & WILKINS  

    Web of Science

    researchmap

  • Dorfin prevents cell death by reducing mitochondrial localizing mutant superoxide dismutase 1 in a neuronal cell model of familial amyotrophic lateral sclerosis

    H Takeuchi, J Niwa, N Hishikawa, S Ishigaki, F Tanaka, M Doyu, G Sobue

    JOURNAL OF NEUROCHEMISTRY   89 ( 1 )   64 - 72   2004年4月

     詳細を見る

    記述言語:英語   出版者・発行元:BLACKWELL PUBLISHING LTD  

    Dorfin is a RINGfinger type ubiquitin ligase for mutant superoxide dismutase 1 (SOD1) that enhances its degradation. Mutant SOD1s cause familial amyotrophic lateral sclerosis (FALS) through the gain of unelucidated toxic properties. We previously showed that the accumulation of mutant SOD1 in the mitochondria triggered the release of cytochrome c, followed by the activation of the caspase cascade and induction of neuronal cell death. In the present study, therefore, we investigated whether Dorfin can modulate the level of mutant SOD1 in the mitochondria and subsequent caspase activation. We showed that Dorfin significantly reduced the amount of mutant SOD1 in the mitochondria, the release of cytochrome c and the activation of the following caspase cascade, thereby preventing eventual neuronal cell death in a neuronal cell model of FALS. These results suggest that reducing the accumulation of mutant SOD1 in the mitochondria may be a new therapeutic strategy for mutant SOD1-associated FALS, and that Dorfin may play a significant role in this.

    DOI: 10.1046/j.1471-4159.2003.02289.x

    Web of Science

    PubMed

    researchmap

  • Dorfin prevents cell death by reducing mitochondrial localizing mutant superoxide dismutase 1 in a neuronal cell model of familial amyotrophic lateral sclerosis. 国際誌

    Hideyuki Takeuchi, Jun-ichi Niwa, Nozomi Hishikawa, Shinsuke Ishigaki, Fumiaki Tanaka, Manabu Doyu, Gen Sobue

    Journal of neurochemistry   89 ( 1 )   64 - 72   2004年4月

     詳細を見る

    記述言語:英語   出版者・発行元:BLACKWELL PUBLISHING LTD  

    Abstract Dorfin is a RING-finger type ubiquitin ligase for mutant superoxide dismutase 1 (SOD1) that enhances its degradation. Mutant SOD1s cause familial amyotrophic lateral sclerosis (FALS) through the gain of unelucidated toxic properties. We previously showed that the accumulation of mutant SOD1 in the mitochondria triggered the release of cytochrome c, followed by the activation of the caspase cascade and induction of neuronal cell death. In the present study, therefore, we investigated whether Dorfin can modulate the level of mutant SOD1 in the mitochondria and subsequent caspase activation. We showed that Dorfin significantly reduced the amount of mutant SOD1 in the mitochondria, the release of cytochrome c and the activation of the following caspase cascade, thereby preventing eventual neuronal cell death in a neuronal cell model of FALS. These results suggest that reducing the accumulation of mutant SOD1 in the mitochondria may be a new therapeutic strategy for mutant SOD1-associated FALS, and that Dorfin may play a significant role in this.

    DOI: 10.1046/j.1471-4159.2003.02289.x

    Web of Science

    PubMed

    researchmap

  • Wide range of lineages of cells expressing nerve growth factor mRNA in the nerve lesions of patients with vasculitic neuropathy: An implication of endoneurial macrophage for nerve regeneration

    N Mitsuma, M Yamamoto, M Iijima, N Hattori, Y Ito, F Tanaka, G Sobue

    NEUROSCIENCE   129 ( 1 )   109 - 117   2004年

     詳細を見る

    記述言語:英語   出版者・発行元:PERGAMON-ELSEVIER SCIENCE LTD  

    In situ localization of nerve growth factor (NGF) mRNA was examined in the nerve lesions of patients with vasculitic neuropathy. Double labeling of in situ hybridization for NGF mRNA and immunohistochemistry for cell markers showed that NGF mRNA was expressed in a wide range of lineages of cells: Schwann cells, infiltrating macrophages, T cells and perivascular cells. Round-shaped macrophages with early-phase features expressed high levels of NGF mRNA, in contrast to late-phase polymorphic macrophages, which expressed low levels of NGF mRNA. NGF mRNA was also expressed universally in T cells with various cell surface markers. Epineurial macrophages surrounding vasculitic lesions and endoneurial T cells expressed high levels of NGF mRNA in the damaged nerves. Moreover, the extent of endoneurial NGF expression level in macrophages was closely related to the degree of axonal regeneration. These results suggest that NGF is expressed in a wide range of lineages of cells but is differentially expressed spatially in vasculitic nerve lesions, and that the expressed NGF, particularly in macrophages, may play an important role in the nerve regeneration process. (C) 2004 IBRO. Published by Elsevier Ltd. All rights reserved.

    DOI: 10.1016/j.neuroscience.2004.06.083

    Web of Science

    researchmap

  • Spinocerebellar ataxia type 2 (SCA2)の一剖検例

    饗場郁子, 吉田眞理, 村上信之, 後藤敦子, 横川ゆき, 片山泰司, 田中章景, 祖父江元, 橋詰良夫

    Neuropathology : official journal the Japanese Society of Neuropathology   23   120 - 120   2003年5月

     詳細を見る

    記述言語:日本語  

    CiNii Books

    researchmap

  • Aggresomes protect cells by enhancing the degradation of toxic polyglutamine-containing protein. 国際誌

    J Paul Taylor, Fumiaki Tanaka, Jon Robitschek, C Miguel Sandoval, Addis Taye, Silva Markovic-Plese, Kenneth H Fischbeck

    Human molecular genetics   12 ( 7 )   749 - 57   2003年4月

     詳細を見る

    記述言語:英語   出版者・発行元:OXFORD UNIV PRESS  

    Expression of misfolded protein in cultured cells frequently leads to the formation of juxtanuclear inclusions that have been termed 'aggresomes'. Aggresome formation is an active cellular response that involves trafficking of the offending protein along microtubules, reorganization of intermediate filaments and recruitment of components of the ubiquitin proteasome system. Whether aggresomes are benevolent or noxious is unknown, but they are of particular interest because of the appearance of similar inclusions in protein deposition diseases. Here we present evidence that aggresomes serve a cytoprotective function and are associated with accelerated turnover of mutant proteins. We show that mutant androgen receptor (AR), the protein responsible for X-linked spinobulbar muscular atrophy, forms insoluble aggregates and is toxic to cultured cells. Mutant AR was also found to form aggresomes in a process distinct from aggregation. Molecular and pharmacological interventions were used to disrupt aggresome formation, revealing their cytoprotective function. Aggresome-forming proteins were found to have an accelerated rate of turnover, and this turnover was slowed by inhibition of aggresome formation. Finally, we show that aggresome-forming proteins become membrane-bound and associate with lysosomal structures. Together, these findings suggest that aggresomes are cytoprotective, serving as cytoplasmic recruitment centers to facilitate degradation of toxic proteins.

    DOI: 10.1093/hmg/ddg074

    Web of Science

    PubMed

    researchmap

  • Aggresomes protect cells by enhancing the degradation of toxic polyglutamine-containing protein

    JP Taylor, F Tanaka, J Robitschek, CM Sandoval, A Taye, S Markovic-Plese, KH Fischbeck

    HUMAN MOLECULAR GENETICS   12 ( 7 )   749 - 757   2003年4月

     詳細を見る

    記述言語:英語   出版者・発行元:OXFORD UNIV PRESS  

    Expression of misfolded protein in cultured cells frequently leads to the formation of juxtanuclear inclusions that have been termed 'aggresomes'. Aggresome formation is an active cellular response that involves trafficking of the offending protein along microtubules, reorganization of intermediate filaments and recruitment of components of the ubiquitin proteasome system. Whether aggresomes are benevolent or noxious is unknown, but they are of particular interest because of the appearance of similar inclusions in protein deposition diseases. Here we present evidence that aggresomes serve a cytoprotective function and are associated with accelerated turnover of mutant proteins. We show that mutant androgen receptor (AR), the protein responsible for X-linked spinobulbar muscular atrophy, forms insoluble aggregates and is toxic to cultured cells. Mutant AR was also found to form aggresomes in a process distinct from aggregation. Molecular and pharmacological interventions were used to disrupt aggresome formation, revealing their cytoprotective function. Aggresome-forming proteins were found to have an accelerated rate of turnover, and this turnover was slowed by inhibition of aggresome formation. Finally, we show that aggresome-forming proteins become membrane-bound and associate with lysosomal structures. Together, these findings suggest that aggresomes are cytoprotective, serving as cytoplasmic recruitment centers to facilitate degradation of toxic proteins.

    DOI: 10.1093/hmg/ddg074

    Web of Science

    researchmap

  • マクロとミクロの疫学 臨床から遺伝子まで 脳神経領域 遺伝性神経疾患の遺伝疫学

    石垣診祐, 服部直樹, 田中章景, 山本正彦, 祖父江元

    現代医療   35 ( 1 )   235-242 - 242   2003年1月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)現代医療社  

    J-GLOBAL

    researchmap

  • Machado-Joseph病の脳糖代謝所見 3D-SSPを用いた検討

    阿部 祐士, 新畑 豊, 加藤 隆司, 田中 章景, 鷲見 幸彦, 加知 輝彦, 蓑島 聡, 伊藤 健吾, 柳澤 信夫, 祖父江 元

    臨床神経学   42 ( 12 )   1336 - 1336   2002年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • Rescue of polyglutamine-mediated cytotoxicity by double-stranded RNA-mediated RNA interference. 国際誌

    Natasha J Caplen, J Paul Taylor, Victoria S Statham, Fumiaki Tanaka, Andrew Fire, Richard A Morgan

    Human molecular genetics   11 ( 2 )   175 - 84   2002年1月

     詳細を見る

    記述言語:英語   出版者・発行元:OXFORD UNIV PRESS  

    RNA interference (RNAi) is a mechanism that appears to control unwanted gene expression in a wide range of species. In Drosophila, RNAi is most effectively induced by double-stranded RNAs (dsRNAs) of over approximately 80 nucleotides (nt) and in mammalian cells an RNAi-like inhibition of gene expression has been shown to be mediated by dsRNAs of approximately 21-23 nt. To test if RNAi can be used to specifically down-regulate a human disease-related transcript we have used Drosophila and human tissue culture models of the dominant genetic disorder spinobulbar muscular atrophy (SBMA). A variety of different dsRNAs were assessed for the ability to inhibit expression of transcripts that included a truncated human androgen receptor (ar) gene containing different CAG repeat lengths (16-112 repeats). In Drosophila cells, dsRNAs corresponding to non-repetitive sequences mediated a high degree of sequence-specific inhibition, whereas RNA duplexes containing CAG repeat tracts only induced gene-specific inhibition when flanking ar sequences were included; dsRNAs containing various lengths of CAG repeats plus ar sequences were unable to induce allele-specific interference. In mammalian cells we tested sequence-specific small dsRNAs of 22 nt; these rescued the toxicity and caspase-3 activation induced by plasmids expressing a transcript encoding an expanded polyglutamine tract. This study demonstrates the feasibility of targeting a transcript associated with an important group of genetic diseases by RNAi.

    Web of Science

    PubMed

    researchmap

  • Rescue of polyglutamine-mediated cytotoxicity by double-stranded RNA-mediated RNA interference

    NJ Caplen, JP Taylor, VS Statham, F Tanaka, A Fire, RA Morgan

    HUMAN MOLECULAR GENETICS   11 ( 2 )   175 - 184   2002年1月

     詳細を見る

    記述言語:英語   出版者・発行元:OXFORD UNIV PRESS  

    RNA interference (RNAi) is a mechanism that appears to control unwanted gene expression in a wide range of species. In Drosophila, RNA! is most effectively induced by double-stranded RNAs (dsRNAs) of over similar to80 nucleotides (nt) and in mammalian cells an RNAi-like-inhibition of gene expression has been shown to be mediated by dsRNAs of similar to21-23 nt. To test if RNAi can be used to specifically down-regulate a human disease-related transcript we have used Drosophila and human tissue culture models of the dominant genetic disorder spinobulbar muscular atrophy (SBMA). A variety of different dsRNAs were assessed for the ability to inhibit expression of transcripts that included a truncated human androgen receptor (ar) gene containing different CAG repeat lengths (16-112 repeats). In Drosophila cells, dsRNAs corresponding to non-repetitive sequences mediated a high degree of sequence-specific inhibition, whereas RNA duplexes containing CAG repeat tracts only induced gene-specific inhibition when flanking ar sequences were included; dsRNAs containing various lengths of CAG repeats plus ar sequences were unable to induce allele-specific interference. In mammalian cells we tested sequence-specific small dsRNAs of 22 nt; these rescued the toxicity and caspase-3 activation induced by plasmids expressing a transcript encoding an expanded polyglutamine tract. This study demonstrates the feasibility of targeting a transcript associated with an important group of genetic diseases by RNAi.

    Web of Science

    researchmap

  • Machado-Joseph病の小脳半球・虫部萎縮に影響を及ぼす因子

    阿部 祐士, 新畑 豊, 田中 章景, 祖父江 元, 加知 輝彦, 加藤 隆司, 伊藤 健吾, 寺尾 心一

    臨床神経学   41 ( 11 )   898 - 898   2001年11月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • Specific bisulfite modification of CTG triplet repeats of the androgen receptor gene, a gene associated with the triplet repeat disease X-linked spinal and bulbar muscular atrophy (Kennedy disease)

    K Ochi, H Nozaki, F Tanaka, S Kato, R Fukuzawa, G Sobue, Y Fukuuchi, Y Toyama, J Hata, A Umezawa

    NEUROSCIENCE RESEARCH COMMUNICATIONS   28 ( 1 )   1 - 10   2001年1月

     詳細を見る

    記述言語:英語   出版者・発行元:JOHN WILEY & SONS LTD  

    Expansion of triplet (CAG)n repeats has been associated with triplet-repeat diseases such as X-linked spinal and bulbar muscular atrophy (SBMA). To elucidate the molecular mechanism of the down-regulated expression of the human androgen receptor gene (hAR) in SBMA patients, we speculated that a certain percentage of the CAG triplets are methylated. We employed the bisulfite method to determine methylation degrees of CAG triplets. Although the bisulfite reaction modified the cytosines in the plus strand CAG repeats, a certain percentage of the minus strand CTG repeats were not modified both in genomic DNA from patients and in bacterial plasmids. This unexpected modification was not seen in unexpanded triplets. Thus, we conclude that a peculiar secondary structure around the expanded CAG or CTG triplets protects itself against bisulfite chemical modification. This specific DNA structural property may account for the pathogenesis of CAG triplet repeat diseases.

    DOI: 10.1002/1520-6769(200101/02)28:1<1::AID-NRC1>3.0.CO;2-H

    Web of Science

    researchmap

  • オリゴCTGリピートプローブを用いた伸長CAGリピート検出法の開発

    澤田 浩一, 田中 章景, 道勇 学, 祖父江 元, 加藤 菊也

    臨床神経学   40 ( 12 )   1344 - 1344   2000年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 歯状核赤核淡蒼球ルイ体萎縮症(DRPLA)におけるatrophin-1遺伝子の体細胞モザイク レーザーマイクロダイセクション法による単一細胞レベルの検討

    渡邊 英孝, 田中 章景, 道勇 学, 祖父江 元, 陸 重雄

    臨床神経学   40 ( 12 )   1318 - 1318   2000年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • SOD1遺伝子に変異を認めた家族性筋萎縮性側索硬化症(FALS) 7家系の検討

    岩井 克成, 吉原 剛, 田口 栄一, 田中 章景, 道勇 学, 祖父江 元

    臨床神経学   40 ( 12 )   1380 - 1380   2000年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • Detection of triplet repeat expansion in the human genome by use of hybridization signal intensity

    K Sawada, M Doyu, F Tanaka, G Sobue, K Kato

    ANALYTICAL BIOCHEMISTRY   286 ( 1 )   59 - 66   2000年11月

     詳細を見る

    記述言語:英語   出版者・発行元:ACADEMIC PRESS INC  

    Triplet repeat disease is a group of hereditary neurodegenerative disorders caused by expansion of trinucleotide repeats such as CAG/CTG, CGG/CCG, and GAA/TTC. Direct detection of the expansion in the patient's genome shortcuts the tedious process needed for identification of disease genes by conventional approaches. Here we describe a method to detect triplet repeat expansion from the hybridization signal intensity, Using a digoxigenin-labeled (CTG)9 probe, the hybridization intensity and number of repeats showed a good linear correlation. The technique detected expansion in genomic DNA in all cases with moderate or large expansion. Even in the case of a small expansion, this method could detect the mutant fragment. The technique has advantages over related techniques because it is more sensitive and can be applied to cases where a small repeat expansion is involved. (C) 2000 Academic Press.

    DOI: 10.1006/abio.2000.4786

    Web of Science

    PubMed

    researchmap

  • Differential somatic CAG repeat instability in variable brain cell lineage in dentatorubral pallidoluysian atrophy (DRPLA): a laser-captured microdissection (LCM)-based analysis

    H Watanabe, F Tanaka, M Doyu, S Riku, M Yoshida, Y Hashizume, G Sobue

    HUMAN GENETICS   107 ( 5 )   452 - 457   2000年11月

     詳細を見る

    記述言語:英語   出版者・発行元:SPRINGER-VERLAG  

    Employing a laser-captured microdissection (LCM), we have investigated the somatic instability of CAG repeats in the variable brain cell lineage in three patients with dentatorubral pallidoluysian atrophy (DRPLA). LCM enables the isolation of single lineage brain cells for subsequent molecular analysis. We have found that CAG repeat size and the range of CAG repeats in the cerebellar granular cells is smaller than those in cerebellar glial cells. Similarly, those in the cerebral neuronal cells are significantly shorter than those in cerebral glial cells. These data directly indicate that the CAG repeat is relatively more stable in neuronal cells than in glial cells. Furthermore, cerebellar granular cells show significantly smaller main CAG repeat size and CAG repeat range than either Purkinje cells or cerebral neuronal cells, suggesting that somatic instability in the CAG repeat is markedly variable even among the different types of neuronal populations. The cell-specific CAG repeat instability may thus be,more complex than has previously been considered. LCM is a powerful tool for elucidating the mechanism of the triplet repeat instability of each cell type.

    DOI: 10.1007/s004390000400

    Web of Science

    researchmap

  • 純粋無動症の歩行障害にセロトニン1A受容体作動薬クエン酸タンドスピロンが奏効した1例

    渡辺 宏久, 足立 弘明, 新畑 豊, 田中 章景, 道勇 学, 祖父江 元, 田所 匡典, 加藤 隆司

    神経治療学   17 ( 5 )   450 - 450   2000年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経治療学会  

    researchmap

  • 【遺伝性脊髄小脳変性症の地域特異性】東海地方における遺伝性脊髄小脳変性症の特異性

    田中 章景, 渡邊 英孝, 祖父江 元

    神経内科   53 ( 2 )   116 - 121   2000年8月

     詳細を見る

    記述言語:日本語   出版者・発行元:(有)科学評論社  

    researchmap

  • Temporal expression of mRNAs for neuropoietic cytokines, interleukin-11 (IL-11), oncostatin M (OSM), cardiotrophin-1 (CT-1) and their receptors (IL-11R alpha and OSMR beta) in peripheral nerve injury

    Y Ito, M Yamamoto, M Li, N Mitsuma, F Tanaka, M Doyu, A Suzumura, T Mitsuma, G Sobue

    NEUROCHEMICAL RESEARCH   25 ( 8 )   1113 - 1118   2000年8月

     詳細を見る

    記述言語:英語   出版者・発行元:KLUWER ACADEMIC/PLENUM PUBL  

    The mRNA expression pattern of the neuropoietic cytokines, interleukin-11 (IL-11), oncostatin M (OSM) and cardiotrophin-1 (CT-1), and their receptor components (IL-11R alpha and OSMR beta) was examined in peripheral nerves on two different types of injury, crush and transection. The IL-11 mRNA increased after nerve damage and immediately returned to control levels. The OSM mRNA expression increased rapidly after nerve injury and relatively high expressions were maintained for at least 14 days. The CT-1 mRNA was not expressed in any time before and after the injury. Interestingly, IL-11R alpha was expressed in the intact nerve and decreased after injury. The expression of OSMR beta increased slightly after the injury. Moreover, temporal mRNA expression pattern of these neuropoietic cytokines and receptors was similar between the crushed and transected models. Each neuropoietic cytokine of IL-11, OSM and CT-1 has its own specific temporal mRNA expression pattern, which is also different from those of ciliary neuro-trophic factor (CNTF), leukemia inhibitory factor (LIF) and interleukin-6 (IL-6). These results suggest that all neuropoietic cytokines have distinctive functions in nerve degeneration and repair process in response to peripheral nerve injury.

    DOI: 10.1023/A:1007674113440

    Web of Science

    researchmap

  • Sisters homozygous for the spinocerebellar ataxia type 6 (SCA6)/CACNA1A gene associated with different clinical phenotypes

    T Kato, F Tanaka, M Yamamoto, E Yosida, T Indo, H Watanabe, T Yoshiwara, M Doyu, G Sobue

    CLINICAL GENETICS   58 ( 1 )   69 - 73   2000年7月

     詳細を見る

    記述言語:英語   出版者・発行元:MUNKSGAARD INT PUBL LTD  

    Spinocerebellar ataxia type 6 (SCA6) is a neurodegenerative disease caused by a CAG repeat expansion in the CACNA1A gene. The neurodegeneration that occurs in CAG repeat diseases is considered to share a common mechanism that may result in the gain of a toxic function related to the expanded polyglutamine tracts. However, the phenotypic expression in homozygotes for CAG repeat diseases has been controversial, and is not clearly related to a gain of functional mechanism. We identified a Japanese family with two sisters who were homozygous for the SCA6 with identical CAG repeat expansion (25/ 25). They showed an earlier age of onset (27 years in both) than their father (44 years), a heterozygote with an expanded allele showing the same CAG repeat length as the homozygotes (25/14). Interestingly, the two sisters showed differences in disease progression and severity, although the age of onset and CAG repeat length were identical. These findings strongly suggest that the gene dosage influences the age of onset, but other unknown factors are also important in the phenotypic expression of homozygous SCA6.

    DOI: 10.1034/j.1399-0004.2000.580112.x

    Web of Science

    researchmap

  • 四肢遠位部優位の筋萎縮,痙性麻痺などを呈し,女性発症例を含む球脊髄性筋萎縮症(SBMA)の1家系

    星野 晃, 寺尾 心一, 小佐野 裕, 満間 照典, 田中 章景, 松本 実千代, 祖父江 元

    臨床神経学   40 ( 5 )   542 - 542   2000年5月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • SOD1変異(Gly93Ser)を有する家族性ALSの2家系 症候の多様性

    岩井 克成, 吉原 剛, 田口 栄一, 田中 章景, 道勇 学, 祖父江 元

    臨床神経学   40 ( 5 )   541 - 541   2000年5月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • An autopsy case with clinically and molecular genetically diagnosed Huntington's disease with only minimal non-specific neuropathological findings

    H Mizuno, H Shibayama, F Tanaka, M Doyu, G Sobue, H Iwata, H Kobayashi, K Yamada, K Iwai, T Takeuchi, N Hashimoto, R Ishihara, Y Ibuki, S Ogasawara, M Ozeki

    CLINICAL NEUROPATHOLOGY   19 ( 2 )   94 - 103   2000年3月

     詳細を見る

    記述言語:英語   出版者・発行元:DUSTRI-VERLAG DR KARL FEISTLE  

    An autopsy case with clinically and molecular genetically diagnosed Huntingon's disease (HD) accompanied with minimal non-specific neuropathological features was reported. When the patient was 45 years old, he had faulty memory, mood swing, personality change and agitation. Neurological and psychiatric examinations revealed choreoathetoid movements in Limbs and trunk, generalized hyperreflexia and mental deterioration. However. cerebellar ataxia and muscle rigidity were not disclosed. Neuroimaging study did not show a definite atrophy of heads of caudate nuclei. Neuroacanthocytosis and Wilson's disease were ruled out by the peripheral blood examination and serum Cu and ceruloplasmin examination. At the age of 55 he died of pneumonia. Post-mortem examination revealed minimal non-specific neuropathological features for HD (Vonsattel's grade 0), that is, no visible fibrillary gliosis in the striatum, and few neuronal loss and only proliferation of astrocytes (astrocytosis) in the striatum. Molecular-genetic study the patient's brain tissues and his youngest son's blood was performed. These studies revealed 40 CAG repeats in the patient, 56 CAG repeats in his youngest son. These results suggest they may be PID. Vonsattel et al. [1998] insist that grade 0 comprises 1% of all HD brains, and grade 1 comprises 4% of all HD brains. But we could not find any reports in which the clinical and neuropathological features were described in detail on the cases with clinically and molecular genetically diagnosed HD without specific pathological findings. Therefore, we present in detail the clinical and neuropathological features of such case.

    Web of Science

    researchmap

  • セロトニン1A受容体作動薬クエン酸タンドスピロンが奏効した純粋無動症の1例

    渡辺 宏久, 山田 新一, 西村 麗, 足立 弘明, 田中 章景, 祖父江 元

    臨床神経学   40 ( 1 )   86 - 86   2000年1月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 15年以上の極めて緩徐な進行性の経過を示したSOD1(His46Arg)変異を有する家族性ALSの1家系

    岩井 克成, 吉原 剛, 田中 章景, 祖父江 元

    臨床神経学   40 ( 1 )   87 - 87   2000年1月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 脊髄疾患 球脊髄性筋萎縮症

    田中 章景, 祖父江 元

    Annual Review神経   2000   253 - 262   2000年1月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)中外医学社  

    researchmap

  • Triggering of neuronal cell death by accumulation of activated SEK1 on nuclear polyglutamine aggregations in PML bodies

    S Yasuda, K Inoue, M Hirabayashi, H Higashiyama, Y Yamamoto, H Fuyuhiro, O Komure, F Tanaka, G Sobue, K Tsuchiya, K Hamada, H Sasaki, K Takeda, H Ichijo, A Kakizuka

    GENES TO CELLS   4 ( 12 )   743 - 756   1999年12月

     詳細を見る

    記述言語:英語   出版者・発行元:BLACKWELL SCIENCE LTD  

    Background: A novel class of inherited human neurodegenerations is now known to be caused by expanded CAG repeats encoding polyglutamines. Polyglutamine-containing protein fragments have been shown to accumulate as aggregates in the nucleus and in the cytoplasm, and to induce cell death when expressed in cultured cells, leading to the proposal that polyglutamine aggregation is an important step in the pathogenesis. Supporting this, nuclear inclusions containing expanded polyglutamines have been identified in neurones from the brains of patients and in neurones from transgenic mouse models of this class of neural disorders.
    Results: We analysed the consequences of polyglutamine expression in PC12 neuronal cells. Activated SEK1 accumulated with nuclear but not cytoplasmic polyglutamine aggregations, which consequently triggers cell death. Cell death induced by polyglutamine expression was inhibited by a dominant-negative SEK1 (DN-SEK1), but not by DN-SEK1 tagged with a nuclear export signal. Steady state SEK1 expression itself was enhanced two to three-fold. Nuclearly aggregated polyglutamines, which were identified in PML bodies, co-localized with not only activated SEK1 but also activated c-Jun. We also observed that nuclear inclusion-positive neurones from brains with Huntington's disease expressed SEK1.
    Conclusions: This study provides molecular links between the neurodegeneration observed in polyglutamine diseases, cell death signalling kinase cascades and nuclear subdomains related to cell death. We propose that the nuclear PML bodies containing polyglutamine aggregates activate the SEK1-JNK kinase cascade, resulting in the transduction of a death signal.

    DOI: 10.1046/j.1365-2443.1999.00294.x

    Web of Science

    PubMed

    researchmap

  • 歯状核赤核・淡蒼球ルイ体萎縮症(DRPLA)の運動関連脳電位(MRCP)

    鷲見 幸彦, 馬渕 千之, 齋藤 浩一, 古池 保雄, 平山 正昭, 田中 章景

    臨床神経学   39 ( 12 )   1469 - 1469   1999年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 分子インデックス法による筋萎縮性側索硬化症(ALS)病態関連分子群の探索

    丹羽 淳一, 道 勇学, 石垣 診祐, 澤田 浩一, 田中 章景, 祖父江 元, 加藤 菊也

    臨床神経学   39 ( 12 )   1367 - 1367   1999年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 球脊髄性筋萎縮症(SBMA)における異常アンドロゲン受容体(AR)の核内封入体の組織分布と細胞変性

    李 ばい, 小林 靖, 田中 章景, 三輪 茂, 山本 正彦, 道勇 学, 祖父江 元, 寺尾 心一, 満間 照典, 橋詰 良夫

    臨床神経学   39 ( 12 )   1392 - 1392   1999年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 分子インデックス法による中脳黒質の発現遺伝子プロファイル パーキンソン病(PD)病態関連分子群の探索

    石垣 診祐, 丹羽 淳一, 道勇 学, 澤田 浩一, 田中 章景, 祖父江 元, 加藤 菊也

    臨床神経学   39 ( 12 )   1308 - 1308   1999年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 球脊髄性筋萎縮症(SBMA)の組織特異的体細胞モザイクはアンドロゲンレセプター(AR)発現レベルと相関する

    田中 章景, 伊藤 泰広, 松本 実千代, 李 めい, 三輪 茂, 犬飼 晃, 道勇 学, 祖父江 元

    臨床神経学   39 ( 12 )   1307 - 1307   1999年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • Machado-Joseph病の脳局所糖代謝所見

    阿部 祐士, 新畑 豊, 田中 章景, 家田 俊明, 祖父江 元, 平山 正昭, 加知 輝彦, 柳澤 信夫, 加藤 隆司, 伊藤 健吾

    臨床神経学   39 ( 12 )   1455 - 1455   1999年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • ハンチントン病(HD)のMRI所見とCAGリピート数との関連

    渡邊 英孝, 田中 章景, 阿部 祐士, 松本 実千代, 祖父江 元

    臨床神経学   39 ( 12 )   1309 - 1309   1999年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • Tissue-specific somatic mosaicism in spinal and bulbar muscular atrophy is dependent on CAG-repeat length and androgen receptor-gene expression level

    F Tanaka, MF Reeves, Y Ito, M Matsumoto, M Li, S Miwa, A Inukai, M Yamamoto, M Doyu, M Yoshida, Y Hashizume, S Terao, T Mitsuma, G Sobue

    AMERICAN JOURNAL OF HUMAN GENETICS   65 ( 4 )   966 - 973   1999年10月

     詳細を見る

    記述言語:英語   出版者・発行元:UNIV CHICAGO PRESS  

    The factors influencing the tissue-specific pattern of somatic mosaicism in GAG-repeat diseases have not yet been fully resolved. We performed a detailed analysis of the degree of somatic mosaicism in various tissues from 20 patients with spinal and bulbar muscular atrophy (SBMA), including 4 who were deceased. The most outstanding feature was the prominent somatic mosaicism observed in the cardiac and skeletal muscles, composed predominantly of postmitotic cells, and in the skin, prostate, and testis. The CNS tissues, liver, and spleen showed the least mosaicism. The tissue distribution of somatic mosaicism in patients with SBMA was markedly different from that in patients with Huntington disease (HD) and from that in patients with dentatorubral-pallidoluysian atrophy (DRPLA). The degree of somatic mosaicism correlated with the GAG-repeat number but not with age at examination. Furthermore, tissues with a higher mosaicism level corresponded well to those with a higher expression Level of androgen receptor protein. The tissue-specific pattern of somatic mosaicism related not only to cell composition with different cell turnover rates but to repeat size and gene expression levels, and postnatal cell division is unlikely to be a major cause of somatic mosaicism probably because of the relative stability of CAG repeat in SBMA.

    DOI: 10.1086/302578

    Web of Science

    researchmap

  • Late-onset familial amyloid polyneuropathy type I (transthyretin Met30-associated familial amyloid polyneuropathy) unrelated to endemic focus in Japan - Clinicopathological and genetic features

    K Misu, N Hattori, M Nagamatsu, S Ikeda, Y Ando, M Nakazato, Y Takei, N Hanyu, Y Usui, F Tanaka, T Harada, A Inukai, Y Hashizume, G Sobue

    BRAIN   122   1951 - 1962   1999年10月

     詳細を見る

    記述言語:英語   出版者・発行元:OXFORD UNIV PRESS  

    Clinicopathological and genetic features were assessed on 35 Japanese families affected by late-onset familial amyloid polyneuropathy type I (transthyretin Met30-associated familial amyloid polyneuropathy, FAP TTR Met30) whose siblings were unrelated to endemic Japanese foci, In these patients (50 years or older), the most common initial symptom was paraesthesias in the legs. Autonomic symptoms were generally mild and did not seriously affect daily activities. The male-to-female ratio was extremely high (10.7:1), A family history was evident in only 11 out of 35 families, and other patients were apparently sporadic, The rate of penetrance was very low Symptomatic siblings of familial cases showed a late age of onset, male preponderance and clinical features similar to those of the probands, Asymptomatic carriers, predominantly female, were detected relatively late in life. The geographical distribution of these late-onset, FAP TTR Met30 cases was scattered throughout Japan. In three autopsy cases and 20 sural nerve biopsy specimens, neurons in sympathetic and sensory ganglia were relatively preserved, Amyloid deposition was seen in the peripheral nervous system, particularly in the sympathetic ganglia, dorsal root ganglia and proximal nerve trunks such as sciatic nerve. These abnormalities were milder than those seen in typical early-onset FAP TTR Met30, as observed in two Japanese endemic foci of this disease. While axonal degeneration was prominent in myelinated fibres, resulting in severe fibre loss, unmyelinated fibres were relatively preserved. Our cases of late-onset FAP TTR Met30 showed features distinct from those of typical early-onset FAP TTR Met30 that occurred in the two Japanese endemic foci, Factors responsible for clinicopathological differences between these two forms of FAP TTR Met30 need to be identified.

    DOI: 10.1093/brain/122.10.1951

    Web of Science

    researchmap

  • SOD1遺伝子にAsn86Ser変異を認め,多様な表現型を示した家族性筋萎縮性側索硬化症の1家系

    渡邊 英孝, 田中 章景, 祖父江 元, 武上 俊彦, 安藤 哲朗

    臨床神経学   39 ( 8 )   900 - 900   1999年8月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 神経症候群II 変性疾患 運動ニューロン疾患 球脊髄性筋萎縮症(Kennedy-Alter-Sung病)

    田中 章景, 祖父江 元

    日本臨床   別冊 ( 神経症候群II )   375 - 378   1999年7月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)日本臨床社  

    researchmap

  • 【Triplet Repeat病 動的突然変異の分子病態と臨床】(CAG)n型-球脊髄性筋萎縮症(spinobulbar muscular atrophy;SBMA) 球脊髄性筋萎縮症におけるアンドロゲン受容体(AR)遺伝子(CAG)nのsomatic mosaicism

    田中 章景, 伊藤 泰広, 祖父江 元

    日本臨床   57 ( 4 )   862 - 868   1999年4月

  • 【Triplet Repeat病 動的突然変異の分子病態と臨床】(CAG)n型-歯状核赤核淡蒼球ルイ体萎縮症(dentatorubral-pallidoluysian atrophy;DRPLA) DRPLA異常遺伝子の神経系におけるCAGリピートsizeのsomatic mosaicism

    伊藤 泰広, 田中 章景, 祖父江 元

    日本臨床   57 ( 4 )   850 - 855   1999年4月

  • 【Triplet Repeat病 動的突然変異の分子病態と臨床】(CAG)n型-マチャド・ジョセフ病(Machado-Joseph disease;MJD) MJDにおけるCAGリピートsizeの神経及び非神経組織におけるsomatic mosaicism

    田中 章景, 伊藤 泰広, 祖父江 元

    日本臨床   57 ( 4 )   838 - 842   1999年4月

  • Machado-Joseph病(MJD)の運動関連脳電位(MRCP)

    鷲見 幸彦, 馬渕 千之, 齋藤 浩一, 古池 保雄, 平山 正昭, 田中 章景

    臨床神経学   39 ( 1 )   147 - 147   1999年1月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 球脊髄性筋萎縮症(SBMA)における核内封入体

    李 ばい, 三輪 茂, 小林 靖, 田中 章景, 道勇 学, 祖父江 元, 寺尾 心一, 満間 照典, 橋詰 良夫

    臨床神経学   39 ( 1 )   187 - 187   1999年1月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 球脊髄性筋萎縮症(SBMA)における(CAG)n周辺の塩基配列の解析

    田中 章景, 道勇 学, 三輪 茂, 祖父江 元

    臨床神経学   39 ( 1 )   167 - 167   1999年1月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 優性遺伝性脊髄小脳変性症の病型別頻度の検討

    渡邊 英孝, 田中 章景, 松本 実千代, 道勇 学, 祖父江 元, 満間 照典

    臨床神経学   39 ( 1 )   272 - 272   1999年1月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 分子インデックス法による筋萎縮性側索硬化症(ALS)病態関連分子群の探索

    丹羽 淳一, 道勇 学, 澤田 浩一, 三輪 茂, 田中 章景, 祖父江 元, 加藤 菊也

    臨床神経学   39 ( 1 )   228 - 228   1999年1月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 分子インデックス法によるアルツハイマー病病態関連分子の探索

    道勇 学, 丹羽 淳一, 澤田 浩一, 三輪 茂, 田中 章景, 祖父江 元, 加藤 菊也

    臨床神経学   39 ( 1 )   185 - 185   1999年1月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • Machado-Joseph病の小脳・脳幹萎縮に対するCAG repeat数の影響

    阿部 祐士, 田中 章景, 松本 実千代, 道勇 学, 祖父江 元, 加知 輝彦

    臨床神経学   39 ( 1 )   276 - 276   1999年1月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • Transgenic mice harboring a full-length human mutant DRPLA gene exhibit age-dependent intergenerational and somatic instabilities of CAG repeats comparable with those in DRPLA patients

    Toshiya Sato, Mutsuo Oyake, Kenji Nakamura, Kazuki Nakao, Yoshimitsu Fukusima, Osamu Onodera, Shuichi Igarashi, Hiroki Takano, Koki Kikugawa, Yoshinori Ishida, Takayoshi Shimohata, Reiji Koide, Takeshi Ikeuchi, Hajime Tanaka, Naonobu Futamura, Ryusuke Matsumura, Tetsuya Takayanagi, Fumiaki Tanaka, Gen Sobue, Osamu Komure, Mie Takahashi, Akira Sano, Yaeko Ichikawa, Jun Goto, Ichiro Kanazawa, Motoya Katsuki, Shoji Tsuji

    Human Molecular Genetics   8 ( 1 )   99 - 106   1999年

     詳細を見る

    Dentatorubral-pallidoluysian atrophy (DRPLA) is one among an increasing number of hereditary neurodegenerative diseases determined as being caused by unstable expansion of CAG repeats coding for polyglutamine stretches. To investigate the molecular mechanisms underlying CAG repeat instability, we established three transgenic lines each harboring a single copy of a full-length human mutant DRPLA gene carrying a CAG repeat expansion. These transgenic mice exhibited an age-dependent increase (+0.31 per year) in male transmission and an age-dependent contraction (-1.21 per year) in female transmission. Similar tendencies in intergenerational instabilities were also observed in human DRPLA parent-offspring pairs. The intergenerational instabilities of the CAG repeats may be interpreted as being derived from the instability occurring during continuous cell division of spermatogonia in the male, and that occurring during the period of meiotic arrest in the female. The transgenic mice also exhibited an age-dependent increase in the degree of somatic mosaicism which occurred in a cell lineage-dependent manner, with the size range of CAG repeats being smaller in the cerebellum than in other tissues including the cerebrum, consistent with observations in autopsied tissues of DRPLA patients. Thus, the transgenic mice described in this study exhibited age-dependent intergenerational as well as somatic instabilities of expanded CAG repeats comparable with those observed in human DRPLA patients, and are therefore expected to serve as good models for investigating the molecular mechanisms of instabilities of CAG repeats.

    DOI: 10.1093/hmg/8.1.99

    Scopus

    PubMed

    researchmap

  • Spinocerebellar atxia type 6(SCA 6)のhomozygoteの1例

    加藤 武志, 曽根 美恵, 岩崎 靖, 吉田 英治, 印東 利勝, 田中 章景, 松本 実千代, 祖父江 元

    臨床神経学   38 ( 12 )   1095 - 1095   1998年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • SCA1の1剖検例

    岩井 克成, 杉浦 真, 鈴木 康弘, 橋爪 眞言, 田中 章景, 吉田 眞理, 橋詰 良夫

    臨床神経学   38 ( 12 )   1095 - 1095   1998年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • Spinocerebellar ataxia type 1(SCA1)の4家系

    田中 章景, 松本 実千代, 満間 典雅, 祖父江 元, 岩井 克成, 橋爪 眞言, 伊藤 泰広, 大川 議徳, 安田 武司, 阿部 祐士

    臨床神経学   38 ( 12 )   1095 - 1095   1998年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • Nonneural nuclear inclusions of androgen receptor protein in spinal and bulbar muscular atrophy

    Li, I, Y Nakagomi, Y Kobayashi, DE Merry, F Tanaka, M Doyu, T Mitsuma, Y Hashizume, KH Fischbeck, G Sobue

    AMERICAN JOURNAL OF PATHOLOGY   153 ( 3 )   695 - 701   1998年9月

     詳細を見る

    記述言語:英語   出版者・発行元:AMER SOC INVESTIGATIVE PATHOLOGY, INC  

    Spinal and bulbar muscular atrophy is an X-linked motor neuronopathy caused by the expansion of an unstable CAG repeat in the coding region of the androgen receptor (AR) gene. Nuclear inclusions of the mutant AR protein have been shown to occur in the spinal motor neurons of spinal and bulbar muscular atrophy (Li M, Kobayashi Y, Merry D, Tanaka F, Doyu M, Hashizume Y, Fischbeck KH, Sobue G: Nuclear inclusions in spinal and bulbar muscular atrophy, Ann Neurol 1998 tin press)), In this study, we demonstrate the tissue-specific distribution, immunochemical features, and fine structure of nuclear inclusions of spinal and bulbar muscular atrophy. Nuclear inclusions were observed in affected spinal and brainstem motor neurons, but not in other, nonaffected neural tissues. Similar nuclear inclusions occurred in nonneural tissues including scrotal skin, dermis, kidney, heart, and testis, but not in the spleen, Liver, and muscle. These inclusions had similar epitope features detectable by antibodies that recognize a small portion of the N-terminus of the AR protein only, and they were ubiquitinated, Electron microscopic immunohistochemistry showed dense aggregates of AR-positive granular material without limiting membrane, both in the neural and nonneural inclusions. These findings indicate that nuclear inclusions of AR protein are present in selected nonneural tissues as well as in neurons that degenerate in spinal and bulbar muscular atrophy, suggesting that a common mechanism underlies in the formation of neural and nonneural nuclear inclusions.

    Web of Science

    researchmap

  • CAG repeat number correlates with the rate of brainstem and cerebellar atrophy in Machado-Joseph disease

    Y Abe, F Tanaka, M Matsumoto, M Doyu, M Hirayama, T Kachi, G Sobue

    NEUROLOGY   51 ( 3 )   882 - 884   1998年9月

     詳細を見る

    記述言語:英語   出版者・発行元:LIPPINCOTT WILLIAMS & WILKINS  

    We compared the CAG repeat length and the severity of the brainstem and cerebellar atrophy visualized by MRI in 30 patients with Machado-Joseph disease. We found a strong correlation between the CAG repeat number and the quotient of the degree of atrophy divided by age at examination. These results suggest that the rate of disease progression is dependent on the CAG repeat size and disease progression may commence at birth.

    Web of Science

    researchmap

  • Nuclear inclusions of the androgen receptor protein in spinal and bulb muscular atrophy

    M Li, S Miwa, Y Kobayashi, DE Merry, M Yamamoto, F Tanaka, M Doyu, Y Hashizume, KH Fischbeck, G Sobue

    ANNALS OF NEUROLOGY   44 ( 2 )   249 - 254   1998年8月

     詳細を見る

    記述言語:英語   出版者・発行元:LIPPINCOTT WILLIAMS & WILKINS  

    Spinal and bulbar muscular atrophy (SBMA) is an X-linked motor neuronopathy caused by the expansion of an unstable CAG repeat in the coding region of the androgen receptor (AR) gene. To study AR protein expression in normal and SBMA individuals, rye used several antibodies that recognize AR protein, and analyzed neural and nonneural tissues by immunohistochemistry and western blotting. Both the normal and the mutant AR proteins were widely distributed, predominantly, but not exclusively, in the cytoplasm of neurons regardless of the pathological involvement, and predominantly in the nuclei of the nonneural tissues in both normal and SBMA individuals, with different expression levels of AR protein among different tissues. In the motor neurons of SBMA patients, there were AR-immunoreactive ubiquitinated nuclear inclusions that were detected by antibodies that recognize a small portion of the N terminus of the AR protein. Absence of other immunoreactive AR epitopes within the inclusion may be due to altered AR configuration, or masking of AR epitopes by other proteins, or proteolytic cleavage of the AR. Our data show that, in addition to the normal cellular distribution of the AR protein, mutant AR-bearing nuclear inclusions are present in SBMA.

    Web of Science

    researchmap

  • 高齢発症の家族性アミロイドポリニューロパチー(FAPtype1)の臨床病理学的検討

    翠 健一郎, 服部 直樹, 市村 みゆき, 田中 章景, 永松 正明, 祖父江 元, 橋詰 良夫

    臨床神経学   38 ( 6 )   549 - 549   1998年6月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 広範な白質病変を認めたハンチントン舞踏病の一例

    水野裕, 柴山漠人, 竹内徹, 石原良子, 小林宏, 岩井清, 小笠原俊一郎, 中川実, 伊吹康雄, 岩田拡, 橋本直季, 祖父江元, 道勇学, 田中章景, 山田堅一

    Neuropathology : official journal the Japanese Society of Neuropathology   18   164 - 164   1998年5月

     詳細を見る

    記述言語:日本語  

    CiNii Books

    researchmap

  • Differential temporal expression of mRNAs for ciliary neurotrophic factor (CNTF), leukemia inhibitory factor (LIF), interleukin-6 (IL-6), and their receptors (CNTFR a alpha, LIFR beta, IL-6R alpha and gp130) in injured peripheral nerves

    Y Ito, M Yamamoto, M Li, M Doyu, F Tanaka, T Mutch, T Mitsuma, G Sobue

    BRAIN RESEARCH   793 ( 1-2 )   321 - 327   1998年5月

     詳細を見る

    記述言語:英語   出版者・発行元:ELSEVIER SCIENCE BV  

    The mRNA expression of the neuropoietic cytokines, ciliary neurotrophic factor (CNTF), leukemia inhibitory factor (LIF), interleukin-6 (IL-6), and their receptor components (CNTFR alpha, LIFR beta, IL-6R alpha and gp130) was examined in peripheral nerves after two different types of injury, crush and transection. The CNTF mRNA expression levels decreased after injury and remained low in the transected model, but recovered in 4 weeks in the crushed model. The LIF mRNA rapidly increased after damage and returned gradually to control levels. The IL-6 mRNA expression increased rapidly within 1 day after injury but dramatically decreased soon after. The CNTFR alpha mRNA levels gradually increased after nerve injury. LIFR beta was expressed in the intact nerve and decreased slightly after injury. The IL-6R alpha expression was observed faintly in the intact nerve and increased significantly soon after injury. There was also an increase in the expression of gp130. Although the temporal expression of these neuropoietic cytokines and receptors was extremely different, their pattern was similar between the crushed and transected models, except for CNTF. These results suggest that the expression of the ligands and receptors are differentially regulated after peripheral nerve injury, implying that each cytokine and signal transduction system has entirely distinctive functions in neuronal regeneration and repair. (C) 1998 Elsevier Science B.V. All rights reserved.

    DOI: 10.1016/S0006-8993(98)00242-X

    Web of Science

    PubMed

    researchmap

  • Auditory and visual event-related potentials and flash visual evoked potentials in Alzheimer's disease: correlations with Mini-Mental State Examination and Raven's Coloured Progressive Matrices

    F Tanaka, T Kachi, T Yamada, G Sobue

    JOURNAL OF THE NEUROLOGICAL SCIENCES   156 ( 1 )   83 - 88   1998年3月

     詳細を見る

    記述言語:英語   出版者・発行元:ELSEVIER SCIENCE BV  

    We investigated possible correlations among neurophysiological examinations [auditory and visual event-related potentials (A-ERPs, V-ERPs), and flash visual evoked potentials (F-VEPs)] and neuropsychological tests [Mini-Mental State Examination (MMSE) and Raven's Coloured Progressive Matrices (RCPM)] in 15 subjects with probable or possible Alzheimer's disease (AD) according to the National Institute of Neurological and Communicative Disorders and Stroke and the Alzheimer's Disease and Related Disorders Association (NINCDS-ADRDA) criteria. The P300 latency of A-ERPs was correlated with the scores of MMSE but not with those of RCPM. The P300 latency of V-ERPs was more significantly correlated with the scores of RCPM than with those of MMSE. The P2 latency of F-VEPs was more significantly correlated with the scores of RCPM than with those of MMSE. The P2 latency of F-VEPs was not correlated with the P300 latency of A-ERPs but was correlated with the P300 latency of V-ERPs. The close relationship among V-ERPs, F-VEPs and RCPM suggests that these examinations at least partly reflect the functions of visual association areas in AD. Furthermore, discrepancy between P300 latency by A-ERPs and V-ERPs suggests that the mechanism responsible for P300 generation is not identical between these two stimulus modalities. (C) 1998 Elsevier Science B.V.

    DOI: 10.1016/S0022-510X(98)00004-5

    Web of Science

    researchmap

  • Somatic mosaicism of the expanded CAG trinucleotide repeat in mRNAs for the responsible gene of Machado-Joseph disease (MJD), dentatorubral-pallidoluysian atrophy (DRPLA), and spinal and bulbar muscular atrophy (SBMA)

    Y Ito, F Tanaka, M Yamamoto, M Doyu, M Nagamatsu, S Riku, T Mitsuma, G Sobue

    NEUROCHEMICAL RESEARCH   23 ( 1 )   25 - 32   1998年1月

     詳細を見る

    記述言語:英語   出版者・発行元:PLENUM PUBL CORP  

    The CAG trinucleotide repeats in mRNAs for the responsible genes of Machado-Joseph disease (MJD), dentatorubral-pallidoluysian atrophy (DRPLA), and X-linked spinal and bulbal muscular atrophy (SBMA) were examined in various neural and nonneural tissues of affected individuals. The tissue-specific variation of expanded CAG repeat alleles were apparent for mRNAs of all three genes. The expanded CAG repeats of the mRNA were shorter in the cerebellum than in other regions of the central nervous system in DRPLA and MJD, but not in SBMA, and were longer in the liver and colon in MJD. Transcripts of the responsible genes with expanded CAG repeats were detected in all tissues studied, and the tissue-specific variation in the CAG repeat size of the mRNA did not correlate with the tissue-specific severity of pathological involvement in these diseases.

    DOI: 10.1023/A:1022441101801

    Web of Science

    PubMed

    researchmap

  • Frequency analysis of autosomal dominant cerebellar ataxias in Japanese patients and clinical characterization of spinocerebellar ataxia type 6

    H Watanabe, F Tanaka, M Matsumoto, M Doyu, T Ando, T Mitsuma, G Sobue

    CLINICAL GENETICS   53 ( 1 )   13 - 19   1998年1月

     詳細を見る

    記述言語:英語   出版者・発行元:MUNKSGAARD INT PUBL LTD  

    Using a molecular diagnostic approach, we investigated 101 kindreds with autosomal dominant cerebellar ataxias (ADCAs) from the central Honshu island of Japan, including spinocerebellar ataxia type 1 (SCA1), spinocerebellar ataxia type 2 (SCA2), Machado-Joseph disease (MJD), dentatorubral and pallidoluysian atrophy (DRPLA) and spinocerebellar ataxia type 6 (SCA6). In our unselected series, MJD was the most common type of ADCA, accounting for 33.7% followed by DRPLA (19.8%), SCA2 (5.9%) and SCA6 (5.9%). No SCA1 mutations were identified. We analysed the clinical features of six molecular confirmed SCA6 kindreds: in each family, there was an expanded allele in the alpha 1A-voltage dependent calcium channel comprising between 23 and 25 CAG repeats. The mean age at onset of symptoms was 43 +/- 13 years. The clinical features consisted predominantly of cerebellar ataxia, dysarthria and horizontal nystagmus, which was generally consistent with ADCA type 3. However several new clinical features were found in some patients: dramatic anticipation, rapid disease progression, severe ataxia associated with action tremor or action myoclonus, and very early onset, which are not described as the classical features of ADCA type 3.

    DOI: 10.1034/j.1399-0004.1998.531530104.x

    Web of Science

    researchmap

  • 発症年齢特異性のある中枢神経疾患;「脊髄小脳変性症と好発年齢」

    田中章景, 道勇 学, 祖父江元

    CLINICAL NEUROSCIENCE   16 ( 1 )   43 - 46   1998年

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)中外医学社  

    researchmap

  • 球脊髄性筋萎縮症(SBMA)におけるアンドロゲン受容体(AR)遺伝子(CAG)nのsomatic mosaicism 3剖検例における検討

    田中 章景

    臨床神経学   37 ( 12 )   1332 - 1332   1997年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 【内科 この1年の進歩】神経疾患

    田中 章景, 若井 正一, 永松 正明

    内科   80 ( 6 )   1052 - 1060   1997年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)南江堂  

    researchmap

  • 【神経系疾患と臨床検査】生化学・遺伝子 球脊髄性筋萎縮症

    道勇 学, 田中 章景, 永松 正明

    臨床検査   41 ( 11 )   1272 - 1276   1997年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)医学書院  

    researchmap

  • 球脊髄性筋萎縮症(SBMA) (特集 Triplet repeat diseases)

    道勇学, 田中章景, 祖父江元

    神経研究の進歩   41 ( 3 )   357 - 366   1997年6月

     詳細を見る

    記述言語:日本語   出版者・発行元:医学書院  

    CiNii Books

    researchmap

  • 後索および視床下核に主病変を持つ家族性脊髄小脳変性症の姉弟例

    安藤哲朗, 橋詰良夫, 吉田真理, 都築豊徳, 久米明人, 田中章景, 祖父江元, 柳務

    Neuropathology : official journal the Japanese Society of Neuropathology   17   86 - 86   1997年5月

     詳細を見る

    記述言語:日本語  

    CiNii Books

    researchmap

  • 遺伝性脊髄小脳変性症の遺伝子診断による病型頻度

    田中 章景

    臨床神経学   37 ( 5 )   457 - 457   1997年5月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • The lateral corticospinal tract and spinal ventral horn in X-linked recessive spinal and bulbar muscular atrophy: A quantitative study

    S Terao, G Sobue, M Li, Y Hashizume, F Tanaka, T Mitsuma

    ACTA NEUROPATHOLOGICA   93 ( 1 )   1 - 6   1997年1月

     詳細を見る

    記述言語:英語   出版者・発行元:SPRINGER VERLAG  

    A quantitative study was performed on spinal cord lesions in seven patients with X-linked recessive spinal and bulbar muscular atrophy. The myelinated fiber density of the lateral corticospinal tracts at the T7 cord level was well preserved for both large and small myelinated fibers. On the other hand, neurons in the L4 ventral horn were markedly depleted; marked loss was noted of the large alpha and medium-sized gamma motor neurons located in the lateral and medial nuclei as well as the small neurons in the intermediate zones of the ventral hem. These results suggest that myelinated fiber density and fiber-size distribution in the corticospinal tract are well preserved and that neuronal loss in the ventral horns is not restricted to alpha and gamma motoneurons but also involves small interneurons.

    Web of Science

    researchmap

  • 運動ニューロン疾患研究の最近の進歩;「球脊髄性筋萎縮症における変異アンドロゲン受容体と運動ニューロン死」

    李 めい, 三輪 茂, 田中章景, 道勇 学, 祖父江元

    神経研究の進歩   41 ( 6 )   904 - 910   1997年

  • 伴性劣性球脊髄性筋萎縮症(SBMA)におけるfounder effectの検討

    田中 章景

    臨床神経学   36 ( 12 )   1504 - 1504   1996年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 球脊髄性筋萎縮症(SBMA)におけるアンドロゲン受容体遺伝子(CAG)nのsomatic mosaicism 3剖検例における検討

    田中 章景

    臨床神経学   36 ( 11 )   1280 - 1280   1996年11月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 球脊髄性筋萎縮症のアンドロゲン受容体遺伝子異常と病態形成

    祖父江元, 道勇学, 田中章景

    神経化学   35 ( 3 )   202 - 203   1996年9月

     詳細を見る

    記述言語:日本語  

    CiNii Books

    researchmap

  • Founder effect in spinal and bulbar muscular atrophy (SBMA)

    F Tanaka, M Doyu, Y Ito, M Matsumoto, T Mitsuma, K Abe, M Aoki, Y Itoyama, KH Fischbeck, G Sobue

    HUMAN MOLECULAR GENETICS   5 ( 9 )   1253 - 1257   1996年9月

     詳細を見る

    記述言語:英語   出版者・発行元:OXFORD UNIV PRESS UNITED KINGDOM  

    We analyzed the polymorphic (CAG)(n) and (GGC)(n) repeats of the androgen receptor gene in 113 unrelated X-linked spinal and bulbar muscular atrophy (SBMA) X chromosomes and 173 control X chromosomes in Japanese males. The control chromosomes had an average CAG repeat number of 21 +/- 3 with a range from 14-32 repeat units, and SBMA chromosomes had a range from 40-55 with a median of 47 +/- 3 copies. The control chromosomes had seven different alleles of the (GGC)(n) repeat with the range of 11 to 17; the most frequent size of (GGC)(n) was 16 (79%), while (GGC)(17) was very rare (1%). However, in SBMA chromosomes only two alleles were seen; the most frequent size of (GGC)(n) was 16 (6l%) followed by 17 (39%). (GGC)(n) size distribution was significantly different between SBMA and control chromosomes (P &lt;0.0001), indicating the presence of linkage disequilibrium. There was no allelic association between the (CAG)(n) and (GGC)(n) microsatellites among control subjects as well as SBMA patients, which suggests that a founder effect makes a more significant contribution to generation of Japanese SBMA chromosomes than new mutations.

    DOI: 10.1093/hmg/5.9.1253

    Web of Science

    researchmap

  • 神経筋伝達障害を認めた伴性劣性球脊髄性筋萎縮症の1例

    川上治, 高野明美, 田中章景, 古池保雄, 祖父江元

    臨床神経学   36 ( 7 )   892 - 894   1996年7月

     詳細を見る

    記述言語:日本語  

    CiNii Books

    researchmap

  • Differential pattern in tissue-specific somatic mosaicism of expanded CAG trinucleotide repeat in dentatorubral-pallidoluysian atrophy, Machado-Joseph disease, and X-linked recessive spinal and bulbar muscular atrophy

    F Tanaka, G Sobue, M Doyu, Y Ito, M Yamamoto, N Shimada, K Yamamoto, S Riku, Y Hshizume, T Mitsuma

    JOURNAL OF THE NEUROLOGICAL SCIENCES   135 ( 1 )   43 - 50   1996年1月

     詳細を見る

    記述言語:英語   出版者・発行元:ELSEVIER SCIENCE BV  

    We investigated the somatic mosaicism of trinucleotide repeat expansion in the neural and nonneural tissues of a dentatorubral-pallidoluysian atrophy (DRPLA), Machado-Joseph disease (MJD), and spinal and bulbar muscular atrophy (SBMA) patient and their correlation to the topographical distribution of the pathological involvement. The spatial pattern of tissue-specific somatic mosaicism in the CAG repeat size was significantly different among the DRPLA, MJD and SBMA patients. The size of the major bands of the mutant CAG repeat allele was significantly smaller in the cerebellar cortex in both DRPLA and MJD patients by 6 and 2 repeat units respectively and larger in the colon and liver of DRPLA by 5 repeats or more. There were also 1-2 repeat-sized small variations of major band size among the neural tissues in DRPLA. In contrast, there was no tissue-specific variation of major bands of CAG repeats and diversity of extra bands among the examined tissues including the cerebellum in the SBMA patient. There was no parallel occurrence of tissue-specific CAG instability and severity of neuropathological involvement in the neural and nonneural tissues of DRPLA, MJD and SBMA patients. Lack of significant tissue-specific somatic mosaicism in SBMA including the cerebellar cortex may suggest that CAG repeat expansion in the mutant androgen receptor gene is far more stable compared with that in DRPLA and MJD as well as those reported in Huntington's disease.

    DOI: 10.1016/0022-510X(95)00249-2

    Web of Science

    researchmap

  • 高齢発症の家族性アミロイドポリニューロパチー(FAP type I)の1家系 : 発症に関する保因者同胞間の変異

    梅村敏隆, 祖父江元, 森下真次, 田中章景, 道勇学, 榊原敏正

    臨床神経学   35 ( 5 )   505 - 508   1995年5月

     詳細を見る

    記述言語:日本語  

    CiNii Books

    researchmap

  • 著明な低カリウム血症に伴った急性両側性後骨間神経麻痺

    森下 真次, 榊原 敏正, 田中 章景

    臨床神経学   33 ( 10 )   1070 - 1074   1993年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    66歳主婦,長時間の雑巾絞りをした後に両前腕に疼痛が出現,翌日より両側の手指のみが伸展不能,著明な低カリウム血症とCK上昇を示し,筋電図上被験筋全体の筋原性変化,後骨間神経支配筋には神経原性変化が混在していた。カリウム補正に伴い速やかに麻痺は回復,筋原性変化も消失したが,神経原性変化は持続した。本例ては低カリウム血症による筋興奮性低下(低カリウム性ミオパチー)が潜在し,その上に雑巾絞りによる軽度な後骨間神経障害が相乗し,同神経支配筋に強い脱力が生じたと推測された。絞扼性神経障害悪化の要因として低カリウム血症の存在も考慮すべきであると考えられた

    researchmap

  • 天幕下梗塞の臨床的検討 MRI所見を中心に

    田中 章景

    脳卒中   13 ( 6 )   606 - 606   1991年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本脳卒中学会  

    researchmap

  • ミオクローヌスを呈する脊髄小脳変性症に対する薬物学的検討 dantrolene sodiumが有効であった2例

    田中 章景

    神経内科治療   8 ( 6 )   621 - 621   1991年11月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経治療学会  

    researchmap

  • 天幕下梗塞の臨床的検討 MRI所見を中心に

    田中 章景

    日本脳卒中学会総会講演抄録集   16回   239 - 239   1991年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本脳卒中学会  

    researchmap

  • 頸椎後縦靱帯骨化症に伴う起立性低血圧の治療 droxidopaが有効であった1例

    田中 章景

    神経内科治療   7 ( 6 )   521 - 522   1990年11月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経治療学会  

    researchmap

  • Charcot-Marie-Tooth型筋萎縮をきたしたspinal extradural arachnoid cystの1例

    田中 章景

    臨床神経学   30 ( 6 )   692 - 693   1990年6月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 穿通枝梗塞における大脳半球および基底核部放線冠部脳血流量

    田中 章景

    脳卒中   11 ( 6 )   756 - 756   1989年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本脳卒中学会  

    researchmap

  • 高血圧性脳症における白質異常のreversibility 治療との関連性について

    田中 章景

    神経内科治療   6 ( 6 )   548 - 548   1989年11月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経治療学会  

    researchmap

  • 穿通枝梗塞における脳血流量 主病巣側及びrisk factorとの関連について

    田中 章景

    臨床神経学   29 ( 11 )   1430 - 1430   1989年11月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • 眼瞼ヘルペスに伴う左動眼神経麻痺の1例

    田中 章景

    臨床神経学   29 ( 5 )   660 - 660   1989年5月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • いわゆるRINDにおける脳血流動態について Xe-CTによる検討

    田中 章景

    臨床神経学   29 ( 2 )   236 - 236   1989年2月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

  • Lacunar stroke patientにおける脳血流動態について Xe-CTによる検討

    田中 章景

    臨床神経学   28 ( 11 )   1338 - 1338   1988年11月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本神経学会  

    researchmap

▼全件表示

Works(作品等)

  • 孤発性ALSの動物モデルの開発

    2007年

     詳細を見る

  • エオジン好性核内封入体(NIHID)の原因遺伝子の探索・同定

    2007年

     詳細を見る

  • ポリグルタミン病の病態解明とそれに基づく治療法の開発

    2005年 - 2009年

     詳細を見る

  • 孤発性ALSの病態関連標的分子の探索と治療法開発

    2005年 - 2006年

     詳細を見る

  • 低分子化合物によるポリグルタミン病治療の開発ー臨床応用に向けて

    2005年 - 2006年

     詳細を見る

  • 老化に伴う神経変性疾患の長期縦断疫学研究:ALSについて

    2005年 - 2006年

     詳細を見る

  • ポリグルタミン病の低分子化合物による治療法の探索ー球脊髄性筋萎縮症を中心に

    2004年 - 2005年

     詳細を見る

▼全件表示

受賞

  • 愛知県難病研究者表彰

    2003年  

     詳細を見る

    受賞国:日本国

    researchmap

共同研究・競争的資金等の研究課題

  • Disconnectomeによる失語症の言語ネットワーク障害の病態解明と症候予測モデルの構築

    研究課題/領域番号:24K14353  2024年4月 - 2027年3月

    日本学術振興会  科学研究費助成事業  基盤研究(C)

    東山 雄一, 森原 啓介, 土井 宏, 田中 章景

      詳細を見る

    配分額:4550000円 ( 直接経費:3500000円 、 間接経費:1050000円 )

    researchmap

  • 神経核内封入体病の病態解明と根本的治療法の開発

    研究課題/領域番号:23H02803  2023年4月 - 2028年3月

    日本学術振興会  科学研究費助成事業  基盤研究(B)

    曽根 淳, 田中 章景, 岩崎 靖, 石井 一弘

      詳細を見る

    配分額:18590000円 ( 直接経費:14300000円 、 間接経費:4290000円 )

    researchmap

  • 孤発性ALSにおける非膜オルガネラの病的動態の解明

    研究課題/領域番号:22K07372  2022年4月 - 2025年3月

    日本学術振興会  科学研究費助成事業  基盤研究(C)

    多田 美紀子, 土井 宏, 竹内 英之, 田中 章景

      詳細を見る

    配分額:4160000円 ( 直接経費:3200000円 、 間接経費:960000円 )

    researchmap

  • 単球系細胞から捉えた全身炎症による神経変性疾患の病態進展の機序解明

    研究課題/領域番号:21K07465  2021年4月 - 2024年3月

    日本学術振興会  科学研究費助成事業 基盤研究(C)  基盤研究(C)

    竹内 英之, 土井 宏, 田中 章景

      詳細を見る

    配分額:4160000円 ( 直接経費:3200000円 、 間接経費:960000円 )

    ALSモデルマウスとしてヒトsuperoxide dismutase1 G93A変異トランスジェニックマウス (SOD1 Tg)、ALS/FTLDモデルマウスとして我々の作出した薬剤誘導性神経特異性TDP-43 コンディショナルノックアウトマウス(TDP-43CKO:薬剤投与後2週間で発症し、4~5週で 衰弱死)を用い、組織マクロファージと循環マクロファージを各々緑色蛍光と赤色蛍光で生体内弁別可能とするCX3CR1-GFP/CCR2-RFPヘテロノックインマウスと交配させることで、CX3CR1-GFP/CCR2-RFP/SOD1 TgマウスおよびCX3CR1-GFP/CCR2-RFP/TDP-43CKOマウスを作出し得た。続いて、野生型マウスを用いて、sublethalな投与量での大腸菌由来リポ多糖(lipopolysaccharide, LPS)またはpoly(I:C)投与の反復可能な条件検討を行い、至適条件を得た。CX3CR1-GFP/CCR2-RFP/SOD1 TgマウスおよびCX3CR1-GFP/CCR2-RFPヘテロノックインマウスに対して、sublethalなLPS、poly(I:C)、生理食塩水を、病初期である12週齢から15週齢まで週1回・4週連続投与を行い、その後の体重減少や運動麻痺を含めた病勢進行への影響、生存曲線の変化、経時的な病理学的変化についての解析を施行中である。

    researchmap

  • 扁桃体腫大を伴う側頭葉てんかんの病態背景の解明と新規治療法の開発

    研究課題/領域番号:21K07419  2021年4月 - 2024年3月

    日本学術振興会  科学研究費助成事業 基盤研究(C)  基盤研究(C)

    國井 美紗子, 土井 宏, 東山 雄一, 田中 章景, 多田 美紀子

      詳細を見る

    配分額:4160000円 ( 直接経費:3200000円 、 間接経費:960000円 )

    本研究では、TLE-AE患者から得られた髄液検体及び切除脳検体を用いた網羅的解析を行い、TLE-AEの背景疾患の解明及び適切な治療法の開発を目指している。
    これまで20名以上の患者の収集に成功している。扁桃体腫大を伴う側頭葉てんかん患者に対し、プロトコールに則り画像検査、髄液検査などの検査を施行し、炎症所見を認めた患者に対して適切な免疫治療を行っている。抗LGI1抗体や抗GAD抗体などの特定の自己抗体が検出され免疫治療が奏功した症例も存在し、全体に占める辺縁系脳炎の割合は高くないものの一定数存在していることが想定される。扁桃体腫大を伴いてんかんを主徴として慢性に経過する症例では、適切な診断をうけていない患者がまだ存在する可能性が考えられ、引き続き患者の収集、解析を続ける予定である。
    一方で、髄液などに異常所見がなく、少量の抗てんかん薬でコントロール良好な症例も存在した。もともと扁桃体腫大を伴う側頭葉てんかんは、難治性の側頭葉てんかん患者より発見されてきた経緯があるが、実際には難治ではない症例でも扁桃体腫大を認める症例も散見することも確認された。当初より背景病態は多岐にわたることが推測されていたが、さらにコントロール良好なてんかん患者で扁桃体腫大を認める症例についても積極的にデータを収集し、背景疾患の解明に務める。
    また、外科的切除はまだ施行に至っていないが、今後手術を検討している症例が存在し、検体が得られればさらに病理学的評価を行う予定である。

    researchmap

  • 脊髄小脳失調症42型疾患修飾治療開発と光遺伝学的手法を用いた病態基盤の解明

    研究課題/領域番号:21K07298  2021年4月 - 2024年3月

    日本学術振興会  科学研究費助成事業 基盤研究(C)  基盤研究(C)

    土井 宏, 竹内 英之, 田中 章景, 石川 太郎, 國井 美紗子

      詳細を見る

    配分額:4160000円 ( 直接経費:3200000円 、 間接経費:960000円 )

    申請者らは研究対象としてきた常染色体優性脊髄小脳失調症(SCA)大家系において、新型DNAシーケンサーを用いて低電位活性化型のT型電位依存性カルシウムチャネル(VGCC)の一種であるCaV3.1をコードするCACNA1Gのミスセンスバリアント、p.Arg1715His(R1715H) を同定した。単一アミノ酸のミスセンスバリアントであるR1715Hにより実際に神経変性が惹起されるかは不明であり、申請者らはその証明には動物モデルの作成が必須であると考え、R1715Hと同等のR1723HバリアントをCRISPR/Cas9を用いたゲノム編集により導入したノックインマウス(Cacna1g_R1723H_KIマウス)を作成した。これまでに申請者らは構造モデリング、ヒト病理検体解析、培養細胞実験を継続するとともにCacna1g_R1723H_KIマウスの多面的解析を行い、このバリアントによるタンパク質凝集性には変化がないこと、行動解析において患者と同様の緩徐進行性の失調症状を示すこと、プルキンエ細胞(PC)の進行性変性を呈すること、PCおよび下オリーブ核神経細胞がカルシウム電流異常を含む電気生理学的異常を呈することを示し、SCA42の表現型を良好に再現するモデルを確立してきた。本研究ではCacna1g_R1723H_KIマウスにT型VGCC修飾薬の投与を行い、その効果を表現型解析、病理学的解析、RNA発現解析など多面的に検証することにより、新たな疾患修飾治療法を開発し疾患克服への道筋をつけること、また光遺伝学的手法を用いて神経変性の病態基盤をin vivoのレベルで解明することを目的とする。

    researchmap

  • 新規イントロンリピート病CANVASの病態解析モデルの構築

    研究課題/領域番号:21K07440  2021年4月 - 2024年3月

    日本学術振興会  科学研究費助成事業 基盤研究(C)  基盤研究(C)

    田中 章景, 土井 宏, 竹内 英之

      詳細を見る

    配分額:4160000円 ( 直接経費:3200000円 、 間接経費:960000円 )

    我々は、本研究を通じ、RFC1遺伝子のイントロン領域のリピート異常に起因するCerebellar ataxia, neuropathy, vestibular areflexia syndrome(CANVAS)の病態解明をめざしている。本年度は、CANVASの原因となる病的リピート(AAGGG)n, (ACAGG)n、非病的リピート(AAAAG)nを含むベクターの作成と、これらを発現させた培養細胞におけるRNA fociの形成を確認することを目的とした。異常伸長リピートは通常のPCR法では検出困難であるが、申請者らは条件検討を重ねた結果、160リピートのAAGGG (CCCTT)160 、260リピートのACAGG (CCTGT)260、9リピートのAAAAG (CTTTT)9を含むベクターの構築に成功した。そして、これらをNeuo2A細胞に発現させ、(AAGGG)5-locked nucleic acid (LNA)プローブ、(ACAGG)5-LNAプローブを用いて、fluorescent in situ hybridization (FISH) 法を施行した。その結果、(ACAGG)5-LNAプローブにより(CCTGT)260発現細胞において核周囲のRNA foci形成を確認した。同様に(AAGGG)5-LNAプローブは特異的に(CCCTT)160発現細胞のRNA fociを同定した。また、各々のプローブがcross reactivityを示さないことも確認した。両プローブとも、非病的リピートである(CTTTT)9発現細胞においてはRNA fociは見られなかった。また、RNA fociはRNase A処理で見られなくなったことより、これらの封入体がRNAで構成されていることが確認された。これらの結果は、CANVASの病態にRNA凝集によるRNA毒性が関与していることを示唆するものであると考えられた。

    researchmap

  • ミクログリアRIPK1の解析に基づくアミロイド‐タウ連関解明と新規治療法の開発

    研究課題/領域番号:21K07420  2021年4月 - 2024年3月

    日本学術振興会  科学研究費助成事業 基盤研究(C)  基盤研究(C)

    勝元 敦子, 竹内 英之, 田中 章景

      詳細を見る

    配分額:4160000円 ( 直接経費:3200000円 、 間接経費:960000円 )

    アルツハイマー病(Alzheimer’s disease;AD)の病態を特徴づける病理所見として、神経細胞内の異常リン酸化タウ凝集(タウ病理)とアミロイドβ(Aβ)の細胞外沈着(アミロイド病理)が挙げられる。近年、疾患関連ミクログリア(disease-associated microglia)と呼ばれるミクログリアの特異なサブタイプがRIPK1(receptor interacting protein 1 kinase)依存性に産生され、神経炎症を惹起しアミロイド病理を増悪させることが報告されている。一方、我々はRIPK1の機能を抑制する分子TAK1(Transforming growth factor (TGF)-β-activated kinase 1)が、タウ蓄積AD動物モデルで神経炎症に対し保護的に作用する実験結果を得たことから、RIPK1によるアミロイド病理とタウ病理の関連を考えた。本研究では、RIPK1のタウ病理への影響およびADの病態形成への関与を明らかにし、RIPK1による神経炎症を抑制することで、アミロイド病理、タウ病理の両者を制御するADの新たな治療法開発への展開を目指している。
    <BR>
    アミロイド蓄積モデルにおいてミクログリア特異的TAK1除去により、RIPK1発現、ミクログリア活性、アミロイド沈着に関して免疫組織学的検討を行った。RIPK1発現はコントロール群と変化なかった。タウ蓄積モデルでTAK1が神経炎症に保護的に作用したのに対し、アミロイド蓄積モデルでは、TAK1除去群でミクログリア活性およびアミロイド沈着が軽減し、相反する結果となった。

    researchmap

  • LOTUSによる神経変性と炎症の制御に基づく多発性硬化症の画期的な治療法開発

    研究課題/領域番号:20K07761  2020年4月 - 2023年3月

    日本学術振興会  科学研究費助成事業 基盤研究(C)  基盤研究(C)

    高橋 慶太, 竹内 英之, 田中 章景

      詳細を見る

    配分額:4290000円 ( 直接経費:3300000円 、 間接経費:990000円 )

    我々はこれまでにNogo受容体の内在性アンタゴニストとして機能するLOTUSが多発性硬化症の病勢悪化に関連して発現の低下をきたし、その結果、多発性硬化症患者において緩除に進行する機能障害の主たる原因である軸索変性を促進させることに係わっていることを明らかにしてきた。これに加え、神経機能分子のLOTUSが神経系の細胞だけでなく免疫細胞であるリンパ球においても作用し、炎症病態に関連すること、さらには抹消の免疫細胞だけでなく中枢神経系の免疫担当細胞であるミクログリアにも作用し、MSの重要な病態である中枢神経炎症にも係わる可能性を突き止めつつある。本研究では神経機能分子であるLOTUSが抹消のリンパ球へ作用して炎症性サイトカインの変動に係わっていることに加え、ミクログリアに対してもLOTUSが結合することまで突き止めた。そしてその過程において非常に興味深い知見も得られている。リンパ球、マイクログリアに発現しているNogo受容体がLOTUSの生理活性を発揮するターゲット分子であると考えられており同様の報告が複数あるが、本研究ではNogo受容体の欠損マウスを用いて解析を行ったところ、LOTUSの結合・生理活性を示唆する結果が得られ、Nogo受容体とは異なるまったく別の重要なターゲット分子の存在が示唆された。これらの分子の同定・解析も含め、引き続きLOTUSを主軸としたMSの病態機序解明と画期的な治療法の開発を進めていく

    researchmap

  • VRと運動学習転移を用いたパーキンソン病における新しい運動訓練の開発

    研究課題/領域番号:20K11160  2020年4月 - 2023年3月

    日本学術振興会  科学研究費助成事業 基盤研究(C)  基盤研究(C)

    上田 直久, 岸田 日帯, 田中 章景

      詳細を見る

    配分額:4420000円 ( 直接経費:3400000円 、 間接経費:1020000円 )

    パーキンソン病(PD)のリハビリテーションには一般的に確立したプロトコールが存在しない.これは,PDでは振戦,筋強剛,動作緩慢,姿勢反射障害など,様々な運動障害を認めるために一定した方法を確立することが困難なためである.一方,健常者,スポーツマンに対する筋力トレーニング,脳卒中患者などにおけるリハビリテーションでは,近年Virtual Reality(VR)技術を用いた運動訓練の報告が増えており,効果が示されている.PDにおけるVRリハビリテーションは少数報告されているが,歩行バランス訓練がほとんどであり,PDで障害を受けやすい巧緻運動を含め,幅広い運動障害に対応できていない.本研究では,PDにおける上肢巧緻運動障害に対するVRリハビリテーションの効果を明らかにする.また,一つの運動に対するVRリハビリテーションの効果が他の運動の改善にも波及する運動学習転移効果についても検討する.さらに神経機能画像も併せて検討し,VRリハビリテーション効果発現のメカニズムについての解剖学的背景を解析する.
    令和2年の目標は,当初は以下であった.
    1.PD患者をリクルートする.各参加者のプロフィールなどの基本データを収集する.参加者はVRリハビリテーションによる運動改善度,運動学習転移度を評価する.
    2.神経専門医がPD患者の症状をMDS-UPDRSに従って定量化する.PDの運動障害度とVRリハビリテーション効果との関連性を明らかにする.
    3.VRリハビリテーション前のMRIにおけるvoxel based morphometryや,リハビリテーション前後の脳血流シンチでの血流分布変化を測定する.Experiment 1で得られる運動改善度やExperiment 2で得られる運動学習転移度との相関を検討する事により,VRリハビリテーション効果やその運動転移効果の解剖学的関連部位を明らかにする.

    researchmap

  • 孤発性ALS病態形成におけるDEAD box RNA helicaseの役割解明

    研究課題/領域番号:19K07845  2019年4月 - 2022年3月

    日本学術振興会  科学研究費助成事業 基盤研究(C)  基盤研究(C)

    多田 美紀子, 土井 宏, 竹内 英之, 田中 章景

      詳細を見る

    配分額:4290000円 ( 直接経費:3300000円 、 間接経費:990000円 )

    我々がポリグルタミン凝集体結合蛋白質(PAIP)として同定してきたFUS/TLS、EWS、TAF15、ubiquilin2、matrin3は、PAIPとしての重要性に留まらず、筋萎縮性側索硬化症(ALS)/前頭側頭葉変性症(FTLD)の責任遺伝子がコードするタンパク質であることが次々と判明している。このことはPAIP解析が、種々の神経変性疾患関連タンパク質の同定にも繋がる優れた方法であることを示している。本研究は、独自の凝集体精製法と質量解析を組み合わせた「凝集体プロテオーム解析」で同定したPAIPを対象に病理学的な解析を行い、我々がALS/FTLD病態関連分子候補として新規に同定したDEAD box RNA helicaseであるDDX5/17に着目したものであり、極めてオリジナリティーの高い研究である。我々は未発表PAIPのうちDDX5/17が孤発性ALS脊髄前角細胞の細胞質で異常蓄積していることを確認している。本研究では孤発性ALS連続剖検例を用いた詳細な免疫組織学的解析を行うことで、孤発性ALSにおけるDDX5/DDX17凝集の局在、特徴、重要性を明らかにする。また培養細胞(Neuro2a細胞、NSC34細胞)において、DDX5/DDX17が変性疾患病因タンパク質(ポリグルタミンタンパク、TDP-43、FUS/TLS)の凝集に与える影響を蛍光顕微鏡で観察・定量し、凝集の相互関係を検討する。NSC34細胞でTDP-43の野生型・変異型、DDX5/DDX17の過剰発現、ノックダウンを行い、マイクロアレイによってmiRNAのプロファイリングを施行することで、孤発症例でみられるmiRNA発現パターンの変化と比較検討する。また孤発性・家族性ALS患者におけるDDX5/DDX17を含めたPAIP遺伝子の変異検索を行う。

    researchmap

  • 神経核内封入体病(NIID)の原因遺伝子同定と病態解明

    研究課題/領域番号:19H03577  2019年4月 - 2022年3月

    日本学術振興会  科学研究費助成事業 基盤研究(B)  基盤研究(B)

    曽根 淳, 田中 章景, 吉田 眞理, 松本 直通

      詳細を見る

    配分額:17680000円 ( 直接経費:13600000円 、 間接経費:4080000円 )

    神経核内封入体病 (Neuronal intranuclear inclusion disease : NIID)の原因遺伝子を同定するため、学会発表などを通じて、疾患概念および皮膚生検の有用性の啓発を行いながら、NIIDが臨床的に疑われる患者に対し、皮膚生検を行い、NIID病理診断例、特に家系例を蓄積し、自然歴を含めた病態を詳しく検討した。
    並行して、NIID家系例の原因遺伝子探索研究を継続し、それまでのマイクロサテライトマーカーを用いた連鎖解析結果、ショートリード型次世代シークエンサーでの解析結果およびSNV情報を元に検討した連鎖解析結果を参考にしながら、ロングリード型次世代シークエンサーを用いた解析を軸に、NIIDの原因遺伝子の探索を進めた。その結果、Oxford nanoporeシークエンサーでの解析により、NIIDの原因遺伝子がNOTCH2NLC遺伝子上のGGCリピート配列の延長であることが明らかとなった。さらに孤発性NIID症例の遺伝子についても、NOTCH2NLC遺伝子のGGCリピート配列の延長を認めた。また、De NovoでのNOTCH2NLC遺伝子上のGGCリピート配列の延長も確認できたことから、臨床上は孤発性NIIDの様相を呈していても、NOTCH2NLC遺伝子上のGGCリピート配列の延長によりNIIDが発症することが明らかとなった。
    さらに、NOTCH2NLC遺伝子のGGCリピートが延長することによって、核内封入体が形成されるまでの過程の解明、その構成タンパク質の解析など、NIIDの分子生物学的な病態の解明、さらには根本的な治療法の開発につながる研究を推進している。

    researchmap

  • 脊髄小脳失調症新規モデルマウスを用いた病態解明と治療法開発

    研究課題/領域番号:18K07503  2018年4月 - 2021年3月

    日本学術振興会  科学研究費助成事業 基盤研究(C)  基盤研究(C)

    土井 宏, 竹内 英之, 田中 章景, 國井 美紗子

      詳細を見る

    配分額:4290000円 ( 直接経費:3300000円 、 間接経費:990000円 )

    電位依存性カルシウムチャネル(Voltage-gated calcium channels: VGCCs)は、多彩なアイソフォームを持ち、各種VGCCs変異は精神疾患やてんかん症候群、家族性片麻痺性片頭痛などの発作性疾患、脊髄小脳失調症(SCA)などの変性疾患に至るまで、広範囲にわたる神経系疾患の発症と関連している。申請者らは研究対象としてきた常染色体優性SCA家系において、CACNA1G変異、R1715Hを同定した。CACNA1Gは低電位活性化型のT型VGCCsの一種であるCaV3.1をコードしており、様々な細胞機能に関与するが、変異によりどのようなメカニズムで神経変性をきたすのかは全く不明である。本研究ではCACNA1GのR1715H変異をゲノム編集により導入・作成したノックインマウス(Cacna1g_R1723H_KIマウス)を行動面、病理学的側面、電気生理学的側面から多面的に解析することで、CACNA1G変異SCAモデルマウスを確立すること、またT型VGCC修飾薬を用いた、新たなSCA治療法を開発することを目的としている。
    本年度は①Cacna1g_R1723H_KIマウスの行動解析・モデルマウスとしての確立、②Cacna1g_R1723H_KIマウスの病理学的・生化学的解析、③Cacna1g_R1723H_KIマウスの電気生理学的、④Cacna1g_R1723H_KIマウスのVGCC機能修飾薬の効果の確認、の4つの研究を行っている。
    ①~③については、「現在までの進捗状況」に示す通り、ほぼ終了しており、モデルマウスを確立した状況である。来年度以降、④に軸足を移した研究を継続している。

    researchmap

  • 神経再生機能分子LOTUSによるALS の治療法開発

    研究課題/領域番号:18K07532  2018年4月 - 2021年3月

    日本学術振興会  科学研究費助成事業 基盤研究(C)  基盤研究(C)

    田中 章景, 高橋 慶太, 土井 宏, 竹内 英之

      詳細を見る

    配分額:4420000円 ( 直接経費:3400000円 、 間接経費:1020000円 )

    筋萎縮性側索硬化症(ALS)の神経変性は、運動ニューロン軸索遠位端のシナプスより軸索変性が始まり、細胞体へと進行していくdistal axonopathyの様式をとる。この分子病態を、ミエリン関連神経突起伸長阻害因子(MAIs)の一つであるNogoとその受容体であるNgR1を介するシグナル伝達が増強することから、Nogoに対するモノクローナル抗体(ozanezumab)の臨床応用が行われたが、第II相試験での有効性は示されなかった。しかし、NgR1はニューロンだけでなくミクログリアやTリンパ球にも発現しており、このシグナル系が中枢神経の炎症を惹起し、ALSにおける非自律性神経変性に関わると考えられる。そこで、我々はNogoを含むNgR1のすべてのリガンドとの結合を阻害し軸索伸長を促進するとともに、ミクログリア、Tリンパ球にも作用する新規神経再生機能分子LOTUSに着目した。本研究では、LOTUS遺伝子改変動物、リコンビナントLOTUSを駆使し、「神経変性」と「神経炎症」を同時に制御しうるALSの画期的な新規治療法の開発と病態解明を行う。平成30年度は、ALSモデルである変異SOD1(G93A)マウスとLOTUS欠損マウスの交配を行い、ロタロッドテスト、ワイヤーハングテストによる運動機能解析を進めている。preliminaryではあるが、LOTUS欠損変異SOD1(G93A)マウスは、17-18週頃より、運動機能の低下が見られ始めており、変異SOD1(G93A)マウスに比べて運動機能低下の速度が速い傾向にある。一方、LOTUS過剰発現SOD1(G93A)マウスにおいては、変異SOD1(G93A)マウスに比べて運動機能障害の進行が遅い傾向にある。現在のところ、ほぼ仮説通りの運動機能を呈しているが、今後さらに例数を増やし週齡を追っていきたい。

    researchmap

  • 生体恒常性センサーである単球系細胞の制御に基づく神経変性疾患の画期的な治療法開発

    研究課題/領域番号:18K07531  2018年4月 - 2021年3月

    日本学術振興会  科学研究費助成事業 基盤研究(C)  基盤研究(C)

    竹内 英之, 土井 宏, 田中 章景

      詳細を見る

    配分額:4420000円 ( 直接経費:3400000円 、 間接経費:1020000円 )

    本研究では、アルツハイマー病および筋萎縮性側索硬化症(ALS)のモデルマウスを用いて、神経変性疾患の病態における神経系・免疫 系・血液系の単球系細胞の役割を明らかにし、新たな診断・治療への展開を図ることを目的としている。本研究の初年度は、神経疾患における神経系・免疫系・血液系の単球系細胞の弁別可視化計測のために、組織マクロファージに緑色蛍光を発現させるCX3 CR1-EGFPノックインマウス(Jungら, Mol Cell Biol, 2000)と、骨髄由来マクロファージに赤色蛍光を発現させるCCR2-RFPノックインマウス(Saederupら, PLoS One, 2010)を、筋萎縮性側索硬化症モデルマウスであるヒト変異superoxide dismutase1(SOD1)マウスと交配することで、ミクログリアなどの組織マクロファージは緑色細胞として、炎症などの病態下で組織浸潤する骨髄由来マクロファージは赤色細胞として、生体内分別や分離採取が可能となるALSモデルマウスを作出した。また、認知症モデルマウスとして、現在、神経特異的薬剤誘導性TDP-43コンディショナルノックアウトマウスにおいても、同様の交配によって、ミクログリアなどの組織マクロファージは緑色細胞として、炎症などの病態下で組織浸潤する骨髄由来マクロファージは赤色細胞として、生体内分別や分離採取が可能となるマウスを作出しつつある。今後、神経系・免疫系・血液系の組織マクロファージと循環マクロファージを経時的に弁別採取し、遺伝子発現およびタンパク発現プロファイルの網羅的解析および機能解析を行う予定である。

    researchmap

  • Loss of functionモデルに基づいたUBQLN2の機能解析

    研究課題/領域番号:18K07504  2018年4月 - 2021年3月

    日本学術振興会  科学研究費助成事業 基盤研究(C)  基盤研究(C)

    田中 健一, 土井 宏, 竹内 英之, 田中 章景

      詳細を見る

    配分額:4420000円 ( 直接経費:3400000円 、 間接経費:1020000円 )

    UBQLN2は家族性筋萎縮性側索硬化症(FALS)の責任遺伝子として同定され、ユビキチン-プロテアソームシステム(UPS)を含む多様な細胞機能に関わることが知られている。しかし、変異から疾患発症にいたる病態機序は不明な点が多い。既報告でUbqln2トータルノックアウトラット・マウスは無症状であることが示されたが、近年UBQLN2変異によって、シャペロン結合性が低下し、凝集体処理能低下をきたすとの報告がなされ、UBQLN2の機能喪失が病態にかかわることが強く示唆されている。哺乳類においてUBQLNは1-4のアイソフォームが存在し、特にUBQLN1との相同性が高いことから、我々はこれまでのトータルノックアウトモデルではGene redundancyのため表現型が出現しなかった可能性があると考えている。我々はCre‐loxP systemを用いて、Ubqln2コンディショナルノックアウトマウス、すなわち、全身または神経細胞でのUbqln2のノックアウト、薬剤誘発によるUbqln2ノックアウトといった複数の系統の作成を行っている。現在Actb-Creマウスとの交配によるトータルノックアウト、Tubb3-Creとの交配による神経特異的ノックアウト、Tamoxifen誘導下に、③UBCプロモーター下 (UBC-cre/ERT2)および④Thy1.2プロモーター下(Thy1-cre/ERT2,-EYFP)にCreを発現するマウスとの交配をおこなっている。2018年度は①、②のマウスに対して運動機能評価としてwire hang test、rotarod testなどの行動解析を行っている。神経特異的コンディショナルノックアウトマウスはlitter mateの非ノックアウトマウスと比較して運動機能が低下傾向である結果が得られている。③、④についてはマウスの系統を確立中である。

    researchmap

  • 多系統萎縮症における低尿酸血症による病態解明

    研究課題/領域番号:17K09805  2017年4月 - 2020年3月

    日本学術振興会  科学研究費助成事業 基盤研究(C)  基盤研究(C)

    児矢野 繁, 田中 章景, 多田 美紀子

      詳細を見る

    配分額:4680000円 ( 直接経費:3600000円 、 間接経費:1080000円 )

    多系統萎縮症患者の発症年齢,罹病期間,予後などの臨床所見を解析し,尿酸トランスポーター遺伝子多型の臨床的特徴を検討した.対象はMSAの診断基準を満たしている患者160例(男82例、女78例)で発症年齢は41-86歳(平均61.1歳)、経過は1-23年(平均5.8年)、病型別にはMSA-Cが100例、MSA-Pが60例であった。これらの症例の血清の尿酸値および髄液の尿酸値と臨床的な関連性、さらに比較および疾患対照群としてパーキンソン病(PD)100例及びその他の変性疾患群(PSP, CBD, ALS)50例における血清および髄液の尿酸値を検討した。
    【結果】MSAの血清尿酸値は160例中48例(30%)で低値を示した。このうち血清尿酸値が2mg/dl以下は15例(9.4%)であった。血清尿酸値は経過が長いほど、障害の程度が強いほど低値を示した。髄液の尿酸値では有意差はないもののMSAにおいて低い傾向が認められた。MSAの病型別の検討では血清尿酸値の頻度はMSA-Cで100例中26例(26%)(2mg/dl以下は5例(5%)), MSA-Pで60例中22例(37%)(2mg/dl以下は10例(17%))と明らかにMSA-Pのほうが血清尿酸値は低い傾向を示していた.その他の変性疾患ではPDで100例中33例(33%)と血清尿酸値は低い傾向にあり、MSAと同等であった。他の疾患群では血清尿酸値の異常は認められなかった。MSAでは血清尿酸値は経過とともに低くなる傾向にあり、特にMSA-Pで顕著であった。パーキンソン病でも血清尿酸値が低い傾向にあることから,パーキンソン病とMSA-Pの低尿酸血症には共通の要因が関連している可能性があることがわかった.

    researchmap

  • ALSにおけるポリグルタミン凝集体結合タンパク質DDX-17異常蓄積の病態解明

    研究課題/領域番号:17K14956  2017年4月 - 2019年3月

    日本学術振興会  科学研究費助成事業 若手研究(B)  若手研究(B)

    多田 美紀子, 田中 章景, 土井 宏, 竹内 英之, 児矢野 繁

      詳細を見る

    配分額:4290000円 ( 直接経費:3300000円 、 間接経費:990000円 )

    我々がポリグルタミン凝集体結合蛋白質(PAIP)として同定したタンパク質はALS/FTLDの病因タンパク質でもあることが次々と判明している。そこで未発表PAIPのうちDEAD box RNAヘリカーゼであるDDX17に着目しALS病態への関与について検討した。孤発性ALS剖検例を抗DDX17抗体で免疫組織学的に評価し腰髄前角細胞の細胞質にDDX17が微細顆粒状に凝集することを見出した。さらにこの顆粒状凝集は小胞体マーカーGRP78、PDIと共局在していることを示した。以上よりDDX17は孤発性ALSにおいて運動ニューロン内で小胞体に蓄積することでALSの病態に関与している可能性が示唆された。

    researchmap

  • 電位依存性カルシウムチャネル関連疾患の分子病態基盤の解明

    研究課題/領域番号:17K16128  2017年4月 - 2019年3月

    日本学術振興会  科学研究費助成事業 若手研究(B)  若手研究(B)

    國井 美紗子, 田中 章景, 松本 直通, 土井 宏, 橋口 俊太, 大場 ちひろ

      詳細を見る

    配分額:4160000円 ( 直接経費:3200000円 、 間接経費:960000円 )

    我々はWest症候群およびRett症候群様の発達障害など重度発達障害を呈した患者から,3種類のCACNA1G変異を同定し,変異型及び野生型のCav3.1につき培養細胞を用いて電気生理学的挙動を検証していた.3種類のうち2種類は2018年に白人の小児患者より報告がなされ,我々の変異も病的であることが確かめられた.電流-電圧曲線やactivation curveなどの基本的な電気生理学的挙動については既報告と同様の挙動を示した.さらに既報告では検証されていなかった共振についても検討を追加した.我々の研究はCACNA1G変異による多様な病態の解明の一助となりうる。

    researchmap

  • 3次元運動解析装置を利用した小脳性運動失調の他覚的評価法の確立

    研究課題/領域番号:16K09727  2016年4月 - 2019年3月

    日本学術振興会  科学研究費助成事業 基盤研究(C)  基盤研究(C)

    上田 直久, 東山 雄一, 田中 章景, 児矢野 繁

      詳細を見る

    配分額:4810000円 ( 直接経費:3700000円 、 間接経費:1110000円 )

    指鼻試験に関して3D運動解析を行った.
    ①指鼻試験に関して,第2指と目標物の相対速度を算出したところ,脊髄小脳変性症患者では,目標物まで直近の時点でも速度が軽度上昇する傾向を認めた.健常者およびパーキンソン病患者では,目標物直近では速度が低下する傾向であった.②指鼻試験における第2指と目標物の相対加速度を算出したところ,脊髄小脳変性症患者では,目標物まで近距離の時点でも加速度が軽度上昇する傾向を認めた.健常者およびパーキンソン病患者では,目標物直近では加速度が低下する傾向であった.

    researchmap

  • 表情定量解析に基づくパーキンソン病の仮面様顔貌の病態解明

    研究課題/領域番号:16K19517  2016年4月 - 2018年3月

    日本学術振興会  科学研究費助成事業 若手研究(B)  若手研究(B)

    東山 雄一, 児矢野 繁, 土井 宏, 田中 章景

      詳細を見る

    配分額:3900000円 ( 直接経費:3000000円 、 間接経費:900000円 )

    パーキンソン病(PD)でみられる仮面様顔貌が,認知情動機能障害や運動症状とどう関連しているのかを明らかにするため,motion capture技術を応用した表情解析を用いPDの表情変化を定量化し,認知・情動機能,運動スコアとの比較検討を行った. PD 38例と健常者24例を対象に解析を行った結果,PD群で表情変動が有意に減少していた.また,表情変動減少は注意・遂行機能を中心とした心理検査,抑うつ症状と関連を認め,安静時fMRI解析の結果,表情変動減少は前頭葉を中心とした機能的結合性の変化と関連していた.以上より,仮面様顔貌は認知情動障害と関連したより高次の症候である可能性が示唆された.

    researchmap

  • 多発性硬化症の神経障害における病態解明と新規治療法の開発

    研究課題/領域番号:16K19518  2016年4月 - 2018年3月

    日本学術振興会  科学研究費助成事業 若手研究(B)  若手研究(B)

    高橋 慶太, 竹居 光太郎, 田中 章景

      詳細を見る

    配分額:3900000円 ( 直接経費:3000000円 、 間接経費:900000円 )

    神経機能分子LOTUSの免疫系における機能と神経系における動態を明らかにした。免疫系においては、LOTUSが結合するリンパ球上の未知の分子Xがサイトカインの分泌に係わることで多発性硬化症の病態に関与していることを明らかにし、神経系では多発性硬化症の神経炎症惹起よるLOTUSの発現変動をmRNAレベルで明らかにし、炎症が神経変性を引き起こす機序の一端を突き止めた。さらに、プロテオミクス解析を行い未知の分子Xの候補を同定した。これらの結果は免疫系と神経系の両面から統合した治療行うための治療ターゲットを提示することにつながり、これまでにない新たな治療法開発につながる大きな成果である。

    researchmap

  • 脊髄小脳変性症の遺伝背景の解析と新規遺伝子同定に基づく病態解明

    研究課題/領域番号:15K09344  2015年4月 - 2018年3月

    日本学術振興会  科学研究費助成事業 基盤研究(C)  基盤研究(C)

    土井 宏, 田中 章景, 田中 健一, 國井 美紗子, 松本 直通, 石川 欽也

      詳細を見る

    配分額:4680000円 ( 直接経費:3600000円 、 間接経費:1080000円 )

    本研究は、既知責任遺伝子に変異を認めない家族例、孤発例の脊髄小脳変性症(spinocerebellar degeneration: SCD)のエクソーム解析を通して、SCDの新規責任遺伝子を解明することを目的とした。
    我々は常染色体優性遺伝家系において、電位依存性カルシウムチャネルCACNA1Gのミスセンス変異を同定した。しかしCACNA1G変異例については我々の研究実施中に他グループから論文報告がなされたため、病理所見を中心に論文を作成中である。また、劣性遺伝性家系、孤発性SCD例の解析では、3家系4名においてこれまでにほとんどSCDの原因として報告のないERCC4変異を同定し報告した。

    researchmap

  • 血液で神経障害を検出する方法の開発

    研究課題/領域番号:15K14353  2015年4月 - 2017年3月

    日本学術振興会  科学研究費助成事業 挑戦的萌芽研究  挑戦的萌芽研究

    竹居 光太郎, 田中 章景, 栗原 裕司

      詳細を見る

    配分額:3900000円 ( 直接経費:3000000円 、 間接経費:900000円 )

    多発性硬化症の病態を反映した有用なバイオマーカーの開発を目的とし、血液中に含まれるLOTUSの検出・定量を試みた。最初に血液中に分泌されるLOTUSのC末端領域の特異的配列を解析し、切断部位の位置を同定して7種の断片を見いだした。その7種の断片ペプチドを作製してMRM法にて検出感度を測定したところ、検出感度がMRM法に適用可能な1種の断片を見いだした。一方、ELISA法に供するためのLOTUSに対する特異抗体作製に必要な抗原ペプチドを同定し、その抗原ペプチドを用いて作製したモノクローナル抗体を用いてウエスタンブロッティング法によって血液中に含まれる微量なLOTUSの検出に成功した。

    researchmap

  • ALS/FTLDにおけるポリグルタミン凝集タンパク質の解析

    研究課題/領域番号:15K18367  2015年4月 - 2017年3月

    日本学術振興会  科学研究費助成事業 若手研究(B)  若手研究(B)

    多田 美紀子, 土井 宏, 児矢野 繁, 田中 章景

      詳細を見る

    配分額:4290000円 ( 直接経費:3300000円 、 間接経費:990000円 )

    ポリグルタミン(polyQ)凝集体蛋白質(PAIP)の一部は筋萎縮性側索硬化症(ALS)や前頭側頭葉変性症(FTLD)の責任遺伝子やタンパク質凝集に関与する因子であることが判明してきている。このことはALS/FTLDとpolyQ病の変性過程に共通メカニズムが働いている可能性を示している。剖検組織の病理学的検討で新規ALS病態関連分子同定を目的とした。我々はPAIPの一つであるMatrin3が孤発性ALSにおいて細胞質内封入体の構成成分であることを示した。Matrin3はその遺伝子変異が家族性ALSの責任遺伝子であることが判明したが、孤発性ALSの病態にも広く関わっていることが示された。

    researchmap

  • ポリグルタミン病におけるカルシウムシグナリングの解明

    研究課題/領域番号:26461315  2014年4月 - 2017年3月

    日本学術振興会  科学研究費助成事業 基盤研究(C)  基盤研究(C)

    児矢野 繁, 田中 章景, 多田 美紀子

      詳細を見る

    配分額:4940000円 ( 直接経費:3800000円 、 間接経費:1140000円 )

    本研究の目的はポリグルタミン病とカルシウムシグナリング異常の関連性を明らかにすることである。
    ポリグルタミン病は原因たんぱく質がカルシウムシグナリングの異常を引き起こし、細胞死へと向かわせる働きがあることが知られている。ポリグルタミン病とカルシウムチャネルの関連性を明らかにするために、CACNA1Aカルシウムチャネルが病態形成に関わることを明らかにし、病因蛋白と結合するカルシウムチャネルサブタイプを同定した。ポリグルタミン病の脳各部位におけるカルシウムチャネルのサブタイプやカルシウム結合蛋白質の発現分布から神経変性に対する抵抗性や脆弱性を示し、各種ポリグルタミン病の選択的病変の有無を確認した。

    researchmap

  • 多発性硬化症における新規バイオマーカーLOTUSの開発と病態の解明

    研究課題/領域番号:26670444  2014年4月 - 2016年3月

    日本学術振興会  科学研究費助成事業 挑戦的萌芽研究  挑戦的萌芽研究

    鈴木 ゆめ, 田中 章景, 岸田 日帯, 竹居 光太郎

      詳細を見る

    配分額:3640000円 ( 直接経費:2800000円 、 間接経費:840000円 )

    患者の脳脊髄液からLOTUS濃度を測定する手法を確立し、その濃度の変動が多発性硬化症の病勢に一致することを明らかにした。多発性硬化症の病勢診断は既存の検査では難しく、臨床応用につながる大きな成果である。また、多発性硬化症のモデルマウスを用いて髄液中のLOTUSの変動が中枢神経の発現の変動に起因していることを証明し、バイオマーカーとして重要であるその機序の一端を明らかにした。さらに、精度の高いモノクローナル抗体を用いた手法で血液検体からもLOTUSの検出に成功し、血液バイオマーカーの開発に向けた重要な基盤を構築した。

    researchmap

  • ポリグルタミン病におけるRNA結合蛋白の解析

    研究課題/領域番号:26670445  2014年4月 - 2016年3月

    日本学術振興会  科学研究費助成事業 挑戦的萌芽研究  挑戦的萌芽研究

    田中 章景, 土井 宏, 児矢野 繁, 多田 美紀子

      詳細を見る

    配分額:3640000円 ( 直接経費:2800000円 、 間接経費:840000円 )

    我々が、凝集体プロテオーム解析により同定したポリグルタミン病核内凝集体構成タンパクの中には、RNA結合タンパクを中心に多くのものが含まれる。そこで、PCBP1, PCBP2, PCBP3, hnRNPU、hnRNP H1、hnRNP H2、hnRNP F、DDX5、DDX17、Matrin 3、SGTAについて 、各種ポリグルタミン病剖検脳における染色性を解析した。この結果、Matrin 3とSGTAが核内凝集体に認められた。このうちSGTAにはハンチントン病モデル細胞において凝集体形成を抑制する作用があることを明らかにしつつある。また、質量解析法を用いてSGTA結合タンパクを複数同定した。

    researchmap

  • 共通分子UBQLN2を通じたポリグルタミン病・ALS/FTLDの統合的病態解明

    研究課題/領域番号:25293207  2013年4月 - 2016年3月

    日本学術振興会  科学研究費助成事業 基盤研究(B)  基盤研究(B)

    田中 章景, 土井 宏, 児矢野 繁, 田中 健一, 貫名 信行

      詳細を見る

    配分額:18850000円 ( 直接経費:14500000円 、 間接経費:4350000円 )

    ALS/FTLD、ポリグルタミン病の神経細胞変性におけるUBQLN2の役割を解明することを目的とした。ALS/FTLDを起こす変異型UBQLN2に対し、野生型と異なる結合性を示す分子の同定を目指して、質量分析装置による解析を行った。この結果、変異型で結合性が低下しているタンパク質の一つとしてHsc71を同定した。また、Hsc71との結合はPXXドメインを持つUBQLN2に特異的な機能であることを明らかにした。さらに、Ubqln2flox/floxマウスとActb-Creマウスの交配で全細胞での、Tubb3-Creマウスとの交配で神経細胞でのノックアウトマウスを作成した。

    researchmap

  • 卓上型次世代シーケンサーを用いた白質脳症の遺伝子診断法の開発と遺伝的背景の解明

    研究課題/領域番号:25461287  2013年4月 - 2016年3月

    日本学術振興会  科学研究費助成事業 基盤研究(C)  基盤研究(C)

    上田 直久, 土井 宏, 田中 章景, 松本 直通

      詳細を見る

    配分額:4940000円 ( 直接経費:3800000円 、 間接経費:1140000円 )

    白質脳症の原因疾患は多岐にわたることが知られている。我々は55種類の白質脳症原因遺伝子を対象に、Agilent社SureSelectを用いたエクソンキャプチャーキットを設計し、原因不明の白質成人脳症患者60名に対して、次世代シーケンサーMiSeqを用いた塩基配列解析を行った。その結果明らかに病的と判断されるNOTCH3の遺伝子変異を4症例に認め、更に、EIF2B2およびPOLR3Aの既知変異を持つ症例を1例ずつ認めた他、複数症例で病的意義不明の変異を認めた。今回我々の解析系により成人白質脳症患者10%が確定診断に至り、8.3%で未知の遺伝子変異を持ち病態への関与が疑われる変異が同定された。

    researchmap

  • NIIDの次世代シークエンサーを用いた病因遺伝子の同定

    研究課題/領域番号:24591257  2012年4月 - 2015年3月

    日本学術振興会  科学研究費助成事業 基盤研究(C)  基盤研究(C)

    曽根 淳, 小池 春樹, 田中 章景, 森下 真一, 菅野 純夫

      詳細を見る

    配分額:5330000円 ( 直接経費:4100000円 、 間接経費:1230000円 )

    家族性NIID家系2家系および孤発性NIIDについて、次世代シークエンサーを用いた全ゲノム解析および全エクソン解析を行なった。得られたvariant情報をもとに、MERLINソフトウエアを用いた連鎖解析を行ったところ、以前行ったマイクロサテライトマーカーを用いた解析とほぼ一致した結果が得られた。この領域にNIIDの原因遺伝子が存在することはほぼ間違いないと結論した。最終的には原因遺伝子の同定には至らなかったものの、継続して検討する必要があると考えられた。また、近年認知症を主症状とした孤発性NIID例が増加してきており、研究に組み込むとともに皮膚生検により診断が可能であることを論文発表した。

    researchmap

  • ポリグルタミン病における細胞周期およびJNKシグナル異常の病態解明と治療法開発

    研究課題/領域番号:23390230  2011年4月 - 2014年3月

    日本学術振興会  科学研究費助成事業 基盤研究(B)  基盤研究(B)

    勝野 雅央, 祖父江 元, 田中 章景, 足立 弘明

      詳細を見る

    配分額:19370000円 ( 直接経費:14900000円 、 間接経費:4470000円 )

    ポリグルタミン病はCAG繰り返し塩基配列の異常延長を原因とする遺伝性神経変性疾患で、変異蛋白質が神経細胞内に集積することが中心的病態であり、治療法開発の重要なターゲットであると考えられている。本研究により、ポリグルタミン病である球脊髄性筋萎縮症(SBMA)において細胞周期調節異常およびJNK経路の異常活性化が神経変性に寄与していること、およびJNKの活性化を標的とする治療がポリグルタミンによる運動ニューロン変性を抑制することが明らかとなった。

    researchmap

  • miRNA発現調節によるポリグルタミン病の治療法開発

    研究課題/領域番号:23390231  2011年4月 - 2014年3月

    日本学術振興会  科学研究費助成事業 基盤研究(B)  基盤研究(B)

    足立 弘明, 祖父江 元, 小池 春樹, 田中 章景, 宮崎 雄

      詳細を見る

    配分額:19370000円 ( 直接経費:14900000円 、 間接経費:4470000円 )

    球脊髄性筋萎縮症(SBMA)はアンドロゲンレセプター(AR)遺伝子のCAGリピートの延長に起因する運動ニューロン病である。ヒト変異ARを発現する培養細胞とトランスジェニックマウスモデル(SBMA-Tg)を使用して、miRNA(micro-RNA)の関与を明らかにした。miR-196aを過剰発現させるAAVベクターをSBMA-Tgの筋肉に投与すると、血行性に神経系や他の筋に到達して、AR mRNAを安定化するRNA結合蛋白質であるCELF2の発現が低下して、変異ARのmRNA発現量が低下した。さらに、変異ARのモノマー及び凝集体の蓄積が脊髄や筋肉で低下してSBMA-Tgの表現型が有意に改善した。

    researchmap

  • パーソナルゲノム解析に基づくALSの疾患関連遺伝子探索と病態解明

    研究課題/領域番号:22129005  2010年4月 - 2015年3月

    日本学術振興会  科学研究費助成事業 新学術領域研究(研究領域提案型)  新学術領域研究(研究領域提案型)

    田中 章景, 土井 宏, 熱田 直樹, 祖父江 元

      詳細を見る

    配分額:51740000円 ( 直接経費:39800000円 、 間接経費:11940000円 )

    家族性ALSの網羅的遺伝子診断システムを開発し、孤発性ALS 469例について解析を行ったところ、対象とした家族性ALS関連28遺伝子のエクソン領域内で、既知の変異が14例に、新規多型が115個認められた。このうち病原性の疑われる多型は30例で計35個であった。また、孤発性ALS患者、コントロール合わせて800例のエクソームシークエンスを行い、データ解析を進めている。JaCALSの前向き臨床情報とリンクさせることで、進行・予後に関わるSNPsの同定をすすめ、少なくとも2つのSNPsにおいてminor alleleを有する患者が急速に進行することを明らかにした。

    researchmap

  • 孤発性 ALS 疾患モデルによる病態解明と治療法開発

    研究課題/領域番号:22390175  2010年 - 2012年

    日本学術振興会  科学研究費助成事業 基盤研究(B)  基盤研究(B)

    田中 章景, 祖父江 元, 勝野 雅央, 飯島 正博

      詳細を見る

    配分額:18590000円 ( 直接経費:14300000円 、 間接経費:4290000円 )

    孤発性 ALS 患者脊髄運動ニューロンにおいて、神経変性過程の初期より発現が低下しているdynactin 1 のホモログである DNC-1 の発現を運動ニューロン特異的にノックダウンした線虫モデルを作成した。その結果、軸索および細胞体の神経変性とともに高度な運動障害を呈した。さらに、変性神経細胞では、オートファゴソームの輸送障害と数の増加がみられた。オートファジーを活性化するラパマイシンと軸索輸送を改善するトリコスタチンを投与したところ、この ALS 疾患モデルの運動機能と軸索変性が著明に改善した。

    researchmap

  • 分子標的を介するポリグルタミン病の根本治療法の開発

    研究課題/領域番号:21229011  2009年5月 - 2014年3月

    日本学術振興会  科学研究費助成事業 基盤研究(S)  基盤研究(S)

    祖父江 元, 田中 章景, 足立 弘明, 勝野 雅央, 飯島 正博, 小池 春樹, 岡田 洋平, 岡野 栄之, 田中 啓二

      詳細を見る

    配分額:158730000円 ( 直接経費:122100000円 、 間接経費:36630000円 )

    球脊髄性筋萎縮症(SBMA)はアンドロゲン受容体遺伝子におけるCAG繰り返し配列の異常延長を原因とする神経変性疾患であり、変異ARが運動ニューロンの核内に集積して神経変性を惹起することが知られている。本研究により、オートファジーが病態に寄与していること、およびシャペロンとオートファジーを活性化する低分子化合物がSBMAにおける神経変性を抑制することが明らかになった。また、SBMAにおいて発現が亢進しているマイクロRNAを外因性に投与することにより、運動ニューロン変性が抑止されることが示された。

    researchmap

  • 家族性アミロイドポリニューロパチーのアミロイド沈着機構の解明と治療への応用

    研究課題/領域番号:21591076  2009年 - 2011年

    日本学術振興会  科学研究費助成事業 基盤研究(C)  基盤研究(C)

    小池 春樹, 伊藤 瑞規, 飯島 正博, 田中 章景, 祖父江 元

      詳細を見る

    配分額:4550000円 ( 直接経費:3500000円 、 間接経費:1050000円 )

    FAP ATTR Val30Metの臨床病理学的特徴の検討を行った.従来からの集積地以外にも症例が全国に分布していることが明らかになり,集積地外の症例は従来型の集積地の症例とは異なる臨床病理像および自然歴を呈することが明らかになった.また,家族歴を認めなかった症例の検討では,約半数の例が慢性炎症性多発性脱髄性根神経炎(CIDP)と診断され,治療も行われていた例も認め,早期診断,早期治療の重要性が確認された.また, FAP ATTR Val30Metは末梢神経疾患の鑑別診断のひとつであることが明らかになった.

    researchmap

  • 孤発性ALSのオートファジー機能解明と新規疾患モデルの確立

    研究課題/領域番号:21659221  2009年

    日本学術振興会  科学研究費助成事業 挑戦的萌芽研究  挑戦的萌芽研究

    田中 章景, 祖父江 元

      詳細を見る

    配分額:3100000円 ( 直接経費:3100000円 )

    我々は、孤発性ALS患者運動ニューロンで見られるdynactin1の発現低下を再現するノックダウン細胞(SH-SY5Y)モデルを構築し、病態解析を行ってきた。このモデルにおいては、autophagosomeの形成が亢進していることをLC3の発現上昇により明らかにしている。しかし、この現象はオートファジー機能が亢進している場合のみならず、autophagosome形成以降、すなわちlysosomeとの癒合によるautophagolysosomeの形成が阻害され、機能が障害されている場合にも起こりうる。このことを明らかにするために、autophagolysosomeのマーカーとしてのMDC(monodansylcadaverine)、lysosome membraneのマーカーであるlgp85および1gp120を用いて検討を行った。この結果、autophagosomeの微小管依存性の移動に障害を来たし、autophagolysosomeの形成が障害されている可能性が明らかとなった。ポリグルタミン病など他の神経変性疾患モデルにおいては、オートファジーの促進による異常タンパク分解が治療につながることが示唆されている。そこで、dynactin1ノックダウン細胞に、オートファジーを促進するrapamycinを加えたところ、細胞生存には影響を及ぼさなかった。この一因として、dynactin1の発現低下状況下では、autophagosome形成のレベルにおいて作用する薬剤を加えても、autophagolysosomeの形成が起こらないためと推定された。一方、dynactin1ノックダウン細胞において、プロテアソーム阻害剤を加え、ユビキチン陽性封入体形成の条件を探ったが、少なくともSH-SY5細胞においては封入体形成が見られなかった。今後、細胞種を変えた他の各種ストレスを加えた検討を行う必要があると考えられた。

    researchmap

  • ポリグルタミン病の分子シャペロン-UPS系を介する病態の解明と治療法の開発

    研究課題/領域番号:20390243  2008年 - 2010年

    日本学術振興会  科学研究費助成事業 基盤研究(B)  基盤研究(B)

    足立 弘明, 祖父江 元, 田中 章景, 勝野 雅央

      詳細を見る

    配分額:18590000円 ( 直接経費:14300000円 、 間接経費:4290000円 )

    異常延長したCAGリピートをもつヒトの全長のアンドロゲンレセプター(AR)遺伝子を発現する球脊髄性筋萎縮症(SBMA)トランスジェニックマウス(SBMAマウス)を用いてペオニ抽出物(PE)投与の効果を検討したところ、PEはストレス応答蛋白の発現レベルを上昇させ、変異ARの凝集体形成を有意に抑制し、ポリグルタミンによる筋力低下、自発的行動減少などの表現型を改善し生存率を大きく向上させた。

    researchmap

  • 孤発性ALSの動物モデルの開発

    研究課題/領域番号:19390238  2007年 - 2008年

    日本学術振興会  科学研究費助成事業 基盤研究(B)  基盤研究(B)

    田中 章景, 祖父江 元, 足立 弘明, 勝野 雅央, 飯島 正博, 道勇 学, 道勇 学

      詳細を見る

    配分額:18720000円 ( 直接経費:14400000円 、 間接経費:4320000円 )

    孤発性ALS患者脊髄運動ニューロンにおいて、神経変性過程の初期より発現が低下しているdynactin1の発現変化を再現する線虫モデルを作成した。このモデルでは、進行性の運動機能障害、運動ニューロン変性を認め、患者運動ニューロンで観察されたcyclin Cの発現増加、核への局在変化を再現していた。これらのことより、dynactin1ノックダウン線虫は孤発性ALSの病態、特に細胞周期関連因子の異常を反映する重要な疾患モデルであると考えられた。

    researchmap

  • エオジン好性核内封入体(NIHID)の原因遺伝子の探索・同定

    研究課題/領域番号:19659225  2007年 - 2008年

    日本学術振興会  科学研究費助成事業 萌芽研究  萌芽研究

    田中 章景, 小池 春樹, 祖父江 元, 田中 章景

      詳細を見る

    配分額:3200000円 ( 直接経費:3200000円 )

    我々が既に報告しているNeuronal intranuclear hyaline inclusion disease (NIHIDもしくはNIID:エオジン好性核内封入体病)の二大家系のDNAサンプルを用いて原因遺伝子検索を行った。マイクロサテライトマーカー(ABI PRISM Linkage Mapping Set Version2.5 MD10)、LINKAGEソフトウエアを用いた連鎖解析により、原因遺伝子の存在が予測される染色体上の部位でのLod score 5.01を得た。
    次に、この近傍の約20cMの部分について、NEDO(新エネルギー産業技術総合開発機構)から公開されているGDBS (Gene Diversity DataBase System)の情報を検索し、更に細分化して解析可能なマイクロサテライトマーカー6個を選択し、再度、パプロタイプ解析およびLINKMAPソフトウエアを用いた3点連鎖解析を行った。その結果、染色体上の約3.8Mbpといったきわめて狭い領域で、突出したLod score 4.65を示す領域を見いだし、原因遺伝子が存在する領域を絞り込むことに成功した。そして、この領域に存在する21個の遺伝子に関してプライマーを設計し、シークエンス解析により原因遺伝子および変異の同定を進めた。
    一方、これらの家系から得られた剖検サンプルを用い、核内封入体の分布、神経細胞脱落の様式、分布を明らかにし、さらに、電子顕微鏡を用いた封入体の解析、免疫染色法を用いた封入体構成成分の解析を行った。また、抽出したタンパク質サンプルを用いた二次元電気泳動および銀染色により、核内封入体構成成分の同定、発現変化を示す蛋白の同定を試みた。

    researchmap

  • ポリグルタミン病の病態抑止療法の開発

    研究課題/領域番号:19209033  2007年 - 2008年

    日本学術振興会  科学研究費助成事業 基盤研究(A)  基盤研究(A)

    祖父江 元, 田中 章景, 足立 弘明, 勝野 雅央, 道勇 学, 道勇 学

      詳細を見る

    配分額:50960000円 ( 直接経費:39200000円 、 間接経費:11760000円 )

    遺伝性運動ニューロン疾患である球脊髄性筋萎縮症(SBMA)のマウスモデルにおいて、分子シャペロンやユビキチン-プロテアソーム系の機能を増強することにより神経変性の進行が抑えられることを明らかにした。また、すでにSBMAのマウスモデルにおいて病態抑止効果が明らかとなっているアンドロゲン低下療法について、患者を対象とした第II相臨床試験を実施し、本治療法が患者においても病態を抑えることを明らかにした。

    researchmap

  • 変異SOD1によるALS病変選択性の分子機序の解明

    研究課題/領域番号:19590987  2007年 - 2008年

    日本学術振興会  科学研究費助成事業 基盤研究(C)  基盤研究(C)

    丹羽 淳一, 祖父江 元, 田中 章景, 田中 章景, 祖父江 元

      詳細を見る

    配分額:4680000円 ( 直接経費:3600000円 、 間接経費:1080000円 )

    SOD1タンパク質は内部にジスルフィド(S-S)結合を形成しうるシステイン残基を4ヶ所(6, 57, 111, 146番アミノ酸)有しており、これらのうち57番と146番が酸化され相互にS-S結合を形成してSOD1分子を安定させている。我々は、6番と111番のシステイン残基の異常な酸化が変異SOD1特異的に脳幹・脊髄で生じてタンパク質凝集を促進し、高分子複合体を形成することで運動ニューロンに毒性を発揮して、筋萎縮性側索硬化症(ALS)を引き起こしていることを見出した。

    researchmap

  • 肝細胞増殖因子(HGF)によるポリグルタミン病の治療開発

    研究課題/領域番号:18599002  2006年 - 2007年

    日本学術振興会  科学研究費助成事業 基盤研究(C)  基盤研究(C)

    足立 弘明, 祖父江 元, 田中 章景, 船越 洋

      詳細を見る

    配分額:3560000円 ( 直接経費:3200000円 、 間接経費:360000円 )

    球脊髄性筋萎縮症(SBMA)は、成人期に発症する緩徐進行性の下位運動ニューロン疾患であり、四肢近位部の筋力低下・筋萎縮と球麻痺を主症状とする。患者は男性のみであり、女性保因者は通常無症状である。病因はアンドロゲン受容体(AR)第1エクソン内のCAGリピートの異常延長であり、異常延長したポリグルタミン鎖が病態の中心と考えられているが、根本的治療は存在しない。本研究では、CAGリピートが異常延長したヒト変異ARを発現するトランスジェニックマウスモデル(SBMA-Tg)を使用して、SBMAのモデルに対する肝細胞増殖因子(hepatocytegrowthfactor: HGF)高発現の治療効果を検討した。HGFは、初代培養肝細胞の増殖活性を指標に肝細胞増殖因子として我国において精製・クローニングされた増殖因子であるが、その後の研究発展によりHGFが多様な細胞に対して、その増殖、細胞移動、分化、生存作用、さらには器官形成・血管新生促進作用を持つことが明らかになってきている。SBMA-TgとHGF高発現マウスのダブルトランスジェニックマウスを作成し、表現型をSBMA-Tgと比較検討した。ダブルトランスジェニックマウスでは、HGFが高発現し、SBMA-Tgの運動能、生存率、体重が改善した。この改善効果は、抗アンドロゲン療法との混合治療でも認められた。HGF高発現は、SBMAの病態を改善させる可能性があると考えられた。

    researchmap

  • ポリグルタミン病の病態解明とそれに基づく治療法の開発

    研究課題/領域番号:17025020  2005年 - 2009年

    日本学術振興会  科学研究費助成事業 特定領域研究  特定領域研究

    祖父江 元, 田中 章景, 勝野 雅央, 服部 直樹, 道勇 学

      詳細を見る

    配分額:167100000円 ( 直接経費:167100000円 )

    変異アンドロゲン受容体(AR)によるTGF-βシグナルの阻害が球脊髄性筋萎縮症(SBMA)における運動ニューロン変性の病態に寄与していることが明らかとなった。また、Hsp90阻害剤をSBMAマウスに投与すると変異ARのUPSでの分解が促進することが示された。以上から、UPSの機能調節やTGF-βなどの細胞内シグナルの是正が、SBMAや他のポリグルタミン病の治療戦略として有望であると考えられた。

    researchmap

  • 低分子化合物によるポリグルタミン病治療の開発-臨床応用に向けて-

    研究課題/領域番号:17209032  2005年 - 2006年

    日本学術振興会  科学研究費助成事業 基盤研究(A)  基盤研究(A)

    祖父江 元, 道勇 学, 田中 章景

      詳細を見る

    配分額:50440000円 ( 直接経費:38800000円 、 間接経費:11640000円 )

    球脊髄性筋萎縮症(SBMA)はアンドロゲン受容体(AR)の遺伝子変異を原因とする運動ニューロン疾患である。我々は、本疾患の病態が男性ホルモンに依存しており、アンドロゲン低下療法が本疾患の治療となることを明らかにしてきた。現在、その臨床応用を推し進めている。
    加えて、他の治療戦略として、ポリグルタミン病の病態に深く関与している熱ショック蛋白質(HSP)を介した治療法について検討した。Hsp90阻害剤である17-AAG(17-allylamino geldanamycin)は、培養細胞において濃度依存性に変異ARの蛋白量を減少させ、マウスモデルの筋萎縮、歩行運動能などを有意に改善した。一方、Hsp70誘導剤であるgeranylgeranylacetone(GGA)はSBMAマウスの脊髄においてHsp70の発現量を増加させ、神経変性を改善した。
    SBMAをはじめとする神経変性疾患では、症状の進行が極めて緩徐であるため、効率的な臨床試験の実施のためには代用エンドポイントとなるべきバイオマーカーが必要である。SBMA患者の陰嚢皮膚における変異アンドロゲン受容体の核内集積の程度は脊髄における集積の程度を反映しており、かつ患者の臨床的重症度と相関していた。以上から、陰嚢皮膚における変異アンドロゲン受容体の核内集積はSBMAの病態を強く反映する優れたバイオマーカーであると考えられる。
    また、発症前のSBMAモデルマウスでは変異アンドロゲン受容体の核内集積によるdynactin1の転写障害がみられ、これが逆行性軸索輸送を阻害し、ニューロフィラメントなどの軸索タンパクの異常蓄積を起こしていることが明らかとなった。SBMAおよび他の運動ニューロン疾患の治療標的として、軸索輸送障害は重要であると考えられた。(750字)

    researchmap

  • 孤発性ALSの病態関連標的分子の探索と治療法開発

    研究課題/領域番号:17390253  2005年 - 2006年

    日本学術振興会  科学研究費助成事業 基盤研究(B)  基盤研究(B)

    田中 章景, 祖父江 元, 道勇 学, 山本 正彦

      詳細を見る

    配分額:15400000円 ( 直接経費:15400000円 )

    孤発性ALSの病態解明、治療法開発には、病態関連分子の発見を出発点としてその分子の動態を把握し、それを反映するモデルを構築することが重要なストラテジーとなりうる。本研究は、レーザーマイクロダイセクション法による脊髄運動ニューロンの単離とcDNAマイクロアレイ解析の組み合わせにより、我々が同定した運動ニューロン特異的な発現変化をきたす分子を出発点としている。これらのうちdynactin1,early growth response3,acetyl-CoA transporter, death receptor5およびcyclin Cの発現動態を残存運動ニューロン数やリン酸化ニューロフィラメントH、ユビキチン化蛋白といった運動ニューロン変性のマーカーとの関連において解析を行った。この結果、dynactin1が孤発性ALSの神経変性過程初期に発現低下を示すことを明らかにした。そこで、この発現変化を培養細胞に再現しALSの疾患モデル作成を試みた。siRNA法によりSH-SY5Y細胞においてdynactin1をノックダウン(KD)し、その影響を各種アッセイによりコントロールと比較検討した。dynactin1-KDにより細胞死が引き起こされることが明らかとなり、その経路としてオートファジーについて検討したところ、autophagosome-lysosomeの癒合障害によるautophagosome形成の促進を認めた。また、ポリユビキチン化蛋白の集積も示唆され、dynactin1 KD細胞ではオートファジーの障害によって、処理しきれないタンパクが細胞内に蓄積することで神経細胞死が生じているものと考えられた。また、ALS患者脊髄運動ニューロンでもオートファジーの障害を示唆する結果を得ており、この細胞培養モデルは孤発性ALSの重要な病態の少なくとも一部を反映したモデルであると考えられる。

    researchmap

  • 球脊髄性筋萎縮症の病態解明と治療法開発

    2005年

      詳細を見る

    資金種別:競争的資金

    researchmap

  • 遺伝性ニューロパチーの原因遺伝子探索と病態解明

    2005年

      詳細を見る

    資金種別:競争的資金

    researchmap

  • 孤発性筋萎縮性側索硬化症の病態関連分子の探索と治療法開発

    2005年

      詳細を見る

    資金種別:競争的資金

    researchmap

  • ポリグルタミン病の低分子化合物による治療法の探策-球脊髄性筋萎縮症を中心に

    研究課題/領域番号:16390250  2004年 - 2005年

    日本学術振興会  科学研究費助成事業 基盤研究(B)  基盤研究(B)

    道勇 学, 祖父江 元, 田中 章景

      詳細を見る

    配分額:14600000円 ( 直接経費:14600000円 )

    成人発症の運動ニューロン疾患について、神経細胞変性の病態を解明し、それに基づく治療法開発を行った。球脊髄性筋萎縮症(SBMA)患者の剖検組織に対して抗ポリグルタミン抗体(1C2)を用いた詳細な免疫組織化学的検索を行ったところ、本症の原因タンパクである変異アンドロゲン受容体(AR)は主として核内にびまん性に分布し、従来病理学的特徴とされてきた核内封入体よりもはるかに高頻度かつ広範囲に観察された。脊髄運動ニューロンの変異ARの核内びまん性集積はAR遺伝子のCAGリピート数と相関しており、変異タンパクの核内びまん性集積が病態形成に重要な役割を果たしていると考えられた。剖検陰嚢皮膚の1C2免疫染色では陰嚢表皮細胞への変異AR蓄積と程度と脊髄前角細胞における蓄積の程度は相関する傾向が認められた。また、生検陰嚢皮膚における変異AR蓄積の程度は運動機能スケール(Noriis score)と相関し、AR遺伝子のCAGリピート数とも相関が示された。
    また、すでにSBMAのマウスモデルにおいてLHRHアナログの治療効果が示されていることに基づき、我々は50名のSBMA患者に対するLHRHアナログのプラセボ対照比較試験を実施した。その結果、LHRHアナログ投与により陰嚢皮膚における変異AR蛋白質の核内集積が有意に抑制され、血清CKも有意に減少、嚥下機能の改善がみられた。
    筋萎縮性側索硬化症については、病態関連分子であるDorfinの結合蛋白質としてVCP/p97を同定し、DorfinのE3活性制御にVCP/p97が重要であることを明らかにした。レーザーマイクロダイセクションとcDNAマイクロアレイを用いた患者脊髄運動ニューロンの遺伝子発現解析では、病態の早期から細胞骨格、軸索輸送や転写に関与する分子および細胞表面抗原や受容体の発現低下が見られた。一方、細胞死に関する分子の遺伝子については多くが発現亢進していた。

    researchmap

  • 神経疾患・腫瘍の統合分子医学的研究

    2003年

      詳細を見る

    資金種別:競争的資金

    researchmap

  • 筋萎縮性側索硬化症(ALS)の遺伝子発現プロファイリングによる病態関連分子の同定

    研究課題/領域番号:10670582  1998年 - 1999年

    日本学術振興会  科学研究費助成事業 基盤研究(C)  基盤研究(C)

    道勇 学, 田中 章景, 祖父江 元

      詳細を見る

    配分額:2900000円 ( 直接経費:2900000円 )

    筋萎縮性側索硬化症(ALS)は運動ニューロンの系統選択的神経細胞死をきたす疾患であり、その分子機構については未だ明らかでない。これまで我々はALSの脊髄前角病変における遺伝子発現の変化を分子インデックス法を用いてプロファイリング化し、ALSにおける神経変性の分子病態を反映していると考えられる発現変化を示した遺伝子群について検討してきた。今年度は、これらの中、2つの新規遺伝子(FI39AおよびFI58G)の完全長cDNAの取得に成功し、各組織の発現分布あるいは細胞内局在などについて検討した。FI39A cDNAは全長約4.4kb、ORFより予測される838残基のアミノ酸配列のN末側にユビキチン系に関与するRing finger/IBRmotif、その前後にbipartite nuclear localization signal(NLS)を有していた。ノーザンブロット解析では各臓器にubiquitousに発現していた。ISHでは、mRNAの発現はALS脊髄前角運動ニューロンを始めとする神経細胞およびグリアに見られた。FI39AをGFP融合蛋白としてCOS7に強制発現させたところ、ERもしくはゴルジ装置と推定されるperinuclearな局在をとっていた。FI58G cDNAは全長約1.8kbで、219アミノ酸残基からなるORFを有していた。既知の蛋白にhomologyは持たないが、内部に核移行シグナル(NLS)が存在し、培養細胞内では核内に局在する蛋白であった。ノーザンブロット解析では中枢神経および心筋・骨格筋に多く発現していた。今後これらの新規遺伝子/蛋白がALSの病態形成メカニズムにいかに関与するかについて更なる検討が必要である。

    researchmap

  • 遺伝子発現プロファイリングによるパーキンソン病の病態関連遺伝子の同定

    研究課題/領域番号:10176210  1998年

    日本学術振興会  科学研究費助成事業 特定領域研究(A)  特定領域研究(A)

    祖父江 元, 若井 正一, 田中 章景, 道勇 学

      詳細を見る

    配分額:1500000円 ( 直接経費:1500000円 )

    本研究では,パーキンソン病(PD)の責任病巣である中脳黒質において変性ドーパミン作動性ニューロンおよびその関連組織がどのような遺伝子発現動態を示すかを分子インデックス法を用いて包括的に把握するとともに,PDの病態に関与する未知の病態関連遺伝子(分子)を同定することを目的とした.病理解剖により得られたPD患者および非神経疾患患者の中脳黒質組織より抽出したtotal RNAをもとにmRNAのcDNAを作成し,分子インデックス法によって合計192×3=576グループの発現遺伝子3'側プロファイルに区分した.現在までに576グループのうち1/3(192)のプロファイルを作成した.PD黒質より得られたプロファイルを各グループ毎に対照例黒質由来のプロファイルと比較検討し,発現量に明らかな差の見られたcDNA断片をクローニングし,その塩基配列を決定した.PDおよび対照間で発現に大きく変化のあったcDNA断片として27クローンを得ることができ,そのうち24クローンの配列を決定した.PD特異的に発現が変化していた既知の分子9クローン(増加3,減少6),データベース検索で既知のESTにマッチしたcDNA断片が8クローン(増加3,減少5),全く未知のcDNA断片が7クローン(増加4,減少3)であった.現在残り2/3のプロファイルの作成を急いでおり,定量PCR・ノーザン分析による正確なPDでの発現量の変化を検討中である.これらの遺伝子群の発現変化はPDの黒質における分子レベルの病態を反映していると考えられ,しかもそのいくつかはPDの病態機序を解明する上で重要な鍵となる分子である可能性がある.またこの結果は,分子インデックス法による遺伝子発現プロファイリングがPDの剖検中脳黒質における遺伝子発現変化を既知,未知を問わず高感度に描出する有用な方法であることを示している.

    researchmap

  • 遺伝性神経変性疾患の遺伝子診断

    1995年

      詳細を見る

    資金種別:競争的資金

    researchmap

▼全件表示